| 1 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRT |
8.04872057891259e-10 |
|
| 2 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIN2 |
8.72003025342849e-10 |
|
| 3 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA20 |
8.72003025342849e-10 |
|
| 4 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRNKL1 |
8.72003025342849e-10 |
|
| 5 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf26 |
8.72003025342849e-10 |
|
| 6 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL690P |
8.72003025342849e-10 |
|
| 7 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSM1 |
8.72003025342849e-10 |
|
| 8 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGAPA2 |
8.72003025342849e-10 |
|
| 9 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL607P |
8.72003025342849e-10 |
|
| 10 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00237 |
8.72003025342849e-10 |
|
| 11 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK1S1 |
8.72003025342849e-10 |
|
| 12 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP477 |
8.72003025342849e-10 |
|
| 13 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRN2 |
8.72003025342849e-10 |
|
| 14 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP140 |
8.72003025342849e-10 |
|
| 15 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX1 |
8.72003025342849e-10 |
|
| 16 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00261 |
8.72003025342849e-10 |
|
| 17 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXA2 |
8.72003025342849e-10 |
|
| 18 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSTR4 |
8.72003025342849e-10 |
|
| 19 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THBD |
8.72003025342849e-10 |
|
| 20 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD93 |
8.72003025342849e-10 |
|
| 21 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00656 |
8.72003025342849e-10 |
|
| 22 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP478 |
8.72003025342849e-10 |
|
| 23 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXT1 |
8.72003025342849e-10 |
|
| 24 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZF1 |
8.72003025342849e-10 |
|
| 25 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPB |
8.72003025342849e-10 |
|
| 26 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP479 |
8.72003025342849e-10 |
|
| 27 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST11 |
8.72003025342849e-10 |
|
| 28 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST13P |
8.72003025342849e-10 |
|
| 29 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST8 |
8.72003025342849e-10 |
|
| 30 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST9L |
8.72003025342849e-10 |
|
| 31 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTL1 |
8.72003025342849e-10 |
|
| 32 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST9 |
8.72003025342849e-10 |
|
| 33 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST3 |
8.72003025342849e-10 |
|
| 34 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST4 |
8.72003025342849e-10 |
|
| 35 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST1 |
8.72003025342849e-10 |
|
| 36 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST2 |
8.72003025342849e-10 |
|
| 37 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST5 |
8.72003025342849e-10 |
|
| 38 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGTLC1 |
8.72003025342849e-10 |
|
| 39 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNDIG1 |
8.72003025342849e-10 |
|
| 40 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST7 |
8.72003025342849e-10 |
|
| 41 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APMAP |
8.72003025342849e-10 |
|
| 42 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSS1 |
8.72003025342849e-10 |
|
| 43 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSX1 |
8.72003025342849e-10 |
|
| 44 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD6 |
8.72003025342849e-10 |
|
| 45 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYGB |
8.72003025342849e-10 |
|
| 46 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD12 |
8.72003025342849e-10 |
|
| 47 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GINS1 |
8.72003025342849e-10 |
|
| 48 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NINL |
8.72003025342849e-10 |
|
| 49 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC17P |
8.72003025342849e-10 |
|
| 50 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANP |
8.72003025342849e-10 |
|
| 51 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL594P |
8.72003025342849e-10 |
|
| 52 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF337 |
8.72003025342849e-10 |
|
| 53 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM182B |
8.72003025342849e-10 |
|
| 54 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM182A |
8.72003025342849e-10 |
|
| 55 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOR1P1 |
8.72003025342849e-10 |
|
| 56 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR663A |
8.72003025342849e-10 |
|
| 57 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRG1B |
8.72003025342849e-10 |
|
| 58 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB115 |
8.72003025342849e-10 |
|
| 59 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB116 |
8.72003025342849e-10 |
|
| 60 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP480 |
8.72003025342849e-10 |
|
| 61 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB118 |
8.72003025342849e-10 |
|
| 62 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB119 |
8.72003025342849e-10 |
|
| 63 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212134.1 |
8.72003025342849e-10 |
|
| 64 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB121 |
8.72003025342849e-10 |
|
| 65 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB122 |
8.72003025342849e-10 |
|
| 66 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB123 |
8.72003025342849e-10 |
|
| 67 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB124 |
8.72003025342849e-10 |
|
| 68 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REM1 |
8.72003025342849e-10 |
|
| 69 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00028 |
8.72003025342849e-10 |
|
| 70 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HM13 |
8.72003025342849e-10 |
|
| 71 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ID1 |
8.72003025342849e-10 |
|
| 72 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3193 |
8.72003025342849e-10 |
|
| 73 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX4I2 |
8.72003025342849e-10 |
|
| 74 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L1 |
8.72003025342849e-10 |
|
| 75 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPX2 |
8.72003025342849e-10 |
|
| 76 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLK2 |
8.72003025342849e-10 |
|
| 77 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXS1 |
8.72003025342849e-10 |
|
| 78 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP15 |
8.72003025342849e-10 |
|
| 79 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL9 |
8.72003025342849e-10 |
|
| 80 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDRG1 |
8.72003025342849e-10 |
|
| 81 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR7 |
8.72003025342849e-10 |
|
| 82 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP481 |
8.72003025342849e-10 |
|
| 83 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCM2L |
8.72003025342849e-10 |
|
| 84 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCK |
8.72003025342849e-10 |
|
| 85 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP482 |
8.72003025342849e-10 |
|
| 86 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM9SF4 |
8.72003025342849e-10 |
|
| 87 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPY26P |
8.72003025342849e-10 |
|
| 88 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAGL2 |
8.72003025342849e-10 |
|
| 89 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POFUT1 |
8.72003025342849e-10 |
|
| 90 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1825 |
8.72003025342849e-10 |
|
| 91 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF3B |
8.72003025342849e-10 |
|
| 92 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASXL1 |
8.72003025342849e-10 |
|
| 93 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf112 |
8.72003025342849e-10 |
|
| 94 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf203 |
8.72003025342849e-10 |
|
| 95 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD7 |
8.72003025342849e-10 |
|
| 96 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNMT3B |
8.72003025342849e-10 |
|
| 97 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPRE1 |
8.72003025342849e-10 |
|
| 98 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB8 |
8.72003025342849e-10 |
|
| 99 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUN5 |
8.72003025342849e-10 |
|
| 100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFB2 |
8.72003025342849e-10 |
|
| 101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFB6 |
8.72003025342849e-10 |
|
| 102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFB3 |
8.72003025342849e-10 |
|
| 103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFB4 |
8.72003025342849e-10 |
|
| 104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFA2 |
8.72003025342849e-10 |
|
| 105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFA4P |
8.72003025342849e-10 |
|
| 106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFA3 |
8.72003025342849e-10 |
|
| 107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFA1 |
8.72003025342849e-10 |
|
| 108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFB1 |
8.72003025342849e-10 |
|
| 109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5RAP1 |
8.72003025342849e-10 |
|
| 110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTA1 |
8.72003025342849e-10 |
|
| 111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL511P |
8.72003025342849e-10 |
|
| 112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBFA2T2 |
8.72003025342849e-10 |
|
| 113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NECAB3 |
8.72003025342849e-10 |
|
| 114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf144 |
8.72003025342849e-10 |
|
| 115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL10 |
8.72003025342849e-10 |
|
| 116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F1 |
8.72003025342849e-10 |
|
| 117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXMP4 |
8.72003025342849e-10 |
|
| 118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF341 |
8.72003025342849e-10 |
|
| 119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP4B |
8.72003025342849e-10 |
|
| 120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALY |
8.72003025342849e-10 |
|
| 121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4755 |
8.72003025342849e-10 |
|
| 122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2S2 |
8.72003025342849e-10 |
|
| 123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIP |
8.72003025342849e-10 |
|
| 124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHCY |
8.72003025342849e-10 |
|
| 125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITCH |
8.72003025342849e-10 |
|
| 126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR644A |
8.72003025342849e-10 |
|
| 127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLRB1 |
8.72003025342849e-10 |
|
| 128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1LC3A |
8.72003025342849e-10 |
|
| 129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGU |
8.72003025342849e-10 |
|
| 130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA6 |
8.72003025342849e-10 |
|
| 131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53INP2 |
8.72003025342849e-10 |
|
| 132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT7 |
8.72003025342849e-10 |
|
| 133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSS2 |
8.72003025342849e-10 |
|
| 134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSS |
8.72003025342849e-10 |
|
| 135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH7B |
8.72003025342849e-10 |
|
| 136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR499A |
8.72003025342849e-10 |
|
| 137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC4AP |
8.72003025342849e-10 |
|
| 138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDEM2 |
8.72003025342849e-10 |
|
| 139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000201151.1 |
8.72003025342849e-10 |
|
| 140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROCR |
8.72003025342849e-10 |
|
| 141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP483 |
8.72003025342849e-10 |
|
| 142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP24 |
8.72003025342849e-10 |
|
| 143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF6 |
8.72003025342849e-10 |
|
| 144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83C |
8.72003025342849e-10 |
|
| 145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCC |
8.72003025342849e-10 |
|
| 146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF5OS |
8.72003025342849e-10 |
|
| 147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF5 |
8.72003025342849e-10 |
|
| 148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP250 |
8.72003025342849e-10 |
|
| 149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf173 |
8.72003025342849e-10 |
|
| 150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERGIC3 |
8.72003025342849e-10 |
|
| 151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FER1L4 |
8.72003025342849e-10 |
|
| 152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG4 |
8.72003025342849e-10 |
|
| 153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE1 |
8.72003025342849e-10 |
|
| 154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFS1 |
8.72003025342849e-10 |
|
| 155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP271 |
8.72003025342849e-10 |
|
| 156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM12 |
8.72003025342849e-10 |
|
| 157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM39 |
8.72003025342849e-10 |
|
| 158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROMO1 |
8.72003025342849e-10 |
|
| 159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238549.1 |
8.72003025342849e-10 |
|
| 160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF20 |
8.72003025342849e-10 |
|
| 161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAND1 |
8.72003025342849e-10 |
|
| 162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNBD2 |
8.72003025342849e-10 |
|
| 163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00657 |
8.72003025342849e-10 |
|
| 164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L1 |
8.72003025342849e-10 |
|
| 165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239089.1 |
8.72003025342849e-10 |
|
| 166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAR2 |
8.72003025342849e-10 |
|
| 167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLGAP4 |
8.72003025342849e-10 |
|
| 168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL9 |
8.72003025342849e-10 |
|
| 169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGIF2 |
8.72003025342849e-10 |
|
| 170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf24 |
8.72003025342849e-10 |
|
| 171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLA2 |
8.72003025342849e-10 |
|
| 172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDRG3 |
8.72003025342849e-10 |
|
| 173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSN1 |
8.72003025342849e-10 |
|
| 174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOGA1 |
8.72003025342849e-10 |
|
| 175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL156P |
8.72003025342849e-10 |
|
| 176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLDC2 |
8.72003025342849e-10 |
|
| 177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMHD1 |
8.72003025342849e-10 |
|
| 178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBL1 |
8.72003025342849e-10 |
|
| 179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH8 |
8.72003025342849e-10 |
|
| 180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPN2 |
8.72003025342849e-10 |
|
| 181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHRH |
8.72003025342849e-10 |
|
| 182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANBAL |
8.72003025342849e-10 |
|
| 183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRC |
8.72003025342849e-10 |
|
| 184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLCAP |
8.72003025342849e-10 |
|
| 185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NNAT |
8.72003025342849e-10 |
|
| 186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00489 |
8.72003025342849e-10 |
|
| 187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNBL1 |
8.72003025342849e-10 |
|
| 188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM2L |
8.72003025342849e-10 |
|
| 189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP185 |
8.72003025342849e-10 |
|
| 190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTI1 |
8.72003025342849e-10 |
|
| 191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPRD1B |
8.72003025342849e-10 |
|
| 192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL237P |
8.72003025342849e-10 |
|
| 193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM2 |
8.72003025342849e-10 |
|
| 194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1755 |
8.72003025342849e-10 |
|
| 195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPI |
8.72003025342849e-10 |
|
| 196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LBP |
8.72003025342849e-10 |
|
| 197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG17 |
8.72003025342849e-10 |
|
| 198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71B |
8.72003025342849e-10 |
|
| 199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71A |
8.72003025342849e-10 |
|
| 200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71C |
8.72003025342849e-10 |
|
| 201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71D |
8.72003025342849e-10 |
|
| 202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71|ENSG00000201811.1 |
8.72003025342849e-10 |
|
| 203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG11 |
8.72003025342849e-10 |
|
| 204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA60 |
8.72003025342849e-10 |
|
| 205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGAPB |
8.72003025342849e-10 |
|
| 206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548O2 |
8.72003025342849e-10 |
|
| 207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADIG |
8.72003025342849e-10 |
|
| 208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP40 |
8.72003025342849e-10 |
|
| 209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC32A1 |
8.72003025342849e-10 |
|
| 210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR5 |
8.72003025342849e-10 |
|
| 211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP173 |
8.72003025342849e-10 |
|
| 212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R16B |
8.72003025342849e-10 |
|
| 213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL116P |
8.72003025342849e-10 |
|
| 214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83D |
8.72003025342849e-10 |
|
| 215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX35 |
8.72003025342849e-10 |
|
| 216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL680P |
8.72003025342849e-10 |
|
| 217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL194P |
8.72003025342849e-10 |
|
| 218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252434.1 |
8.72003025342849e-10 |
|
| 219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAFB |
8.72003025342849e-10 |
|
| 220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP484 |
8.72003025342849e-10 |
|
| 221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP1 |
8.72003025342849e-10 |
|
| 222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCG1 |
8.72003025342849e-10 |
|
| 223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZHX3 |
8.72003025342849e-10 |
|
| 224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL615P |
8.72003025342849e-10 |
|
| 225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPIN3 |
8.72003025342849e-10 |
|
| 226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMILIN3 |
8.72003025342849e-10 |
|
| 227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD6 |
8.72003025342849e-10 |
|
| 228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212224.1 |
8.72003025342849e-10 |
|
| 229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP100 |
8.72003025342849e-10 |
|
| 230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL666P |
8.72003025342849e-10 |
|
| 231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA15|ENSG00000252193.1 |
8.72003025342849e-10 |
|
| 232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF6 |
8.72003025342849e-10 |
|
| 233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L3MBTL1 |
8.72003025342849e-10 |
|
| 234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK2 |
8.72003025342849e-10 |
|
| 235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT52 |
8.72003025342849e-10 |
|
| 236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBL2 |
8.72003025342849e-10 |
|
| 237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTSF1L |
8.72003025342849e-10 |
|
| 238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOX2 |
8.72003025342849e-10 |
|
| 239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL443P |
8.72003025342849e-10 |
|
| 240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JPH2 |
8.72003025342849e-10 |
|
| 241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSER1 |
8.72003025342849e-10 |
|
| 242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDAP1L1 |
8.72003025342849e-10 |
|
| 243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FITM2 |
8.72003025342849e-10 |
|
| 244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HDML |
8.72003025342849e-10 |
|
| 245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNF4A |
8.72003025342849e-10 |
|
| 246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3646 |
8.72003025342849e-10 |
|
| 247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf62 |
8.72003025342849e-10 |
|
| 248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTPAL |
8.72003025342849e-10 |
|
| 249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERINC3 |
8.72003025342849e-10 |
|
| 250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKIG |
8.72003025342849e-10 |
|
| 251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADA |
8.72003025342849e-10 |
|
| 252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WISP2 |
8.72003025342849e-10 |
|
| 253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK15 |
8.72003025342849e-10 |
|
| 254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMS4 |
8.72003025342849e-10 |
|
| 255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL31P |
8.72003025342849e-10 |
|
| 256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAB |
8.72003025342849e-10 |
|
| 257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC1L |
8.72003025342849e-10 |
|
| 258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM34 |
8.72003025342849e-10 |
|
| 259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK4 |
8.72003025342849e-10 |
|
| 260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNS1 |
8.72003025342849e-10 |
|
| 261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC5 |
8.72003025342849e-10 |
|
| 262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC12 |
8.72003025342849e-10 |
|
| 263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI3 |
8.72003025342849e-10 |
|
| 264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMG1 |
8.72003025342849e-10 |
|
| 265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMG2 |
8.72003025342849e-10 |
|
| 266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLPI |
8.72003025342849e-10 |
|
| 267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATN4 |
8.72003025342849e-10 |
|
| 268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBPJL |
8.72003025342849e-10 |
|
| 269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDC4 |
8.72003025342849e-10 |
|
| 270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYS1 |
8.72003025342849e-10 |
|
| 271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG5 |
8.72003025342849e-10 |
|
| 272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBNDD2 |
8.72003025342849e-10 |
|
| 273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGT |
8.72003025342849e-10 |
|
| 274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC2 |
8.72003025342849e-10 |
|
| 275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINT3 |
8.72003025342849e-10 |
|
| 276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC6 |
8.72003025342849e-10 |
|
| 277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPPIN |
8.72003025342849e-10 |
|
| 278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC8 |
8.72003025342849e-10 |
|
| 279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP485 |
8.72003025342849e-10 |
|
| 280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC9 |
8.72003025342849e-10 |
|
| 281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC10A |
8.72003025342849e-10 |
|
| 282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC11 |
8.72003025342849e-10 |
|
| 283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC10B |
8.72003025342849e-10 |
|
| 284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC13 |
8.72003025342849e-10 |
|
| 285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3617 |
8.72003025342849e-10 |
|
| 286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINT4 |
8.72003025342849e-10 |
|
| 287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC3 |
8.72003025342849e-10 |
|
| 288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC38P |
8.72003025342849e-10 |
|
| 289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNTTIP1 |
8.72003025342849e-10 |
|
| 290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2C |
8.72003025342849e-10 |
|
| 291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNC2 |
8.72003025342849e-10 |
|
| 292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX21 |
8.72003025342849e-10 |
|
| 293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT8 |
8.72003025342849e-10 |
|
| 294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM3 |
8.72003025342849e-10 |
|
| 295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM1 |
8.72003025342849e-10 |
|
| 296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEURL2 |
8.72003025342849e-10 |
|
| 297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA25 |
8.72003025342849e-10 |
|
| 298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSA |
8.72003025342849e-10 |
|
| 299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLTP |
8.72003025342849e-10 |
|
| 300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCIF1 |
8.72003025342849e-10 |
|
| 301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF335 |
8.72003025342849e-10 |
|
| 302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP9 |
8.72003025342849e-10 |
|
| 303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A5 |
8.72003025342849e-10 |
|
| 304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA5 |
8.72003025342849e-10 |
|
| 305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD40 |
8.72003025342849e-10 |
|
| 306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH22 |
8.72003025342849e-10 |
|
| 307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35C2 |
8.72003025342849e-10 |
|
| 308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMO2 |
8.72003025342849e-10 |
|
| 309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF334 |
8.72003025342849e-10 |
|
| 310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCSTAMP |
8.72003025342849e-10 |
|
| 311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC13A3 |
8.72003025342849e-10 |
|
| 312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53RK |
8.72003025342849e-10 |
|
| 313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A10 |
8.72003025342849e-10 |
|
| 314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP33 |
8.72003025342849e-10 |
|
| 315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EYA2 |
8.72003025342849e-10 |
|
| 316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3616 |
8.72003025342849e-10 |
|
| 317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND8 |
8.72003025342849e-10 |
|
| 318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL243P |
8.72003025342849e-10 |
|
| 319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA3 |
8.72003025342849e-10 |
|
| 320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULF2 |
8.72003025342849e-10 |
|
| 321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PREX1 |
8.72003025342849e-10 |
|
| 322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFGEF2 |
8.72003025342849e-10 |
|
| 323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSE1L |
8.72003025342849e-10 |
|
| 324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAU1 |
8.72003025342849e-10 |
|
| 325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX27 |
8.72003025342849e-10 |
|
| 326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNFX1 |
8.72003025342849e-10 |
|
| 327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD12B |
8.72003025342849e-10 |
|
| 328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD12C |
8.72003025342849e-10 |
|
| 329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD12 |
8.72003025342849e-10 |
|
| 330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAS1 |
8.72003025342849e-10 |
|
| 331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNB1 |
8.72003025342849e-10 |
|
| 332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGIS |
8.72003025342849e-10 |
|
| 333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT5 |
8.72003025342849e-10 |
|
| 334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL197P |
8.72003025342849e-10 |
|
| 335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A8 |
8.72003025342849e-10 |
|
| 336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA2 |
8.72003025342849e-10 |
|
| 337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF114 |
8.72003025342849e-10 |
|
| 338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239157.1 |
8.72003025342849e-10 |
|
| 339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAI1 |
8.72003025342849e-10 |
|
| 340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00651 |
8.72003025342849e-10 |
|
| 341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM189 |
8.72003025342849e-10 |
|
| 342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2V1 |
8.72003025342849e-10 |
|
| 343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPB |
8.72003025342849e-10 |
|
| 344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL636P |
8.72003025342849e-10 |
|
| 345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN1 |
8.72003025342849e-10 |
|
| 346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL672P |
8.72003025342849e-10 |
|
| 347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM65C |
8.72003025342849e-10 |
|
| 348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR645 |
8.72003025342849e-10 |
|
| 349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARD6B |
8.72003025342849e-10 |
|
| 350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAS4 |
8.72003025342849e-10 |
|
| 351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADNP |
8.72003025342849e-10 |
|
| 352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPM1 |
8.72003025342849e-10 |
|
| 353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOCS3 |
8.72003025342849e-10 |
|
| 354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNG1 |
8.72003025342849e-10 |
|
| 355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFATC2 |
8.72003025342849e-10 |
|
| 356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3194 |
8.72003025342849e-10 |
|
| 357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP9A |
8.72003025342849e-10 |
|
| 358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SALL4 |
8.72003025342849e-10 |
|
| 359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL603P |
8.72003025342849e-10 |
|
| 360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP64 |
8.72003025342849e-10 |
|
| 361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSHZ2 |
8.72003025342849e-10 |
|
| 362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP184 |
8.72003025342849e-10 |
|
| 363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF217 |
8.72003025342849e-10 |
|
| 364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAS1 |
8.72003025342849e-10 |
|
| 365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4756 |
8.72003025342849e-10 |
|
| 366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP24A1 |
8.72003025342849e-10 |
|
| 367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFDN4 |
8.72003025342849e-10 |
|
| 368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK5 |
8.72003025342849e-10 |
|
| 369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC7P |
8.72003025342849e-10 |
|
| 370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLN4 |
8.72003025342849e-10 |
|
| 371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP487 |
8.72003025342849e-10 |
|
| 372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MC3R |
8.72003025342849e-10 |
|
| 373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM210B |
8.72003025342849e-10 |
|
| 374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AURKA |
8.72003025342849e-10 |
|
| 375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTF1 |
8.72003025342849e-10 |
|
| 376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASS4 |
8.72003025342849e-10 |
|
| 377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTFDC1 |
8.72003025342849e-10 |
|
| 378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238294.1 |
8.72003025342849e-10 |
|
| 379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT7 |
8.72003025342849e-10 |
|
| 380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM209A |
8.72003025342849e-10 |
|
| 381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM209B |
8.72003025342849e-10 |
|
| 382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252536.1 |
8.72003025342849e-10 |
|
| 383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP2C |
8.72003025342849e-10 |
|
| 384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL170P |
8.72003025342849e-10 |
|
| 385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP7 |
8.72003025342849e-10 |
|
| 386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4325 |
8.72003025342849e-10 |
|
| 387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPO11 |
8.72003025342849e-10 |
|
| 388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAE1 |
8.72003025342849e-10 |
|
| 389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L3 |
8.72003025342849e-10 |
|
| 390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM38 |
8.72003025342849e-10 |
|
| 391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTCFL |
8.72003025342849e-10 |
|
| 392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCK1 |
8.72003025342849e-10 |
|
| 393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBP1 |
8.72003025342849e-10 |
|
| 394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMEPA1 |
8.72003025342849e-10 |
|
| 395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4532 |
8.72003025342849e-10 |
|
| 396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf85 |
8.72003025342849e-10 |
|
| 397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD60 |
8.72003025342849e-10 |
|
| 398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP4R1L |
8.72003025342849e-10 |
|
| 399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB22A |
8.72003025342849e-10 |
|
| 400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAPB |
8.72003025342849e-10 |
|
| 401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APCDD1L |
8.72003025342849e-10 |
|
| 402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGC4294 |
8.72003025342849e-10 |
|
| 403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX16 |
8.72003025342849e-10 |
|
| 404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPEPL1 |
8.72003025342849e-10 |
|
| 405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR296 |
8.72003025342849e-10 |
|
| 406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR298 |
8.72003025342849e-10 |
|
| 407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAS |
8.72003025342849e-10 |
|
| 408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELFCD |
8.72003025342849e-10 |
|
| 409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSZ |
8.72003025342849e-10 |
|
| 410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB1 |
8.72003025342849e-10 |
|
| 411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5E |
8.72003025342849e-10 |
|
| 412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLMO2 |
8.72003025342849e-10 |
|
| 413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF831 |
8.72003025342849e-10 |
|
| 414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDN3 |
8.72003025342849e-10 |
|
| 415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHACTR3 |
8.72003025342849e-10 |
|
| 416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCP2 |
8.72003025342849e-10 |
|
| 417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM217B |
8.72003025342849e-10 |
|
| 418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3D |
8.72003025342849e-10 |
|
| 419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH26 |
8.72003025342849e-10 |
|
| 420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf197 |
8.72003025342849e-10 |
|
| 421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR646 |
8.72003025342849e-10 |
|
| 422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4533 |
8.72003025342849e-10 |
|
| 423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AG2 |
8.72003025342849e-10 |
|
| 424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH4 |
8.72003025342849e-10 |
|
| 425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1257 |
8.72003025342849e-10 |
|
| 426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF4 |
8.72003025342849e-10 |
|
| 427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM14B |
8.72003025342849e-10 |
|
| 428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA7 |
8.72003025342849e-10 |
|
| 429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SS18L1 |
8.72003025342849e-10 |
|
| 430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTG2 |
8.72003025342849e-10 |
|
| 431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRH3 |
8.72003025342849e-10 |
|
| 432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL2 |
8.72003025342849e-10 |
|
| 433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRM1 |
8.72003025342849e-10 |
|
| 434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMA5 |
8.72003025342849e-10 |
|
| 435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4758 |
8.72003025342849e-10 |
|
| 436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS21 |
8.72003025342849e-10 |
|
| 437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABLES2 |
8.72003025342849e-10 |
|
| 438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP8NL |
8.72003025342849e-10 |
|
| 439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA5 |
8.72003025342849e-10 |
|
| 440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf166 |
8.72003025342849e-10 |
|
| 441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR133A2 |
8.72003025342849e-10 |
|
| 442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO4A1 |
8.72003025342849e-10 |
|
| 443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00686 |
8.72003025342849e-10 |
|
| 444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTSR1 |
8.72003025342849e-10 |
|
| 445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00659 |
8.72003025342849e-10 |
|
| 446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGBP |
8.72003025342849e-10 |
|
| 447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGFR |
8.72003025342849e-10 |
|
| 448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL9A3 |
8.72003025342849e-10 |
|
| 449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCFL5 |
8.72003025342849e-10 |
|
| 450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIDO1 |
8.72003025342849e-10 |
|
| 451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GID8 |
8.72003025342849e-10 |
|
| 452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A9 |
8.72003025342849e-10 |
|
| 453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHE23 |
8.72003025342849e-10 |
|
| 454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00029 |
8.72003025342849e-10 |
|
| 455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAR1A |
8.72003025342849e-10 |
|
| 456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAR1B |
8.72003025342849e-10 |
|
| 457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YTHDF1 |
8.72003025342849e-10 |
|
| 458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC7 |
8.72003025342849e-10 |
|
| 459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3196 |
8.72003025342849e-10 |
|
| 460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAIN4 |
8.72003025342849e-10 |
|
| 461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFGAP1 |
8.72003025342849e-10 |
|
| 462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4326 |
8.72003025342849e-10 |
|
| 463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL20A1 |
8.72003025342849e-10 |
|
| 464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA4 |
8.72003025342849e-10 |
|
| 465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ2 |
8.72003025342849e-10 |
|
| 466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1A2 |
8.72003025342849e-10 |
|
| 467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPDPF |
8.72003025342849e-10 |
|
| 468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf195 |
8.72003025342849e-10 |
|
| 469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTK6 |
8.72003025342849e-10 |
|
| 470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRMS |
8.72003025342849e-10 |
|
| 471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELZ2 |
8.72003025342849e-10 |
|
| 472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMEB2 |
8.72003025342849e-10 |
|
| 473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD16B |
8.72003025342849e-10 |
|
| 474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFRP1 |
8.72003025342849e-10 |
|
| 475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20ORF135 |
8.72003025342849e-10 |
|
| 476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf201 |
8.72003025342849e-10 |
|
| 477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC5 |
8.72003025342849e-10 |
|
| 478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIME1 |
8.72003025342849e-10 |
|
| 479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00176 |
8.72003025342849e-10 |
|
| 480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1914 |
8.72003025342849e-10 |
|
| 481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR647 |
8.72003025342849e-10 |
|
| 482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYT1 |
8.72003025342849e-10 |
|
| 483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPBWR2 |
8.72003025342849e-10 |
|
| 484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPRL1 |
8.72003025342849e-10 |
|
| 485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCMTD2 |
8.72003025342849e-10 |
|
| 486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF6 |
8.72003025342849e-10 |
|
| 487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS19 |
8.72003025342849e-10 |
|
| 488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTEL1 |
8.72003025342849e-10 |
|
| 489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD10 |
8.72003025342849e-10 |
|
| 490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A4RG |
8.72003025342849e-10 |
|
| 491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX18 |
8.72003025342849e-10 |
|
| 492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMN3 |
8.72003025342849e-10 |
|
| 493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEA2 |
8.72003025342849e-10 |
|
| 494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF6B |
8.72003025342849e-10 |
|
| 495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPD52L2 |
8.72003025342849e-10 |
|
| 496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCKL1 |
8.72003025342849e-10 |
|
| 497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB46 |
8.72003025342849e-10 |
|
| 498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZGPAT |
8.72003025342849e-10 |
|
| 499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF512B |
8.72003025342849e-10 |
|
| 500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTFR |
1.12609521707441e-09 |
|
| 501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP25L |
1.12609521707441e-09 |
|
| 502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN3 |
1.12609521707441e-09 |
|
| 503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID3C |
1.12609521707441e-09 |
|
| 504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALT |
1.12609521707441e-09 |
|
| 505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGMAR1 |
1.12609521707441e-09 |
|
| 506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL11RA |
1.12609521707441e-09 |
|
| 507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR6 |
5.74358238747408e-09 |
|
| 508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX19 |
2.04528507463664e-08 |
|
| 509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL167P |
2.04528507463664e-08 |
|
| 510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA7 |
3.07104857100171e-08 |
|
| 511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSC5D |
3.07104857100171e-08 |
|
| 512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBK2 |
3.07104857100171e-08 |
|
| 513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK110 |
3.07104857100171e-08 |
|
| 514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCAR |
3.07692690215688e-08 |
|
| 515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR2DL1 |
3.07692690215688e-08 |
|
| 516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR2DL3 |
3.07692690215688e-08 |
|
| 517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR2DL4 |
3.07692690215688e-08 |
|
| 518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR2DS4 |
3.07692690215688e-08 |
|
| 519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR3DL1 |
3.07692690215688e-08 |
|
| 520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR3DL2 |
3.07692690215688e-08 |
|
| 521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR3DL3 |
3.07692690215688e-08 |
|
| 522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCR1 |
3.07692690215688e-08 |
|
| 523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP6 |
3.07692690215688e-08 |
|
| 524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH13 |
3.07692690215688e-08 |
|
| 525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS8L1 |
3.07692690215688e-08 |
|
| 526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNT1 |
3.07692690215688e-08 |
|
| 527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAAF3 |
3.07692690215688e-08 |
|
| 528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNI3 |
3.07692690215688e-08 |
|
| 529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF581 |
3.07692690215688e-08 |
|
| 530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC106 |
3.07692690215688e-08 |
|
| 531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U2AF2 |
3.07692690215688e-08 |
|
| 532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPN1 |
3.07692690215688e-08 |
|
| 533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP9 |
3.07692690215688e-08 |
|
| 534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP109 |
3.07692690215688e-08 |
|
| 535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL4AL1 |
3.07692690215688e-08 |
|
| 536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL4A |
3.07692690215688e-08 |
|
| 537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP11 |
3.07692690215688e-08 |
|
| 538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP4 |
3.07692690215688e-08 |
|
| 539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP13 |
3.07692690215688e-08 |
|
| 540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP5 |
3.07692690215688e-08 |
|
| 541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP8 |
3.07692690215688e-08 |
|
| 542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF787 |
3.07692690215688e-08 |
|
| 543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF444 |
3.07692690215688e-08 |
|
| 544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF583 |
3.07692690215688e-08 |
|
| 545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF667 |
3.07692690215688e-08 |
|
| 546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF471 |
3.07692690215688e-08 |
|
| 547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP28 |
3.07692690215688e-08 |
|
| 548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF470 |
3.07692690215688e-08 |
|
| 549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF835 |
3.07692690215688e-08 |
|
| 550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIM2 |
3.07692690215688e-08 |
|
| 551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEG3 |
3.07692690215688e-08 |
|
| 552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIMT1 |
3.07692690215688e-08 |
|
| 553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP29 |
3.07692690215688e-08 |
|
| 554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUXA |
3.07692690215688e-08 |
|
| 555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252683.1 |
3.07692690215688e-08 |
|
| 556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIM3 |
3.07692690215688e-08 |
|
| 557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF264 |
3.07692690215688e-08 |
|
| 558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AURKC |
3.07692690215688e-08 |
|
| 559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF805 |
3.07692690215688e-08 |
|
| 560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF135 |
3.07692690215688e-08 |
|
| 561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN18 |
3.07692690215688e-08 |
|
| 562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF329 |
3.07692690215688e-08 |
|
| 563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF331 |
5.33853105055826e-08 |
|
| 564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPRX |
5.33853105055826e-08 |
|
| 565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1323 |
5.33853105055826e-08 |
|
| 566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR371A |
5.33853105055826e-08 |
|
| 567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR371B |
5.33853105055826e-08 |
|
| 568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR372 |
5.33853105055826e-08 |
|
| 569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR373 |
5.33853105055826e-08 |
|
| 570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR498 |
5.33853105055826e-08 |
|
| 571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR516A1 |
5.33853105055826e-08 |
|
| 572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR516A2 |
5.33853105055826e-08 |
|
| 573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR516B1 |
5.33853105055826e-08 |
|
| 574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR516B2 |
5.33853105055826e-08 |
|
| 575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR517A |
5.33853105055826e-08 |
|
| 576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR517B |
5.33853105055826e-08 |
|
| 577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR517C |
5.33853105055826e-08 |
|
| 578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518A1 |
5.33853105055826e-08 |
|
| 579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518A2 |
5.33853105055826e-08 |
|
| 580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518B |
5.33853105055826e-08 |
|
| 581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518C |
5.33853105055826e-08 |
|
| 582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518D |
5.33853105055826e-08 |
|
| 583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518E |
5.33853105055826e-08 |
|
| 584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR518F |
5.33853105055826e-08 |
|
| 585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519A1 |
5.33853105055826e-08 |
|
| 586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519A2 |
5.33853105055826e-08 |
|
| 587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519B |
5.33853105055826e-08 |
|
| 588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519C |
5.33853105055826e-08 |
|
| 589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519D |
5.33853105055826e-08 |
|
| 590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR519E |
5.33853105055826e-08 |
|
| 591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520A |
5.33853105055826e-08 |
|
| 592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520B |
5.33853105055826e-08 |
|
| 593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520C |
5.33853105055826e-08 |
|
| 594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520D |
5.33853105055826e-08 |
|
| 595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520E |
5.33853105055826e-08 |
|
| 596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520F |
5.33853105055826e-08 |
|
| 597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520G |
5.33853105055826e-08 |
|
| 598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR520H |
5.33853105055826e-08 |
|
| 599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR522 |
5.33853105055826e-08 |
|
| 600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR523 |
5.33853105055826e-08 |
|
| 601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR524 |
5.33853105055826e-08 |
|
| 602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR525 |
5.33853105055826e-08 |
|
| 603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR526A1 |
5.33853105055826e-08 |
|
| 604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR526A2 |
5.33853105055826e-08 |
|
| 605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR526B |
5.33853105055826e-08 |
|
| 606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR527 |
5.33853105055826e-08 |
|
| 607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP12 |
5.33853105055826e-08 |
|
| 608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL317P |
5.33853105055826e-08 |
|
| 609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYADM |
5.33853105055826e-08 |
|
| 610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCG |
5.33853105055826e-08 |
|
| 611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG7 |
5.33853105055826e-08 |
|
| 612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG8 |
5.33853105055826e-08 |
|
| 613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG6 |
5.33853105055826e-08 |
|
| 614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR935 |
5.33853105055826e-08 |
|
| 615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM1 |
9.60280966966209e-08 |
|
| 616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARM1 |
9.60280966966209e-08 |
|
| 617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT3 |
9.60280966966209e-08 |
|
| 618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LENG1 |
9.60280966966209e-08 |
|
| 619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC4 |
9.60280966966209e-08 |
|
| 620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBOAT7 |
9.60280966966209e-08 |
|
| 621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSEN34 |
9.60280966966209e-08 |
|
| 622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS9 |
9.60280966966209e-08 |
|
| 623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA3 |
9.60280966966209e-08 |
|
| 624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA4 |
9.60280966966209e-08 |
|
| 625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA5 |
9.60280966966209e-08 |
|
| 626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA6 |
9.60280966966209e-08 |
|
| 627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRB2 |
9.60280966966209e-08 |
|
| 628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRB3 |
9.60280966966209e-08 |
|
| 629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRB5 |
9.60280966966209e-08 |
|
| 630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4752 |
9.60280966966209e-08 |
|
| 631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAIR1 |
9.60280966966209e-08 |
|
| 632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAIR2 |
9.60280966966209e-08 |
|
| 633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA2 |
9.60280966966209e-08 |
|
| 634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRA1 |
9.60280966966209e-08 |
|
| 635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf96 |
1.85144201414467e-07 |
|
| 636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB125 |
1.85144201414467e-07 |
|
| 637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB126 |
1.85144201414467e-07 |
|
| 638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB127 |
1.85144201414467e-07 |
|
| 639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB128 |
1.85144201414467e-07 |
|
| 640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB129 |
1.85144201414467e-07 |
|
| 641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB132 |
1.85144201414467e-07 |
|
| 642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRSN2 |
1.85144201414467e-07 |
|
| 643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBCK1 |
1.85144201414467e-07 |
|
| 644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX12 |
1.85144201414467e-07 |
|
| 645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D20 |
1.85144201414467e-07 |
|
| 646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIB3 |
1.85144201414467e-07 |
|
| 647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC3 |
1.85144201414467e-07 |
|
| 648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK2A1 |
1.85144201414467e-07 |
|
| 649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF15 |
1.85144201414467e-07 |
|
| 650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRXN1 |
1.85144201414467e-07 |
|
| 651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRT2 |
1.85144201414467e-07 |
|
| 652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC52A3 |
1.85144201414467e-07 |
|
| 653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM110A |
1.85144201414467e-07 |
|
| 654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPT4 |
1.85144201414467e-07 |
|
| 655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPO4 |
1.85144201414467e-07 |
|
| 656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf202 |
1.85144201414467e-07 |
|
| 657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMF1 |
1.85144201414467e-07 |
|
| 658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM74B |
1.85144201414467e-07 |
|
| 659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD21L1 |
1.85144201414467e-07 |
|
| 660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNPH |
1.85144201414467e-07 |
|
| 661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDCBP2 |
1.85144201414467e-07 |
|
| 662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP1A |
1.85144201414467e-07 |
|
| 663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSFL1C |
1.85144201414467e-07 |
|
| 664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRPB2 |
1.85144201414467e-07 |
|
| 665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRPD |
1.85144201414467e-07 |
|
| 666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRPB1 |
1.85144201414467e-07 |
|
| 667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRPG |
1.85144201414467e-07 |
|
| 668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL561P |
1.85144201414467e-07 |
|
| 669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRPA |
1.85144201414467e-07 |
|
| 670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDYN |
1.85144201414467e-07 |
|
| 671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK35 |
1.85144201414467e-07 |
|
| 672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM3 |
1.85144201414467e-07 |
|
| 673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM6 |
1.85144201414467e-07 |
|
| 674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPB |
1.85144201414467e-07 |
|
| 675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD119 |
1.85144201414467e-07 |
|
| 676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF343 |
1.85144201414467e-07 |
|
| 677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC2 |
1.85144201414467e-07 |
|
| 678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1292 |
1.85144201414467e-07 |
|
| 679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP56 |
1.85144201414467e-07 |
|
| 680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000271798.1 |
1.85144201414467e-07 |
|
| 681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD110 |
1.85144201414467e-07 |
|
| 682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD86 |
1.85144201414467e-07 |
|
| 683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000229686.1 |
1.85144201414467e-07 |
|
| 684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD57 |
1.85144201414467e-07 |
|
| 685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDH3B |
1.85144201414467e-07 |
|
| 686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBF4 |
1.85144201414467e-07 |
|
| 687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPXM1 |
1.85144201414467e-07 |
|
| 688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf141 |
1.85144201414467e-07 |
|
| 689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM239 |
1.85144201414467e-07 |
|
| 690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCED1A |
1.85144201414467e-07 |
|
| 691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS16 |
1.85144201414467e-07 |
|
| 692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRA |
1.85144201414467e-07 |
|
| 693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNRH2 |
1.85144201414467e-07 |
|
| 694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS26 |
1.85144201414467e-07 |
|
| 695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXT |
1.85144201414467e-07 |
|
| 696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVP |
1.85144201414467e-07 |
|
| 697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL555P |
1.85144201414467e-07 |
|
| 698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBOX5 |
1.85144201414467e-07 |
|
| 699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASTKD5 |
1.85144201414467e-07 |
|
| 700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZTS3 |
1.85144201414467e-07 |
|
| 701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDRGK1 |
1.85144201414467e-07 |
|
| 702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPA |
1.85144201414467e-07 |
|
| 703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A11 |
1.85144201414467e-07 |
|
| 704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf194 |
1.85144201414467e-07 |
|
| 705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL839P |
1.85144201414467e-07 |
|
| 706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000201346.1 |
1.85144201414467e-07 |
|
| 707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATRN |
1.85144201414467e-07 |
|
| 708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFRA4 |
1.85144201414467e-07 |
|
| 709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM33 |
1.85144201414467e-07 |
|
| 710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC1 |
1.85144201414467e-07 |
|
| 711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA12B |
1.85144201414467e-07 |
|
| 712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf27 |
1.85144201414467e-07 |
|
| 713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPEF1 |
1.85144201414467e-07 |
|
| 714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC25B |
1.85144201414467e-07 |
|
| 715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPB |
1.85144201414467e-07 |
|
| 716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP5S1 |
1.85144201414467e-07 |
|
| 717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAVS |
1.85144201414467e-07 |
|
| 718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR103A2 |
1.85144201414467e-07 |
|
| 719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANK2 |
1.85144201414467e-07 |
|
| 720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF24 |
1.85144201414467e-07 |
|
| 721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMOX |
1.85144201414467e-07 |
|
| 722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA1D |
1.85144201414467e-07 |
|
| 723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRNP |
1.85144201414467e-07 |
|
| 724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRND |
1.85144201414467e-07 |
|
| 725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRNT |
1.85144201414467e-07 |
|
| 726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF2 |
1.85144201414467e-07 |
|
| 727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC23A2 |
1.85144201414467e-07 |
|
| 728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252096.1 |
1.85144201414467e-07 |
|
| 729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252058.1 |
1.85144201414467e-07 |
|
| 730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL514P |
1.85144201414467e-07 |
|
| 731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP474 |
1.85144201414467e-07 |
|
| 732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM230 |
1.85144201414467e-07 |
|
| 733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNA |
1.85144201414467e-07 |
|
| 734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212517.1 |
1.85144201414467e-07 |
|
| 735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDS2 |
1.85144201414467e-07 |
|
| 736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROKR2 |
1.85144201414467e-07 |
|
| 737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPCPD1 |
1.85144201414467e-07 |
|
| 738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00654 |
1.85144201414467e-07 |
|
| 739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00658 |
1.85144201414467e-07 |
|
| 740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf196 |
1.85144201414467e-07 |
|
| 741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHGB |
1.85144201414467e-07 |
|
| 742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT6 |
1.85144201414467e-07 |
|
| 743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM8 |
1.85144201414467e-07 |
|
| 744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL498P |
1.85144201414467e-07 |
|
| 745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRLS1 |
1.85144201414467e-07 |
|
| 746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRN4 |
1.85144201414467e-07 |
|
| 747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FERMT1 |
1.85144201414467e-07 |
|
| 748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP2 |
1.85144201414467e-07 |
|
| 749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoR26 |
1.85144201414467e-07 |
|
| 750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL547P |
1.85144201414467e-07 |
|
| 751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAO1 |
1.85144201414467e-07 |
|
| 752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMX4 |
1.85144201414467e-07 |
|
| 753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCB1 |
1.85144201414467e-07 |
|
| 754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU105B |
1.85144201414467e-07 |
|
| 755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCB4 |
1.85144201414467e-07 |
|
| 756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMP5 |
1.85144201414467e-07 |
|
| 757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK7 |
1.85144201414467e-07 |
|
| 758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKEF1 |
1.85144201414467e-07 |
|
| 759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAP25 |
1.85144201414467e-07 |
|
| 760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKKS |
1.85144201414467e-07 |
|
| 761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLX4IP |
1.85144201414467e-07 |
|
| 762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAG1 |
1.85144201414467e-07 |
|
| 763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf187 |
1.85144201414467e-07 |
|
| 764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00687 |
1.85144201414467e-07 |
|
| 765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP111 |
1.85144201414467e-07 |
|
| 766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD3 |
1.85144201414467e-07 |
|
| 767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTLC3 |
1.85144201414467e-07 |
|
| 768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISM1 |
1.85144201414467e-07 |
|
| 769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TASP1 |
1.85144201414467e-07 |
|
| 770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESF1 |
1.85144201414467e-07 |
|
| 771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF5 |
1.85144201414467e-07 |
|
| 772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEL1L2 |
1.85144201414467e-07 |
|
| 773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MACROD2 |
1.85144201414467e-07 |
|
| 774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL864P |
1.85144201414467e-07 |
|
| 775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLRT3 |
1.85144201414467e-07 |
|
| 776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP475 |
1.85144201414467e-07 |
|
| 777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF16B |
1.85144201414467e-07 |
|
| 778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPB2 |
1.85144201414467e-07 |
|
| 779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOR |
1.85144201414467e-07 |
|
| 780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212165.1 |
1.85144201414467e-07 |
|
| 781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK2 |
1.85144201414467e-07 |
|
| 782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BFSP1 |
1.85144201414467e-07 |
|
| 783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSTN |
1.85144201414467e-07 |
|
| 784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP69 |
1.85144201414467e-07 |
|
| 785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRBP1 |
1.85144201414467e-07 |
|
| 786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DZANK1 |
1.85144201414467e-07 |
|
| 787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP476 |
1.85144201414467e-07 |
|
| 788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3F |
1.85144201414467e-07 |
|
| 789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3192 |
1.85144201414467e-07 |
|
| 790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP9 |
1.85144201414467e-07 |
|
| 791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC23B |
1.85144201414467e-07 |
|
| 792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00493 |
1.85144201414467e-07 |
|
| 793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTD1 |
1.85144201414467e-07 |
|
| 794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL638P |
1.85144201414467e-07 |
|
| 795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC34P |
1.85144201414467e-07 |
|
| 796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00652 |
1.85144201414467e-07 |
|
| 797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C20orf78 |
1.85144201414467e-07 |
|
| 798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCP2D1 |
1.85144201414467e-07 |
|
| 799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A3 |
1.85144201414467e-07 |
|
| 800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF254 |
3.96739051167216e-07 |
|
| 801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF726 |
3.96739051167216e-07 |
|
| 802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00662 |
4.84042748105651e-07 |
|
| 803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238514.1 |
4.84042748105651e-07 |
|
| 804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00906 |
4.84042748105651e-07 |
|
| 805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP470 |
4.84042748105651e-07 |
|
| 806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRFS1 |
4.84042748105651e-07 |
|
| 807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL340P |
4.84042748105651e-07 |
|
| 808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM2B |
4.84042748105651e-07 |
|
| 809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POP4 |
4.84042748105651e-07 |
|
| 810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP471 |
4.84042748105651e-07 |
|
| 811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP472 |
4.84042748105651e-07 |
|
| 812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF507 |
4.84042748105651e-07 |
|
| 813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L3 |
4.84042748105651e-07 |
|
| 814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD5 |
4.84042748105651e-07 |
|
| 815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD27 |
4.84042748105651e-07 |
|
| 816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000201388.1 |
4.84042748105651e-07 |
|
| 817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL789P |
4.84042748105651e-07 |
|
| 818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS9BP |
4.84042748105651e-07 |
|
| 819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT19 |
4.84042748105651e-07 |
|
| 820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD12 |
4.84042748105651e-07 |
|
| 821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A9 |
4.84042748105651e-07 |
|
| 822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP22 |
4.84042748105651e-07 |
|
| 823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP89 |
4.84042748105651e-07 |
|
| 824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf40 |
4.84042748105651e-07 |
|
| 825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHPN2 |
4.84042748105651e-07 |
|
| 826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH1 |
4.84042748105651e-07 |
|
| 827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR88 |
4.84042748105651e-07 |
|
| 828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP3 |
4.84042748105651e-07 |
|
| 829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A10 |
4.84042748105651e-07 |
|
| 830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPA |
4.84042748105651e-07 |
|
| 831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPG |
4.84042748105651e-07 |
|
| 832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEPD |
4.84042748105651e-07 |
|
| 833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST8 |
4.84042748105651e-07 |
|
| 834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM14A |
4.84042748105651e-07 |
|
| 835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0355 |
4.84042748105651e-07 |
|
| 836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHF1 |
4.85469456412702e-07 |
|
| 837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf12 |
4.85469456412702e-07 |
|
| 838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNE1 |
4.85469456412702e-07 |
|
| 839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URI1 |
4.85469456412702e-07 |
|
| 840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF536 |
4.85469456412702e-07 |
|
| 841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSHZ3 |
4.85469456412702e-07 |
|
| 842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEG5 |
4.85469456412702e-07 |
|
| 843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00864 |
1.00466888552919e-06 |
|
| 844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA11 |
1.59640234598246e-06 |
|
| 845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF5AL1 |
1.59640234598246e-06 |
|
| 846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00857 |
1.59640234598246e-06 |
|
| 847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBL1P |
1.59640234598246e-06 |
|
| 848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2B |
1.59640234598246e-06 |
|
| 849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2E |
1.59640234598246e-06 |
|
| 850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAC9 |
1.59640234598246e-06 |
|
| 851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTPA1 |
1.59640234598246e-06 |
|
| 852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTPA2 |
1.59640234598246e-06 |
|
| 853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTPD |
1.59640234598246e-06 |
|
| 854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM254 |
1.59640234598246e-06 |
|
| 855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAT1A |
1.59640234598246e-06 |
|
| 856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYDC1 |
1.59640234598246e-06 |
|
| 857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYDC2 |
1.59640234598246e-06 |
|
| 858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM213A |
1.59640234598246e-06 |
|
| 859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN14 |
1.59640234598246e-06 |
|
| 860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D4B |
1.59640234598246e-06 |
|
| 861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRG3 |
1.59640234598246e-06 |
|
| 862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCSER2 |
1.59640234598246e-06 |
|
| 863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP84 |
1.59640234598246e-06 |
|
| 864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRID1 |
1.59640234598246e-06 |
|
| 865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP238 |
1.59640234598246e-06 |
|
| 866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP322 |
1.59640234598246e-06 |
|
| 867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR346 |
1.59640234598246e-06 |
|
| 868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WAPAL |
1.59640234598246e-06 |
|
| 869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN4 |
1.59640234598246e-06 |
|
| 870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDB3 |
1.59640234598246e-06 |
|
| 871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252189.1 |
1.59640234598246e-06 |
|
| 872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMPR1A |
1.59640234598246e-06 |
|
| 873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMRN2 |
1.59640234598246e-06 |
|
| 874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNCG |
1.59640234598246e-06 |
|
| 875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADIRF |
1.59640234598246e-06 |
|
| 876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP11 |
1.59640234598246e-06 |
|
| 877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25A |
1.59640234598246e-06 |
|
| 878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLUD1 |
1.59640234598246e-06 |
|
| 879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM35A |
1.59640234598246e-06 |
|
| 880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00863 |
1.59640234598246e-06 |
|
| 881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2A |
1.59640234598246e-06 |
|
| 882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2D |
1.59640234598246e-06 |
|
| 883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL733P |
1.59640234598246e-06 |
|
| 884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MINPP1 |
1.59640234598246e-06 |
|
| 885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPSS2 |
1.59640234598246e-06 |
|
| 886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD1 |
1.59640234598246e-06 |
|
| 887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFL1P1 |
1.59640234598246e-06 |
|
| 888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL78P |
1.59640234598246e-06 |
|
| 889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLLN |
1.59640234598246e-06 |
|
| 890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTEN |
1.59640234598246e-06 |
|
| 891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000200891.1 |
1.59640234598246e-06 |
|
| 892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNLS |
1.59640234598246e-06 |
|
| 893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPJ |
1.59640234598246e-06 |
|
| 894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPF |
1.59640234598246e-06 |
|
| 895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPK |
1.59640234598246e-06 |
|
| 896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPN |
1.59640234598246e-06 |
|
| 897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPM |
1.59640234598246e-06 |
|
| 898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD22 |
1.59640234598246e-06 |
|
| 899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAMBPL1 |
1.59640234598246e-06 |
|
| 900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTA2 |
1.59640234598246e-06 |
|
| 901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAS |
1.59640234598246e-06 |
|
| 902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238991.1 |
1.59640234598246e-06 |
|
| 903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CH25H |
1.59640234598246e-06 |
|
| 904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPA |
1.59640234598246e-06 |
|
| 905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIT2 |
1.59640234598246e-06 |
|
| 906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIT3 |
1.59640234598246e-06 |
|
| 907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIT1B |
1.59640234598246e-06 |
|
| 908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIT1 |
1.59640234598246e-06 |
|
| 909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIT5 |
1.59640234598246e-06 |
|
| 910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A12 |
1.59640234598246e-06 |
|
| 911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANK1 |
1.59640234598246e-06 |
|
| 912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR107 |
1.59640234598246e-06 |
|
| 913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF20B |
1.59640234598246e-06 |
|
| 914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00865 |
1.59640234598246e-06 |
|
| 915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP143 |
1.59640234598246e-06 |
|
| 916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR7 |
1.59640234598246e-06 |
|
| 917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP30 |
1.59640234598246e-06 |
|
| 918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD1 |
1.59640234598246e-06 |
|
| 919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00502 |
1.59640234598246e-06 |
|
| 920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGF5 |
1.59640234598246e-06 |
|
| 921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECTD2 |
1.59640234598246e-06 |
|
| 922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3C |
1.59640234598246e-06 |
|
| 923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNKS2 |
1.59640234598246e-06 |
|
| 924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFBP3 |
1.59640234598246e-06 |
|
| 925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTAF1 |
1.59640234598246e-06 |
|
| 926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPEB3 |
1.59640234598246e-06 |
|
| 927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252993.1 |
1.59640234598246e-06 |
|
| 928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH5 |
1.59640234598246e-06 |
|
| 929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHEX |
1.59640234598246e-06 |
|
| 930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDE |
1.59640234598246e-06 |
|
| 931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF11 |
1.59640234598246e-06 |
|
| 932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL644P |
1.59640234598246e-06 |
|
| 933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC6 |
1.59640234598246e-06 |
|
| 934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP26C1 |
1.59640234598246e-06 |
|
| 935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP26A1 |
1.59640234598246e-06 |
|
| 936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOF |
1.59640234598246e-06 |
|
| 937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP55 |
1.59640234598246e-06 |
|
| 938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP323 |
1.59640234598246e-06 |
|
| 939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FFAR4 |
1.59640234598246e-06 |
|
| 940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP4 |
1.59640234598246e-06 |
|
| 941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6C |
1.59640234598246e-06 |
|
| 942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRA10AC1 |
1.59640234598246e-06 |
|
| 943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGI1 |
1.59640234598246e-06 |
|
| 944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35G1 |
1.59640234598246e-06 |
|
| 945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIPSL |
1.59640234598246e-06 |
|
| 946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCE1 |
1.59640234598246e-06 |
|
| 947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P26 |
1.59640234598246e-06 |
|
| 948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOC3L |
1.59640234598246e-06 |
|
| 949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D12 |
1.59640234598246e-06 |
|
| 950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2C18 |
1.59640234598246e-06 |
|
| 951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2C19 |
1.59640234598246e-06 |
|
| 952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2C9 |
1.59640234598246e-06 |
|
| 953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2C8 |
1.59640234598246e-06 |
|
| 954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf129 |
1.59640234598246e-06 |
|
| 955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM1 |
1.59640234598246e-06 |
|
| 956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORBS1 |
1.59640234598246e-06 |
|
| 957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH18A1 |
1.59640234598246e-06 |
|
| 958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTN3 |
1.59640234598246e-06 |
|
| 959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD1 |
1.59640234598246e-06 |
|
| 960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf131 |
1.59640234598246e-06 |
|
| 961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CC2D2B |
1.59640234598246e-06 |
|
| 962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNJ |
1.59640234598246e-06 |
|
| 963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3157 |
1.59640234598246e-06 |
|
| 964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF518A |
1.59640234598246e-06 |
|
| 965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLNK |
1.59640234598246e-06 |
|
| 966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNTT |
1.59640234598246e-06 |
|
| 967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPALIN |
1.59640234598246e-06 |
|
| 968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLL2 |
1.59640234598246e-06 |
|
| 969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM9SF3 |
1.59640234598246e-06 |
|
| 970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3AP1 |
1.59640234598246e-06 |
|
| 971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP324 |
1.59640234598246e-06 |
|
| 972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR607 |
1.59640234598246e-06 |
|
| 973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCOR |
1.59640234598246e-06 |
|
| 974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf12 |
1.59640234598246e-06 |
|
| 975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLIT1 |
1.59640234598246e-06 |
|
| 976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP19 |
1.59640234598246e-06 |
|
| 977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRAT1 |
1.59640234598246e-06 |
|
| 978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRAT2 |
1.59640234598246e-06 |
|
| 979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP12 |
1.59640234598246e-06 |
|
| 980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAM1 |
1.59640234598246e-06 |
|
| 981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC1 |
1.59640234598246e-06 |
|
| 982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC16 |
1.59640234598246e-06 |
|
| 983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMS19 |
1.59640234598246e-06 |
|
| 984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBTD1 |
1.59640234598246e-06 |
|
| 985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD2 |
1.59640234598246e-06 |
|
| 986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOGA1 |
1.59640234598246e-06 |
|
| 987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4K2A |
1.59640234598246e-06 |
|
| 988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf62 |
1.59640234598246e-06 |
|
| 989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORN4 |
1.59640234598246e-06 |
|
| 990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVPI1 |
1.59640234598246e-06 |
|
| 991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARVELD1 |
1.59640234598246e-06 |
|
| 992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE27 |
1.59640234598246e-06 |
|
| 993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFRP5 |
1.59640234598246e-06 |
|
| 994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00866 |
1.59640234598246e-06 |
|
| 995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA7B |
1.59640234598246e-06 |
|
| 996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTAC1 |
1.59640234598246e-06 |
|
| 997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HCC1L |
1.59640234598246e-06 |
|
| 998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOXL4 |
1.59640234598246e-06 |
|
| 999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYROXD2 |
1.59640234598246e-06 |
|
| 1000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1287 |
1.59640234598246e-06 |
|
| 1001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPS1 |
1.59640234598246e-06 |
|
| 1002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4685 |
1.59640234598246e-06 |
|
| 1003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPSE2 |
1.59640234598246e-06 |
|
| 1004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNNM1 |
1.59640234598246e-06 |
|
| 1005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOT1 |
1.59640234598246e-06 |
|
| 1006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238588.1 |
1.59640234598246e-06 |
|
| 1007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A28 |
1.59640234598246e-06 |
|
| 1008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD7 |
1.59640234598246e-06 |
|
| 1009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUTC |
1.59640234598246e-06 |
|
| 1010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX15 |
1.59640234598246e-06 |
|
| 1011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC2 |
1.59640234598246e-06 |
|
| 1012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNMBP |
1.59640234598246e-06 |
|
| 1013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238472.1 |
1.59640234598246e-06 |
|
| 1014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPN1 |
1.59640234598246e-06 |
|
| 1015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERLIN1 |
1.59640234598246e-06 |
|
| 1016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHUK |
1.59640234598246e-06 |
|
| 1017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWF19L1 |
1.59640234598246e-06 |
|
| 1018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA12|ENSG00000212464.1 |
1.59640234598246e-06 |
|
| 1019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S2 |
1.59640234598246e-06 |
|
| 1020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD2L1 |
1.59640234598246e-06 |
|
| 1021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCD |
1.59640234598246e-06 |
|
| 1022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00263 |
1.59640234598246e-06 |
|
| 1023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT8B |
1.59640234598246e-06 |
|
| 1024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC31B |
1.59640234598246e-06 |
|
| 1025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB8 |
1.59640234598246e-06 |
|
| 1026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIF1AN |
1.59640234598246e-06 |
|
| 1027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX2 |
1.59640234598246e-06 |
|
| 1028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM178A |
1.59640234598246e-06 |
|
| 1029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR608 |
1.59640234598246e-06 |
|
| 1030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL43 |
1.59640234598246e-06 |
|
| 1031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4G |
1.59640234598246e-06 |
|
| 1032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf2 |
1.59640234598246e-06 |
|
| 1033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZTS2 |
1.59640234598246e-06 |
|
| 1034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD7 |
1.59640234598246e-06 |
|
| 1035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFXN3 |
1.59640234598246e-06 |
|
| 1036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAZALD1 |
1.59640234598246e-06 |
|
| 1037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLX1NB |
1.59640234598246e-06 |
|
| 1038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HUG1 |
1.59640234598246e-06 |
|
| 1039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLX1 |
1.59640234598246e-06 |
|
| 1040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LBX1 |
1.59640234598246e-06 |
|
| 1041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252844.1 |
1.59640234598246e-06 |
|
| 1042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTRC |
1.59640234598246e-06 |
|
| 1043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239091.1 |
1.59640234598246e-06 |
|
| 1044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPCD |
1.59640234598246e-06 |
|
| 1045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLL |
1.59640234598246e-06 |
|
| 1046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW4 |
1.59640234598246e-06 |
|
| 1047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF8 |
1.59640234598246e-06 |
|
| 1048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGEA5 |
1.59640234598246e-06 |
|
| 1049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPM3 |
1.59640234598246e-06 |
|
| 1050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNIP2 |
1.59640234598246e-06 |
|
| 1051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf76 |
1.59640234598246e-06 |
|
| 1052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPS6 |
1.59640234598246e-06 |
|
| 1053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000253068.1 |
1.59640234598246e-06 |
|
| 1054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDB1 |
1.59640234598246e-06 |
|
| 1055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPRC1 |
1.59640234598246e-06 |
|
| 1056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOLC1 |
1.59640234598246e-06 |
|
| 1057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL3 |
1.59640234598246e-06 |
|
| 1058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITX3 |
1.59640234598246e-06 |
|
| 1059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBF1 |
1.59640234598246e-06 |
|
| 1060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKB2 |
1.59640234598246e-06 |
|
| 1061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSD |
1.59640234598246e-06 |
|
| 1062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUEDC2 |
1.59640234598246e-06 |
|
| 1063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL15 |
1.59640234598246e-06 |
|
| 1064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR146B |
1.59640234598246e-06 |
|
| 1065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf95 |
1.59640234598246e-06 |
|
| 1066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM180 |
1.59640234598246e-06 |
|
| 1067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR1A |
1.59640234598246e-06 |
|
| 1068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUFU |
1.59640234598246e-06 |
|
| 1069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL21P |
1.59640234598246e-06 |
|
| 1070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM8 |
1.59640234598246e-06 |
|
| 1071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL3 |
1.59640234598246e-06 |
|
| 1072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFXN2 |
1.59640234598246e-06 |
|
| 1073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP1L |
1.59640234598246e-06 |
|
| 1074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP17A1 |
1.59640234598246e-06 |
|
| 1075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf32 |
1.59640234598246e-06 |
|
| 1076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNB2 |
3.93604713233575e-06 |
|
| 1077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN6 |
3.93604713233575e-06 |
|
| 1078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL5B |
3.93604713233575e-06 |
|
| 1079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALP |
4.485792651443e-06 |
|
| 1080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN5B |
4.485792651443e-06 |
|
| 1081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN5A |
4.485792651443e-06 |
|
| 1082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN5C |
4.485792651443e-06 |
|
| 1083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN5D |
4.485792651443e-06 |
|
| 1084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF542 |
4.485792651443e-06 |
|
| 1085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF582 |
4.485792651443e-06 |
|
| 1086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF71 |
4.485792651443e-06 |
|
| 1087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM17 |
4.485792651443e-06 |
|
| 1088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF460 |
4.485792651443e-06 |
|
| 1089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF543 |
4.485792651443e-06 |
|
| 1090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF304 |
4.485792651443e-06 |
|
| 1091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC2P1 |
4.485792651443e-06 |
|
| 1092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF547 |
4.485792651443e-06 |
|
| 1093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF548 |
4.485792651443e-06 |
|
| 1094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF17 |
4.485792651443e-06 |
|
| 1095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF749 |
4.485792651443e-06 |
|
| 1096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VN1R1 |
4.485792651443e-06 |
|
| 1097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF419 |
4.485792651443e-06 |
|
| 1098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF772 |
4.485792651443e-06 |
|
| 1099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF773 |
4.485792651443e-06 |
|
| 1100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF549 |
4.485792651443e-06 |
|
| 1101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF550 |
4.485792651443e-06 |
|
| 1102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF416 |
4.485792651443e-06 |
|
| 1103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIK1 |
4.485792651443e-06 |
|
| 1104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF530 |
4.485792651443e-06 |
|
| 1105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF134 |
4.485792651443e-06 |
|
| 1106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF211 |
4.485792651443e-06 |
|
| 1107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN4 |
4.485792651443e-06 |
|
| 1108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF551 |
4.485792651443e-06 |
|
| 1109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF154 |
4.485792651443e-06 |
|
| 1110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF671 |
4.485792651443e-06 |
|
| 1111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF776 |
4.485792651443e-06 |
|
| 1112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF586 |
4.485792651443e-06 |
|
| 1113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF552 |
4.485792651443e-06 |
|
| 1114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF587B |
4.485792651443e-06 |
|
| 1115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF814 |
4.485792651443e-06 |
|
| 1116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF587 |
4.485792651443e-06 |
|
| 1117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF417 |
4.485792651443e-06 |
|
| 1118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF418 |
4.485792651443e-06 |
|
| 1119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF256 |
4.485792651443e-06 |
|
| 1120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf18 |
4.485792651443e-06 |
|
| 1121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF606 |
4.485792651443e-06 |
|
| 1122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN1 |
4.485792651443e-06 |
|
| 1123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL526P |
4.485792651443e-06 |
|
| 1124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF274 |
4.485792651443e-06 |
|
| 1125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF544 |
4.485792651443e-06 |
|
| 1126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF8 |
4.485792651443e-06 |
|
| 1127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN22 |
4.485792651443e-06 |
|
| 1128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A1BG |
8.12279817752337e-06 |
|
| 1129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF497 |
8.12279817752337e-06 |
|
| 1130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP473 |
8.12279817752337e-06 |
|
| 1131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP2A |
8.12279817752337e-06 |
|
| 1132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4754 |
8.12279817752337e-06 |
|
| 1133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MZF1 |
8.12279817752337e-06 |
|
| 1134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL525P |
8.12279817752337e-06 |
|
| 1135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL693P |
8.12279817752337e-06 |
|
| 1136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL23AP79 |
8.12279817752337e-06 |
|
| 1137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS5 |
8.12279817752337e-06 |
|
| 1138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A5 |
8.12279817752337e-06 |
|
| 1139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM28 |
8.12279817752337e-06 |
|
| 1140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2M |
8.12279817752337e-06 |
|
| 1141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB45 |
8.12279817752337e-06 |
|
| 1142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF132 |
8.12279817752337e-06 |
|
| 1143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF324B |
8.12279817752337e-06 |
|
| 1144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF324 |
8.12279817752337e-06 |
|
| 1145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF446 |
8.12279817752337e-06 |
|
| 1146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF584 |
8.12279817752337e-06 |
|
| 1147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF837 |
8.12279817752337e-06 |
|
| 1148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF808 |
8.65319152332233e-06 |
|
| 1149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF701 |
8.65319152332233e-06 |
|
| 1150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF137P |
8.65319152332233e-06 |
|
| 1151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF83 |
8.65319152332233e-06 |
|
| 1152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF28 |
8.65319152332233e-06 |
|
| 1153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF320 |
8.65319152332233e-06 |
|
| 1154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF321P |
8.65319152332233e-06 |
|
| 1155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF468 |
8.65319152332233e-06 |
|
| 1156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF600 |
8.65319152332233e-06 |
|
| 1157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF611 |
8.65319152332233e-06 |
|
| 1158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF702P |
8.65319152332233e-06 |
|
| 1159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF816 |
8.65319152332233e-06 |
|
| 1160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF888 |
8.65319152332233e-06 |
|
| 1161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF160 |
8.65319152332233e-06 |
|
| 1162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF347 |
8.65319152332233e-06 |
|
| 1163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF415 |
8.65319152332233e-06 |
|
| 1164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF665 |
8.65319152332233e-06 |
|
| 1165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF677 |
8.65319152332233e-06 |
|
| 1166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VN1R2 |
8.65319152332233e-06 |
|
| 1167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VN1R4 |
8.65319152332233e-06 |
|
| 1168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM90A27P |
8.65319152332233e-06 |
|
| 1169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC8 |
8.65319152332233e-06 |
|
| 1170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM90A28P |
8.65319152332233e-06 |
|
| 1171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF845 |
8.65319152332233e-06 |
|
| 1172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF525 |
8.65319152332233e-06 |
|
| 1173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF765 |
8.65319152332233e-06 |
|
| 1174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPM3P9 |
8.65319152332233e-06 |
|
| 1175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF761 |
8.65319152332233e-06 |
|
| 1176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF813 |
8.65319152332233e-06 |
|
| 1177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf112 |
1.37337376723279e-05 |
|
| 1178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200545.1 |
1.37337376723279e-05 |
|
| 1179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP303 |
1.37337376723279e-05 |
|
| 1180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXDC2 |
1.37337376723279e-05 |
|
| 1181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4675 |
1.37337376723279e-05 |
|
| 1182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEBL |
1.37337376723279e-05 |
|
| 1183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf113 |
1.37337376723279e-05 |
|
| 1184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251749.1 |
1.37337376723279e-05 |
|
| 1185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC10 |
1.37337376723279e-05 |
|
| 1186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1915 |
1.37337376723279e-05 |
|
| 1187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKIDA1 |
1.37337376723279e-05 |
|
| 1188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT10 |
1.37337376723279e-05 |
|
| 1189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC1 |
1.37337376723279e-05 |
|
| 1190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP219 |
1.37337376723279e-05 |
|
| 1191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP37 |
1.37337376723279e-05 |
|
| 1192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBLN1 |
1.37337376723279e-05 |
|
| 1193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMI1 |
1.37337376723279e-05 |
|
| 1194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD3 |
1.37337376723279e-05 |
|
| 1195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG6 |
1.37337376723279e-05 |
|
| 1196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP4K2A |
1.37337376723279e-05 |
|
| 1197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC3 |
1.37337376723279e-05 |
|
| 1198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP304 |
1.37337376723279e-05 |
|
| 1199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSRB2 |
1.37337376723279e-05 |
|
| 1200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252049.1 |
1.37337376723279e-05 |
|
| 1201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTF1A |
1.37337376723279e-05 |
|
| 1202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf115 |
1.37337376723279e-05 |
|
| 1203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf67 |
1.37337376723279e-05 |
|
| 1204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238515.1 |
1.37337376723279e-05 |
|
| 1205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD1 |
1.37337376723279e-05 |
|
| 1206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1217 |
1.37337376723279e-05 |
|
| 1207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR603 |
1.37337376723279e-05 |
|
| 1208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP21 |
1.37337376723279e-05 |
|
| 1209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP305 |
1.37337376723279e-05 |
|
| 1210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRTFDC1 |
1.37337376723279e-05 |
|
| 1211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP241 |
1.37337376723279e-05 |
|
| 1212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENKUR |
1.37337376723279e-05 |
|
| 1213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THNSL1 |
1.37337376723279e-05 |
|
| 1214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR158 |
1.37337376723279e-05 |
|
| 1215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP220 |
1.37337376723279e-05 |
|
| 1216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP306 |
1.37337376723279e-05 |
|
| 1217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO3A |
1.37337376723279e-05 |
|
| 1218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAD2 |
1.37337376723279e-05 |
|
| 1219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBB1IP |
1.37337376723279e-05 |
|
| 1220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP307 |
1.37337376723279e-05 |
|
| 1221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00264 |
1.37337376723279e-05 |
|
| 1222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDSS1 |
1.37337376723279e-05 |
|
| 1223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABI1 |
1.37337376723279e-05 |
|
| 1224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA57|ENSG00000223027.1 |
1.37337376723279e-05 |
|
| 1225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238414.1 |
1.37337376723279e-05 |
|
| 1226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00614 |
1.37337376723279e-05 |
|
| 1227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD26 |
1.37337376723279e-05 |
|
| 1228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YME1L1 |
1.37337376723279e-05 |
|
| 1229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MASTL |
1.37337376723279e-05 |
|
| 1230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACBD5 |
1.37337376723279e-05 |
|
| 1231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A6P |
1.37337376723279e-05 |
|
| 1232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC4P1 |
1.37337376723279e-05 |
|
| 1233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCHD3 |
1.37337376723279e-05 |
|
| 1234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB18 |
1.37337376723279e-05 |
|
| 1235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKX |
1.37337376723279e-05 |
|
| 1236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC4 |
1.37337376723279e-05 |
|
| 1237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP132 |
1.37337376723279e-05 |
|
| 1238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP7 |
1.37337376723279e-05 |
|
| 1239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000222666.1 |
1.37337376723279e-05 |
|
| 1240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP39 |
1.37337376723279e-05 |
|
| 1241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WAC |
1.37337376723279e-05 |
|
| 1242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC6P |
1.37337376723279e-05 |
|
| 1243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAMBI |
1.37337376723279e-05 |
|
| 1244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00837 |
1.37337376723279e-05 |
|
| 1245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf126 |
1.37337376723279e-05 |
|
| 1246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP308 |
1.37337376723279e-05 |
|
| 1247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYZL1 |
1.37337376723279e-05 |
|
| 1248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCHD3P1 |
1.37337376723279e-05 |
|
| 1249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVIL |
1.37337376723279e-05 |
|
| 1250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR604 |
1.37337376723279e-05 |
|
| 1251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD115|ENSG00000212411.1 |
1.37337376723279e-05 |
|
| 1252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR938 |
1.37337376723279e-05 |
|
| 1253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1462 |
1.37337376723279e-05 |
|
| 1254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTPAP |
1.37337376723279e-05 |
|
| 1255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL241P |
1.37337376723279e-05 |
|
| 1256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K8 |
1.37337376723279e-05 |
|
| 1257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL63P |
1.37337376723279e-05 |
|
| 1258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYZL2 |
1.37337376723279e-05 |
|
| 1259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVILP1 |
1.37337376723279e-05 |
|
| 1260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF438 |
1.37337376723279e-05 |
|
| 1261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT5 |
1.43785361984561e-05 |
|
| 1262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRH |
1.43785361984561e-05 |
|
| 1263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM86B |
1.43785361984561e-05 |
|
| 1264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP6R1 |
1.43785361984561e-05 |
|
| 1265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPBP1 |
1.43785361984561e-05 |
|
| 1266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRSK1 |
1.43785361984561e-05 |
|
| 1267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM150B |
1.43785361984561e-05 |
|
| 1268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6B2 |
1.43785361984561e-05 |
|
| 1269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUV420H2 |
1.43785361984561e-05 |
|
| 1270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71E2 |
1.43785361984561e-05 |
|
| 1271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL11 |
1.43785361984561e-05 |
|
| 1272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM190 |
1.43785361984561e-05 |
|
| 1273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM238 |
1.43785361984561e-05 |
|
| 1274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL28 |
1.43785361984561e-05 |
|
| 1275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2S |
1.43785361984561e-05 |
|
| 1276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISOC2 |
1.43785361984561e-05 |
|
| 1277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF628 |
1.43785361984561e-05 |
|
| 1278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT14 |
1.43785361984561e-05 |
|
| 1279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238486.1 |
1.45525338305363e-05 |
|
| 1280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00085 |
1.45525338305363e-05 |
|
| 1281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR125A |
1.45525338305363e-05 |
|
| 1282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR99B |
1.45525338305363e-05 |
|
| 1283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7E |
1.45525338305363e-05 |
|
| 1284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAS1 |
1.45525338305363e-05 |
|
| 1285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FPR1 |
1.45525338305363e-05 |
|
| 1286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FPR2 |
1.45525338305363e-05 |
|
| 1287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FPR3 |
1.45525338305363e-05 |
|
| 1288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCCAT3 |
1.45525338305363e-05 |
|
| 1289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF350 |
1.45525338305363e-05 |
|
| 1290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF432 |
1.45525338305363e-05 |
|
| 1291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF577 |
1.45525338305363e-05 |
|
| 1292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF613 |
1.45525338305363e-05 |
|
| 1293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF614 |
1.45525338305363e-05 |
|
| 1294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF615 |
1.45525338305363e-05 |
|
| 1295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF649 |
1.45525338305363e-05 |
|
| 1296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF841 |
1.45525338305363e-05 |
|
| 1297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP7 |
1.47362945269736e-05 |
|
| 1298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP2 |
1.47362945269736e-05 |
|
| 1299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R12C |
1.47362945269736e-05 |
|
| 1300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239137.1 |
1.47362945269736e-05 |
|
| 1301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF579 |
1.47362945269736e-05 |
|
| 1302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIZ1 |
1.47362945269736e-05 |
|
| 1303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF524 |
1.47362945269736e-05 |
|
| 1304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF865 |
1.47362945269736e-05 |
|
| 1305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF784 |
1.47362945269736e-05 |
|
| 1306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF580 |
1.47362945269736e-05 |
|
| 1307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF7L2 |
1.51657028918395e-05 |
|
| 1308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HABP2 |
1.51657028918395e-05 |
|
| 1309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRAP |
1.51657028918395e-05 |
|
| 1310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP7 |
1.51657028918395e-05 |
|
| 1311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHS1 |
1.51657028918395e-05 |
|
| 1312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA17|ENSG00000212589.1 |
1.51657028918395e-05 |
|
| 1313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLRE1A |
1.51657028918395e-05 |
|
| 1314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLRC2 |
1.51657028918395e-05 |
|
| 1315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRB1 |
1.51657028918395e-05 |
|
| 1316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf118 |
1.51657028918395e-05 |
|
| 1317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2110 |
1.51657028918395e-05 |
|
| 1318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD1 |
1.51657028918395e-05 |
|
| 1319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA2 |
1.51657028918395e-05 |
|
| 1320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFAP1L2 |
1.51657028918395e-05 |
|
| 1321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL384P |
1.51657028918395e-05 |
|
| 1322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABLIM1 |
1.51657028918395e-05 |
|
| 1323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238577.1 |
1.51657028918395e-05 |
|
| 1324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM160B1 |
1.51657028918395e-05 |
|
| 1325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRUB1 |
1.51657028918395e-05 |
|
| 1326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATRNL1 |
1.51657028918395e-05 |
|
| 1327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFRA1 |
1.51657028918395e-05 |
|
| 1328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC172 |
1.51657028918395e-05 |
|
| 1329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNLIPRP3 |
1.51657028918395e-05 |
|
| 1330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNLIP |
1.51657028918395e-05 |
|
| 1331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNLIPRP1 |
1.51657028918395e-05 |
|
| 1332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNLIPRP2 |
1.51657028918395e-05 |
|
| 1333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf82 |
1.51657028918395e-05 |
|
| 1334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA12A |
1.51657028918395e-05 |
|
| 1335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENO4 |
1.51657028918395e-05 |
|
| 1336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1598 |
1.51657028918395e-05 |
|
| 1337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAX1 |
1.51657028918395e-05 |
|
| 1338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3663 |
1.51657028918395e-05 |
|
| 1339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK18 |
1.51657028918395e-05 |
|
| 1340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC18A2 |
1.51657028918395e-05 |
|
| 1341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD8 |
1.51657028918395e-05 |
|
| 1342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMX2OS |
1.51657028918395e-05 |
|
| 1343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMX2 |
1.51657028918395e-05 |
|
| 1344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11FIP2 |
1.51657028918395e-05 |
|
| 1345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC2 |
1.51657028918395e-05 |
|
| 1346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM204A |
1.51657028918395e-05 |
|
| 1347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00867 |
1.51657028918395e-05 |
|
| 1348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRLHR |
1.51657028918395e-05 |
|
| 1349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACUL1 |
1.51657028918395e-05 |
|
| 1350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251836.1 |
1.51657028918395e-05 |
|
| 1351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3A |
1.51657028918395e-05 |
|
| 1352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOS1 |
1.51657028918395e-05 |
|
| 1353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA19|ENSG00000207468.1 |
1.51657028918395e-05 |
|
| 1354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA19|ENSG00000222588.1 |
1.51657028918395e-05 |
|
| 1355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM45A |
1.51657028918395e-05 |
|
| 1356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFXN4 |
1.51657028918395e-05 |
|
| 1357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX3 |
1.51657028918395e-05 |
|
| 1358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRK5 |
1.51657028918395e-05 |
|
| 1359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL749P |
1.51657028918395e-05 |
|
| 1360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4681 |
1.51657028918395e-05 |
|
| 1361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS10 |
1.51657028918395e-05 |
|
| 1362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIAL1 |
1.51657028918395e-05 |
|
| 1363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG3 |
1.51657028918395e-05 |
|
| 1364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5F |
1.51657028918395e-05 |
|
| 1365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL846P |
1.51657028918395e-05 |
|
| 1366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCMBP |
1.51657028918395e-05 |
|
| 1367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC23IP |
1.51657028918395e-05 |
|
| 1368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4682 |
1.51657028918395e-05 |
|
| 1369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAPDC1A |
1.51657028918395e-05 |
|
| 1370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf85 |
1.51657028918395e-05 |
|
| 1371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR11 |
1.51657028918395e-05 |
|
| 1372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP167 |
1.51657028918395e-05 |
|
| 1373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR2 |
1.51657028918395e-05 |
|
| 1374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATE1 |
1.51657028918395e-05 |
|
| 1375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSMCE4A |
1.51657028918395e-05 |
|
| 1376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACC2 |
1.51657028918395e-05 |
|
| 1377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD16 |
1.51657028918395e-05 |
|
| 1378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA1 |
1.51657028918395e-05 |
|
| 1379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3941 |
1.51657028918395e-05 |
|
| 1380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMS2 |
1.51657028918395e-05 |
|
| 1381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTRA1 |
1.51657028918395e-05 |
|
| 1382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMBT1 |
1.51657028918395e-05 |
|
| 1383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf120 |
1.51657028918395e-05 |
|
| 1384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUZD1 |
1.51657028918395e-05 |
|
| 1385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM24B |
1.51657028918395e-05 |
|
| 1386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM24A |
1.51657028918395e-05 |
|
| 1387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf88 |
1.51657028918395e-05 |
|
| 1388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSTK |
1.51657028918395e-05 |
|
| 1389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKZF5 |
1.51657028918395e-05 |
|
| 1390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACADSB |
1.51657028918395e-05 |
|
| 1391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMX2 |
1.51657028918395e-05 |
|
| 1392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMX3 |
1.51657028918395e-05 |
|
| 1393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BUB3 |
1.51657028918395e-05 |
|
| 1394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR26 |
1.51657028918395e-05 |
|
| 1395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPXM2 |
1.51657028918395e-05 |
|
| 1396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST15 |
1.51657028918395e-05 |
|
| 1397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAT |
1.51657028918395e-05 |
|
| 1398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHPP |
1.51657028918395e-05 |
|
| 1399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM53B |
1.51657028918395e-05 |
|
| 1400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL10 |
1.51657028918395e-05 |
|
| 1401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM175B |
1.51657028918395e-05 |
|
| 1402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZRANB1 |
1.51657028918395e-05 |
|
| 1403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTBP2 |
1.51657028918395e-05 |
|
| 1404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4296 |
1.51657028918395e-05 |
|
| 1405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX36 |
1.51657028918395e-05 |
|
| 1406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf137 |
1.51657028918395e-05 |
|
| 1407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP21 |
1.51657028918395e-05 |
|
| 1408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UROS |
1.51657028918395e-05 |
|
| 1409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4484 |
1.51657028918395e-05 |
|
| 1410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCCIP |
1.51657028918395e-05 |
|
| 1411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX32 |
1.51657028918395e-05 |
|
| 1412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANK1 |
1.51657028918395e-05 |
|
| 1413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM12 |
1.51657028918395e-05 |
|
| 1414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP328 |
1.51657028918395e-05 |
|
| 1415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00601 |
1.51657028918395e-05 |
|
| 1416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf90 |
1.51657028918395e-05 |
|
| 1417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD60|ENSG00000199321.1 |
1.51657028918395e-05 |
|
| 1418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK1 |
1.51657028918395e-05 |
|
| 1419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM196A |
1.51657028918395e-05 |
|
| 1420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPS |
1.51657028918395e-05 |
|
| 1421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXI2 |
1.51657028918395e-05 |
|
| 1422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD33 |
1.55583242430479e-05 |
|
| 1423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLECL1 |
1.55583242430479e-05 |
|
| 1424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLON5 |
1.55583242430479e-05 |
|
| 1425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG10L |
1.55583242430479e-05 |
|
| 1426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETFB |
1.55583242430479e-05 |
|
| 1427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDND2 |
1.55583242430479e-05 |
|
| 1428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKG7 |
1.55583242430479e-05 |
|
| 1429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIM2 |
1.55583242430479e-05 |
|
| 1430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC10 |
1.55583242430479e-05 |
|
| 1431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC8 |
1.55583242430479e-05 |
|
| 1432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM18 |
1.55583242430479e-05 |
|
| 1433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC12 |
1.55583242430479e-05 |
|
| 1434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC6 |
1.55583242430479e-05 |
|
| 1435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF175 |
1.55583242430479e-05 |
|
| 1436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC5 |
1.55583242430479e-05 |
|
| 1437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC14 |
1.55583242430479e-05 |
|
| 1438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF616 |
1.55583242430479e-05 |
|
| 1439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238630.1 |
1.55583242430479e-05 |
|
| 1440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF836 |
1.55583242430479e-05 |
|
| 1441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R1A |
1.55583242430479e-05 |
|
| 1442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF766 |
1.55583242430479e-05 |
|
| 1443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR643 |
1.55583242430479e-05 |
|
| 1444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF480 |
1.55583242430479e-05 |
|
| 1445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF610 |
1.55583242430479e-05 |
|
| 1446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF528 |
1.55583242430479e-05 |
|
| 1447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF534 |
1.55583242430479e-05 |
|
| 1448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF578 |
1.55583242430479e-05 |
|
| 1449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF880 |
1.55583242430479e-05 |
|
| 1450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSCAR |
1.55583242430479e-05 |
|
| 1451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA3 |
1.55583242430479e-05 |
|
| 1452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFPT |
1.55583242430479e-05 |
|
| 1453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF31 |
1.55583242430479e-05 |
|
| 1454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIR3DX1 |
1.55583242430479e-05 |
|
| 1455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP318 |
1.76943079989167e-05 |
|
| 1456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548F1 |
1.76943079989167e-05 |
|
| 1457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238355.1 |
1.76943079989167e-05 |
|
| 1458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L5 |
1.76943079989167e-05 |
|
| 1459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZWINT |
1.76943079989167e-05 |
|
| 1460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD2|ENSG00000238707.1 |
1.76943079989167e-05 |
|
| 1461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3924 |
1.76943079989167e-05 |
|
| 1462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPMK |
1.76943079989167e-05 |
|
| 1463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238970.1 |
1.76943079989167e-05 |
|
| 1464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CISD1 |
1.76943079989167e-05 |
|
| 1465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2D1 |
1.76943079989167e-05 |
|
| 1466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAM |
1.76943079989167e-05 |
|
| 1467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BICC1 |
1.76943079989167e-05 |
|
| 1468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP196 |
1.76943079989167e-05 |
|
| 1469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00844 |
1.76943079989167e-05 |
|
| 1470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHYHIPL |
1.76943079989167e-05 |
|
| 1471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM13C |
1.76943079989167e-05 |
|
| 1472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A9 |
1.76943079989167e-05 |
|
| 1473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00948 |
1.76943079989167e-05 |
|
| 1474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC6 |
1.76943079989167e-05 |
|
| 1475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf40 |
1.76943079989167e-05 |
|
| 1476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANK3 |
1.76943079989167e-05 |
|
| 1477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK1 |
1.76943079989167e-05 |
|
| 1478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOBTB1 |
1.76943079989167e-05 |
|
| 1479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00845 |
1.76943079989167e-05 |
|
| 1480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM26 |
1.76943079989167e-05 |
|
| 1481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf107 |
1.76943079989167e-05 |
|
| 1482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID5B |
1.76943079989167e-05 |
|
| 1483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTKN2 |
1.76943079989167e-05 |
|
| 1484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL591P |
1.76943079989167e-05 |
|
| 1485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF365 |
1.76943079989167e-05 |
|
| 1486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADO |
1.76943079989167e-05 |
|
| 1487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGR2 |
1.76943079989167e-05 |
|
| 1488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRBF2 |
1.76943079989167e-05 |
|
| 1489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMJD1C |
1.76943079989167e-05 |
|
| 1490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1296 |
1.76943079989167e-05 |
|
| 1491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP3 |
1.76943079989167e-05 |
|
| 1492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNA3 |
1.87389257960691e-05 |
|
| 1493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoR442|ENSG00000252203.1 |
1.87389257960691e-05 |
|
| 1494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239000.1 |
1.87389257960691e-05 |
|
| 1495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRTM3 |
1.87389257960691e-05 |
|
| 1496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC12 |
1.87389257960691e-05 |
|
| 1497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL394P |
1.87389257960691e-05 |
|
| 1498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT1 |
1.87389257960691e-05 |
|
| 1499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC4 |
1.87389257960691e-05 |
|
| 1500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL220P |
1.87389257960691e-05 |
|
| 1501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYPN |
1.87389257960691e-05 |
|
| 1502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP202 |
1.87389257960691e-05 |
|
| 1503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATOH7 |
1.87389257960691e-05 |
|
| 1504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBLD |
1.87389257960691e-05 |
|
| 1505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPH3 |
1.87389257960691e-05 |
|
| 1506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUFY2 |
1.87389257960691e-05 |
|
| 1507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNA2 |
1.87389257960691e-05 |
|
| 1508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP319 |
1.87389257960691e-05 |
|
| 1509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00849 |
1.87389257960691e-05 |
|
| 1510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A16 |
1.87389257960691e-05 |
|
| 1511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TET1 |
1.87389257960691e-05 |
|
| 1512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251926.1 |
1.87389257960691e-05 |
|
| 1513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCAR1 |
1.87389257960691e-05 |
|
| 1514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD98 |
1.87389257960691e-05 |
|
| 1515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOX1 |
1.87389257960691e-05 |
|
| 1516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX50 |
1.87389257960691e-05 |
|
| 1517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX21 |
1.87389257960691e-05 |
|
| 1518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL373P |
1.87389257960691e-05 |
|
| 1519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1279 |
1.87389257960691e-05 |
|
| 1520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRGN |
1.87389257960691e-05 |
|
| 1521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS26A |
1.87389257960691e-05 |
|
| 1522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPV3L1 |
1.87389257960691e-05 |
|
| 1523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HKDC1 |
1.87389257960691e-05 |
|
| 1524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HK1 |
1.87389257960691e-05 |
|
| 1525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACR2 |
1.87389257960691e-05 |
|
| 1526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN15 |
1.87389257960691e-05 |
|
| 1527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROG3 |
1.87389257960691e-05 |
|
| 1528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf35 |
1.87389257960691e-05 |
|
| 1529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL13A1 |
1.87389257960691e-05 |
|
| 1530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFY2 |
1.87389257960691e-05 |
|
| 1531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIFM2 |
1.87389257960691e-05 |
|
| 1532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYSND1 |
1.87389257960691e-05 |
|
| 1533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAR1A |
1.87389257960691e-05 |
|
| 1534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPA1 |
1.87389257960691e-05 |
|
| 1535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPFFR1 |
1.87389257960691e-05 |
|
| 1536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC20 |
1.87389257960691e-05 |
|
| 1537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4EBP2 |
1.87389257960691e-05 |
|
| 1538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NODAL |
1.87389257960691e-05 |
|
| 1539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALD1 |
1.87389257960691e-05 |
|
| 1540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRF1 |
1.87389257960691e-05 |
|
| 1541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS14 |
1.87389257960691e-05 |
|
| 1542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBATA |
1.87389257960691e-05 |
|
| 1543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGPL1 |
1.87389257960691e-05 |
|
| 1544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBD1 |
1.87389257960691e-05 |
|
| 1545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC5B |
1.87389257960691e-05 |
|
| 1546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC29A3 |
1.87389257960691e-05 |
|
| 1547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238918.1 |
1.87389257960691e-05 |
|
| 1548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH23 |
1.87389257960691e-05 |
|
| 1549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf105 |
1.87389257960691e-05 |
|
| 1550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf54 |
1.87389257960691e-05 |
|
| 1551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSAP |
1.87389257960691e-05 |
|
| 1552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST3 |
1.87389257960691e-05 |
|
| 1553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOCK2 |
1.87389257960691e-05 |
|
| 1554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCC1 |
1.87389257960691e-05 |
|
| 1555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA36|ENSG00000200294.1 |
1.87389257960691e-05 |
|
| 1556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC16 |
1.87389257960691e-05 |
|
| 1557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDIT4 |
1.87389257960691e-05 |
|
| 1558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB12 |
1.87389257960691e-05 |
|
| 1559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICU1 |
1.87389257960691e-05 |
|
| 1560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCU |
1.87389257960691e-05 |
|
| 1561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4676 |
1.87389257960691e-05 |
|
| 1562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OIT3 |
1.87389257960691e-05 |
|
| 1563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G12B |
1.87389257960691e-05 |
|
| 1564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P4HA1 |
1.87389257960691e-05 |
|
| 1565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT13 |
1.87389257960691e-05 |
|
| 1566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221164.1 |
1.87389257960691e-05 |
|
| 1567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECD |
1.87389257960691e-05 |
|
| 1568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM149B1 |
1.87389257960691e-05 |
|
| 1569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC9 |
1.87389257960691e-05 |
|
| 1570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS16 |
1.87389257960691e-05 |
|
| 1571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC18 |
1.87389257960691e-05 |
|
| 1572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238983.1 |
1.87389257960691e-05 |
|
| 1573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA7 |
1.87389257960691e-05 |
|
| 1574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSS51 |
1.87389257960691e-05 |
|
| 1575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP3CB |
1.87389257960691e-05 |
|
| 1576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP54 |
1.87389257960691e-05 |
|
| 1577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOZ1 |
1.87389257960691e-05 |
|
| 1578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNPO2L |
1.87389257960691e-05 |
|
| 1579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP5 |
1.87389257960691e-05 |
|
| 1580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP320 |
1.87389257960691e-05 |
|
| 1581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMS1P4 |
1.87389257960691e-05 |
|
| 1582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLUD1P3 |
1.87389257960691e-05 |
|
| 1583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC24C |
1.87389257960691e-05 |
|
| 1584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT11 |
1.87389257960691e-05 |
|
| 1585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRPP1 |
1.87389257960691e-05 |
|
| 1586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD1 |
1.87389257960691e-05 |
|
| 1587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM8 |
1.87389257960691e-05 |
|
| 1588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDST2 |
1.87389257960691e-05 |
|
| 1589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2G |
1.87389257960691e-05 |
|
| 1590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf55 |
1.87389257960691e-05 |
|
| 1591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAU |
1.87389257960691e-05 |
|
| 1592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCL |
1.87389257960691e-05 |
|
| 1593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3M1 |
1.87389257960691e-05 |
|
| 1594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADK |
1.87389257960691e-05 |
|
| 1595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT6B |
1.87389257960691e-05 |
|
| 1596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUPD1 |
1.87389257960691e-05 |
|
| 1597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP13 |
1.87389257960691e-05 |
|
| 1598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD8 |
1.87389257960691e-05 |
|
| 1599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VDAC2 |
1.87389257960691e-05 |
|
| 1600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMTD1 |
1.87389257960691e-05 |
|
| 1601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF503 |
1.87389257960691e-05 |
|
| 1602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR606 |
1.87389257960691e-05 |
|
| 1603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf11 |
1.87389257960691e-05 |
|
| 1604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL518P |
1.87389257960691e-05 |
|
| 1605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252888.1 |
1.87389257960691e-05 |
|
| 1606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMA1 |
1.87389257960691e-05 |
|
| 1607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP321 |
1.87389257960691e-05 |
|
| 1608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLG5 |
1.87389257960691e-05 |
|
| 1609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL284P |
1.87389257960691e-05 |
|
| 1610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3A |
1.87389257960691e-05 |
|
| 1611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS24 |
1.87389257960691e-05 |
|
| 1612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA71|ENSG00000201393.1 |
1.87389257960691e-05 |
|
| 1613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMIZ1 |
1.87389257960691e-05 |
|
| 1614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIF |
1.87389257960691e-05 |
|
| 1615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC24 |
1.87389257960691e-05 |
|
| 1616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHITM |
1.87389257960691e-05 |
|
| 1617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf99 |
1.87389257960691e-05 |
|
| 1618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDHR1 |
1.87389257960691e-05 |
|
| 1619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIT2 |
1.87389257960691e-05 |
|
| 1620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIT1 |
1.87389257960691e-05 |
|
| 1621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGR |
1.87389257960691e-05 |
|
| 1622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00858 |
1.87389257960691e-05 |
|
| 1623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELLS |
1.87389257960691e-05 |
|
| 1624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH15 |
2.26411923807124e-05 |
|
| 1625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00856 |
2.31537618691213e-05 |
|
| 1626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00595 |
2.31537618691213e-05 |
|
| 1627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAML2 |
2.54422888680272e-05 |
|
| 1628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMTK3 |
2.75836585370559e-05 |
|
| 1629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT2B1 |
2.75836585370559e-05 |
|
| 1630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83E |
2.75836585370559e-05 |
|
| 1631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA4 |
2.75836585370559e-05 |
|
| 1632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL18 |
2.75836585370559e-05 |
|
| 1633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPHK2 |
2.75836585370559e-05 |
|
| 1634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBP |
2.75836585370559e-05 |
|
| 1635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA11 |
2.75836585370559e-05 |
|
| 1636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC1P |
2.75836585370559e-05 |
|
| 1637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTN5 |
2.75836585370559e-05 |
|
| 1638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT2 |
2.75836585370559e-05 |
|
| 1639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL345P |
2.75836585370559e-05 |
|
| 1640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAMSTR |
2.75836585370559e-05 |
|
| 1641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASIP1 |
2.75836585370559e-05 |
|
| 1642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IZUMO1 |
2.75836585370559e-05 |
|
| 1643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT1 |
2.75836585370559e-05 |
|
| 1644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF21 |
2.75836585370559e-05 |
|
| 1645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAT2 |
2.75836585370559e-05 |
|
| 1646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B14 |
2.75836585370559e-05 |
|
| 1647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA4 |
2.75836585370559e-05 |
|
| 1648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R15A |
2.75836585370559e-05 |
|
| 1649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TULP2 |
2.75836585370559e-05 |
|
| 1650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUCB1 |
2.75836585370559e-05 |
|
| 1651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHDH |
2.75836585370559e-05 |
|
| 1652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAX |
2.75836585370559e-05 |
|
| 1653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTL |
2.75836585370559e-05 |
|
| 1654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYS1 |
2.75836585370559e-05 |
|
| 1655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUVBL2 |
2.75836585370559e-05 |
|
| 1656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHB |
2.75836585370559e-05 |
|
| 1657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB2 |
2.75836585370559e-05 |
|
| 1658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB |
2.75836585370559e-05 |
|
| 1659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB1 |
2.75836585370559e-05 |
|
| 1660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB5 |
2.75836585370559e-05 |
|
| 1661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB7 |
2.75836585370559e-05 |
|
| 1662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGB8 |
2.75836585370559e-05 |
|
| 1663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTF4 |
2.75836585370559e-05 |
|
| 1664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA7 |
2.75836585370559e-05 |
|
| 1665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL708P |
2.75836585370559e-05 |
|
| 1666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP70 |
2.75836585370559e-05 |
|
| 1667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN7B |
2.75836585370559e-05 |
|
| 1668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf73 |
2.75836585370559e-05 |
|
| 1669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIA3 |
2.75836585370559e-05 |
|
| 1670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRC |
2.75836585370559e-05 |
|
| 1671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM4 |
2.75836585370559e-05 |
|
| 1672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A16 |
2.75836585370559e-05 |
|
| 1673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4324 |
2.75836585370559e-05 |
|
| 1674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD37 |
2.75836585370559e-05 |
|
| 1675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEAD2 |
2.75836585370559e-05 |
|
| 1676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKKL1 |
2.75836585370559e-05 |
|
| 1677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC155 |
2.75836585370559e-05 |
|
| 1678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTH2 |
2.75836585370559e-05 |
|
| 1679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A7 |
2.75836585370559e-05 |
|
| 1680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIH1D1 |
2.75836585370559e-05 |
|
| 1681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH16A1 |
2.75836585370559e-05 |
|
| 1682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLT3LG |
2.75836585370559e-05 |
|
| 1683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL13A |
2.75836585370559e-05 |
|
| 1684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD32A |
2.75836585370559e-05 |
|
| 1685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD33|ENSG00000199631.1 |
2.75836585370559e-05 |
|
| 1686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD34 |
2.75836585370559e-05 |
|
| 1687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD35A |
2.75836585370559e-05 |
|
| 1688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS11 |
2.75836585370559e-05 |
|
| 1689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD35B |
2.75836585370559e-05 |
|
| 1690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGRT |
2.75836585370559e-05 |
|
| 1691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR150 |
2.75836585370559e-05 |
|
| 1692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCN3 |
2.75836585370559e-05 |
|
| 1693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOSIP |
2.75836585370559e-05 |
|
| 1694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRG2 |
2.75836585370559e-05 |
|
| 1695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10ORF32 |
3.25687112040507e-05 |
|
| 1696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AS3MT |
3.25687112040507e-05 |
|
| 1697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNNM2 |
3.25687112040507e-05 |
|
| 1698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C2 |
3.25687112040507e-05 |
|
| 1699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INA |
3.25687112040507e-05 |
|
| 1700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGF6 |
3.25687112040507e-05 |
|
| 1701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF5 |
3.25687112040507e-05 |
|
| 1702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALHM1 |
3.25687112040507e-05 |
|
| 1703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALHM2 |
3.25687112040507e-05 |
|
| 1704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1307 |
3.25687112040507e-05 |
|
| 1705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD11 |
3.25687112040507e-05 |
|
| 1706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USMG5 |
3.25687112040507e-05 |
|
| 1707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALHM3 |
3.25687112040507e-05 |
|
| 1708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEURL |
3.25687112040507e-05 |
|
| 1709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3PXD2A |
3.25687112040507e-05 |
|
| 1710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OBFC1 |
3.25687112040507e-05 |
|
| 1711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLK |
3.25687112040507e-05 |
|
| 1712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL524P |
3.25687112040507e-05 |
|
| 1713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL17A1 |
3.25687112040507e-05 |
|
| 1714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR936 |
3.25687112040507e-05 |
|
| 1715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFR1 |
3.25687112040507e-05 |
|
| 1716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR96 |
3.25687112040507e-05 |
|
| 1717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR609 |
3.25687112040507e-05 |
|
| 1718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTO1 |
3.25687112040507e-05 |
|
| 1719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTO2 |
3.25687112040507e-05 |
|
| 1720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPRIP |
3.25687112040507e-05 |
|
| 1721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC147 |
3.25687112040507e-05 |
|
| 1722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238620.1 |
3.25687112040507e-05 |
|
| 1723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORCS3 |
3.25687112040507e-05 |
|
| 1724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORCS1 |
3.25687112040507e-05 |
|
| 1725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP325 |
3.25687112040507e-05 |
|
| 1726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP326 |
3.25687112040507e-05 |
|
| 1727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP278 |
3.85292638810375e-05 |
|
| 1728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPNPEP1 |
3.85292638810375e-05 |
|
| 1729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U4|ENSG00000272160.1 |
3.85292638810375e-05 |
|
| 1730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADD3 |
3.85292638810375e-05 |
|
| 1731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL450P |
3.85292638810375e-05 |
|
| 1732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXI1 |
3.85292638810375e-05 |
|
| 1733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMNDC1 |
3.85292638810375e-05 |
|
| 1734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP5 |
3.85292638810375e-05 |
|
| 1735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC3 |
3.85292638810375e-05 |
|
| 1736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239125.1 |
3.85292638810375e-05 |
|
| 1737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL686P |
3.85292638810375e-05 |
|
| 1738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM20 |
3.85292638810375e-05 |
|
| 1739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP288 |
3.85292638810375e-05 |
|
| 1740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP327 |
3.85292638810375e-05 |
|
| 1741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD4 |
3.85292638810375e-05 |
|
| 1742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBIP1 |
3.85292638810375e-05 |
|
| 1743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4680 |
3.85292638810375e-05 |
|
| 1744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHOC2 |
3.85292638810375e-05 |
|
| 1745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548E |
3.85292638810375e-05 |
|
| 1746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA2A |
3.85292638810375e-05 |
|
| 1747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPAM |
3.85292638810375e-05 |
|
| 1748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECTB |
3.85292638810375e-05 |
|
| 1749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY2GP |
3.85292638810375e-05 |
|
| 1750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSL5 |
3.85292638810375e-05 |
|
| 1751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC6 |
3.85292638810375e-05 |
|
| 1752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VTI1A |
3.85292638810375e-05 |
|
| 1753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4295 |
3.85292638810375e-05 |
|
| 1754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTYH1 |
4.22308838575747e-05 |
|
| 1755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LENG8 |
4.22308838575747e-05 |
|
| 1756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42EP5 |
4.22308838575747e-05 |
|
| 1757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LENG9 |
4.22308838575747e-05 |
|
| 1758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN7 |
4.54991970126883e-05 |
|
| 1759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARK4 |
4.54991970126883e-05 |
|
| 1760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R37 |
4.54991970126883e-05 |
|
| 1761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKPD1 |
4.54991970126883e-05 |
|
| 1762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC6A |
4.54991970126883e-05 |
|
| 1763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S3 |
4.54991970126883e-05 |
|
| 1764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC3L2 |
4.54991970126883e-05 |
|
| 1765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKM |
4.54991970126883e-05 |
|
| 1766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD3EAP |
4.54991970126883e-05 |
|
| 1767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC1 |
4.54991970126883e-05 |
|
| 1768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC2 |
4.54991970126883e-05 |
|
| 1769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLC3 |
4.54991970126883e-05 |
|
| 1770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R13L |
4.54991970126883e-05 |
|
| 1771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOSB |
4.54991970126883e-05 |
|
| 1772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN2 |
4.54991970126883e-05 |
|
| 1773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1N |
4.54991970126883e-05 |
|
| 1774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VASP |
4.54991970126883e-05 |
|
| 1775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPA3 |
4.54991970126883e-05 |
|
| 1776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR4 |
4.54991970126883e-05 |
|
| 1777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML2 |
4.54991970126883e-05 |
|
| 1778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR330 |
4.54991970126883e-05 |
|
| 1779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL836P |
4.54991970126883e-05 |
|
| 1780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIPR |
4.54991970126883e-05 |
|
| 1781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR642A |
4.54991970126883e-05 |
|
| 1782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPD2 |
4.54991970126883e-05 |
|
| 1783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QPCTL |
4.54991970126883e-05 |
|
| 1784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO46 |
4.54991970126883e-05 |
|
| 1785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMPK |
4.54991970126883e-05 |
|
| 1786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX5 |
4.54991970126883e-05 |
|
| 1787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMWD |
4.54991970126883e-05 |
|
| 1788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH6A |
4.54991970126883e-05 |
|
| 1789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYMPK |
4.54991970126883e-05 |
|
| 1790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXA3 |
4.54991970126883e-05 |
|
| 1791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF2BP1 |
4.54991970126883e-05 |
|
| 1792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYPOP |
4.54991970126883e-05 |
|
| 1793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOS2 |
4.54991970126883e-05 |
|
| 1794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOVA2 |
4.54991970126883e-05 |
|
| 1795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC61 |
4.54991970126883e-05 |
|
| 1796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR769 |
4.54991970126883e-05 |
|
| 1797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGLYRP1 |
4.54991970126883e-05 |
|
| 1798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFL4 |
4.54991970126883e-05 |
|
| 1799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFL3 |
4.54991970126883e-05 |
|
| 1800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFL2 |
4.54991970126883e-05 |
|
| 1801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFL1 |
4.54991970126883e-05 |
|
| 1802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIF3A |
4.54991970126883e-05 |
|
| 1803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP5C |
4.54991970126883e-05 |
|
| 1804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC8 |
4.54991970126883e-05 |
|
| 1805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMAL1 |
4.54991970126883e-05 |
|
| 1806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMAL2 |
4.54991970126883e-05 |
|
| 1807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP5D1 |
4.54991970126883e-05 |
|
| 1808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALM3 |
4.54991970126883e-05 |
|
| 1809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGIR |
4.54991970126883e-05 |
|
| 1810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG8 |
4.54991970126883e-05 |
|
| 1811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DACT3 |
4.54991970126883e-05 |
|
| 1812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKD2 |
4.54991970126883e-05 |
|
| 1813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL364P |
4.54991970126883e-05 |
|
| 1814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320E |
4.54991970126883e-05 |
|
| 1815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRN4 |
4.54991970126883e-05 |
|
| 1816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKRP |
4.54991970126883e-05 |
|
| 1817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A5 |
4.54991970126883e-05 |
|
| 1818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP2S1 |
4.54991970126883e-05 |
|
| 1819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP35 |
4.54991970126883e-05 |
|
| 1820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252071.1 |
4.54991970126883e-05 |
|
| 1821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAS1 |
4.54991970126883e-05 |
|
| 1822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM160 |
4.54991970126883e-05 |
|
| 1823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H4 |
4.54991970126883e-05 |
|
| 1824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL533P |
4.54991970126883e-05 |
|
| 1825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAE1 |
4.54991970126883e-05 |
|
| 1826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBC3 |
4.54991970126883e-05 |
|
| 1827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3191 |
4.54991970126883e-05 |
|
| 1828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC9 |
4.54991970126883e-05 |
|
| 1829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR24 |
4.54991970126883e-05 |
|
| 1830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5AR1 |
4.54991970126883e-05 |
|
| 1831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5AR2 |
4.54991970126883e-05 |
|
| 1832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX34 |
4.54991970126883e-05 |
|
| 1833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEIS3 |
4.54991970126883e-05 |
|
| 1834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC8A2 |
4.54991970126883e-05 |
|
| 1835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPTN |
4.54991970126883e-05 |
|
| 1836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPA |
4.54991970126883e-05 |
|
| 1837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF541 |
4.54991970126883e-05 |
|
| 1838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL322P |
4.54991970126883e-05 |
|
| 1839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTSCR1 |
4.54991970126883e-05 |
|
| 1840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHD2 |
4.54991970126883e-05 |
|
| 1841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTSCR2 |
4.54991970126883e-05 |
|
| 1842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD23|ENSG00000221803.1 |
4.54991970126883e-05 |
|
| 1843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPW1 |
4.54991970126883e-05 |
|
| 1844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRX1 |
4.54991970126883e-05 |
|
| 1845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRX |
4.54991970126883e-05 |
|
| 1846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRX2P |
4.54991970126883e-05 |
|
| 1847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT2A1 |
4.54991970126883e-05 |
|
| 1848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSPH1 |
4.54991970126883e-05 |
|
| 1849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELSPBP1 |
4.54991970126883e-05 |
|
| 1850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABP5 |
4.54991970126883e-05 |
|
| 1851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4C |
4.54991970126883e-05 |
|
| 1852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIG1 |
4.54991970126883e-05 |
|
| 1853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf68 |
4.54991970126883e-05 |
|
| 1854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF114 |
4.54991970126883e-05 |
|
| 1855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD8 |
4.54991970126883e-05 |
|
| 1856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC114 |
4.54991970126883e-05 |
|
| 1857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMP3 |
4.54991970126883e-05 |
|
| 1858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM143 |
4.54991970126883e-05 |
|
| 1859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNGR4 |
4.54991970126883e-05 |
|
| 1860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDELR1 |
4.54991970126883e-05 |
|
| 1861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN2D |
4.54991970126883e-05 |
|
| 1862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRWD1 |
4.54991970126883e-05 |
|
| 1863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ14 |
4.54991970126883e-05 |
|
| 1864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTH2 |
4.54991970126883e-05 |
|
| 1865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR12 |
4.54991970126883e-05 |
|
| 1866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAS |
4.54991970126883e-05 |
|
| 1867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAF1 |
4.54991970126883e-05 |
|
| 1868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADM5 |
4.54991970126883e-05 |
|
| 1869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L12 |
4.54991970126883e-05 |
|
| 1870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPT1C |
4.54991970126883e-05 |
|
| 1871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF3 |
4.54991970126883e-05 |
|
| 1872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5088 |
4.54991970126883e-05 |
|
| 1873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT1 |
4.54991970126883e-05 |
|
| 1874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSKS |
4.54991970126883e-05 |
|
| 1875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP2A1 |
4.54991970126883e-05 |
|
| 1876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUZ |
4.54991970126883e-05 |
|
| 1877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED25 |
4.54991970126883e-05 |
|
| 1878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTOV1 |
4.54991970126883e-05 |
|
| 1879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4749 |
4.54991970126883e-05 |
|
| 1880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNKP |
4.54991970126883e-05 |
|
| 1881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKT1S1 |
4.54991970126883e-05 |
|
| 1882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF5 |
4.54991970126883e-05 |
|
| 1883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL4I1 |
4.54991970126883e-05 |
|
| 1884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4750 |
4.54991970126883e-05 |
|
| 1885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4751 |
4.54991970126883e-05 |
|
| 1886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP62 |
4.54991970126883e-05 |
|
| 1887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC11 |
4.54991970126883e-05 |
|
| 1888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC16 |
4.54991970126883e-05 |
|
| 1889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D17 |
4.54991970126883e-05 |
|
| 1890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221125.1 |
4.54991970126883e-05 |
|
| 1891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VRK3 |
4.54991970126883e-05 |
|
| 1892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF473 |
4.54991970126883e-05 |
|
| 1893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IZUMO2 |
4.54991970126883e-05 |
|
| 1894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH14 |
4.54991970126883e-05 |
|
| 1895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNC3 |
4.54991970126883e-05 |
|
| 1896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPSB |
4.54991970126883e-05 |
|
| 1897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1H2 |
4.54991970126883e-05 |
|
| 1898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPSA |
4.54991970126883e-05 |
|
| 1899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLD1 |
4.54991970126883e-05 |
|
| 1900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL324P |
4.54991970126883e-05 |
|
| 1901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIB |
4.54991970126883e-05 |
|
| 1902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBPC2 |
4.54991970126883e-05 |
|
| 1903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71E1 |
4.54991970126883e-05 |
|
| 1904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC10 |
4.54991970126883e-05 |
|
| 1905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JOSD2 |
4.54991970126883e-05 |
|
| 1906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPDH |
4.54991970126883e-05 |
|
| 1907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC4B |
4.54991970126883e-05 |
|
| 1908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT3 |
4.54991970126883e-05 |
|
| 1909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf81 |
4.54991970126883e-05 |
|
| 1910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHANK1 |
4.54991970126883e-05 |
|
| 1911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC11A |
4.54991970126883e-05 |
|
| 1912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR32 |
4.54991970126883e-05 |
|
| 1913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACPT |
4.54991970126883e-05 |
|
| 1914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf48 |
4.54991970126883e-05 |
|
| 1915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD88A |
4.54991970126883e-05 |
|
| 1916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD88B |
4.54991970126883e-05 |
|
| 1917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD88C |
4.54991970126883e-05 |
|
| 1918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK1 |
4.54991970126883e-05 |
|
| 1919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK15 |
4.54991970126883e-05 |
|
| 1920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK2 |
4.54991970126883e-05 |
|
| 1921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK3 |
4.54991970126883e-05 |
|
| 1922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK4 |
4.54991970126883e-05 |
|
| 1923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLKP1 |
4.54991970126883e-05 |
|
| 1924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK5 |
4.54991970126883e-05 |
|
| 1925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK6 |
4.54991970126883e-05 |
|
| 1926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK7 |
4.54991970126883e-05 |
|
| 1927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK8 |
4.54991970126883e-05 |
|
| 1928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK9 |
4.54991970126883e-05 |
|
| 1929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK10 |
4.54991970126883e-05 |
|
| 1930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK11 |
4.54991970126883e-05 |
|
| 1931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK12 |
4.54991970126883e-05 |
|
| 1932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK13 |
4.54991970126883e-05 |
|
| 1933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLK14 |
4.54991970126883e-05 |
|
| 1934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTU1 |
4.54991970126883e-05 |
|
| 1935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC7 |
4.54991970126883e-05 |
|
| 1936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC9 |
4.54991970126883e-05 |
|
| 1937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC17P |
4.54991970126883e-05 |
|
| 1938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC22P |
4.54991970126883e-05 |
|
| 1939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000253027.1 |
4.61987326536573e-05 |
|
| 1940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLC |
4.61987326536573e-05 |
|
| 1941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAM |
4.61987326536573e-05 |
|
| 1942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVRL2 |
4.61987326536573e-05 |
|
| 1943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM40 |
4.61987326536573e-05 |
|
| 1944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOE |
4.61987326536573e-05 |
|
| 1945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOC1 |
4.61987326536573e-05 |
|
| 1946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOC1P1 |
4.61987326536573e-05 |
|
| 1947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOC4 |
4.61987326536573e-05 |
|
| 1948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOC2 |
4.61987326536573e-05 |
|
| 1949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPTM1 |
4.61987326536573e-05 |
|
| 1950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELB |
4.61987326536573e-05 |
|
| 1951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLASRP |
4.61987326536573e-05 |
|
| 1952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF296 |
4.61987326536573e-05 |
|
| 1953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADARB2 |
6.35497662995199e-05 |
|
| 1954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF6 |
6.35497662995199e-05 |
|
| 1955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1E2 |
6.35497662995199e-05 |
|
| 1956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1C1 |
6.35497662995199e-05 |
|
| 1957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000238840.1 |
6.35497662995199e-05 |
|
| 1958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1C2 |
6.35497662995199e-05 |
|
| 1959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000239148.1 |
6.35497662995199e-05 |
|
| 1960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARD3 |
7.0121365805309e-05 |
|
| 1961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL2 |
7.0121365805309e-05 |
|
| 1962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3611 |
7.0121365805309e-05 |
|
| 1963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREM |
7.0121365805309e-05 |
|
| 1964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNY |
7.0121365805309e-05 |
|
| 1965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJD4 |
7.0121365805309e-05 |
|
| 1966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD8 |
7.0121365805309e-05 |
|
| 1967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4683 |
7.0121365805309e-05 |
|
| 1968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIP2C |
7.06419883882425e-05 |
|
| 1969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP297 |
7.06419883882425e-05 |
|
| 1970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP298 |
7.06419883882425e-05 |
|
| 1971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB8 |
7.06419883882425e-05 |
|
| 1972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND11 |
7.06419883882425e-05 |
|
| 1973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL754P |
7.06419883882425e-05 |
|
| 1974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5699 |
7.06419883882425e-05 |
|
| 1975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR26 |
7.06419883882425e-05 |
|
| 1976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP4B |
7.06419883882425e-05 |
|
| 1977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP4 |
7.06419883882425e-05 |
|
| 1978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDI1 |
7.06419883882425e-05 |
|
| 1979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDI2 |
7.06419883882425e-05 |
|
| 1980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00200 |
7.06419883882425e-05 |
|
| 1981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR37 |
7.06419883882425e-05 |
|
| 1982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00700 |
7.06419883882425e-05 |
|
| 1983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00701 |
7.06419883882425e-05 |
|
| 1984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKP |
7.06419883882425e-05 |
|
| 1985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITRM1 |
7.06419883882425e-05 |
|
| 1986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00702 |
7.06419883882425e-05 |
|
| 1987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00703 |
7.06419883882425e-05 |
|
| 1988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00704 |
7.06419883882425e-05 |
|
| 1989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00705 |
7.06419883882425e-05 |
|
| 1990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1C3 |
7.06419883882425e-05 |
|
| 1991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000251740.1 |
7.06419883882425e-05 |
|
| 1992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000239142.1 |
7.06419883882425e-05 |
|
| 1993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1CL1 |
7.06419883882425e-05 |
|
| 1994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1C4 |
7.06419883882425e-05 |
|
| 1995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000251909.1 |
7.06419883882425e-05 |
|
| 1996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1C7P |
7.06419883882425e-05 |
|
| 1997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCN3 |
7.06419883882425e-05 |
|
| 1998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBAL3 |
7.06419883882425e-05 |
|
| 1999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NET1 |
7.06419883882425e-05 |
|
| 2000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALML5 |
7.06419883882425e-05 |
|
| 2001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALML3 |
7.06419883882425e-05 |
|
| 2002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB13 |
7.06419883882425e-05 |
|
| 2003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL445P |
7.06419883882425e-05 |
|
| 2004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM208B |
7.06419883882425e-05 |
|
| 2005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDI2 |
7.06419883882425e-05 |
|
| 2006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD16 |
7.06419883882425e-05 |
|
| 2007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO18 |
7.06419883882425e-05 |
|
| 2008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL15RA |
7.06419883882425e-05 |
|
| 2009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL2RA |
7.06419883882425e-05 |
|
| 2010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA14 |
7.06419883882425e-05 |
|
| 2011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM17 |
7.06419883882425e-05 |
|
| 2012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKFB3 |
7.06419883882425e-05 |
|
| 2013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP78 |
7.06419883882425e-05 |
|
| 2014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3155A |
7.06419883882425e-05 |
|
| 2015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP667F0711 |
7.06419883882425e-05 |
|
| 2016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCQ |
7.06419883882425e-05 |
|
| 2017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00707 |
7.06419883882425e-05 |
|
| 2018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFMBT2 |
7.06419883882425e-05 |
|
| 2019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH5 |
7.06419883882425e-05 |
|
| 2020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH2 |
7.06419883882425e-05 |
|
| 2021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIN |
7.06419883882425e-05 |
|
| 2022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5C1 |
7.06419883882425e-05 |
|
| 2023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF3 |
7.06419883882425e-05 |
|
| 2024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA3 |
7.06419883882425e-05 |
|
| 2025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00708 |
7.06419883882425e-05 |
|
| 2026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP299 |
7.06419883882425e-05 |
|
| 2027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00709 |
7.06419883882425e-05 |
|
| 2028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTA1P |
7.06419883882425e-05 |
|
| 2029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00710 |
7.06419883882425e-05 |
|
| 2030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF2 |
7.06419883882425e-05 |
|
| 2031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP6NL |
7.06419883882425e-05 |
|
| 2032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECHDC3 |
7.06419883882425e-05 |
|
| 2033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROSER2 |
7.06419883882425e-05 |
|
| 2034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPF2 |
7.06419883882425e-05 |
|
| 2035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHTKD1 |
7.06419883882425e-05 |
|
| 2036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AK |
7.06419883882425e-05 |
|
| 2037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC61A2 |
7.06419883882425e-05 |
|
| 2038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272507.1 |
7.06419883882425e-05 |
|
| 2039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238900.1 |
7.06419883882425e-05 |
|
| 2040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT5 |
7.06419883882425e-05 |
|
| 2041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC123 |
7.06419883882425e-05 |
|
| 2042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL232P |
7.06419883882425e-05 |
|
| 2043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL198P |
7.06419883882425e-05 |
|
| 2044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK1D |
7.06419883882425e-05 |
|
| 2045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45|ENSG00000252438.1 |
7.06419883882425e-05 |
|
| 2046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC39P |
7.06419883882425e-05 |
|
| 2047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4480 |
7.06419883882425e-05 |
|
| 2048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548Q |
7.06419883882425e-05 |
|
| 2049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC3 |
7.06419883882425e-05 |
|
| 2050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP300 |
7.06419883882425e-05 |
|
| 2051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPTN |
7.06419883882425e-05 |
|
| 2052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM10 |
7.06419883882425e-05 |
|
| 2053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCMA |
7.06419883882425e-05 |
|
| 2054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHYH |
7.06419883882425e-05 |
|
| 2055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPHS1 |
7.06419883882425e-05 |
|
| 2056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND7 |
7.06419883882425e-05 |
|
| 2057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF18 |
7.06419883882425e-05 |
|
| 2058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD4A |
7.06419883882425e-05 |
|
| 2059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP301 |
7.06419883882425e-05 |
|
| 2060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4293 |
7.06419883882425e-05 |
|
| 2061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1265 |
7.06419883882425e-05 |
|
| 2062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM107B |
7.06419883882425e-05 |
|
| 2063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP302 |
7.06419883882425e-05 |
|
| 2064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDNF |
7.06419883882425e-05 |
|
| 2065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA14 |
7.06419883882425e-05 |
|
| 2066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUV39H2 |
7.06419883882425e-05 |
|
| 2067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLRE1C |
7.06419883882425e-05 |
|
| 2068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEIG1 |
7.06419883882425e-05 |
|
| 2069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLAH |
7.06419883882425e-05 |
|
| 2070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACBD7 |
7.06419883882425e-05 |
|
| 2071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf111 |
7.06419883882425e-05 |
|
| 2072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMT2 |
7.06419883882425e-05 |
|
| 2073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP38 |
7.06419883882425e-05 |
|
| 2074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM171A1 |
7.06419883882425e-05 |
|
| 2075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA8 |
7.06419883882425e-05 |
|
| 2076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM188A |
7.06419883882425e-05 |
|
| 2077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239130.1 |
7.06419883882425e-05 |
|
| 2078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252537.1 |
7.06419883882425e-05 |
|
| 2079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238552.1 |
7.06419883882425e-05 |
|
| 2080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTER |
7.06419883882425e-05 |
|
| 2081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QL3 |
7.06419883882425e-05 |
|
| 2082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSU1 |
7.06419883882425e-05 |
|
| 2083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUBN |
7.06419883882425e-05 |
|
| 2084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDMT1 |
7.06419883882425e-05 |
|
| 2085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIM |
7.06419883882425e-05 |
|
| 2086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA6 |
7.06419883882425e-05 |
|
| 2087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPLA |
7.06419883882425e-05 |
|
| 2088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAM |
7.06419883882425e-05 |
|
| 2089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoR442|ENSG00000251959.1 |
7.06419883882425e-05 |
|
| 2090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRC1L1 |
7.06419883882425e-05 |
|
| 2091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRC1 |
7.06419883882425e-05 |
|
| 2092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A12 |
7.06419883882425e-05 |
|
| 2093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM236|ENSG00000148483.7 |
7.06419883882425e-05 |
|
| 2094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM236|ENSG00000184040.7 |
7.06419883882425e-05 |
|
| 2095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000237002.2 |
8.63417153190715e-05 |
|
| 2096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAMPTL |
8.63417153190715e-05 |
|
| 2097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD30A |
8.63417153190715e-05 |
|
| 2098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL314P |
8.63417153190715e-05 |
|
| 2099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L7 |
8.63417153190715e-05 |
|
| 2100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF248 |
8.63417153190715e-05 |
|
| 2101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF25 |
8.63417153190715e-05 |
|
| 2102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF33A |
8.63417153190715e-05 |
|
| 2103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF37A |
8.63417153190715e-05 |
|
| 2104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B7P2 |
8.63417153190715e-05 |
|
| 2105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT7P9 |
8.63417153190715e-05 |
|
| 2106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL150P |
9.74587526264559e-05 |
|
| 2107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPI |
9.74587526264559e-05 |
|
| 2108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD2L |
9.74587526264559e-05 |
|
| 2109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL154P |
9.74587526264559e-05 |
|
| 2110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA2 |
9.74587526264559e-05 |
|
| 2111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WTIP |
9.74587526264559e-05 |
|
| 2112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1B2P |
9.74587526264559e-05 |
|
| 2113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB2B2 |
9.74587526264559e-05 |
|
| 2114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD111|ENSG00000252230.1 |
9.74587526264559e-05 |
|
| 2115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF302 |
9.74587526264559e-05 |
|
| 2116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF181 |
9.74587526264559e-05 |
|
| 2117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF599 |
9.74587526264559e-05 |
|
| 2118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00904 |
9.74587526264559e-05 |
|
| 2119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF30 |
9.74587526264559e-05 |
|
| 2120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF792 |
9.74587526264559e-05 |
|
| 2121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD1A |
9.74587526264559e-05 |
|
| 2122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN1B |
9.74587526264559e-05 |
|
| 2123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPN |
9.74587526264559e-05 |
|
| 2124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD3 |
9.74587526264559e-05 |
|
| 2125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGI4 |
9.74587526264559e-05 |
|
| 2126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD1 |
9.74587526264559e-05 |
|
| 2127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD7 |
9.74587526264559e-05 |
|
| 2128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD5 |
9.74587526264559e-05 |
|
| 2129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM187B |
9.74587526264559e-05 |
|
| 2130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSR |
9.74587526264559e-05 |
|
| 2131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USF2 |
9.74587526264559e-05 |
|
| 2132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAMP |
9.74587526264559e-05 |
|
| 2133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAG |
9.74587526264559e-05 |
|
| 2134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD22 |
9.74587526264559e-05 |
|
| 2135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5196 |
9.74587526264559e-05 |
|
| 2136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FFAR1 |
9.74587526264559e-05 |
|
| 2137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FFAR3 |
9.74587526264559e-05 |
|
| 2138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR42 |
9.74587526264559e-05 |
|
| 2139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL491P |
9.74587526264559e-05 |
|
| 2140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FFAR2 |
9.74587526264559e-05 |
|
| 2141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRTDAP |
9.74587526264559e-05 |
|
| 2142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMKN |
9.74587526264559e-05 |
|
| 2143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBSN |
9.74587526264559e-05 |
|
| 2144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAPDHS |
9.74587526264559e-05 |
|
| 2145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM147 |
9.74587526264559e-05 |
|
| 2146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP4A |
9.74587526264559e-05 |
|
| 2147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS5 |
9.74587526264559e-05 |
|
| 2148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM42 |
9.74587526264559e-05 |
|
| 2149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV2 |
9.74587526264559e-05 |
|
| 2150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6B1 |
9.74587526264559e-05 |
|
| 2151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL765P |
9.74587526264559e-05 |
|
| 2152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK1A |
9.74587526264559e-05 |
|
| 2153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB32 |
9.74587526264559e-05 |
|
| 2154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMT2B |
9.74587526264559e-05 |
|
| 2155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP7 |
9.74587526264559e-05 |
|
| 2156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFLR1 |
9.74587526264559e-05 |
|
| 2157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN37 |
9.74587526264559e-05 |
|
| 2158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSENEN |
9.74587526264559e-05 |
|
| 2159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U2AF1L4 |
9.74587526264559e-05 |
|
| 2160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf55 |
9.74587526264559e-05 |
|
| 2161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB6 |
9.74587526264559e-05 |
|
| 2162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP33 |
9.74587526264559e-05 |
|
| 2163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRODH2 |
9.74587526264559e-05 |
|
| 2164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPHS1 |
9.74587526264559e-05 |
|
| 2165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIRREL2 |
9.74587526264559e-05 |
|
| 2166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APLP1 |
9.74587526264559e-05 |
|
| 2167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL402P |
9.74587526264559e-05 |
|
| 2168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBID |
9.74587526264559e-05 |
|
| 2169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCST |
9.74587526264559e-05 |
|
| 2170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYROBP |
9.74587526264559e-05 |
|
| 2171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRFN3 |
9.74587526264559e-05 |
|
| 2172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHAF1 |
9.74587526264559e-05 |
|
| 2173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNE4 |
9.74587526264559e-05 |
|
| 2174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH6 |
9.74587526264559e-05 |
|
| 2175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIP3 |
9.74587526264559e-05 |
|
| 2176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP8 |
9.74587526264559e-05 |
|
| 2177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR62 |
9.74587526264559e-05 |
|
| 2178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVOL3 |
9.74587526264559e-05 |
|
| 2179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2I |
9.74587526264559e-05 |
|
| 2180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCB |
9.74587526264559e-05 |
|
| 2181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPNS1 |
9.74587526264559e-05 |
|
| 2182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7A1 |
9.74587526264559e-05 |
|
| 2183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF565 |
9.74587526264559e-05 |
|
| 2184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL287P |
9.74587526264559e-05 |
|
| 2185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF146 |
9.74587526264559e-05 |
|
| 2186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00665 |
9.74587526264559e-05 |
|
| 2187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNYL2 |
9.984879531999e-05 |
|
| 2188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00839 |
9.984879531999e-05 |
|
| 2189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF37BP |
9.984879531999e-05 |
|
| 2190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF33B |
9.984879531999e-05 |
|
| 2191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMS1 |
9.984879531999e-05 |
|
| 2192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238732.1 |
9.984879531999e-05 |
|
| 2193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5100 |
9.984879531999e-05 |
|
| 2194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RET |
9.984879531999e-05 |
|
| 2195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSGALNACT2 |
9.984879531999e-05 |
|
| 2196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGEF1A |
9.984879531999e-05 |
|
| 2197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC11P |
9.984879531999e-05 |
|
| 2198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD4 |
9.984879531999e-05 |
|
| 2199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPF |
9.984879531999e-05 |
|
| 2200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221400.1 |
9.984879531999e-05 |
|
| 2201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF487 |
9.984879531999e-05 |
|
| 2202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF239 |
9.984879531999e-05 |
|
| 2203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF485 |
9.984879531999e-05 |
|
| 2204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF32 |
9.984879531999e-05 |
|
| 2205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00619 |
9.984879531999e-05 |
|
| 2206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00840 |
9.984879531999e-05 |
|
| 2207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00841 |
9.984879531999e-05 |
|
| 2208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL12 |
9.984879531999e-05 |
|
| 2209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM72 |
9.984879531999e-05 |
|
| 2210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF4 |
9.984879531999e-05 |
|
| 2211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf10 |
9.984879531999e-05 |
|
| 2212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf25 |
9.984879531999e-05 |
|
| 2213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP164P1 |
9.984879531999e-05 |
|
| 2214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF22 |
9.984879531999e-05 |
|
| 2215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSU1P2 |
9.984879531999e-05 |
|
| 2216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13A1 |
9.984879531999e-05 |
|
| 2217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX5 |
9.984879531999e-05 |
|
| 2218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH8 |
9.984879531999e-05 |
|
| 2219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND4 |
9.984879531999e-05 |
|
| 2220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP10 |
9.984879531999e-05 |
|
| 2221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP4 |
9.984879531999e-05 |
|
| 2222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP9 |
9.984879531999e-05 |
|
| 2223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANTXRLP1 |
9.984879531999e-05 |
|
| 2224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANTXRL |
9.984879531999e-05 |
|
| 2225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA8L1 |
9.984879531999e-05 |
|
| 2226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA8L2 |
9.984879531999e-05 |
|
| 2227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA8 |
9.984879531999e-05 |
|
| 2228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAH2C |
9.984879531999e-05 |
|
| 2229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMS1P1 |
9.984879531999e-05 |
|
| 2230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMS1P2 |
9.984879531999e-05 |
|
| 2231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf43 |
9.984879531999e-05 |
|
| 2232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM21B |
9.984879531999e-05 |
|
| 2233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM21C |
9.984879531999e-05 |
|
| 2234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25B |
9.984879531999e-05 |
|
| 2235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25E |
9.984879531999e-05 |
|
| 2236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25G |
9.984879531999e-05 |
|
| 2237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM35BP |
9.984879531999e-05 |
|
| 2238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRIN2 |
9.984879531999e-05 |
|
| 2239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00842 |
9.984879531999e-05 |
|
| 2240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY4R |
9.984879531999e-05 |
|
| 2241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN20A |
9.984879531999e-05 |
|
| 2242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP3 |
9.984879531999e-05 |
|
| 2243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL248P |
9.984879531999e-05 |
|
| 2244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL453P |
9.984879531999e-05 |
|
| 2245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP310 |
9.984879531999e-05 |
|
| 2246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP311 |
9.984879531999e-05 |
|
| 2247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP312 |
9.984879531999e-05 |
|
| 2248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP313 |
9.984879531999e-05 |
|
| 2249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT15 |
9.984879531999e-05 |
|
| 2250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF488 |
9.984879531999e-05 |
|
| 2251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF2 |
9.984879531999e-05 |
|
| 2252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF10 |
9.984879531999e-05 |
|
| 2253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMS1P5 |
9.984879531999e-05 |
|
| 2254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25C |
9.984879531999e-05 |
|
| 2255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMPD2 |
9.984879531999e-05 |
|
| 2256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLUD1P2 |
9.984879531999e-05 |
|
| 2257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN20B |
9.984879531999e-05 |
|
| 2258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL527P |
9.984879531999e-05 |
|
| 2259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP314 |
9.984879531999e-05 |
|
| 2260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP315 |
9.984879531999e-05 |
|
| 2261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK8 |
9.984879531999e-05 |
|
| 2262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP22 |
9.984879531999e-05 |
|
| 2263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDFY4 |
9.984879531999e-05 |
|
| 2264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC18 |
9.984879531999e-05 |
|
| 2265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4294 |
9.984879531999e-05 |
|
| 2266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM4 |
9.984879531999e-05 |
|
| 2267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM170B |
9.984879531999e-05 |
|
| 2268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf128 |
9.984879531999e-05 |
|
| 2269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf71 |
9.984879531999e-05 |
|
| 2270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRGX |
9.984879531999e-05 |
|
| 2271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC6 |
9.984879531999e-05 |
|
| 2272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGBD3 |
9.984879531999e-05 |
|
| 2273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAT |
9.984879531999e-05 |
|
| 2274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC18A3 |
9.984879531999e-05 |
|
| 2275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf53 |
9.984879531999e-05 |
|
| 2276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGDHL |
9.984879531999e-05 |
|
| 2277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARG |
9.984879531999e-05 |
|
| 2278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP7 |
9.984879531999e-05 |
|
| 2279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP8 |
9.984879531999e-05 |
|
| 2280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM21D |
9.984879531999e-05 |
|
| 2281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM25D |
9.984879531999e-05 |
|
| 2282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSMB |
9.984879531999e-05 |
|
| 2283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP316 |
9.984879531999e-05 |
|
| 2284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000223182.1 |
9.984879531999e-05 |
|
| 2285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM23B |
9.984879531999e-05 |
|
| 2286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA4 |
9.984879531999e-05 |
|
| 2287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP6 |
9.984879531999e-05 |
|
| 2288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAH2 |
9.984879531999e-05 |
|
| 2289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM21A |
9.984879531999e-05 |
|
| 2290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00843 |
9.984879531999e-05 |
|
| 2291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRPP4 |
9.984879531999e-05 |
|
| 2292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP317 |
9.984879531999e-05 |
|
| 2293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGMS1 |
9.984879531999e-05 |
|
| 2294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000223111.1 |
9.984879531999e-05 |
|
| 2295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM23 |
9.984879531999e-05 |
|
| 2296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAH2B |
9.984879531999e-05 |
|
| 2297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A1CF |
9.984879531999e-05 |
|
| 2298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKG1 |
9.984879531999e-05 |
|
| 2299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR605 |
9.984879531999e-05 |
|
| 2300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTF2T |
9.984879531999e-05 |
|
| 2301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKK1 |
9.984879531999e-05 |
|
| 2302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBL2 |
9.984879531999e-05 |
|
| 2303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF229 |
0.0001028280069717 |
|
| 2304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF180 |
0.0001028280069717 |
|
| 2305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM20 |
0.0001028280069717 |
|
| 2306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM22P |
0.0001028280069717 |
|
| 2307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF23 |
0.0001028280069717 |
|
| 2308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVR |
0.0001028280069717 |
|
| 2309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM19 |
0.0001028280069717 |
|
| 2310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM16 |
0.0001028280069717 |
|
| 2311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ6|ENSG00000252200.1 |
0.0001028280069717 |
|
| 2312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL3 |
0.0001028280069717 |
|
| 2313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF155 |
0.000138779078142748 |
|
| 2314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF230 |
0.000138779078142748 |
|
| 2315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF222 |
0.000138779078142748 |
|
| 2316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF223 |
0.000138779078142748 |
|
| 2317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF284 |
0.000138779078142748 |
|
| 2318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL53P |
0.000138779078142748 |
|
| 2319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF224 |
0.000138779078142748 |
|
| 2320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF225 |
0.000138779078142748 |
|
| 2321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF234 |
0.000138779078142748 |
|
| 2322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF226 |
0.000138779078142748 |
|
| 2323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF227 |
0.000138779078142748 |
|
| 2324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF235 |
0.000138779078142748 |
|
| 2325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF233 |
0.000138779078142748 |
|
| 2326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF112 |
0.000138779078142748 |
|
| 2327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF285 |
0.000138779078142748 |
|
| 2328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM4E |
0.000142030533017201 |
|
| 2329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF8 |
0.000142030533017201 |
|
| 2330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC82 |
0.000142030533017201 |
|
| 2331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JRKL |
0.000142030533017201 |
|
| 2332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP346 |
0.000142030533017201 |
|
| 2333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP347 |
0.000142030533017201 |
|
| 2334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL222P |
0.000142030533017201 |
|
| 2335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL5 |
0.000142030533017201 |
|
| 2336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1377 |
0.000142030533017201 |
|
| 2337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf70 |
0.000142030533017201 |
|
| 2338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252679.1 |
0.000142030533017201 |
|
| 2339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239154.1 |
0.000142030533017201 |
|
| 2340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YAP1 |
0.000142030533017201 |
|
| 2341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC2 |
0.000142030533017201 |
|
| 2342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC3 |
0.000142030533017201 |
|
| 2343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM123 |
0.000142030533017201 |
|
| 2344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP7 |
0.000142030533017201 |
|
| 2345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP20 |
0.000142030533017201 |
|
| 2346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP27 |
0.000142030533017201 |
|
| 2347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP8 |
0.000142030533017201 |
|
| 2348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WTAPP1 |
0.000142030533017201 |
|
| 2349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP10 |
0.000142030533017201 |
|
| 2350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP1 |
0.000142030533017201 |
|
| 2351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP3 |
0.000142030533017201 |
|
| 2352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP12 |
0.000142030533017201 |
|
| 2353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP13 |
0.000142030533017201 |
|
| 2354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCUN1D5 |
0.000142030533017201 |
|
| 2355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC2H1 |
0.000142030533017201 |
|
| 2356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4693 |
0.000142030533017201 |
|
| 2357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFD |
0.000142030533017201 |
|
| 2358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDI1 |
0.000142030533017201 |
|
| 2359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP348 |
0.000142030533017201 |
|
| 2360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP12 |
0.000142030533017201 |
|
| 2361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP4 |
0.000142030533017201 |
|
| 2362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP5 |
0.000142030533017201 |
|
| 2363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP1 |
0.000142030533017201 |
|
| 2364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD16 |
0.000142030533017201 |
|
| 2365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD17 |
0.000142030533017201 |
|
| 2366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD18 |
0.000142030533017201 |
|
| 2367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIA4 |
0.000142030533017201 |
|
| 2368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSANTD4 |
0.000142030533017201 |
|
| 2369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD3 |
0.000142030533017201 |
|
| 2370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AASDHPPT |
0.000142030533017201 |
|
| 2371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY1A2 |
0.000142030533017201 |
|
| 2372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWF19L2 |
0.000142030533017201 |
|
| 2373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH8 |
0.000142030533017201 |
|
| 2374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMOD1 |
0.000142030533017201 |
|
| 2375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLN |
0.000142030533017201 |
|
| 2376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F2 |
0.000142030533017201 |
|
| 2377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL5 |
0.000142030533017201 |
|
| 2378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB39A |
0.000142030533017201 |
|
| 2379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAT1 |
0.000142030533017201 |
|
| 2380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAT |
0.000142030533017201 |
|
| 2381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATM |
0.000142030533017201 |
|
| 2382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf65 |
0.000142030533017201 |
|
| 2383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDELC2 |
0.000142030533017201 |
|
| 2384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXPH5 |
0.000142030533017201 |
|
| 2385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX10 |
0.000142030533017201 |
|
| 2386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP349 |
0.000142030533017201 |
|
| 2387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD39|ENSG00000264997.1 |
0.000142030533017201 |
|
| 2388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf87 |
0.000142030533017201 |
|
| 2389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H12C |
0.000142030533017201 |
|
| 2390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDX |
0.000142030533017201 |
|
| 2391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDX1 |
0.000142030533017201 |
|
| 2392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP20 |
0.000142030533017201 |
|
| 2393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP350 |
0.000142030533017201 |
|
| 2394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf53 |
0.000142030533017201 |
|
| 2395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf92 |
0.000142030533017201 |
|
| 2396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf93 |
0.000142030533017201 |
|
| 2397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4491 |
0.000142030533017201 |
|
| 2398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU2AF1 |
0.000142030533017201 |
|
| 2399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTG4 |
0.000142030533017201 |
|
| 2400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf88 |
0.000142030533017201 |
|
| 2401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR34B |
0.000142030533017201 |
|
| 2402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR34C |
0.000142030533017201 |
|
| 2403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAYN |
0.000142030533017201 |
|
| 2404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIK2 |
0.000142030533017201 |
|
| 2405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP273 |
0.000142030533017201 |
|
| 2406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R1B |
0.000142030533017201 |
|
| 2407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG9 |
0.000142030533017201 |
|
| 2408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDXACB1 |
0.000142030533017201 |
|
| 2409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf1 |
0.000142030533017201 |
|
| 2410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYAB |
0.000142030533017201 |
|
| 2411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB2 |
0.000142030533017201 |
|
| 2412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf52 |
0.000142030533017201 |
|
| 2413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIXDC1 |
0.000142030533017201 |
|
| 2414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP351 |
0.000142030533017201 |
|
| 2415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLAT |
0.000142030533017201 |
|
| 2416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF526 |
0.000144758313448401 |
|
| 2417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSK3A |
0.000144758313448401 |
|
| 2418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERF |
0.000144758313448401 |
|
| 2419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIC |
0.000144758313448401 |
|
| 2420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAFAH1B3 |
0.000144758313448401 |
|
| 2421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR19 |
0.000144758313448401 |
|
| 2422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM145 |
0.000144758313448401 |
|
| 2423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGF8 |
0.000144758313448401 |
|
| 2424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNFN |
0.000144758313448401 |
|
| 2425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPE |
0.000144758313448401 |
|
| 2426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL17 |
0.000144758313448401 |
|
| 2427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM1 |
0.000144758313448401 |
|
| 2428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM8 |
0.000144758313448401 |
|
| 2429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD177 |
0.000144758313448401 |
|
| 2430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAMP10 |
0.000144758313448401 |
|
| 2431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG10P |
0.000144758313448401 |
|
| 2432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG11 |
0.000144758313448401 |
|
| 2433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG1 |
0.000144758313448401 |
|
| 2434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG2 |
0.000144758313448401 |
|
| 2435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG3 |
0.000144758313448401 |
|
| 2436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG4 |
0.000144758313448401 |
|
| 2437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG5 |
0.000144758313448401 |
|
| 2438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG6 |
0.000144758313448401 |
|
| 2439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG7 |
0.000144758313448401 |
|
| 2440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG8 |
0.000144758313448401 |
|
| 2441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSG9 |
0.000144758313448401 |
|
| 2442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX101 |
0.000144758313448401 |
|
| 2443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD3 |
0.000144758313448401 |
|
| 2444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDB3 |
0.000144758313448401 |
|
| 2445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETHE1 |
0.000144758313448401 |
|
| 2446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF575 |
0.000144758313448401 |
|
| 2447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC1 |
0.000144758313448401 |
|
| 2448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PINLYP |
0.000144758313448401 |
|
| 2449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRGQ |
0.000144758313448401 |
|
| 2450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRM5 |
0.000144758313448401 |
|
| 2451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF576 |
0.000144758313448401 |
|
| 2452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF428 |
0.000144758313448401 |
|
| 2453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADM4 |
0.000144758313448401 |
|
| 2454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL368P |
0.000144758313448401 |
|
| 2455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRGC |
0.000144758313448401 |
|
| 2456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG9 |
0.000144758313448401 |
|
| 2457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNN4 |
0.000144758313448401 |
|
| 2458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD5 |
0.000144758313448401 |
|
| 2459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF283 |
0.000144758313448401 |
|
| 2460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF404 |
0.000144758313448401 |
|
| 2461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF45 |
0.000144758313448401 |
|
| 2462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BANF2 |
0.000176769293190993 |
|
| 2463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX5 |
0.000176769293190993 |
|
| 2464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVOL2 |
0.000176769293190993 |
|
| 2465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD17 |
0.000176769293190993 |
|
| 2466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGME1 |
0.000176769293190993 |
|
| 2467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRP2BP |
0.000176769293190993 |
|
| 2468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PET117 |
0.000176769293190993 |
|
| 2469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL14P |
0.000176769293190993 |
|
| 2470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF133 |
0.000176769293190993 |
|
| 2471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP74 |
0.000176769293190993 |
|
| 2472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P11 |
0.000176769293190993 |
|
| 2473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00851 |
0.000176769293190993 |
|
| 2474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD15 |
0.000192100186814814 |
|
| 2475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP309 |
0.000235165821046324 |
|
| 2476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238625.1 |
0.000237729769524742 |
|
| 2477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BUD13 |
0.000237729769524742 |
|
| 2478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF259 |
0.000237729769524742 |
|
| 2479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOA5 |
0.000237729769524742 |
|
| 2480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOA4 |
0.000237729769524742 |
|
| 2481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOC3 |
0.000237729769524742 |
|
| 2482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOA1 |
0.000238813297630092 |
|
| 2483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIK3 |
0.000238813297630092 |
|
| 2484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P6 |
0.000238813297630092 |
|
| 2485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAFAH1B2 |
0.000238813297630092 |
|
| 2486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIDT2 |
0.000238813297630092 |
|
| 2487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAGLN |
0.000238813297630092 |
|
| 2488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK7 |
0.000238813297630092 |
|
| 2489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF214 |
0.000238813297630092 |
|
| 2490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA11|ENSG00000252992.1 |
0.000238813297630092 |
|
| 2491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BACE1 |
0.000238813297630092 |
|
| 2492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP164 |
0.000238813297630092 |
|
| 2493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCAML1 |
0.000238813297630092 |
|
| 2494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD2 |
0.000238813297630092 |
|
| 2495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXYD6 |
0.000238813297630092 |
|
| 2496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS13 |
0.000238813297630092 |
|
| 2497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL10RA |
0.000238813297630092 |
|
| 2498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS4 |
0.000238813297630092 |
|
| 2499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN4B |
0.000238813297630092 |
|
| 2500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN2B |
0.000238813297630092 |
|
| 2501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMICA1 |
0.000238813297630092 |
|
| 2502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPZL3 |
0.000238813297630092 |
|
| 2503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPZL2 |
0.000238813297630092 |
|
| 2504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD3E |
0.000238813297630092 |
|
| 2505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD3D |
0.000238813297630092 |
|
| 2506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD3G |
0.000238813297630092 |
|
| 2507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE4A |
0.000238813297630092 |
|
| 2508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5L |
0.000238813297630092 |
|
| 2509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL86P |
0.000238813297630092 |
|
| 2510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMT2A |
0.000238813297630092 |
|
| 2511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM25 |
0.000238813297630092 |
|
| 2512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC36 |
0.000238813297630092 |
|
| 2513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT46 |
0.000238813297630092 |
|
| 2514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARCN1 |
0.000238813297630092 |
|
| 2515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDB1 |
0.000238813297630092 |
|
| 2516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREH |
0.000238813297630092 |
|
| 2517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX6 |
0.000238813297630092 |
|
| 2518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR5 |
0.000238813297630092 |
|
| 2519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL9L |
0.000238813297630092 |
|
| 2520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4492 |
0.000238813297630092 |
|
| 2521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK2 |
0.000238813297630092 |
|
| 2522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL688P |
0.000238813297630092 |
|
| 2523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXR1 |
0.000238813297630092 |
|
| 2524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL529P |
0.000238813297630092 |
|
| 2525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC84 |
0.000238813297630092 |
|
| 2526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS25 |
0.000238813297630092 |
|
| 2527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3656 |
0.000238813297630092 |
|
| 2528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC4 |
0.000238813297630092 |
|
| 2529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC37A4 |
0.000238813297630092 |
|
| 2530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYOU1 |
0.000238813297630092 |
|
| 2531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS11 |
0.000238813297630092 |
|
| 2532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMBS |
0.000238813297630092 |
|
| 2533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPAGT1 |
0.000238813297630092 |
|
| 2534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFX |
0.000238813297630092 |
|
| 2535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD2L |
0.000238813297630092 |
|
| 2536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HINFP |
0.000238813297630092 |
|
| 2537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCG4 |
0.000238813297630092 |
|
| 2538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRX1 |
0.000238813297630092 |
|
| 2539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD3 |
0.000238813297630092 |
|
| 2540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC153 |
0.000238813297630092 |
|
| 2541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBL |
0.000238813297630092 |
|
| 2542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCAM |
0.000238813297630092 |
|
| 2543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000252119.1 |
0.000238813297630092 |
|
| 2544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF26 |
0.000238813297630092 |
|
| 2545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF5 |
0.000238813297630092 |
|
| 2546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFRP |
0.000238813297630092 |
|
| 2547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP2 |
0.000238813297630092 |
|
| 2548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THY1 |
0.000238813297630092 |
|
| 2549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVRL1 |
0.000238813297630092 |
|
| 2550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM29 |
0.000238813297630092 |
|
| 2551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAF |
0.000238813297630092 |
|
| 2552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU2F3 |
0.000238813297630092 |
|
| 2553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM136 |
0.000238813297630092 |
|
| 2554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF12 |
0.000238813297630092 |
|
| 2555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIK4 |
0.000238813297630092 |
|
| 2556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKNOX2 |
0.000238813297630092 |
|
| 2557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEZ1 |
0.000238813297630092 |
|
| 2558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EI24 |
0.000238813297630092 |
|
| 2559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STT3A |
0.000238813297630092 |
|
| 2560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHEK1 |
0.000238813297630092 |
|
| 2561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACRV1 |
0.000238813297630092 |
|
| 2562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATE1 |
0.000238813297630092 |
|
| 2563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTM |
0.000238813297630092 |
|
| 2564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPCML |
0.000238813297630092 |
|
| 2565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238693.1 |
0.000238813297630092 |
|
| 2566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA19 |
0.000238813297630092 |
|
| 2567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4697 |
0.000238813297630092 |
|
| 2568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF9B |
0.000238813297630092 |
|
| 2569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAM3 |
0.000238813297630092 |
|
| 2570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPD3 |
0.000238813297630092 |
|
| 2571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS26B |
0.000238813297630092 |
|
| 2572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THYN1 |
0.000238813297630092 |
|
| 2573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAD8 |
0.000238813297630092 |
|
| 2574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GAT1 |
0.000238813297630092 |
|
| 2575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLB1L2 |
0.000238813297630092 |
|
| 2576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLB1L3 |
0.000238813297630092 |
|
| 2577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAE |
0.000243218988795202 |
|
| 2578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRK |
0.000243218988795202 |
|
| 2579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1C |
0.000243218988795202 |
|
| 2580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5K |
0.000243218988795202 |
|
| 2581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITPNA |
0.000243218988795202 |
|
| 2582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC43A2 |
0.000243218988795202 |
|
| 2583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL105P |
0.000243218988795202 |
|
| 2584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238946.1 |
0.000243218988795202 |
|
| 2585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARF1 |
0.000243218988795202 |
|
| 2586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RILP |
0.000243218988795202 |
|
| 2587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF8 |
0.000243218988795202 |
|
| 2588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR22HG |
0.000243218988795202 |
|
| 2589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLCD2 |
0.000243218988795202 |
|
| 2590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR81 |
0.000243218988795202 |
|
| 2591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINF2 |
0.000243218988795202 |
|
| 2592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC18B |
0.000244961441520086 |
|
| 2593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB15 |
0.000244961441520086 |
|
| 2594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD7 |
0.000244961441520086 |
|
| 2595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAUR |
0.000249059557349551 |
|
| 2596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF221 |
0.000249059557349551 |
|
| 2597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF12 |
0.000344287823120792 |
|
| 2598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238902.1 |
0.000344287823120792 |
|
| 2599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MB21D2 |
0.000344287823120792 |
|
| 2600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRASLS |
0.000344287823120792 |
|
| 2601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP13A5 |
0.000344287823120792 |
|
| 2602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP13A4 |
0.000344287823120792 |
|
| 2603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPA1 |
0.000344287823120792 |
|
| 2604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL447P |
0.000344287823120792 |
|
| 2605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES1 |
0.000344287823120792 |
|
| 2606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL215P |
0.000344287823120792 |
|
| 2607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00887 |
0.000344287823120792 |
|
| 2608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPN2 |
0.000344287823120792 |
|
| 2609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC15 |
0.000344287823120792 |
|
| 2610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP5 |
0.000344287823120792 |
|
| 2611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP13A3 |
0.000344287823120792 |
|
| 2612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00884 |
0.000344287823120792 |
|
| 2613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM44 |
0.000344287823120792 |
|
| 2614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAP2 |
0.000344287823120792 |
|
| 2615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOD |
0.000344287823120792 |
|
| 2616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00969 |
0.000344287823120792 |
|
| 2617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR570 |
0.000344287823120792 |
|
| 2618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC20 |
0.000344287823120792 |
|
| 2619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC4 |
0.000344287823120792 |
|
| 2620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R2 |
0.000344287823120792 |
|
| 2621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL773P |
0.000344287823120792 |
|
| 2622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC24P |
0.000344287823120792 |
|
| 2623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHAP1 |
0.000344287823120792 |
|
| 2624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNK2 |
0.000344287823120792 |
|
| 2625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFRC |
0.000344287823120792 |
|
| 2626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00885 |
0.000344287823120792 |
|
| 2627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC19 |
0.000344287823120792 |
|
| 2628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC51A |
0.000344287823120792 |
|
| 2629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCYT1A |
0.000344287823120792 |
|
| 2630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTEX1D2 |
0.000344287823120792 |
|
| 2631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF19 |
0.000344287823120792 |
|
| 2632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN7 |
0.000344287823120792 |
|
| 2633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL434P |
0.000344287823120792 |
|
| 2634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL738P |
0.000344287823120792 |
|
| 2635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF168 |
0.000344287823120792 |
|
| 2636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCO1 |
0.000344287823120792 |
|
| 2637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR53 |
0.000344287823120792 |
|
| 2638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO45 |
0.000344287823120792 |
|
| 2639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRROS |
0.000344287823120792 |
|
| 2640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGX |
0.000344287823120792 |
|
| 2641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP19 |
0.000344287823120792 |
|
| 2642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFI2 |
0.000344287823120792 |
|
| 2643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCBP2 |
0.000344287823120792 |
|
| 2644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK2 |
0.000344287823120792 |
|
| 2645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGZ |
0.000344287823120792 |
|
| 2646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP5 |
0.000344287823120792 |
|
| 2647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U4|ENSG00000272359.1 |
0.000344287823120792 |
|
| 2648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZEB1 |
0.000596729964168596 |
|
| 2649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP12 |
0.000596729964168596 |
|
| 2650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSTN |
0.000740508832122178 |
|
| 2651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTS2B |
0.000740508832122178 |
|
| 2652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC50 |
0.000740508832122178 |
|
| 2653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLG1 |
0.000740508832122178 |
|
| 2654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMB2 |
0.000821565774494992 |
|
| 2655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP148 |
0.000821565774494992 |
|
| 2656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMAT3 |
0.000821565774494992 |
|
| 2657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3CA |
0.000821565774494992 |
|
| 2658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000201957.1 |
0.000821565774494992 |
|
| 2659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMB3 |
0.000821565774494992 |
|
| 2660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF639 |
0.000821565774494992 |
|
| 2661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFN1 |
0.000821565774494992 |
|
| 2662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB4 |
0.000821565774494992 |
|
| 2663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL6A |
0.000821565774494992 |
|
| 2664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL47 |
0.000821565774494992 |
|
| 2665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB5 |
0.000821565774494992 |
|
| 2666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239096.1 |
0.000821565774494992 |
|
| 2667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP13 |
0.000821565774494992 |
|
| 2668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX5L |
0.000821565774494992 |
|
| 2669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP149 |
0.000821565774494992 |
|
| 2670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000201810.1 |
0.000821565774494992 |
|
| 2671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC14 |
0.000821565774494992 |
|
| 2672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC39 |
0.000821565774494992 |
|
| 2673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL229P |
0.000821565774494992 |
|
| 2674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXR1 |
0.000821565774494992 |
|
| 2675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC19 |
0.000821565774494992 |
|
| 2676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX2 |
0.000821565774494992 |
|
| 2677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP265 |
0.000821565774494992 |
|
| 2678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARS2 |
0.000898862891688612 |
|
| 2679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMD1 |
0.000898862891688612 |
|
| 2680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL825P |
0.00102552029081571 |
|
| 2681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF5B |
0.00102552029081571 |
|
| 2682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPC1 |
0.00102552029081571 |
|
| 2683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC7 |
0.00102552029081571 |
|
| 2684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB1 |
0.00102552029081571 |
|
| 2685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL847P |
0.00102552029081571 |
|
| 2686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRP1 |
0.00102552029081571 |
|
| 2687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL398P |
0.00102552029081571 |
|
| 2688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00838 |
0.00102552029081571 |
|
| 2689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf68 |
0.00112626420324169 |
|
| 2690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2C2 |
0.00128207744432984 |
|
| 2691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS25 |
0.00128207744432984 |
|
| 2692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE20 |
0.00128207744432984 |
|
| 2693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A4P1 |
0.00128207744432984 |
|
| 2694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTAP |
0.00148092806141564 |
|
| 2695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf53 |
0.00148092806141564 |
|
| 2696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2A |
0.00148092806141564 |
|
| 2697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC6 |
0.00150683473386348 |
|
| 2698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR135 |
0.00159580875536613 |
|
| 2699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L3HYPDH |
0.00159580875536613 |
|
| 2700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF121 |
0.00171374959482429 |
|
| 2701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL18BP |
0.00171374959482429 |
|
| 2702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUMA1 |
0.00171374959482429 |
|
| 2703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3165 |
0.00171374959482429 |
|
| 2704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRTOMT |
0.00171374959482429 |
|
| 2705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMTOR1 |
0.00171374959482429 |
|
| 2706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238768.1 |
0.00171374959482429 |
|
| 2707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC15 |
0.00171374959482429 |
|
| 2708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLR3 |
0.00171374959482429 |
|
| 2709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLR1 |
0.00171374959482429 |
|
| 2710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLR2 |
0.00171374959482429 |
|
| 2711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPPL1 |
0.00171374959482429 |
|
| 2712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHOX2A |
0.00171374959482429 |
|
| 2713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINH1 |
0.00171374959482429 |
|
| 2714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP6 |
0.00171374959482429 |
|
| 2715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOGAT2 |
0.00171374959482429 |
|
| 2716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL786P |
0.00171374959482429 |
|
| 2717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGAT2 |
0.00171374959482429 |
|
| 2718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70E |
0.00171374959482429 |
|
| 2719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB38 |
0.00171374959482429 |
|
| 2720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3166 |
0.00171374959482429 |
|
| 2721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239086.1 |
0.00171374959482429 |
|
| 2722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTNR1B |
0.00171374959482429 |
|
| 2723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA9 |
0.00171374959482429 |
|
| 2724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000207112.1 |
0.00171374959482429 |
|
| 2725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1D |
0.00171374959482429 |
|
| 2726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA1|ENSG00000206834.1 |
0.00171374959482429 |
|
| 2727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA32|ENSG00000206799.1 |
0.00171374959482429 |
|
| 2728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA8|ENSG00000207304.1 |
0.00171374959482429 |
|
| 2729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD6 |
0.00171374959482429 |
|
| 2730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1304 |
0.00171374959482429 |
|
| 2731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000207145.1 |
0.00171374959482429 |
|
| 2732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD5|ENSG00000239195.1 |
0.00171374959482429 |
|
| 2733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000210825.1 |
0.00171374959482429 |
|
| 2734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf54 |
0.00171374959482429 |
|
| 2735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED17 |
0.00171374959482429 |
|
| 2736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL195P |
0.00171374959482429 |
|
| 2737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238437.1 |
0.00171374959482429 |
|
| 2738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLR4 |
0.00171374959482429 |
|
| 2739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLRN3 |
0.00208736591903691 |
|
| 2740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRE |
0.00208736591903691 |
|
| 2741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKI67 |
0.00208736591903691 |
|
| 2742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGMT |
0.00208736591903691 |
|
| 2743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBF3 |
0.00208736591903691 |
|
| 2744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4297 |
0.00208736591903691 |
|
| 2745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00959 |
0.00208736591903691 |
|
| 2746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRX3 |
0.00208736591903691 |
|
| 2747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378C |
0.00208736591903691 |
|
| 2748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCERG1L |
0.00208736591903691 |
|
| 2749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R2D |
0.00208736591903691 |
|
| 2750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIP3 |
0.00208736591903691 |
|
| 2751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAKMIP3 |
0.00208736591903691 |
|
| 2752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYSL4 |
0.00208736591903691 |
|
| 2753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM53A |
0.00216725600074441 |
|
| 2754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLBP |
0.00216725600074441 |
|
| 2755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM129 |
0.00216725600074441 |
|
| 2756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACC3 |
0.00216725600074441 |
|
| 2757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR3 |
0.00216725600074441 |
|
| 2758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LETM1 |
0.00216725600074441 |
|
| 2759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFAP1 |
0.00216725600074441 |
|
| 2760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABLIM2 |
0.00216725600074441 |
|
| 2761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL704P |
0.00230373081467894 |
|
| 2762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSPRY |
0.00237076968574801 |
|
| 2763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDHD3 |
0.00237076968574801 |
|
| 2764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252592.1 |
0.00242524072900252 |
|
| 2765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC90B |
0.00242524072900252 |
|
| 2766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238666.1 |
0.00242524072900252 |
|
| 2767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS23 |
0.00242524072900252 |
|
| 2768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM5 |
0.00242524072900252 |
|
| 2769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP296 |
0.00322861981161715 |
|
| 2770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMNC |
0.00322861981161715 |
|
| 2771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYDC2 |
0.00322861981161715 |
|
| 2772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP222 |
0.00322861981161715 |
|
| 2773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSG1 |
0.00322861981161715 |
|
| 2774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM43A |
0.00322861981161715 |
|
| 2775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XXYLT1 |
0.00322861981161715 |
|
| 2776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3137 |
0.00322861981161715 |
|
| 2777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL36P |
0.00322861981161715 |
|
| 2778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMOTL1 |
0.00354572735072789 |
|
| 2779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWC15 |
0.00354572735072789 |
|
| 2780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM4D |
0.00354572735072789 |
|
| 2781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENDOD1 |
0.00354572735072789 |
|
| 2782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SESN3 |
0.00354572735072789 |
|
| 2783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM76B |
0.00354572735072789 |
|
| 2784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP57 |
0.00354572735072789 |
|
| 2785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR2 |
0.00354572735072789 |
|
| 2786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP345 |
0.00354572735072789 |
|
| 2787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1260B |
0.00354572735072789 |
|
| 2788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP53 |
0.00354572735072789 |
|
| 2789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP42 |
0.00354572735072789 |
|
| 2790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP115 |
0.00354572735072789 |
|
| 2791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238388.1 |
0.00354572735072789 |
|
| 2792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM133 |
0.00354572735072789 |
|
| 2793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGR |
0.00354572735072789 |
|
| 2794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3920 |
0.00354572735072789 |
|
| 2795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN5 |
0.00366853505104081 |
|
| 2796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIH1D2 |
0.00419001108711692 |
|
| 2797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf57 |
0.00419001108711692 |
|
| 2798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM8B |
0.00419001108711692 |
|
| 2799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHD |
0.00419001108711692 |
|
| 2800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL18 |
0.00419001108711692 |
|
| 2801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX12 |
0.00419001108711692 |
|
| 2802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCO2 |
0.00419001108711692 |
|
| 2803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTS |
0.00419001108711692 |
|
| 2804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf34 |
0.00419001108711692 |
|
| 2805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snosnR66 |
0.00419001108711692 |
|
| 2806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAM1 |
0.00419001108711692 |
|
| 2807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC12 |
0.00419001108711692 |
|
| 2808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKK1 |
0.00419001108711692 |
|
| 2809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRD2 |
0.00419001108711692 |
|
| 2810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4301 |
0.00419001108711692 |
|
| 2811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS5 |
0.00419001108711692 |
|
| 2812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZW10 |
0.00419001108711692 |
|
| 2813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN25 |
0.00419001108711692 |
|
| 2814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF4P4 |
0.00419001108711692 |
|
| 2815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP28 |
0.00419001108711692 |
|
| 2816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR3B |
0.00419001108711692 |
|
| 2817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR3A |
0.00419001108711692 |
|
| 2818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB16 |
0.00419001108711692 |
|
| 2819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NNMT |
0.00419001108711692 |
|
| 2820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf71 |
0.00419001108711692 |
|
| 2821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM7 |
0.00419001108711692 |
|
| 2822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM129B |
0.0043108344753866 |
|
| 2823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP1 |
0.0043108344753866 |
|
| 2824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3911 |
0.0043108344753866 |
|
| 2825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTRH1 |
0.0043108344753866 |
|
| 2826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf117 |
0.0043108344753866 |
|
| 2827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC16 |
0.0043108344753866 |
|
| 2828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf50 |
0.0043108344753866 |
|
| 2829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTMT1 |
0.0043108344753866 |
|
| 2830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB6 |
0.0043108344753866 |
|
| 2831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRX2 |
0.0043108344753866 |
|
| 2832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO2 |
0.00440641718985979 |
|
| 2833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPE1 |
0.00440641718985979 |
|
| 2834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238724.1 |
0.00440641718985979 |
|
| 2835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPE4 |
0.00440641718985979 |
|
| 2836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPE2 |
0.00440641718985979 |
|
| 2837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA59|ENSG00000252870.1 |
0.00440641718985979 |
|
| 2838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADM1 |
0.00440641718985979 |
|
| 2839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239153.1 |
0.00440641718985979 |
|
| 2840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00900 |
0.00440641718985979 |
|
| 2841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP121 |
0.00440641718985979 |
|
| 2842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP279 |
0.00440641718985979 |
|
| 2843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETS1 |
0.00440641718985979 |
|
| 2844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLI1 |
0.00440641718985979 |
|
| 2845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ1 |
0.00440641718985979 |
|
| 2846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ5 |
0.00440641718985979 |
|
| 2847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf45 |
0.00440641718985979 |
|
| 2848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53AIP1 |
0.00440641718985979 |
|
| 2849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP32 |
0.00440641718985979 |
|
| 2850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BARX2 |
0.00440641718985979 |
|
| 2851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM45B |
0.00440641718985979 |
|
| 2852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFRKB |
0.00440641718985979 |
|
| 2853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM10 |
0.00440641718985979 |
|
| 2854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00167 |
0.00440641718985979 |
|
| 2855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APLP2 |
0.00440641718985979 |
|
| 2856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST14 |
0.00440641718985979 |
|
| 2857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB44 |
0.00440641718985979 |
|
| 2858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS8 |
0.00440641718985979 |
|
| 2859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS15 |
0.00440641718985979 |
|
| 2860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf44 |
0.00440641718985979 |
|
| 2861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC12P |
0.00440641718985979 |
|
| 2862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCEL |
0.0045645216813065 |
|
| 2863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECTA |
0.0045645216813065 |
|
| 2864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SC5D |
0.0045645216813065 |
|
| 2865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORL1 |
0.0045645216813065 |
|
| 2866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR125B1 |
0.0045645216813065 |
|
| 2867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLID |
0.0045645216813065 |
|
| 2868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7A2 |
0.0045645216813065 |
|
| 2869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR100 |
0.0045645216813065 |
|
| 2870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC10P |
0.0045645216813065 |
|
| 2871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC5P |
0.0045645216813065 |
|
| 2872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBASH3B |
0.0045645216813065 |
|
| 2873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239079.1 |
0.0045645216813065 |
|
| 2874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTAM |
0.0045645216813065 |
|
| 2875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf63 |
0.0045645216813065 |
|
| 2876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSX |
0.0045645216813065 |
|
| 2877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA8 |
0.0045645216813065 |
|
| 2878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14E |
0.0045645216813065 |
|
| 2879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14C |
0.0045645216813065 |
|
| 2880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14D |
0.0045645216813065 |
|
| 2881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLMP |
0.0045645216813065 |
|
| 2882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000200496.1 |
0.0045645216813065 |
|
| 2883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4493 |
0.0045645216813065 |
|
| 2884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD1B |
0.0045645216813065 |
|
| 2885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN3B |
0.0045645216813065 |
|
| 2886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF202 |
0.0045645216813065 |
|
| 2887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6X1 |
0.0045645216813065 |
|
| 2888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6M1 |
0.0045645216813065 |
|
| 2889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM225 |
0.0045645216813065 |
|
| 2890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8D4 |
0.0045645216813065 |
|
| 2891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D5 |
0.0045645216813065 |
|
| 2892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6T1 |
0.0045645216813065 |
|
| 2893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10S1 |
0.0045645216813065 |
|
| 2894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G4 |
0.0045645216813065 |
|
| 2895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G9 |
0.0045645216813065 |
|
| 2896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G8 |
0.0045645216813065 |
|
| 2897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G7 |
0.0045645216813065 |
|
| 2898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA5A |
0.0045645216813065 |
|
| 2899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10D3 |
0.0045645216813065 |
|
| 2900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8D1 |
0.0045645216813065 |
|
| 2901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8D2 |
0.0045645216813065 |
|
| 2902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8B2 |
0.0045645216813065 |
|
| 2903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8B3 |
0.0045645216813065 |
|
| 2904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8B4 |
0.0045645216813065 |
|
| 2905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8B8 |
0.0045645216813065 |
|
| 2906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8B12 |
0.0045645216813065 |
|
| 2907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8A1 |
0.0045645216813065 |
|
| 2908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANX3 |
0.0045645216813065 |
|
| 2909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBRG1 |
0.0045645216813065 |
|
| 2910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIAE |
0.0045645216813065 |
|
| 2911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP352 |
0.0045645216813065 |
|
| 2912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPA17 |
0.0045645216813065 |
|
| 2913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRGN |
0.0045645216813065 |
|
| 2914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG2 |
0.0045645216813065 |
|
| 2915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESAM |
0.0045645216813065 |
|
| 2916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSANTD2 |
0.0045645216813065 |
|
| 2917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROBO3 |
0.0045645216813065 |
|
| 2918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROBO4 |
0.0045645216813065 |
|
| 2919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEPACAM |
0.0045645216813065 |
|
| 2920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEPN1 |
0.0045645216813065 |
|
| 2921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC15 |
0.0045645216813065 |
|
| 2922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC37A2 |
0.0045645216813065 |
|
| 2923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM218 |
0.0045645216813065 |
|
| 2924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT18P59 |
0.0045645216813065 |
|
| 2925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATE2 |
0.0045645216813065 |
|
| 2926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATE3 |
0.0045645216813065 |
|
| 2927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATE4 |
0.0045645216813065 |
|
| 2928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYLS1 |
0.0045645216813065 |
|
| 2929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUS3 |
0.0045645216813065 |
|
| 2930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX25 |
0.0045645216813065 |
|
| 2931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDON |
0.0045645216813065 |
|
| 2932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPUSD4 |
0.0045645216813065 |
|
| 2933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM118B |
0.0045645216813065 |
|
| 2934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL351P |
0.0045645216813065 |
|
| 2935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPR |
0.0045645216813065 |
|
| 2936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXRED1 |
0.0045645216813065 |
|
| 2937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIRAP |
0.0045645216813065 |
|
| 2938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238855.1 |
0.0045645216813065 |
|
| 2939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCPS |
0.0045645216813065 |
|
| 2940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL4 |
0.0045645216813065 |
|
| 2941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIRREL3 |
0.0045645216813065 |
|
| 2942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3167 |
0.0045645216813065 |
|
| 2943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf68 |
0.00462889139094935 |
|
| 2944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRAP1 |
0.00462889139094935 |
|
| 2945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSGA10IP |
0.00462889139094935 |
|
| 2946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SART1 |
0.00462889139094935 |
|
| 2947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF1AD |
0.00462889139094935 |
|
| 2948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BANF1 |
0.00462889139094935 |
|
| 2949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CST6 |
0.00462889139094935 |
|
| 2950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPER1 |
0.00462889139094935 |
|
| 2951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAL3ST3 |
0.00462889139094935 |
|
| 2952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B2 |
0.00462889139094935 |
|
| 2953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238752.1 |
0.00462889139094935 |
|
| 2954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACS1 |
0.00462889139094935 |
|
| 2955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238763.1 |
0.00463812454144907 |
|
| 2956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLC2 |
0.00463812454144907 |
|
| 2957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB1B |
0.00463812454144907 |
|
| 2958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNIH2 |
0.00463812454144907 |
|
| 2959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIF1A |
0.00463812454144907 |
|
| 2960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM151A |
0.00463812454144907 |
|
| 2961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD248 |
0.00463812454144907 |
|
| 2962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIN1 |
0.00463812454144907 |
|
| 2963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRMS1 |
0.00463812454144907 |
|
| 2964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT1 |
0.00463812454144907 |
|
| 2965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC29A2 |
0.00463812454144907 |
|
| 2966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAS4 |
0.00463812454144907 |
|
| 2967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA43|ENSG00000201733.1 |
0.00463812454144907 |
|
| 2968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL11 |
0.00463812454144907 |
|
| 2969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PELI3 |
0.00463812454144907 |
|
| 2970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP3 |
0.00463812454144907 |
|
| 2971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS1 |
0.00463812454144907 |
|
| 2972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC24 |
0.00463812454144907 |
|
| 2973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTN3 |
0.00463812454144907 |
|
| 2974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSF |
0.00463812454144907 |
|
| 2975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC87 |
0.00463812454144907 |
|
| 2976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCS |
0.00463812454144907 |
|
| 2977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM14 |
0.00463812454144907 |
|
| 2978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM4 |
0.00463812454144907 |
|
| 2979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM4B |
0.00463812454144907 |
|
| 2980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTBN2 |
0.00463812454144907 |
|
| 2981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL12P |
0.00463812454144907 |
|
| 2982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf80 |
0.00463812454144907 |
|
| 2983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PC |
0.00463812454144907 |
|
| 2984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCE1 |
0.00463812454144907 |
|
| 2985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRFN4 |
0.00463812454144907 |
|
| 2986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3163 |
0.00463812454144907 |
|
| 2987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf86 |
0.00463812454144907 |
|
| 2988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252709.1 |
0.00463812454144907 |
|
| 2989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT12 |
0.00463812454144907 |
|
| 2990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOD |
0.00463812454144907 |
|
| 2991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM2A |
0.00463812454144907 |
|
| 2992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238892.1 |
0.00463812454144907 |
|
| 2993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP14 |
0.0047501873881638 |
|
| 2994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP82 |
0.0047501873881638 |
|
| 2995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF566 |
0.0047501873881638 |
|
| 2996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF260 |
0.0047501873881638 |
|
| 2997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF529 |
0.0047501873881638 |
|
| 2998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF382 |
0.0047501873881638 |
|
| 2999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF461 |
0.0047501873881638 |
|
| 3000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF567 |
0.0047501873881638 |
|
| 3001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF850 |
0.0047501873881638 |
|
| 3002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF790 |
0.0047501873881638 |
|
| 3003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF345 |
0.0047501873881638 |
|
| 3004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF829 |
0.0047501873881638 |
|
| 3005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF568 |
0.0047501873881638 |
|
| 3006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF420 |
0.0047501873881638 |
|
| 3007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF585A |
0.0047501873881638 |
|
| 3008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF585B |
0.0047501873881638 |
|
| 3009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF383 |
0.0047501873881638 |
|
| 3010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HKR1 |
0.0047501873881638 |
|
| 3011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF527 |
0.0047501873881638 |
|
| 3012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF569 |
0.0047501873881638 |
|
| 3013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF570 |
0.0047501873881638 |
|
| 3014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF793 |
0.0047501873881638 |
|
| 3015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF540 |
0.0047501873881638 |
|
| 3016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF571 |
0.0047501873881638 |
|
| 3017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP30 |
0.0047501873881638 |
|
| 3018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF781 |
0.0047501873881638 |
|
| 3019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF607 |
0.0047501873881638 |
|
| 3020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF573 |
0.0047501873881638 |
|
| 3021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR87 |
0.0047501873881638 |
|
| 3022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIPA1L3 |
0.0047501873881638 |
|
| 3023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPF1 |
0.0047501873881638 |
|
| 3024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL663P |
0.0047501873881638 |
|
| 3025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINT2 |
0.0047501873881638 |
|
| 3026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R14A |
0.0047501873881638 |
|
| 3027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf33 |
0.0047501873881638 |
|
| 3028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIF1B |
0.0047501873881638 |
|
| 3029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK6 |
0.0047501873881638 |
|
| 3030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPERG |
0.0047501873881638 |
|
| 3031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238838.1 |
0.0047501873881638 |
|
| 3032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD8 |
0.0047501873881638 |
|
| 3033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGN |
0.0047501873881638 |
|
| 3034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRED3 |
0.0047501873881638 |
|
| 3035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM98C |
0.0047501873881638 |
|
| 3036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRP4 |
0.0047501873881638 |
|
| 3037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RYR1 |
0.0047501873881638 |
|
| 3038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4K1 |
0.0047501873881638 |
|
| 3039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3K |
0.0047501873881638 |
|
| 3040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTN4 |
0.0047501873881638 |
|
| 3041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN12 |
0.0047501873881638 |
|
| 3042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS7 |
0.0047501873881638 |
|
| 3043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS7B |
0.0047501873881638 |
|
| 3044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS4 |
0.0047501873881638 |
|
| 3045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECH1 |
0.0047501873881638 |
|
| 3046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPL |
0.0047501873881638 |
|
| 3047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RINL |
0.0047501873881638 |
|
| 3048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT2 |
0.0047501873881638 |
|
| 3049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBIB |
0.0047501873881638 |
|
| 3050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SARS2 |
0.0047501873881638 |
|
| 3051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS12 |
0.0047501873881638 |
|
| 3052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO17 |
0.0047501873881638 |
|
| 3053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO27 |
0.0047501873881638 |
|
| 3054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPL |
0.0047501873881638 |
|
| 3055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251709.1 |
0.0047501873881638 |
|
| 3056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK4 |
0.0047501873881638 |
|
| 3057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCCRP1 |
0.0047501873881638 |
|
| 3058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCN |
0.0047501873881638 |
|
| 3059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNL3 |
0.0047501873881638 |
|
| 3060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNL4 |
0.0047501873881638 |
|
| 3061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNL2 |
0.0047501873881638 |
|
| 3062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNL1 |
0.0047501873881638 |
|
| 3063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRFN1 |
0.0047501873881638 |
|
| 3064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMFG |
0.0047501873881638 |
|
| 3065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD4B |
0.0047501873881638 |
|
| 3066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL566P |
0.0047501873881638 |
|
| 3067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAF1 |
0.0047501873881638 |
|
| 3068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED29 |
0.0047501873881638 |
|
| 3069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4530 |
0.0047501873881638 |
|
| 3070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG2 |
0.0047501873881638 |
|
| 3071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP36 |
0.0047501873881638 |
|
| 3072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS16 |
0.0047501873881638 |
|
| 3073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT5H |
0.0047501873881638 |
|
| 3074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLL3 |
0.0047501873881638 |
|
| 3075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM50 |
0.0047501873881638 |
|
| 3076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELV |
0.0047501873881638 |
|
| 3077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EID2B |
0.0047501873881638 |
|
| 3078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EID2 |
0.0047501873881638 |
|
| 3079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS13 |
0.0047501873881638 |
|
| 3080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS16 |
0.0047501873881638 |
|
| 3081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS17A |
0.0047501873881638 |
|
| 3082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS14 |
0.0047501873881638 |
|
| 3083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLC |
0.0047501873881638 |
|
| 3084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR641 |
0.0047501873881638 |
|
| 3085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf47 |
0.0047501873881638 |
|
| 3086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD3 |
0.0047501873881638 |
|
| 3087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIPK4 |
0.0047501873881638 |
|
| 3088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRX |
0.0047501873881638 |
|
| 3089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERTAD1 |
0.0047501873881638 |
|
| 3090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERTAD3 |
0.0047501873881638 |
|
| 3091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLVRB |
0.0047501873881638 |
|
| 3092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTBN4 |
0.0047501873881638 |
|
| 3093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTBP4 |
0.0047501873881638 |
|
| 3094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL758P |
0.0047501873881638 |
|
| 3095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHKBP1 |
0.0047501873881638 |
|
| 3096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUMBL |
0.0047501873881638 |
|
| 3097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCK4 |
0.0047501873881638 |
|
| 3098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPKC |
0.0047501873881638 |
|
| 3099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf54 |
0.0047501873881638 |
|
| 3100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPA |
0.0047501873881638 |
|
| 3101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIA |
0.0047501873881638 |
|
| 3102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB4B |
0.0047501873881638 |
|
| 3103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGLN2 |
0.0047501873881638 |
|
| 3104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2A6 |
0.0047501873881638 |
|
| 3105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2A7 |
0.0047501873881638 |
|
| 3106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2G1P |
0.0047501873881638 |
|
| 3107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2B7P1 |
0.0047501873881638 |
|
| 3108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2B6 |
0.0047501873881638 |
|
| 3109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2A13 |
0.0047501873881638 |
|
| 3110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2F1 |
0.0047501873881638 |
|
| 3111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2S1 |
0.0047501873881638 |
|
| 3112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL718P |
0.0047501873881638 |
|
| 3113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AXL |
0.0047501873881638 |
|
| 3114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPUL1 |
0.0047501873881638 |
|
| 3115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL34P |
0.0047501873881638 |
|
| 3116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFB1 |
0.0047501873881638 |
|
| 3117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC97 |
0.0047501873881638 |
|
| 3118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B9D2 |
0.0047501873881638 |
|
| 3119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCKDHA |
0.0047501873881638 |
|
| 3120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM91 |
0.0047501873881638 |
|
| 3121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC5 |
0.0047501873881638 |
|
| 3122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT8 |
0.0047501873881638 |
|
| 3123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5SL |
0.0047501873881638 |
|
| 3124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf69 |
0.0047501873881638 |
|
| 3125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM21 |
0.0047501873881638 |
|
| 3126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAMP3 |
0.0047501873881638 |
|
| 3127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM4 |
0.0047501873881638 |
|
| 3128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM7 |
0.0047501873881638 |
|
| 3129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM5 |
0.0047501873881638 |
|
| 3130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEA |
0.0047501873881638 |
|
| 3131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM3 |
0.0047501873881638 |
|
| 3132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEACAM6 |
0.0047501873881638 |
|
| 3133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD4 |
0.0047501873881638 |
|
| 3134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTC2 |
0.0047501873881638 |
|
| 3135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS19 |
0.0047501873881638 |
|
| 3136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD79A |
0.0047501873881638 |
|
| 3137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF1 |
0.0047501873881638 |
|
| 3138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABAC1 |
0.0047501873881638 |
|
| 3139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1A3 |
0.0047501873881638 |
|
| 3140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIK5 |
0.0047501873881638 |
|
| 3141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF574 |
0.0047501873881638 |
|
| 3142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU2F2 |
0.0047501873881638 |
|
| 3143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4323 |
0.0047501873881638 |
|
| 3144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252356.1 |
0.0047501873881638 |
|
| 3145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEDD2 |
0.0047501873881638 |
|
| 3146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00587 |
0.00634649442348334 |
|
| 3147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYLC2 |
0.00634649442348334 |
|
| 3148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP291 |
0.00634649442348334 |
|
| 3149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC2 |
0.00634649442348334 |
|
| 3150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13F1 |
0.00634649442348334 |
|
| 3151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C4 |
0.00634649442348334 |
|
| 3152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C3 |
0.00634649442348334 |
|
| 3153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C8 |
0.00634649442348334 |
|
| 3154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C2 |
0.00634649442348334 |
|
| 3155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C5 |
0.00634649442348334 |
|
| 3156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13C9 |
0.00634649442348334 |
|
| 3157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13D1 |
0.00634649442348334 |
|
| 3158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPSNAP3A |
0.00634649442348334 |
|
| 3159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPSNAP3B |
0.00634649442348334 |
|
| 3160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA1 |
0.00634649442348334 |
|
| 3161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP191 |
0.00634649442348334 |
|
| 3162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC44A1 |
0.00634649442348334 |
|
| 3163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSD1L |
0.00634649442348334 |
|
| 3164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKTN |
0.00634649442348334 |
|
| 3165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAL2 |
0.00634649442348334 |
|
| 3166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM38B |
0.00634649442348334 |
|
| 3167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP77 |
0.00634649442348334 |
|
| 3168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP292 |
0.00634649442348334 |
|
| 3169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF462 |
0.00634649442348334 |
|
| 3170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD23B |
0.00634649442348334 |
|
| 3171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF4 |
0.00634649442348334 |
|
| 3172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL659P |
0.00634649442348334 |
|
| 3173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP293 |
0.00634649442348334 |
|
| 3174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL7B |
0.00634649442348334 |
|
| 3175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL7A |
0.00634649442348334 |
|
| 3176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKBKAP |
0.00634649442348334 |
|
| 3177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM206A |
0.00634649442348334 |
|
| 3178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNAL1 |
0.00634649442348334 |
|
| 3179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM245 |
0.00634649442348334 |
|
| 3180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR32 |
0.00634649442348334 |
|
| 3181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRRS1L |
0.00634649442348334 |
|
| 3182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L4B |
0.00634649442348334 |
|
| 3183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN3 |
0.00634649442348334 |
|
| 3184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3927 |
0.00634649442348334 |
|
| 3185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALM2 |
0.00634649442348334 |
|
| 3186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP2 |
0.00634649442348334 |
|
| 3187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRB1 |
0.00645023782505549 |
|
| 3188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LILRB4 |
0.00645023782505549 |
|
| 3189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRIQ3 |
0.00659690797811652 |
|
| 3190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FPGT |
0.00659690797811652 |
|
| 3191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNI3K |
0.00659690797811652 |
|
| 3192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2B |
0.00679802556436671 |
|
| 3193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP63 |
0.00709022914363011 |
|
| 3194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPREL1 |
0.00709022914363011 |
|
| 3195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL486P |
0.00709022914363011 |
|
| 3196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN1 |
0.00709022914363011 |
|
| 3197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN16 |
0.00709022914363011 |
|
| 3198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM207 |
0.00709022914363011 |
|
| 3199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RAP |
0.00709022914363011 |
|
| 3200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1E |
0.00742203292202126 |
|
| 3201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ4 |
0.00742203292202126 |
|
| 3202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDELR3 |
0.00742203292202126 |
|
| 3203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX17 |
0.00742203292202126 |
|
| 3204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMC1 |
0.00742203292202126 |
|
| 3205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM227A |
0.00742203292202126 |
|
| 3206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBY1 |
0.00742203292202126 |
|
| 3207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM22 |
0.00742203292202126 |
|
| 3208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JOSD1 |
0.00742203292202126 |
|
| 3209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP1 |
0.00742203292202126 |
|
| 3210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUN2 |
0.00742203292202126 |
|
| 3211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAL4 |
0.00742203292202126 |
|
| 3212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPTXR |
0.00742203292202126 |
|
| 3213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX6 |
0.00742203292202126 |
|
| 3214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3A |
0.00742203292202126 |
|
| 3215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3B |
0.00742203292202126 |
|
| 3216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3C |
0.00742203292202126 |
|
| 3217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3D |
0.00742203292202126 |
|
| 3218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3F |
0.00742203292202126 |
|
| 3219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3G |
0.00742203292202126 |
|
| 3220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC3H |
0.00742203292202126 |
|
| 3221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX7 |
0.00742203292202126 |
|
| 3222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFB |
0.00742203292202126 |
|
| 3223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL3 |
0.00742203292202126 |
|
| 3224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD83B |
0.00742203292202126 |
|
| 3225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD83A |
0.00742203292202126 |
|
| 3226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD43|ENSG00000263764.1 |
0.00742203292202126 |
|
| 3227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNGR1 |
0.00742203292202126 |
|
| 3228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAB1 |
0.00742203292202126 |
|
| 3229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT3 |
0.00742203292202126 |
|
| 3230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCR7L |
0.00742203292202126 |
|
| 3231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF4 |
0.00742203292202126 |
|
| 3232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS19BP1 |
0.00742203292202126 |
|
| 3233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1I |
0.00742203292202126 |
|
| 3234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTHD1 |
0.00742203292202126 |
|
| 3235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP210 |
0.00742203292202126 |
|
| 3236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAP2 |
0.00742203292202126 |
|
| 3237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83F |
0.00742203292202126 |
|
| 3238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNRC6B |
0.00742203292202126 |
|
| 3239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADSL |
0.00742203292202126 |
|
| 3240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGSM3 |
0.00742203292202126 |
|
| 3241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKL1 |
0.00742203292202126 |
|
| 3242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCHR1 |
0.00742203292202126 |
|
| 3243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A17 |
0.00742203292202126 |
|
| 3244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4766 |
0.00742203292202126 |
|
| 3245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST13 |
0.00742203292202126 |
|
| 3246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB7 |
0.00742203292202126 |
|
| 3247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPNPEP3 |
0.00742203292202126 |
|
| 3248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238887.1 |
0.00742203292202126 |
|
| 3249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBX1 |
0.00742203292202126 |
|
| 3250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1281 |
0.00742203292202126 |
|
| 3251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNG1 |
0.00822256780468211 |
|
| 3252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4A2 |
0.00822256780468211 |
|
| 3253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD2|ENSG00000238942.1 |
0.00822256780468211 |
|
| 3254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFC4 |
0.00822256780468211 |
|
| 3255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA4|ENSG00000263776.1 |
0.00822256780468211 |
|
| 3256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000200320.1 |
0.00822256780468211 |
|
| 3257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000200418.1 |
0.00822256780468211 |
|
| 3258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA81|ENSG00000221420.2 |
0.00822256780468211 |
|
| 3259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADIPOQ |
0.00822256780468211 |
|
| 3260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GAL1 |
0.00822256780468211 |
|
| 3261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL39L |
0.00822256780468211 |
|
| 3262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTP1 |
0.00822256780468211 |
|
| 3263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MASP1 |
0.00822256780468211 |
|
| 3264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTP4 |
0.00822256780468211 |
|
| 3265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239093.1 |
0.00822256780468211 |
|
| 3266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SST |
0.00822256780468211 |
|
| 3267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTP2 |
0.00822256780468211 |
|
| 3268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL6 |
0.00822256780468211 |
|
| 3269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPP |
0.00822256780468211 |
|
| 3270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR28 |
0.00822256780468211 |
|
| 3271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRG1 |
0.00822256780468211 |
|
| 3272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3147 |
0.00836966043954712 |
|
| 3273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF716 |
0.00836966043954712 |
|
| 3274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEUTX |
0.00904157352563029 |
|
| 3275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYRK1B |
0.00904157352563029 |
|
| 3276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBL |
0.00904157352563029 |
|
| 3277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGBP |
0.00904157352563029 |
|
| 3278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC4 |
0.00904157352563029 |
|
| 3279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF546 |
0.00904157352563029 |
|
| 3280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF780B |
0.00904157352563029 |
|
| 3281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF780A |
0.00904157352563029 |
|
| 3282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K10 |
0.00904157352563029 |
|
| 3283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC9B |
0.00904157352563029 |
|
| 3284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTD2 |
0.00904157352563029 |
|
| 3285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKT2 |
0.00904157352563029 |
|
| 3286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR3 |
0.00960818961074794 |
|
| 3287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HORMAD2 |
0.00960818961074794 |
|
| 3288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIF |
0.00960818961074794 |
|
| 3289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGC20647 |
0.00960818961074794 |
|
| 3290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSM |
0.00960818961074794 |
|
| 3291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATSL3 |
0.00960818961074794 |
|
| 3292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D10A |
0.00960818961074794 |
|
| 3293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3A1 |
0.00960818961074794 |
|
| 3294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC157 |
0.00960818961074794 |
|
| 3295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF215 |
0.00960818961074794 |
|
| 3296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L2 |
0.00960818961074794 |
|
| 3297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1658 |
0.00960818961074794 |
|
| 3298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTFP1 |
0.00960818961074794 |
|
| 3299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L3 |
0.00960818961074794 |
|
| 3300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L4 |
0.00960818961074794 |
|
| 3301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L6 |
0.00960818961074794 |
|
| 3302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAL3ST1 |
0.00960818961074794 |
|
| 3303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PES1 |
0.00960818961074794 |
|
| 3304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCN2 |
0.00960818961074794 |
|
| 3305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35E4 |
0.00960818961074794 |
|
| 3306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP18 |
0.00960818961074794 |
|
| 3307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBP2 |
0.00960818961074794 |
|
| 3308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3200 |
0.00960818961074794 |
|
| 3309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORC2 |
0.00960818961074794 |
|
| 3310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUG1 |
0.00960818961074794 |
|
| 3311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL633P |
0.00960818961074794 |
|
| 3312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMTN |
0.00960818961074794 |
|
| 3313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5J |
0.00960818961074794 |
|
| 3314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G3 |
0.00960818961074794 |
|
| 3315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3928 |
0.00960818961074794 |
|
| 3316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF185 |
0.00960818961074794 |
|
| 3317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMK2 |
0.00960818961074794 |
|
| 3318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3IP1 |
0.00960818961074794 |
|
| 3319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP496 |
0.00960818961074794 |
|
| 3320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATZ1 |
0.00960818961074794 |
|
| 3321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRG1 |
0.00960818961074794 |
|
| 3322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4ENIF1 |
0.00960818961074794 |
|
| 3323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFI1 |
0.00960818961074794 |
|
| 3324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PISD |
0.00960818961074794 |
|
| 3325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR14L |
0.00960818961074794 |
|
| 3326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPDC5 |
0.00960818961074794 |
|
| 3327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL20P |
0.00960818961074794 |
|
| 3328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPIFC |
0.00960818961074794 |
|
| 3329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO7 |
0.00960818961074794 |
|
| 3330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYN3 |
0.00960818961074794 |
|
| 3331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP497 |
0.00960818961074794 |
|
| 3332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMP3 |
0.00960818961074794 |
|
| 3333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FPGS |
0.00964871741819595 |
|
| 3334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENG |
0.00964871741819595 |
|
| 3335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP296 |
0.00964871741819595 |
|
| 3336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK1 |
0.00964871741819595 |
|
| 3337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4672 |
0.00964871741819595 |
|
| 3338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC6 |
0.00964871741819595 |
|
| 3339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAIF1 |
0.00964871741819595 |
|
| 3340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A25 |
0.00964871741819595 |
|
| 3341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP3 |
0.00965324462176709 |
|
| 3342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL6 |
0.00965324462176709 |
|
| 3343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD18B |
0.00965324462176709 |
|
| 3344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTENP1 |
0.00965324462176709 |
|
| 3345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238491.1 |
0.0109991556812395 |
|
| 3346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APTX |
0.0114735756974389 |
|
| 3347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJA1 |
0.0114735756974389 |
|
| 3348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMU1 |
0.0114735756974389 |
|
| 3349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT1 |
0.0114735756974389 |
|
| 3350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC15P |
0.0114735756974389 |
|
| 3351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK4 |
0.0114735756974389 |
|
| 3352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG1 |
0.0114735756974389 |
|
| 3353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP5 |
0.0114735756974389 |
|
| 3354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFX1 |
0.0114735756974389 |
|
| 3355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP7 |
0.0114735756974389 |
|
| 3356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS3 |
0.0114735756974389 |
|
| 3357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP281 |
0.0127529486153163 |
|
| 3358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACO1 |
0.0127529486153163 |
|
| 3359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX58 |
0.0127529486153163 |
|
| 3360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOPORS |
0.0127529486153163 |
|
| 3361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB6 |
0.0127529486153163 |
|
| 3362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GVQW1 |
0.0127529486153163 |
|
| 3363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1L |
0.0127529486153163 |
|
| 3364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM215 |
0.0127529486153163 |
|
| 3365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP59 |
0.0139888176939229 |
|
| 3366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP78 |
0.0139888176939229 |
|
| 3367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSAT1 |
0.0139888176939229 |
|
| 3368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLE4 |
0.0139888176939229 |
|
| 3369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLE1 |
0.0139888176939229 |
|
| 3370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP287 |
0.0139888176939229 |
|
| 3371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD95|ENSG00000200969.1 |
0.0139888176939229 |
|
| 3372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31D5P |
0.0139888176939229 |
|
| 3373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31D4 |
0.0139888176939229 |
|
| 3374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31D3 |
0.0139888176939229 |
|
| 3375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31D1 |
0.0139888176939229 |
|
| 3376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASEF |
0.0139888176939229 |
|
| 3377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP242 |
0.0139888176939229 |
|
| 3378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD3 |
0.0139888176939229 |
|
| 3379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238608.1 |
0.0139888176939229 |
|
| 3380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252256.1 |
0.0139888176939229 |
|
| 3381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDNK |
0.0139888176939229 |
|
| 3382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBQLN1 |
0.0139888176939229 |
|
| 3383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GKAP1 |
0.0139888176939229 |
|
| 3384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF27 |
0.0139888176939229 |
|
| 3385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf64 |
0.0139888176939229 |
|
| 3386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPK |
0.0139888176939229 |
|
| 3387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMI1 |
0.0139888176939229 |
|
| 3388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC28A3 |
0.0139888176939229 |
|
| 3389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTRK2 |
0.0139888176939229 |
|
| 3390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGTPBP1 |
0.0139888176939229 |
|
| 3391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA35 |
0.0139888176939229 |
|
| 3392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLM1 |
0.0139888176939229 |
|
| 3393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf153 |
0.0139888176939229 |
|
| 3394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP264 |
0.0139888176939229 |
|
| 3395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISCA1 |
0.0139888176939229 |
|
| 3396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC6 |
0.0139888176939229 |
|
| 3397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS1 |
0.0139888176939229 |
|
| 3398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf170 |
0.0139888176939229 |
|
| 3399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212421.1 |
0.0139888176939229 |
|
| 3400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAPK1 |
0.0139888176939229 |
|
| 3401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSL |
0.0139888176939229 |
|
| 3402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSL3P |
0.0139888176939229 |
|
| 3403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31E1 |
0.0139888176939229 |
|
| 3404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31C1 |
0.0139888176939229 |
|
| 3405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK20 |
0.0139888176939229 |
|
| 3406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000271923.1 |
0.0139888176939229 |
|
| 3407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252299.1 |
0.0139888176939229 |
|
| 3408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIN1 |
0.0139888176939229 |
|
| 3409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXNL2 |
0.0139888176939229 |
|
| 3410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4289 |
0.0139888176939229 |
|
| 3411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf47 |
0.0139888176939229 |
|
| 3412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S1PR3 |
0.0139888176939229 |
|
| 3413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHC3 |
0.0139888176939229 |
|
| 3414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKS2 |
0.0139888176939229 |
|
| 3415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3153 |
0.0139888176939229 |
|
| 3416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SECISBP2 |
0.0139888176939229 |
|
| 3417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4D |
0.0139888176939229 |
|
| 3418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GADD45G |
0.0139888176939229 |
|
| 3419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4290 |
0.0139888176939229 |
|
| 3420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRAS2 |
0.0139888176939229 |
|
| 3421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYK |
0.0139888176939229 |
|
| 3422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00484 |
0.0139888176939229 |
|
| 3423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AUH |
0.0139888176939229 |
|
| 3424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFIL3 |
0.0139888176939229 |
|
| 3425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROR2 |
0.0139888176939229 |
|
| 3426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTLC1 |
0.0139888176939229 |
|
| 3427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00475 |
0.0139888176939229 |
|
| 3428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238996.1 |
0.0139888176939229 |
|
| 3429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IARS |
0.0139888176939229 |
|
| 3430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA84 |
0.0139888176939229 |
|
| 3431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL8 |
0.0139888176939229 |
|
| 3432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPN |
0.0139888176939229 |
|
| 3433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPP |
0.0139888176939229 |
|
| 3434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECM2 |
0.0139888176939229 |
|
| 3435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4670 |
0.0139888176939229 |
|
| 3436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGN |
0.0139888176939229 |
|
| 3437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OMD |
0.0139888176939229 |
|
| 3438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPPK |
0.0139888176939229 |
|
| 3439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BICD2 |
0.0139888176939229 |
|
| 3440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD19P |
0.0139888176939229 |
|
| 3441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF484 |
0.0139888176939229 |
|
| 3442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD3 |
0.0139888176939229 |
|
| 3443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUSD3 |
0.0139888176939229 |
|
| 3444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf89 |
0.0139888176939229 |
|
| 3445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NINJ1 |
0.0139888176939229 |
|
| 3446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNK2 |
0.0139888176939229 |
|
| 3447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf129 |
0.0139888176939229 |
|
| 3448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM120AOS |
0.0139888176939229 |
|
| 3449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM120A |
0.0139888176939229 |
|
| 3450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF2 |
0.0139888176939229 |
|
| 3451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4291 |
0.0139888176939229 |
|
| 3452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BARX1 |
0.0139888176939229 |
|
| 3453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPDC1 |
0.0139888176939229 |
|
| 3454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7A1 |
0.0139888176939229 |
|
| 3455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7DHG |
0.0139888176939229 |
|
| 3456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7F1 |
0.0139888176939229 |
|
| 3457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7D |
0.0139888176939229 |
|
| 3458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238792.1 |
0.0139888176939229 |
|
| 3459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF169 |
0.0139888176939229 |
|
| 3460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2F |
0.0139888176939229 |
|
| 3461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIATL1 |
0.0139888176939229 |
|
| 3462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCAT7 |
0.0139888176939229 |
|
| 3463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBP2 |
0.0139888176939229 |
|
| 3464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBP1 |
0.0139888176939229 |
|
| 3465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf3 |
0.0139888176939229 |
|
| 3466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2278 |
0.0139888176939229 |
|
| 3467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR23B |
0.0139888176939229 |
|
| 3468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR27B |
0.0139888176939229 |
|
| 3469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3074 |
0.0139888176939229 |
|
| 3470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP288 |
0.0139888176939229 |
|
| 3471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238746.1 |
0.0139888176939229 |
|
| 3472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCH1 |
0.0139888176939229 |
|
| 3473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00476 |
0.0139888176939229 |
|
| 3474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP434H0512 |
0.0139888176939229 |
|
| 3475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC6L2 |
0.0139888176939229 |
|
| 3476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP289 |
0.0139888176939229 |
|
| 3477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00092 |
0.0139888176939229 |
|
| 3478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B3 |
0.0139888176939229 |
|
| 3479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35D2 |
0.0139888176939229 |
|
| 3480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF367 |
0.0139888176939229 |
|
| 3481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HABP4 |
0.0139888176939229 |
|
| 3482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC14B |
0.0139888176939229 |
|
| 3483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAED1 |
0.0139888176939229 |
|
| 3484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF510 |
0.0139888176939229 |
|
| 3485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD7 |
0.0139888176939229 |
|
| 3486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMOD1 |
0.0139888176939229 |
|
| 3487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSTD2 |
0.0139888176939229 |
|
| 3488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCBP1 |
0.0139888176939229 |
|
| 3489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPA |
0.0139888176939229 |
|
| 3490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF618 |
0.0139888176939229 |
|
| 3491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMBP |
0.0139888176939229 |
|
| 3492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF12 |
0.0139888176939229 |
|
| 3493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL27A1 |
0.0139888176939229 |
|
| 3494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR455 |
0.0139888176939229 |
|
| 3495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORM1 |
0.0139888176939229 |
|
| 3496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORM2 |
0.0139888176939229 |
|
| 3497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKNA |
0.0139888176939229 |
|
| 3498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DFNB31 |
0.0139888176939229 |
|
| 3499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238530.1 |
0.0139888176939229 |
|
| 3500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1G1 |
0.0139888176939229 |
|
| 3501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf91 |
0.0139888176939229 |
|
| 3502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF15 |
0.0139888176939229 |
|
| 3503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF8 |
0.0139888176939229 |
|
| 3504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNC |
0.0139888176939229 |
|
| 3505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEC1 |
0.0139888176939229 |
|
| 3506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00474 |
0.0139888176939229 |
|
| 3507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPPA |
0.0139888176939229 |
|
| 3508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCC |
0.0167181867070235 |
|
| 3509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK32C |
0.016807222687433 |
|
| 3510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC27 |
0.016807222687433 |
|
| 3511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWWP2B |
0.016807222687433 |
|
| 3512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C10orf91 |
0.016807222687433 |
|
| 3513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5A |
0.016807222687433 |
|
| 3514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC40 |
0.016807222687433 |
|
| 3515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR123 |
0.016807222687433 |
|
| 3516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNDC1 |
0.016807222687433 |
|
| 3517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTF1 |
0.016807222687433 |
|
| 3518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VENTX |
0.016807222687433 |
|
| 3519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR202 |
0.016807222687433 |
|
| 3520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM8 |
0.016807222687433 |
|
| 3521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBGCP2 |
0.016807222687433 |
|
| 3522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF511 |
0.016807222687433 |
|
| 3523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALY |
0.016807222687433 |
|
| 3524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAP1 |
0.016807222687433 |
|
| 3525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUOM |
0.016807222687433 |
|
| 3526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECHS1 |
0.016807222687433 |
|
| 3527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3944 |
0.016807222687433 |
|
| 3528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAOX |
0.016807222687433 |
|
| 3529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTG1 |
0.016807222687433 |
|
| 3530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2E1 |
0.016807222687433 |
|
| 3531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRG2B |
0.016807222687433 |
|
| 3532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRN |
0.016807222687433 |
|
| 3533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCE1 |
0.016807222687433 |
|
| 3534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR944 |
0.0182213438932871 |
|
| 3535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP486 |
0.019254061203448 |
|
| 3536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36|ENSG00000252227.1 |
0.019254061203448 |
|
| 3537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00494 |
0.019254061203448 |
|
| 3538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASTN2 |
0.0194640630277875 |
|
| 3539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM32 |
0.0194640630277875 |
|
| 3540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70C |
0.0194640630277875 |
|
| 3541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP128 |
0.0194640630277875 |
|
| 3542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP125 |
0.0194640630277875 |
|
| 3543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL15A1 |
0.0196881000769391 |
|
| 3544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBR1 |
0.0196881000769391 |
|
| 3545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP290 |
0.0196881000769391 |
|
| 3546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL794P |
0.0196881000769391 |
|
| 3547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG2 |
0.0196881000769391 |
|
| 3548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC61B |
0.0196881000769391 |
|
| 3549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP225 |
0.0196881000769391 |
|
| 3550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf65 |
0.0201784279534885 |
|
| 3551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AQ |
0.0201784279534885 |
|
| 3552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRA2B |
0.0201784279534885 |
|
| 3553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL637P |
0.0201784279534885 |
|
| 3554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV5 |
0.0201784279534885 |
|
| 3555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGS |
0.0201784279534885 |
|
| 3556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCCD1 |
0.0201784279534885 |
|
| 3557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP9B |
0.0204139053436569 |
|
| 3558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L9 |
0.021733232573925 |
|
| 3559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDRBS2 |
0.021733232573925 |
|
| 3560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP1C |
0.021733232573925 |
|
| 3561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD65|ENSG00000212229.1 |
0.021733232573925 |
|
| 3562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP208 |
0.021733232573925 |
|
| 3563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC28 |
0.0234508343869625 |
|
| 3564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL162P |
0.0234508343869625 |
|
| 3565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHEK2 |
0.0234508343869625 |
|
| 3566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSCB |
0.0234508343869625 |
|
| 3567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC117 |
0.0234508343869625 |
|
| 3568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XBP1 |
0.0234508343869625 |
|
| 3569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNRF3 |
0.0234508343869625 |
|
| 3570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf31 |
0.0234508343869625 |
|
| 3571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KREMEN1 |
0.0234508343869625 |
|
| 3572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMID1 |
0.0234508343869625 |
|
| 3573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDD3 |
0.0234508343869625 |
|
| 3574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EWSR1 |
0.0234508343869625 |
|
| 3575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS2L1 |
0.0234508343869625 |
|
| 3576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASL10A |
0.0234508343869625 |
|
| 3577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1B1 |
0.0234508343869625 |
|
| 3578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD125 |
0.0234508343869625 |
|
| 3579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL1S |
0.0234508343869625 |
|
| 3580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL1 |
0.0234508343869625 |
|
| 3581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEFH |
0.0234508343869625 |
|
| 3582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC5 |
0.0234508343869625 |
|
| 3583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPSNAP1 |
0.0234508343869625 |
|
| 3584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NF2 |
0.0234508343869625 |
|
| 3585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABP7 |
0.0234508343869625 |
|
| 3586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMAT5 |
0.0234508343869625 |
|
| 3587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCR10 |
0.0234508343869625 |
|
| 3588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCC2 |
0.0234508343869625 |
|
| 3589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4797 |
0.0241985347620022 |
|
| 3590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT3 |
0.0243535197494029 |
|
| 3591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4473 |
0.0243535197494029 |
|
| 3592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4474 |
0.0243535197494029 |
|
| 3593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOCAD |
0.0243535197494029 |
|
| 3594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR491 |
0.0243535197494029 |
|
| 3595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA30|ENSG00000202189.1 |
0.0243535197494029 |
|
| 3596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPLAD2 |
0.0243535197494029 |
|
| 3597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNB1 |
0.0243535197494029 |
|
| 3598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNW1 |
0.0243535197494029 |
|
| 3599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA21 |
0.0243535197494029 |
|
| 3600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA4 |
0.0243535197494029 |
|
| 3601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA10 |
0.0243535197494029 |
|
| 3602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA16 |
0.0243535197494029 |
|
| 3603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA7 |
0.0243535197494029 |
|
| 3604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA17 |
0.0243535197494029 |
|
| 3605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA14 |
0.0243535197494029 |
|
| 3606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA5 |
0.0243535197494029 |
|
| 3607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL9 |
0.0243535197494029 |
|
| 3608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA6 |
0.0243535197494029 |
|
| 3609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA13 |
0.0243535197494029 |
|
| 3610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA2 |
0.0243535197494029 |
|
| 3611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA8 |
0.0243535197494029 |
|
| 3612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNA1 |
0.0243535197494029 |
|
| 3613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR31HG |
0.0243535197494029 |
|
| 3614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNE |
0.0243535197494029 |
|
| 3615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR31 |
0.0243535197494029 |
|
| 3616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD39|ENSG00000264379.1 |
0.0243535197494029 |
|
| 3617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL151P |
0.0243535197494029 |
|
| 3618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTA1 |
0.0243535197494029 |
|
| 3619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAVL2 |
0.0243535197494029 |
|
| 3620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IZUMO3 |
0.0243535197494029 |
|
| 3621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRPP5 |
0.0243535197494029 |
|
| 3622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP120 |
0.0243535197494029 |
|
| 3623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUSC1 |
0.0243535197494029 |
|
| 3624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252580.1 |
0.0243535197494029 |
|
| 3625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAAP1 |
0.0243535197494029 |
|
| 3626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL100P |
0.0243535197494029 |
|
| 3627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAA |
0.0243535197494029 |
|
| 3628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT74 |
0.0243535197494029 |
|
| 3629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC19 |
0.0243535197494029 |
|
| 3630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEK |
0.0243535197494029 |
|
| 3631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP280 |
0.0243535197494029 |
|
| 3632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00032 |
0.0243535197494029 |
|
| 3633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EQTN |
0.0243535197494029 |
|
| 3634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB3B |
0.0243535197494029 |
|
| 3635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNK |
0.0243535197494029 |
|
| 3636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf72 |
0.0243535197494029 |
|
| 3637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINGO2 |
0.0243535197494029 |
|
| 3638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR873 |
0.0243535197494029 |
|
| 3639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR876 |
0.0243535197494029 |
|
| 3640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLGN1 |
0.0253773625289699 |
|
| 3641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP234 |
0.0253773625289699 |
|
| 3642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAALADL2 |
0.0253773625289699 |
|
| 3643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP40 |
0.0253773625289699 |
|
| 3644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4789 |
0.0253773625289699 |
|
| 3645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000271842.1 |
0.0253773625289699 |
|
| 3646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP147 |
0.0253773625289699 |
|
| 3647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBL1XR1 |
0.0253773625289699 |
|
| 3648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00501 |
0.0253773625289699 |
|
| 3649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00578 |
0.0253773625289699 |
|
| 3650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP52 |
0.0253773625289699 |
|
| 3651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000200288.1 |
0.0253773625289699 |
|
| 3652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF2BP2 |
0.0253773625289699 |
|
| 3653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB11 |
0.0253773625289699 |
|
| 3654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHSG |
0.0253773625289699 |
|
| 3655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FETUB |
0.0253773625289699 |
|
| 3656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRG |
0.0253773625289699 |
|
| 3657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDH1 |
0.0253773625289699 |
|
| 3658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0226 |
0.0253773625289699 |
|
| 3659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR922 |
0.0253773625289699 |
|
| 3660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FYTTD1 |
0.0253773625289699 |
|
| 3661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRCH3 |
0.0253773625289699 |
|
| 3662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD18DP |
0.0253773625289699 |
|
| 3663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM157A |
0.0253773625289699 |
|
| 3664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCG |
0.0253773625289699 |
|
| 3665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMLN |
0.0253773625289699 |
|
| 3666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL35A |
0.0253773625289699 |
|
| 3667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF680 |
0.0264479084859631 |
|
| 3668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF107 |
0.0264479084859631 |
|
| 3669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF138 |
0.0264479084859631 |
|
| 3670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF273 |
0.0264479084859631 |
|
| 3671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF117 |
0.0264479084859631 |
|
| 3672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT6P3 |
0.0264479084859631 |
|
| 3673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS4L1 |
0.0264479084859631 |
|
| 3674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS4L2 |
0.0264479084859631 |
|
| 3675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA15|ENSG00000207062.1 |
0.0264479084859631 |
|
| 3676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA22|ENSG00000207344.1 |
0.0264479084859631 |
|
| 3677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000200130.1 |
0.0264479084859631 |
|
| 3678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000252102.1 |
0.0264479084859631 |
|
| 3679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF92 |
0.0264479084859631 |
|
| 3680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT6P1 |
0.0264479084859631 |
|
| 3681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA15|ENSG00000206785.1 |
0.0264479084859631 |
|
| 3682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA22|ENSG00000206634.1 |
0.0264479084859631 |
|
| 3683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VKORC1L1 |
0.0264479084859631 |
|
| 3684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSB |
0.0264479084859631 |
|
| 3685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASL |
0.0264479084859631 |
|
| 3686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRCP |
0.0264479084859631 |
|
| 3687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPST1 |
0.0264479084859631 |
|
| 3688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00174 |
0.0264479084859631 |
|
| 3689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252265.1 |
0.0264479084859631 |
|
| 3690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD7 |
0.0264479084859631 |
|
| 3691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABGEF1 |
0.0264479084859631 |
|
| 3692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238841.1 |
0.0264479084859631 |
|
| 3693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2IRD1P1 |
0.0264479084859631 |
|
| 3694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM248 |
0.0264479084859631 |
|
| 3695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL43P |
0.0264479084859631 |
|
| 3696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBDS |
0.0264479084859631 |
|
| 3697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYW1 |
0.0264479084859631 |
|
| 3698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMS2P4 |
0.0264479084859631 |
|
| 3699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3L4 |
0.0264479084859631 |
|
| 3700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD4 |
0.0265207410346218 |
|
| 3701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM43 |
0.0265207410346218 |
|
| 3702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPC |
0.0265207410346218 |
|
| 3703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM3 |
0.0265207410346218 |
|
| 3704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP124 |
0.0265207410346218 |
|
| 3705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A6 |
0.0265207410346218 |
|
| 3706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIP2 |
0.0265207410346218 |
|
| 3707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC174 |
0.0265207410346218 |
|
| 3708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf20 |
0.0265207410346218 |
|
| 3709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD5 |
0.0265207410346218 |
|
| 3710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN7 |
0.0265207410346218 |
|
| 3711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BP5 |
0.0265207410346218 |
|
| 3712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238891.1 |
0.0265207410346218 |
|
| 3713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL6 |
0.0265207410346218 |
|
| 3714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EAF1 |
0.0265207410346218 |
|
| 3715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLQ |
0.0265207410346218 |
|
| 3716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4270 |
0.0265207410346218 |
|
| 3717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL110P |
0.0265207410346218 |
|
| 3718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HACL1 |
0.0265207410346218 |
|
| 3719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTD |
0.0265207410346218 |
|
| 3720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD28 |
0.0265207410346218 |
|
| 3721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3134 |
0.0265207410346218 |
|
| 3722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL4P |
0.0265207410346218 |
|
| 3723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR563 |
0.0265207410346218 |
|
| 3724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT15 |
0.0265207410346218 |
|
| 3725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH3 |
0.0265207410346218 |
|
| 3726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXNAD1 |
0.0265207410346218 |
|
| 3727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFTN1 |
0.0265207410346218 |
|
| 3728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00690 |
0.0265207410346218 |
|
| 3729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAZL |
0.0265207410346218 |
|
| 3730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCL2 |
0.0265207410346218 |
|
| 3731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3714 |
0.0265207410346218 |
|
| 3732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D5 |
0.0265207410346218 |
|
| 3733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U7|ENSG00000271841.1 |
0.0265207410346218 |
|
| 3734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SATB1 |
0.0265207410346218 |
|
| 3735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH8 |
0.0265207410346218 |
|
| 3736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4791 |
0.0265207410346218 |
|
| 3737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFHB |
0.0265207410346218 |
|
| 3738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB5A |
0.0265207410346218 |
|
| 3739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PP2D1 |
0.0265207410346218 |
|
| 3740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT2B |
0.0265207410346218 |
|
| 3741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3135A |
0.0265207410346218 |
|
| 3742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGOL1 |
0.0265207410346218 |
|
| 3743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P22 |
0.0265207410346218 |
|
| 3744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL855P |
0.0267632470379964 |
|
| 3745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF733P |
0.0267632470379964 |
|
| 3746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMP3 |
0.0280238627154114 |
|
| 3747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMC3 |
0.0291951175780349 |
|
| 3748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIF1L |
0.0291951175780349 |
|
| 3749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF727 |
0.0307159238453729 |
|
| 3750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF679 |
0.0307159238453729 |
|
| 3751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF736 |
0.0307159238453729 |
|
| 3752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF675 |
0.0316776381622654 |
|
| 3753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF681 |
0.0316776381622654 |
|
| 3754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPSAP58 |
0.0316776381622654 |
|
| 3755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL703P |
0.0320084526740607 |
|
| 3756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP150 |
0.0320084526740607 |
|
| 3757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP11B |
0.0320084526740607 |
|
| 3758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCUN1D1 |
0.0320084526740607 |
|
| 3759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCCC1 |
0.0320084526740607 |
|
| 3760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCF2L2 |
0.0320084526740607 |
|
| 3761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT5 |
0.0320084526740607 |
|
| 3762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP151 |
0.0320084526740607 |
|
| 3763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC5 |
0.0320084526740607 |
|
| 3764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP2M1 |
0.0320084526740607 |
|
| 3765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2AB1P |
0.0320084526740607 |
|
| 3766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DVL3 |
0.0320084526740607 |
|
| 3767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2B5 |
0.0320084526740607 |
|
| 3768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR3C |
0.0320084526740607 |
|
| 3769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR3D |
0.0320084526740607 |
|
| 3770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR3E |
0.0320084526740607 |
|
| 3771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL24 |
0.0320084526740607 |
|
| 3772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL6 |
0.0320084526740607 |
|
| 3773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00888 |
0.0320084526740607 |
|
| 3774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP6D1 |
0.0320084526740607 |
|
| 3775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4448 |
0.0320084526740607 |
|
| 3776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARL |
0.0320084526740607 |
|
| 3777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA4|ENSG00000251730.1 |
0.0320084526740607 |
|
| 3778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000199363.1 |
0.0320084526740607 |
|
| 3779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000201229.1 |
0.0320084526740607 |
|
| 3780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA81|ENSG00000253092.1 |
0.0320084526740607 |
|
| 3781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YEATS2 |
0.0320084526740607 |
|
| 3782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCF3 |
0.0320084526740607 |
|
| 3783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA5B2 |
0.0320084526740607 |
|
| 3784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG3 |
0.0320084526740607 |
|
| 3785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECE2 |
0.0320084526740607 |
|
| 3786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1224 |
0.0320084526740607 |
|
| 3787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2N2 |
0.0320084526740607 |
|
| 3788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD2 |
0.0320084526740607 |
|
| 3789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4G1 |
0.0320084526740607 |
|
| 3790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD66|ENSG00000212158.1 |
0.0320084526740607 |
|
| 3791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM131A |
0.0320084526740607 |
|
| 3792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN2 |
0.0320084526740607 |
|
| 3793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2H |
0.0320084526740607 |
|
| 3794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THPO |
0.0320084526740607 |
|
| 3795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRD |
0.0320084526740607 |
|
| 3796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHB3 |
0.0320084526740607 |
|
| 3797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEF1 |
0.0320084526740607 |
|
| 3798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF782 |
0.035038527219177 |
|
| 3799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIATL2 |
0.035038527219177 |
|
| 3800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM2G |
0.035038527219177 |
|
| 3801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSV |
0.035038527219177 |
|
| 3802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC180 |
0.035038527219177 |
|
| 3803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXE1 |
0.035038527219177 |
|
| 3804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf156 |
0.035038527219177 |
|
| 3805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEMGN |
0.035038527219177 |
|
| 3806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32B |
0.035038527219177 |
|
| 3807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANS |
0.035038527219177 |
|
| 3808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM14 |
0.035038527219177 |
|
| 3809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO2A |
0.035038527219177 |
|
| 3810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D2 |
0.035038527219177 |
|
| 3811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABBR2 |
0.035038527219177 |
|
| 3812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKS6 |
0.035038527219177 |
|
| 3813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT12 |
0.035038527219177 |
|
| 3814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR4A3 |
0.035038527219177 |
|
| 3815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX17 |
0.035038527219177 |
|
| 3816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERP44 |
0.035038527219177 |
|
| 3817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INVS |
0.035038527219177 |
|
| 3818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL75P |
0.035038527219177 |
|
| 3819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX10 |
0.035038527219177 |
|
| 3820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSANTD3 |
0.035038527219177 |
|
| 3821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEFF1 |
0.035038527219177 |
|
| 3822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MURC |
0.035038527219177 |
|
| 3823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP87 |
0.035038527219177 |
|
| 3824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPPR1 |
0.035038527219177 |
|
| 3825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000253041.1 |
0.035038527219177 |
|
| 3826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAAT |
0.035038527219177 |
|
| 3827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL50 |
0.035038527219177 |
|
| 3828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF189 |
0.035038527219177 |
|
| 3829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDOB |
0.035038527219177 |
|
| 3830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM246 |
0.035038527219177 |
|
| 3831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF20 |
0.035038527219177 |
|
| 3832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN3A |
0.035038527219177 |
|
| 3833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP3R2 |
0.035038527219177 |
|
| 3834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf152 |
0.035038527219177 |
|
| 3835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC8 |
0.035038527219177 |
|
| 3836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXN |
0.035038527219177 |
|
| 3837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVEP1 |
0.035038527219177 |
|
| 3838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUSK |
0.035038527219177 |
|
| 3839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR1 |
0.035038527219177 |
|
| 3840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P18 |
0.035038527219177 |
|
| 3841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2K2 |
0.035038527219177 |
|
| 3842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0368 |
0.035038527219177 |
|
| 3843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP294 |
0.035038527219177 |
|
| 3844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF483 |
0.035038527219177 |
|
| 3845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGR1 |
0.035038527219177 |
|
| 3846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A5P |
0.035038527219177 |
|
| 3847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC25 |
0.035038527219177 |
|
| 3848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG10 |
0.035038527219177 |
|
| 3849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf84 |
0.035038527219177 |
|
| 3850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGCG |
0.035038527219177 |
|
| 3851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4668 |
0.035038527219177 |
|
| 3852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUSD1 |
0.035038527219177 |
|
| 3853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTBP3 |
0.035038527219177 |
|
| 3854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL57P |
0.035038527219177 |
|
| 3855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP295 |
0.035038527219177 |
|
| 3856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL430P |
0.035038527219177 |
|
| 3857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSDL2 |
0.035038527219177 |
|
| 3858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf147 |
0.035038527219177 |
|
| 3859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1958 |
0.035038527219177 |
|
| 3860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INIP |
0.035038527219177 |
|
| 3861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX30 |
0.035038527219177 |
|
| 3862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC46A2 |
0.035038527219177 |
|
| 3863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM225A |
0.035038527219177 |
|
| 3864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM225B |
0.035038527219177 |
|
| 3865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP37 |
0.035038527219177 |
|
| 3866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF883 |
0.035038527219177 |
|
| 3867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC31A2 |
0.035038527219177 |
|
| 3868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP15 |
0.035038527219177 |
|
| 3869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC31A1 |
0.035038527219177 |
|
| 3870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC26 |
0.035038527219177 |
|
| 3871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF4 |
0.035038527219177 |
|
| 3872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF183 |
0.035038527219177 |
|
| 3873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR31 |
0.035038527219177 |
|
| 3874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALAD |
0.035038527219177 |
|
| 3875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf43 |
0.035038527219177 |
|
| 3876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLE3 |
0.035038527219177 |
|
| 3877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS3 |
0.035038527219177 |
|
| 3878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC11P |
0.0351231295083115 |
|
| 3879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAP2 |
0.0351231295083115 |
|
| 3880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAI3 |
0.035153879630117 |
|
| 3881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMBRD1 |
0.035153879630117 |
|
| 3882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL19A1 |
0.035153879630117 |
|
| 3883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL9A1 |
0.035153879630117 |
|
| 3884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM135A |
0.035153879630117 |
|
| 3885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf57 |
0.035153879630117 |
|
| 3886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAP1 |
0.035153879630117 |
|
| 3887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GAT2 |
0.035153879630117 |
|
| 3888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272445.1 |
0.035153879630117 |
|
| 3889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR1B |
0.035153879630117 |
|
| 3890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252932.1 |
0.035153879630117 |
|
| 3891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRAK1BP1 |
0.035153879630117 |
|
| 3892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHIP |
0.035153879630117 |
|
| 3893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN3 |
0.035153879630117 |
|
| 3894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCA5 |
0.035153879630117 |
|
| 3895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BGRL2 |
0.035153879630117 |
|
| 3896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL4 |
0.035153879630117 |
|
| 3897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTK |
0.035153879630117 |
|
| 3898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCKDHB |
0.035153879630117 |
|
| 3899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM46A |
0.035153879630117 |
|
| 3900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP210 |
0.035153879630117 |
|
| 3901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000206886.1 |
0.035153879630117 |
|
| 3902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM20C |
0.0356284200148684 |
|
| 3903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFA |
0.0356284200148684 |
|
| 3904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAR1B |
0.0356284200148684 |
|
| 3905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR2 |
0.0356284200148684 |
|
| 3906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUN1 |
0.0356284200148684 |
|
| 3907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GET4 |
0.0356284200148684 |
|
| 3908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAP1 |
0.0356284200148684 |
|
| 3909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf50 |
0.0356284200148684 |
|
| 3910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX19 |
0.0356284200148684 |
|
| 3911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2W1 |
0.0356284200148684 |
|
| 3912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPER |
0.0356284200148684 |
|
| 3913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR146 |
0.0356284200148684 |
|
| 3914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR339 |
0.0356284200148684 |
|
| 3915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND2A |
0.0356284200148684 |
|
| 3916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNCX |
0.0356284200148684 |
|
| 3917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICALL2 |
0.0356284200148684 |
|
| 3918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS1 |
0.0356284200148684 |
|
| 3919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAFK |
0.0356284200148684 |
|
| 3920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM184A |
0.0356284200148684 |
|
| 3921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMG3 |
0.0356284200148684 |
|
| 3922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELFN1 |
0.0356284200148684 |
|
| 3923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAD1L1 |
0.0356284200148684 |
|
| 3924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4655 |
0.0356284200148684 |
|
| 3925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTSJ2 |
0.0356284200148684 |
|
| 3926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT1 |
0.0356284200148684 |
|
| 3927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX8 |
0.0356284200148684 |
|
| 3928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST12 |
0.0356284200148684 |
|
| 3929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3B |
0.0356284200148684 |
|
| 3930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIFIN |
0.0356284200148684 |
|
| 3931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LFNG |
0.0356284200148684 |
|
| 3932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4648 |
0.0356284200148684 |
|
| 3933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRAT1 |
0.0356284200148684 |
|
| 3934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238857.1 |
0.0356284200148684 |
|
| 3935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCE |
0.0356284200148684 |
|
| 3936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTYH3 |
0.0356284200148684 |
|
| 3937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMZ1 |
0.0356284200148684 |
|
| 3938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNA12 |
0.0356284200148684 |
|
| 3939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD11 |
0.0356284200148684 |
|
| 3940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP130 |
0.0356284200148684 |
|
| 3941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDK1 |
0.0356284200148684 |
|
| 3942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA4 |
0.0356284200148684 |
|
| 3943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF14 |
0.0356284200148684 |
|
| 3944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THSD7A |
0.0356284200148684 |
|
| 3945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANSL2 |
0.0357293991424258 |
|
| 3946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA34 |
0.0357293991424258 |
|
| 3947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA2A |
0.0357293991424258 |
|
| 3948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA2B |
0.0357293991424258 |
|
| 3949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNT1 |
0.0357293991424258 |
|
| 3950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00935 |
0.0357293991424258 |
|
| 3951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY6 |
0.0357293991424258 |
|
| 3952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4701 |
0.0357293991424258 |
|
| 3953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNB3 |
0.0357293991424258 |
|
| 3954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX23 |
0.0357293991424258 |
|
| 3955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RND1 |
0.0357293991424258 |
|
| 3956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARF3 |
0.0357293991424258 |
|
| 3957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC65 |
0.0357293991424258 |
|
| 3958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP11 |
0.0357293991424258 |
|
| 3959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238395.1 |
0.0357293991424258 |
|
| 3960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT10B |
0.0357293991424258 |
|
| 3961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT1 |
0.0357293991424258 |
|
| 3962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDN |
0.0357293991424258 |
|
| 3963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAG1 |
0.0357293991424258 |
|
| 3964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMT2D |
0.0357293991424258 |
|
| 3965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHEBL1 |
0.0357293991424258 |
|
| 3966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHH |
0.0357293991424258 |
|
| 3967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMBR1L |
0.0357293991424258 |
|
| 3968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA1B |
0.0357293991424258 |
|
| 3969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA1A |
0.0357293991424258 |
|
| 3970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA1C |
0.0357293991424258 |
|
| 3971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPH |
0.0357293991424258 |
|
| 3972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QL4 |
0.0357293991424258 |
|
| 3973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TROAP |
0.0357293991424258 |
|
| 3974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC22 |
0.0357293991424258 |
|
| 3975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATS2 |
0.0357293991424258 |
|
| 3976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH3 |
0.0357293991424258 |
|
| 3977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCRS1 |
0.0357293991424258 |
|
| 3978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF40B |
0.0357293991424258 |
|
| 3979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM186B |
0.0357293991424258 |
|
| 3980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMNL3 |
0.0357293991424258 |
|
| 3981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMBIM6 |
0.0357293991424258 |
|
| 3982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCKAP5L |
0.0357293991424258 |
|
| 3983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCDIN3D |
0.0357293991424258 |
|
| 3984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAIM2 |
0.0357293991424258 |
|
| 3985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP2 |
0.0357293991424258 |
|
| 3986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP5 |
0.0357293991424258 |
|
| 3987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP6 |
0.0357293991424258 |
|
| 3988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RACGAP1 |
0.0357293991424258 |
|
| 3989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIC1 |
0.0357293991424258 |
|
| 3990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCD1 |
0.0357293991424258 |
|
| 3991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX14 |
0.0357293991424258 |
|
| 3992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPD1 |
0.0357293991424258 |
|
| 3993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS5 |
0.0357293991424258 |
|
| 3994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMA1 |
0.0357293991424258 |
|
| 3995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1293 |
0.0357293991424258 |
|
| 3996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM186A |
0.0357293991424258 |
|
| 3997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP4 |
0.0357293991424258 |
|
| 3998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIP2B |
0.0357293991424258 |
|
| 3999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL7A |
0.0357293991424258 |
|
| 4000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIGD1C |
0.0357293991424258 |
|
| 4001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC11A2 |
0.0357293991424258 |
|
| 4002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272028.1 |
0.0357293991424258 |
|
| 4003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LETMD1 |
0.0357293991424258 |
|
| 4004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRNP2 |
0.0357293991424258 |
|
| 4005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFCP2 |
0.0357293991424258 |
|
| 4006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU6F1 |
0.0357293991424258 |
|
| 4007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAZAP2 |
0.0357293991424258 |
|
| 4008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAGP |
0.0357293991424258 |
|
| 4009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIN2 |
0.0357293991424258 |
|
| 4010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELA1 |
0.0357293991424258 |
|
| 4011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT6 |
0.0357293991424258 |
|
| 4012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A8 |
0.0357293991424258 |
|
| 4013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT5 |
0.0357293991424258 |
|
| 4014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT71 |
0.0357293991424258 |
|
| 4015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT74 |
0.0357293991424258 |
|
| 4016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT72 |
0.0357293991424258 |
|
| 4017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT73 |
0.0357293991424258 |
|
| 4018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT2 |
0.0357293991424258 |
|
| 4019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT1 |
0.0357293991424258 |
|
| 4020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT77 |
0.0357293991424258 |
|
| 4021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT76 |
0.0357293991424258 |
|
| 4022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT3 |
0.0357293991424258 |
|
| 4023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT4 |
0.0357293991424258 |
|
| 4024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT79 |
0.0357293991424258 |
|
| 4025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT78 |
0.0357293991424258 |
|
| 4026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT8 |
0.0357293991424258 |
|
| 4027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT18 |
0.0357293991424258 |
|
| 4028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4B |
0.0357293991424258 |
|
| 4029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP6 |
0.0357293991424258 |
|
| 4030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOAT2 |
0.0357293991424258 |
|
| 4031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRYD3 |
0.0357293991424258 |
|
| 4032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TENC1 |
0.0357293991424258 |
|
| 4033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSAD |
0.0357293991424258 |
|
| 4034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF740 |
0.0357293991424258 |
|
| 4035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB7 |
0.0357293991424258 |
|
| 4036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARG |
0.0357293991424258 |
|
| 4037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD5 |
0.0357293991424258 |
|
| 4038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESPL1 |
0.0357293991424258 |
|
| 4039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFDN5 |
0.0357293991424258 |
|
| 4040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf10 |
0.0357293991424258 |
|
| 4041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAAS |
0.0357293991424258 |
|
| 4042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX5 |
0.0357293991424258 |
|
| 4043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL390P |
0.0357293991424258 |
|
| 4044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA1 |
0.0357293991424258 |
|
| 4045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFE2 |
0.0357293991424258 |
|
| 4046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPZ1 |
0.0357293991424258 |
|
| 4047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR148B |
0.0357293991424258 |
|
| 4048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL744P |
0.0357293991424258 |
|
| 4049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR84 |
0.0357293991424258 |
|
| 4050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF385A |
0.0357293991424258 |
|
| 4051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF385D |
0.0389330794271663 |
|
| 4052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB1P5 |
0.0389330794271663 |
|
| 4053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2E2 |
0.0389330794271663 |
|
| 4054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RP2 |
0.039494121557264 |
|
| 4055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf31 |
0.039494121557264 |
|
| 4056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF16 |
0.039494121557264 |
|
| 4057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGN |
0.039494121557264 |
|
| 4058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB11 |
0.039494121557264 |
|
| 4059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM10 |
0.039494121557264 |
|
| 4060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA1 |
0.039494121557264 |
|
| 4061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INE1 |
0.039494121557264 |
|
| 4062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK16 |
0.039494121557264 |
|
| 4063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP11 |
0.039494121557264 |
|
| 4064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL785P |
0.039494121557264 |
|
| 4065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238729.1 |
0.039494121557264 |
|
| 4066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF157 |
0.039494121557264 |
|
| 4067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11C |
0.039494121557264 |
|
| 4068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF41 |
0.039494121557264 |
|
| 4069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf24 |
0.039494121557264 |
|
| 4070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDRG2 |
0.040794860496738 |
|
| 4071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF40 |
0.040794860496738 |
|
| 4072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF219 |
0.040794860496738 |
|
| 4073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM253 |
0.040794860496738 |
|
| 4074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AU1 |
0.040794860496738 |
|
| 4075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00641 |
0.040794860496738 |
|
| 4076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPC |
0.040794860496738 |
|
| 4077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPGRIP1 |
0.040794860496738 |
|
| 4078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT16H |
0.040794860496738 |
|
| 4079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD8 |
0.040794860496738 |
|
| 4080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD9 |
0.040794860496738 |
|
| 4081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD8 |
0.040794860496738 |
|
| 4082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL650P |
0.040794860496738 |
|
| 4083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB2B |
0.040794860496738 |
|
| 4084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOX4 |
0.040794860496738 |
|
| 4085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL3 |
0.040794860496738 |
|
| 4086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SALL2 |
0.040794860496738 |
|
| 4087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G3 |
0.040794860496738 |
|
| 4088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10G2 |
0.040794860496738 |
|
| 4089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD4 |
0.040794860496738 |
|
| 4090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAD1 |
0.040794860496738 |
|
| 4091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4E2 |
0.040794860496738 |
|
| 4092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6J1 |
0.040794860496738 |
|
| 4093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAC |
0.040794860496738 |
|
| 4094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ10 |
0.040794860496738 |
|
| 4095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ11 |
0.040794860496738 |
|
| 4096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ12 |
0.040794860496738 |
|
| 4097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ13 |
0.040794860496738 |
|
| 4098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ14 |
0.040794860496738 |
|
| 4099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ16 |
0.040794860496738 |
|
| 4100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ17 |
0.040794860496738 |
|
| 4101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ18 |
0.040794860496738 |
|
| 4102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ19 |
0.040794860496738 |
|
| 4103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ1 |
0.040794860496738 |
|
| 4104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ20 |
0.040794860496738 |
|
| 4105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ21 |
0.040794860496738 |
|
| 4106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ22 |
0.040794860496738 |
|
| 4107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ23 |
0.040794860496738 |
|
| 4108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ24 |
0.040794860496738 |
|
| 4109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ25 |
0.040794860496738 |
|
| 4110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ26 |
0.040794860496738 |
|
| 4111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ27 |
0.040794860496738 |
|
| 4112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ28 |
0.040794860496738 |
|
| 4113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ29 |
0.040794860496738 |
|
| 4114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ2 |
0.040794860496738 |
|
| 4115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ30 |
0.040794860496738 |
|
| 4116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ31 |
0.040794860496738 |
|
| 4117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ32 |
0.040794860496738 |
|
| 4118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ33 |
0.040794860496738 |
|
| 4119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ34 |
0.040794860496738 |
|
| 4120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ35 |
0.040794860496738 |
|
| 4121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ36 |
0.040794860496738 |
|
| 4122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ37 |
0.040794860496738 |
|
| 4123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ38 |
0.040794860496738 |
|
| 4124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ39 |
0.040794860496738 |
|
| 4125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ3 |
0.040794860496738 |
|
| 4126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ40 |
0.040794860496738 |
|
| 4127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ41 |
0.040794860496738 |
|
| 4128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ42 |
0.040794860496738 |
|
| 4129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ43 |
0.040794860496738 |
|
| 4130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ44 |
0.040794860496738 |
|
| 4131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ45 |
0.040794860496738 |
|
| 4132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ46 |
0.040794860496738 |
|
| 4133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ47 |
0.040794860496738 |
|
| 4134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ48 |
0.040794860496738 |
|
| 4135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ49 |
0.040794860496738 |
|
| 4136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ4 |
0.040794860496738 |
|
| 4137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ50 |
0.040794860496738 |
|
| 4138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ52 |
0.040794860496738 |
|
| 4139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ53 |
0.040794860496738 |
|
| 4140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ54 |
0.040794860496738 |
|
| 4141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ56 |
0.040794860496738 |
|
| 4142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ57 |
0.040794860496738 |
|
| 4143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ58 |
0.040794860496738 |
|
| 4144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ59 |
0.040794860496738 |
|
| 4145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ5 |
0.040794860496738 |
|
| 4146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ61 |
0.040794860496738 |
|
| 4147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ6 |
0.040794860496738 |
|
| 4148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ7 |
0.040794860496738 |
|
| 4149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ8 |
0.040794860496738 |
|
| 4150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAJ9 |
0.040794860496738 |
|
| 4151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV10 |
0.040794860496738 |
|
| 4152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV14DV4 |
0.040794860496738 |
|
| 4153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV16 |
0.040794860496738 |
|
| 4154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV17 |
0.040794860496738 |
|
| 4155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV18 |
0.040794860496738 |
|
| 4156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV19 |
0.040794860496738 |
|
| 4157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV20 |
0.040794860496738 |
|
| 4158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV21 |
0.040794860496738 |
|
| 4159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV22 |
0.040794860496738 |
|
| 4160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV23DV6 |
0.040794860496738 |
|
| 4161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV24 |
0.040794860496738 |
|
| 4162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV25 |
0.040794860496738 |
|
| 4163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV27 |
0.040794860496738 |
|
| 4164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV29DV5 |
0.040794860496738 |
|
| 4165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV2 |
0.040794860496738 |
|
| 4166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV30 |
0.040794860496738 |
|
| 4167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV34 |
0.040794860496738 |
|
| 4168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV35 |
0.040794860496738 |
|
| 4169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV36DV7 |
0.040794860496738 |
|
| 4170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV39 |
0.040794860496738 |
|
| 4171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV3 |
0.040794860496738 |
|
| 4172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV40 |
0.040794860496738 |
|
| 4173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV41 |
0.040794860496738 |
|
| 4174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV4 |
0.040794860496738 |
|
| 4175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV5 |
0.040794860496738 |
|
| 4176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV6 |
0.040794860496738 |
|
| 4177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAV7 |
0.040794860496738 |
|
| 4178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDC |
0.040794860496738 |
|
| 4179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDD1 |
0.040794860496738 |
|
| 4180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDD2 |
0.040794860496738 |
|
| 4181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDD3 |
0.040794860496738 |
|
| 4182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDJ1 |
0.040794860496738 |
|
| 4183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDJ2 |
0.040794860496738 |
|
| 4184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDJ3 |
0.040794860496738 |
|
| 4185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDJ4 |
0.040794860496738 |
|
| 4186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDV1 |
0.040794860496738 |
|
| 4187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDV2 |
0.040794860496738 |
|
| 4188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDV3 |
0.040794860496738 |
|
| 4189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXA1L |
0.040794860496738 |
|
| 4190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A7 |
0.040794860496738 |
|
| 4191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD41|ENSG00000212302.1 |
0.040794860496738 |
|
| 4192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL52 |
0.040794860496738 |
|
| 4193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP14 |
0.040794860496738 |
|
| 4194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP10 |
0.040794860496738 |
|
| 4195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REM2 |
0.040794860496738 |
|
| 4196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM23 |
0.040794860496738 |
|
| 4197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT5 |
0.040794860496738 |
|
| 4198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS4 |
0.040794860496738 |
|
| 4199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4707 |
0.040794860496738 |
|
| 4200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AJUBA |
0.040794860496738 |
|
| 4201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf93 |
0.040794860496738 |
|
| 4202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB5 |
0.040794860496738 |
|
| 4203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000252114.1 |
0.040794860496738 |
|
| 4204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB11 |
0.040794860496738 |
|
| 4205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH24 |
0.040794860496738 |
|
| 4206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACIN1 |
0.040794860496738 |
|
| 4207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf119 |
0.040794860496738 |
|
| 4208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPE |
0.040794860496738 |
|
| 4209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A8 |
0.040794860496738 |
|
| 4210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf164 |
0.040794860496738 |
|
| 4211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOMEZ |
0.040794860496738 |
|
| 4212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3E |
0.040794860496738 |
|
| 4213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L2 |
0.040794860496738 |
|
| 4214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPN1 |
0.040794860496738 |
|
| 4215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A17 |
0.040794860496738 |
|
| 4216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFS |
0.040794860496738 |
|
| 4217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL25 |
0.040794860496738 |
|
| 4218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM5 |
0.040794860496738 |
|
| 4219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH6 |
0.040794860496738 |
|
| 4220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR208A |
0.040794860496738 |
|
| 4221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH7 |
0.040794860496738 |
|
| 4222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR208B |
0.040794860496738 |
|
| 4223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGDN |
0.040794860496738 |
|
| 4224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFHX2 |
0.040794860496738 |
|
| 4225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THTPA |
0.040794860496738 |
|
| 4226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1G2 |
0.040794860496738 |
|
| 4227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JPH4 |
0.040794860496738 |
|
| 4228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS2 |
0.040794860496738 |
|
| 4229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP205 |
0.040794860496738 |
|
| 4230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00596 |
0.040794860496738 |
|
| 4231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS4 |
0.040794860496738 |
|
| 4232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS4L2 |
0.040794860496738 |
|
| 4233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS4L1 |
0.040794860496738 |
|
| 4234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC16B |
0.040794860496738 |
|
| 4235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE6 |
0.040794860496738 |
|
| 4236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRL |
0.040794860496738 |
|
| 4237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCK2 |
0.040794860496738 |
|
| 4238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF11 |
0.040794860496738 |
|
| 4239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FITM1 |
0.040794860496738 |
|
| 4240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC9 |
0.040794860496738 |
|
| 4241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSME1 |
0.040794860496738 |
|
| 4242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSME2 |
0.040794860496738 |
|
| 4243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF31 |
0.040794860496738 |
|
| 4244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF9 |
0.040794860496738 |
|
| 4245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP383 |
0.040794860496738 |
|
| 4246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REC8 |
0.040794860496738 |
|
| 4247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO4 |
0.040794860496738 |
|
| 4248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM9SF1 |
0.040794860496738 |
|
| 4249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP4A |
0.040794860496738 |
|
| 4250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSK4 |
0.040794860496738 |
|
| 4251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDP1 |
0.040794860496738 |
|
| 4252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEDD8 |
0.040794860496738 |
|
| 4253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMPR2 |
0.040794860496738 |
|
| 4254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TINF2 |
0.040794860496738 |
|
| 4255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM1 |
0.040794860496738 |
|
| 4256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABGGTA |
0.040794860496738 |
|
| 4257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS1 |
0.040794860496738 |
|
| 4258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP9 |
0.040794860496738 |
|
| 4259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIDEB |
0.040794860496738 |
|
| 4260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTB4R2 |
0.040794860496738 |
|
| 4261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTB4R |
0.040794860496738 |
|
| 4262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY4 |
0.040794860496738 |
|
| 4263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPK3 |
0.040794860496738 |
|
| 4264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFATC4 |
0.040794860496738 |
|
| 4265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NYNRIN |
0.040794860496738 |
|
| 4266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLN3 |
0.040794860496738 |
|
| 4267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHNYN |
0.040794860496738 |
|
| 4268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR39U1 |
0.040794860496738 |
|
| 4269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMA1 |
0.040794860496738 |
|
| 4270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSG |
0.040794860496738 |
|
| 4271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZMH |
0.040794860496738 |
|
| 4272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZMB |
0.040794860496738 |
|
| 4273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP6 |
0.040794860496738 |
|
| 4274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2R2 |
0.0409572514719642 |
|
| 4275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP214 |
0.0417020009398883 |
|
| 4276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM78A |
0.0417020009398883 |
|
| 4277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAPDC3 |
0.0417020009398883 |
|
| 4278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRC2B |
0.0417020009398883 |
|
| 4279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD62A |
0.0417020009398883 |
|
| 4280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD62B |
0.0417020009398883 |
|
| 4281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMT1 |
0.0417020009398883 |
|
| 4282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCK1 |
0.0417020009398883 |
|
| 4283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF1 |
0.0417020009398883 |
|
| 4284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL328P |
0.0417020009398883 |
|
| 4285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000212395.1 |
0.0417020009398883 |
|
| 4286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED27 |
0.0417020009398883 |
|
| 4287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTNG2 |
0.0417020009398883 |
|
| 4288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETX |
0.0417020009398883 |
|
| 4289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTF1 |
0.0417020009398883 |
|
| 4290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf171 |
0.0417020009398883 |
|
| 4291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BARHL1 |
0.0417020009398883 |
|
| 4292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX31 |
0.0417020009398883 |
|
| 4293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C4 |
0.0417020009398883 |
|
| 4294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK8 |
0.0417020009398883 |
|
| 4295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf9 |
0.0417020009398883 |
|
| 4296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC1 |
0.0417020009398883 |
|
| 4297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFI1B |
0.0417020009398883 |
|
| 4298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AW |
0.0417020009398883 |
|
| 4299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C5 |
0.0417020009398883 |
|
| 4300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELP |
0.0417020009398883 |
|
| 4301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEL |
0.0417020009398883 |
|
| 4302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGDS |
0.0417020009398883 |
|
| 4303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238657.1 |
0.0417020009398883 |
|
| 4304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBGT1 |
0.0417020009398883 |
|
| 4305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OBP2B |
0.0417020009398883 |
|
| 4306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABO |
0.0417020009398883 |
|
| 4307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SURF6 |
0.0417020009398883 |
|
| 4308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED22 |
0.0417020009398883 |
|
| 4309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL7A |
0.0417020009398883 |
|
| 4310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD24 |
0.0417020009398883 |
|
| 4311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36A |
0.0417020009398883 |
|
| 4312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36B |
0.0417020009398883 |
|
| 4313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36C |
0.0417020009398883 |
|
| 4314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SURF1 |
0.0417020009398883 |
|
| 4315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SURF2 |
0.0417020009398883 |
|
| 4316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SURF4 |
0.0417020009398883 |
|
| 4317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf96 |
0.0417020009398883 |
|
| 4318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO4 |
0.0417020009398883 |
|
| 4319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS13 |
0.0417020009398883 |
|
| 4320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACFD1 |
0.0417020009398883 |
|
| 4321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A6 |
0.0417020009398883 |
|
| 4322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM8C |
0.0417020009398883 |
|
| 4323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTSL2 |
0.0417020009398883 |
|
| 4324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM163B |
0.0417020009398883 |
|
| 4325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBH |
0.0417020009398883 |
|
| 4326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SARDH |
0.0417020009398883 |
|
| 4327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAV2 |
0.0417020009398883 |
|
| 4328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00094 |
0.0417020009398883 |
|
| 4329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD3 |
0.0417020009398883 |
|
| 4330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR5 |
0.0417020009398883 |
|
| 4331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC |
0.0417020009398883 |
|
| 4332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXRA |
0.0417020009398883 |
|
| 4333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4669 |
0.0417020009398883 |
|
| 4334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL5A1 |
0.0417020009398883 |
|
| 4335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689A |
0.0417020009398883 |
|
| 4336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689B |
0.0417020009398883 |
|
| 4337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689C |
0.0417020009398883 |
|
| 4338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689D1 |
0.0417020009398883 |
|
| 4339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689D2 |
0.0417020009398883 |
|
| 4340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689E |
0.0417020009398883 |
|
| 4341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3689F |
0.0417020009398883 |
|
| 4342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCN2 |
0.0417020009398883 |
|
| 4343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCN1 |
0.0417020009398883 |
|
| 4344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFM1 |
0.0417020009398883 |
|
| 4345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf62 |
0.0417020009398883 |
|
| 4346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R26 |
0.0417020009398883 |
|
| 4347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf116 |
0.0417020009398883 |
|
| 4348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS2 |
0.0417020009398883 |
|
| 4349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN1 |
0.0417020009398883 |
|
| 4350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OBP2A |
0.0417020009398883 |
|
| 4351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAEP |
0.0417020009398883 |
|
| 4352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLT6D1 |
0.0417020009398883 |
|
| 4353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN9 |
0.0417020009398883 |
|
| 4354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOHLH1 |
0.0417020009398883 |
|
| 4355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNT1 |
0.0417020009398883 |
|
| 4356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMSAP1 |
0.0417020009398883 |
|
| 4357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAC1 |
0.0417020009398883 |
|
| 4358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACC2 |
0.0417020009398883 |
|
| 4359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf69 |
0.0417020009398883 |
|
| 4360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD9 |
0.0417020009398883 |
|
| 4361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP434A062 |
0.0417020009398883 |
|
| 4362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNLZ |
0.0417020009398883 |
|
| 4363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPSM1 |
0.0417020009398883 |
|
| 4364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX3 |
0.0417020009398883 |
|
| 4365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QSOX2 |
0.0417020009398883 |
|
| 4366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT6A |
0.0417568525955664 |
|
| 4367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC88B |
0.0426298490831865 |
|
| 4368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA4 |
0.0426298490831865 |
|
| 4369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1237 |
0.0426298490831865 |
|
| 4370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A11 |
0.0426298490831865 |
|
| 4371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A12 |
0.0426298490831865 |
|
| 4372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRXN2 |
0.0426298490831865 |
|
| 4373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRP2 |
0.0426298490831865 |
|
| 4374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYGM |
0.0426298490831865 |
|
| 4375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF1 |
0.0426298490831865 |
|
| 4376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4K2 |
0.0426298490831865 |
|
| 4377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEN1 |
0.0426298490831865 |
|
| 4378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACY3 |
0.0426298490831865 |
|
| 4379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH3B2 |
0.0426298490831865 |
|
| 4380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf72 |
0.0426298490831865 |
|
| 4381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOC2GP |
0.0426298490831865 |
|
| 4382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86C2P |
0.0426298490831865 |
|
| 4383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTP1 |
0.0426298490831865 |
|
| 4384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFV1 |
0.0426298490831865 |
|
| 4385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT8 |
0.0426298490831865 |
|
| 4386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL59P |
0.0426298490831865 |
|
| 4387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX10 |
0.0426298490831865 |
|
| 4388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC93B1 |
0.0426298490831865 |
|
| 4389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH3B1 |
0.0426298490831865 |
|
| 4390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS8 |
0.0426298490831865 |
|
| 4391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4691 |
0.0426298490831865 |
|
| 4392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCIRG1 |
0.0426298490831865 |
|
| 4393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHKA |
0.0426298490831865 |
|
| 4394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUV420H1 |
0.0426298490831865 |
|
| 4395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf24 |
0.0426298490831865 |
|
| 4396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP5 |
0.0426298490831865 |
|
| 4397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP6R3 |
0.0426298490831865 |
|
| 4398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAL |
0.0426298490831865 |
|
| 4399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTL5 |
0.0426298490831865 |
|
| 4400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPT1A |
0.0426298490831865 |
|
| 4401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL21 |
0.0426298490831865 |
|
| 4402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHMBP2 |
0.0426298490831865 |
|
| 4403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRD |
0.0426298490831865 |
|
| 4404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRF |
0.0426298490831865 |
|
| 4405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPCN2 |
0.0426298490831865 |
|
| 4406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3164 |
0.0426298490831865 |
|
| 4407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYEOV |
0.0426298490831865 |
|
| 4408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCND1 |
0.0426298490831865 |
|
| 4409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORAOV1 |
0.0426298490831865 |
|
| 4410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF19 |
0.0426298490831865 |
|
| 4411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF4 |
0.0426298490831865 |
|
| 4412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF3 |
0.0426298490831865 |
|
| 4413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO1 |
0.0426298490831865 |
|
| 4414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FADD |
0.0426298490831865 |
|
| 4415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIA1 |
0.0426298490831865 |
|
| 4416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548K |
0.0426298490831865 |
|
| 4417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTTN |
0.0426298490831865 |
|
| 4418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHANK2 |
0.0426298490831865 |
|
| 4419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3664 |
0.0426298490831865 |
|
| 4420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHCR7 |
0.0426298490831865 |
|
| 4421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NADSYN1 |
0.0426298490831865 |
|
| 4422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC93B6 |
0.0426298490831865 |
|
| 4423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP7P8 |
0.0426298490831865 |
|
| 4424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86C1 |
0.0426298490831865 |
|
| 4425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF705E |
0.0426298490831865 |
|
| 4426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB108B |
0.0426298490831865 |
|
| 4427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP342 |
0.0426298490831865 |
|
| 4428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPB |
0.0426298490831865 |
|
| 4429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE2A |
0.0426298490831865 |
|
| 4430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR139 |
0.0426298490831865 |
|
| 4431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARAP1 |
0.0426298490831865 |
|
| 4432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD10 |
0.0426298490831865 |
|
| 4433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4692 |
0.0426298490831865 |
|
| 4434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG16L2 |
0.0426298490831865 |
|
| 4435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCHSD2 |
0.0426298490831865 |
|
| 4436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY2 |
0.0426298490831865 |
|
| 4437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY6 |
0.0426298490831865 |
|
| 4438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF17 |
0.0426298490831865 |
|
| 4439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELT |
0.0426298490831865 |
|
| 4440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM168A |
0.0426298490831865 |
|
| 4441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHB1 |
0.0426298490831865 |
|
| 4442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB6A |
0.0426298490831865 |
|
| 4443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL48 |
0.0426298490831865 |
|
| 4444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP243 |
0.0426298490831865 |
|
| 4445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COA4 |
0.0426298490831865 |
|
| 4446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAAF1 |
0.0426298490831865 |
|
| 4447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB13 |
0.0426298490831865 |
|
| 4448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCP2 |
0.0426298490831865 |
|
| 4449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCP3 |
0.0426298490831865 |
|
| 4450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD3 |
0.0426298490831865 |
|
| 4451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPME1 |
0.0426298490831865 |
|
| 4452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP343 |
0.0426298490831865 |
|
| 4453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P4HA3 |
0.0426298490831865 |
|
| 4454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7|ENSG00000206913.1 |
0.0426298490831865 |
|
| 4455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM2L1 |
0.0426298490831865 |
|
| 4456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AL |
0.0426298490831865 |
|
| 4457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNE3 |
0.0426298490831865 |
|
| 4458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPT2 |
0.0426298490831865 |
|
| 4459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLD3 |
0.0426298490831865 |
|
| 4460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP297 |
0.0426298490831865 |
|
| 4461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRDL2 |
0.0426298490831865 |
|
| 4462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD43|ENSG00000212277.1 |
0.0426298490831865 |
|
| 4463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4696 |
0.0426298490831865 |
|
| 4464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF169 |
0.0426298490831865 |
|
| 4465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRRA1 |
0.0426298490831865 |
|
| 4466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL239P |
0.0426298490831865 |
|
| 4467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPCS2 |
0.0426298490831865 |
|
| 4468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEU3 |
0.0426298490831865 |
|
| 4469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AT4 |
0.0426298490831865 |
|
| 4470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO2B1 |
0.0426298490831865 |
|
| 4471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPBGL |
0.0426298490831865 |
|
| 4472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRB1 |
0.0426298490831865 |
|
| 4473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR326 |
0.0426298490831865 |
|
| 4474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS3 |
0.0426298490831865 |
|
| 4475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD15A |
0.0426298490831865 |
|
| 4476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD15B |
0.0426298490831865 |
|
| 4477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL35 |
0.0426298490831865 |
|
| 4478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPD5 |
0.0426298490831865 |
|
| 4479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UVRAG |
0.0426298490831865 |
|
| 4480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP344 |
0.0426298490831865 |
|
| 4481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT11 |
0.0426298490831865 |
|
| 4482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKRIR |
0.0426298490831865 |
|
| 4483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf30 |
0.0426298490831865 |
|
| 4484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC32 |
0.0426298490831865 |
|
| 4485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY2EP |
0.0426298490831865 |
|
| 4486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSKU |
0.0426298490831865 |
|
| 4487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACER3 |
0.0426298490831865 |
|
| 4488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT6 |
0.0426298490831865 |
|
| 4489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN5 |
0.0426298490831865 |
|
| 4490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OMP |
0.0426298490831865 |
|
| 4491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO7A |
0.0426298490831865 |
|
| 4492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPD4 |
0.0426298490831865 |
|
| 4493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK1 |
0.0426298490831865 |
|
| 4494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP434E1119 |
0.0426298490831865 |
|
| 4495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLNS1A |
0.0426298490831865 |
|
| 4496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP11 |
0.0426298490831865 |
|
| 4497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSF1 |
0.0426298490831865 |
|
| 4498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAMDC |
0.0426298490831865 |
|
| 4499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS4 |
0.0426298490831865 |
|
| 4500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD14 |
0.0426298490831865 |
|
| 4501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THRSP |
0.0426298490831865 |
|
| 4502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFC2 |
0.0426298490831865 |
|
| 4503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG8 |
0.0426298490831865 |
|
| 4504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD21 |
0.0426298490831865 |
|
| 4505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP35 |
0.0426298490831865 |
|
| 4506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAB2 |
0.0426298490831865 |
|
| 4507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NARS2 |
0.0426298490831865 |
|
| 4508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TENM4 |
0.0426298490831865 |
|
| 4509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR708 |
0.0426298490831865 |
|
| 4510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5579 |
0.0426298490831865 |
|
| 4511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM181B |
0.0426298490831865 |
|
| 4512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRCP |
0.0426298490831865 |
|
| 4513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238995.1 |
0.0426298490831865 |
|
| 4514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf82 |
0.0426298490831865 |
|
| 4515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB30 |
0.0426298490831865 |
|
| 4516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCF11 |
0.0426298490831865 |
|
| 4517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD42 |
0.0426298490831865 |
|
| 4518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLG2 |
0.0426298490831865 |
|
| 4519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM126B |
0.0426298490831865 |
|
| 4520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM126A |
0.0426298490831865 |
|
| 4521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREBZF |
0.0426298490831865 |
|
| 4522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC89 |
0.0426298490831865 |
|
| 4523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYTL2 |
0.0426298490831865 |
|
| 4524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC83 |
0.0426298490831865 |
|
| 4525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PICALM |
0.0426298490831865 |
|
| 4526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EED |
0.0426298490831865 |
|
| 4527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf73 |
0.0426298490831865 |
|
| 4528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL225P |
0.0426298490831865 |
|
| 4529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC81 |
0.0426298490831865 |
|
| 4530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ME3 |
0.0426298490831865 |
|
| 4531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD4 |
0.0426298490831865 |
|
| 4532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM135 |
0.0426298490831865 |
|
| 4533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSC |
0.0426298490831865 |
|
| 4534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYR |
0.0426298490831865 |
|
| 4535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOX4 |
0.0426298490831865 |
|
| 4536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLH1B |
0.0426298490831865 |
|
| 4537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM49C |
0.0426298490831865 |
|
| 4538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM49D1 |
0.0426298490831865 |
|
| 4539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM49 |
0.0426298490831865 |
|
| 4540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM64B |
0.0426298490831865 |
|
| 4541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM77 |
0.0426298490831865 |
|
| 4542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000207299.1 |
0.0426298490831865 |
|
| 4543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAALAD2 |
0.0426298490831865 |
|
| 4544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHORDC1 |
0.0426298490831865 |
|
| 4545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DISC1FP1 |
0.0426298490831865 |
|
| 4546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4490 |
0.0426298490831865 |
|
| 4547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1261 |
0.0426298490831865 |
|
| 4548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAT3 |
0.0426298490831865 |
|
| 4549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC67 |
0.0426298490831865 |
|
| 4550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC36A4 |
0.0426298490831865 |
|
| 4551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCO4 |
0.0426298490831865 |
|
| 4552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL223P |
0.0426298490831865 |
|
| 4553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1731 |
0.0426298490831865 |
|
| 4554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM5 |
0.0426298490831865 |
|
| 4555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEPHL1 |
0.0426298490831865 |
|
| 4556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANX1 |
0.0426298490831865 |
|
| 4557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR83 |
0.0426298490831865 |
|
| 4558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRE11A |
0.0426298490831865 |
|
| 4559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548L |
0.0426298490831865 |
|
| 4560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD49 |
0.0426298490831865 |
|
| 4561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT4 |
0.0426298490831865 |
|
| 4562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIWIL4 |
0.0426298490831865 |
|
| 4563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKG |
0.0443227858802526 |
|
| 4564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00516 |
0.0449543189463553 |
|
| 4565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED15P1 |
0.0449543189463553 |
|
| 4566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED15P6 |
0.0449543189463553 |
|
| 4567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11H12 |
0.0449543189463553 |
|
| 4568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K13 |
0.0449543189463553 |
|
| 4569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K14 |
0.0449543189463553 |
|
| 4570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K15 |
0.0449543189463553 |
|
| 4571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K1 |
0.0449543189463553 |
|
| 4572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K2 |
0.0449543189463553 |
|
| 4573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K5 |
0.0449543189463553 |
|
| 4574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4M1 |
0.0449543189463553 |
|
| 4575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4N2 |
0.0449543189463553 |
|
| 4576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4Q2 |
0.0449543189463553 |
|
| 4577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4Q3 |
0.0449543189463553 |
|
| 4578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEG |
0.0449543189463553 |
|
| 4579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEM |
0.0449543189463553 |
|
| 4580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238492.1 |
0.0449543189463553 |
|
| 4581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4L1 |
0.0449543189463553 |
|
| 4582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP380 |
0.0449543189463553 |
|
| 4583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4K17 |
0.0449543189463553 |
|
| 4584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4N5 |
0.0449543189463553 |
|
| 4585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP381 |
0.0449543189463553 |
|
| 4586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11G2 |
0.0449543189463553 |
|
| 4587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11H6 |
0.0449543189463553 |
|
| 4588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11H7 |
0.0449543189463553 |
|
| 4589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11H4 |
0.0449543189463553 |
|
| 4590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC5 |
0.0449543189463553 |
|
| 4591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNB1IP1 |
0.0449543189463553 |
|
| 4592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA79|ENSG00000222489.1 |
0.0449543189463553 |
|
| 4593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD126 |
0.0449543189463553 |
|
| 4594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPPH1 |
0.0449543189463553 |
|
| 4595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP2 |
0.0449543189463553 |
|
| 4596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEP1 |
0.0449543189463553 |
|
| 4597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP382 |
0.0449543189463553 |
|
| 4598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL33 |
0.0449543189463553 |
|
| 4599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSGEP |
0.0449543189463553 |
|
| 4600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APEX1 |
0.0449543189463553 |
|
| 4601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM55B |
0.0449543189463553 |
|
| 4602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNP |
0.0449543189463553 |
|
| 4603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE10 |
0.0449543189463553 |
|
| 4604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE9 |
0.0449543189463553 |
|
| 4605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE11 |
0.0449543189463553 |
|
| 4606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE12 |
0.0449543189463553 |
|
| 4607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6S1 |
0.0449543189463553 |
|
| 4608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANG |
0.0449543189463553 |
|
| 4609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE4 |
0.0449543189463553 |
|
| 4610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDDM3A |
0.0449543189463553 |
|
| 4611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDDM3B |
0.0449543189463553 |
|
| 4612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE6 |
0.0449543189463553 |
|
| 4613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE1 |
0.0449543189463553 |
|
| 4614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL189P |
0.0449543189463553 |
|
| 4615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE2 |
0.0449543189463553 |
|
| 4616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE3 |
0.0449543189463553 |
|
| 4617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL17 |
0.0449543189463553 |
|
| 4618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A2 |
0.0449543189463553 |
|
| 4619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPPP2 |
0.0449543189463553 |
|
| 4620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE13 |
0.0449543189463553 |
|
| 4621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE7 |
0.0449543189463553 |
|
| 4622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASE8 |
0.0449543189463553 |
|
| 4623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL7 |
0.0458643025380865 |
|
| 4624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKACB |
0.0458643025380865 |
|
| 4625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA2|ENSG00000199959.1 |
0.0458643025380865 |
|
| 4626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD13 |
0.0458643025380865 |
|
| 4627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UOX |
0.0458643025380865 |
|
| 4628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE2B |
0.0458643025380865 |
|
| 4629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPF1 |
0.0458643025380865 |
|
| 4630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG5 |
0.0458643025380865 |
|
| 4631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA1 |
0.0458643025380865 |
|
| 4632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTBS |
0.0458643025380865 |
|
| 4633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf180 |
0.0458643025380865 |
|
| 4634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX2IP |
0.0458643025380865 |
|
| 4635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR3 |
0.0458643025380865 |
|
| 4636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCOLN2 |
0.0458643025380865 |
|
| 4637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR63 |
0.0458643025380865 |
|
| 4638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCOLN3 |
0.0458643025380865 |
|
| 4639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV1 |
0.0462200355326272 |
|
| 4640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT14 |
0.0467069926179086 |
|
| 4641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS17 |
0.0467069926179086 |
|
| 4642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF713 |
0.0467069926179086 |
|
| 4643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL64P |
0.0467069926179086 |
|
| 4644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBAS |
0.0467069926179086 |
|
| 4645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSPH |
0.0467069926179086 |
|
| 4646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42BPG |
0.0479573515215929 |
|
| 4647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP5B1 |
0.0479573515215929 |
|
| 4648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL2 |
0.0479573515215929 |
|
| 4649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG2A |
0.0479573515215929 |
|
| 4650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BATF2 |
0.0479573515215929 |
|
| 4651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf85 |
0.0479573515215929 |
|
| 4652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN1 |
0.0479573515215929 |
|
| 4653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC85B |
0.0479573515215929 |
|
| 4654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42EP2 |
0.0479573515215929 |
|
| 4655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA5 |
0.0479573515215929 |
|
| 4656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFL1 |
0.0479573515215929 |
|
| 4657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSW |
0.0479573515215929 |
|
| 4658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPF2 |
0.0479573515215929 |
|
| 4659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFEMP2 |
0.0479573515215929 |
|
| 4660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHBP1L1 |
0.0479573515215929 |
|
| 4661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHD1 |
0.0479573515215929 |
|
| 4662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM89B |
0.0479573515215929 |
|
| 4663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAU |
0.0479573515215929 |
|
| 4664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIBP |
0.0479573515215929 |
|
| 4665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOSL1 |
0.0479573515215929 |
|
| 4666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD8 |
0.0479573515215929 |
|
| 4667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPHA2 |
0.0479573515215929 |
|
| 4668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT5 |
0.0479573515215929 |
|
| 4669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK7 |
0.0479573515215929 |
|
| 4670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTBP3 |
0.0479573515215929 |
|
| 4671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MALAT1 |
0.0479573515215929 |
|
| 4672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K11 |
0.0479573515215929 |
|
| 4673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR192 |
0.0479573515215929 |
|
| 4674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4489 |
0.0479573515215929 |
|
| 4675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4690 |
0.0479573515215929 |
|
| 4676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL49 |
0.0479573515215929 |
|
| 4677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUS81 |
0.0479573515215929 |
|
| 4678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAALADL1 |
0.0479573515215929 |
|
| 4679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEAT1 |
0.0479573515215929 |
|
| 4680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVOL1 |
0.0479573515215929 |
|
| 4681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNXL3 |
0.0479573515215929 |
|
| 4682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLA2 |
0.0479573515215929 |
|
| 4683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R5B |
0.0479573515215929 |
|
| 4684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELA |
0.0479573515215929 |
|
| 4685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL114P |
0.0479573515215929 |
|
| 4686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL309P |
0.0479573515215929 |
|
| 4687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEH2C |
0.0479573515215929 |
|
| 4688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAC3D1 |
0.0479573515215929 |
|
| 4689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCYL1 |
0.0479573515215929 |
|
| 4690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIPA1 |
0.0479573515215929 |
|
| 4691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A20 |
0.0479573515215929 |
|
| 4692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A45 |
0.0479573515215929 |
|
| 4693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX15 |
0.0479573515215929 |
|
| 4694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX32 |
0.0479573515215929 |
|
| 4695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYC |
0.0479573515215929 |
|
| 4696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSSCA1 |
0.0479573515215929 |
|
| 4697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYVN1 |
0.0479573515215929 |
|
| 4698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD3 |
0.0479573515215929 |
|
| 4699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM7SF2 |
0.0479573515215929 |
|
| 4700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS51 |
0.0479573515215929 |
|
| 4701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFPL1 |
0.0479573515215929 |
|
| 4702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNHIT2 |
0.0479573515215929 |
|
| 4703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL10 |
0.0480543525948992 |
|
| 4704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAS2 |
0.0487619370788321 |
|
| 4705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238901.1 |
0.0487619370788321 |
|
| 4706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTF1 |
0.0487719327486887 |
|
| 4707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5B |
0.0487719327486887 |
|
| 4708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000252448.1 |
0.0487719327486887 |
|
| 4709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3A3 |
0.0487719327486887 |
|
| 4710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHL3 |
0.0487719327486887 |
|
| 4711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP11L |
0.0487719327486887 |
|
| 4712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU3F1 |
0.0487719327486887 |
|
| 4713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3659 |
0.0487719327486887 |
|
| 4714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1L4 |
0.0505686299232778 |
|
| 4715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPF3 |
0.0510893775279475 |
|
| 4716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP69B |
0.0523243763537984 |
|
| 4717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10X1 |
0.0531378132499155 |
|
| 4718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6P1 |
0.0531378132499155 |
|
| 4719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6Y1 |
0.0531378132499155 |
|
| 4720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGFR |
0.054064172639994 |
|
| 4721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPH3 |
0.054064172639994 |
|
| 4722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOP |
0.054064172639994 |
|
| 4723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35B1 |
0.054064172639994 |
|
| 4724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM117A |
0.054064172639994 |
|
| 4725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT7 |
0.054064172639994 |
|
| 4726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAC4 |
0.054064172639994 |
|
| 4727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX4 |
0.054064172639994 |
|
| 4728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX3 |
0.054064172639994 |
|
| 4729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA3 |
0.054064172639994 |
|
| 4730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDK2 |
0.054064172639994 |
|
| 4731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD14 |
0.054064172639994 |
|
| 4732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R9B |
0.054064172639994 |
|
| 4733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCA |
0.054064172639994 |
|
| 4734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HILS1 |
0.054064172639994 |
|
| 4735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL1A1 |
0.054064172639994 |
|
| 4736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf62 |
0.054064172639994 |
|
| 4737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NARF |
0.054064172639994 |
|
| 4738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXK2 |
0.054064172639994 |
|
| 4739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238403.1 |
0.054064172639994 |
|
| 4740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR45B |
0.054064172639994 |
|
| 4741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB40B |
0.054064172639994 |
|
| 4742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4525 |
0.054064172639994 |
|
| 4743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FN3KRP |
0.054064172639994 |
|
| 4744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FN3K |
0.054064172639994 |
|
| 4745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCD |
0.054064172639994 |
|
| 4746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF750 |
0.054064172639994 |
|
| 4747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNTL1 |
0.054064172639994 |
|
| 4748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METRNL |
0.054064172639994 |
|
| 4749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00511 |
0.0557094937184551 |
|
| 4750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS8 |
0.056329120643389 |
|
| 4751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf70 |
0.056329120643389 |
|
| 4752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHHADH |
0.056329120643389 |
|
| 4753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K13 |
0.056329120643389 |
|
| 4754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239146.1 |
0.056329120643389 |
|
| 4755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM41A |
0.056329120643389 |
|
| 4756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPH |
0.056329120643389 |
|
| 4757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP2 |
0.056329120643389 |
|
| 4758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239135.1 |
0.0584175494297837 |
|
| 4759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM92 |
0.0584175494297837 |
|
| 4760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XYLT2 |
0.0584175494297837 |
|
| 4761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL27 |
0.0584175494297837 |
|
| 4762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EME1 |
0.0584175494297837 |
|
| 4763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC59 |
0.0584175494297837 |
|
| 4764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSF2 |
0.0584175494297837 |
|
| 4765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAD |
0.0584175494297837 |
|
| 4766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSAD1 |
0.0584175494297837 |
|
| 4767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCBPAP |
0.0584175494297837 |
|
| 4768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPN3 |
0.0584175494297837 |
|
| 4769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA20 |
0.0584175494297837 |
|
| 4770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1G |
0.0584175494297837 |
|
| 4771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC3 |
0.0584175494297837 |
|
| 4772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD40 |
0.0584175494297837 |
|
| 4773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUC7L3 |
0.0584175494297837 |
|
| 4774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00483 |
0.0584175494297837 |
|
| 4775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFIKKN2 |
0.0584175494297837 |
|
| 4776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOB1 |
0.0584175494297837 |
|
| 4777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG9 |
0.0584175494297837 |
|
| 4778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238815.1 |
0.0584175494297837 |
|
| 4779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME1 |
0.0584175494297837 |
|
| 4780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME2 |
0.0584175494297837 |
|
| 4781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBTD1 |
0.0584175494297837 |
|
| 4782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP18 |
0.0584175494297837 |
|
| 4783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL699P |
0.0584175494297837 |
|
| 4784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA10 |
0.0584175494297837 |
|
| 4785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ178 |
0.0584175494297837 |
|
| 4786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf112 |
0.0584175494297837 |
|
| 4787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF2B |
0.0584175494297837 |
|
| 4788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP14 |
0.0584175494297837 |
|
| 4789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOM1L1 |
0.0584175494297837 |
|
| 4790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX11 |
0.0584175494297837 |
|
| 4791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP4 |
0.0584175494297837 |
|
| 4792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HLF |
0.0584175494297837 |
|
| 4793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMD |
0.0584175494297837 |
|
| 4794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM100 |
0.0584175494297837 |
|
| 4795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCTP |
0.0584175494297837 |
|
| 4796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKFN1 |
0.0584175494297837 |
|
| 4797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOG |
0.0584175494297837 |
|
| 4798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf67 |
0.0584175494297837 |
|
| 4799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKE |
0.0584175494297837 |
|
| 4800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM25 |
0.0584175494297837 |
|
| 4801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3614 |
0.0584175494297837 |
|
| 4802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COIL |
0.0584175494297837 |
|
| 4803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCPEP1 |
0.0584175494297837 |
|
| 4804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF126P1 |
0.0584175494297837 |
|
| 4805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP1 |
0.0584175494297837 |
|
| 4806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSI2 |
0.0584175494297837 |
|
| 4807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL437P |
0.0584175494297837 |
|
| 4808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL449P |
0.0584175494297837 |
|
| 4809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP94 |
0.0584175494297837 |
|
| 4810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS23 |
0.0584175494297837 |
|
| 4811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUEDC1 |
0.0584175494297837 |
|
| 4812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEZF1 |
0.0584175494297837 |
|
| 4813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF1 |
0.0584175494297837 |
|
| 4814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLL2 |
0.0584175494297837 |
|
| 4815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D1 |
0.0584175494297837 |
|
| 4816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D2 |
0.0584175494297837 |
|
| 4817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPX |
0.0584175494297837 |
|
| 4818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKS1 |
0.0584175494297837 |
|
| 4819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPO |
0.0584175494297837 |
|
| 4820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPO |
0.0584175494297837 |
|
| 4821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BZRAP1 |
0.0584175494297837 |
|
| 4822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR142 |
0.0584175494297837 |
|
| 4823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4736 |
0.0584175494297837 |
|
| 4824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT4H1 |
0.0584175494297837 |
|
| 4825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF43 |
0.0584175494297837 |
|
| 4826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSF5 |
0.0584175494297837 |
|
| 4827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR4 |
0.0584175494297837 |
|
| 4828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT4 |
0.0584175494297837 |
|
| 4829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf47 |
0.0584175494297837 |
|
| 4830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX14 |
0.0584175494297837 |
|
| 4831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212195.1 |
0.0584175494297837 |
|
| 4832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51C |
0.0584175494297837 |
|
| 4833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1E |
0.0584175494297837 |
|
| 4834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL716P |
0.0584175494297837 |
|
| 4835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM37 |
0.0584175494297837 |
|
| 4836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKA2 |
0.0584175494297837 |
|
| 4837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR454 |
0.0584175494297837 |
|
| 4838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR301A |
0.0584175494297837 |
|
| 4839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR11 |
0.0584175494297837 |
|
| 4840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG8 |
0.0584175494297837 |
|
| 4841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPD1 |
0.0584175494297837 |
|
| 4842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YPEL2 |
0.0584175494297837 |
|
| 4843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4729 |
0.0584175494297837 |
|
| 4844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX40 |
0.0584175494297837 |
|
| 4845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLTC |
0.0584175494297837 |
|
| 4846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTRH2 |
0.0584175494297837 |
|
| 4847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VMP1 |
0.0584175494297837 |
|
| 4848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR21 |
0.0584175494297837 |
|
| 4849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBD1 |
0.0584175494297837 |
|
| 4850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KB1 |
0.0584175494297837 |
|
| 4851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNFT1 |
0.0584175494297837 |
|
| 4852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR6 |
0.0584175494297837 |
|
| 4853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4737 |
0.0584175494297837 |
|
| 4854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA4 |
0.0584175494297837 |
|
| 4855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP32 |
0.0584175494297837 |
|
| 4856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000252577.1 |
0.0584175494297837 |
|
| 4857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf64 |
0.0584175494297837 |
|
| 4858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL12P38 |
0.0584175494297837 |
|
| 4859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APPBP2 |
0.0584175494297837 |
|
| 4860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1D |
0.0584175494297837 |
|
| 4861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAS3 |
0.0584175494297837 |
|
| 4862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL606P |
0.0584175494297837 |
|
| 4863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL448P |
0.0584175494297837 |
|
| 4864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238799.1 |
0.0584175494297837 |
|
| 4865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX2 |
0.0584175494297837 |
|
| 4866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf82 |
0.0584175494297837 |
|
| 4867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX4 |
0.0584175494297837 |
|
| 4868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACA2 |
0.0584175494297837 |
|
| 4869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRIP1 |
0.0584175494297837 |
|
| 4870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS2 |
0.0584175494297837 |
|
| 4871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED13 |
0.0584175494297837 |
|
| 4872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL800P |
0.0584175494297837 |
|
| 4873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3P2 |
0.0584175494297837 |
|
| 4874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB3 |
0.0584175494297837 |
|
| 4875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL2A |
0.0584175494297837 |
|
| 4876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLK2 |
0.0584175494297837 |
|
| 4877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRC2 |
0.0584175494297837 |
|
| 4878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH10 |
0.0584175494297837 |
|
| 4879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR633 |
0.0584175494297837 |
|
| 4880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TANC2 |
0.0584175494297837 |
|
| 4881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB561 |
0.0584175494297837 |
|
| 4882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACE |
0.0584175494297837 |
|
| 4883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH6 |
0.0584175494297837 |
|
| 4884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF7 |
0.0584175494297837 |
|
| 4885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACO1 |
0.0584175494297837 |
|
| 4886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K3 |
0.0584175494297837 |
|
| 4887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMD2 |
0.0584175494297837 |
|
| 4888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRADA |
0.0584175494297837 |
|
| 4889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC47 |
0.0584175494297837 |
|
| 4890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX42 |
0.0584175494297837 |
|
| 4891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTSJ3 |
0.0584175494297837 |
|
| 4892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC5 |
0.0584175494297837 |
|
| 4893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCD2 |
0.0584175494297837 |
|
| 4894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL805P |
0.0584175494297837 |
|
| 4895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCAM1P |
0.0584175494297837 |
|
| 4896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSH1 |
0.0584175494297837 |
|
| 4897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSH2 |
0.0584175494297837 |
|
| 4898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSHL1 |
0.0584175494297837 |
|
| 4899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GH2 |
0.0584175494297837 |
|
| 4900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GH1 |
0.0584175494297837 |
|
| 4901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD79B |
0.0584175494297837 |
|
| 4902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN4A |
0.0584175494297837 |
|
| 4903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf72 |
0.0584175494297837 |
|
| 4904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICAM2 |
0.0584175494297837 |
|
| 4905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERN1 |
0.0584175494297837 |
|
| 4906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA76|ENSG00000266402.2 |
0.0584175494297837 |
|
| 4907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD104 |
0.0584175494297837 |
|
| 4908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX2 |
0.0584175494297837 |
|
| 4909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MILR1 |
0.0584175494297837 |
|
| 4910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLG2 |
0.0584175494297837 |
|
| 4911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX5 |
0.0584175494297837 |
|
| 4912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3064 |
0.0584175494297837 |
|
| 4913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5047 |
0.0584175494297837 |
|
| 4914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP95 |
0.0584175494297837 |
|
| 4915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMURF2 |
0.0584175494297837 |
|
| 4916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHM1P |
0.0584175494297837 |
|
| 4917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL409P |
0.0584175494297837 |
|
| 4918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A3 |
0.0584175494297837 |
|
| 4919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL404P |
0.0584175494297837 |
|
| 4920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A6P1 |
0.0584175494297837 |
|
| 4921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMZ2P1 |
0.0584175494297837 |
|
| 4922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNA13 |
0.0584175494297837 |
|
| 4923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS9 |
0.0584175494297837 |
|
| 4924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AXIN2 |
0.0584175494297837 |
|
| 4925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP112 |
0.0584175494297837 |
|
| 4926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOH |
0.0584175494297837 |
|
| 4927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP444 |
0.0584175494297837 |
|
| 4928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCA |
0.0584175494297837 |
|
| 4929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL735P |
0.0584175494297837 |
|
| 4930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP445 |
0.0584175494297837 |
|
| 4931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR634 |
0.0584175494297837 |
|
| 4932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG5 |
0.0584175494297837 |
|
| 4933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP446 |
0.0584175494297837 |
|
| 4934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG4 |
0.0584175494297837 |
|
| 4935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG1 |
0.0584175494297837 |
|
| 4936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELZ |
0.0584175494297837 |
|
| 4937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP447 |
0.0584175494297837 |
|
| 4938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA8|ENSG00000207410.1 |
0.0584175494297837 |
|
| 4939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD12 |
0.0584175494297837 |
|
| 4940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITPNC1 |
0.0584175494297837 |
|
| 4941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238612.1 |
0.0584175494297837 |
|
| 4942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL756P |
0.0584175494297837 |
|
| 4943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548D2 |
0.0584175494297837 |
|
| 4944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL11 |
0.0584175494297837 |
|
| 4945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA38B |
0.0584175494297837 |
|
| 4946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPTF |
0.0584175494297837 |
|
| 4947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL622P |
0.0584175494297837 |
|
| 4948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf58 |
0.0584175494297837 |
|
| 4949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA2 |
0.0584175494297837 |
|
| 4950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00674 |
0.0584175494297837 |
|
| 4951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A16P |
0.0584175494297837 |
|
| 4952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMZ2 |
0.0584175494297837 |
|
| 4953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSG |
0.0584175494297837 |
|
| 4954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A6 |
0.0584175494297837 |
|
| 4955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAR1A |
0.0584175494297837 |
|
| 4956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIPI1 |
0.0584175494297837 |
|
| 4957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR635 |
0.0584175494297837 |
|
| 4958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM20A |
0.0584175494297837 |
|
| 4959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA8 |
0.0584175494297837 |
|
| 4960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA9 |
0.0584175494297837 |
|
| 4961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA6 |
0.0584175494297837 |
|
| 4962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4524B |
0.0584175494297837 |
|
| 4963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA10 |
0.0584175494297837 |
|
| 4964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA5 |
0.0584175494297837 |
|
| 4965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252352.1 |
0.0584175494297837 |
|
| 4966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K6 |
0.0584175494297837 |
|
| 4967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX13 |
0.05956776072186 |
|
| 4968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC44A5 |
0.0600285198224993 |
|
| 4969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACADM |
0.0600285198224993 |
|
| 4970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABGGTB |
0.0600285198224993 |
|
| 4971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45C |
0.0600285198224993 |
|
| 4972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45A |
0.0600285198224993 |
|
| 4973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45B |
0.0600285198224993 |
|
| 4974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSH4 |
0.0600285198224993 |
|
| 4975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB17 |
0.0600285198224993 |
|
| 4976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC3 |
0.0600285198224993 |
|
| 4977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC5 |
0.0600285198224993 |
|
| 4978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGK |
0.0600285198224993 |
|
| 4979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK5 |
0.0600285198224993 |
|
| 4980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP247 |
0.0600285198224993 |
|
| 4981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPHN2 |
0.0600285198224993 |
|
| 4982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXK1 |
0.062923155149412 |
|
| 4983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238781.1 |
0.062923155149412 |
|
| 4984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP5Z1 |
0.062923155149412 |
|
| 4985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4656 |
0.062923155149412 |
|
| 4986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RADIL |
0.062923155149412 |
|
| 4987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPOLB |
0.062923155149412 |
|
| 4988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMD2 |
0.062923155149412 |
|
| 4989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBAK |
0.062923155149412 |
|
| 4990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF216P1 |
0.062923155149412 |
|
| 4991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF890P |
0.062923155149412 |
|
| 4992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIPI2 |
0.062923155149412 |
|
| 4993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC29A4 |
0.062923155149412 |
|
| 4994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNRC18 |
0.062923155149412 |
|
| 4995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL18 |
0.062923155149412 |
|
| 4996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238394.1 |
0.062923155149412 |
|
| 4997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR589 |
0.062923155149412 |
|
| 4998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTB |
0.062923155149412 |
|
| 4999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSCN1 |
0.062923155149412 |
|
| 5000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF216 |
0.062923155149412 |
|
| 5001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCZ1 |
0.062923155149412 |
|
| 5002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCM |
0.062923155149412 |
|
| 5003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMS2 |
0.062923155149412 |
|
| 5004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL556P |
0.062923155149412 |
|
| 5005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH10B |
0.062923155149412 |
|
| 5006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF815P |
0.062923155149412 |
|
| 5007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIMP2 |
0.062923155149412 |
|
| 5008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA42|ENSG00000207217.1 |
0.062923155149412 |
|
| 5009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2AK1 |
0.062923155149412 |
|
| 5010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD61 |
0.062923155149412 |
|
| 5011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL851P |
0.062923155149412 |
|
| 5012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP42 |
0.062923155149412 |
|
| 5013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTH3 |
0.062923155149412 |
|
| 5014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM220A |
0.062923155149412 |
|
| 5015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAC1 |
0.062923155149412 |
|
| 5016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAGLB |
0.062923155149412 |
|
| 5017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDELR2 |
0.062923155149412 |
|
| 5018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ20306 |
0.062923155149412 |
|
| 5019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRID2IP |
0.062923155149412 |
|
| 5020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC4 |
0.062923155149412 |
|
| 5021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf26 |
0.062923155149412 |
|
| 5022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF853 |
0.062923155149412 |
|
| 5023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF12 |
0.062923155149412 |
|
| 5024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMS2CL |
0.062923155149412 |
|
| 5025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH10B2 |
0.062923155149412 |
|
| 5026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCZ1B |
0.062923155149412 |
|
| 5027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3683 |
0.062923155149412 |
|
| 5028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1GALT1 |
0.062923155149412 |
|
| 5029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL28A1 |
0.062923155149412 |
|
| 5030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIOS |
0.062923155149412 |
|
| 5031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPA3 |
0.062923155149412 |
|
| 5032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLCCI1 |
0.062923155149412 |
|
| 5033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICA1 |
0.062923155149412 |
|
| 5034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPH1 |
0.062923155149412 |
|
| 5035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212422.1 |
0.062923155149412 |
|
| 5036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM106B |
0.062923155149412 |
|
| 5037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWDE |
0.062923155149412 |
|
| 5038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCIN |
0.062923155149412 |
|
| 5039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL4A |
0.062923155149412 |
|
| 5040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000199470.1 |
0.062923155149412 |
|
| 5041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP228 |
0.062923155149412 |
|
| 5042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKB |
0.062923155149412 |
|
| 5043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGMO |
0.062923155149412 |
|
| 5044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEOX2 |
0.062923155149412 |
|
| 5045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISPD |
0.062923155149412 |
|
| 5046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOSTDC1 |
0.062923155149412 |
|
| 5047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC72 |
0.062923155149412 |
|
| 5048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKMY2 |
0.062923155149412 |
|
| 5049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BZW2 |
0.062923155149412 |
|
| 5050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN13 |
0.062923155149412 |
|
| 5051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGR2 |
0.062923155149412 |
|
| 5052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGR3 |
0.062923155149412 |
|
| 5053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHR |
0.062923155149412 |
|
| 5054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000199473.1 |
0.062923155149412 |
|
| 5055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPS1L1 |
0.062923155149412 |
|
| 5056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC9 |
0.062923155149412 |
|
| 5057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP266 |
0.062923155149412 |
|
| 5058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FERD3L |
0.062923155149412 |
|
| 5059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3146 |
0.062923155149412 |
|
| 5060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM196 |
0.062923155149412 |
|
| 5061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWIST1 |
0.062923155149412 |
|
| 5062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWISTNB |
0.062923155149412 |
|
| 5063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MACC1 |
0.062923155149412 |
|
| 5064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB8 |
0.062923155149412 |
|
| 5065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000200753.1 |
0.062923155149412 |
|
| 5066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB5 |
0.062923155149412 |
|
| 5067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP8 |
0.062923155149412 |
|
| 5068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL542P |
0.062923155149412 |
|
| 5069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP4 |
0.062923155149412 |
|
| 5070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1183 |
0.062923155149412 |
|
| 5071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH11 |
0.062923155149412 |
|
| 5072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA7L |
0.062923155149412 |
|
| 5073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF5 |
0.062923155149412 |
|
| 5074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP227 |
0.062923155149412 |
|
| 5075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STEAP1B |
0.062923155149412 |
|
| 5076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL6 |
0.062923155149412 |
|
| 5077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM7 |
0.062923155149412 |
|
| 5078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD93 |
0.062923155149412 |
|
| 5079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM126A |
0.062923155149412 |
|
| 5080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL7 |
0.062923155149412 |
|
| 5081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUPL2 |
0.062923155149412 |
|
| 5082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPNMB |
0.062923155149412 |
|
| 5083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MALSU1 |
0.062923155149412 |
|
| 5084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF2BP3 |
0.062923155149412 |
|
| 5085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD65|ENSG00000212264.1 |
0.062923155149412 |
|
| 5086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRA2A |
0.062923155149412 |
|
| 5087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC126 |
0.062923155149412 |
|
| 5088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM221A |
0.062923155149412 |
|
| 5089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK31 |
0.062923155149412 |
|
| 5090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238849.1 |
0.062923155149412 |
|
| 5091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP228 |
0.062923155149412 |
|
| 5092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239098.1 |
0.062923155149412 |
|
| 5093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY |
0.062923155149412 |
|
| 5094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP6 |
0.062923155149412 |
|
| 5095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DFNA5 |
0.062923155149412 |
|
| 5096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL3 |
0.062923155149412 |
|
| 5097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYCS |
0.062923155149412 |
|
| 5098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf31 |
0.062923155149412 |
|
| 5099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPVF |
0.062923155149412 |
|
| 5100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000202233.1 |
0.062923155149412 |
|
| 5101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR148A |
0.062923155149412 |
|
| 5102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFE2L3 |
0.062923155149412 |
|
| 5103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA2B1 |
0.062923155149412 |
|
| 5104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX3 |
0.062923155149412 |
|
| 5105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX10 |
0.062923155149412 |
|
| 5106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0087 |
0.062923155149412 |
|
| 5107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf71 |
0.062923155149412 |
|
| 5108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKAP2 |
0.062923155149412 |
|
| 5109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA1 |
0.062923155149412 |
|
| 5110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOTAIRM1 |
0.062923155149412 |
|
| 5111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA2 |
0.062923155149412 |
|
| 5112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA3 |
0.062923155149412 |
|
| 5113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA4 |
0.062923155149412 |
|
| 5114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA5 |
0.062923155149412 |
|
| 5115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA6 |
0.062923155149412 |
|
| 5116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA7 |
0.062923155149412 |
|
| 5117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA9 |
0.062923155149412 |
|
| 5118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA10 |
0.062923155149412 |
|
| 5119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR196B |
0.062923155149412 |
|
| 5120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA11 |
0.062923155149412 |
|
| 5121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXA13 |
0.062923155149412 |
|
| 5122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOTTIP |
0.062923155149412 |
|
| 5123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVX1 |
0.062923155149412 |
|
| 5124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIBADH |
0.062923155149412 |
|
| 5125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAX1BP1 |
0.062923155149412 |
|
| 5126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAZF1 |
0.062923155149412 |
|
| 5127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL365P |
0.062923155149412 |
|
| 5128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB5 |
0.062923155149412 |
|
| 5129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIL |
0.062923155149412 |
|
| 5130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPVL |
0.062923155149412 |
|
| 5131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHN2 |
0.062923155149412 |
|
| 5132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR15 |
0.062923155149412 |
|
| 5133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR550A3 |
0.062923155149412 |
|
| 5134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIPF3 |
0.062923155149412 |
|
| 5135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238906.1 |
0.062923155149412 |
|
| 5136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRN1 |
0.062923155149412 |
|
| 5137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP14 |
0.062923155149412 |
|
| 5138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA8 |
0.062923155149412 |
|
| 5139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf41 |
0.062923155149412 |
|
| 5140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR550A1 |
0.062923155149412 |
|
| 5141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNRF2 |
0.062923155149412 |
|
| 5142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOD1 |
0.062923155149412 |
|
| 5143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGCT |
0.062923155149412 |
|
| 5144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GARS |
0.062923155149412 |
|
| 5145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRHR2 |
0.062923155149412 |
|
| 5146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INMT |
0.062923155149412 |
|
| 5147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM188B |
0.062923155149412 |
|
| 5148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP1 |
0.062923155149412 |
|
| 5149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHRHR |
0.062923155149412 |
|
| 5150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCYAP1R1 |
0.062923155149412 |
|
| 5151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROD6 |
0.062923155149412 |
|
| 5152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC129 |
0.062923155149412 |
|
| 5153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R17 |
0.062923155149412 |
|
| 5154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE1C |
0.062923155149412 |
|
| 5155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM5 |
0.062923155149412 |
|
| 5156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVL9 |
0.062923155149412 |
|
| 5157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR550A2 |
0.062923155149412 |
|
| 5158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000251999.1 |
0.062923155149412 |
|
| 5159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD2 |
0.062923155149412 |
|
| 5160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RP9P |
0.062923155149412 |
|
| 5161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP9 |
0.062923155149412 |
|
| 5162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C3A |
0.062923155149412 |
|
| 5163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL505P |
0.062923155149412 |
|
| 5164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS9 |
0.062923155149412 |
|
| 5165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RP9 |
0.062923155149412 |
|
| 5166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252706.1 |
0.062923155149412 |
|
| 5167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP229 |
0.062923155149412 |
|
| 5168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMPER |
0.062923155149412 |
|
| 5169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPSR1 |
0.062923155149412 |
|
| 5170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL132P |
0.062923155149412 |
|
| 5171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000251802.1 |
0.062923155149412 |
|
| 5172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L1 |
0.062923155149412 |
|
| 5173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548N |
0.062923155149412 |
|
| 5174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L2P1 |
0.062923155149412 |
|
| 5175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX20 |
0.062923155149412 |
|
| 5176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERPUD2 |
0.062923155149412 |
|
| 5177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT7 |
0.062923155149412 |
|
| 5178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PP13004 |
0.062923155149412 |
|
| 5179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEPD1 |
0.062923155149412 |
|
| 5180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0895 |
0.062923155149412 |
|
| 5181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANLN |
0.062923155149412 |
|
| 5182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOAH |
0.062923155149412 |
|
| 5183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMO1 |
0.062923155149412 |
|
| 5184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1200 |
0.062923155149412 |
|
| 5185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238772.1 |
0.062923155149412 |
|
| 5186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000200113.1 |
0.062923155149412 |
|
| 5187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPDR1 |
0.062923155149412 |
|
| 5188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR141 |
0.062923155149412 |
|
| 5189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME8 |
0.062923155149412 |
|
| 5190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFRP4 |
0.062923155149412 |
|
| 5191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD3NL |
0.062923155149412 |
|
| 5192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGC1 |
0.062923155149412 |
|
| 5193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGC2 |
0.062923155149412 |
|
| 5194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGJ1 |
0.062923155149412 |
|
| 5195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGJ2 |
0.062923155149412 |
|
| 5196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGJP1 |
0.062923155149412 |
|
| 5197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGJP2 |
0.062923155149412 |
|
| 5198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGJP |
0.062923155149412 |
|
| 5199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV10 |
0.062923155149412 |
|
| 5200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV11 |
0.062923155149412 |
|
| 5201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV1 |
0.062923155149412 |
|
| 5202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV2 |
0.062923155149412 |
|
| 5203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV3 |
0.062923155149412 |
|
| 5204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV4 |
0.062923155149412 |
|
| 5205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV5 |
0.062923155149412 |
|
| 5206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV8 |
0.062923155149412 |
|
| 5207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRGV9 |
0.062923155149412 |
|
| 5208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMPH |
0.062923155149412 |
|
| 5209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL83P |
0.062923155149412 |
|
| 5210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM183B |
0.062923155149412 |
|
| 5211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS41 |
0.062923155149412 |
|
| 5212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU6F2 |
0.062923155149412 |
|
| 5213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA20|ENSG00000206947.1 |
0.062923155149412 |
|
| 5214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YAE1D1 |
0.062923155149412 |
|
| 5215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALA |
0.062923155149412 |
|
| 5216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00265 |
0.062923155149412 |
|
| 5217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL496P |
0.062923155149412 |
|
| 5218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK13 |
0.062923155149412 |
|
| 5219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf10 |
0.062923155149412 |
|
| 5220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPLKIP |
0.062923155149412 |
|
| 5221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INHBA |
0.062923155149412 |
|
| 5222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLVRA |
0.062923155149412 |
|
| 5223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS24 |
0.062923155149412 |
|
| 5224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URGCP |
0.062923155149412 |
|
| 5225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMIZ2 |
0.062923155149412 |
|
| 5226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIA |
0.062923155149412 |
|
| 5227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFV |
0.062923155149412 |
|
| 5228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PURB |
0.062923155149412 |
|
| 5229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4657 |
0.062923155149412 |
|
| 5230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1G |
0.062923155149412 |
|
| 5231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG15 |
0.062923155149412 |
|
| 5232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCM2 |
0.062923155149412 |
|
| 5233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACAD |
0.062923155149412 |
|
| 5234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBRG4 |
0.062923155149412 |
|
| 5235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA5A |
0.062923155149412 |
|
| 5236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA5B |
0.062923155149412 |
|
| 5237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA5C |
0.062923155149412 |
|
| 5238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf65 |
0.062923155149412 |
|
| 5239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HUS1 |
0.062923155149412 |
|
| 5240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00525 |
0.062923155149412 |
|
| 5241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1L1 |
0.062923155149412 |
|
| 5242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf69 |
0.062923155149412 |
|
| 5243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUN3 |
0.062923155149412 |
|
| 5244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf57 |
0.062923155149412 |
|
| 5245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPP1 |
0.062923155149412 |
|
| 5246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA13 |
0.062923155149412 |
|
| 5247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWC2 |
0.062923155149412 |
|
| 5248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZPBP |
0.062923155149412 |
|
| 5249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf72 |
0.062923155149412 |
|
| 5250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKZF1 |
0.062923155149412 |
|
| 5251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIGNL1 |
0.062923155149412 |
|
| 5252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDC |
0.062923155149412 |
|
| 5253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA4|ENSG00000201133.1 |
0.062923155149412 |
|
| 5254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238354.1 |
0.062923155149412 |
|
| 5255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSTM2A |
0.062923155149412 |
|
| 5256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC61G |
0.062923155149412 |
|
| 5257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000252054.1 |
0.062923155149412 |
|
| 5258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LANCL2 |
0.062923155149412 |
|
| 5259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VOPP1 |
0.062923155149412 |
|
| 5260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP9L |
0.062923155149412 |
|
| 5261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA15|ENSG00000207168.1 |
0.062923155149412 |
|
| 5262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA22|ENSG00000206603.1 |
0.062923155149412 |
|
| 5263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMF2 |
0.062923155149412 |
|
| 5264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHKG1 |
0.062923155149412 |
|
| 5265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD2 |
0.062923155149412 |
|
| 5266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238673.1 |
0.062923155149412 |
|
| 5267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUPR1L |
0.062923155149412 |
|
| 5268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL816P |
0.062923155149412 |
|
| 5269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF479 |
0.062923155149412 |
|
| 5270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD58 |
0.0635272279267678 |
|
| 5271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AC |
0.0635272279267678 |
|
| 5272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF3 |
0.0635272279267678 |
|
| 5273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320B1 |
0.0635272279267678 |
|
| 5274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf137 |
0.0635272279267678 |
|
| 5275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD2 |
0.0635272279267678 |
|
| 5276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGFRN |
0.0635272279267678 |
|
| 5277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP55 |
0.0635272279267678 |
|
| 5278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD101 |
0.0635272279267678 |
|
| 5279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTF2 |
0.0635272279267678 |
|
| 5280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR942 |
0.0635272279267678 |
|
| 5281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM45 |
0.0635272279267678 |
|
| 5282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VTCN1 |
0.0635272279267678 |
|
| 5283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN1A2 |
0.0635272279267678 |
|
| 5284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM46C |
0.0635272279267678 |
|
| 5285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212266.1 |
0.0635272279267678 |
|
| 5286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDAP2 |
0.0635272279267678 |
|
| 5287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR3 |
0.0635272279267678 |
|
| 5288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG17 |
0.0635272279267678 |
|
| 5289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP56 |
0.0635272279267678 |
|
| 5290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX15 |
0.0635272279267678 |
|
| 5291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WARS2 |
0.0635272279267678 |
|
| 5292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238679.1 |
0.0635272279267678 |
|
| 5293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAO2 |
0.0635272279267678 |
|
| 5294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD3B2 |
0.0635272279267678 |
|
| 5295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD3B1 |
0.0635272279267678 |
|
| 5296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00622 |
0.0635272279267678 |
|
| 5297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF697 |
0.0635272279267678 |
|
| 5298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHGDH |
0.0635272279267678 |
|
| 5299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGCS2 |
0.0635272279267678 |
|
| 5300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG4 |
0.0635272279267678 |
|
| 5301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM30 |
0.0635272279267678 |
|
| 5302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAP3 |
0.0682343367471531 |
|
| 5303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTRT2 |
0.0682343367471531 |
|
| 5304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGRN |
0.0682343367471531 |
|
| 5305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD65 |
0.0682343367471531 |
|
| 5306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD3A |
0.0682343367471531 |
|
| 5307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD3B |
0.0682343367471531 |
|
| 5308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD3C |
0.0682343367471531 |
|
| 5309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AURKAIP1 |
0.0682343367471531 |
|
| 5310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALT6 |
0.0682343367471531 |
|
| 5311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf159 |
0.0682343367471531 |
|
| 5312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf170 |
0.0682343367471531 |
|
| 5313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf222 |
0.0682343367471531 |
|
| 5314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf233 |
0.0682343367471531 |
|
| 5315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf86 |
0.0682343367471531 |
|
| 5316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALML6 |
0.0682343367471531 |
|
| 5317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNL2 |
0.0682343367471531 |
|
| 5318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK11A |
0.0682343367471531 |
|
| 5319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK11B |
0.0682343367471531 |
|
| 5320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF3L |
0.0682343367471531 |
|
| 5321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX11L1 |
0.0682343367471531 |
|
| 5322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DVL1 |
0.0682343367471531 |
|
| 5323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM132A |
0.0682343367471531 |
|
| 5324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138A |
0.0682343367471531 |
|
| 5325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM213B |
0.0682343367471531 |
|
| 5326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM41C |
0.0682343367471531 |
|
| 5327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM87B |
0.0682343367471531 |
|
| 5328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRD |
0.0682343367471531 |
|
| 5329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTPD1 |
0.0682343367471531 |
|
| 5330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB1 |
0.0682343367471531 |
|
| 5331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES4 |
0.0682343367471531 |
|
| 5332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES5 |
0.0682343367471531 |
|
| 5333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISG15 |
0.0682343367471531 |
|
| 5334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL17 |
0.0682343367471531 |
|
| 5335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00115 |
0.0682343367471531 |
|
| 5336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00982 |
0.0682343367471531 |
|
| 5337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIB2 |
0.0682343367471531 |
|
| 5338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR200A |
0.0682343367471531 |
|
| 5339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR200B |
0.0682343367471531 |
|
| 5340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR429 |
0.0682343367471531 |
|
| 5341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMEL1 |
0.0682343367471531 |
|
| 5342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP23B |
0.0682343367471531 |
|
| 5343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORN1 |
0.0682343367471531 |
|
| 5344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL20 |
0.0682343367471531 |
|
| 5345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXRA8 |
0.0682343367471531 |
|
| 5346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NADK |
0.0682343367471531 |
|
| 5347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOC2L |
0.0682343367471531 |
|
| 5348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F16 |
0.0682343367471531 |
|
| 5349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F29 |
0.0682343367471531 |
|
| 5350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F5 |
0.0682343367471531 |
|
| 5351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANK4 |
0.0682343367471531 |
|
| 5352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX10 |
0.0682343367471531 |
|
| 5353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCH2 |
0.0682343367471531 |
|
| 5354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHN1 |
0.0682343367471531 |
|
| 5355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM16 |
0.0682343367471531 |
|
| 5356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCZ |
0.0682343367471531 |
|
| 5357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUSL1 |
0.0682343367471531 |
|
| 5358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RER1 |
0.0682343367471531 |
|
| 5359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL657P |
0.0682343367471531 |
|
| 5360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF223 |
0.0682343367471531 |
|
| 5361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD11 |
0.0682343367471531 |
|
| 5362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCNN1D |
0.0682343367471531 |
|
| 5363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDF4 |
0.0682343367471531 |
|
| 5364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKI |
0.0682343367471531 |
|
| 5365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35E2B |
0.0682343367471531 |
|
| 5366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35E2 |
0.0682343367471531 |
|
| 5367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSU72 |
0.0682343367471531 |
|
| 5368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS1R3 |
0.0682343367471531 |
|
| 5369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM240 |
0.0682343367471531 |
|
| 5370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM52 |
0.0682343367471531 |
|
| 5371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM88B |
0.0682343367471531 |
|
| 5372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF14 |
0.0682343367471531 |
|
| 5373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF18 |
0.0682343367471531 |
|
| 5374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF4 |
0.0682343367471531 |
|
| 5375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC34 |
0.0682343367471531 |
|
| 5376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL10 |
0.0682343367471531 |
|
| 5377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2J2 |
0.0682343367471531 |
|
| 5378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA1 |
0.0682343367471531 |
|
| 5379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF16 |
0.0682343367471531 |
|
| 5380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGF6 |
0.0682343367471531 |
|
| 5381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR551A |
0.0682343367471531 |
|
| 5382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRG1L |
0.0682343367471531 |
|
| 5383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WRAP73 |
0.0682343367471531 |
|
| 5384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP73 |
0.0682343367471531 |
|
| 5385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC27 |
0.0682343367471531 |
|
| 5386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM1 |
0.0682343367471531 |
|
| 5387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC47 |
0.0682343367471531 |
|
| 5388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL574P |
0.0682343367471531 |
|
| 5389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf24 |
0.0684729554262139 |
|
| 5390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAH |
0.0684729554262139 |
|
| 5391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238910.1 |
0.0684729554262139 |
|
| 5392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL305P |
0.0684729554262139 |
|
| 5393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A1 |
0.0684729554262139 |
|
| 5394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1B1P1 |
0.0684729554262139 |
|
| 5395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf42 |
0.0684729554262139 |
|
| 5396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL2 |
0.0684729554262139 |
|
| 5397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A4 |
0.0684729554262139 |
|
| 5398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL3 |
0.0684729554262139 |
|
| 5399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL3S |
0.0684729554262139 |
|
| 5400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTCB |
0.0684729554262139 |
|
| 5401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4764 |
0.0684729554262139 |
|
| 5402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHL1 |
0.068559790524485 |
|
| 5403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN4 |
0.068559790524485 |
|
| 5404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN6 |
0.068559790524485 |
|
| 5405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP144 |
0.068559790524485 |
|
| 5406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL120P |
0.068559790524485 |
|
| 5407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD2 |
0.0686556409121937 |
|
| 5408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251938.1 |
0.0686556409121937 |
|
| 5409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX4 |
0.0696073621973053 |
|
| 5410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLI3 |
0.0702186422800567 |
|
| 5411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf25 |
0.0702186422800567 |
|
| 5412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECW1 |
0.0702186422800567 |
|
| 5413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3943 |
0.0702186422800567 |
|
| 5414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL32 |
0.0702186422800567 |
|
| 5415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA2 |
0.0702186422800567 |
|
| 5416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK17A |
0.0702186422800567 |
|
| 5417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COA1 |
0.0702186422800567 |
|
| 5418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2D4 |
0.0702186422800567 |
|
| 5419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2J4 |
0.0702186422800567 |
|
| 5420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYE1 |
0.0702186422800567 |
|
| 5421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA4CP |
0.0702186422800567 |
|
| 5422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00957 |
0.0702186422800567 |
|
| 5423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBNL |
0.0702186422800567 |
|
| 5424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAM2 |
0.0702186422800567 |
|
| 5425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLM |
0.0702186422800567 |
|
| 5426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AEBP1 |
0.0702186422800567 |
|
| 5427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4649 |
0.0702186422800567 |
|
| 5428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLD2 |
0.0702186422800567 |
|
| 5429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP230 |
0.0702186422800567 |
|
| 5430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL7 |
0.0702186422800567 |
|
| 5431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCK |
0.0702186422800567 |
|
| 5432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YKT6 |
0.0702186422800567 |
|
| 5433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2B |
0.0702186422800567 |
|
| 5434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDCD3 |
0.0702186422800567 |
|
| 5435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPC1L1 |
0.0702186422800567 |
|
| 5436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX56 |
0.0702186422800567 |
|
| 5437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED4 |
0.0702186422800567 |
|
| 5438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGDH |
0.0702186422800567 |
|
| 5439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAMP3 |
0.0702186422800567 |
|
| 5440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY1 |
0.0702186422800567 |
|
| 5441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT7P2 |
0.0702186422800567 |
|
| 5442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP1 |
0.0702186422800567 |
|
| 5443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP3 |
0.0702186422800567 |
|
| 5444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS15P1 |
0.0702186422800567 |
|
| 5445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNS3 |
0.0702186422800567 |
|
| 5446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFR |
0.0702186422800567 |
|
| 5447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACP6 |
0.0709610732940199 |
|
| 5448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A12P |
0.0709610732940199 |
|
| 5449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD34A |
0.0709610732940199 |
|
| 5450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD35 |
0.0709610732940199 |
|
| 5451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL9 |
0.0709610732940199 |
|
| 5452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOLA1 |
0.0709610732940199 |
|
| 5453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD160 |
0.0709610732940199 |
|
| 5454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD1L |
0.0709610732940199 |
|
| 5455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM72B |
0.0709610732940199 |
|
| 5456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM72C |
0.0709610732940199 |
|
| 5457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM72D |
0.0709610732940199 |
|
| 5458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR1A |
0.0709610732940199 |
|
| 5459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR1B |
0.0709610732940199 |
|
| 5460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR1C |
0.0709610732940199 |
|
| 5461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO5 |
0.0709610732940199 |
|
| 5462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA5 |
0.0709610732940199 |
|
| 5463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA8 |
0.0709610732940199 |
|
| 5464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNRHR2 |
0.0709610732940199 |
|
| 5465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR89A |
0.0709610732940199 |
|
| 5466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR89B |
0.0709610732940199 |
|
| 5467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR89C |
0.0709610732940199 |
|
| 5468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HFE2 |
0.0709610732940199 |
|
| 5469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2AA3 |
0.0709610732940199 |
|
| 5470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2AA4 |
0.0709610732940199 |
|
| 5471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2AB |
0.0709610732940199 |
|
| 5472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2AC |
0.0709610732940199 |
|
| 5473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2BA |
0.0709610732940199 |
|
| 5474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2BE |
0.0709610732940199 |
|
| 5475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H2BF |
0.0709610732940199 |
|
| 5476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H3A |
0.0709610732940199 |
|
| 5477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H3C |
0.0709610732940199 |
|
| 5478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H3D |
0.0709610732940199 |
|
| 5479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H4A |
0.0709610732940199 |
|
| 5480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST2H4B |
0.0709610732940199 |
|
| 5481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYDIN2 |
0.0709610732940199 |
|
| 5482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA10 |
0.0709610732940199 |
|
| 5483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00623 |
0.0709610732940199 |
|
| 5484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00624 |
0.0709610732940199 |
|
| 5485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIX1L |
0.0709610732940199 |
|
| 5486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF10 |
0.0709610732940199 |
|
| 5487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF11 |
0.0709610732940199 |
|
| 5488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF12 |
0.0709610732940199 |
|
| 5489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF14 |
0.0709610732940199 |
|
| 5490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF15 |
0.0709610732940199 |
|
| 5491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF16 |
0.0709610732940199 |
|
| 5492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF20 |
0.0709610732940199 |
|
| 5493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF24 |
0.0709610732940199 |
|
| 5494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF8 |
0.0709610732940199 |
|
| 5495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF9 |
0.0709610732940199 |
|
| 5496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTCH2NL |
0.0709610732940199 |
|
| 5497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT17 |
0.0709610732940199 |
|
| 5498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE4DIP |
0.0709610732940199 |
|
| 5499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZK1P1 |
0.0709610732940199 |
|
| 5500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZK1 |
0.0709610732940199 |
|
| 5501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX11B |
0.0709610732940199 |
|
| 5502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIAS3 |
0.0709610732940199 |
|
| 5503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3C |
0.0709610732940199 |
|
| 5504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3GL |
0.0709610732940199 |
|
| 5505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIAL4A |
0.0709610732940199 |
|
| 5506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIAL4B |
0.0709610732940199 |
|
| 5507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIAL4C |
0.0709610732940199 |
|
| 5508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIAL4D |
0.0709610732940199 |
|
| 5509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIAL4G |
0.0709610732940199 |
|
| 5510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAB2 |
0.0709610732940199 |
|
| 5511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM8A |
0.0709610732940199 |
|
| 5512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP88 |
0.0709610732940199 |
|
| 5513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL261P |
0.0709610732940199 |
|
| 5514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP57 |
0.0709610732940199 |
|
| 5515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP58 |
0.0709610732940199 |
|
| 5516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP59 |
0.0709610732940199 |
|
| 5517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF115 |
0.0709610732940199 |
|
| 5518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC22B |
0.0709610732940199 |
|
| 5519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRGAP2B |
0.0709610732940199 |
|
| 5520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SV2A |
0.0709610732940199 |
|
| 5521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNIP |
0.0709610732940199 |
|
| 5522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L12 |
0.0720344449068295 |
|
| 5523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND4C |
0.074316255715672 |
|
| 5524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238348.1 |
0.074316255715672 |
|
| 5525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6 |
0.074316255715672 |
|
| 5526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACER2 |
0.074316255715672 |
|
| 5527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THRB |
0.0771804990339788 |
|
| 5528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4792 |
0.0771804990339788 |
|
| 5529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL216P |
0.0771804990339788 |
|
| 5530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP125 |
0.0771804990339788 |
|
| 5531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARB |
0.0771804990339788 |
|
| 5532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP126 |
0.0771804990339788 |
|
| 5533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD5|ENSG00000272166.1 |
0.0771804990339788 |
|
| 5534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP2B |
0.0771804990339788 |
|
| 5535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4442 |
0.0771804990339788 |
|
| 5536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGLY1 |
0.0771804990339788 |
|
| 5537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXSM |
0.0771804990339788 |
|
| 5538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00692 |
0.0771804990339788 |
|
| 5539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC3B |
0.0771804990339788 |
|
| 5540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK10 |
0.0771804990339788 |
|
| 5541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A7 |
0.0771804990339788 |
|
| 5542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL859P |
0.0771804990339788 |
|
| 5543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EOMES |
0.0771804990339788 |
|
| 5544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMC1 |
0.0771804990339788 |
|
| 5545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZI2 |
0.0771804990339788 |
|
| 5546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239155.1 |
0.0772410049533931 |
|
| 5547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL5RA |
0.0774485565960373 |
|
| 5548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA43|ENSG00000253049.1 |
0.0774485565960373 |
|
| 5549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRNT1 |
0.0774485565960373 |
|
| 5550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRBN |
0.0774485565960373 |
|
| 5551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMF1 |
0.0774485565960373 |
|
| 5552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRN1 |
0.0774485565960373 |
|
| 5553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETMAR |
0.0774485565960373 |
|
| 5554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPR1 |
0.0774485565960373 |
|
| 5555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGOT |
0.0774485565960373 |
|
| 5556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239126.1 |
0.0774485565960373 |
|
| 5557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHE40 |
0.0774485565960373 |
|
| 5558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL8B |
0.0774485565960373 |
|
| 5559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDEM1 |
0.0774485565960373 |
|
| 5560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4790 |
0.0774485565960373 |
|
| 5561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL553P |
0.0774485565960373 |
|
| 5562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM7 |
0.0774485565960373 |
|
| 5563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC17P |
0.0774485565960373 |
|
| 5564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMCD1 |
0.0774485565960373 |
|
| 5565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00312 |
0.0774485565960373 |
|
| 5566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSUH2 |
0.0774485565960373 |
|
| 5567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAV3 |
0.0774485565960373 |
|
| 5568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXTR |
0.0774485565960373 |
|
| 5569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD18 |
0.0774485565960373 |
|
| 5570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA43|ENSG00000199815.1 |
0.0774485565960373 |
|
| 5571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRGAP3 |
0.0774485565960373 |
|
| 5572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THUMPD3 |
0.0774485565960373 |
|
| 5573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD5 |
0.0774485565960373 |
|
| 5574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFPL4 |
0.0774485565960373 |
|
| 5575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR14 |
0.0774485565960373 |
|
| 5576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE9 |
0.0774485565960373 |
|
| 5577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRPF1 |
0.0774485565960373 |
|
| 5578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGG1 |
0.0774485565960373 |
|
| 5579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK1 |
0.0774485565960373 |
|
| 5580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TADA3 |
0.0774485565960373 |
|
| 5581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC4 |
0.0774485565960373 |
|
| 5582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL3 |
0.0774485565960373 |
|
| 5583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPUSD3 |
0.0774485565960373 |
|
| 5584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIDEC |
0.0774485565960373 |
|
| 5585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAGN1 |
0.0774485565960373 |
|
| 5586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17RE |
0.0774485565960373 |
|
| 5587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17RC |
0.0774485565960373 |
|
| 5588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRELD1 |
0.0774485565960373 |
|
| 5589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRT3 |
0.0774485565960373 |
|
| 5590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC3 |
0.0774485565960373 |
|
| 5591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIDECP |
0.0774485565960373 |
|
| 5592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCD2 |
0.0774485565960373 |
|
| 5593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCD2OS |
0.0774485565960373 |
|
| 5594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRK1 |
0.0774485565960373 |
|
| 5595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238642.1 |
0.0774485565960373 |
|
| 5596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VHL |
0.0774485565960373 |
|
| 5597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238345.1 |
0.0774485565960373 |
|
| 5598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRAK2 |
0.0774485565960373 |
|
| 5599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TATDN2 |
0.0774485565960373 |
|
| 5600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00852 |
0.0774485565960373 |
|
| 5601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHRLOS |
0.0774485565960373 |
|
| 5602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHRL |
0.0774485565960373 |
|
| 5603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC13 |
0.0774485565960373 |
|
| 5604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2B2 |
0.0774485565960373 |
|
| 5605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378B |
0.0774485565960373 |
|
| 5606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR885 |
0.0774485565960373 |
|
| 5607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00606 |
0.0774485565960373 |
|
| 5608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A11 |
0.0774485565960373 |
|
| 5609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VGLL4 |
0.0774485565960373 |
|
| 5610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAMM41 |
0.0774485565960373 |
|
| 5611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL147P |
0.0774485565960373 |
|
| 5612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYN2 |
0.0774485565960373 |
|
| 5613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMP4 |
0.0774485565960373 |
|
| 5614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPARG |
0.0774485565960373 |
|
| 5615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSEN2 |
0.0774485565960373 |
|
| 5616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP123 |
0.0774485565960373 |
|
| 5617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf83 |
0.0774485565960373 |
|
| 5618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKRN2 |
0.0774485565960373 |
|
| 5619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAF1 |
0.0774485565960373 |
|
| 5620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239140.1 |
0.0774485565960373 |
|
| 5621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM40 |
0.0774485565960373 |
|
| 5622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAND2 |
0.0774485565960373 |
|
| 5623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL32 |
0.0774485565960373 |
|
| 5624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7A |
0.0774485565960373 |
|
| 5625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQSEC1 |
0.0774485565960373 |
|
| 5626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP210 |
0.0774485565960373 |
|
| 5627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC11 |
0.0774485565960373 |
|
| 5628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLN2 |
0.0774485565960373 |
|
| 5629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00620 |
0.0774485565960373 |
|
| 5630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT7A |
0.0774485565960373 |
|
| 5631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD5P1 |
0.0774485565960373 |
|
| 5632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRXL |
0.0774485565960373 |
|
| 5633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DERL2 |
0.0777364493117855 |
|
| 5634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIS12 |
0.0777364493117855 |
|
| 5635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP1 |
0.0777364493117855 |
|
| 5636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WSCD1 |
0.0777364493117855 |
|
| 5637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIPL1 |
0.0777364493117855 |
|
| 5638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM64A |
0.0777364493117855 |
|
| 5639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACKR6 |
0.0777364493117855 |
|
| 5640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0753 |
0.0777364493117855 |
|
| 5641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP435 |
0.0777364493117855 |
|
| 5642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED31 |
0.0777364493117855 |
|
| 5643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC17 |
0.0777364493117855 |
|
| 5644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf100 |
0.0777364493117855 |
|
| 5645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4520B |
0.0777364493117855 |
|
| 5646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC13A5 |
0.0777364493117855 |
|
| 5647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAF1 |
0.0777364493117855 |
|
| 5648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO39 |
0.0777364493117855 |
|
| 5649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT1 |
0.0777364493117855 |
|
| 5650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX12P2 |
0.0777364493117855 |
|
| 5651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX12 |
0.0777364493117855 |
|
| 5652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf49 |
0.0777364493117855 |
|
| 5653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR497HG |
0.0777364493117855 |
|
| 5654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEK |
0.0777364493117855 |
|
| 5655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL6B |
0.0777364493117855 |
|
| 5656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A11 |
0.0777364493117855 |
|
| 5657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A13 |
0.0777364493117855 |
|
| 5658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC10A |
0.0777364493117855 |
|
| 5659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASGR2 |
0.0777364493117855 |
|
| 5660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASGR1 |
0.0777364493117855 |
|
| 5661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLG4 |
0.0777364493117855 |
|
| 5662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACADVL |
0.0777364493117855 |
|
| 5663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DVL2 |
0.0777364493117855 |
|
| 5664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR324 |
0.0777364493117855 |
|
| 5665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF23 |
0.0777364493117855 |
|
| 5666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABARAP |
0.0777364493117855 |
|
| 5667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDNEP1 |
0.0777364493117855 |
|
| 5668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELP5 |
0.0777364493117855 |
|
| 5669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN7 |
0.0777364493117855 |
|
| 5670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A4 |
0.0777364493117855 |
|
| 5671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YBX2 |
0.0777364493117855 |
|
| 5672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF5A |
0.0777364493117855 |
|
| 5673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPS2 |
0.0777364493117855 |
|
| 5674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEURL4 |
0.0777364493117855 |
|
| 5675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAP1 |
0.0777364493117855 |
|
| 5676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD11 |
0.0777364493117855 |
|
| 5677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM95 |
0.0777364493117855 |
|
| 5678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNK1 |
0.0777364493117855 |
|
| 5679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLSCR3 |
0.0777364493117855 |
|
| 5680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLGN2 |
0.0777364493117855 |
|
| 5681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM256 |
0.0777364493117855 |
|
| 5682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPEM1 |
0.0777364493117855 |
|
| 5683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf74 |
0.0777364493117855 |
|
| 5684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF11 |
0.0777364493117855 |
|
| 5685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM102 |
0.0777364493117855 |
|
| 5686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNB1 |
0.0777364493117855 |
|
| 5687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB4 |
0.0777364493117855 |
|
| 5688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35G6 |
0.0777364493117855 |
|
| 5689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2A |
0.0777364493117855 |
|
| 5690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF12 |
0.0777364493117855 |
|
| 5691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP3 |
0.0777364493117855 |
|
| 5692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF13 |
0.0777364493117855 |
|
| 5693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4A1 |
0.0777364493117855 |
|
| 5694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000209582.1 |
0.0777364493117855 |
|
| 5695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000264772.2 |
0.0777364493117855 |
|
| 5696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD10 |
0.0777364493117855 |
|
| 5697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD68 |
0.0777364493117855 |
|
| 5698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXR2 |
0.0777364493117855 |
|
| 5699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPDU1 |
0.0777364493117855 |
|
| 5700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX15 |
0.0777364493117855 |
|
| 5701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHBG |
0.0777364493117855 |
|
| 5702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251860.1 |
0.0777364493117855 |
|
| 5703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAT2 |
0.0777364493117855 |
|
| 5704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1B2 |
0.0777364493117855 |
|
| 5705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53 |
0.0777364493117855 |
|
| 5706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WRAP53 |
0.0777364493117855 |
|
| 5707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNB3 |
0.0777364493117855 |
|
| 5708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH2 |
0.0777364493117855 |
|
| 5709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL29P2 |
0.0777364493117855 |
|
| 5710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM6B |
0.0777364493117855 |
|
| 5711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5D1 |
0.0777364493117855 |
|
| 5712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSMD1 |
0.0777364493117855 |
|
| 5713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM88 |
0.0777364493117855 |
|
| 5714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD3 |
0.0777364493117855 |
|
| 5715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA21|ENSG00000252835.1 |
0.0777364493117855 |
|
| 5716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNAB3 |
0.0777364493117855 |
|
| 5717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTROB |
0.0777364493117855 |
|
| 5718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC1 |
0.0777364493117855 |
|
| 5719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY2D |
0.0777364493117855 |
|
| 5720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238676.1 |
0.0777364493117855 |
|
| 5721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX15B |
0.0777364493117855 |
|
| 5722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX12B |
0.0777364493117855 |
|
| 5723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4314 |
0.0777364493117855 |
|
| 5724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOXE3 |
0.0777364493117855 |
|
| 5725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES7 |
0.0777364493117855 |
|
| 5726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PER1 |
0.0777364493117855 |
|
| 5727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP2 |
0.0777364493117855 |
|
| 5728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD118 |
0.0777364493117855 |
|
| 5729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM107 |
0.0777364493117855 |
|
| 5730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf59 |
0.0777364493117855 |
|
| 5731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3676 |
0.0777364493117855 |
|
| 5732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AURKB |
0.0777364493117855 |
|
| 5733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00324 |
0.0777364493117855 |
|
| 5734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTC1 |
0.0777364493117855 |
|
| 5735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFAS |
0.0777364493117855 |
|
| 5736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A35 |
0.0777364493117855 |
|
| 5737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANGRF |
0.0777364493117855 |
|
| 5738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF15 |
0.0777364493117855 |
|
| 5739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA69|ENSG00000212206.1 |
0.0777364493117855 |
|
| 5740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF4 |
0.0777364493117855 |
|
| 5741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRBA2 |
0.0777364493117855 |
|
| 5742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL26 |
0.0777364493117855 |
|
| 5743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF222 |
0.0777364493117855 |
|
| 5744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDEL1 |
0.0777364493117855 |
|
| 5745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH10 |
0.0777364493117855 |
|
| 5746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL129P |
0.0777364493117855 |
|
| 5747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC42 |
0.0777364493117855 |
|
| 5748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYE4 |
0.0777364493117855 |
|
| 5749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD6L |
0.0777364493117855 |
|
| 5750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R6 |
0.0777364493117855 |
|
| 5751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R5 |
0.0777364493117855 |
|
| 5752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTN1 |
0.0777364493117855 |
|
| 5753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX8 |
0.0777364493117855 |
|
| 5754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR16 |
0.0777364493117855 |
|
| 5755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP43 |
0.0777364493117855 |
|
| 5756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS7C |
0.0777364493117855 |
|
| 5757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLP2R |
0.0777364493117855 |
|
| 5758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCVRN |
0.0777364493117855 |
|
| 5759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS7 |
0.0777364493117855 |
|
| 5760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH13 |
0.0777364493117855 |
|
| 5761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH8 |
0.0777364493117855 |
|
| 5762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH4 |
0.0777364493117855 |
|
| 5763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH1 |
0.0777364493117855 |
|
| 5764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH2 |
0.0777364493117855 |
|
| 5765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH3 |
0.0777364493117855 |
|
| 5766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCO1 |
0.0777364493117855 |
|
| 5767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADPRM |
0.0777364493117855 |
|
| 5768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM220 |
0.0777364493117855 |
|
| 5769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGOH2 |
0.0777364493117855 |
|
| 5770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00675 |
0.0777364493117855 |
|
| 5771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIRT |
0.0777364493117855 |
|
| 5772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL601P |
0.0777364493117855 |
|
| 5773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA6 |
0.0777364493117855 |
|
| 5774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH9 |
0.0777364493117855 |
|
| 5775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF18 |
0.0777364493117855 |
|
| 5776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL21P122 |
0.0777364493117855 |
|
| 5777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K4 |
0.0777364493117855 |
|
| 5778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR744 |
0.0777364493117855 |
|
| 5779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00670 |
0.0777364493117855 |
|
| 5780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOCD |
0.0777364493117855 |
|
| 5781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP44 |
0.0777364493117855 |
|
| 5782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1269B |
0.0777364493117855 |
|
| 5783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL550P |
0.0777364493117855 |
|
| 5784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAC2 |
0.0777364493117855 |
|
| 5785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST3A1 |
0.0777364493117855 |
|
| 5786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548H3 |
0.0777364493117855 |
|
| 5787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX10 |
0.0777364493117855 |
|
| 5788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000252305.1 |
0.0777364493117855 |
|
| 5789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT15 |
0.0777364493117855 |
|
| 5790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT1 |
0.0777364493117855 |
|
| 5791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT4 |
0.0777364493117855 |
|
| 5792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT7 |
0.0777364493117855 |
|
| 5793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT8 |
0.0777364493117855 |
|
| 5794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST3B1 |
0.0777364493117855 |
|
| 5795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4731 |
0.0777364493117855 |
|
| 5796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMP22 |
0.0777364493117855 |
|
| 5797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL792P |
0.0777364493117855 |
|
| 5798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000252129.1 |
0.0777364493117855 |
|
| 5799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT3 |
0.0777364493117855 |
|
| 5800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM16 |
0.0777364493117855 |
|
| 5801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TVP23C |
0.0777364493117855 |
|
| 5802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238806.1 |
0.0777364493117855 |
|
| 5803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D26 |
0.0777364493117855 |
|
| 5804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF286A |
0.0777364493117855 |
|
| 5805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP436 |
0.0777364493117855 |
|
| 5806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADORA2B |
0.0777364493117855 |
|
| 5807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM7 |
0.0777364493117855 |
|
| 5808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC19 |
0.0777364493117855 |
|
| 5809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOR1 |
0.0777364493117855 |
|
| 5810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL442P |
0.0777364493117855 |
|
| 5811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGL |
0.0777364493117855 |
|
| 5812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1288 |
0.0777364493117855 |
|
| 5813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPV |
0.0777364493117855 |
|
| 5814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBB |
0.0777364493117855 |
|
| 5815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV2 |
0.0777364493117855 |
|
| 5816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM211A |
0.0777364493117855 |
|
| 5817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF287 |
0.0777364493117855 |
|
| 5818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF624 |
0.0777364493117855 |
|
| 5819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC144A |
0.0777364493117855 |
|
| 5820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL620P |
0.0777364493117855 |
|
| 5821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT16P2 |
0.0777364493117855 |
|
| 5822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT17P1 |
0.0777364493117855 |
|
| 5823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP32P1 |
0.0777364493117855 |
|
| 5824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D27 |
0.0777364493117855 |
|
| 5825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF13B |
0.0777364493117855 |
|
| 5826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPRIP |
0.0777364493117855 |
|
| 5827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL775P |
0.0777364493117855 |
|
| 5828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD6 |
0.0777364493117855 |
|
| 5829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLCN |
0.0777364493117855 |
|
| 5830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS3 |
0.0777364493117855 |
|
| 5831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5M |
0.0777364493117855 |
|
| 5832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED9 |
0.0777364493117855 |
|
| 5833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASD1 |
0.0777364493117855 |
|
| 5834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEMT |
0.0777364493117855 |
|
| 5835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCR2 |
0.0777364493117855 |
|
| 5836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAI1 |
0.0777364493117855 |
|
| 5837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCR5 |
0.0777364493117855 |
|
| 5838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR33B |
0.0777364493117855 |
|
| 5839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SREBF1 |
0.0777364493117855 |
|
| 5840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOM1L2 |
0.0777364493117855 |
|
| 5841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC48 |
0.0777364493117855 |
|
| 5842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATPAF2 |
0.0777364493117855 |
|
| 5843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GID4 |
0.0777364493117855 |
|
| 5844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRG2 |
0.0777364493117855 |
|
| 5845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO15A |
0.0777364493117855 |
|
| 5846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238691.1 |
0.0777364493117855 |
|
| 5847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH5 |
0.0777364493117855 |
|
| 5848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LLGL1 |
0.0777364493117855 |
|
| 5849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLII |
0.0777364493117855 |
|
| 5850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCR7 |
0.0777364493117855 |
|
| 5851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP3A |
0.0777364493117855 |
|
| 5852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCR8 |
0.0777364493117855 |
|
| 5853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHMT1 |
0.0777364493117855 |
|
| 5854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVPLL |
0.0777364493117855 |
|
| 5855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC144B |
0.0777364493117855 |
|
| 5856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM106A |
0.0777364493117855 |
|
| 5857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT16P1 |
0.0777364493117855 |
|
| 5858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT17P2 |
0.0777364493117855 |
|
| 5859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS9C |
0.0777364493117855 |
|
| 5860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL639P |
0.0777364493117855 |
|
| 5861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D28 |
0.0777364493117855 |
|
| 5862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP32P2 |
0.0777364493117855 |
|
| 5863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF286B |
0.0777364493117855 |
|
| 5864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM16L |
0.0777364493117855 |
|
| 5865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW10 |
0.0777364493117855 |
|
| 5866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TVP23B |
0.0777364493117855 |
|
| 5867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPSAP2 |
0.0777364493117855 |
|
| 5868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL627P |
0.0777364493117855 |
|
| 5869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH3A2 |
0.0777364493117855 |
|
| 5870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252349.1 |
0.0777364493117855 |
|
| 5871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC47A2 |
0.0777364493117855 |
|
| 5872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH3A1 |
0.0777364493117855 |
|
| 5873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK2 |
0.0777364493117855 |
|
| 5874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP10 |
0.0777364493117855 |
|
| 5875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPECC1 |
0.0777364493117855 |
|
| 5876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC144CP |
0.0777364493117855 |
|
| 5877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL17P |
0.0777364493117855 |
|
| 5878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000266839.2 |
0.0777364493117855 |
|
| 5879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPF3AP2 |
0.0777364493117855 |
|
| 5880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP32P3 |
0.0777364493117855 |
|
| 5881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT16P3 |
0.0777364493117855 |
|
| 5882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS9B |
0.0777364493117855 |
|
| 5883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOS2P3 |
0.0777364493117855 |
|
| 5884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDRT15L2 |
0.0777364493117855 |
|
| 5885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC144NL |
0.0777364493117855 |
|
| 5886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP22 |
0.0777364493117855 |
|
| 5887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS7B |
0.0777364493117855 |
|
| 5888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM11 |
0.0777364493117855 |
|
| 5889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL426P |
0.0777364493117855 |
|
| 5890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf103 |
0.0777364493117855 |
|
| 5891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K3 |
0.0777364493117855 |
|
| 5892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ12 |
0.0777364493117855 |
|
| 5893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf51 |
0.0777364493117855 |
|
| 5894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27L |
0.0777364493117855 |
|
| 5895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTND1P15 |
0.0777364493117855 |
|
| 5896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L1 |
0.0777364493117855 |
|
| 5897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBBP4 |
0.0777364493117855 |
|
| 5898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4522 |
0.0777364493117855 |
|
| 5899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WSB1 |
0.0777364493117855 |
|
| 5900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3P5 |
0.0777364493117855 |
|
| 5901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KSR1 |
0.0777364493117855 |
|
| 5902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS9 |
0.0777364493117855 |
|
| 5903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL576P |
0.0777364493117855 |
|
| 5904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOS2 |
0.0777364493117855 |
|
| 5905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM9 |
0.0777364493117855 |
|
| 5906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000251818.1 |
0.0777364493117855 |
|
| 5907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000202389.1 |
0.0777364493117855 |
|
| 5908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLK |
0.0777364493117855 |
|
| 5909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
Vault|ENSG00000252283.1 |
0.0777364493117855 |
|
| 5910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYY2 |
0.0777364493117855 |
|
| 5911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPY2 |
0.0777364493117855 |
|
| 5912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT18P55 |
0.0777364493117855 |
|
| 5913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM97 |
0.0777364493117855 |
|
| 5914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT20 |
0.0777364493117855 |
|
| 5915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP1 |
0.0777364493117855 |
|
| 5916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLDIP2 |
0.0777364493117855 |
|
| 5917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM199 |
0.0777364493117855 |
|
| 5918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4723 |
0.0777364493117855 |
|
| 5919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SARM1 |
0.0777364493117855 |
|
| 5920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEBOX |
0.0777364493117855 |
|
| 5921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VTN |
0.0777364493117855 |
|
| 5922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC46A1 |
0.0777364493117855 |
|
| 5923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC13A2 |
0.0777364493117855 |
|
| 5924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXN1 |
0.0777364493117855 |
|
| 5925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC119 |
0.0777364493117855 |
|
| 5926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGS |
0.0777364493117855 |
|
| 5927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDOC |
0.0777364493117855 |
|
| 5928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG5 |
0.0777364493117855 |
|
| 5929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0100 |
0.0777364493117855 |
|
| 5930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK494 |
0.0777364493117855 |
|
| 5931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDF2 |
0.0777364493117855 |
|
| 5932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT6H |
0.0777364493117855 |
|
| 5933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROCA1 |
0.0777364493117855 |
|
| 5934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB34 |
0.0777364493117855 |
|
| 5935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL23A |
0.0777364493117855 |
|
| 5936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD42B |
0.0777364493117855 |
|
| 5937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD42A |
0.0777364493117855 |
|
| 5938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD4A |
0.0777364493117855 |
|
| 5939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD4B |
0.0777364493117855 |
|
| 5940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLCD1 |
0.0777364493117855 |
|
| 5941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK8 |
0.0777364493117855 |
|
| 5942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF4 |
0.0777364493117855 |
|
| 5943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM222B |
0.0777364493117855 |
|
| 5944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERAL1 |
0.0777364493117855 |
|
| 5945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4732 |
0.0777364493117855 |
|
| 5946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLOT2 |
0.0777364493117855 |
|
| 5947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS13 |
0.0777364493117855 |
|
| 5948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF12 |
0.0777364493117855 |
|
| 5949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIPOX |
0.0777364493117855 |
|
| 5950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEZ6 |
0.0777364493117855 |
|
| 5951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO18A |
0.0777364493117855 |
|
| 5952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIAF1 |
0.0777364493117855 |
|
| 5953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBA1 |
0.0777364493117855 |
|
| 5954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUFIP2 |
0.0777364493117855 |
|
| 5955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4523 |
0.0777364493117855 |
|
| 5956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAOK1 |
0.0777364493117855 |
|
| 5957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD15 |
0.0777364493117855 |
|
| 5958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIT1 |
0.0777364493117855 |
|
| 5959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53I13 |
0.0777364493117855 |
|
| 5960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD13B |
0.0777364493117855 |
|
| 5961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO6 |
0.0777364493117855 |
|
| 5962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSH2 |
0.0777364493117855 |
|
| 5963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252657.1 |
0.0777364493117855 |
|
| 5964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239129.1 |
0.0777364493117855 |
|
| 5965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB5 |
0.0777364493117855 |
|
| 5966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P13 |
0.0777364493117855 |
|
| 5967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3184 |
0.0777364493117855 |
|
| 5968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR423 |
0.0777364493117855 |
|
| 5969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSRP1 |
0.0777364493117855 |
|
| 5970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A4 |
0.0777364493117855 |
|
| 5971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLMH |
0.0777364493117855 |
|
| 5972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD63|ENSG00000252112.1 |
0.0777364493117855 |
|
| 5973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMIGD1 |
0.0777364493117855 |
|
| 5974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPD |
0.0777364493117855 |
|
| 5975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOSR1 |
0.0777364493117855 |
|
| 5976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D29 |
0.0777364493117855 |
|
| 5977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMURF2P1 |
0.0777364493117855 |
|
| 5978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD5 |
0.0777364493117855 |
|
| 5979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRLF3 |
0.0777364493117855 |
|
| 5980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37BP1 |
0.0777364493117855 |
|
| 5981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL316P |
0.0777364493117855 |
|
| 5982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUZ12P |
0.0777364493117855 |
|
| 5983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEFM |
0.0777364493117855 |
|
| 5984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAP2 |
0.0777364493117855 |
|
| 5985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL138P |
0.0777364493117855 |
|
| 5986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF135 |
0.0777364493117855 |
|
| 5987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4733 |
0.0777364493117855 |
|
| 5988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NF1 |
0.0777364493117855 |
|
| 5989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OMG |
0.0777364493117855 |
|
| 5990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVI2B |
0.0777364493117855 |
|
| 5991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVI2A |
0.0777364493117855 |
|
| 5992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11FIP4 |
0.0777364493117855 |
|
| 5993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL79P |
0.0777364493117855 |
|
| 5994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL45P |
0.0777364493117855 |
|
| 5995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4724 |
0.0777364493117855 |
|
| 5996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR193A |
0.0777364493117855 |
|
| 5997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC7P |
0.0777364493117855 |
|
| 5998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR365B |
0.0777364493117855 |
|
| 5999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4725 |
0.0777364493117855 |
|
| 6000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPRS |
0.0777364493117855 |
|
| 6001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP6 |
0.0777364493117855 |
|
| 6002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUZ12 |
0.0777364493117855 |
|
| 6003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP437 |
0.0777364493117855 |
|
| 6004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37B |
0.0777364493117855 |
|
| 6005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GL1P1 |
0.0777364493117855 |
|
| 6006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOT1 |
0.0777364493117855 |
|
| 6007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDL3 |
0.0777364493117855 |
|
| 6008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf75 |
0.0777364493117855 |
|
| 6009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR632 |
0.0777364493117855 |
|
| 6010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF207 |
0.0777364493117855 |
|
| 6011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD11 |
0.0777364493117855 |
|
| 6012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5R1 |
0.0777364493117855 |
|
| 6013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1D |
0.0777364493117855 |
|
| 6014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM98 |
0.0777364493117855 |
|
| 6015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA3 |
0.0777364493117855 |
|
| 6016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIC2 |
0.0777364493117855 |
|
| 6017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf102 |
0.0777364493117855 |
|
| 6018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL11 |
0.0777364493117855 |
|
| 6019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL13 |
0.0777364493117855 |
|
| 6020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL1 |
0.0777364493117855 |
|
| 6021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL2 |
0.0777364493117855 |
|
| 6022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL7 |
0.0777364493117855 |
|
| 6023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL8 |
0.0777364493117855 |
|
| 6024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP438 |
0.0777364493117855 |
|
| 6025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM132E |
0.0777364493117855 |
|
| 6026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT6B |
0.0777364493117855 |
|
| 6027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF830 |
0.0777364493117855 |
|
| 6028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIG3 |
0.0777364493117855 |
|
| 6029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFFL |
0.0777364493117855 |
|
| 6030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238858.1 |
0.0777364493117855 |
|
| 6031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51D |
0.0777364493117855 |
|
| 6032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
Vault|ENSG00000252328.1 |
0.0777364493117855 |
|
| 6033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC8 |
0.0777364493117855 |
|
| 6034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLE1 |
0.0777364493117855 |
|
| 6035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC45B |
0.0777364493117855 |
|
| 6036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35G3 |
0.0777364493117855 |
|
| 6037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN5 |
0.0777364493117855 |
|
| 6038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN11 |
0.0777364493117855 |
|
| 6039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN12 |
0.0777364493117855 |
|
| 6040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN13 |
0.0777364493117855 |
|
| 6041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN12L |
0.0777364493117855 |
|
| 6042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFN14 |
0.0777364493117855 |
|
| 6043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP2B1 |
0.0777364493117855 |
|
| 6044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX12 |
0.0777364493117855 |
|
| 6045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD7 |
0.0777364493117855 |
|
| 6046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASL10B |
0.0777364493117855 |
|
| 6047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS2L2 |
0.0777364493117855 |
|
| 6048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP28 |
0.0777364493117855 |
|
| 6049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf50 |
0.0777364493117855 |
|
| 6050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF15 |
0.0777364493117855 |
|
| 6051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf66 |
0.0777364493117855 |
|
| 6052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL5 |
0.0777364493117855 |
|
| 6053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP274 |
0.0777364493117855 |
|
| 6054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDM1 |
0.0777364493117855 |
|
| 6055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYZL6 |
0.0777364493117855 |
|
| 6056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL16 |
0.0777364493117855 |
|
| 6057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL14 |
0.0777364493117855 |
|
| 6058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL15 |
0.0777364493117855 |
|
| 6059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL23 |
0.0777364493117855 |
|
| 6060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL18 |
0.0777364493117855 |
|
| 6061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL3L1 |
0.0777364493117855 |
|
| 6062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL3L3 |
0.0777364493117855 |
|
| 6063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL3 |
0.0777364493117855 |
|
| 6064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL4L1 |
0.0777364493117855 |
|
| 6065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL4L2 |
0.0777364493117855 |
|
| 6066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL4 |
0.0777364493117855 |
|
| 6067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGNBP2 |
0.0777364493117855 |
|
| 6068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO19 |
0.0777364493117855 |
|
| 6069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGW |
0.0777364493117855 |
|
| 6070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL301P |
0.0777364493117855 |
|
| 6071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP439 |
0.0777364493117855 |
|
| 6072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3B |
0.0777364493117855 |
|
| 6073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3C |
0.0777364493117855 |
|
| 6074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3G |
0.0777364493117855 |
|
| 6075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3H |
0.0777364493117855 |
|
| 6076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNHIT3 |
0.0777364493117855 |
|
| 6077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS11 |
0.0777364493117855 |
|
| 6078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRM1 |
0.0777364493117855 |
|
| 6079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX1 |
0.0777364493117855 |
|
| 6080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AATF |
0.0777364493117855 |
|
| 6081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2909 |
0.0777364493117855 |
|
| 6082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACACA |
0.0777364493117855 |
|
| 6083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB1P24 |
0.0777364493117855 |
|
| 6084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf78 |
0.0777364493117855 |
|
| 6085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TADA2A |
0.0777364493117855 |
|
| 6086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP14 |
0.0777364493117855 |
|
| 6087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNRG |
0.0777364493117855 |
|
| 6088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX52 |
0.0777364493117855 |
|
| 6089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNF1B |
0.0777364493117855 |
|
| 6090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3F |
0.0777364493117855 |
|
| 6091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D3 |
0.0777364493117855 |
|
| 6092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL45 |
0.0777364493117855 |
|
| 6093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR179 |
0.0777364493117855 |
|
| 6094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS7 |
0.0777364493117855 |
|
| 6095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL458P |
0.0777364493117855 |
|
| 6096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP23 |
0.0777364493117855 |
|
| 6097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRCIN1 |
0.0777364493117855 |
|
| 6098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL102P |
0.0777364493117855 |
|
| 6099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf96 |
0.0777364493117855 |
|
| 6100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4734 |
0.0777364493117855 |
|
| 6101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT6 |
0.0777364493117855 |
|
| 6102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CISD3 |
0.0777364493117855 |
|
| 6103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4726 |
0.0777364493117855 |
|
| 6104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP440 |
0.0777364493117855 |
|
| 6105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGF2 |
0.0777364493117855 |
|
| 6106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB3 |
0.0777364493117855 |
|
| 6107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP4K2B |
0.0777364493117855 |
|
| 6108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWC25 |
0.0777364493117855 |
|
| 6109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4727 |
0.0777364493117855 |
|
| 6110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf98 |
0.0777364493117855 |
|
| 6111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL23 |
0.0777364493117855 |
|
| 6112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA21|ENSG00000199293.1 |
0.0777364493117855 |
|
| 6113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA21|ENSG00000252699.1 |
0.0777364493117855 |
|
| 6114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LASP1 |
0.0777364493117855 |
|
| 6115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00672 |
0.0777364493117855 |
|
| 6116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO47 |
0.0777364493117855 |
|
| 6117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A11P |
0.0777364493117855 |
|
| 6118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXDC1 |
0.0777364493117855 |
|
| 6119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL5C |
0.0777364493117855 |
|
| 6120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNB1 |
0.0777364493117855 |
|
| 6121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL19 |
0.0777364493117855 |
|
| 6122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAC2 |
0.0777364493117855 |
|
| 6123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL20 |
0.0777364493117855 |
|
| 6124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED1 |
0.0777364493117855 |
|
| 6125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK12 |
0.0777364493117855 |
|
| 6126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROD2 |
0.0777364493117855 |
|
| 6127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R1B |
0.0777364493117855 |
|
| 6128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD3 |
0.0777364493117855 |
|
| 6129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCAP |
0.0777364493117855 |
|
| 6130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMT |
0.0777364493117855 |
|
| 6131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAP3 |
0.0777364493117855 |
|
| 6132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERBB2 |
0.0777364493117855 |
|
| 6133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4728 |
0.0777364493117855 |
|
| 6134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIEN1 |
0.0777364493117855 |
|
| 6135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRB7 |
0.0777364493117855 |
|
| 6136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKZF3 |
0.0777364493117855 |
|
| 6137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZPBP2 |
0.0777364493117855 |
|
| 6138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSDMB |
0.0777364493117855 |
|
| 6139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORMDL3 |
0.0777364493117855 |
|
| 6140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC3C |
0.0777364493117855 |
|
| 6141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSDMA |
0.0777364493117855 |
|
| 6142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD3 |
0.0777364493117855 |
|
| 6143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF3 |
0.0777364493117855 |
|
| 6144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED24 |
0.0777364493117855 |
|
| 6145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD124 |
0.0777364493117855 |
|
| 6146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THRA |
0.0777364493117855 |
|
| 6147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1D1 |
0.0777364493117855 |
|
| 6148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSL1 |
0.0777364493117855 |
|
| 6149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC3 |
0.0777364493117855 |
|
| 6150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEFL1 |
0.0777364493117855 |
|
| 6151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIPF2 |
0.0777364493117855 |
|
| 6152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P8 |
0.0777364493117855 |
|
| 6153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC6 |
0.0777364493117855 |
|
| 6154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARA |
0.0777364493117855 |
|
| 6155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJD3 |
0.0777364493117855 |
|
| 6156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP441 |
0.0777364493117855 |
|
| 6157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP2A |
0.0777364493117855 |
|
| 6158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP4 |
0.0777364493117855 |
|
| 6159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNS4 |
0.0777364493117855 |
|
| 6160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR7 |
0.0777364493117855 |
|
| 6161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT222 |
0.0777364493117855 |
|
| 6162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCE1 |
0.0777364493117855 |
|
| 6163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT24 |
0.0777364493117855 |
|
| 6164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT223P |
0.0777364493117855 |
|
| 6165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT25 |
0.0777364493117855 |
|
| 6166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT26 |
0.0777364493117855 |
|
| 6167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT27 |
0.0777364493117855 |
|
| 6168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT28 |
0.0777364493117855 |
|
| 6169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT10 |
0.0777364493117855 |
|
| 6170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM99 |
0.0777364493117855 |
|
| 6171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT12 |
0.0777364493117855 |
|
| 6172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT20 |
0.0777364493117855 |
|
| 6173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT23 |
0.0777364493117855 |
|
| 6174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT39 |
0.0777364493117855 |
|
| 6175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT40 |
0.0777364493117855 |
|
| 6176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT33A |
0.0777364493117855 |
|
| 6177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT33B |
0.0777364493117855 |
|
| 6178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT31 |
0.0777364493117855 |
|
| 6179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT34 |
0.0777364493117855 |
|
| 6180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT37 |
0.0777364493117855 |
|
| 6181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT38 |
0.0777364493117855 |
|
| 6182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT32 |
0.0777364493117855 |
|
| 6183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT35 |
0.0777364493117855 |
|
| 6184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT36 |
0.0777364493117855 |
|
| 6185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT13 |
0.0777364493117855 |
|
| 6186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT15 |
0.0777364493117855 |
|
| 6187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT19 |
0.0777364493117855 |
|
| 6188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00974 |
0.0777364493117855 |
|
| 6189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT9 |
0.0777364493117855 |
|
| 6190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT14 |
0.0777364493117855 |
|
| 6191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT16 |
0.0777364493117855 |
|
| 6192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JUP |
0.0777364493117855 |
|
| 6193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT17 |
0.0777364493117855 |
|
| 6194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT42P |
0.0777364493117855 |
|
| 6195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF1 |
0.0777364493117855 |
|
| 6196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAST |
0.0777364493117855 |
|
| 6197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAP1 |
0.0777364493117855 |
|
| 6198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP442 |
0.0777364493117855 |
|
| 6199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL399P |
0.0777364493117855 |
|
| 6200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPREL4 |
0.0777364493117855 |
|
| 6201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP10 |
0.0777364493117855 |
|
| 6202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C3B |
0.0777364493117855 |
|
| 6203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL10 |
0.0777364493117855 |
|
| 6204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL871P |
0.0777364493117855 |
|
| 6205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL11 |
0.0777364493117855 |
|
| 6206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACLY |
0.0777364493117855 |
|
| 6207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC25 |
0.0777364493117855 |
|
| 6208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNP |
0.0777364493117855 |
|
| 6209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC7 |
0.0777364493117855 |
|
| 6210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKIRAS2 |
0.0777364493117855 |
|
| 6211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF385C |
0.0777364493117855 |
|
| 6212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX58 |
0.0777364493117855 |
|
| 6213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT2A |
0.0777364493117855 |
|
| 6214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB9 |
0.0777364493117855 |
|
| 6215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB5C |
0.0777364493117855 |
|
| 6216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH4 |
0.0777364493117855 |
|
| 6217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCRT |
0.0777364493117855 |
|
| 6218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHDC |
0.0777364493117855 |
|
| 6219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT5B |
0.0777364493117855 |
|
| 6220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT5A |
0.0777364493117855 |
|
| 6221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT3 |
0.0777364493117855 |
|
| 6222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTRF |
0.0777364493117855 |
|
| 6223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0A1 |
0.0777364493117855 |
|
| 6224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AT |
0.0777364493117855 |
|
| 6225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5010 |
0.0777364493117855 |
|
| 6226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAGLU |
0.0777364493117855 |
|
| 6227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B1 |
0.0777364493117855 |
|
| 6228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COASY |
0.0777364493117855 |
|
| 6229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLX |
0.0777364493117855 |
|
| 6230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC3IP |
0.0777364493117855 |
|
| 6231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM134C |
0.0777364493117855 |
|
| 6232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBG1 |
0.0777364493117855 |
|
| 6233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBG2 |
0.0777364493117855 |
|
| 6234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR10 |
0.0777364493117855 |
|
| 6235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP1 |
0.0777364493117855 |
|
| 6236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHH3 |
0.0777364493117855 |
|
| 6237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EZH1 |
0.0777364493117855 |
|
| 6238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAMP2 |
0.0777364493117855 |
|
| 6239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS25 |
0.0777364493117855 |
|
| 6240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNK4 |
0.0777364493117855 |
|
| 6241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTD1 |
0.0777364493117855 |
|
| 6242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COA3 |
0.0777364493117855 |
|
| 6243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BECN1 |
0.0777364493117855 |
|
| 6244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSME3 |
0.0777364493117855 |
|
| 6245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOC2 |
0.0777364493117855 |
|
| 6246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOC3 |
0.0777364493117855 |
|
| 6247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOC4P |
0.0777364493117855 |
|
| 6248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00671 |
0.0777364493117855 |
|
| 6249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G6PC |
0.0777364493117855 |
|
| 6250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P2 |
0.0777364493117855 |
|
| 6251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212149.1 |
0.0777364493117855 |
|
| 6252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AARSD1 |
0.0777364493117855 |
|
| 6253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGES3L |
0.0777364493117855 |
|
| 6254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNDC1 |
0.0777364493117855 |
|
| 6255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL27 |
0.0777364493117855 |
|
| 6256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI35 |
0.0777364493117855 |
|
| 6257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAT1 |
0.0777364493117855 |
|
| 6258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RND2 |
0.0777364493117855 |
|
| 6259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRCA1 |
0.0777364493117855 |
|
| 6260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBR2 |
0.0777364493117855 |
|
| 6261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBR1 |
0.0777364493117855 |
|
| 6262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL4D |
0.0777364493117855 |
|
| 6263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00854 |
0.0777364493117855 |
|
| 6264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00910 |
0.0777364493117855 |
|
| 6265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM106A |
0.0777364493117855 |
|
| 6266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2117 |
0.0777364493117855 |
|
| 6267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX8 |
0.0777364493117855 |
|
| 6268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV4 |
0.0777364493117855 |
|
| 6269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEOX1 |
0.0777364493117855 |
|
| 6270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOST |
0.0777364493117855 |
|
| 6271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP3 |
0.0777364493117855 |
|
| 6272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf105 |
0.0777364493117855 |
|
| 6273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP3 |
0.0777364493117855 |
|
| 6274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300LG |
0.0777364493117855 |
|
| 6275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP2 |
0.0777364493117855 |
|
| 6276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM215A |
0.0777364493117855 |
|
| 6277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPY |
0.0777364493117855 |
|
| 6278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYY |
0.0777364493117855 |
|
| 6279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAGS |
0.0777364493117855 |
|
| 6280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM101 |
0.0777364493117855 |
|
| 6281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221044.1 |
0.0777364493117855 |
|
| 6282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM12 |
0.0777364493117855 |
|
| 6283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G6PC3 |
0.0777364493117855 |
|
| 6284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC5 |
0.0777364493117855 |
|
| 6285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf53 |
0.0777364493117855 |
|
| 6286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB16 |
0.0777364493117855 |
|
| 6287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMUB2 |
0.0777364493117855 |
|
| 6288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN7L3 |
0.0777364493117855 |
|
| 6289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBTF |
0.0777364493117855 |
|
| 6290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A1 |
0.0777364493117855 |
|
| 6291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL507P |
0.0777364493117855 |
|
| 6292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNDC3A |
0.0777364493117855 |
|
| 6293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221496.1 |
0.0777364493117855 |
|
| 6294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A39 |
0.0777364493117855 |
|
| 6295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRN |
0.0777364493117855 |
|
| 6296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM171A2 |
0.0777364493117855 |
|
| 6297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA2B |
0.0777364493117855 |
|
| 6298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH8 |
0.0777364493117855 |
|
| 6299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL258P |
0.0777364493117855 |
|
| 6300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD2 |
0.0777364493117855 |
|
| 6301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf104 |
0.0777364493117855 |
|
| 6302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC43 |
0.0777364493117855 |
|
| 6303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBF4B |
0.0777364493117855 |
|
| 6304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL819P |
0.0777364493117855 |
|
| 6305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM11 |
0.0777364493117855 |
|
| 6306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJC1 |
0.0777364493117855 |
|
| 6307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIGD1B |
0.0777364493117855 |
|
| 6308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFTUD2 |
0.0777364493117855 |
|
| 6309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL405P |
0.0777364493117855 |
|
| 6310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC103 |
0.0777364493117855 |
|
| 6311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM187A |
0.0777364493117855 |
|
| 6312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFAP |
0.0777364493117855 |
|
| 6313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF18B |
0.0777364493117855 |
|
| 6314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QL1 |
0.0777364493117855 |
|
| 6315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAKD |
0.0777364493117855 |
|
| 6316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMT1 |
0.0777364493117855 |
|
| 6317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCD3 |
0.0777364493117855 |
|
| 6318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACBD4 |
0.0777364493117855 |
|
| 6319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEXIM1 |
0.0777364493117855 |
|
| 6320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEXIM2 |
0.0777364493117855 |
|
| 6321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMNL1 |
0.0777364493117855 |
|
| 6322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA32 |
0.0777364493117855 |
|
| 6323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K14 |
0.0777364493117855 |
|
| 6324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP443 |
0.0777364493117855 |
|
| 6325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP27 |
0.0777364493117855 |
|
| 6326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL17A |
0.0777364493117855 |
|
| 6327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL17B |
0.0777364493117855 |
|
| 6328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRHR1 |
0.0777364493117855 |
|
| 6329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM215B |
0.0777364493117855 |
|
| 6330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANSL1 |
0.0777364493117855 |
|
| 6331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A2 |
0.0777364493117855 |
|
| 6332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A4P |
0.0777364493117855 |
|
| 6333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A |
0.0777364493117855 |
|
| 6334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPT |
0.0777364493117855 |
|
| 6335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSF |
0.0777364493117855 |
|
| 6336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHM1 |
0.0777364493117855 |
|
| 6337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL199P |
0.0777364493117855 |
|
| 6338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL656P |
0.0777364493117855 |
|
| 6339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL730P |
0.0777364493117855 |
|
| 6340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL739P |
0.0777364493117855 |
|
| 6341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPPL2C |
0.0777364493117855 |
|
| 6342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STH |
0.0777364493117855 |
|
| 6343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT3 |
0.0777364493117855 |
|
| 6344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT9B |
0.0777364493117855 |
|
| 6345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC3P |
0.0777364493117855 |
|
| 6346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOSR2 |
0.0777364493117855 |
|
| 6347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5089 |
0.0777364493117855 |
|
| 6348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A17P |
0.0777364493117855 |
|
| 6349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPRML |
0.0777364493117855 |
|
| 6350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL270P |
0.0777364493117855 |
|
| 6351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC27 |
0.0777364493117855 |
|
| 6352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL4 |
0.0777364493117855 |
|
| 6353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252088.1 |
0.0777364493117855 |
|
| 6354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB3 |
0.0777364493117855 |
|
| 6355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB13 |
0.0777364493117855 |
|
| 6356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL45P2 |
0.0777364493117855 |
|
| 6357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPEPPS |
0.0777364493117855 |
|
| 6358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNB1 |
0.0777364493117855 |
|
| 6359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBKBP1 |
0.0777364493117855 |
|
| 6360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX21 |
0.0777364493117855 |
|
| 6361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL7 |
0.0777364493117855 |
|
| 6362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL10 |
0.0777364493117855 |
|
| 6363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC46 |
0.0777364493117855 |
|
| 6364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRN2 |
0.0777364493117855 |
|
| 6365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP6 |
0.0777364493117855 |
|
| 6366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP2 |
0.0777364493117855 |
|
| 6367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPO |
0.0777364493117855 |
|
| 6368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR15L |
0.0777364493117855 |
|
| 6369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5RAP3 |
0.0777364493117855 |
|
| 6370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPZ2 |
0.0777364493117855 |
|
| 6371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR152 |
0.0777364493117855 |
|
| 6372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFE2L1 |
0.0777364493117855 |
|
| 6373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX1 |
0.0777364493117855 |
|
| 6374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX11 |
0.0777364493117855 |
|
| 6375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKAP1 |
0.0777364493117855 |
|
| 6376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1203 |
0.0777364493117855 |
|
| 6377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200538.1 |
0.0777364493117855 |
|
| 6378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB1 |
0.0777364493117855 |
|
| 6379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB2 |
0.0777364493117855 |
|
| 6380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB3 |
0.0777364493117855 |
|
| 6381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB4 |
0.0777364493117855 |
|
| 6382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR10A |
0.0777364493117855 |
|
| 6383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB5 |
0.0777364493117855 |
|
| 6384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB6 |
0.0777364493117855 |
|
| 6385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB7 |
0.0777364493117855 |
|
| 6386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB8 |
0.0777364493117855 |
|
| 6387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB9 |
0.0777364493117855 |
|
| 6388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR196A1 |
0.0777364493117855 |
|
| 6389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXB13 |
0.0777364493117855 |
|
| 6390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3185 |
0.0777364493117855 |
|
| 6391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAC |
0.0777364493117855 |
|
| 6392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL6 |
0.0777364493117855 |
|
| 6393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL125P |
0.0777364493117855 |
|
| 6394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCOCO2 |
0.0777364493117855 |
|
| 6395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000212565.1 |
0.0777364493117855 |
|
| 6396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5G1 |
0.0777364493117855 |
|
| 6397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Z |
0.0777364493117855 |
|
| 6398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNF8 |
0.0777364493117855 |
|
| 6399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238804.1 |
0.0777364493117855 |
|
| 6400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIP |
0.0777364493117855 |
|
| 6401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF2BP1 |
0.0777364493117855 |
|
| 6402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALNT2 |
0.0777364493117855 |
|
| 6403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNGT2 |
0.0777364493117855 |
|
| 6404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABI3 |
0.0777364493117855 |
|
| 6405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHOSPHO1 |
0.0777364493117855 |
|
| 6406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF652 |
0.0777364493117855 |
|
| 6407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHB |
0.0777364493117855 |
|
| 6408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SI |
0.0780503903178656 |
|
| 6409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK3 |
0.0780503903178656 |
|
| 6410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A10 |
0.0784767026048468 |
|
| 6411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPN2 |
0.0784767026048468 |
|
| 6412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83G |
0.0784767026048468 |
|
| 6413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAPL |
0.0784767026048468 |
|
| 6414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAP |
0.0784767026048468 |
|
| 6415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD3A |
0.0784767026048468 |
|
| 6416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD3C |
0.0784767026048468 |
|
| 6417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD3D |
0.0784767026048468 |
|
| 6418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B9D1 |
0.0784767026048468 |
|
| 6419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1180 |
0.0784767026048468 |
|
| 6420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK7 |
0.0784767026048468 |
|
| 6421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP4 |
0.0784767026048468 |
|
| 6422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF112 |
0.0784767026048468 |
|
| 6423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC47A1 |
0.0784767026048468 |
|
| 6424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA59B |
0.0784767026048468 |
|
| 6425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2E1 |
0.0791760875643281 |
|
| 6426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKIRAS1 |
0.0791760875643281 |
|
| 6427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL15 |
0.0791760875643281 |
|
| 6428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1D2 |
0.0791760875643281 |
|
| 6429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00691 |
0.0791760875643281 |
|
| 6430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A2 |
0.0792903227638025 |
|
| 6431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf49 |
0.0794800857247275 |
|
| 6432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABR |
0.0808080183609512 |
|
| 6433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf97 |
0.0808080183609512 |
|
| 6434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBIL5P |
0.0808080183609512 |
|
| 6435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOC2B |
0.0808080183609512 |
|
| 6436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM101B |
0.0808080183609512 |
|
| 6437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM57A |
0.0808080183609512 |
|
| 6438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN4 |
0.0808080183609512 |
|
| 6439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLOD4 |
0.0808080183609512 |
|
| 6440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3183 |
0.0808080183609512 |
|
| 6441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXN |
0.0808080183609512 |
|
| 6442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNMTL1 |
0.0808080183609512 |
|
| 6443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPH3AL |
0.0808080183609512 |
|
| 6444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM22 |
0.0808080183609512 |
|
| 6445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS53 |
0.0808080183609512 |
|
| 6446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHA9 |
0.0808080183609512 |
|
| 6447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUSC5 |
0.0808080183609512 |
|
| 6448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINF1 |
0.0808080183609512 |
|
| 6449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMYD4 |
0.0808080183609512 |
|
| 6450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPA1 |
0.0808080183609512 |
|
| 6451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN4RL1 |
0.0808080183609512 |
|
| 6452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH1 |
0.0808080183609512 |
|
| 6453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVCA2 |
0.0808080183609512 |
|
| 6454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIC1 |
0.0808080183609512 |
|
| 6455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR132 |
0.0808080183609512 |
|
| 6456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR212 |
0.0808080183609512 |
|
| 6457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG6 |
0.0808080183609512 |
|
| 6458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL624P |
0.0808080183609512 |
|
| 6459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRR |
0.0808080183609512 |
|
| 6460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD91A |
0.0808080183609512 |
|
| 6461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD91B |
0.0808080183609512 |
|
| 6462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSR1 |
0.0808080183609512 |
|
| 6463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGSM2 |
0.0808080183609512 |
|
| 6464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNT |
0.0808080183609512 |
|
| 6465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL16 |
0.0808080183609512 |
|
| 6466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL33P |
0.0808080183609512 |
|
| 6467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAFAH1B1 |
0.0808080183609512 |
|
| 6468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239024.1 |
0.0808080183609512 |
|
| 6469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL608P |
0.0808080183609512 |
|
| 6470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLUH |
0.0808080183609512 |
|
| 6471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1253 |
0.0808080183609512 |
|
| 6472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL605P |
0.0808080183609512 |
|
| 6473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP1GAP2 |
0.0808080183609512 |
|
| 6474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1D2 |
0.0808080183609512 |
|
| 6475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1D5 |
0.0808080183609512 |
|
| 6476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1G1 |
0.0808080183609512 |
|
| 6477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1A2 |
0.0808080183609512 |
|
| 6478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1A1 |
0.0808080183609512 |
|
| 6479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1D4 |
0.0808080183609512 |
|
| 6480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR3A2 |
0.0808080183609512 |
|
| 6481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR3A1 |
0.0808080183609512 |
|
| 6482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR3A4P |
0.0808080183609512 |
|
| 6483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1E1 |
0.0808080183609512 |
|
| 6484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR3A3 |
0.0808080183609512 |
|
| 6485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1E2 |
0.0808080183609512 |
|
| 6486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA22 |
0.0808080183609512 |
|
| 6487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPA |
0.0808080183609512 |
|
| 6488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV3 |
0.0808080183609512 |
|
| 6489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHPK |
0.0808080183609512 |
|
| 6490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV1 |
0.0808080183609512 |
|
| 6491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNS |
0.0808080183609512 |
|
| 6492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC6 |
0.0808080183609512 |
|
| 6493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX5 |
0.0808080183609512 |
|
| 6494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAX1BP3 |
0.0808080183609512 |
|
| 6495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAE |
0.0808080183609512 |
|
| 6496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSG2 |
0.0808080183609512 |
|
| 6497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf85 |
0.0808080183609512 |
|
| 6498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMKK1 |
0.0808080183609512 |
|
| 6499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX1 |
0.0808080183609512 |
|
| 6500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2A3 |
0.0808080183609512 |
|
| 6501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZZEF1 |
0.0808080183609512 |
|
| 6502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP434 |
0.0808080183609512 |
|
| 6503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238807.1 |
0.0808080183609512 |
|
| 6504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5D2 |
0.0808080183609512 |
|
| 6505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKFY1 |
0.0808080183609512 |
|
| 6506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2G1 |
0.0808080183609512 |
|
| 6507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL774P |
0.0808080183609512 |
|
| 6508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPNS3 |
0.0808080183609512 |
|
| 6509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPNS2 |
0.0808080183609512 |
|
| 6510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBBP1A |
0.0808080183609512 |
|
| 6511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT6 |
0.0808080183609512 |
|
| 6512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMTNL2 |
0.0808080183609512 |
|
| 6513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX15 |
0.0808080183609512 |
|
| 6514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PELP1 |
0.0808080183609512 |
|
| 6515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRB2 |
0.0808080183609512 |
|
| 6516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED11 |
0.0808080183609512 |
|
| 6517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL16 |
0.0808080183609512 |
|
| 6518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND15 |
0.0808080183609512 |
|
| 6519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTPD2 |
0.0808080183609512 |
|
| 6520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF5 |
0.0808080183609512 |
|
| 6521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VMO1 |
0.0808080183609512 |
|
| 6522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD2 |
0.0808080183609512 |
|
| 6523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB6 |
0.0808080183609512 |
|
| 6524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MINK1 |
0.0808080183609512 |
|
| 6525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL171P |
0.0808080183609512 |
|
| 6526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL784P |
0.0808080183609512 |
|
| 6527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNE |
0.0808080183609512 |
|
| 6528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf107 |
0.0808080183609512 |
|
| 6529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP1BA |
0.0808080183609512 |
|
| 6530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A11 |
0.0808080183609512 |
|
| 6531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF167 |
0.0808080183609512 |
|
| 6532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENO3 |
0.0808080183609512 |
|
| 6533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFN1 |
0.0808080183609512 |
|
| 6534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG7 |
0.0808080183609512 |
|
| 6535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMTA2 |
0.0808080183609512 |
|
| 6536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INCA1 |
0.0808080183609512 |
|
| 6537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF1C |
0.0808080183609512 |
|
| 6538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC52A1 |
0.0808080183609512 |
|
| 6539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP3 |
0.0808080183609512 |
|
| 6540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP6 |
0.0808080183609512 |
|
| 6541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF232 |
0.0808080183609512 |
|
| 6542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF594 |
0.0808080183609512 |
|
| 6543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCIMP |
0.0808080183609512 |
|
| 6544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABEP1 |
0.0808080183609512 |
|
| 6545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP88 |
0.0808080183609512 |
|
| 6546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPAIN |
0.0808080183609512 |
|
| 6547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QBP |
0.0808080183609512 |
|
| 6548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX33 |
0.0808080183609512 |
|
| 6549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCC3 |
0.0834479716402939 |
|
| 6550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR720 |
0.0884710032864152 |
|
| 6551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCHE |
0.0884710032864152 |
|
| 6552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP298 |
0.0884710032864152 |
|
| 6553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBBX |
0.0884710032864152 |
|
| 6554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINI2 |
0.0884710032864152 |
|
| 6555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR49 |
0.0884710032864152 |
|
| 6556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD10 |
0.0884710032864152 |
|
| 6557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINI1 |
0.0884710032864152 |
|
| 6558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLIM4 |
0.0884710032864152 |
|
| 6559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFEM1P |
0.0884710032864152 |
|
| 6560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR551B |
0.0884710032864152 |
|
| 6561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MECOM |
0.0884710032864152 |
|
| 6562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTRT3 |
0.0884710032864152 |
|
| 6563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TERC |
0.0884710032864152 |
|
| 6564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYNN |
0.0884710032864152 |
|
| 6565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC34 |
0.0884710032864152 |
|
| 6566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRIQ4 |
0.0884710032864152 |
|
| 6567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC31 |
0.0884710032864152 |
|
| 6568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD7 |
0.0884710032864152 |
|
| 6569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC62 |
0.0884710032864152 |
|
| 6570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR160 |
0.0884710032864152 |
|
| 6571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHC3 |
0.0884710032864152 |
|
| 6572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCI |
0.0884710032864152 |
|
| 6573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKIL |
0.0884710032864152 |
|
| 6574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN11 |
0.0884710032864152 |
|
| 6575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A14 |
0.0884710032864152 |
|
| 6576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5P3 |
0.0884710032864152 |
|
| 6577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL22L1 |
0.0884710032864152 |
|
| 6578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF5A2 |
0.0884710032864152 |
|
| 6579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A2 |
0.0884710032864152 |
|
| 6580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNIK |
0.0884710032864152 |
|
| 6581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR569 |
0.0884710032864152 |
|
| 6582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD1 |
0.0884710032864152 |
|
| 6583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PP13439 |
0.0884710032864152 |
|
| 6584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM212 |
0.0884710032864152 |
|
| 6585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238359.1 |
0.0884710032864152 |
|
| 6586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC3B |
0.0884710032864152 |
|
| 6587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL141P |
0.0884710032864152 |
|
| 6588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHSR |
0.0884710032864152 |
|
| 6589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF10 |
0.0884710032864152 |
|
| 6590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCEH1 |
0.0884710032864152 |
|
| 6591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECT2 |
0.0884710032864152 |
|
| 6592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000200355.1 |
0.0884710032864152 |
|
| 6593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA16 |
0.0884710032864152 |
|
| 6594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239141.1 |
0.0884710032864152 |
|
| 6595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA11 |
0.0902133692775023 |
|
| 6596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACE1 |
0.0903460470178499 |
|
| 6597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXO3 |
0.0903460470178499 |
|
| 6598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00222 |
0.0903460470178499 |
|
| 6599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF259P1 |
0.0903460470178499 |
|
| 6600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC2 |
0.0903460470178499 |
|
| 6601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SESN1 |
0.0903460470178499 |
|
| 6602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP57L1 |
0.0903460470178499 |
|
| 6603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf183 |
0.0903460470178499 |
|
| 6604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC162P |
0.0903460470178499 |
|
| 6605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238474.1 |
0.0903460470178499 |
|
| 6606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD164 |
0.0903460470178499 |
|
| 6607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIL6 |
0.0903460470178499 |
|
| 6608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPD2 |
0.0903460470178499 |
|
| 6609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICAL1 |
0.0903460470178499 |
|
| 6610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB24 |
0.0903460470178499 |
|
| 6611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK9 |
0.0903460470178499 |
|
| 6612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIG4 |
0.0903460470178499 |
|
| 6613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR6 |
0.0903460470178499 |
|
| 6614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASF1 |
0.0903460470178499 |
|
| 6615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC40 |
0.0903460470178499 |
|
| 6616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL24 |
0.0903460470178499 |
|
| 6617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDO |
0.0903460470178499 |
|
| 6618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A16 |
0.0903460470178499 |
|
| 6619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL617P |
0.0903460470178499 |
|
| 6620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK19 |
0.0903460470178499 |
|
| 6621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212587.1 |
0.0903460470178499 |
|
| 6622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMD1 |
0.0903460470178499 |
|
| 6623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C6 |
0.0903460470178499 |
|
| 6624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238775.1 |
0.0903460470178499 |
|
| 6625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPF2 |
0.0903460470178499 |
|
| 6626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A10 |
0.0903460470178499 |
|
| 6627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1919 |
0.0903460470178499 |
|
| 6628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REV3L |
0.0903460470178499 |
|
| 6629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF3IP2 |
0.0903460470178499 |
|
| 6630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf3 |
0.0903460470178499 |
|
| 6631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239015.1 |
0.0903460470178499 |
|
| 6632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FYN |
0.0903460470178499 |
|
| 6633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WISP3 |
0.0903460470178499 |
|
| 6634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBE1 |
0.0903460470178499 |
|
| 6635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM229B |
0.0903460470178499 |
|
| 6636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMA4 |
0.0903460470178499 |
|
| 6637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFPL4B |
0.0903460470178499 |
|
| 6638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239095.1 |
0.0903460470178499 |
|
| 6639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000253091.1 |
0.0903460470178499 |
|
| 6640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238563.1 |
0.0903460470178499 |
|
| 6641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCKS |
0.0903460470178499 |
|
| 6642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC2 |
0.0903460470178499 |
|
| 6643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST5 |
0.0903460470178499 |
|
| 6644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP213 |
0.0903460470178499 |
|
| 6645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRK |
0.0903460470178499 |
|
| 6646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5DC1 |
0.0903460470178499 |
|
| 6647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL10A1 |
0.0903460470178499 |
|
| 6648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPYL4 |
0.0903460470178499 |
|
| 6649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSE |
0.0903460470178499 |
|
| 6650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPYL1 |
0.0903460470178499 |
|
| 6651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM26F |
0.0903460470178499 |
|
| 6652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC3L |
0.0903460470178499 |
|
| 6653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM26E |
0.0903460470178499 |
|
| 6654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM26D |
0.0903460470178499 |
|
| 6655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RWDD1 |
0.0903460470178499 |
|
| 6656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH4A |
0.0903460470178499 |
|
| 6657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZUFSP |
0.0903460470178499 |
|
| 6658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA5 |
0.0903460470178499 |
|
| 6659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM162B |
0.0903460470178499 |
|
| 6660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRC6A |
0.0903460470178499 |
|
| 6661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX6 |
0.0903460470178499 |
|
| 6662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP214 |
0.0903460470178499 |
|
| 6663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VGLL2 |
0.0903460470178499 |
|
| 6664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROS1 |
0.0903460470178499 |
|
| 6665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP18 |
0.0903460470178499 |
|
| 6666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP51 |
0.0903460470178499 |
|
| 6667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOPC |
0.0903460470178499 |
|
| 6668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCBLD1 |
0.0903460470178499 |
|
| 6669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUS1 |
0.0903460470178499 |
|
| 6670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F1 |
0.0903460470178499 |
|
| 6671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP85L |
0.0903460470178499 |
|
| 6672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM9 |
0.0903460470178499 |
|
| 6673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLN |
0.0903460470178499 |
|
| 6674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP231 |
0.0910753091860901 |
|
| 6675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL371P |
0.0910753091860901 |
|
| 6676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AUTS2 |
0.0910753091860901 |
|
| 6677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBSCR17 |
0.0910753091860901 |
|
| 6678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP75 |
0.0910753091860901 |
|
| 6679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALN1 |
0.0910753091860901 |
|
| 6680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP232 |
0.0910753091860901 |
|
| 6681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL377P |
0.0910753091860901 |
|
| 6682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL625P |
0.0910753091860901 |
|
| 6683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYW1B |
0.0910753091860901 |
|
| 6684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2IRD1 |
0.0910753091860901 |
|
| 6685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP233 |
0.0910753091860901 |
|
| 6686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2I |
0.0910753091860901 |
|
| 6687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3L2 |
0.0910753091860901 |
|
| 6688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2IRD2 |
0.0910753091860901 |
|
| 6689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCF1 |
0.0910753091860901 |
|
| 6690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD121B |
0.0957472728363904 |
|
| 6691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD121A |
0.0957472728363904 |
|
| 6692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP114 |
0.0957472728363904 |
|
| 6693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF12 |
0.0957472728363904 |
|
| 6694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAP1 |
0.0957472728363904 |
|
| 6695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP282 |
0.0957472728363904 |
|
| 6696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF24 |
0.0957472728363904 |
|
| 6697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT2 |
0.0957472728363904 |
|
| 6698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1161 |
0.0957472728363904 |
|
| 6699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf24 |
0.0957472728363904 |
|
| 6700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM219A |
0.0957472728363904 |
|
| 6701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAI1 |
0.0957472728363904 |
|
| 6702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP24 |
0.0957472728363904 |
|
| 6703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECRL |
0.10264618238914 |
|
| 6704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA5 |
0.10264618238914 |
|
| 6705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1269A |
0.10264618238914 |
|
| 6706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPC |
0.10264618238914 |
|
| 6707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAP1 |
0.10264618238914 |
|
| 6708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA6 |
0.10264618238914 |
|
| 6709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNRHR |
0.10264618238914 |
|
| 6710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000202374.1 |
0.10264618238914 |
|
| 6711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11D |
0.10264618238914 |
|
| 6712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11A |
0.10264618238914 |
|
| 6713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11F |
0.10264618238914 |
|
| 6714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11GP |
0.10264618238914 |
|
| 6715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTLP10 |
0.10264618238914 |
|
| 6716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11BNL |
0.10264618238914 |
|
| 6717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11B |
0.10264618238914 |
|
| 6718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YTHDC1 |
0.10264618238914 |
|
| 6719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS11E |
0.10264618238914 |
|
| 6720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2A3 |
0.10264618238914 |
|
| 6721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B10 |
0.10264618238914 |
|
| 6722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B11 |
0.10264618238914 |
|
| 6723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B15 |
0.10264618238914 |
|
| 6724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B17 |
0.10264618238914 |
|
| 6725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B28 |
0.10264618238914 |
|
| 6726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B7 |
0.10264618238914 |
|
| 6727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2B4 |
0.10264618238914 |
|
| 6728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2A1 |
0.10264618238914 |
|
| 6729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT2A2 |
0.10264618238914 |
|
| 6730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1B1 |
0.10264618238914 |
|
| 6731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1E1 |
0.10264618238914 |
|
| 6732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSN1S1 |
0.10264618238914 |
|
| 6733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSN2 |
0.10264618238914 |
|
| 6734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STATH |
0.10264618238914 |
|
| 6735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTN3 |
0.10264618238914 |
|
| 6736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTN1 |
0.10264618238914 |
|
| 6737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSN1S2AP |
0.10264618238914 |
|
| 6738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf40 |
0.10264618238914 |
|
| 6739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODAM |
0.10264618238914 |
|
| 6740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDCSP |
0.10264618238914 |
|
| 6741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSN3 |
0.10264618238914 |
|
| 6742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABS1 |
0.10264618238914 |
|
| 6743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMR3A |
0.10264618238914 |
|
| 6744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMR3B |
0.10264618238914 |
|
| 6745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROL1 |
0.10264618238914 |
|
| 6746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC7 |
0.10264618238914 |
|
| 6747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMTN |
0.10264618238914 |
|
| 6748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMBN |
0.10264618238914 |
|
| 6749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENAM |
0.10264618238914 |
|
| 6750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGJ |
0.10264618238914 |
|
| 6751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP3 |
0.10264618238914 |
|
| 6752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUFY3 |
0.10264618238914 |
|
| 6753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238318.1 |
0.10264618238914 |
|
| 6754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRSF1 |
0.10264618238914 |
|
| 6755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB1B |
0.10264618238914 |
|
| 6756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCK |
0.10264618238914 |
|
| 6757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A4 |
0.10264618238914 |
|
| 6758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GC |
0.10264618238914 |
|
| 6759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP163 |
0.10264618238914 |
|
| 6760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPFFR2 |
0.10264618238914 |
|
| 6761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS3 |
0.10264618238914 |
|
| 6762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC9P |
0.10264618238914 |
|
| 6763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC5P |
0.10264618238914 |
|
| 6764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX18 |
0.10264618238914 |
|
| 6765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD17 |
0.10264618238914 |
|
| 6766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000221639.1 |
0.10264618238914 |
|
| 6767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALB |
0.10264618238914 |
|
| 6768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFP |
0.10264618238914 |
|
| 6769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFM |
0.10264618238914 |
|
| 6770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF6 |
0.10264618238914 |
|
| 6771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL8 |
0.10264618238914 |
|
| 6772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL6 |
0.10264618238914 |
|
| 6773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PF4V1 |
0.10264618238914 |
|
| 6774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL1 |
0.10264618238914 |
|
| 6775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PF4 |
0.10264618238914 |
|
| 6776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPBP |
0.10264618238914 |
|
| 6777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL5 |
0.10264618238914 |
|
| 6778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL218P |
0.10264618238914 |
|
| 6779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL3 |
0.10264618238914 |
|
| 6780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPBPP2 |
0.10264618238914 |
|
| 6781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL2 |
0.10264618238914 |
|
| 6782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFD2L |
0.10264618238914 |
|
| 6783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPGN |
0.10264618238914 |
|
| 6784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EREG |
0.10264618238914 |
|
| 6785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AREG |
0.10264618238914 |
|
| 6786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AREGB |
0.10264618238914 |
|
| 6787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTC |
0.10264618238914 |
|
| 6788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARM1 |
0.10264618238914 |
|
| 6789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCHY1 |
0.10264618238914 |
|
| 6790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP6 |
0.10264618238914 |
|
| 6791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf26 |
0.10264618238914 |
|
| 6792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKL2 |
0.10264618238914 |
|
| 6793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G3BP2 |
0.10264618238914 |
|
| 6794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USO1 |
0.10264618238914 |
|
| 6795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPEF2 |
0.10264618238914 |
|
| 6796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAAA |
0.10264618238914 |
|
| 6797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDAD1 |
0.10264618238914 |
|
| 6798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL9 |
0.10264618238914 |
|
| 6799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ART3 |
0.10264618238914 |
|
| 6800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL10 |
0.10264618238914 |
|
| 6801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL11 |
0.10264618238914 |
|
| 6802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP54 |
0.10264618238914 |
|
| 6803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARB2 |
0.10264618238914 |
|
| 6804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM47E |
0.10264618238914 |
|
| 6805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC158 |
0.10264618238914 |
|
| 6806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD50|ENSG00000199857.1 |
0.10264618238914 |
|
| 6807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHROOM3 |
0.10264618238914 |
|
| 6808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4450 |
0.10264618238914 |
|
| 6809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AH |
0.10264618238914 |
|
| 6810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOWAHB |
0.10264618238914 |
|
| 6811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT11 |
0.10264618238914 |
|
| 6812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNI |
0.10264618238914 |
|
| 6813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNG2 |
0.10264618238914 |
|
| 6814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL13 |
0.10264618238914 |
|
| 6815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD75|ENSG00000221711.1 |
0.10264618238914 |
|
| 6816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT6L |
0.10264618238914 |
|
| 6817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL1 |
0.10264618238914 |
|
| 6818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRAS1 |
0.10264618238914 |
|
| 6819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA3 |
0.10264618238914 |
|
| 6820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238816.1 |
0.10264618238914 |
|
| 6821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP2K |
0.10264618238914 |
|
| 6822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5096 |
0.10264618238914 |
|
| 6823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR3 |
0.10264618238914 |
|
| 6824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL127P |
0.10264618238914 |
|
| 6825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GK2 |
0.10264618238914 |
|
| 6826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00989 |
0.10264618238914 |
|
| 6827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7E94P |
0.10264618238914 |
|
| 6828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCAT4 |
0.10264618238914 |
|
| 6829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212620.1 |
0.10264618238914 |
|
| 6830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANTXR2 |
0.10264618238914 |
|
| 6831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM8 |
0.10264618238914 |
|
| 6832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF5 |
0.10264618238914 |
|
| 6833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf22 |
0.10264618238914 |
|
| 6834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP3 |
0.10264618238914 |
|
| 6835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKG2 |
0.10264618238914 |
|
| 6836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGEF1B |
0.10264618238914 |
|
| 6837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252762.1 |
0.10264618238914 |
|
| 6838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPD |
0.10264618238914 |
|
| 6839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD42|ENSG00000202440.1 |
0.10264618238914 |
|
| 6840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPDL |
0.10264618238914 |
|
| 6841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENOPH1 |
0.10264618238914 |
|
| 6842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR575 |
0.10264618238914 |
|
| 6843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC31A |
0.10264618238914 |
|
| 6844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP9 |
0.10264618238914 |
|
| 6845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN54 |
0.10264618238914 |
|
| 6846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoR442|ENSG00000252834.1 |
0.10264618238914 |
|
| 6847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS4 |
0.10264618238914 |
|
| 6848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAC8 |
0.10264618238914 |
|
| 6849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ2 |
0.10264618238914 |
|
| 6850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPSE |
0.10264618238914 |
|
| 6851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELQ |
0.10264618238914 |
|
| 6852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS18C |
0.10264618238914 |
|
| 6853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM175A |
0.10264618238914 |
|
| 6854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT9 |
0.10264618238914 |
|
| 6855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDS1 |
0.10264618238914 |
|
| 6856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDFY3 |
0.10264618238914 |
|
| 6857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL552P |
0.10264618238914 |
|
| 6858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP48 |
0.10264618238914 |
|
| 6859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP24 |
0.10264618238914 |
|
| 6860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4451 |
0.10264618238914 |
|
| 6861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK10 |
0.10264618238914 |
|
| 6862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP96 |
0.10264618238914 |
|
| 6863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4452 |
0.10264618238914 |
|
| 6864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN13 |
0.10264618238914 |
|
| 6865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A6 |
0.10264618238914 |
|
| 6866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf36 |
0.10264618238914 |
|
| 6867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFF1 |
0.10264618238914 |
|
| 6868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL8 |
0.10264618238914 |
|
| 6869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5705 |
0.10264618238914 |
|
| 6870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B13 |
0.10264618238914 |
|
| 6871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B11 |
0.10264618238914 |
|
| 6872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL681P |
0.10264618238914 |
|
| 6873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT9 |
0.10264618238914 |
|
| 6874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPARCL1 |
0.10264618238914 |
|
| 6875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSPP |
0.10264618238914 |
|
| 6876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMP1 |
0.10264618238914 |
|
| 6877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238652.1 |
0.10264618238914 |
|
| 6878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IBSP |
0.10264618238914 |
|
| 6879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEPE |
0.10264618238914 |
|
| 6880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPP1 |
0.10264618238914 |
|
| 6881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD2 |
0.10264618238914 |
|
| 6882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCG2 |
0.10264618238914 |
|
| 6883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC31P |
0.10264618238914 |
|
| 6884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1K |
0.10264618238914 |
|
| 6885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC6 |
0.10264618238914 |
|
| 6886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC5 |
0.10264618238914 |
|
| 6887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC3 |
0.10264618238914 |
|
| 6888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGY |
0.10264618238914 |
|
| 6889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYURF |
0.10264618238914 |
|
| 6890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP244 |
0.10264618238914 |
|
| 6891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L5 |
0.10264618238914 |
|
| 6892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM13A |
0.10264618238914 |
|
| 6893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD2 |
0.10264618238914 |
|
| 6894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRIN3 |
0.10264618238914 |
|
| 6895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNCA |
0.10264618238914 |
|
| 6896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMRN1 |
0.10264618238914 |
|
| 6897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCSER1 |
0.10264618238914 |
|
| 6898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP248 |
0.10264618238914 |
|
| 6899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRID2 |
0.10264618238914 |
|
| 6900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP164 |
0.10264618238914 |
|
| 6901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATOH1 |
0.10264618238914 |
|
| 6902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCAD1 |
0.10264618238914 |
|
| 6903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPGDS |
0.10264618238914 |
|
| 6904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM5 |
0.10264618238914 |
|
| 6905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMPR1B |
0.10264618238914 |
|
| 6906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC5C |
0.10264618238914 |
|
| 6907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDHA2 |
0.10264618238914 |
|
| 6908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP28 |
0.10264618238914 |
|
| 6909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STPG2 |
0.10264618238914 |
|
| 6910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP1GDS1 |
0.10264618238914 |
|
| 6911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN5 |
0.10264618238914 |
|
| 6912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4E |
0.10264618238914 |
|
| 6913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METAP1 |
0.10264618238914 |
|
| 6914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3684 |
0.10264618238914 |
|
| 6915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH5 |
0.10264618238914 |
|
| 6916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH4 |
0.10264618238914 |
|
| 6917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNAP1 |
0.10264618238914 |
|
| 6918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH6 |
0.10264618238914 |
|
| 6919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH1A |
0.10264618238914 |
|
| 6920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH1B |
0.10264618238914 |
|
| 6921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH1C |
0.10264618238914 |
|
| 6922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADH7 |
0.10264618238914 |
|
| 6923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf17 |
0.10264618238914 |
|
| 6924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT10A |
0.10264618238914 |
|
| 6925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTTP |
0.10264618238914 |
|
| 6926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAPP1 |
0.10264618238914 |
|
| 6927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMTOR3 |
0.10264618238914 |
|
| 6928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB14 |
0.10264618238914 |
|
| 6929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFZ |
0.10264618238914 |
|
| 6930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDIT4L |
0.10264618238914 |
|
| 6931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMCN |
0.10264618238914 |
|
| 6932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP3CA |
0.10264618238914 |
|
| 6933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1255A |
0.10264618238914 |
|
| 6934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BANK1 |
0.10264618238914 |
|
| 6935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A8 |
0.10264618238914 |
|
| 6936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL728P |
0.10264618238914 |
|
| 6937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKB1 |
0.10264618238914 |
|
| 6938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANBA |
0.10264618238914 |
|
| 6939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2D3 |
0.10264618238914 |
|
| 6940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CISD2 |
0.10264618238914 |
|
| 6941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238948.1 |
0.10264618238914 |
|
| 6942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9B1 |
0.10264618238914 |
|
| 6943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9B2 |
0.10264618238914 |
|
| 6944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDH2 |
0.10264618238914 |
|
| 6945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPE |
0.10264618238914 |
|
| 6946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACR3 |
0.10264618238914 |
|
| 6947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXXC4 |
0.10264618238914 |
|
| 6948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252136.1 |
0.10264618238914 |
|
| 6949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TET2 |
0.10264618238914 |
|
| 6950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL89P |
0.10264618238914 |
|
| 6951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPA2 |
0.10264618238914 |
|
| 6952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF38 |
0.10264618238914 |
|
| 6953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS12 |
0.10264618238914 |
|
| 6954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTCD |
0.10264618238914 |
|
| 6955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPNT |
0.10264618238914 |
|
| 6956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCK |
0.10264618238914 |
|
| 6957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIMP1 |
0.10264618238914 |
|
| 6958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMD1 |
0.10264618238914 |
|
| 6959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX26 |
0.103247250893921 |
|
| 6960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA8 |
0.103247250893921 |
|
| 6961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIFM3 |
0.103247250893921 |
|
| 6962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARVCF |
0.103247250893921 |
|
| 6963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCRP2 |
0.103247250893921 |
|
| 6964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf29 |
0.103247250893921 |
|
| 6965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf39 |
0.103247250893921 |
|
| 6966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC116 |
0.103247250893921 |
|
| 6967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC45 |
0.103247250893921 |
|
| 6968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN5 |
0.103247250893921 |
|
| 6969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLTCL1 |
0.103247250893921 |
|
| 6970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMT |
0.103247250893921 |
|
| 6971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRKL |
0.103247250893921 |
|
| 6972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR14 |
0.103247250893921 |
|
| 6973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR2 |
0.103247250893921 |
|
| 6974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR5 |
0.103247250893921 |
|
| 6975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR6L |
0.103247250893921 |
|
| 6976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR6 |
0.103247250893921 |
|
| 6977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGCR8 |
0.103247250893921 |
|
| 6978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM230A |
0.103247250893921 |
|
| 6979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM230B |
0.103247250893921 |
|
| 6980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM230C |
0.103247250893921 |
|
| 6981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT2 |
0.103247250893921 |
|
| 6982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT3P |
0.103247250893921 |
|
| 6983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGTLC3 |
0.103247250893921 |
|
| 6984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB1L |
0.103247250893921 |
|
| 6985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP1BB |
0.103247250893921 |
|
| 6986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSC2 |
0.103247250893921 |
|
| 6987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIC2 |
0.103247250893921 |
|
| 6988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIRA |
0.103247250893921 |
|
| 6989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL22 |
0.103247250893921 |
|
| 6990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZTR1 |
0.103247250893921 |
|
| 6991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED15 |
0.103247250893921 |
|
| 6992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1286 |
0.103247250893921 |
|
| 6993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1306 |
0.103247250893921 |
|
| 6994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR130B |
0.103247250893921 |
|
| 6995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR185 |
0.103247250893921 |
|
| 6996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR301B |
0.103247250893921 |
|
| 6997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3618 |
0.103247250893921 |
|
| 6998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4761 |
0.103247250893921 |
|
| 6999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR649 |
0.103247250893921 |
|
| 7000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL40 |
0.103247250893921 |
|
| 7001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX6P |
0.103247250893921 |
|
| 7002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX6 |
0.103247250893921 |
|
| 7003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4KAP1 |
0.103247250893921 |
|
| 7004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4KAP2 |
0.103247250893921 |
|
| 7005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4KA |
0.103247250893921 |
|
| 7006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L4P |
0.103247250893921 |
|
| 7007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L7 |
0.103247250893921 |
|
| 7008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIL2 |
0.103247250893921 |
|
| 7009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRODH |
0.103247250893921 |
|
| 7010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP1 |
0.103247250893921 |
|
| 7011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMBP3B |
0.103247250893921 |
|
| 7012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMBP3C |
0.103247250893921 |
|
| 7013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMBP3 |
0.103247250893921 |
|
| 7014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP131 |
0.103247250893921 |
|
| 7015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP221 |
0.103247250893921 |
|
| 7016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP63 |
0.103247250893921 |
|
| 7017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL168P |
0.103247250893921 |
|
| 7018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL280P |
0.103247250893921 |
|
| 7019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL389P |
0.103247250893921 |
|
| 7020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL812P |
0.103247250893921 |
|
| 7021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN4R |
0.103247250893921 |
|
| 7022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARF2 |
0.103247250893921 |
|
| 7023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000252020.1 |
0.103247250893921 |
|
| 7024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000252143.1 |
0.103247250893921 |
|
| 7025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000252571.1 |
0.103247250893921 |
|
| 7026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000252024.1 |
0.103247250893921 |
|
| 7027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000252314.1 |
0.103247250893921 |
|
| 7028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000252605.1 |
0.103247250893921 |
|
| 7029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDF2L1 |
0.103247250893921 |
|
| 7030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT5 |
0.103247250893921 |
|
| 7031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPIND1 |
0.103247250893921 |
|
| 7032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A1 |
0.103247250893921 |
|
| 7033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A4 |
0.103247250893921 |
|
| 7034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPD4P1 |
0.103247250893921 |
|
| 7035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAP29 |
0.103247250893921 |
|
| 7036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA15|ENSG00000251940.1 |
0.103247250893921 |
|
| 7037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA77|ENSG00000264346.1 |
0.103247250893921 |
|
| 7038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TANGO2 |
0.103247250893921 |
|
| 7039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX1 |
0.103247250893921 |
|
| 7040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP7 |
0.103247250893921 |
|
| 7041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM191A |
0.103247250893921 |
|
| 7042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM191C |
0.103247250893921 |
|
| 7043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT2A |
0.103247250893921 |
|
| 7044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSK2 |
0.103247250893921 |
|
| 7045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA3FP |
0.103247250893921 |
|
| 7046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNRD2 |
0.103247250893921 |
|
| 7047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2L3 |
0.103247250893921 |
|
| 7048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFD1L |
0.103247250893921 |
|
| 7049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP18 |
0.103247250893921 |
|
| 7050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP41 |
0.103247250893921 |
|
| 7051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YDJC |
0.103247250893921 |
|
| 7052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YPEL1 |
0.103247250893921 |
|
| 7053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC8 |
0.103247250893921 |
|
| 7054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF74 |
0.103247250893921 |
|
| 7055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252402.1 |
0.103247250893921 |
|
| 7056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252799.1 |
0.103247250893921 |
|
| 7057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000271796.1 |
0.103247250893921 |
|
| 7058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK1 |
0.103247250893921 |
|
| 7059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP493 |
0.103247250893921 |
|
| 7060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1F |
0.103247250893921 |
|
| 7061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCR |
0.103247250893921 |
|
| 7062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES5AP1 |
0.103247250893921 |
|
| 7063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGTLC2 |
0.103247250893921 |
|
| 7064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAZ |
0.103247250893921 |
|
| 7065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLC1 |
0.103247250893921 |
|
| 7066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLC2 |
0.103247250893921 |
|
| 7067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLC3 |
0.103247250893921 |
|
| 7068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLC7 |
0.103247250893921 |
|
| 7069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ1 |
0.103247250893921 |
|
| 7070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ2 |
0.103247250893921 |
|
| 7071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ3 |
0.103247250893921 |
|
| 7072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ4 |
0.103247250893921 |
|
| 7073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ5 |
0.103247250893921 |
|
| 7074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ6 |
0.103247250893921 |
|
| 7075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLJ7 |
0.103247250893921 |
|
| 7076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLL5 |
0.103247250893921 |
|
| 7077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR650 |
0.103247250893921 |
|
| 7078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L1P |
0.103247250893921 |
|
| 7079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF24P |
0.103247250893921 |
|
| 7080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAME |
0.103247250893921 |
|
| 7081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB36 |
0.103247250893921 |
|
| 7082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL263P |
0.103247250893921 |
|
| 7083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTDR1 |
0.103247250893921 |
|
| 7084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP3B |
0.103247250893921 |
|
| 7085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPREB1 |
0.103247250893921 |
|
| 7086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC8P1 |
0.103247250893921 |
|
| 7087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF280A |
0.103247250893921 |
|
| 7088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF280B |
0.103247250893921 |
|
| 7089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239066.1 |
0.103247250893921 |
|
| 7090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf43 |
0.103247250893921 |
|
| 7091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSBP11 |
0.103247250893921 |
|
| 7092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGLL1 |
0.103247250893921 |
|
| 7093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGL4 |
0.103247250893921 |
|
| 7094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPREB3 |
0.103247250893921 |
|
| 7095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF70 |
0.103247250893921 |
|
| 7096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf15 |
0.103247250893921 |
|
| 7097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD10 |
0.103247250893921 |
|
| 7098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP11 |
0.103247250893921 |
|
| 7099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCB1 |
0.103247250893921 |
|
| 7100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DERL3 |
0.103247250893921 |
|
| 7101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A11 |
0.103247250893921 |
|
| 7102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL268P |
0.103247250893921 |
|
| 7103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIF |
0.103247250893921 |
|
| 7104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABIN1 |
0.103247250893921 |
|
| 7105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDTL |
0.103247250893921 |
|
| 7106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDT |
0.103247250893921 |
|
| 7107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTT1 |
0.103247250893921 |
|
| 7108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTT2B |
0.103247250893921 |
|
| 7109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTT2 |
0.103247250893921 |
|
| 7110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTTP2 |
0.103247250893921 |
|
| 7111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUSD2 |
0.103247250893921 |
|
| 7112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT5 |
0.103247250893921 |
|
| 7113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L9P |
0.103247250893921 |
|
| 7114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPECC1L |
0.103247250893921 |
|
| 7115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADORA2A |
0.103247250893921 |
|
| 7116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPB1 |
0.103247250893921 |
|
| 7117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCD1 |
0.103247250893921 |
|
| 7118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPD3 |
0.103247250893921 |
|
| 7119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM211B |
0.103247250893921 |
|
| 7120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGT1 |
0.103247250893921 |
|
| 7121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIWIL3 |
0.103247250893921 |
|
| 7122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGSM1 |
0.103247250893921 |
|
| 7123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000199783.1 |
0.103247250893921 |
|
| 7124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM211 |
0.103247250893921 |
|
| 7125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1671 |
0.103247250893921 |
|
| 7126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBB3 |
0.103247250893921 |
|
| 7127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBB2 |
0.103247250893921 |
|
| 7128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRBK2 |
0.103247250893921 |
|
| 7129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBB2P1 |
0.103247250893921 |
|
| 7130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP5L |
0.103247250893921 |
|
| 7131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP494 |
0.103247250893921 |
|
| 7132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO18B |
0.103247250893921 |
|
| 7133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP169 |
0.103247250893921 |
|
| 7134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEZ6L |
0.103247250893921 |
|
| 7135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL757P |
0.103247250893921 |
|
| 7136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD42|ENSG00000201209.1 |
0.103247250893921 |
|
| 7137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF493 |
0.104439621652883 |
|
| 7138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00664 |
0.104439621652883 |
|
| 7139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF429 |
0.104439621652883 |
|
| 7140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF100 |
0.104439621652883 |
|
| 7141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF43 |
0.104439621652883 |
|
| 7142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF208 |
0.104439621652883 |
|
| 7143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF257 |
0.104439621652883 |
|
| 7144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF676 |
0.104439621652883 |
|
| 7145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF729 |
0.104439621652883 |
|
| 7146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF98 |
0.104439621652883 |
|
| 7147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL860P |
0.104439621652883 |
|
| 7148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF492 |
0.104439621652883 |
|
| 7149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF99 |
0.104439621652883 |
|
| 7150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF728 |
0.104439621652883 |
|
| 7151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF730 |
0.104439621652883 |
|
| 7152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF724P |
0.104439621652883 |
|
| 7153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF91 |
0.104439621652883 |
|
| 7154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf105 |
0.104705769279913 |
|
| 7155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F4 |
0.104705769279913 |
|
| 7156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP99 |
0.104705769279913 |
|
| 7157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf37 |
0.104705769279913 |
|
| 7158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL598P |
0.104705769279913 |
|
| 7159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR10 |
0.104705769279913 |
|
| 7160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA3 |
0.104705769279913 |
|
| 7161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID4A |
0.104705769279913 |
|
| 7162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM20L |
0.104705769279913 |
|
| 7163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM9 |
0.104705769279913 |
|
| 7164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0586 |
0.104705769279913 |
|
| 7165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DACT1 |
0.104705769279913 |
|
| 7166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAAM1 |
0.104705769279913 |
|
| 7167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JKAMP |
0.104705769279913 |
|
| 7168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC175 |
0.104705769279913 |
|
| 7169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN1 |
0.104705769279913 |
|
| 7170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5586 |
0.104705769279913 |
|
| 7171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC9 |
0.104705769279913 |
|
| 7172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNXL4 |
0.104705769279913 |
|
| 7173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS7 |
0.104705769279913 |
|
| 7174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1A |
0.104705769279913 |
|
| 7175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf39 |
0.104705769279913 |
|
| 7176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX6 |
0.104705769279913 |
|
| 7177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000253014.1 |
0.104705769279913 |
|
| 7178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX1 |
0.104705769279913 |
|
| 7179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX4 |
0.104705769279913 |
|
| 7180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNAT1 |
0.104705769279913 |
|
| 7181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT5 |
0.104705769279913 |
|
| 7182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A6 |
0.104705769279913 |
|
| 7183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCH |
0.104705769279913 |
|
| 7184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252380.1 |
0.104705769279913 |
|
| 7185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM30B |
0.104705769279913 |
|
| 7186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIF1A |
0.104705769279913 |
|
| 7187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPC1 |
0.104705769279913 |
|
| 7188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT16 |
0.104705769279913 |
|
| 7189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00643 |
0.104705769279913 |
|
| 7190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00644 |
0.104705769279913 |
|
| 7191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH5 |
0.104705769279913 |
|
| 7192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4423 |
0.106070626078535 |
|
| 7193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYDE2 |
0.106070626078535 |
|
| 7194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf52 |
0.106070626078535 |
|
| 7195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL10 |
0.106070626078535 |
|
| 7196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDAH1 |
0.106070626078535 |
|
| 7197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYR61 |
0.106070626078535 |
|
| 7198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD81|ENSG00000199934.1 |
0.106070626078535 |
|
| 7199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNHIT6 |
0.106070626078535 |
|
| 7200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL24A1 |
0.106070626078535 |
|
| 7201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP51 |
0.106070626078535 |
|
| 7202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF2L |
0.106070626078535 |
|
| 7203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCA2 |
0.106070626078535 |
|
| 7204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCA1 |
0.106070626078535 |
|
| 7205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCA4 |
0.106070626078535 |
|
| 7206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCA3P |
0.106070626078535 |
|
| 7207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GLB1 |
0.106070626078535 |
|
| 7208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS2ST1 |
0.106070626078535 |
|
| 7209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMO4 |
0.106070626078535 |
|
| 7210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP52 |
0.106070626078535 |
|
| 7211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL583P |
0.106070626078535 |
|
| 7212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKN2 |
0.106070626078535 |
|
| 7213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2B |
0.106070626078535 |
|
| 7214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCBL2 |
0.106070626078535 |
|
| 7215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMXL1 |
0.106070626078535 |
|
| 7216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP3 |
0.106070626078535 |
|
| 7217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP1 |
0.106070626078535 |
|
| 7218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP2 |
0.106070626078535 |
|
| 7219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP7 |
0.106070626078535 |
|
| 7220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP4 |
0.106070626078535 |
|
| 7221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP5 |
0.106070626078535 |
|
| 7222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP6 |
0.106070626078535 |
|
| 7223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBP1P1 |
0.106070626078535 |
|
| 7224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC8B |
0.106070626078535 |
|
| 7225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC8C |
0.106070626078535 |
|
| 7226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239176.1 |
0.106070626078535 |
|
| 7227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC8D |
0.106070626078535 |
|
| 7228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP272 |
0.106070626078535 |
|
| 7229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF326 |
0.106070626078535 |
|
| 7230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199666.1 |
0.106070626078535 |
|
| 7231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BARHL2 |
0.106070626078535 |
|
| 7232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF644 |
0.106070626078535 |
|
| 7233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HFM1 |
0.106070626078535 |
|
| 7234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC7 |
0.106070626078535 |
|
| 7235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBR3 |
0.106070626078535 |
|
| 7236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL653P |
0.106070626078535 |
|
| 7237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL235P |
0.106070626078535 |
|
| 7238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRDT |
0.106070626078535 |
|
| 7239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHX4 |
0.106070626078535 |
|
| 7240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD8 |
0.106070626078535 |
|
| 7241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1107 |
0.106070626078535 |
|
| 7242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf146 |
0.106070626078535 |
|
| 7243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTBP12 |
0.106070626078535 |
|
| 7244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLMN |
0.106070626078535 |
|
| 7245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPAP2 |
0.106070626078535 |
|
| 7246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL824P |
0.106070626078535 |
|
| 7247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFI1 |
0.106070626078535 |
|
| 7248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVI5 |
0.106070626078535 |
|
| 7249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL5 |
0.106070626078535 |
|
| 7250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD21 |
0.106070626078535 |
|
| 7251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA66|ENSG00000251795.1 |
0.106070626078535 |
|
| 7252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA66|ENSG00000207523.1 |
0.106070626078535 |
|
| 7253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM69A |
0.106070626078535 |
|
| 7254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000207022.1 |
0.106070626078535 |
|
| 7255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL692P |
0.106070626078535 |
|
| 7256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP123 |
0.106070626078535 |
|
| 7257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTF2 |
0.106070626078535 |
|
| 7258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED5 |
0.106070626078535 |
|
| 7259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC18 |
0.106070626078535 |
|
| 7260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DR1 |
0.106070626078535 |
|
| 7261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNBP1L |
0.106070626078535 |
|
| 7262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP53 |
0.106070626078535 |
|
| 7263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAR3 |
0.106070626078535 |
|
| 7264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR760 |
0.106070626078535 |
|
| 7265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNTTIP2 |
0.106070626078535 |
|
| 7266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCLM |
0.106070626078535 |
|
| 7267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA4 |
0.106070626078535 |
|
| 7268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP29 |
0.106070626078535 |
|
| 7269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL440P |
0.106070626078535 |
|
| 7270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238389.1 |
0.106070626078535 |
|
| 7271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCD3 |
0.106070626078535 |
|
| 7272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F3 |
0.106070626078535 |
|
| 7273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378G |
0.106070626078535 |
|
| 7274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC44A3 |
0.106070626078535 |
|
| 7275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNN3 |
0.106070626078535 |
|
| 7276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG14 |
0.106070626078535 |
|
| 7277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM56 |
0.106070626078535 |
|
| 7278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RWDD3 |
0.106070626078535 |
|
| 7279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL831P |
0.106070626078535 |
|
| 7280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP270 |
0.106070626078535 |
|
| 7281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTBP2 |
0.106070626078535 |
|
| 7282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYD |
0.106070626078535 |
|
| 7283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR137HG |
0.106070626078535 |
|
| 7284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX7 |
0.106070626078535 |
|
| 7285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPPR5 |
0.106070626078535 |
|
| 7286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPPR4 |
0.106070626078535 |
|
| 7287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALMD |
0.106070626078535 |
|
| 7288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRRS1 |
0.106070626078535 |
|
| 7289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGL |
0.106070626078535 |
|
| 7290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35A3 |
0.106070626078535 |
|
| 7291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIAT1 |
0.106070626078535 |
|
| 7292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SASS6 |
0.106070626078535 |
|
| 7293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT13 |
0.106070626078535 |
|
| 7294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC39 |
0.106070626078535 |
|
| 7295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBT |
0.106070626078535 |
|
| 7296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTCA |
0.106070626078535 |
|
| 7297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR553 |
0.106070626078535 |
|
| 7298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC14A |
0.106070626078535 |
|
| 7299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR88 |
0.106070626078535 |
|
| 7300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCAM1 |
0.106070626078535 |
|
| 7301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXTL2 |
0.106070626078535 |
|
| 7302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A7 |
0.106070626078535 |
|
| 7303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH5 |
0.106070626078535 |
|
| 7304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA16|ENSG00000252765.1 |
0.106070626078535 |
|
| 7305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238296.1 |
0.106070626078535 |
|
| 7306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S1PR1 |
0.106070626078535 |
|
| 7307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFM3 |
0.106070626078535 |
|
| 7308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL11A1 |
0.106070626078535 |
|
| 7309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP285 |
0.106070626078535 |
|
| 7310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMY1A |
0.106070626078535 |
|
| 7311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMY1B |
0.106070626078535 |
|
| 7312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMY1C |
0.106070626078535 |
|
| 7313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMY2A |
0.106070626078535 |
|
| 7314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMY2B |
0.106070626078535 |
|
| 7315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNPC3 |
0.106070626078535 |
|
| 7316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT6 |
0.106070626078535 |
|
| 7317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTNG1 |
0.106070626078535 |
|
| 7318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAV3 |
0.106070626078535 |
|
| 7319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A24 |
0.106070626078535 |
|
| 7320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF4 |
0.106070626078535 |
|
| 7321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A24P1 |
0.106070626078535 |
|
| 7322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF5P |
0.106070626078535 |
|
| 7323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF6 |
0.106070626078535 |
|
| 7324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM102B |
0.106070626078535 |
|
| 7325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HENMT1 |
0.106070626078535 |
|
| 7326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF38B |
0.106070626078535 |
|
| 7327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC7 |
0.106070626078535 |
|
| 7328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP3 |
0.106070626078535 |
|
| 7329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKNAD1 |
0.106070626078535 |
|
| 7330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA42 |
0.106070626078535 |
|
| 7331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPSM2 |
0.106070626078535 |
|
| 7332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCC1 |
0.106070626078535 |
|
| 7333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR47 |
0.106070626078535 |
|
| 7334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF13 |
0.106070626078535 |
|
| 7335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf194 |
0.106070626078535 |
|
| 7336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1324 |
0.106070626078535 |
|
| 7337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA2 |
0.106070626078535 |
|
| 7338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM167B |
0.106070626078535 |
|
| 7339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SARS |
0.106070626078535 |
|
| 7340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELSR2 |
0.106070626078535 |
|
| 7341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSRC1 |
0.106070626078535 |
|
| 7342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBPHL |
0.106070626078535 |
|
| 7343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORT1 |
0.106070626078535 |
|
| 7344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA5 |
0.106070626078535 |
|
| 7345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYPL2 |
0.106070626078535 |
|
| 7346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN7L2 |
0.106070626078535 |
|
| 7347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB561D1 |
0.106070626078535 |
|
| 7348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMIGO1 |
0.106070626078535 |
|
| 7349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR61 |
0.106070626078535 |
|
| 7350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAI3 |
0.106070626078535 |
|
| 7351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6V |
0.106070626078535 |
|
| 7352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR197 |
0.106070626078535 |
|
| 7353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAT2 |
0.106070626078535 |
|
| 7354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMPD2 |
0.106070626078535 |
|
| 7355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTM1 |
0.106070626078535 |
|
| 7356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTM2 |
0.106070626078535 |
|
| 7357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTM4 |
0.106070626078535 |
|
| 7358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTM5 |
0.106070626078535 |
|
| 7359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTM3 |
0.106070626078535 |
|
| 7360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS8L3 |
0.106070626078535 |
|
| 7361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF1 |
0.106070626078535 |
|
| 7362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHCYL1 |
0.106070626078535 |
|
| 7363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRIP1 |
0.106070626078535 |
|
| 7364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALX3 |
0.106070626078535 |
|
| 7365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBL4B |
0.106070626078535 |
|
| 7366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A17 |
0.106070626078535 |
|
| 7367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNC4 |
0.106070626078535 |
|
| 7368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000200536.1 |
0.106070626078535 |
|
| 7369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM15 |
0.106070626078535 |
|
| 7370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A4 |
0.106070626078535 |
|
| 7371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMTOR5 |
0.106070626078535 |
|
| 7372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROK1 |
0.106070626078535 |
|
| 7373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYMP |
0.106070626078535 |
|
| 7374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA10 |
0.106070626078535 |
|
| 7375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA2 |
0.106070626078535 |
|
| 7376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA3 |
0.106070626078535 |
|
| 7377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD53 |
0.106070626078535 |
|
| 7378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIF1 |
0.106070626078535 |
|
| 7379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP54 |
0.106070626078535 |
|
| 7380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRAM2 |
0.106070626078535 |
|
| 7381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEPT1 |
0.106070626078535 |
|
| 7382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND2D |
0.106070626078535 |
|
| 7383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHI3L2 |
0.106070626078535 |
|
| 7384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHIAP2 |
0.106070626078535 |
|
| 7385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHIA |
0.106070626078535 |
|
| 7386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIFO |
0.106070626078535 |
|
| 7387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGCP1 |
0.106070626078535 |
|
| 7388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVGP1 |
0.106070626078535 |
|
| 7389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR77 |
0.106070626078535 |
|
| 7390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5F1 |
0.106070626078535 |
|
| 7391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL2RB |
0.110139372356361 |
|
| 7392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF6 |
0.110139372356361 |
|
| 7393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSTR3 |
0.110139372356361 |
|
| 7394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAC2 |
0.110139372356361 |
|
| 7395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTH4 |
0.110139372356361 |
|
| 7396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELFN2 |
0.110139372356361 |
|
| 7397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFNG |
0.110139372356361 |
|
| 7398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD10 |
0.110139372356361 |
|
| 7399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42EP1 |
0.110139372356361 |
|
| 7400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS2 |
0.110139372356361 |
|
| 7401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGA1 |
0.110139372356361 |
|
| 7402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BP1 |
0.110139372356361 |
|
| 7403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDXP |
0.110139372356361 |
|
| 7404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL385P |
0.110139372356361 |
|
| 7405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS1 |
0.110139372356361 |
|
| 7406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL12 |
0.110139372356361 |
|
| 7407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIOBP |
0.110139372356361 |
|
| 7408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238569.1 |
0.110139372356361 |
|
| 7409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCAT |
0.110139372356361 |
|
| 7410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H1F0 |
0.110139372356361 |
|
| 7411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD54 |
0.110139372356361 |
|
| 7412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALR3 |
0.110139372356361 |
|
| 7413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR658 |
0.110139372356361 |
|
| 7414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3L |
0.110139372356361 |
|
| 7415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR659 |
0.110139372356361 |
|
| 7416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICALL1 |
0.110139372356361 |
|
| 7417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf23 |
0.110139372356361 |
|
| 7418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2F |
0.110139372356361 |
|
| 7419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX10 |
0.110139372356361 |
|
| 7420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4534 |
0.110139372356361 |
|
| 7421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PICK1 |
0.110139372356361 |
|
| 7422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A8 |
0.110139372356361 |
|
| 7423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAIAP2L2 |
0.110139372356361 |
|
| 7424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G6 |
0.110139372356361 |
|
| 7425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAFF |
0.110139372356361 |
|
| 7426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM184B |
0.110139372356361 |
|
| 7427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOJ |
0.112102688926744 |
|
| 7428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRD |
0.114503145490287 |
|
| 7429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRBK1 |
0.115073661143597 |
|
| 7430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD13D |
0.115073661143597 |
|
| 7431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSH3 |
0.115073661143597 |
|
| 7432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLD4 |
0.115073661143597 |
|
| 7433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP239 |
0.115073661143597 |
|
| 7434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCF1 |
0.115073661143597 |
|
| 7435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD9A |
0.115073661143597 |
|
| 7436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1CA |
0.115073661143597 |
|
| 7437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D10C |
0.115073661143597 |
|
| 7438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARNS1 |
0.115073661143597 |
|
| 7439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KB2 |
0.115073661143597 |
|
| 7440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO1B |
0.115073661143597 |
|
| 7441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRCAP |
0.115073661143597 |
|
| 7442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABP4 |
0.115073661143597 |
|
| 7443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR152 |
0.115073661143597 |
|
| 7444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM134 |
0.115073661143597 |
|
| 7445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIP |
0.115073661143597 |
|
| 7446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITPNM1 |
0.115073661143597 |
|
| 7447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK2AP2 |
0.115073661143597 |
|
| 7448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABP2 |
0.115073661143597 |
|
| 7449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTCH2 |
0.119255370180995 |
|
| 7450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EP300 |
0.122543804188583 |
|
| 7451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L3MBTL2 |
0.122543804188583 |
|
| 7452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHADL |
0.122543804188583 |
|
| 7453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANGAP1 |
0.122543804188583 |
|
| 7454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H7B |
0.122543804188583 |
|
| 7455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEF |
0.122543804188583 |
|
| 7456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOB2 |
0.122543804188583 |
|
| 7457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF5A |
0.122543804188583 |
|
| 7458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACO2 |
0.122543804188583 |
|
| 7459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3H |
0.122543804188583 |
|
| 7460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSDC2 |
0.122543804188583 |
|
| 7461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMM1 |
0.122543804188583 |
|
| 7462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DESI1 |
0.122543804188583 |
|
| 7463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC6 |
0.122543804188583 |
|
| 7464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHP2L1 |
0.122543804188583 |
|
| 7465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf46 |
0.122543804188583 |
|
| 7466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEI1 |
0.122543804188583 |
|
| 7467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC22P |
0.122543804188583 |
|
| 7468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC134 |
0.122543804188583 |
|
| 7469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SREBF2 |
0.122543804188583 |
|
| 7470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPM |
0.122543804188583 |
|
| 7471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00634 |
0.122543804188583 |
|
| 7472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR33A |
0.122543804188583 |
|
| 7473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378I |
0.122543804188583 |
|
| 7474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT3 |
0.122543804188583 |
|
| 7475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA8 |
0.122543804188583 |
|
| 7476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF13C |
0.122543804188583 |
|
| 7477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP2NL |
0.122543804188583 |
|
| 7478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAGA |
0.122543804188583 |
|
| 7479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM109B |
0.122543804188583 |
|
| 7480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238498.1 |
0.122543804188583 |
|
| 7481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMDT1 |
0.122543804188583 |
|
| 7482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA6 |
0.122543804188583 |
|
| 7483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2D6 |
0.122543804188583 |
|
| 7484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2D7P1 |
0.122543804188583 |
|
| 7485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF20 |
0.122543804188583 |
|
| 7486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFAM1 |
0.122543804188583 |
|
| 7487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLDIP3 |
0.122543804188583 |
|
| 7488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP80 |
0.122543804188583 |
|
| 7489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP7A |
0.122543804188583 |
|
| 7490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP7B |
0.122543804188583 |
|
| 7491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERHL2 |
0.122543804188583 |
|
| 7492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERHL |
0.122543804188583 |
|
| 7493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU12 |
0.122543804188583 |
|
| 7494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5R3 |
0.122543804188583 |
|
| 7495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5L2 |
0.122543804188583 |
|
| 7496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A4GALT |
0.122543804188583 |
|
| 7497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFGAP3 |
0.122543804188583 |
|
| 7498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACSIN2 |
0.122543804188583 |
|
| 7499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL1 |
0.122543804188583 |
|
| 7500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIK |
0.122543804188583 |
|
| 7501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCAT |
0.122543804188583 |
|
| 7502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPO |
0.122543804188583 |
|
| 7503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL12 |
0.122543804188583 |
|
| 7504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCUBE1 |
0.122543804188583 |
|
| 7505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPPED1 |
0.122543804188583 |
|
| 7506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB6 |
0.122543804188583 |
|
| 7507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT4A1 |
0.122543804188583 |
|
| 7508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA5 |
0.122543804188583 |
|
| 7509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA3 |
0.122543804188583 |
|
| 7510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMM50 |
0.122543804188583 |
|
| 7511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARVB |
0.122543804188583 |
|
| 7512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARVG |
0.122543804188583 |
|
| 7513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1644 |
0.122543804188583 |
|
| 7514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDOC1L |
0.122543804188583 |
|
| 7515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00207 |
0.122543804188583 |
|
| 7516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00229 |
0.122543804188583 |
|
| 7517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR5 |
0.122543804188583 |
|
| 7518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP8 |
0.122543804188583 |
|
| 7519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF21B |
0.122543804188583 |
|
| 7520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP50 |
0.122543804188583 |
|
| 7521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0930 |
0.122543804188583 |
|
| 7522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1249 |
0.122543804188583 |
|
| 7523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK3A |
0.122543804188583 |
|
| 7524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM118A |
0.122543804188583 |
|
| 7525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC1B |
0.122543804188583 |
|
| 7526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIBC2 |
0.122543804188583 |
|
| 7527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLN1 |
0.122543804188583 |
|
| 7528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN10 |
0.122543804188583 |
|
| 7529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4762 |
0.122543804188583 |
|
| 7530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT7B |
0.122543804188583 |
|
| 7531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00899 |
0.122543804188583 |
|
| 7532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf26 |
0.122543804188583 |
|
| 7533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ27365 |
0.122543804188583 |
|
| 7534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3619 |
0.122543804188583 |
|
| 7535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4763 |
0.122543804188583 |
|
| 7536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7A3 |
0.122543804188583 |
|
| 7537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7B |
0.122543804188583 |
|
| 7538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPARA |
0.122543804188583 |
|
| 7539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDPF1 |
0.122543804188583 |
|
| 7540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKDREJ |
0.122543804188583 |
|
| 7541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC38 |
0.122543804188583 |
|
| 7542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTSE1 |
0.122543804188583 |
|
| 7543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMU |
0.122543804188583 |
|
| 7544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELSR1 |
0.122543804188583 |
|
| 7545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD4 |
0.122543804188583 |
|
| 7546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERK |
0.122543804188583 |
|
| 7547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D22A |
0.122543804188583 |
|
| 7548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00898 |
0.122543804188583 |
|
| 7549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3201 |
0.122543804188583 |
|
| 7550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM19A5 |
0.122543804188583 |
|
| 7551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4535 |
0.122543804188583 |
|
| 7552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACR |
0.122543804188583 |
|
| 7553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADM2 |
0.122543804188583 |
|
| 7554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG12 |
0.122543804188583 |
|
| 7555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSA |
0.122543804188583 |
|
| 7556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD1 |
0.122543804188583 |
|
| 7557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C22orf34 |
0.122543804188583 |
|
| 7558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHKB |
0.122543804188583 |
|
| 7559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPT1B |
0.122543804188583 |
|
| 7560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRELD2 |
0.122543804188583 |
|
| 7561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND6B |
0.122543804188583 |
|
| 7562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC10 |
0.122543804188583 |
|
| 7563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17REL |
0.122543804188583 |
|
| 7564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC7B |
0.122543804188583 |
|
| 7565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMF2 |
0.122543804188583 |
|
| 7566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK11 |
0.122543804188583 |
|
| 7567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK12 |
0.122543804188583 |
|
| 7568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK8IP2 |
0.122543804188583 |
|
| 7569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIOX |
0.122543804188583 |
|
| 7570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3667 |
0.122543804188583 |
|
| 7571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLC1 |
0.122543804188583 |
|
| 7572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOV10L1 |
0.122543804188583 |
|
| 7573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPH2 |
0.122543804188583 |
|
| 7574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF3B |
0.122543804188583 |
|
| 7575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANX2 |
0.122543804188583 |
|
| 7576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIM3 |
0.122543804188583 |
|
| 7577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNB2 |
0.122543804188583 |
|
| 7578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP6R2 |
0.122543804188583 |
|
| 7579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABL2B |
0.122543804188583 |
|
| 7580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP252 |
0.122543804188583 |
|
| 7581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL500P |
0.122543804188583 |
|
| 7582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBF1 |
0.122543804188583 |
|
| 7583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCO2 |
0.122543804188583 |
|
| 7584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHANK3 |
0.122543804188583 |
|
| 7585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCE3 |
0.122543804188583 |
|
| 7586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRABD |
0.122543804188583 |
|
| 7587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL8 |
0.122543804188583 |
|
| 7588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBGCP6 |
0.122543804188583 |
|
| 7589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYMP |
0.122543804188583 |
|
| 7590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED4 |
0.122543804188583 |
|
| 7591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPHB5 |
0.124394619904855 |
|
| 7592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R5E |
0.124394619904855 |
|
| 7593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL540P |
0.124394619904855 |
|
| 7594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000252800.1 |
0.124394619904855 |
|
| 7595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR89 |
0.124394619904855 |
|
| 7596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200693.1 |
0.124394619904855 |
|
| 7597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNE2 |
0.124394619904855 |
|
| 7598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESR2 |
0.124394619904855 |
|
| 7599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548H1 |
0.124394619904855 |
|
| 7600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFD1 |
0.124394619904855 |
|
| 7601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB25 |
0.124394619904855 |
|
| 7602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP5 |
0.124394619904855 |
|
| 7603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB1 |
0.124394619904855 |
|
| 7604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA2 |
0.124394619904855 |
|
| 7605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R36 |
0.124394619904855 |
|
| 7606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG3 |
0.124394619904855 |
|
| 7607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTB |
0.124394619904855 |
|
| 7608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHURC1 |
0.124394619904855 |
|
| 7609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX2 |
0.124394619904855 |
|
| 7610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB15 |
0.124394619904855 |
|
| 7611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNTB |
0.124394619904855 |
|
| 7612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAX |
0.124394619904855 |
|
| 7613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4706 |
0.124394619904855 |
|
| 7614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4708 |
0.124394619904855 |
|
| 7615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT8 |
0.124394619904855 |
|
| 7616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR625 |
0.124394619904855 |
|
| 7617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00238 |
0.124394619904855 |
|
| 7618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPHN |
0.124394619904855 |
|
| 7619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71D |
0.124394619904855 |
|
| 7620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP5 |
0.124394619904855 |
|
| 7621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1D |
0.124394619904855 |
|
| 7622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2S1 |
0.124394619904855 |
|
| 7623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEK2 |
0.124394619904855 |
|
| 7624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5694 |
0.124394619904855 |
|
| 7625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM229B |
0.124394619904855 |
|
| 7626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHH1 |
0.124394619904855 |
|
| 7627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGH |
0.124394619904855 |
|
| 7628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARG2 |
0.124394619904855 |
|
| 7629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VTI1B |
0.124394619904855 |
|
| 7630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH11 |
0.124394619904855 |
|
| 7631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH12 |
0.124394619904855 |
|
| 7632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL369P |
0.124394619904855 |
|
| 7633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE26 |
0.124394619904855 |
|
| 7634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252792.1 |
0.124394619904855 |
|
| 7635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL213P |
0.124394619904855 |
|
| 7636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL224P |
0.124394619904855 |
|
| 7637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTN1 |
0.124394619904855 |
|
| 7638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF5 |
0.124394619904855 |
|
| 7639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXD2 |
0.124394619904855 |
|
| 7640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT16 |
0.124394619904855 |
|
| 7641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERH |
0.124394619904855 |
|
| 7642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A9 |
0.124394619904855 |
|
| 7643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHD1 |
0.124394619904855 |
|
| 7644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC177|ENSG00000255994.1 |
0.124394619904855 |
|
| 7645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC177|ENSG00000267909.1 |
0.124394619904855 |
|
| 7646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0247 |
0.124394619904855 |
|
| 7647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSTL4 |
0.127054649837142 |
|
| 7648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00340 |
0.127232450169814 |
|
| 7649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP240 |
0.127232450169814 |
|
| 7650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRL |
0.127232450169814 |
|
| 7651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDGFL1 |
0.127232450169814 |
|
| 7652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRSN1 |
0.127232450169814 |
|
| 7653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD46|ENSG00000251830.1 |
0.127232450169814 |
|
| 7654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCDC2 |
0.127232450169814 |
|
| 7655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAAG1 |
0.127232450169814 |
|
| 7656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRS2 |
0.127232450169814 |
|
| 7657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPLD1 |
0.127232450169814 |
|
| 7658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH5A1 |
0.127232450169814 |
|
| 7659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0319 |
0.127232450169814 |
|
| 7660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDP2 |
0.127232450169814 |
|
| 7661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT13 |
0.127232450169814 |
|
| 7662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf62 |
0.127232450169814 |
|
| 7663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMNN |
0.127232450169814 |
|
| 7664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM65B |
0.127232450169814 |
|
| 7665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL334P |
0.127232450169814 |
|
| 7666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMAHP |
0.127232450169814 |
|
| 7667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5P5 |
0.127232450169814 |
|
| 7668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC16A |
0.127232450169814 |
|
| 7669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238322.1 |
0.127232450169814 |
|
| 7670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AA |
0.127232450169814 |
|
| 7671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BA |
0.127232450169814 |
|
| 7672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGN |
0.127232450169814 |
|
| 7673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A4 |
0.127232450169814 |
|
| 7674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A1 |
0.127232450169814 |
|
| 7675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A3 |
0.127232450169814 |
|
| 7676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A2 |
0.127232450169814 |
|
| 7677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM38 |
0.127232450169814 |
|
| 7678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1A |
0.127232450169814 |
|
| 7679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3A |
0.127232450169814 |
|
| 7680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4A |
0.127232450169814 |
|
| 7681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4B |
0.127232450169814 |
|
| 7682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AB |
0.127232450169814 |
|
| 7683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3B |
0.127232450169814 |
|
| 7684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1C |
0.127232450169814 |
|
| 7685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BB |
0.127232450169814 |
|
| 7686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3C |
0.127232450169814 |
|
| 7687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HFE |
0.127232450169814 |
|
| 7688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4C |
0.127232450169814 |
|
| 7689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1T |
0.127232450169814 |
|
| 7690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BC |
0.127232450169814 |
|
| 7691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AC |
0.127232450169814 |
|
| 7692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1E |
0.127232450169814 |
|
| 7693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BD |
0.127232450169814 |
|
| 7694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BE |
0.127232450169814 |
|
| 7695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4D |
0.127232450169814 |
|
| 7696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3D |
0.127232450169814 |
|
| 7697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AD |
0.127232450169814 |
|
| 7698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BF |
0.127232450169814 |
|
| 7699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4E |
0.127232450169814 |
|
| 7700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BG |
0.127232450169814 |
|
| 7701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AE |
0.127232450169814 |
|
| 7702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3E |
0.127232450169814 |
|
| 7703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1D |
0.127232450169814 |
|
| 7704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4F |
0.127232450169814 |
|
| 7705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4G |
0.127232450169814 |
|
| 7706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3F |
0.127232450169814 |
|
| 7707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BH |
0.127232450169814 |
|
| 7708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BI |
0.127232450169814 |
|
| 7709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3G |
0.127232450169814 |
|
| 7710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4H |
0.127232450169814 |
|
| 7711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN3A2 |
0.127232450169814 |
|
| 7712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN2A2 |
0.127232450169814 |
|
| 7713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN3A1 |
0.127232450169814 |
|
| 7714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN2A1 |
0.127232450169814 |
|
| 7715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN2A3P |
0.127232450169814 |
|
| 7716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN3A3 |
0.127232450169814 |
|
| 7717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTN1A1 |
0.127232450169814 |
|
| 7718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG11 |
0.127232450169814 |
|
| 7719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN4 |
0.127232450169814 |
|
| 7720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABT1 |
0.127232450169814 |
|
| 7721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF322 |
0.127232450169814 |
|
| 7722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSBP2 |
0.127232450169814 |
|
| 7723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00240 |
0.127232450169814 |
|
| 7724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRNAI2 |
0.127232450169814 |
|
| 7725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BJ |
0.127232450169814 |
|
| 7726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AG |
0.127232450169814 |
|
| 7727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BK |
0.127232450169814 |
|
| 7728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4I |
0.127232450169814 |
|
| 7729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AH |
0.127232450169814 |
|
| 7730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3143 |
0.127232450169814 |
|
| 7731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS16 |
0.127232450169814 |
|
| 7732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121L2 |
0.127232450169814 |
|
| 7733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF391 |
0.127232450169814 |
|
| 7734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF184 |
0.127232450169814 |
|
| 7735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRNAI6 |
0.127232450169814 |
|
| 7736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AI |
0.127232450169814 |
|
| 7737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AJ |
0.127232450169814 |
|
| 7738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BL |
0.127232450169814 |
|
| 7739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BM |
0.127232450169814 |
|
| 7740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3H |
0.127232450169814 |
|
| 7741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4J |
0.127232450169814 |
|
| 7742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4K |
0.127232450169814 |
|
| 7743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AK |
0.127232450169814 |
|
| 7744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BN |
0.127232450169814 |
|
| 7745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AL |
0.127232450169814 |
|
| 7746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H1B |
0.127232450169814 |
|
| 7747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3I |
0.127232450169814 |
|
| 7748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H4L |
0.127232450169814 |
|
| 7749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H3J |
0.127232450169814 |
|
| 7750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2AM |
0.127232450169814 |
|
| 7751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST1H2BO |
0.127232450169814 |
|
| 7752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2B2 |
0.127232450169814 |
|
| 7753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2B6 |
0.127232450169814 |
|
| 7754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199851.1 |
0.127232450169814 |
|
| 7755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF165 |
0.127232450169814 |
|
| 7756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN12P1 |
0.127232450169814 |
|
| 7757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN16 |
0.127232450169814 |
|
| 7758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN8 |
0.127232450169814 |
|
| 7759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF192P1 |
0.127232450169814 |
|
| 7760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN9 |
0.127232450169814 |
|
| 7761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN4 |
0.127232450169814 |
|
| 7762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAPL |
0.127232450169814 |
|
| 7763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGBD1 |
0.127232450169814 |
|
| 7764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN31 |
0.127232450169814 |
|
| 7765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN3 |
0.127232450169814 |
|
| 7766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN12 |
0.127232450169814 |
|
| 7767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN23 |
0.127232450169814 |
|
| 7768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX6 |
0.127232450169814 |
|
| 7769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX5 |
0.127232450169814 |
|
| 7770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAND3 |
0.127232450169814 |
|
| 7771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00533 |
0.127232450169814 |
|
| 7772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG14 |
0.127232450169814 |
|
| 7773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM27 |
0.127232450169814 |
|
| 7774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf100 |
0.127232450169814 |
|
| 7775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL471P |
0.127232450169814 |
|
| 7776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG15 |
0.127232450169814 |
|
| 7777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG16 |
0.127232450169814 |
|
| 7778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF311 |
0.127232450169814 |
|
| 7779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2W1 |
0.127232450169814 |
|
| 7780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2B3 |
0.127232450169814 |
|
| 7781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2J1 |
0.127232450169814 |
|
| 7782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2J2 |
0.127232450169814 |
|
| 7783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2J3 |
0.127232450169814 |
|
| 7784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14J1 |
0.127232450169814 |
|
| 7785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5V1 |
0.127232450169814 |
|
| 7786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR12D3 |
0.127232450169814 |
|
| 7787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR12D2 |
0.127232450169814 |
|
| 7788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR12D1P |
0.127232450169814 |
|
| 7789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11A1 |
0.127232450169814 |
|
| 7790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10C1 |
0.127232450169814 |
|
| 7791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2H1 |
0.127232450169814 |
|
| 7792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAS1L |
0.127232450169814 |
|
| 7793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABBR1 |
0.127232450169814 |
|
| 7794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBD |
0.127232450169814 |
|
| 7795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2H2 |
0.127232450169814 |
|
| 7796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD32B |
0.127232450169814 |
|
| 7797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOG |
0.127232450169814 |
|
| 7798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP57 |
0.127232450169814 |
|
| 7799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG9 |
0.127232450169814 |
|
| 7800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNRD1 |
0.127232450169814 |
|
| 7801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R11 |
0.127232450169814 |
|
| 7802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF39 |
0.127232450169814 |
|
| 7803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM31 |
0.127232450169814 |
|
| 7804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000252228.1 |
0.127232450169814 |
|
| 7805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM40 |
0.127232450169814 |
|
| 7806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM10 |
0.127232450169814 |
|
| 7807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM15 |
0.127232450169814 |
|
| 7808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM26 |
0.127232450169814 |
|
| 7809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG17 |
0.127232450169814 |
|
| 7810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR4 |
0.127238783810587 |
|
| 7811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBC1 |
0.127238783810587 |
|
| 7812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR147A |
0.127238783810587 |
|
| 7813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5RAP2 |
0.127238783810587 |
|
| 7814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGF9 |
0.127238783810587 |
|
| 7815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW2 |
0.127238783810587 |
|
| 7816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD5 |
0.127238783810587 |
|
| 7817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF19 |
0.127238783810587 |
|
| 7818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF1 |
0.127238783810587 |
|
| 7819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5 |
0.127238783810587 |
|
| 7820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTRL |
0.127238783810587 |
|
| 7821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB14 |
0.127238783810587 |
|
| 7822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL181P |
0.127238783810587 |
|
| 7823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSN |
0.127238783810587 |
|
| 7824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOM |
0.127238783810587 |
|
| 7825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGTA1P |
0.127238783810587 |
|
| 7826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL187P |
0.127238783810587 |
|
| 7827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAB2IP |
0.127238783810587 |
|
| 7828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL11 |
0.127238783810587 |
|
| 7829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4478 |
0.127238783810587 |
|
| 7830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA8 |
0.127238783810587 |
|
| 7831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORN5 |
0.127238783810587 |
|
| 7832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX6 |
0.127238783810587 |
|
| 7833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM18 |
0.127238783810587 |
|
| 7834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRRF |
0.127238783810587 |
|
| 7835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL227P |
0.127238783810587 |
|
| 7836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGS1 |
0.127238783810587 |
|
| 7837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1J1 |
0.127238783810587 |
|
| 7838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1J2 |
0.127238783810587 |
|
| 7839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1J4 |
0.127238783810587 |
|
| 7840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1N1 |
0.127238783810587 |
|
| 7841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1N2 |
0.127238783810587 |
|
| 7842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1L8 |
0.127238783810587 |
|
| 7843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1Q1 |
0.127238783810587 |
|
| 7844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1B1 |
0.127238783810587 |
|
| 7845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1L1 |
0.127238783810587 |
|
| 7846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1L3 |
0.127238783810587 |
|
| 7847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1L6 |
0.127238783810587 |
|
| 7848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5C1 |
0.127238783810587 |
|
| 7849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1K1 |
0.127238783810587 |
|
| 7850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCL |
0.127238783810587 |
|
| 7851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RC3H2 |
0.127238783810587 |
|
| 7852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD90 |
0.127238783810587 |
|
| 7853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB6 |
0.127238783810587 |
|
| 7854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB26 |
0.127238783810587 |
|
| 7855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABGAP1 |
0.127238783810587 |
|
| 7856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR21 |
0.127238783810587 |
|
| 7857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR600HG |
0.127238783810587 |
|
| 7858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRBP |
0.127238783810587 |
|
| 7859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRB2 |
0.127238783810587 |
|
| 7860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND1A |
0.127238783810587 |
|
| 7861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR601 |
0.127238783810587 |
|
| 7862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX2 |
0.127238783810587 |
|
| 7863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK6 |
0.127238783810587 |
|
| 7864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB7 |
0.127238783810587 |
|
| 7865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR144 |
0.127238783810587 |
|
| 7866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR5A1 |
0.127238783810587 |
|
| 7867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR6A1 |
0.127238783810587 |
|
| 7868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL302P |
0.127238783810587 |
|
| 7869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181A2HG |
0.127238783810587 |
|
| 7870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181A2 |
0.127238783810587 |
|
| 7871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181B2 |
0.127238783810587 |
|
| 7872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFML2A |
0.127238783810587 |
|
| 7873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR38 |
0.127238783810587 |
|
| 7874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL35 |
0.127238783810587 |
|
| 7875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC5L |
0.127238783810587 |
|
| 7876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA1 |
0.127238783810587 |
|
| 7877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPKAP1 |
0.127238783810587 |
|
| 7878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL30P |
0.127238783810587 |
|
| 7879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBX3 |
0.127238783810587 |
|
| 7880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MVB12B |
0.127238783810587 |
|
| 7881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRON |
0.127238783810587 |
|
| 7882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD116|ENSG00000252985.1 |
0.127238783810587 |
|
| 7883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMX1B |
0.127238783810587 |
|
| 7884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB43 |
0.127238783810587 |
|
| 7885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB34 |
0.127238783810587 |
|
| 7886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGPS1 |
0.127238783810587 |
|
| 7887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL2 |
0.127238783810587 |
|
| 7888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GARNL3 |
0.127238783810587 |
|
| 7889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A8 |
0.127238783810587 |
|
| 7890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF79 |
0.127238783810587 |
|
| 7891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL12 |
0.127238783810587 |
|
| 7892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA65 |
0.127238783810587 |
|
| 7893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRSAM1 |
0.127238783810587 |
|
| 7894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR2A |
0.127238783810587 |
|
| 7895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D3C |
0.127238783810587 |
|
| 7896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK9 |
0.127238783810587 |
|
| 7897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3960 |
0.127238783810587 |
|
| 7898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC4 |
0.127238783810587 |
|
| 7899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP5KL1 |
0.127238783810587 |
|
| 7900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPM2 |
0.127238783810587 |
|
| 7901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM102A |
0.127238783810587 |
|
| 7902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGES2 |
0.127238783810587 |
|
| 7903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN2 |
0.127238783810587 |
|
| 7904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf16 |
0.127238783810587 |
|
| 7905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIZ1 |
0.127238783810587 |
|
| 7906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1 |
0.127238783810587 |
|
| 7907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR199B |
0.127238783810587 |
|
| 7908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3154 |
0.127238783810587 |
|
| 7909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA2 |
0.127238783810587 |
|
| 7910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SWI5 |
0.127238783810587 |
|
| 7911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRUB2 |
0.127238783810587 |
|
| 7912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ4 |
0.127238783810587 |
|
| 7913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A4 |
0.127238783810587 |
|
| 7914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URM1 |
0.127238783810587 |
|
| 7915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERCAM |
0.127238783810587 |
|
| 7916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF2 |
0.127238783810587 |
|
| 7917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLE1 |
0.127238783810587 |
|
| 7918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTAN1 |
0.127238783810587 |
|
| 7919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR34 |
0.127238783810587 |
|
| 7920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGA1P4 |
0.127238783810587 |
|
| 7921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SET |
0.127238783810587 |
|
| 7922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKN3 |
0.127238783810587 |
|
| 7923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL560P |
0.127238783810587 |
|
| 7924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC12 |
0.127238783810587 |
|
| 7925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZER1 |
0.127238783810587 |
|
| 7926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239055.1 |
0.127238783810587 |
|
| 7927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D13 |
0.127238783810587 |
|
| 7928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf114 |
0.127238783810587 |
|
| 7929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENDOG |
0.127238783810587 |
|
| 7930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCBL1 |
0.127238783810587 |
|
| 7931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC8A |
0.127238783810587 |
|
| 7932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHYHD1 |
0.127238783810587 |
|
| 7933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOLK |
0.127238783810587 |
|
| 7934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP188 |
0.127238783810587 |
|
| 7935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GLB2 |
0.127238783810587 |
|
| 7936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM73B |
0.127238783810587 |
|
| 7937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOLPP1 |
0.127238783810587 |
|
| 7938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRAT |
0.127238783810587 |
|
| 7939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R4 |
0.127238783810587 |
|
| 7940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IER5L |
0.127238783810587 |
|
| 7941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf106 |
0.127238783810587 |
|
| 7942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL159P |
0.127238783810587 |
|
| 7943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00963 |
0.127238783810587 |
|
| 7944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGES |
0.127238783810587 |
|
| 7945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR1B |
0.127238783810587 |
|
| 7946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR1A |
0.127238783810587 |
|
| 7947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf78 |
0.127238783810587 |
|
| 7948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP20 |
0.127238783810587 |
|
| 7949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNBP1 |
0.127238783810587 |
|
| 7950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR107 |
0.127238783810587 |
|
| 7951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCS1 |
0.127238783810587 |
|
| 7952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMCN2 |
0.127238783810587 |
|
| 7953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL665P |
0.127238783810587 |
|
| 7954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASS1 |
0.127238783810587 |
|
| 7955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238298.1 |
0.127238783810587 |
|
| 7956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUBP3 |
0.127238783810587 |
|
| 7957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM12 |
0.127238783810587 |
|
| 7958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC2 |
0.127238783810587 |
|
| 7959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABL1 |
0.127238783810587 |
|
| 7960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QRFP |
0.127238783810587 |
|
| 7961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIBCD1 |
0.127238783810587 |
|
| 7962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252582.1 |
0.127238783810587 |
|
| 7963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPC4 |
0.127238783810587 |
|
| 7964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDCCAG3 |
0.127238783810587 |
|
| 7965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMPCA |
0.127238783810587 |
|
| 7966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5E |
0.127238783810587 |
|
| 7967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC16A |
0.127238783810587 |
|
| 7968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf163 |
0.127238783810587 |
|
| 7969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTCH1 |
0.127238783810587 |
|
| 7970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4673 |
0.127238783810587 |
|
| 7971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4674 |
0.127238783810587 |
|
| 7972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252440.1 |
0.127238783810587 |
|
| 7973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT2 |
0.127238783810587 |
|
| 7974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFL7 |
0.127238783810587 |
|
| 7975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR126 |
0.127238783810587 |
|
| 7976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM69B |
0.127238783810587 |
|
| 7977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG7 |
0.127238783810587 |
|
| 7978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN10 |
0.127238783810587 |
|
| 7979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN6 |
0.127238783810587 |
|
| 7980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN8 |
0.127238783810587 |
|
| 7981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN15 |
0.127238783810587 |
|
| 7982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM141 |
0.127238783810587 |
|
| 7983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1984 |
0.127238783810587 |
|
| 7984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABL6 |
0.127238783810587 |
|
| 7985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf172 |
0.127238783810587 |
|
| 7986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDF1 |
0.127238783810587 |
|
| 7987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAMDC4 |
0.127238783810587 |
|
| 7988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4292 |
0.127238783810587 |
|
| 7989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHPT1 |
0.127238783810587 |
|
| 7990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4479 |
0.127238783810587 |
|
| 7991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF2 |
0.127238783810587 |
|
| 7992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8G |
0.127238783810587 |
|
| 7993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW5 |
0.127238783810587 |
|
| 7994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCN12 |
0.127238783810587 |
|
| 7995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf141 |
0.127238783810587 |
|
| 7996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCNL1 |
0.127238783810587 |
|
| 7997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGDS |
0.127238783810587 |
|
| 7998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf142 |
0.127238783810587 |
|
| 7999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC3 |
0.127238783810587 |
|
| 8000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA2 |
0.127238783810587 |
|
| 8001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf139 |
0.127238783810587 |
|
| 8002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT7 |
0.127238783810587 |
|
| 8003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPDC1 |
0.127238783810587 |
|
| 8004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD2 |
0.127238783810587 |
|
| 8005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAPCD2 |
0.127238783810587 |
|
| 8006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UAP1L1 |
0.127238783810587 |
|
| 8007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN1B1 |
0.127238783810587 |
|
| 8008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD62 |
0.127238783810587 |
|
| 8009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP7 |
0.127238783810587 |
|
| 8010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238824.1 |
0.127238783810587 |
|
| 8011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN1 |
0.127238783810587 |
|
| 8012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC2 |
0.127238783810587 |
|
| 8013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC26 |
0.127238783810587 |
|
| 8014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3621 |
0.127238783810587 |
|
| 8015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSNA1 |
0.127238783810587 |
|
| 8016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM210 |
0.127238783810587 |
|
| 8017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf169 |
0.127238783810587 |
|
| 8018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM166A |
0.127238783810587 |
|
| 8019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDOR1 |
0.127238783810587 |
|
| 8020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF208 |
0.127238783810587 |
|
| 8021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF224 |
0.127238783810587 |
|
| 8022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC34A3 |
0.127238783810587 |
|
| 8023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM203 |
0.127238783810587 |
|
| 8024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRN |
0.127238783810587 |
|
| 8025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB4B |
0.127238783810587 |
|
| 8026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf173 |
0.127238783810587 |
|
| 8027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELFB |
0.127238783810587 |
|
| 8028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXD3 |
0.127238783810587 |
|
| 8029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRARP |
0.127238783810587 |
|
| 8030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR4A |
0.127238783810587 |
|
| 8031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOXA1 |
0.127238783810587 |
|
| 8032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000272272.1 |
0.127238783810587 |
|
| 8033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD8 |
0.127238783810587 |
|
| 8034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSMF |
0.127238783810587 |
|
| 8035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA7 |
0.127238783810587 |
|
| 8036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH7 |
0.127238783810587 |
|
| 8037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL41 |
0.127238783810587 |
|
| 8038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND19 |
0.127238783810587 |
|
| 8039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRDC1 |
0.127238783810587 |
|
| 8040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf37 |
0.127238783810587 |
|
| 8041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHMT1 |
0.127238783810587 |
|
| 8042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR602 |
0.127238783810587 |
|
| 8043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1B |
0.127238783810587 |
|
| 8044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM157B |
0.127238783810587 |
|
| 8045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBBP5 |
0.127238783810587 |
|
| 8046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD46|ENSG00000201009.1 |
0.136200727420524 |
|
| 8047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD3 |
0.136200727420524 |
|
| 8048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272393.1 |
0.136200727420524 |
|
| 8049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC4 |
0.136200727420524 |
|
| 8050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRGUK |
0.136200727420524 |
|
| 8051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35B4 |
0.136200727420524 |
|
| 8052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1B1 |
0.136200727420524 |
|
| 8053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1B10 |
0.136200727420524 |
|
| 8054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1B15 |
0.136200727420524 |
|
| 8055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPGM |
0.136200727420524 |
|
| 8056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALD1 |
0.136200727420524 |
|
| 8057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGBL3 |
0.136200727420524 |
|
| 8058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf49 |
0.136200727420524 |
|
| 8059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM140 |
0.136200727420524 |
|
| 8060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR91 |
0.136200727420524 |
|
| 8061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRA8 |
0.136200727420524 |
|
| 8062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT4 |
0.136200727420524 |
|
| 8063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP205 |
0.136200727420524 |
|
| 8064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf73 |
0.136200727420524 |
|
| 8065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC13A4 |
0.136200727420524 |
|
| 8066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM180A |
0.136200727420524 |
|
| 8067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUZP6 |
0.136200727420524 |
|
| 8068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238488.1 |
0.136200727420524 |
|
| 8069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRM2 |
0.136200727420524 |
|
| 8070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR490 |
0.136200727420524 |
|
| 8071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTN |
0.136200727420524 |
|
| 8072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD81|ENSG00000202023.1 |
0.136200727420524 |
|
| 8073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTPN |
0.13958498529841 |
|
| 8074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOV10 |
0.140873083844065 |
|
| 8075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOC |
0.140873083844065 |
|
| 8076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1J |
0.140873083844065 |
|
| 8077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM19A3 |
0.140873083844065 |
|
| 8078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCWPW2 |
0.141197776970118 |
|
| 8079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMS3 |
0.141197776970118 |
|
| 8080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199927.1 |
0.141197776970118 |
|
| 8081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBR2 |
0.141197776970118 |
|
| 8082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GADL1 |
0.141197776970118 |
|
| 8083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP127 |
0.141197776970118 |
|
| 8084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STT3B |
0.141197776970118 |
|
| 8085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPD1L |
0.141197776970118 |
|
| 8086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238646.1 |
0.141197776970118 |
|
| 8087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM8 |
0.141197776970118 |
|
| 8088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM7 |
0.141197776970118 |
|
| 8089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM6 |
0.141197776970118 |
|
| 8090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC1LI1 |
0.141197776970118 |
|
| 8091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT10 |
0.141197776970118 |
|
| 8092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLB1 |
0.141197776970118 |
|
| 8093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPPE |
0.141197776970118 |
|
| 8094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL296P |
0.141197776970118 |
|
| 8095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTAP |
0.141197776970118 |
|
| 8096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUSD5 |
0.141197776970118 |
|
| 8097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL2 |
0.141197776970118 |
|
| 8098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBP1 |
0.141197776970118 |
|
| 8099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD6IP |
0.141197776970118 |
|
| 8100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ1 |
0.141724303681809 |
|
| 8101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ1OT1 |
0.141724303681809 |
|
| 8102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGEF |
0.14184989978867 |
|
| 8103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG16L1 |
0.14184989978867 |
|
| 8104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAG |
0.14184989978867 |
|
| 8105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKD |
0.14184989978867 |
|
| 8106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEKR1 |
0.142528416071613 |
|
| 8107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP177 |
0.142528416071613 |
|
| 8108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00880 |
0.142528416071613 |
|
| 8109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00881 |
0.142528416071613 |
|
| 8110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNL1 |
0.142528416071613 |
|
| 8111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP146 |
0.142528416071613 |
|
| 8112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEPH1 |
0.142528416071613 |
|
| 8113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTX3 |
0.142528416071613 |
|
| 8114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf55 |
0.142528416071613 |
|
| 8115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP46 |
0.142528416071613 |
|
| 8116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHOX2 |
0.142528416071613 |
|
| 8117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSRC1 |
0.142528416071613 |
|
| 8118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLF1 |
0.142528416071613 |
|
| 8119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFM1 |
0.142528416071613 |
|
| 8120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LXN |
0.142528416071613 |
|
| 8121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARRES1 |
0.142528416071613 |
|
| 8122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD1 |
0.142528416071613 |
|
| 8123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCJ |
0.142528416071613 |
|
| 8124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3919 |
0.142528416071613 |
|
| 8125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCHIP1 |
0.142528416071613 |
|
| 8126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL12A |
0.142528416071613 |
|
| 8127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf80 |
0.142528416071613 |
|
| 8128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT80 |
0.142528416071613 |
|
| 8129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC4 |
0.142528416071613 |
|
| 8130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR15B |
0.142528416071613 |
|
| 8131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM59 |
0.142528416071613 |
|
| 8132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA4 |
0.142528416071613 |
|
| 8133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA7 |
0.142528416071613 |
|
| 8134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT8P12 |
0.142528416071613 |
|
| 8135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL14 |
0.142528416071613 |
|
| 8136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000207084.1 |
0.142528416071613 |
|
| 8137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1L |
0.142528416071613 |
|
| 8138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALNT1 |
0.142528416071613 |
|
| 8139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMD3 |
0.142528416071613 |
|
| 8140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTSSB |
0.142528416071613 |
|
| 8141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOL1 |
0.142528416071613 |
|
| 8142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT64 |
0.142528416071613 |
|
| 8143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238398.1 |
0.142528416071613 |
|
| 8144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1263 |
0.142528416071613 |
|
| 8145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM8 |
0.143450521681108 |
|
| 8146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF800 |
0.143450521681108 |
|
| 8147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCC1 |
0.143450521681108 |
|
| 8148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARF5 |
0.143450521681108 |
|
| 8149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSCN3 |
0.143450521681108 |
|
| 8150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX4 |
0.143450521681108 |
|
| 8151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SND1 |
0.143450521681108 |
|
| 8152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC4 |
0.143450521681108 |
|
| 8153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR593 |
0.143450521681108 |
|
| 8154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEP |
0.143450521681108 |
|
| 8155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM28 |
0.143450521681108 |
|
| 8156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRT4 |
0.143450521681108 |
|
| 8157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPDH1 |
0.143450521681108 |
|
| 8158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71F1 |
0.143450521681108 |
|
| 8159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71F2 |
0.143450521681108 |
|
| 8160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HILPDA |
0.143450521681108 |
|
| 8161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL2B |
0.143450521681108 |
|
| 8162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP242 |
0.143450521681108 |
|
| 8163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP243 |
0.143450521681108 |
|
| 8164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALU |
0.143450521681108 |
|
| 8165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL81P |
0.143450521681108 |
|
| 8166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN1SW |
0.143450521681108 |
|
| 8167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC136 |
0.143450521681108 |
|
| 8168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLNC |
0.143450521681108 |
|
| 8169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCP |
0.143450521681108 |
|
| 8170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1F |
0.143450521681108 |
|
| 8171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF5 |
0.143450521681108 |
|
| 8172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNPO3 |
0.143450521681108 |
|
| 8173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL306P |
0.143450521681108 |
|
| 8174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238733.1 |
0.143450521681108 |
|
| 8175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN33 |
0.143450521681108 |
|
| 8176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMO |
0.143450521681108 |
|
| 8177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHCYL2 |
0.143450521681108 |
|
| 8178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRIP2 |
0.143450521681108 |
|
| 8179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMKR1 |
0.143450521681108 |
|
| 8180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRF1 |
0.143450521681108 |
|
| 8181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP244 |
0.143450521681108 |
|
| 8182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR182 |
0.143450521681108 |
|
| 8183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR183 |
0.143450521681108 |
|
| 8184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR96 |
0.143450521681108 |
|
| 8185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2H |
0.143450521681108 |
|
| 8186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3HC1 |
0.143450521681108 |
|
| 8187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP245 |
0.143450521681108 |
|
| 8188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC10 |
0.143450521681108 |
|
| 8189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNA4 |
0.143450521681108 |
|
| 8190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR3 |
0.143475236529964 |
|
| 8191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASF2 |
0.143475236529964 |
|
| 8192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHDC1 |
0.143475236529964 |
|
| 8193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGR |
0.143475236529964 |
|
| 8194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI6 |
0.143475236529964 |
|
| 8195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM76A |
0.143475236529964 |
|
| 8196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX12 |
0.143475236529964 |
|
| 8197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R8 |
0.143475236529964 |
|
| 8198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA1 |
0.143475236529964 |
|
| 8199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEMIS2 |
0.143475236529964 |
|
| 8200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPA2 |
0.143475236529964 |
|
| 8201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPDL3B |
0.143475236529964 |
|
| 8202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR8 |
0.143475236529964 |
|
| 8203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EYA3 |
0.143475236529964 |
|
| 8204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL559P |
0.143475236529964 |
|
| 8205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTAFR |
0.143475236529964 |
|
| 8206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC8 |
0.143475236529964 |
|
| 8207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATPIF1 |
0.143475236529964 |
|
| 8208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SESN2 |
0.143475236529964 |
|
| 8209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED18 |
0.143475236529964 |
|
| 8210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHACTR4 |
0.143475236529964 |
|
| 8211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC27P |
0.143475236529964 |
|
| 8212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCC1 |
0.143475236529964 |
|
| 8213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG3 |
0.143475236529964 |
|
| 8214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73B |
0.143475236529964 |
|
| 8215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238821.1 |
0.143475236529964 |
|
| 8216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRNAU1AP |
0.143475236529964 |
|
| 8217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG12 |
0.143475236529964 |
|
| 8218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD99 |
0.143475236529964 |
|
| 8219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF12 |
0.143475236529964 |
|
| 8220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB42 |
0.143475236529964 |
|
| 8221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU11 |
0.143475236529964 |
|
| 8222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMEB1 |
0.143475236529964 |
|
| 8223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA24|ENSG00000252777.1 |
0.143475236529964 |
|
| 8224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YTHDF2 |
0.143475236529964 |
|
| 8225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPRD1 |
0.143475236529964 |
|
| 8226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41 |
0.143475236529964 |
|
| 8227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM200B |
0.143475236529964 |
|
| 8228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF4 |
0.143475236529964 |
|
| 8229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MECR |
0.143475236529964 |
|
| 8230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRU |
0.143475236529964 |
|
| 8231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAPTM5 |
0.143475236529964 |
|
| 8232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATN1 |
0.143475236529964 |
|
| 8233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4420 |
0.143475236529964 |
|
| 8234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP91 |
0.143475236529964 |
|
| 8235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDC3 |
0.143475236529964 |
|
| 8236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUM1 |
0.143475236529964 |
|
| 8237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD103A |
0.143475236529964 |
|
| 8238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD103B |
0.143475236529964 |
|
| 8239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD85 |
0.143475236529964 |
|
| 8240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAIN1 |
0.143475236529964 |
|
| 8241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP40 |
0.143475236529964 |
|
| 8242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC17 |
0.143475236529964 |
|
| 8243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP3 |
0.143475236529964 |
|
| 8244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERINC2 |
0.143475236529964 |
|
| 8245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TINAGL1 |
0.143475236529964 |
|
| 8246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCRTR1 |
0.143475236529964 |
|
| 8247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEF1 |
0.143475236529964 |
|
| 8248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL16A1 |
0.143475236529964 |
|
| 8249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAI2 |
0.143475236529964 |
|
| 8250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4254 |
0.143475236529964 |
|
| 8251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOCD1 |
0.143475236529964 |
|
| 8252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTP4A2 |
0.143475236529964 |
|
| 8253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDRBS1 |
0.143475236529964 |
|
| 8254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM39B |
0.143475236529964 |
|
| 8255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5585 |
0.143475236529964 |
|
| 8256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA6 |
0.143475236529964 |
|
| 8257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXLNA |
0.143475236529964 |
|
| 8258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC28B |
0.143475236529964 |
|
| 8259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCC |
0.143475236529964 |
|
| 8260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCDC2B |
0.143475236529964 |
|
| 8261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM234 |
0.143475236529964 |
|
| 8262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3I |
0.143475236529964 |
|
| 8263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR9LP |
0.143475236529964 |
|
| 8264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM167B |
0.143475236529964 |
|
| 8265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCK |
0.143475236529964 |
|
| 8266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC1 |
0.143475236529964 |
|
| 8267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCKSL1 |
0.143475236529964 |
|
| 8268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSK3 |
0.143475236529964 |
|
| 8269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSDC1 |
0.143475236529964 |
|
| 8270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM229A |
0.143475236529964 |
|
| 8271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL122P |
0.143475236529964 |
|
| 8272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB8B |
0.143475236529964 |
|
| 8273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB8A |
0.143475236529964 |
|
| 8274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB8OS |
0.143475236529964 |
|
| 8275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP4 |
0.143475236529964 |
|
| 8276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNC |
0.143475236529964 |
|
| 8277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1522 |
0.143475236529964 |
|
| 8278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YARS |
0.143475236529964 |
|
| 8279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100PBP |
0.143475236529964 |
|
| 8280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC5 |
0.143475236529964 |
|
| 8281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPCA |
0.143475236529964 |
|
| 8282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM54 |
0.143475236529964 |
|
| 8283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF19B |
0.143475236529964 |
|
| 8284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG48 |
0.143475236529964 |
|
| 8285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK2 |
0.143475236529964 |
|
| 8286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADC |
0.143475236529964 |
|
| 8287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM62 |
0.143475236529964 |
|
| 8288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF362 |
0.143475236529964 |
|
| 8289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A3GALT2 |
0.143475236529964 |
|
| 8290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHC2 |
0.143475236529964 |
|
| 8291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3605 |
0.143475236529964 |
|
| 8292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP16 |
0.143475236529964 |
|
| 8293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN20 |
0.143475236529964 |
|
| 8294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSMD2 |
0.143475236529964 |
|
| 8295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB4 |
0.143475236529964 |
|
| 8296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP42 |
0.143475236529964 |
|
| 8297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf94 |
0.143475236529964 |
|
| 8298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR552 |
0.143475236529964 |
|
| 8299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM12 |
0.143475236529964 |
|
| 8300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB5 |
0.143475236529964 |
|
| 8301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB4 |
0.143475236529964 |
|
| 8302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB3 |
0.143475236529964 |
|
| 8303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA4 |
0.143475236529964 |
|
| 8304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLGAP3 |
0.143475236529964 |
|
| 8305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252728.1 |
0.143475236529964 |
|
| 8306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM6NB |
0.143475236529964 |
|
| 8307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM6 |
0.143475236529964 |
|
| 8308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM1 |
0.143475236529964 |
|
| 8309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFPQ |
0.143475236529964 |
|
| 8310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL136P |
0.143475236529964 |
|
| 8311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM4 |
0.143475236529964 |
|
| 8312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL503P |
0.143475236529964 |
|
| 8313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000201542.1 |
0.143475236529964 |
|
| 8314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5P1 |
0.143475236529964 |
|
| 8315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0319L |
0.143475236529964 |
|
| 8316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCDN |
0.143475236529964 |
|
| 8317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP2E |
0.143475236529964 |
|
| 8318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB2 |
0.143475236529964 |
|
| 8319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL281P |
0.143475236529964 |
|
| 8320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf216 |
0.143475236529964 |
|
| 8321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLSPN |
0.143475236529964 |
|
| 8322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGO4 |
0.143475236529964 |
|
| 8323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGO1 |
0.143475236529964 |
|
| 8324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGO3 |
0.143475236529964 |
|
| 8325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT2 |
0.143475236529964 |
|
| 8326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADPRHL2 |
0.143475236529964 |
|
| 8327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL8A2 |
0.143475236529964 |
|
| 8328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC3 |
0.143475236529964 |
|
| 8329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP7D1 |
0.143475236529964 |
|
| 8330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL131P |
0.143475236529964 |
|
| 8331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THRAP3 |
0.143475236529964 |
|
| 8332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3D21 |
0.143475236529964 |
|
| 8333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVA1B |
0.143475236529964 |
|
| 8334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK40 |
0.143475236529964 |
|
| 8335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM10 |
0.143475236529964 |
|
| 8336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSCP1 |
0.143475236529964 |
|
| 8337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000201448.1 |
0.143475236529964 |
|
| 8338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS15 |
0.143475236529964 |
|
| 8339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF3R |
0.143475236529964 |
|
| 8340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIK3 |
0.143475236529964 |
|
| 8341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4255 |
0.143475236529964 |
|
| 8342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP43 |
0.143475236529964 |
|
| 8343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H12A |
0.143475236529964 |
|
| 8344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEAF6 |
0.143475236529964 |
|
| 8345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5581 |
0.143475236529964 |
|
| 8346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNIP1 |
0.143475236529964 |
|
| 8347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNALI1 |
0.143475236529964 |
|
| 8348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNL2 |
0.143475236529964 |
|
| 8349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPO1 |
0.143475236529964 |
|
| 8350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf109 |
0.143475236529964 |
|
| 8351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA8 |
0.143475236529964 |
|
| 8352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA10 |
0.143475236529964 |
|
| 8353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238871.1 |
0.143475236529964 |
|
| 8354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANEAL |
0.143475236529964 |
|
| 8355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YRDC |
0.143475236529964 |
|
| 8356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf122 |
0.143475236529964 |
|
| 8357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAGC |
0.143475236529964 |
|
| 8358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCBP |
0.143475236529964 |
|
| 8359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA9 |
0.143475236529964 |
|
| 8360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDL2 |
0.143475236529964 |
|
| 8361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKIRIN1 |
0.143475236529964 |
|
| 8362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS5 |
0.143475236529964 |
|
| 8363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MACF1 |
0.143475236529964 |
|
| 8364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP44 |
0.143475236529964 |
|
| 8365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0754 |
0.143475236529964 |
|
| 8366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP8A |
0.143475236529964 |
|
| 8367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC4 |
0.143475236529964 |
|
| 8368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA55 |
0.143475236529964 |
|
| 8369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEYL |
0.143475236529964 |
|
| 8370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPCAL4 |
0.143475236529964 |
|
| 8371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C1A |
0.143475236529964 |
|
| 8372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIE |
0.143475236529964 |
|
| 8373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP8B |
0.143475236529964 |
|
| 8374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXCT2 |
0.143475236529964 |
|
| 8375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIT1 |
0.143475236529964 |
|
| 8376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCL |
0.143475236529964 |
|
| 8377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD2A |
0.143475236529964 |
|
| 8378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAP1 |
0.143475236529964 |
|
| 8379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPT1 |
0.143475236529964 |
|
| 8380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLF |
0.143475236529964 |
|
| 8381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO2 |
0.143475236529964 |
|
| 8382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMPSTE24 |
0.143475236529964 |
|
| 8383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL9A2 |
0.143475236529964 |
|
| 8384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAP2 |
0.143475236529964 |
|
| 8385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP69 |
0.143475236529964 |
|
| 8386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXO5 |
0.143475236529964 |
|
| 8387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF684 |
0.143475236529964 |
|
| 8388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMS3 |
0.143475236529964 |
|
| 8389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFYC |
0.143475236529964 |
|
| 8390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30E |
0.143475236529964 |
|
| 8391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30C1 |
0.143475236529964 |
|
| 8392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ4 |
0.143475236529964 |
|
| 8393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL326P |
0.143475236529964 |
|
| 8394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CITED4 |
0.143475236529964 |
|
| 8395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTPS1 |
0.143475236529964 |
|
| 8396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLFNL1 |
0.143475236529964 |
|
| 8397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCMH1 |
0.143475236529964 |
|
| 8398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXO6 |
0.143475236529964 |
|
| 8399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP45 |
0.143475236529964 |
|
| 8400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDN2 |
0.143475236529964 |
|
| 8401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIVEP3 |
0.143475236529964 |
|
| 8402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCA2B |
0.143475236529964 |
|
| 8403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCA2A |
0.143475236529964 |
|
| 8404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXJ3 |
0.143475236529964 |
|
| 8405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMKLA |
0.143475236529964 |
|
| 8406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND12 |
0.143475236529964 |
|
| 8407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPCS |
0.143475236529964 |
|
| 8408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC30 |
0.143475236529964 |
|
| 8409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIH |
0.143475236529964 |
|
| 8410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YBX1 |
0.143475236529964 |
|
| 8411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN19 |
0.143475236529964 |
|
| 8412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPRE1 |
0.143475236529964 |
|
| 8413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf50 |
0.143475236529964 |
|
| 8414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC23 |
0.143475236529964 |
|
| 8415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERMAP |
0.143475236529964 |
|
| 8416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF691 |
0.143475236529964 |
|
| 8417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A1 |
0.143475236529964 |
|
| 8418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM183A |
0.143475236529964 |
|
| 8419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBNA1BP2 |
0.143475236529964 |
|
| 8420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR65 |
0.143475236529964 |
|
| 8421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP46 |
0.143475236529964 |
|
| 8422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM125 |
0.143475236529964 |
|
| 8423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf210 |
0.143475236529964 |
|
| 8424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIE1 |
0.143475236529964 |
|
| 8425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPL |
0.143475236529964 |
|
| 8426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC20 |
0.143475236529964 |
|
| 8427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL1 |
0.143475236529964 |
|
| 8428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED8 |
0.143475236529964 |
|
| 8429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SZT2 |
0.143475236529964 |
|
| 8430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYI |
0.143475236529964 |
|
| 8431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRF |
0.143475236529964 |
|
| 8432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM4A |
0.143475236529964 |
|
| 8433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL3 |
0.143475236529964 |
|
| 8434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARTN |
0.143475236529964 |
|
| 8435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO13 |
0.143475236529964 |
|
| 8436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH2 |
0.143475236529964 |
|
| 8437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0B |
0.143475236529964 |
|
| 8438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT2 |
0.143475236529964 |
|
| 8439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC24 |
0.143475236529964 |
|
| 8440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A9 |
0.143475236529964 |
|
| 8441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF17 |
0.143475236529964 |
|
| 8442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL479P |
0.143475236529964 |
|
| 8443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMAP1 |
0.143475236529964 |
|
| 8444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERI3 |
0.143475236529964 |
|
| 8445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF220 |
0.143475236529964 |
|
| 8446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5584 |
0.143475236529964 |
|
| 8447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM53 |
0.143475236529964 |
|
| 8448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf228 |
0.143475236529964 |
|
| 8449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF2C |
0.143475236529964 |
|
| 8450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEST4 |
0.143475236529964 |
|
| 8451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD19 |
0.143475236529964 |
|
| 8452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK3 |
0.143475236529964 |
|
| 8453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS8 |
0.143475236529964 |
|
| 8454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38A |
0.143475236529964 |
|
| 8455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38B |
0.143475236529964 |
|
| 8456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD46|ENSG00000200913.1 |
0.143475236529964 |
|
| 8457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD55 |
0.143475236529964 |
|
| 8458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTEX1D4 |
0.143475236529964 |
|
| 8459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCH2 |
0.143475236529964 |
|
| 8460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2B3 |
0.143475236529964 |
|
| 8461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP47 |
0.143475236529964 |
|
| 8462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECTD3 |
0.143475236529964 |
|
| 8463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UROD |
0.143475236529964 |
|
| 8464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM5 |
0.143475236529964 |
|
| 8465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPDL |
0.143475236529964 |
|
| 8466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUTYH |
0.143475236529964 |
|
| 8467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TESK2 |
0.143475236529964 |
|
| 8468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOE1 |
0.143475236529964 |
|
| 8469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238945.1 |
0.143475236529964 |
|
| 8470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC163P |
0.143475236529964 |
|
| 8471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMACHC |
0.143475236529964 |
|
| 8472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX1 |
0.143475236529964 |
|
| 8473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1A1 |
0.143475236529964 |
|
| 8474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NASP |
0.143475236529964 |
|
| 8475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC17 |
0.143475236529964 |
|
| 8476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPBP1L1 |
0.143475236529964 |
|
| 8477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM69 |
0.143475236529964 |
|
| 8478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPP |
0.143475236529964 |
|
| 8479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAST2 |
0.143475236529964 |
|
| 8480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R3 |
0.143475236529964 |
|
| 8481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN1 |
0.143475236529964 |
|
| 8482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMGNT1 |
0.143475236529964 |
|
| 8483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LURAP1 |
0.143475236529964 |
|
| 8484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD54L |
0.143475236529964 |
|
| 8485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC41 |
0.143475236529964 |
|
| 8486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRH |
0.143475236529964 |
|
| 8487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN4 |
0.143475236529964 |
|
| 8488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAAH |
0.143475236529964 |
|
| 8489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00505 |
0.143475236529964 |
|
| 8490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMBX1 |
0.143475236529964 |
|
| 8491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNCN |
0.143475236529964 |
|
| 8492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKNK1 |
0.143475236529964 |
|
| 8493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB3C |
0.143475236529964 |
|
| 8494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATPAF1 |
0.143475236529964 |
|
| 8495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB14 |
0.143475236529964 |
|
| 8496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX38 |
0.143475236529964 |
|
| 8497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4B1 |
0.143475236529964 |
|
| 8498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4Z2P |
0.143475236529964 |
|
| 8499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4A11 |
0.143475236529964 |
|
| 8500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4X1 |
0.143475236529964 |
|
| 8501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4Z1 |
0.143475236529964 |
|
| 8502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4A22 |
0.143475236529964 |
|
| 8503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00853 |
0.143475236529964 |
|
| 8504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZK1IP1 |
0.143475236529964 |
|
| 8505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAL1 |
0.143475236529964 |
|
| 8506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STIL |
0.143475236529964 |
|
| 8507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMPK1 |
0.143475236529964 |
|
| 8508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXE3 |
0.143475236529964 |
|
| 8509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD2 |
0.143475236529964 |
|
| 8510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRABD2B |
0.143475236529964 |
|
| 8511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKINTL |
0.143475236529964 |
|
| 8512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A9 |
0.143475236529964 |
|
| 8513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR761 |
0.143475236529964 |
|
| 8514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3B |
0.143475236529964 |
|
| 8515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP48 |
0.143475236529964 |
|
| 8516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL290P |
0.143475236529964 |
|
| 8517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC12 |
0.143475236529964 |
|
| 8518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KTI12 |
0.143475236529964 |
|
| 8519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTF3L4 |
0.143475236529964 |
|
| 8520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE9 |
0.143475236529964 |
|
| 8521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL788P |
0.143475236529964 |
|
| 8522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CC2D1B |
0.143475236529964 |
|
| 8523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC1 |
0.143475236529964 |
|
| 8524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF38A |
0.143475236529964 |
|
| 8525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC11 |
0.143475236529964 |
|
| 8526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239063.1 |
0.143475236529964 |
|
| 8527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX7 |
0.143475236529964 |
|
| 8528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM159A |
0.143475236529964 |
|
| 8529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELRC1 |
0.143475236529964 |
|
| 8530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL62P |
0.143475236529964 |
|
| 8531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZYG11B |
0.143475236529964 |
|
| 8532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZYG11A |
0.143475236529964 |
|
| 8533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECHDC2 |
0.143475236529964 |
|
| 8534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCP2 |
0.143475236529964 |
|
| 8535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1273F |
0.143475236529964 |
|
| 8536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5095 |
0.143475236529964 |
|
| 8537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1273G |
0.143475236529964 |
|
| 8538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PODN |
0.143475236529964 |
|
| 8539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A7 |
0.143475236529964 |
|
| 8540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPT2 |
0.143475236529964 |
|
| 8541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf123 |
0.143475236529964 |
|
| 8542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGOH |
0.143475236529964 |
|
| 8543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP8 |
0.143475236529964 |
|
| 8544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A3P1 |
0.143475236529964 |
|
| 8545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTB1 |
0.143475236529964 |
|
| 8546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIS1 |
0.143475236529964 |
|
| 8547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDC1 |
0.143475236529964 |
|
| 8548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA58|ENSG00000201003.1 |
0.143475236529964 |
|
| 8549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF1 |
0.143475236529964 |
|
| 8550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIO1 |
0.143475236529964 |
|
| 8551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB11 |
0.143475236529964 |
|
| 8552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC42 |
0.143475236529964 |
|
| 8553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLRAD1 |
0.143475236529964 |
|
| 8554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM59 |
0.143475236529964 |
|
| 8555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4781 |
0.143475236529964 |
|
| 8556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEANC2 |
0.143475236529964 |
|
| 8557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCP2 |
0.143475236529964 |
|
| 8558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5RL |
0.143475236529964 |
|
| 8559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL37 |
0.143475236529964 |
|
| 8560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSBP3 |
0.143475236529964 |
|
| 8561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf191 |
0.143475236529964 |
|
| 8562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252646.1 |
0.143475236529964 |
|
| 8563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT11 |
0.143475236529964 |
|
| 8564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM151A |
0.143475236529964 |
|
| 8565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH7 |
0.143475236529964 |
|
| 8566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC4 |
0.143475236529964 |
|
| 8567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf177 |
0.143475236529964 |
|
| 8568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARS2 |
0.143475236529964 |
|
| 8569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC22 |
0.143475236529964 |
|
| 8570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHCR24 |
0.143475236529964 |
|
| 8571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM61 |
0.143475236529964 |
|
| 8572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSND |
0.143475236529964 |
|
| 8573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK9 |
0.143475236529964 |
|
| 8574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP24 |
0.143475236529964 |
|
| 8575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4422 |
0.143475236529964 |
|
| 8576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP291 |
0.143475236529964 |
|
| 8577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAP2B |
0.143475236529964 |
|
| 8578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAA2 |
0.143475236529964 |
|
| 8579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf168 |
0.143475236529964 |
|
| 8580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8A |
0.143475236529964 |
|
| 8581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8B |
0.143475236529964 |
|
| 8582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAB1 |
0.143475236529964 |
|
| 8583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OMA1 |
0.143475236529964 |
|
| 8584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL713P |
0.143475236529964 |
|
| 8585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACSTD2 |
0.143475236529964 |
|
| 8586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYSM1 |
0.143475236529964 |
|
| 8587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JUN |
0.143475236529964 |
|
| 8588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGGY |
0.143475236529964 |
|
| 8589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4711 |
0.143475236529964 |
|
| 8590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOOK1 |
0.143475236529964 |
|
| 8591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2J2 |
0.143475236529964 |
|
| 8592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL475P |
0.143475236529964 |
|
| 8593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf87 |
0.143475236529964 |
|
| 8594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFIA |
0.143475236529964 |
|
| 8595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM2D1 |
0.143475236529964 |
|
| 8596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INADL |
0.143475236529964 |
|
| 8597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL180P |
0.143475236529964 |
|
| 8598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L1TD1 |
0.143475236529964 |
|
| 8599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANK4 |
0.143475236529964 |
|
| 8600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP1 |
0.143475236529964 |
|
| 8601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK7 |
0.143475236529964 |
|
| 8602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL3 |
0.143475236529964 |
|
| 8603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG4C |
0.143475236529964 |
|
| 8604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00466 |
0.143475236529964 |
|
| 8605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP49 |
0.143475236529964 |
|
| 8606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD3 |
0.143475236529964 |
|
| 8607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG6 |
0.143475236529964 |
|
| 8608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB3BP |
0.143475236529964 |
|
| 8609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB7 |
0.143475236529964 |
|
| 8610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL488P |
0.143475236529964 |
|
| 8611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLEU2L |
0.143475236529964 |
|
| 8612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM1 |
0.143475236529964 |
|
| 8613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL130P |
0.143475236529964 |
|
| 8614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROR1 |
0.143475236529964 |
|
| 8615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2U |
0.143475236529964 |
|
| 8616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACHD1 |
0.143475236529964 |
|
| 8617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4794 |
0.143475236529964 |
|
| 8618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAVER2 |
0.143475236529964 |
|
| 8619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAK1 |
0.143475236529964 |
|
| 8620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3671 |
0.143475236529964 |
|
| 8621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK4 |
0.143475236529964 |
|
| 8622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC6 |
0.143475236529964 |
|
| 8623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPROT |
0.143475236529964 |
|
| 8624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPR |
0.143475236529964 |
|
| 8625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238931.1 |
0.143475236529964 |
|
| 8626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL854P |
0.143475236529964 |
|
| 8627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE4B |
0.143475236529964 |
|
| 8628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGIP1 |
0.143475236529964 |
|
| 8629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3117 |
0.143475236529964 |
|
| 8630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTEX1D1 |
0.143475236529964 |
|
| 8631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSL5 |
0.143475236529964 |
|
| 8632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR78 |
0.143475236529964 |
|
| 8633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIER1 |
0.143475236529964 |
|
| 8634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35D1 |
0.143475236529964 |
|
| 8635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf141 |
0.143475236529964 |
|
| 8636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252433.1 |
0.143475236529964 |
|
| 8637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL23R |
0.143475236529964 |
|
| 8638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC4P |
0.143475236529964 |
|
| 8639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL12RB2 |
0.143475236529964 |
|
| 8640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERBP1 |
0.143475236529964 |
|
| 8641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL392P |
0.143475236529964 |
|
| 8642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GADD45A |
0.143475236529964 |
|
| 8643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG12 |
0.143475236529964 |
|
| 8644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRAS3 |
0.143475236529964 |
|
| 8645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WLS |
0.143475236529964 |
|
| 8646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1262 |
0.143475236529964 |
|
| 8647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPE65 |
0.143475236529964 |
|
| 8648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPDC1 |
0.143475236529964 |
|
| 8649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC7 |
0.143475236529964 |
|
| 8650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL538P |
0.143475236529964 |
|
| 8651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIN1P1 |
0.143475236529964 |
|
| 8652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC40 |
0.143475236529964 |
|
| 8653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL242P |
0.143475236529964 |
|
| 8654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF11 |
0.143475236529964 |
|
| 8655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD13C |
0.143475236529964 |
|
| 8656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHLA3 |
0.143475236529964 |
|
| 8657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTH |
0.143475236529964 |
|
| 8658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGER3 |
0.143475236529964 |
|
| 8659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZRANB2 |
0.143475236529964 |
|
| 8660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR186 |
0.143475236529964 |
|
| 8661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEGR1 |
0.143475236529964 |
|
| 8662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP19 |
0.143475236529964 |
|
| 8663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP50 |
0.143475236529964 |
|
| 8664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC8P |
0.143475236529964 |
|
| 8665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC53 |
0.143475236529964 |
|
| 8666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf173 |
0.143475236529964 |
|
| 8667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYZ |
0.143475236529964 |
|
| 8668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYW3 |
0.143475236529964 |
|
| 8669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX8 |
0.143475236529964 |
|
| 8670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZZZ3 |
0.143475236529964 |
|
| 8671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP20 |
0.143475236529964 |
|
| 8672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL370P |
0.143475236529964 |
|
| 8673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP33 |
0.143475236529964 |
|
| 8674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM73A |
0.143475236529964 |
|
| 8675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP21 |
0.143475236529964 |
|
| 8676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEXN |
0.143475236529964 |
|
| 8677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUBP1 |
0.143475236529964 |
|
| 8678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB4 |
0.143475236529964 |
|
| 8679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIPC2 |
0.143475236529964 |
|
| 8680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP22 |
0.143475236529964 |
|
| 8681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGFR |
0.143475236529964 |
|
| 8682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP23 |
0.143475236529964 |
|
| 8683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI44L |
0.143475236529964 |
|
| 8684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI44 |
0.143475236529964 |
|
| 8685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELTD1 |
0.143475236529964 |
|
| 8686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf162 |
0.143475236529964 |
|
| 8687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADORA3 |
0.143475236529964 |
|
| 8688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP1A |
0.143475236529964 |
|
| 8689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM212B |
0.143475236529964 |
|
| 8690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX20 |
0.143475236529964 |
|
| 8691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCND3 |
0.143475236529964 |
|
| 8692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239111.1 |
0.143475236529964 |
|
| 8693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238761.1 |
0.143475236529964 |
|
| 8694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTTNBP2NL |
0.143475236529964 |
|
| 8695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT2B |
0.143475236529964 |
|
| 8696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST7L |
0.143475236529964 |
|
| 8697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPZA1 |
0.143475236529964 |
|
| 8698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238975.1 |
0.143475236529964 |
|
| 8699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A1 |
0.143475236529964 |
|
| 8700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIG2 |
0.143475236529964 |
|
| 8701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGI3 |
0.143475236529964 |
|
| 8702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHTF1 |
0.143475236529964 |
|
| 8703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSBN1 |
0.143475236529964 |
|
| 8704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN22 |
0.143475236529964 |
|
| 8705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L15 |
0.143475236529964 |
|
| 8706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP4B1 |
0.143475236529964 |
|
| 8707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLRE1B |
0.143475236529964 |
|
| 8708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIPK1 |
0.143475236529964 |
|
| 8709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFML3 |
0.143475236529964 |
|
| 8710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT6 |
0.143475236529964 |
|
| 8711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM33 |
0.143475236529964 |
|
| 8712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAS2 |
0.143475236529964 |
|
| 8713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND2C |
0.143475236529964 |
|
| 8714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMPD1 |
0.143475236529964 |
|
| 8715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL432P |
0.143475236529964 |
|
| 8716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRAS |
0.143475236529964 |
|
| 8717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSDE1 |
0.143475236529964 |
|
| 8718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIKE1 |
0.143475236529964 |
|
| 8719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCP1 |
0.143475236529964 |
|
| 8720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSHB |
0.143475236529964 |
|
| 8721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN2 |
0.143475236529964 |
|
| 8722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGF |
0.143475236529964 |
|
| 8723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL420P |
0.143475236529964 |
|
| 8724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA42|ENSG00000207502.1 |
0.143475236529964 |
|
| 8725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VANGL1 |
0.143475236529964 |
|
| 8726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASQ2 |
0.143475236529964 |
|
| 8727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLH2 |
0.143475236529964 |
|
| 8728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A15 |
0.143475236529964 |
|
| 8729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAB21L3 |
0.143475236529964 |
|
| 8730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221040.1 |
0.143475236529964 |
|
| 8731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1A1 |
0.143475236529964 |
|
| 8732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1A1OS |
0.143475236529964 |
|
| 8733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EYS |
0.144034745663865 |
|
| 8734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00693 |
0.145159125400436 |
|
| 8735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF860 |
0.145159125400436 |
|
| 8736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000201701.1 |
0.145159125400436 |
|
| 8737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM71 |
0.145159125400436 |
|
| 8738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR4 |
0.145159125400436 |
|
| 8739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP128 |
0.145159125400436 |
|
| 8740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLASP2 |
0.145159125400436 |
|
| 8741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPP21 |
0.145159125400436 |
|
| 8742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAC |
0.145159125400436 |
|
| 8743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP227 |
0.145159125400436 |
|
| 8744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLK3 |
0.145159125400436 |
|
| 8745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPD1P6 |
0.145159125400436 |
|
| 8746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRANK1 |
0.145159125400436 |
|
| 8747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC4P |
0.145159125400436 |
|
| 8748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPM2AIP1 |
0.145159125400436 |
|
| 8749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLH1 |
0.145159125400436 |
|
| 8750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRFIP2 |
0.145159125400436 |
|
| 8751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238929.1 |
0.145159125400436 |
|
| 8752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA4 |
0.145159125400436 |
|
| 8753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP129 |
0.145159125400436 |
|
| 8754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf35 |
0.145159125400436 |
|
| 8755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA9 |
0.145159125400436 |
|
| 8756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDSPL |
0.145159125400436 |
|
| 8757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR26A1 |
0.145159125400436 |
|
| 8758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VILL |
0.145159125400436 |
|
| 8759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCD1 |
0.145159125400436 |
|
| 8760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLEC1 |
0.145159125400436 |
|
| 8761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAA1 |
0.145159125400436 |
|
| 8762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYD88 |
0.145159125400436 |
|
| 8763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXSR1 |
0.145159125400436 |
|
| 8764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A13 |
0.145159125400436 |
|
| 8765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A14 |
0.145159125400436 |
|
| 8766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XYLB |
0.145159125400436 |
|
| 8767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVR2B |
0.145159125400436 |
|
| 8768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOG |
0.145159125400436 |
|
| 8769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN5A |
0.145159125400436 |
|
| 8770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN10A |
0.145159125400436 |
|
| 8771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN11A |
0.145159125400436 |
|
| 8772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR48 |
0.145159125400436 |
|
| 8773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GORASP1 |
0.145159125400436 |
|
| 8774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC21A |
0.145159125400436 |
|
| 8775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRNP1 |
0.145159125400436 |
|
| 8776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XIRP1 |
0.145159125400436 |
|
| 8777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CX3CR1 |
0.145159125400436 |
|
| 8778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR8 |
0.145159125400436 |
|
| 8779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A38 |
0.145159125400436 |
|
| 8780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPSA |
0.145159125400436 |
|
| 8781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000202363.1 |
0.145159125400436 |
|
| 8782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA6 |
0.145159125400436 |
|
| 8783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOBP |
0.145159125400436 |
|
| 8784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYRIP |
0.145159125400436 |
|
| 8785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL411P |
0.145159125400436 |
|
| 8786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000202517.1 |
0.145159125400436 |
|
| 8787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF1B |
0.145159125400436 |
|
| 8788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD3 |
0.145159125400436 |
|
| 8789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL14 |
0.145159125400436 |
|
| 8790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF619 |
0.145159125400436 |
|
| 8791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF620 |
0.145159125400436 |
|
| 8792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF621 |
0.145159125400436 |
|
| 8793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNB1 |
0.145159125400436 |
|
| 8794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK4 |
0.145159125400436 |
|
| 8795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA21|ENSG00000252409.1 |
0.145159125400436 |
|
| 8796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP58 |
0.145159125400436 |
|
| 8797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAK1 |
0.145159125400436 |
|
| 8798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000212145.2 |
0.145159125400436 |
|
| 8799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCK |
0.145159125400436 |
|
| 8800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYZL4 |
0.145159125400436 |
|
| 8801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIPR1 |
0.145159125400436 |
|
| 8802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC22C |
0.145159125400436 |
|
| 8803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SS18L2 |
0.145159125400436 |
|
| 8804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKTR |
0.145159125400436 |
|
| 8805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB47 |
0.145159125400436 |
|
| 8806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL567P |
0.145159125400436 |
|
| 8807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL40 |
0.145159125400436 |
|
| 8808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC13 |
0.145159125400436 |
|
| 8809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHATL |
0.145159125400436 |
|
| 8810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIGD1A |
0.145159125400436 |
|
| 8811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACKR2 |
0.145159125400436 |
|
| 8812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRBOX1 |
0.145159125400436 |
|
| 8813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP8B1 |
0.145159125400436 |
|
| 8814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF662 |
0.145159125400436 |
|
| 8815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM198A |
0.145159125400436 |
|
| 8816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTDC2 |
0.145159125400436 |
|
| 8817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRK |
0.145159125400436 |
|
| 8818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL517P |
0.145159125400436 |
|
| 8819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO10 |
0.145159125400436 |
|
| 8820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD5 |
0.145159125400436 |
|
| 8821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOPAZ1 |
0.145159125400436 |
|
| 8822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCAIM |
0.145159125400436 |
|
| 8823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00694 |
0.145159125400436 |
|
| 8824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF445 |
0.145159125400436 |
|
| 8825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF852 |
0.145159125400436 |
|
| 8826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN7 |
0.145159125400436 |
|
| 8827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF660 |
0.145159125400436 |
|
| 8828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF197 |
0.145159125400436 |
|
| 8829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF35 |
0.145159125400436 |
|
| 8830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF502 |
0.145159125400436 |
|
| 8831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF501 |
0.145159125400436 |
|
| 8832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1143 |
0.145159125400436 |
|
| 8833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF15 |
0.145159125400436 |
|
| 8834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR564 |
0.145159125400436 |
|
| 8835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM42 |
0.145159125400436 |
|
| 8836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM4 |
0.145159125400436 |
|
| 8837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC3 |
0.145159125400436 |
|
| 8838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC7 |
0.145159125400436 |
|
| 8839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC3B |
0.145159125400436 |
|
| 8840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCP1 |
0.145159125400436 |
|
| 8841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM158 |
0.145159125400436 |
|
| 8842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000202268.1 |
0.145159125400436 |
|
| 8843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SACM1L |
0.145159125400436 |
|
| 8844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL145P |
0.145159125400436 |
|
| 8845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A20 |
0.145159125400436 |
|
| 8846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZTFL1 |
0.145159125400436 |
|
| 8847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR9 |
0.145159125400436 |
|
| 8848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FYCO1 |
0.145159125400436 |
|
| 8849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR6 |
0.145159125400436 |
|
| 8850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XCR1 |
0.145159125400436 |
|
| 8851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR3 |
0.145159125400436 |
|
| 8852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR1 |
0.145159125400436 |
|
| 8853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR2 |
0.145159125400436 |
|
| 8854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR5 |
0.145159125400436 |
|
| 8855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACKR5 |
0.145159125400436 |
|
| 8856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTF |
0.145159125400436 |
|
| 8857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTP3 |
0.145159125400436 |
|
| 8858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC2 |
0.145159125400436 |
|
| 8859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUZPP1 |
0.145159125400436 |
|
| 8860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDGF1 |
0.145159125400436 |
|
| 8861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD77|ENSG00000251967.1 |
0.145159125400436 |
|
| 8862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALS2CL |
0.145159125400436 |
|
| 8863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMIE |
0.145159125400436 |
|
| 8864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS50 |
0.145159125400436 |
|
| 8865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS46 |
0.145159125400436 |
|
| 8866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS42 |
0.145159125400436 |
|
| 8867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS44 |
0.145159125400436 |
|
| 8868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS45 |
0.145159125400436 |
|
| 8869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL3 |
0.145159125400436 |
|
| 8870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTH1R |
0.145159125400436 |
|
| 8871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC12 |
0.145159125400436 |
|
| 8872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBEAL2 |
0.145159125400436 |
|
| 8873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF9 |
0.145159125400436 |
|
| 8874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239128.1 |
0.145159125400436 |
|
| 8875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL18 |
0.145159125400436 |
|
| 8876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN23 |
0.145159125400436 |
|
| 8877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAP |
0.145159125400436 |
|
| 8878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238350.1 |
0.145159125400436 |
|
| 8879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELP6 |
0.145159125400436 |
|
| 8880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL870P |
0.145159125400436 |
|
| 8881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPG5 |
0.145159125400436 |
|
| 8882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCC1 |
0.145159125400436 |
|
| 8883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX30 |
0.145159125400436 |
|
| 8884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4 |
0.145159125400436 |
|
| 8885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1226 |
0.145159125400436 |
|
| 8886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL664P |
0.145159125400436 |
|
| 8887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC25A |
0.145159125400436 |
|
| 8888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4443 |
0.145159125400436 |
|
| 8889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMP |
0.145159125400436 |
|
| 8890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF589 |
0.145159125400436 |
|
| 8891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME6 |
0.145159125400436 |
|
| 8892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2115 |
0.145159125400436 |
|
| 8893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK8 |
0.145159125400436 |
|
| 8894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW12 |
0.145159125400436 |
|
| 8895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL321P |
0.145159125400436 |
|
| 8896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNB1 |
0.145159125400436 |
|
| 8897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC51 |
0.145159125400436 |
|
| 8898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMA7 |
0.145159125400436 |
|
| 8899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATRIP |
0.145159125400436 |
|
| 8900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA5 |
0.145159125400436 |
|
| 8901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREX1 |
0.145159125400436 |
|
| 8902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKFB4 |
0.145159125400436 |
|
| 8903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCN2 |
0.145159125400436 |
|
| 8904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL7A1 |
0.145159125400436 |
|
| 8905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR711 |
0.145159125400436 |
|
| 8906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRC1 |
0.145159125400436 |
|
| 8907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM89 |
0.145159125400436 |
|
| 8908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A6 |
0.145159125400436 |
|
| 8909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELSR3 |
0.145159125400436 |
|
| 8910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4793 |
0.145159125400436 |
|
| 8911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCKIPSD |
0.145159125400436 |
|
| 8912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IP6K2 |
0.145159125400436 |
|
| 8913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAR2A |
0.145159125400436 |
|
| 8914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A20 |
0.145159125400436 |
|
| 8915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARIH2OS |
0.145159125400436 |
|
| 8916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARIH2 |
0.145159125400436 |
|
| 8917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P4HTM |
0.145159125400436 |
|
| 8918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR6 |
0.145159125400436 |
|
| 8919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DALRD3 |
0.145159125400436 |
|
| 8920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR191 |
0.145159125400436 |
|
| 8921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR425 |
0.145159125400436 |
|
| 8922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF3 |
0.145159125400436 |
|
| 8923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPDH2 |
0.145159125400436 |
|
| 8924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QRICH1 |
0.145159125400436 |
|
| 8925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL182P |
0.145159125400436 |
|
| 8926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QARS |
0.145159125400436 |
|
| 8927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP19 |
0.145159125400436 |
|
| 8928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMB2 |
0.145159125400436 |
|
| 8929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC71 |
0.145159125400436 |
|
| 8930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC8B |
0.145159125400436 |
|
| 8931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf84 |
0.145159125400436 |
|
| 8932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC36 |
0.145159125400436 |
|
| 8933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf62 |
0.145159125400436 |
|
| 8934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4271 |
0.145159125400436 |
|
| 8935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP4 |
0.145159125400436 |
|
| 8936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX1 |
0.145159125400436 |
|
| 8937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOA |
0.145159125400436 |
|
| 8938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTA |
0.145159125400436 |
|
| 8939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMT |
0.145159125400436 |
|
| 8940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NICN1 |
0.145159125400436 |
|
| 8941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAG1 |
0.145159125400436 |
|
| 8942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP130 |
0.145159125400436 |
|
| 8943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSN |
0.145159125400436 |
|
| 8944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APEH |
0.145159125400436 |
|
| 8945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MST1 |
0.145159125400436 |
|
| 8946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF123 |
0.145159125400436 |
|
| 8947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMIGO3 |
0.145159125400436 |
|
| 8948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMPPB |
0.145159125400436 |
|
| 8949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IP6K1 |
0.145159125400436 |
|
| 8950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDHR4 |
0.145159125400436 |
|
| 8951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM212A |
0.145159125400436 |
|
| 8952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5193 |
0.145159125400436 |
|
| 8953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA7 |
0.145159125400436 |
|
| 8954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAIP |
0.145159125400436 |
|
| 8955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMKV |
0.145159125400436 |
|
| 8956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL217P |
0.145159125400436 |
|
| 8957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MST1R |
0.145159125400436 |
|
| 8958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MON1A |
0.145159125400436 |
|
| 8959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM6 |
0.145159125400436 |
|
| 8960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM5 |
0.145159125400436 |
|
| 8961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3F |
0.145159125400436 |
|
| 8962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR566 |
0.145159125400436 |
|
| 8963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAT1 |
0.145159125400436 |
|
| 8964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A3 |
0.145159125400436 |
|
| 8965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAI2 |
0.145159125400436 |
|
| 8966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3B |
0.145159125400436 |
|
| 8967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSMEM2 |
0.145159125400436 |
|
| 8968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFRD2 |
0.145159125400436 |
|
| 8969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYAL3 |
0.145159125400436 |
|
| 8970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYAL1 |
0.145159125400436 |
|
| 8971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT6 |
0.145159125400436 |
|
| 8972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYAL2 |
0.145159125400436 |
|
| 8973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUSC2 |
0.145159125400436 |
|
| 8974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF1 |
0.145159125400436 |
|
| 8975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYND10 |
0.145159125400436 |
|
| 8976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPRL2 |
0.145159125400436 |
|
| 8977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB561D2 |
0.145159125400436 |
|
| 8978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM115 |
0.145159125400436 |
|
| 8979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA2D2 |
0.145159125400436 |
|
| 8980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP131 |
0.145159125400436 |
|
| 8981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf18 |
0.145159125400436 |
|
| 8982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEMK1 |
0.145159125400436 |
|
| 8983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CISH |
0.145159125400436 |
|
| 8984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPKAPK3 |
0.145159125400436 |
|
| 8985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK3 |
0.145159125400436 |
|
| 8986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4787 |
0.145159125400436 |
|
| 8987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANF |
0.145159125400436 |
|
| 8988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM15B |
0.145159125400436 |
|
| 8989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPRBP |
0.145159125400436 |
|
| 8990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD54L2 |
0.145159125400436 |
|
| 8991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC29P |
0.145159125400436 |
|
| 8992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX264 |
0.145159125400436 |
|
| 8993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP132 |
0.145159125400436 |
|
| 8994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM2 |
0.145159125400436 |
|
| 8995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCF6 |
0.145159125400436 |
|
| 8996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCF3 |
0.145159125400436 |
|
| 8997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCF2 |
0.145159125400436 |
|
| 8998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL504P |
0.145159125400436 |
|
| 8999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCF5 |
0.145159125400436 |
|
| 9000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCF1 |
0.145159125400436 |
|
| 9001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP9 |
0.145159125400436 |
|
| 9002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP3 |
0.145159125400436 |
|
| 9003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR62 |
0.145159125400436 |
|
| 9004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBP4 |
0.145159125400436 |
|
| 9005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD14B |
0.145159125400436 |
|
| 9006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD14A |
0.145159125400436 |
|
| 9007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACY1 |
0.145159125400436 |
|
| 9008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL29 |
0.145159125400436 |
|
| 9009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP7 |
0.145159125400436 |
|
| 9010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00696 |
0.145159125400436 |
|
| 9011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POC1A |
0.145159125400436 |
|
| 9012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALAS1 |
0.145159125400436 |
|
| 9013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR9 |
0.145159125400436 |
|
| 9014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWF2 |
0.145159125400436 |
|
| 9015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1M |
0.145159125400436 |
|
| 9016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR82 |
0.145159125400436 |
|
| 9017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7G |
0.145159125400436 |
|
| 9018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYCTK |
0.145159125400436 |
|
| 9019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR135A1 |
0.145159125400436 |
|
| 9020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH1 |
0.145159125400436 |
|
| 9021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAP1 |
0.145159125400436 |
|
| 9022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF7 |
0.145159125400436 |
|
| 9023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3G |
0.145159125400436 |
|
| 9024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNC1 |
0.145159125400436 |
|
| 9025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NISCH |
0.145159125400436 |
|
| 9026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAB1 |
0.145159125400436 |
|
| 9027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5DC2 |
0.145159125400436 |
|
| 9028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM4 |
0.145159125400436 |
|
| 9029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBRM1 |
0.145159125400436 |
|
| 9030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC16P |
0.145159125400436 |
|
| 9031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNL3 |
0.145159125400436 |
|
| 9032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD19B|ENSG00000238862.1 |
0.145159125400436 |
|
| 9033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD19B|ENSG00000252787.1 |
0.145159125400436 |
|
| 9034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD19|ENSG00000212493.1 |
0.145159125400436 |
|
| 9035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD19|ENSG00000222345.1 |
0.145159125400436 |
|
| 9036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD69 |
0.145159125400436 |
|
| 9037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLT8D1 |
0.145159125400436 |
|
| 9038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPCS1 |
0.145159125400436 |
|
| 9039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK4 |
0.145159125400436 |
|
| 9040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH1 |
0.145159125400436 |
|
| 9041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH3 |
0.145159125400436 |
|
| 9042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH4 |
0.145159125400436 |
|
| 9043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUSTN1 |
0.145159125400436 |
|
| 9044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM110 |
0.145159125400436 |
|
| 9045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFMBT1 |
0.145159125400436 |
|
| 9046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFT1 |
0.145159125400436 |
|
| 9047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCD |
0.145159125400436 |
|
| 9048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TKT |
0.145159125400436 |
|
| 9049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238565.1 |
0.145159125400436 |
|
| 9050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCP1A |
0.145159125400436 |
|
| 9051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL821P |
0.145159125400436 |
|
| 9052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38|ENSG00000207109.1 |
0.145159125400436 |
|
| 9053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212608.1 |
0.145159125400436 |
|
| 9054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1D |
0.145159125400436 |
|
| 9055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD63|ENSG00000251987.1 |
0.145159125400436 |
|
| 9056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHDH |
0.145159125400436 |
|
| 9057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17RB |
0.145159125400436 |
|
| 9058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR8 |
0.145159125400436 |
|
| 9059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELK |
0.145159125400436 |
|
| 9060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA2D3 |
0.145159125400436 |
|
| 9061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRG |
0.145159125400436 |
|
| 9062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRTM1 |
0.145159125400436 |
|
| 9063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT5A |
0.145159125400436 |
|
| 9064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERC2 |
0.145159125400436 |
|
| 9065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3938 |
0.145159125400436 |
|
| 9066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP45 |
0.145159125400436 |
|
| 9067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP133 |
0.145159125400436 |
|
| 9068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC66 |
0.145159125400436 |
|
| 9069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM208A |
0.145159125400436 |
|
| 9070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF3 |
0.145159125400436 |
|
| 9071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA12 |
0.145159125400436 |
|
| 9072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17RD |
0.145159125400436 |
|
| 9073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HESX1 |
0.145159125400436 |
|
| 9074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APPL1 |
0.145159125400436 |
|
| 9075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB14 |
0.145159125400436 |
|
| 9076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH12 |
0.145159125400436 |
|
| 9077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238905.1 |
0.145159125400436 |
|
| 9078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE12 |
0.145159125400436 |
|
| 9079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARF4 |
0.145159125400436 |
|
| 9080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC26P |
0.145159125400436 |
|
| 9081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND6A |
0.145159125400436 |
|
| 9082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLMAP |
0.145159125400436 |
|
| 9083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLNB |
0.145159125400436 |
|
| 9084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE1L3 |
0.145159125400436 |
|
| 9085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD6 |
0.145159125400436 |
|
| 9086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP14 |
0.145159125400436 |
|
| 9087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXK |
0.145159125400436 |
|
| 9088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDHB |
0.145159125400436 |
|
| 9089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD6 |
0.145159125400436 |
|
| 9090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOX2 |
0.145159125400436 |
|
| 9091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM107A |
0.145159125400436 |
|
| 9092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM3D |
0.145159125400436 |
|
| 9093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf67 |
0.145159125400436 |
|
| 9094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHIT |
0.145159125400436 |
|
| 9095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPCDR1 |
0.145159125400436 |
|
| 9096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212211.1 |
0.145159125400436 |
|
| 9097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRG |
0.145159125400436 |
|
| 9098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf14 |
0.145159125400436 |
|
| 9099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEZF2 |
0.145159125400436 |
|
| 9100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADPS |
0.145159125400436 |
|
| 9101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL863P |
0.145159125400436 |
|
| 9102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00698 |
0.145159125400436 |
|
| 9103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNPR |
0.145159125400436 |
|
| 9104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP134 |
0.145159125400436 |
|
| 9105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTN |
0.145159125400436 |
|
| 9106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAI |
0.146040940016099 |
|
| 9107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP6C |
0.146040940016099 |
|
| 9108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABEPK |
0.146040940016099 |
|
| 9109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA5 |
0.146040940016099 |
|
| 9110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAPVD1 |
0.146040940016099 |
|
| 9111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC178 |
0.146311457005439 |
|
| 9112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRB10 |
0.147496266144444 |
|
| 9113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COBL |
0.147496266144444 |
|
| 9114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL292P |
0.147496266144444 |
|
| 9115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000253028.1 |
0.147496266144444 |
|
| 9116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238506.1 |
0.147496266144444 |
|
| 9117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP218 |
0.147496266144444 |
|
| 9118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251824.1 |
0.151887337476386 |
|
| 9119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP384 |
0.151887337476386 |
|
| 9120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS29 |
0.151887337476386 |
|
| 9121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL1 |
0.151887337476386 |
|
| 9122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRR1 |
0.151887337476386 |
|
| 9123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT2 |
0.151887337476386 |
|
| 9124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL36AL |
0.151887337476386 |
|
| 9125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAAF2 |
0.151887337476386 |
|
| 9126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLE2 |
0.151887337476386 |
|
| 9127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC30P |
0.151887337476386 |
|
| 9128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC1 |
0.151887337476386 |
|
| 9129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC2 |
0.151887337476386 |
|
| 9130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEMF |
0.151887337476386 |
|
| 9131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL3 |
0.151887337476386 |
|
| 9132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL2 |
0.151887337476386 |
|
| 9133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARF6 |
0.151887337476386 |
|
| 9134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf182 |
0.151887337476386 |
|
| 9135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP193 |
0.151887337476386 |
|
| 9136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf183 |
0.151887337476386 |
|
| 9137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL21D |
0.151887337476386 |
|
| 9138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOS2 |
0.151887337476386 |
|
| 9139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L2HGDH |
0.151887337476386 |
|
| 9140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4504 |
0.151887337476386 |
|
| 9141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5S |
0.151887337476386 |
|
| 9142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKL1 |
0.151887337476386 |
|
| 9143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4K5 |
0.151887337476386 |
|
| 9144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATL1 |
0.151887337476386 |
|
| 9145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAV1 |
0.151887337476386 |
|
| 9146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL452P |
0.151887337476386 |
|
| 9147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIN |
0.151887337476386 |
|
| 9148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU83B |
0.151887337476386 |
|
| 9149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYGL |
0.151887337476386 |
|
| 9150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD12B |
0.151887337476386 |
|
| 9151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM9 |
0.151887337476386 |
|
| 9152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000201376.1 |
0.151887337476386 |
|
| 9153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMX1 |
0.151887337476386 |
|
| 9154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00519 |
0.151887337476386 |
|
| 9155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00640 |
0.151887337476386 |
|
| 9156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD6 |
0.151887337476386 |
|
| 9157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP385 |
0.151887337476386 |
|
| 9158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG2 |
0.151887337476386 |
|
| 9159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf166 |
0.151887337476386 |
|
| 9160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NID2 |
0.151887337476386 |
|
| 9161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGDR |
0.151887337476386 |
|
| 9162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGER2 |
0.151887337476386 |
|
| 9163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC16 |
0.151887337476386 |
|
| 9164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR137C |
0.151887337476386 |
|
| 9165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERO1L |
0.151887337476386 |
|
| 9166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC6 |
0.151887337476386 |
|
| 9167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STYX |
0.151887337476386 |
|
| 9168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPNAT1 |
0.151887337476386 |
|
| 9169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL588P |
0.151887337476386 |
|
| 9170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FERMT2 |
0.151887337476386 |
|
| 9171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDHD1 |
0.151887337476386 |
|
| 9172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5580 |
0.151887337476386 |
|
| 9173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP4 |
0.151887337476386 |
|
| 9174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN3 |
0.151887337476386 |
|
| 9175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNIH |
0.151887337476386 |
|
| 9176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMFB |
0.151887337476386 |
|
| 9177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGRRF1 |
0.151887337476386 |
|
| 9178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD4A |
0.151887337476386 |
|
| 9179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCH1 |
0.151887337476386 |
|
| 9180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC9P |
0.151887337476386 |
|
| 9181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4308 |
0.151887337476386 |
|
| 9182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDHD1 |
0.151887337476386 |
|
| 9183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS4 |
0.151887337476386 |
|
| 9184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK1IP1L |
0.151887337476386 |
|
| 9185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS3 |
0.151887337476386 |
|
| 9186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLGAP5 |
0.151887337476386 |
|
| 9187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO34 |
0.151887337476386 |
|
| 9188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG14 |
0.151887337476386 |
|
| 9189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBPL2 |
0.151887337476386 |
|
| 9190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KTN1 |
0.151887337476386 |
|
| 9191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00520 |
0.151887337476386 |
|
| 9192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL13AP3 |
0.151887337476386 |
|
| 9193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PELI2 |
0.151887337476386 |
|
| 9194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM260 |
0.151887337476386 |
|
| 9195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTX2 |
0.151887337476386 |
|
| 9196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL461P |
0.151887337476386 |
|
| 9197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC5 |
0.151887337476386 |
|
| 9198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP5M1 |
0.151887337476386 |
|
| 9199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA30 |
0.151887337476386 |
|
| 9200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRT1 |
0.152392890512897 |
|
| 9201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRT2 |
0.152392890512897 |
|
| 9202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRT3 |
0.152392890512897 |
|
| 9203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP279 |
0.152392890512897 |
|
| 9204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCFD2 |
0.157140842300469 |
|
| 9205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC57 |
0.158204575772809 |
|
| 9206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1D |
0.158204575772809 |
|
| 9207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A3 |
0.158204575772809 |
|
| 9208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238947.1 |
0.158204575772809 |
|
| 9209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD7 |
0.158204575772809 |
|
| 9210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SECTM1 |
0.158204575772809 |
|
| 9211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX19 |
0.158204575772809 |
|
| 9212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTS2R |
0.158204575772809 |
|
| 9213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGFOD3 |
0.158204575772809 |
|
| 9214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEXDC |
0.158204575772809 |
|
| 9215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM4C |
0.159402158178036 |
|
| 9216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENHO |
0.160534318537229 |
|
| 9217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL27 |
0.160534318537229 |
|
| 9218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIT |
0.162826697708859 |
|
| 9219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL424P |
0.162826697708859 |
|
| 9220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDR |
0.162826697708859 |
|
| 9221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL822P |
0.162826697708859 |
|
| 9222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRD5A3 |
0.162826697708859 |
|
| 9223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM165 |
0.162826697708859 |
|
| 9224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLOCK |
0.162826697708859 |
|
| 9225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP30 |
0.162826697708859 |
|
| 9226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCL2 |
0.162826697708859 |
|
| 9227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMU |
0.162826697708859 |
|
| 9228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC1 |
0.162826697708859 |
|
| 9229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP135 |
0.162826697708859 |
|
| 9230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP161 |
0.162826697708859 |
|
| 9231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1211 |
0.162826697708859 |
|
| 9232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP162 |
0.162826697708859 |
|
| 9233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AASDH |
0.162826697708859 |
|
| 9234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAT |
0.162826697708859 |
|
| 9235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAICS |
0.162826697708859 |
|
| 9236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP72 |
0.162826697708859 |
|
| 9237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL9 |
0.162826697708859 |
|
| 9238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEGL |
0.162826697708859 |
|
| 9239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOPX |
0.162826697708859 |
|
| 9240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL492P |
0.162826697708859 |
|
| 9241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL357P |
0.162826697708859 |
|
| 9242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK2 |
0.162826697708859 |
|
| 9243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REST |
0.162826697708859 |
|
| 9244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOA1 |
0.162826697708859 |
|
| 9245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2B |
0.162826697708859 |
|
| 9246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238579.1 |
0.162826697708859 |
|
| 9247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP7 |
0.162826697708859 |
|
| 9248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238541.1 |
0.162826697708859 |
|
| 9249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238925.1 |
0.162826697708859 |
|
| 9250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL33 |
0.166843150012402 |
|
| 9251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf38 |
0.166843150012402 |
|
| 9252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLDC |
0.166843150012402 |
|
| 9253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL123P |
0.166843150012402 |
|
| 9254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL25P |
0.166843150012402 |
|
| 9255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPD52L3 |
0.166843150012402 |
|
| 9256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UHRF2 |
0.166843150012402 |
|
| 9257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252110.1 |
0.166843150012402 |
|
| 9258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf123 |
0.166843150012402 |
|
| 9259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD27|ENSG00000251699.1 |
0.166843150012402 |
|
| 9260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTRN |
0.170447309919174 |
|
| 9261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPCL1 |
0.170643182853432 |
|
| 9262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF10 |
0.170643182853432 |
|
| 9263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF11 |
0.170643182853432 |
|
| 9264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF12 |
0.170643182853432 |
|
| 9265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF13 |
0.170643182853432 |
|
| 9266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF14 |
0.170643182853432 |
|
| 9267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF15 |
0.170643182853432 |
|
| 9268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF16 |
0.170643182853432 |
|
| 9269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF17 |
0.170643182853432 |
|
| 9270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF18 |
0.170643182853432 |
|
| 9271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF19 |
0.170643182853432 |
|
| 9272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF1 |
0.170643182853432 |
|
| 9273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF21 |
0.170643182853432 |
|
| 9274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF22 |
0.170643182853432 |
|
| 9275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF2 |
0.170643182853432 |
|
| 9276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF3 |
0.170643182853432 |
|
| 9277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF4 |
0.170643182853432 |
|
| 9278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF5 |
0.170643182853432 |
|
| 9279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF6 |
0.170643182853432 |
|
| 9280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF7 |
0.170643182853432 |
|
| 9281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF8 |
0.170643182853432 |
|
| 9282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF9 |
0.170643182853432 |
|
| 9283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAMEF20 |
0.170643182853432 |
|
| 9284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC38 |
0.170643182853432 |
|
| 9285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDPN |
0.170643182853432 |
|
| 9286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP41 |
0.170643182853432 |
|
| 9287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA11|ENSG00000253085.1 |
0.170643182853432 |
|
| 9288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM2 |
0.170643182853432 |
|
| 9289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAZN |
0.170643182853432 |
|
| 9290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM51 |
0.170643182853432 |
|
| 9291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf195 |
0.170643182853432 |
|
| 9292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHAD1 |
0.170643182853432 |
|
| 9293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFHD2 |
0.170643182853432 |
|
| 9294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTRC |
0.170643182853432 |
|
| 9295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELA2A |
0.170643182853432 |
|
| 9296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELA2B |
0.170643182853432 |
|
| 9297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP9 |
0.170643182853432 |
|
| 9298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC16 |
0.170643182853432 |
|
| 9299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA21|ENSG00000251866.1 |
0.170643182853432 |
|
| 9300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGMAT |
0.170643182853432 |
|
| 9301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDI2 |
0.170643182853432 |
|
| 9302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSC1A1 |
0.170643182853432 |
|
| 9303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHM2 |
0.170643182853432 |
|
| 9304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLIM1 |
0.170643182853432 |
|
| 9305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A34 |
0.170643182853432 |
|
| 9306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM82 |
0.170643182853432 |
|
| 9307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPEN |
0.170643182853432 |
|
| 9308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238818.1 |
0.170643182853432 |
|
| 9309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB17 |
0.170643182853432 |
|
| 9310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf64 |
0.170643182853432 |
|
| 9311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB7 |
0.170643182853432 |
|
| 9312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCNKA |
0.170643182853432 |
|
| 9313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCNKB |
0.170643182853432 |
|
| 9314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM131C |
0.170643182853432 |
|
| 9315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA2 |
0.170643182853432 |
|
| 9316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF19 |
0.170643182853432 |
|
| 9317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO7P1 |
0.170643182853432 |
|
| 9318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf134 |
0.170643182853432 |
|
| 9319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSG1 |
0.170643182853432 |
|
| 9320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO42 |
0.170643182853432 |
|
| 9321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SZRD1 |
0.170643182853432 |
|
| 9322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA21 |
0.170643182853432 |
|
| 9323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NECAP2 |
0.170643182853432 |
|
| 9324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CROCCP3 |
0.170643182853432 |
|
| 9325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP13A2 |
0.170643182853432 |
|
| 9326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CROCCP2 |
0.170643182853432 |
|
| 9327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CROCC |
0.170643182853432 |
|
| 9328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESPNP |
0.170643182853432 |
|
| 9329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP2 |
0.170643182853432 |
|
| 9330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3675 |
0.170643182853432 |
|
| 9331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MST1L |
0.170643182853432 |
|
| 9332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF1 |
0.170643182853432 |
|
| 9333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U1|ENSG00000228549.2 |
0.170643182853432 |
|
| 9334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U1|ENSG00000233421.3 |
0.170643182853432 |
|
| 9335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHB |
0.170643182853432 |
|
| 9336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PADI2 |
0.170643182853432 |
|
| 9337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PADI1 |
0.170643182853432 |
|
| 9338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PADI3 |
0.170643182853432 |
|
| 9339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3972 |
0.170643182853432 |
|
| 9340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PADI4 |
0.170643182853432 |
|
| 9341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PADI6 |
0.170643182853432 |
|
| 9342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCC2 |
0.170643182853432 |
|
| 9343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239020.1 |
0.170643182853432 |
|
| 9344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF10L |
0.170643182853432 |
|
| 9345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL8 |
0.170643182853432 |
|
| 9346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC7A |
0.170643182853432 |
|
| 9347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX7 |
0.170643182853432 |
|
| 9348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS1R2 |
0.170643182853432 |
|
| 9349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH4A1 |
0.170643182853432 |
|
| 9350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4695 |
0.170643182853432 |
|
| 9351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1290 |
0.170643182853432 |
|
| 9352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFFO2 |
0.170643182853432 |
|
| 9353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QA |
0.170643182853432 |
|
| 9354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL97P |
0.171869792735931 |
|
| 9355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SS18 |
0.171869792735931 |
|
| 9356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA8 |
0.171869792735931 |
|
| 9357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF4B |
0.171869792735931 |
|
| 9358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252921.1 |
0.171869792735931 |
|
| 9359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD1 |
0.171869792735931 |
|
| 9360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000265369.2 |
0.171869792735931 |
|
| 9361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP4 |
0.171869792735931 |
|
| 9362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST9 |
0.171869792735931 |
|
| 9363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH2 |
0.171869792735931 |
|
| 9364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSC3 |
0.171869792735931 |
|
| 9365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSC2 |
0.171869792735931 |
|
| 9366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238376.1 |
0.171869792735931 |
|
| 9367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSC1 |
0.171869792735931 |
|
| 9368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSG1 |
0.171869792735931 |
|
| 9369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSG4 |
0.171869792735931 |
|
| 9370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSG3 |
0.171869792735931 |
|
| 9371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSG2 |
0.171869792735931 |
|
| 9372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTR |
0.171869792735931 |
|
| 9373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT6 |
0.171869792735931 |
|
| 9374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP44 |
0.171869792735931 |
|
| 9375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC37A7P |
0.171869792735931 |
|
| 9376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A52 |
0.171869792735931 |
|
| 9377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC8 |
0.171869792735931 |
|
| 9378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF125 |
0.171869792735931 |
|
| 9379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF138 |
0.171869792735931 |
|
| 9380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238982.1 |
0.171869792735931 |
|
| 9381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAREM |
0.171869792735931 |
|
| 9382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP453 |
0.171869792735931 |
|
| 9383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEP1B |
0.171869792735931 |
|
| 9384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP11P1 |
0.171869792735931 |
|
| 9385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL14 |
0.171869792735931 |
|
| 9386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASXL3 |
0.171869792735931 |
|
| 9387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL4 |
0.171869792735931 |
|
| 9388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTNA |
0.171869792735931 |
|
| 9389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPRE2 |
0.171869792735931 |
|
| 9390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF397 |
0.171869792735931 |
|
| 9391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN30 |
0.171869792735931 |
|
| 9392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF271 |
0.171869792735931 |
|
| 9393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF24 |
0.171869792735931 |
|
| 9394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF396 |
0.171869792735931 |
|
| 9395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INO80C |
0.171869792735931 |
|
| 9396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT1 |
0.171869792735931 |
|
| 9397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR187 |
0.171869792735931 |
|
| 9398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3929 |
0.171869792735931 |
|
| 9399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf21 |
0.171869792735931 |
|
| 9400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPRD1A |
0.171869792735931 |
|
| 9401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A6 |
0.171869792735931 |
|
| 9402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELP2 |
0.171869792735931 |
|
| 9403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOCOS |
0.171869792735931 |
|
| 9404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHOD3 |
0.171869792735931 |
|
| 9405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252078.1 |
0.171869792735931 |
|
| 9406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPGS2 |
0.171869792735931 |
|
| 9407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1328 |
0.171869792735931 |
|
| 9408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF4 |
0.171869792735931 |
|
| 9409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4318 |
0.171869792735931 |
|
| 9410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP182 |
0.171869792735931 |
|
| 9411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00669 |
0.171869792735931 |
|
| 9412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3C3 |
0.171869792735931 |
|
| 9413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00907 |
0.171869792735931 |
|
| 9414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP454 |
0.171869792735931 |
|
| 9415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIT2 |
0.171869792735931 |
|
| 9416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT4 |
0.171869792735931 |
|
| 9417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETBP1 |
0.171869792735931 |
|
| 9418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC14A2 |
0.171869792735931 |
|
| 9419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPG5 |
0.171869792735931 |
|
| 9420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf25 |
0.171869792735931 |
|
| 9421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF165 |
0.171869792735931 |
|
| 9422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KATNAL2 |
0.171869792735931 |
|
| 9423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD4 |
0.171869792735931 |
|
| 9424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCC |
0.171869792735931 |
|
| 9425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf49 |
0.172820910256243 |
|
| 9426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC7 |
0.172820910256243 |
|
| 9427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN7 |
0.172820910256243 |
|
| 9428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD6 |
0.172820910256243 |
|
| 9429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200222.1 |
0.172820910256243 |
|
| 9430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRICKLE2 |
0.172820910256243 |
|
| 9431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS9 |
0.172820910256243 |
|
| 9432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A26 |
0.172820910256243 |
|
| 9433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL482P |
0.172820910256243 |
|
| 9434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIG1 |
0.172820910256243 |
|
| 9435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD8 |
0.172820910256243 |
|
| 9436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUCLG2 |
0.172820910256243 |
|
| 9437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM19A1 |
0.172820910256243 |
|
| 9438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM19A4 |
0.172820910256243 |
|
| 9439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP135 |
0.172820910256243 |
|
| 9440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EOGT |
0.172820910256243 |
|
| 9441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMF1 |
0.172820910256243 |
|
| 9442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3136 |
0.172820910256243 |
|
| 9443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA3 |
0.172820910256243 |
|
| 9444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL6IP5 |
0.172820910256243 |
|
| 9445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMOD3 |
0.172820910256243 |
|
| 9446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD4B |
0.172820910256243 |
|
| 9447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MITF |
0.172820910256243 |
|
| 9448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL418P |
0.172820910256243 |
|
| 9449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXP1 |
0.172820910256243 |
|
| 9450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1284 |
0.172820910256243 |
|
| 9451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4E3 |
0.172820910256243 |
|
| 9452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR27 |
0.172820910256243 |
|
| 9453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROK2 |
0.172820910256243 |
|
| 9454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL271P |
0.172820910256243 |
|
| 9455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00877 |
0.172820910256243 |
|
| 9456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00870 |
0.172820910256243 |
|
| 9457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RYBP |
0.172820910256243 |
|
| 9458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238568.1 |
0.172820910256243 |
|
| 9459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP136 |
0.172820910256243 |
|
| 9460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHQ1 |
0.172820910256243 |
|
| 9461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GXYLT2 |
0.172820910256243 |
|
| 9462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP4R2 |
0.172820910256243 |
|
| 9463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBLN2 |
0.172820910256243 |
|
| 9464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238416.1 |
0.172820910256243 |
|
| 9465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZRN3 |
0.172820910256243 |
|
| 9466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN3 |
0.172820910256243 |
|
| 9467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL294P |
0.172820910256243 |
|
| 9468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86DP |
0.172820910256243 |
|
| 9469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRG2C |
0.172820910256243 |
|
| 9470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00960 |
0.172820910256243 |
|
| 9471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1324 |
0.172820910256243 |
|
| 9472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4273 |
0.172820910256243 |
|
| 9473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL92P |
0.172820910256243 |
|
| 9474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF717 |
0.172820910256243 |
|
| 9475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROBO2 |
0.172820910256243 |
|
| 9476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL647P |
0.172820910256243 |
|
| 9477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP61 |
0.172820910256243 |
|
| 9478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROBO1 |
0.172820910256243 |
|
| 9479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL751P |
0.172820910256243 |
|
| 9480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3923 |
0.172820910256243 |
|
| 9481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBE1 |
0.172820910256243 |
|
| 9482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSAMP |
0.17875222738515 |
|
| 9483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC39B |
0.180464634127663 |
|
| 9484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL795P |
0.183750974561018 |
|
| 9485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTSCR1 |
0.183750974561018 |
|
| 9486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLN2 |
0.183750974561018 |
|
| 9487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AV |
0.183750974561018 |
|
| 9488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NETO1 |
0.183750974561018 |
|
| 9489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP460 |
0.183750974561018 |
|
| 9490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL401P |
0.183750974561018 |
|
| 9491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO15 |
0.183750974561018 |
|
| 9492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM21 |
0.183750974561018 |
|
| 9493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL551P |
0.183750974561018 |
|
| 9494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5A |
0.183750974561018 |
|
| 9495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf63 |
0.183750974561018 |
|
| 9496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM69C |
0.183750974561018 |
|
| 9497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNDP2 |
0.183750974561018 |
|
| 9498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNDP1 |
0.183750974561018 |
|
| 9499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00909 |
0.183750974561018 |
|
| 9500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF407 |
0.183750974561018 |
|
| 9501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZADH2 |
0.183750974561018 |
|
| 9502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSHZ1 |
0.183750974561018 |
|
| 9503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM21 |
0.183750974561018 |
|
| 9504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF516 |
0.183750974561018 |
|
| 9505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00908 |
0.183750974561018 |
|
| 9506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00683 |
0.183750974561018 |
|
| 9507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF236 |
0.183750974561018 |
|
| 9508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBP |
0.183750974561018 |
|
| 9509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALR1 |
0.183750974561018 |
|
| 9510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000199392.1 |
0.183750974561018 |
|
| 9511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP461 |
0.183750974561018 |
|
| 9512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SALL3 |
0.183750974561018 |
|
| 9513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADNP2 |
0.183750974561018 |
|
| 9514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDP1 |
0.183750974561018 |
|
| 9515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSBP1L1 |
0.183750974561018 |
|
| 9516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNG2 |
0.183750974561018 |
|
| 9517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFATC1 |
0.183750974561018 |
|
| 9518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARD6G |
0.183750974561018 |
|
| 9519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PQLC1 |
0.183750974561018 |
|
| 9520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBFADN |
0.183750974561018 |
|
| 9521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBFA |
0.183750974561018 |
|
| 9522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNL4A |
0.183750974561018 |
|
| 9523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACCSL |
0.184284023527463 |
|
| 9524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACCS |
0.184284023527463 |
|
| 9525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXT2 |
0.184284023527463 |
|
| 9526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALX4 |
0.184284023527463 |
|
| 9527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD82 |
0.184284023527463 |
|
| 9528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM11 |
0.184284023527463 |
|
| 9529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT13 |
0.184284023527463 |
|
| 9530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST1 |
0.184284023527463 |
|
| 9531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35C1 |
0.184284023527463 |
|
| 9532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51B |
0.184409927584129 |
|
| 9533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL706P |
0.184409927584129 |
|
| 9534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL108P |
0.184409927584129 |
|
| 9535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP36L1 |
0.184409927584129 |
|
| 9536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG10B |
0.186467758822512 |
|
| 9537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG10 |
0.186467758822512 |
|
| 9538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP358 |
0.186467758822512 |
|
| 9539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP359 |
0.186467758822512 |
|
| 9540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT10 |
0.186467758822512 |
|
| 9541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO1B3 |
0.18877946290075 |
|
| 9542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LST3 |
0.18877946290075 |
|
| 9543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO1B7 |
0.18877946290075 |
|
| 9544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMGDH |
0.191483981970394 |
|
| 9545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHMT2 |
0.191483981970394 |
|
| 9546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHMT |
0.191483981970394 |
|
| 9547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P1 |
0.191483981970394 |
|
| 9548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000206592.1 |
0.191483981970394 |
|
| 9549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMY |
0.191483981970394 |
|
| 9550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOMER1 |
0.191483981970394 |
|
| 9551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPD4 |
0.191483981970394 |
|
| 9552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMYA5 |
0.191483981970394 |
|
| 9553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTX3 |
0.191483981970394 |
|
| 9554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THBS4 |
0.191483981970394 |
|
| 9555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERINC5 |
0.191483981970394 |
|
| 9556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239159.1 |
0.191483981970394 |
|
| 9557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000251828.1 |
0.191483981970394 |
|
| 9558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPZ1 |
0.191483981970394 |
|
| 9559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE16 |
0.191483981970394 |
|
| 9560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM151B |
0.191483981970394 |
|
| 9561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHFR |
0.191483981970394 |
|
| 9562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L2 |
0.191483981970394 |
|
| 9563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSH3 |
0.191483981970394 |
|
| 9564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRF2 |
0.191483981970394 |
|
| 9565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKMT2 |
0.191483981970394 |
|
| 9566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC9 |
0.191483981970394 |
|
| 9567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT12 |
0.191483981970394 |
|
| 9568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSBP2 |
0.191483981970394 |
|
| 9569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG10 |
0.191483981970394 |
|
| 9570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL378P |
0.191483981970394 |
|
| 9571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS23 |
0.191483981970394 |
|
| 9572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6AP1L |
0.191483981970394 |
|
| 9573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM167A |
0.191483981970394 |
|
| 9574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000238835.1 |
0.191483981970394 |
|
| 9575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC4 |
0.191483981970394 |
|
| 9576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCAN |
0.191483981970394 |
|
| 9577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAPLN1 |
0.191483981970394 |
|
| 9578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP295 |
0.191483981970394 |
|
| 9579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INHBC |
0.194258570155479 |
|
| 9580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INHBE |
0.194258570155479 |
|
| 9581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLI1 |
0.194258570155479 |
|
| 9582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP9 |
0.194258570155479 |
|
| 9583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARS |
0.194258570155479 |
|
| 9584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL312P |
0.194258570155479 |
|
| 9585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDIT3 |
0.194258570155479 |
|
| 9586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD6 |
0.194258570155479 |
|
| 9587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR616 |
0.194258570155479 |
|
| 9588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN2 |
0.194258570155479 |
|
| 9589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF5A |
0.194258570155479 |
|
| 9590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP4K2C |
0.194258570155479 |
|
| 9591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTX3 |
0.194258570155479 |
|
| 9592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF25 |
0.194258570155479 |
|
| 9593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALNT1 |
0.194258570155479 |
|
| 9594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A10 |
0.194258570155479 |
|
| 9595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238436.1 |
0.194258570155479 |
|
| 9596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OS9 |
0.194258570155479 |
|
| 9597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP2 |
0.194258570155479 |
|
| 9598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN31 |
0.194258570155479 |
|
| 9599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK4 |
0.194258570155479 |
|
| 9600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH9 |
0.194258570155479 |
|
| 9601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP27B1 |
0.194258570155479 |
|
| 9602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL1 |
0.194258570155479 |
|
| 9603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL21B |
0.194258570155479 |
|
| 9604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSFM |
0.194258570155479 |
|
| 9605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVIL |
0.194258570155479 |
|
| 9606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDSP2 |
0.194258570155479 |
|
| 9607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR26A2 |
0.194258570155479 |
|
| 9608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAT4 |
0.195297806285887 |
|
| 9609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD2 |
0.197636615915963 |
|
| 9610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLBP1 |
0.197636615915963 |
|
| 9611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCI |
0.197636615915963 |
|
| 9612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLG |
0.197636615915963 |
|
| 9613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00925 |
0.197636615915963 |
|
| 9614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS6 |
0.199450179782179 |
|
| 9615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL158P |
0.199450179782179 |
|
| 9616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLIN2 |
0.199450179782179 |
|
| 9617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRSK2 |
0.200681391041239 |
|
| 9618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP1B |
0.205046121911698 |
|
| 9619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2B4 |
0.207144407806761 |
|
| 9620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA77|ENSG00000221643.1 |
0.207144407806761 |
|
| 9621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAX1 |
0.207144407806761 |
|
| 9622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED6 |
0.207144407806761 |
|
| 9623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H11A |
0.207144407806761 |
|
| 9624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPE |
0.207144407806761 |
|
| 9625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00303 |
0.207144407806761 |
|
| 9626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX13 |
0.207144407806761 |
|
| 9627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETNK2 |
0.207144407806761 |
|
| 9628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REN |
0.207144407806761 |
|
| 9629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KISS1 |
0.207144407806761 |
|
| 9630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLT1A |
0.207144407806761 |
|
| 9631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA6 |
0.207144407806761 |
|
| 9632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R15B |
0.207144407806761 |
|
| 9633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3C2B |
0.207144407806761 |
|
| 9634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDM4 |
0.207144407806761 |
|
| 9635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP74 |
0.207144407806761 |
|
| 9636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRN2 |
0.207144407806761 |
|
| 9637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKK2 |
0.208614765378753 |
|
| 9638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252566.1 |
0.208614765378753 |
|
| 9639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPSS1 |
0.208614765378753 |
|
| 9640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGMS2 |
0.208614765378753 |
|
| 9641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2U1 |
0.208614765378753 |
|
| 9642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HADH |
0.208614765378753 |
|
| 9643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEF1 |
0.208614765378753 |
|
| 9644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL34 |
0.208614765378753 |
|
| 9645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSTC |
0.208614765378753 |
|
| 9646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETNPPL |
0.208614765378753 |
|
| 9647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL25A1 |
0.208614765378753 |
|
| 9648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC24B |
0.208614765378753 |
|
| 9649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL55P |
0.208614765378753 |
|
| 9650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR576 |
0.208614765378753 |
|
| 9651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC109B |
0.208614765378753 |
|
| 9652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP6 |
0.208614765378753 |
|
| 9653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G12A |
0.208614765378753 |
|
| 9654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFI |
0.208614765378753 |
|
| 9655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAR1 |
0.208614765378753 |
|
| 9656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRH |
0.208614765378753 |
|
| 9657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIT3 |
0.208614765378753 |
|
| 9658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGF |
0.208614765378753 |
|
| 9659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL6 |
0.208614765378753 |
|
| 9660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL275P |
0.208614765378753 |
|
| 9661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPEP |
0.208614765378753 |
|
| 9662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITX2 |
0.208614765378753 |
|
| 9663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR297 |
0.208614765378753 |
|
| 9664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf32 |
0.208614765378753 |
|
| 9665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1AR |
0.208614765378753 |
|
| 9666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIFA |
0.208614765378753 |
|
| 9667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPK1 |
0.208614765378753 |
|
| 9668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROG2 |
0.208614765378753 |
|
| 9669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf21 |
0.208614765378753 |
|
| 9670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP7 |
0.208614765378753 |
|
| 9671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR302A |
0.208614765378753 |
|
| 9672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR302B |
0.208614765378753 |
|
| 9673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR302C |
0.208614765378753 |
|
| 9674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR302D |
0.208614765378753 |
|
| 9675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR367 |
0.208614765378753 |
|
| 9676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANK2 |
0.208614765378753 |
|
| 9677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL184P |
0.208614765378753 |
|
| 9678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2D |
0.208614765378753 |
|
| 9679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSJ |
0.208614765378753 |
|
| 9680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT8 |
0.208614765378753 |
|
| 9681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR577 |
0.208614765378753 |
|
| 9682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL808P |
0.208614765378753 |
|
| 9683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDST4 |
0.208614765378753 |
|
| 9684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L13 |
0.208614765378753 |
|
| 9685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAM1L1 |
0.208614765378753 |
|
| 9686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C3AP1 |
0.208614765378753 |
|
| 9687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDST3 |
0.208614765378753 |
|
| 9688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG8 |
0.208614765378753 |
|
| 9689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS12 |
0.208614765378753 |
|
| 9690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP170P1 |
0.208614765378753 |
|
| 9691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL14 |
0.208614765378753 |
|
| 9692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC24D |
0.208614765378753 |
|
| 9693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNPO2 |
0.208614765378753 |
|
| 9694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOZ2 |
0.208614765378753 |
|
| 9695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP53 |
0.208614765378753 |
|
| 9696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf3 |
0.208614765378753 |
|
| 9697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP2 |
0.208614765378753 |
|
| 9698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE5A |
0.208614765378753 |
|
| 9699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221245.1 |
0.208614765378753 |
|
| 9700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAD2L1 |
0.208614765378753 |
|
| 9701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM5 |
0.208614765378753 |
|
| 9702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDNF |
0.208614765378753 |
|
| 9703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP137 |
0.208614765378753 |
|
| 9704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNIP3 |
0.208614765378753 |
|
| 9705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QRFPR |
0.208614765378753 |
|
| 9706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA5 |
0.208614765378753 |
|
| 9707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM155 |
0.208614765378753 |
|
| 9708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC9 |
0.208614765378753 |
|
| 9709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNA2 |
0.208614765378753 |
|
| 9710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS7 |
0.208614765378753 |
|
| 9711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC3 |
0.208614765378753 |
|
| 9712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL335P |
0.208614765378753 |
|
| 9713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1109 |
0.208614765378753 |
|
| 9714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAD1 |
0.208614765378753 |
|
| 9715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL2 |
0.208614765378753 |
|
| 9716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL21 |
0.208614765378753 |
|
| 9717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS12 |
0.208614765378753 |
|
| 9718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF2 |
0.208614765378753 |
|
| 9719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT6 |
0.208614765378753 |
|
| 9720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA5 |
0.208614765378753 |
|
| 9721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRY1 |
0.208614765378753 |
|
| 9722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD50 |
0.208614765378753 |
|
| 9723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTU |
0.208614765378753 |
|
| 9724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A31 |
0.208614765378753 |
|
| 9725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA4L |
0.208614765378753 |
|
| 9726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK4 |
0.208614765378753 |
|
| 9727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD8 |
0.208614765378753 |
|
| 9728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf29 |
0.208614765378753 |
|
| 9729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP1B |
0.208614765378753 |
|
| 9730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGRMC2 |
0.208614765378753 |
|
| 9731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238802.1 |
0.208614765378753 |
|
| 9732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF17 |
0.208614765378753 |
|
| 9733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCLT1 |
0.208614765378753 |
|
| 9734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf33 |
0.208614765378753 |
|
| 9735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5P4 |
0.208614765378753 |
|
| 9736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN18 |
0.208772213474224 |
|
| 9737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53I11 |
0.208772213474224 |
|
| 9738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRY2 |
0.208772213474224 |
|
| 9739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F3 |
0.209743112887592 |
|
| 9740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4671 |
0.209743112887592 |
|
| 9741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COA6 |
0.209743112887592 |
|
| 9742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARBP1 |
0.209743112887592 |
|
| 9743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000212144.1 |
0.209743112887592 |
|
| 9744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF2BP2 |
0.209743112887592 |
|
| 9745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00184 |
0.209743112887592 |
|
| 9746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P16 |
0.209743112887592 |
|
| 9747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL668P |
0.209743112887592 |
|
| 9748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM20 |
0.209743112887592 |
|
| 9749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID4B |
0.209743112887592 |
|
| 9750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM34 |
0.209743112887592 |
|
| 9751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA14B |
0.209743112887592 |
|
| 9752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4753 |
0.209743112887592 |
|
| 9753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGPS1 |
0.209743112887592 |
|
| 9754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCE |
0.209743112887592 |
|
| 9755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALNT2 |
0.209743112887592 |
|
| 9756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG4 |
0.209743112887592 |
|
| 9757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYST |
0.209743112887592 |
|
| 9758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1537 |
0.209743112887592 |
|
| 9759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NID1 |
0.209743112887592 |
|
| 9760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR137B |
0.209743112887592 |
|
| 9761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERO1LB |
0.209743112887592 |
|
| 9762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252638.1 |
0.209743112887592 |
|
| 9763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDARADD |
0.209743112887592 |
|
| 9764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS8 |
0.209743112887592 |
|
| 9765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR1 |
0.209743112887592 |
|
| 9766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTN2 |
0.209743112887592 |
|
| 9767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTR |
0.209743112887592 |
|
| 9768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1HL1 |
0.209743112887592 |
|
| 9769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RYR2 |
0.209743112887592 |
|
| 9770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP195 |
0.209743112887592 |
|
| 9771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4428 |
0.209743112887592 |
|
| 9772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252290.1 |
0.209743112887592 |
|
| 9773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZP4 |
0.209743112887592 |
|
| 9774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L11 |
0.209743112887592 |
|
| 9775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRM3 |
0.209743112887592 |
|
| 9776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMN2 |
0.209743112887592 |
|
| 9777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GREM2 |
0.209743112887592 |
|
| 9778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS7 |
0.209743112887592 |
|
| 9779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3123 |
0.209743112887592 |
|
| 9780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FH |
0.209743112887592 |
|
| 9781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMO |
0.209743112887592 |
|
| 9782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN3 |
0.209743112887592 |
|
| 9783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHML |
0.209743112887592 |
|
| 9784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR64 |
0.209743112887592 |
|
| 9785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXO1 |
0.209743112887592 |
|
| 9786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1LC3C |
0.209743112887592 |
|
| 9787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD5 |
0.209743112887592 |
|
| 9788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP81 |
0.209743112887592 |
|
| 9789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP12 |
0.209743112887592 |
|
| 9790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP170 |
0.209743112887592 |
|
| 9791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDCCAG8 |
0.209743112887592 |
|
| 9792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4677 |
0.209743112887592 |
|
| 9793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKT3 |
0.209743112887592 |
|
| 9794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB18 |
0.209743112887592 |
|
| 9795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL148P |
0.209743112887592 |
|
| 9796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf100 |
0.209743112887592 |
|
| 9797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADSS |
0.209743112887592 |
|
| 9798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf101 |
0.209743112887592 |
|
| 9799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DESI2 |
0.209743112887592 |
|
| 9800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX20 |
0.209743112887592 |
|
| 9801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPU |
0.209743112887592 |
|
| 9802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP55 |
0.209743112887592 |
|
| 9803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB2 |
0.209743112887592 |
|
| 9804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GML |
0.211048926690824 |
|
| 9805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP11B1 |
0.211048926690824 |
|
| 9806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP11B2 |
0.211048926690824 |
|
| 9807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6E |
0.211048926690824 |
|
| 9808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf31 |
0.211048926690824 |
|
| 9809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6H |
0.211048926690824 |
|
| 9810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPIHBP1 |
0.211048926690824 |
|
| 9811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP41 |
0.211048926690824 |
|
| 9812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLI4 |
0.211048926690824 |
|
| 9813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF696 |
0.211048926690824 |
|
| 9814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOP1MT |
0.211048926690824 |
|
| 9815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHPN1 |
0.211048926690824 |
|
| 9816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAFA |
0.211048926690824 |
|
| 9817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H3 |
0.211048926690824 |
|
| 9818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000254144.2 |
0.211048926690824 |
|
| 9819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSDMD |
0.211048926690824 |
|
| 9820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH6 |
0.211048926690824 |
|
| 9821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1D |
0.211048926690824 |
|
| 9822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPRT1 |
0.211048926690824 |
|
| 9823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD5 |
0.211048926690824 |
|
| 9824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYCRL |
0.211048926690824 |
|
| 9825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSTA3 |
0.211048926690824 |
|
| 9826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF623 |
0.211048926690824 |
|
| 9827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC166 |
0.211048926690824 |
|
| 9828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83H |
0.211048926690824 |
|
| 9829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK15 |
0.211048926690824 |
|
| 9830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4664 |
0.211048926690824 |
|
| 9831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF707 |
0.211048926690824 |
|
| 9832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRIB |
0.211048926690824 |
|
| 9833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR937 |
0.211048926690824 |
|
| 9834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUF60 |
0.211048926690824 |
|
| 9835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRBP2 |
0.211048926690824 |
|
| 9836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPPK1 |
0.211048926690824 |
|
| 9837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEC |
0.211048926690824 |
|
| 9838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR661 |
0.211048926690824 |
|
| 9839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP10 |
0.211048926690824 |
|
| 9840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRINA |
0.211048926690824 |
|
| 9841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATC1 |
0.211048926690824 |
|
| 9842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPLAH |
0.211048926690824 |
|
| 9843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC4 |
0.211048926690824 |
|
| 9844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPAA1 |
0.211048926690824 |
|
| 9845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYC1 |
0.211048926690824 |
|
| 9846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHARPIN |
0.211048926690824 |
|
| 9847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1875 |
0.211048926690824 |
|
| 9848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAF1 |
0.211048926690824 |
|
| 9849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM203A |
0.211048926690824 |
|
| 9850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH1 |
0.211048926690824 |
|
| 9851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCK5 |
0.211048926690824 |
|
| 9852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP39 |
0.211048926690824 |
|
| 9853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOP1 |
0.211048926690824 |
|
| 9854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf33 |
0.211048926690824 |
|
| 9855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf82 |
0.211048926690824 |
|
| 9856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD5 |
0.211048926690824 |
|
| 9857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF1 |
0.211048926690824 |
|
| 9858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYHR1 |
0.211048926690824 |
|
| 9859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGAT1 |
0.211048926690824 |
|
| 9860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM203B |
0.211048926690824 |
|
| 9861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL6 |
0.211048926690824 |
|
| 9862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXH1 |
0.211048926690824 |
|
| 9863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPT |
0.211048926690824 |
|
| 9864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSF1 |
0.211048926690824 |
|
| 9865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIFC2 |
0.211048926690824 |
|
| 9866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC14 |
0.211048926690824 |
|
| 9867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC24 |
0.211048926690824 |
|
| 9868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD3 |
0.211048926690824 |
|
| 9869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1234 |
0.211048926690824 |
|
| 9870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR939 |
0.211048926690824 |
|
| 9871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R16A |
0.211048926690824 |
|
| 9872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RECQL4 |
0.211048926690824 |
|
| 9873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL395P |
0.211048926690824 |
|
| 9874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL8 |
0.211048926690824 |
|
| 9875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRT1 |
0.211048926690824 |
|
| 9876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCXA |
0.211048926690824 |
|
| 9877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCXB |
0.211048926690824 |
|
| 9878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A4 |
0.211048926690824 |
|
| 9879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC52A2 |
0.211048926690824 |
|
| 9880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM249 |
0.211048926690824 |
|
| 9881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TONSL |
0.211048926690824 |
|
| 9882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS28 |
0.211048926690824 |
|
| 9883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF16 |
0.211048926690824 |
|
| 9884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF250 |
0.211048926690824 |
|
| 9885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF251 |
0.211048926690824 |
|
| 9886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF252P |
0.211048926690824 |
|
| 9887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF34 |
0.211048926690824 |
|
| 9888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF517 |
0.211048926690824 |
|
| 9889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF7 |
0.211048926690824 |
|
| 9890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPRD2 |
0.215648557588458 |
|
| 9891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARS2 |
0.215648557588458 |
|
| 9892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECM1 |
0.215648557588458 |
|
| 9893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00568 |
0.215648557588458 |
|
| 9894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTSL4 |
0.215648557588458 |
|
| 9895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4257 |
0.215648557588458 |
|
| 9896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf138 |
0.215648557588458 |
|
| 9897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL473P |
0.215648557588458 |
|
| 9898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL600P |
0.215648557588458 |
|
| 9899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCL1 |
0.215648557588458 |
|
| 9900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENSA |
0.215648557588458 |
|
| 9901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000253047.1 |
0.215648557588458 |
|
| 9902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLPH3L |
0.215648557588458 |
|
| 9903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM185A |
0.215914889189593 |
|
| 9904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL13 |
0.215914889189593 |
|
| 9905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP198 |
0.215914889189593 |
|
| 9906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC17 |
0.215914889189593 |
|
| 9907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC10 |
0.215914889189593 |
|
| 9908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPEPLD |
0.215914889189593 |
|
| 9909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L2P2 |
0.215914889189593 |
|
| 9910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMPCB |
0.215914889189593 |
|
| 9911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC2 |
0.215914889189593 |
|
| 9912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC2 |
0.215914889189593 |
|
| 9913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A5 |
0.215914889189593 |
|
| 9914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELN |
0.215914889189593 |
|
| 9915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP86 |
0.215914889189593 |
|
| 9916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC5 |
0.215914889189593 |
|
| 9917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL8P |
0.215914889189593 |
|
| 9918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251911.1 |
0.215914889189593 |
|
| 9919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMT2E |
0.215914889189593 |
|
| 9920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPK2 |
0.215914889189593 |
|
| 9921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUS7 |
0.215914889189593 |
|
| 9922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RINT1 |
0.215914889189593 |
|
| 9923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB10 |
0.215914889189593 |
|
| 9924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN7L1 |
0.215914889189593 |
|
| 9925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDHR3 |
0.215914889189593 |
|
| 9926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYPL1 |
0.215914889189593 |
|
| 9927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAMPT |
0.215914889189593 |
|
| 9928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC71L |
0.215914889189593 |
|
| 9929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP236 |
0.215914889189593 |
|
| 9930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3CG |
0.215914889189593 |
|
| 9931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAR2B |
0.215914889189593 |
|
| 9932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBP1 |
0.215914889189593 |
|
| 9933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG5 |
0.215914889189593 |
|
| 9934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR22 |
0.215914889189593 |
|
| 9935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUS4L |
0.215914889189593 |
|
| 9936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAP29 |
0.215914889189593 |
|
| 9937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000238832.1 |
0.215914889189593 |
|
| 9938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A4 |
0.215914889189593 |
|
| 9939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLL1 |
0.215914889189593 |
|
| 9940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A3 |
0.215914889189593 |
|
| 9941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF423 |
0.217132241429646 |
|
| 9942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNEP1R1 |
0.217132241429646 |
|
| 9943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR3 |
0.217132241429646 |
|
| 9944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P3 |
0.217132241429646 |
|
| 9945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252526.1 |
0.217132241429646 |
|
| 9946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPD5 |
0.217132241429646 |
|
| 9947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY7 |
0.217132241429646 |
|
| 9948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD7 |
0.217132241429646 |
|
| 9949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238544.1 |
0.217132241429646 |
|
| 9950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252077.1 |
0.217132241429646 |
|
| 9951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKD1 |
0.217132241429646 |
|
| 9952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX20 |
0.217132241429646 |
|
| 9953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOD2 |
0.217132241429646 |
|
| 9954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYLD |
0.217132241429646 |
|
| 9955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP426 |
0.217132241429646 |
|
| 9956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SALL1 |
0.217132241429646 |
|
| 9957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA1P48 |
0.217132241429646 |
|
| 9958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP142 |
0.217132241429646 |
|
| 9959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf97 |
0.217132241429646 |
|
| 9960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00919 |
0.217132241429646 |
|
| 9961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4300 |
0.217475983986168 |
|
| 9962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL205P |
0.219848721448602 |
|
| 9963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252014.1 |
0.219848721448602 |
|
| 9964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH10 |
0.219848721448602 |
|
| 9965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC4L |
0.219848721448602 |
|
| 9966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00613 |
0.219848721448602 |
|
| 9967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH18 |
0.219848721448602 |
|
| 9968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00616 |
0.219848721448602 |
|
| 9969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A11 |
0.219848721448602 |
|
| 9970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00498 |
0.219848721448602 |
|
| 9971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00499 |
0.219848721448602 |
|
| 9972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00500 |
0.219848721448602 |
|
| 9973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCRN4L |
0.219848721448602 |
|
| 9974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELF2 |
0.219848721448602 |
|
| 9975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL382P |
0.219848721448602 |
|
| 9976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL311P |
0.219848721448602 |
|
| 9977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGARP |
0.219848721448602 |
|
| 9978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFC1 |
0.219848721448602 |
|
| 9979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA15 |
0.219848721448602 |
|
| 9980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000239005.1 |
0.219848721448602 |
|
| 9981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB33B |
0.219848721448602 |
|
| 9982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD7 |
0.219848721448602 |
|
| 9983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGST2 |
0.219848721448602 |
|
| 9984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP237 |
0.219848721448602 |
|
| 9985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAML3 |
0.219848721448602 |
|
| 9986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP253 |
0.219848721448602 |
|
| 9987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCOC |
0.219848721448602 |
|
| 9988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252300.1 |
0.219848721448602 |
|
| 9989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLGN |
0.219848721448602 |
|
| 9990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMOD2 |
0.219848721448602 |
|
| 9991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCP1 |
0.219848721448602 |
|
| 9992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL152P |
0.219848721448602 |
|
| 9993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D9 |
0.219848721448602 |
|
| 9994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF150 |
0.219848721448602 |
|
| 9995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF330 |
0.219848721448602 |
|
| 9996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238695.1 |
0.219848721448602 |
|
| 9997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL15 |
0.219848721448602 |
|
| 9998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP4B |
0.219848721448602 |
|
| 9999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP38 |
0.219848721448602 |
|
| 10000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAB1 |
0.219848721448602 |
|
| 10001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3139 |
0.219848721448602 |
|
| 10002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCA5 |
0.219848721448602 |
|
| 10003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSBP5 |
0.219848721448602 |
|
| 10004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FREM3 |
0.219848721448602 |
|
| 10005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYPA |
0.219848721448602 |
|
| 10006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYPB |
0.219848721448602 |
|
| 10007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYPE |
0.219848721448602 |
|
| 10008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHIP |
0.219848721448602 |
|
| 10009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC10 |
0.219848721448602 |
|
| 10010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP235 |
0.219848721448602 |
|
| 10011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCE1 |
0.219848721448602 |
|
| 10012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD4 |
0.219848721448602 |
|
| 10013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD1 |
0.219848721448602 |
|
| 10014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMAA |
0.219848721448602 |
|
| 10015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf51 |
0.219848721448602 |
|
| 10016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF827 |
0.219848721448602 |
|
| 10017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM6 |
0.219848721448602 |
|
| 10018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU4F2 |
0.219848721448602 |
|
| 10019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC29 |
0.219848721448602 |
|
| 10020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548G |
0.219848721448602 |
|
| 10021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDNRA |
0.219848721448602 |
|
| 10022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFPL3 |
0.220774876408459 |
|
| 10023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLK1 |
0.223522782598029 |
|
| 10024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL8 |
0.223522782598029 |
|
| 10025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRB2 |
0.22433639634447 |
|
| 10026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA6 |
0.22433639634447 |
|
| 10027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA1 |
0.22433639634447 |
|
| 10028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRG2 |
0.22433639634447 |
|
| 10029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNG1 |
0.22433639634447 |
|
| 10030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDCD2 |
0.22433639634447 |
|
| 10031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMMR |
0.22433639634447 |
|
| 10032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAT2B |
0.22433639634447 |
|
| 10033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP60 |
0.22433639634447 |
|
| 10034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TENM2 |
0.22433639634447 |
|
| 10035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000253065.1 |
0.22433639634447 |
|
| 10036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGI1 |
0.228573606662642 |
|
| 10037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B4 |
0.229314725647135 |
|
| 10038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR11 |
0.229314725647135 |
|
| 10039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD7B |
0.229314725647135 |
|
| 10040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS45 |
0.229314725647135 |
|
| 10041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHO1 |
0.229314725647135 |
|
| 10042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL480P |
0.229314725647135 |
|
| 10043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32E |
0.229314725647135 |
|
| 10044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA14 |
0.229314725647135 |
|
| 10045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238526.1 |
0.229314725647135 |
|
| 10046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APH1A |
0.229314725647135 |
|
| 10047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf54 |
0.229314725647135 |
|
| 10048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf51 |
0.229314725647135 |
|
| 10049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS21 |
0.229314725647135 |
|
| 10050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF3 |
0.229314725647135 |
|
| 10051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HORMAD1 |
0.229314725647135 |
|
| 10052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSS |
0.229314725647135 |
|
| 10053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSK |
0.229314725647135 |
|
| 10054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARNT |
0.229314725647135 |
|
| 10055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETDB1 |
0.229314725647135 |
|
| 10056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS2 |
0.229314725647135 |
|
| 10057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA9 |
0.229314725647135 |
|
| 10058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM63A |
0.229314725647135 |
|
| 10059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRUNE |
0.229314725647135 |
|
| 10060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIPL |
0.229314725647135 |
|
| 10061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf56 |
0.229314725647135 |
|
| 10062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42SE1 |
0.229314725647135 |
|
| 10063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT11 |
0.229314725647135 |
|
| 10064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABPB2 |
0.229314725647135 |
|
| 10065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA6C |
0.229314725647135 |
|
| 10066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYSMD1 |
0.229314725647135 |
|
| 10067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCNM1 |
0.229314725647135 |
|
| 10068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP8L2 |
0.229314725647135 |
|
| 10069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMOD4 |
0.229314725647135 |
|
| 10070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS72 |
0.229314725647135 |
|
| 10071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP5K1A |
0.229314725647135 |
|
| 10072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD4 |
0.229314725647135 |
|
| 10073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF687 |
0.229314725647135 |
|
| 10074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4KB |
0.229314725647135 |
|
| 10075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL444P |
0.229314725647135 |
|
| 10076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX5 |
0.229314725647135 |
|
| 10077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POGZ |
0.229314725647135 |
|
| 10078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB4 |
0.229314725647135 |
|
| 10079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELENBP1 |
0.229314725647135 |
|
| 10080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P25 |
0.229314725647135 |
|
| 10081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGN |
0.229314725647135 |
|
| 10082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA44 |
0.229314725647135 |
|
| 10083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUFT1 |
0.229314725647135 |
|
| 10084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR554 |
0.229314725647135 |
|
| 10085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX27 |
0.229314725647135 |
|
| 10086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF3 |
0.229314725647135 |
|
| 10087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIIAD1 |
0.229314725647135 |
|
| 10088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL9 |
0.229314725647135 |
|
| 10089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAZ3 |
0.229314725647135 |
|
| 10090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRKH |
0.229314725647135 |
|
| 10091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINGO4 |
0.229314725647135 |
|
| 10092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RORC |
0.229314725647135 |
|
| 10093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD4D |
0.229314725647135 |
|
| 10094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEM5 |
0.229314725647135 |
|
| 10095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEM4 |
0.229314725647135 |
|
| 10096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A10 |
0.229314725647135 |
|
| 10097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF18P |
0.229314725647135 |
|
| 10098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A11 |
0.229314725647135 |
|
| 10099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCHHL1 |
0.229314725647135 |
|
| 10100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCHH |
0.229314725647135 |
|
| 10101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPTN |
0.229314725647135 |
|
| 10102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRNR |
0.229314725647135 |
|
| 10103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLG |
0.229314725647135 |
|
| 10104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLG2 |
0.229314725647135 |
|
| 10105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRNN |
0.229314725647135 |
|
| 10106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE5A |
0.229314725647135 |
|
| 10107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRCT1 |
0.229314725647135 |
|
| 10108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE3B |
0.229314725647135 |
|
| 10109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE3C |
0.229314725647135 |
|
| 10110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE3D |
0.229314725647135 |
|
| 10111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE3E |
0.229314725647135 |
|
| 10112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE3A |
0.229314725647135 |
|
| 10113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE2D |
0.229314725647135 |
|
| 10114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00302 |
0.229314725647135 |
|
| 10115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE2B |
0.229314725647135 |
|
| 10116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE2C |
0.229314725647135 |
|
| 10117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE2A |
0.229314725647135 |
|
| 10118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE4A |
0.229314725647135 |
|
| 10119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf68 |
0.229314725647135 |
|
| 10120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPRP |
0.229314725647135 |
|
| 10121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1F |
0.229314725647135 |
|
| 10122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1C |
0.229314725647135 |
|
| 10123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1D |
0.229314725647135 |
|
| 10124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1E |
0.229314725647135 |
|
| 10125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1B |
0.229314725647135 |
|
| 10126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE1A |
0.229314725647135 |
|
| 10127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCE6A |
0.229314725647135 |
|
| 10128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCP |
0.229314725647135 |
|
| 10129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IVL |
0.229314725647135 |
|
| 10130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR4 |
0.229314725647135 |
|
| 10131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR1A |
0.229314725647135 |
|
| 10132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR3 |
0.229314725647135 |
|
| 10133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252920.1 |
0.229314725647135 |
|
| 10134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR1B |
0.229314725647135 |
|
| 10135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2D |
0.229314725647135 |
|
| 10136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2A |
0.229314725647135 |
|
| 10137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2B |
0.229314725647135 |
|
| 10138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2E |
0.229314725647135 |
|
| 10139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2F |
0.229314725647135 |
|
| 10140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRR2G |
0.229314725647135 |
|
| 10141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LELP1 |
0.229314725647135 |
|
| 10142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR9 |
0.229314725647135 |
|
| 10143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOR |
0.229314725647135 |
|
| 10144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGLYRP3 |
0.229314725647135 |
|
| 10145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGLYRP4 |
0.229314725647135 |
|
| 10146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A12 |
0.229314725647135 |
|
| 10147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A8 |
0.229314725647135 |
|
| 10148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A9 |
0.229314725647135 |
|
| 10149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A7A |
0.229314725647135 |
|
| 10150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A7L2 |
0.229314725647135 |
|
| 10151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A7 |
0.229314725647135 |
|
| 10152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL44P |
0.229314725647135 |
|
| 10153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A3 |
0.229314725647135 |
|
| 10154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A4 |
0.229314725647135 |
|
| 10155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A5 |
0.229314725647135 |
|
| 10156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A6 |
0.229314725647135 |
|
| 10157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A2 |
0.229314725647135 |
|
| 10158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A16 |
0.229314725647135 |
|
| 10159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A14 |
0.229314725647135 |
|
| 10160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A13 |
0.229314725647135 |
|
| 10161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100A1 |
0.229314725647135 |
|
| 10162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHTOP |
0.229314725647135 |
|
| 10163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPIN |
0.229314725647135 |
|
| 10164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILF2 |
0.229314725647135 |
|
| 10165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPR1 |
0.229314725647135 |
|
| 10166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS3 |
0.229314725647135 |
|
| 10167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL372P |
0.229314725647135 |
|
| 10168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238511.1 |
0.229314725647135 |
|
| 10169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A3 |
0.229314725647135 |
|
| 10170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATAD2B |
0.229314725647135 |
|
| 10171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND4B |
0.229314725647135 |
|
| 10172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTC2 |
0.229314725647135 |
|
| 10173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A1 |
0.229314725647135 |
|
| 10174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB3L4 |
0.229314725647135 |
|
| 10175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JTB |
0.229314725647135 |
|
| 10176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB13 |
0.229314725647135 |
|
| 10177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP210L |
0.229314725647135 |
|
| 10178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS27 |
0.229314725647135 |
|
| 10179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252669.1 |
0.229314725647135 |
|
| 10180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5698 |
0.229314725647135 |
|
| 10181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPM3 |
0.229314725647135 |
|
| 10182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL431P |
0.229314725647135 |
|
| 10183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR190B |
0.229314725647135 |
|
| 10184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf189 |
0.229314725647135 |
|
| 10185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf43 |
0.229314725647135 |
|
| 10186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAP2L |
0.229314725647135 |
|
| 10187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA58|ENSG00000201129.1 |
0.229314725647135 |
|
| 10188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAX1 |
0.229314725647135 |
|
| 10189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD59|ENSG00000252682.1 |
0.229314725647135 |
|
| 10190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP10 |
0.229314725647135 |
|
| 10191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8B2 |
0.229314725647135 |
|
| 10192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL6R |
0.229314725647135 |
|
| 10193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHE |
0.229314725647135 |
|
| 10194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD10 |
0.229314725647135 |
|
| 10195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Q1 |
0.229314725647135 |
|
| 10196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNB2 |
0.229314725647135 |
|
| 10197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAR |
0.229314725647135 |
|
| 10198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNN3 |
0.229314725647135 |
|
| 10199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMVK |
0.229314725647135 |
|
| 10200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBXIP1 |
0.229314725647135 |
|
| 10201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYGO2 |
0.229314725647135 |
|
| 10202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHC1 |
0.229314725647135 |
|
| 10203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKS1B|ENSG00000173207.8 |
0.229314725647135 |
|
| 10204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4258 |
0.229314725647135 |
|
| 10205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLAD1 |
0.229314725647135 |
|
| 10206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LENEP |
0.229314725647135 |
|
| 10207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB7B |
0.229314725647135 |
|
| 10208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCST2 |
0.229314725647135 |
|
| 10209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCST1 |
0.229314725647135 |
|
| 10210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM15 |
0.229314725647135 |
|
| 10211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNA3 |
0.229314725647135 |
|
| 10212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNA4 |
0.229314725647135 |
|
| 10213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNA1 |
0.229314725647135 |
|
| 10214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPM3 |
0.229314725647135 |
|
| 10215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC50A1 |
0.229314725647135 |
|
| 10216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRTCAP2 |
0.229314725647135 |
|
| 10217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM46 |
0.229314725647135 |
|
| 10218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR92B |
0.229314725647135 |
|
| 10219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC1 |
0.229314725647135 |
|
| 10220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THBS3 |
0.229314725647135 |
|
| 10221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTX1 |
0.229314725647135 |
|
| 10222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBAP1 |
0.229314725647135 |
|
| 10223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBA |
0.229314725647135 |
|
| 10224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM189B |
0.229314725647135 |
|
| 10225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAMP3 |
0.229314725647135 |
|
| 10226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLK2 |
0.229314725647135 |
|
| 10227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCN3 |
0.229314725647135 |
|
| 10228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKLR |
0.229314725647135 |
|
| 10229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDPS |
0.229314725647135 |
|
| 10230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUSC1 |
0.229314725647135 |
|
| 10231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASH1L |
0.229314725647135 |
|
| 10232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR555 |
0.229314725647135 |
|
| 10233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238805.1 |
0.229314725647135 |
|
| 10234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSTO1 |
0.229314725647135 |
|
| 10235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YY1AP1 |
0.229314725647135 |
|
| 10236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAP3 |
0.229314725647135 |
|
| 10237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GON4L |
0.229314725647135 |
|
| 10238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT11 |
0.229314725647135 |
|
| 10239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIT1 |
0.229314725647135 |
|
| 10240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0907 |
0.229314725647135 |
|
| 10241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA42|ENSG00000207475.1 |
0.229314725647135 |
|
| 10242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA4|ENSG00000252808.1 |
0.229314725647135 |
|
| 10243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXFP4 |
0.229314725647135 |
|
| 10244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF2 |
0.229314725647135 |
|
| 10245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSR2 |
0.229314725647135 |
|
| 10246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBQLN4 |
0.229314725647135 |
|
| 10247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMTOR2 |
0.229314725647135 |
|
| 10248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB25 |
0.229314725647135 |
|
| 10249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEX3A |
0.229314725647135 |
|
| 10250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMNA |
0.229314725647135 |
|
| 10251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4A |
0.229314725647135 |
|
| 10252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000252236.1 |
0.229314725647135 |
|
| 10253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A44 |
0.229314725647135 |
|
| 10254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMF1 |
0.229314725647135 |
|
| 10255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BGLAP |
0.229314725647135 |
|
| 10256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR6 |
0.229314725647135 |
|
| 10257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG5 |
0.229314725647135 |
|
| 10258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf85 |
0.229314725647135 |
|
| 10259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM79 |
0.229314725647135 |
|
| 10260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VHLL |
0.229314725647135 |
|
| 10261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT3 |
0.229314725647135 |
|
| 10262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSACC |
0.229314725647135 |
|
| 10263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBG |
0.229314725647135 |
|
| 10264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf61 |
0.229314725647135 |
|
| 10265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEF2D |
0.229314725647135 |
|
| 10266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQGAP3 |
0.229314725647135 |
|
| 10267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238843.1 |
0.229314725647135 |
|
| 10268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC24 |
0.229314725647135 |
|
| 10269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOA1BP |
0.229314725647135 |
|
| 10270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH4 |
0.229314725647135 |
|
| 10271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAPLN2 |
0.229314725647135 |
|
| 10272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAN |
0.229314725647135 |
|
| 10273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NES |
0.229314725647135 |
|
| 10274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRABP2 |
0.229314725647135 |
|
| 10275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISG20L2 |
0.229314725647135 |
|
| 10276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRNAD1 |
0.229314725647135 |
|
| 10277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL24 |
0.229314725647135 |
|
| 10278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDGF |
0.229314725647135 |
|
| 10279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRCC |
0.229314725647135 |
|
| 10280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D2A |
0.229314725647135 |
|
| 10281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTRK1 |
0.229314725647135 |
|
| 10282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSRR |
0.229314725647135 |
|
| 10283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEAR1 |
0.229314725647135 |
|
| 10284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC71 |
0.229314725647135 |
|
| 10285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF11 |
0.229314725647135 |
|
| 10286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR765 |
0.229314725647135 |
|
| 10287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL612P |
0.229314725647135 |
|
| 10288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV3L |
0.229314725647135 |
|
| 10289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV3 |
0.229314725647135 |
|
| 10290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL5 |
0.229314725647135 |
|
| 10291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL4 |
0.229314725647135 |
|
| 10292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL3 |
0.229314725647135 |
|
| 10293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL2 |
0.229314725647135 |
|
| 10294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL1 |
0.229314725647135 |
|
| 10295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD5L |
0.229314725647135 |
|
| 10296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIRREL |
0.229314725647135 |
|
| 10297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD1D |
0.229314725647135 |
|
| 10298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD1A |
0.229314725647135 |
|
| 10299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD1C |
0.229314725647135 |
|
| 10300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD1B |
0.229314725647135 |
|
| 10301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD1E |
0.229314725647135 |
|
| 10302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10T2 |
0.229314725647135 |
|
| 10303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10K2 |
0.229314725647135 |
|
| 10304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10K1 |
0.229314725647135 |
|
| 10305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10R2 |
0.229314725647135 |
|
| 10306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10Z1 |
0.229314725647135 |
|
| 10307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTA1 |
0.229314725647135 |
|
| 10308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6K2 |
0.229314725647135 |
|
| 10309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6K3 |
0.229314725647135 |
|
| 10310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6K6 |
0.229314725647135 |
|
| 10311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6N1 |
0.229314725647135 |
|
| 10312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6N2 |
0.229314725647135 |
|
| 10313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNDA |
0.229314725647135 |
|
| 10314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYHIN1 |
0.229314725647135 |
|
| 10315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI16 |
0.229314725647135 |
|
| 10316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIM2 |
0.229314725647135 |
|
| 10317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADM3 |
0.229314725647135 |
|
| 10318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP60 |
0.229314725647135 |
|
| 10319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DARC |
0.229314725647135 |
|
| 10320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCER1A |
0.229314725647135 |
|
| 10321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10J3 |
0.229314725647135 |
|
| 10322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10J4 |
0.229314725647135 |
|
| 10323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10J1 |
0.229314725647135 |
|
| 10324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10J5 |
0.229314725647135 |
|
| 10325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APCS |
0.229314725647135 |
|
| 10326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRP |
0.229314725647135 |
|
| 10327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP23 |
0.229314725647135 |
|
| 10328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRL6 |
0.229314725647135 |
|
| 10329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAMF8 |
0.229314725647135 |
|
| 10330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf204 |
0.229314725647135 |
|
| 10331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD64|ENSG00000212161.1 |
0.229314725647135 |
|
| 10332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG8 |
0.229314725647135 |
|
| 10333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC19 |
0.229314725647135 |
|
| 10334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAGLN2 |
0.229314725647135 |
|
| 10335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF9 |
0.229314725647135 |
|
| 10336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAMF9 |
0.229314725647135 |
|
| 10337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGM |
0.229314725647135 |
|
| 10338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ10 |
0.229314725647135 |
|
| 10339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ9 |
0.229314725647135 |
|
| 10340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF8 |
0.229314725647135 |
|
| 10341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1A2 |
0.229314725647135 |
|
| 10342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1A4 |
0.229314725647135 |
|
| 10343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASQ1 |
0.229314725647135 |
|
| 10344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEA15 |
0.229314725647135 |
|
| 10345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF8 |
0.229314725647135 |
|
| 10346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX19 |
0.229314725647135 |
|
| 10347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPA |
0.229314725647135 |
|
| 10348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCSTN |
0.229314725647135 |
|
| 10349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLH1 |
0.229314725647135 |
|
| 10350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VANGL2 |
0.229314725647135 |
|
| 10351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAMF6 |
0.229314725647135 |
|
| 10352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD84 |
0.229314725647135 |
|
| 10353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAMF1 |
0.229314725647135 |
|
| 10354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD48 |
0.229314725647135 |
|
| 10355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAMF7 |
0.229314725647135 |
|
| 10356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY9 |
0.229314725647135 |
|
| 10357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD244 |
0.229314725647135 |
|
| 10358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITLN1 |
0.229314725647135 |
|
| 10359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITLN2 |
0.229314725647135 |
|
| 10360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F11R |
0.229314725647135 |
|
| 10361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSTD1 |
0.229314725647135 |
|
| 10362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USF1 |
0.229314725647135 |
|
| 10363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP30 |
0.229314725647135 |
|
| 10364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVRL4 |
0.229314725647135 |
|
| 10365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC9 |
0.229314725647135 |
|
| 10366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFDN2 |
0.229314725647135 |
|
| 10367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIT1 |
0.229314725647135 |
|
| 10368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEDD |
0.229314725647135 |
|
| 10369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000238934.1 |
0.229314725647135 |
|
| 10370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFC1 |
0.229314725647135 |
|
| 10371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP21 |
0.229314725647135 |
|
| 10372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT3 |
0.229314725647135 |
|
| 10373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPOX |
0.229314725647135 |
|
| 10374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS4 |
0.229314725647135 |
|
| 10375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS2 |
0.229314725647135 |
|
| 10376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCER1G |
0.229314725647135 |
|
| 10377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOA2 |
0.229314725647135 |
|
| 10378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5187 |
0.229314725647135 |
|
| 10379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1I3 |
0.229314725647135 |
|
| 10380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM40L |
0.229314725647135 |
|
| 10381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCP4L1 |
0.229314725647135 |
|
| 10382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPZ |
0.229314725647135 |
|
| 10383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHC |
0.229314725647135 |
|
| 10384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf192 |
0.229314725647135 |
|
| 10385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR2A |
0.229314725647135 |
|
| 10386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR2B |
0.229314725647135 |
|
| 10387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR2C |
0.229314725647135 |
|
| 10388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR3A |
0.229314725647135 |
|
| 10389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCGR3B |
0.229314725647135 |
|
| 10390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA6 |
0.229314725647135 |
|
| 10391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL31P11 |
0.229314725647135 |
|
| 10392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRLA |
0.229314725647135 |
|
| 10393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCRLB |
0.229314725647135 |
|
| 10394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL466P |
0.229314725647135 |
|
| 10395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP12 |
0.229314725647135 |
|
| 10396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF6 |
0.229314725647135 |
|
| 10397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFML2B |
0.229314725647135 |
|
| 10398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOS1AP |
0.229314725647135 |
|
| 10399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4654 |
0.229314725647135 |
|
| 10400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP61 |
0.229314725647135 |
|
| 10401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR556 |
0.229314725647135 |
|
| 10402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf226 |
0.229314725647135 |
|
| 10403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf111 |
0.229314725647135 |
|
| 10404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D1B |
0.229314725647135 |
|
| 10405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UHMK1 |
0.229314725647135 |
|
| 10406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UAP1 |
0.229314725647135 |
|
| 10407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDR2 |
0.229314725647135 |
|
| 10408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL861P |
0.229314725647135 |
|
| 10409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B7 |
0.229314725647135 |
|
| 10410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf110 |
0.229314725647135 |
|
| 10411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS4 |
0.229314725647135 |
|
| 10412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS5 |
0.229314725647135 |
|
| 10413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUF2 |
0.229314725647135 |
|
| 10414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252740.1 |
0.229314725647135 |
|
| 10415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP62 |
0.229314725647135 |
|
| 10416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP63 |
0.229314725647135 |
|
| 10417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212538.1 |
0.229314725647135 |
|
| 10418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBX1 |
0.229314725647135 |
|
| 10419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252359.1 |
0.229314725647135 |
|
| 10420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMX1A |
0.229314725647135 |
|
| 10421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXRG |
0.229314725647135 |
|
| 10422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC52 |
0.229314725647135 |
|
| 10423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGST3 |
0.229314725647135 |
|
| 10424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH9A1 |
0.229314725647135 |
|
| 10425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO1 |
0.229314725647135 |
|
| 10426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCK2 |
0.229314725647135 |
|
| 10427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP64 |
0.229314725647135 |
|
| 10428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM78B |
0.229314725647135 |
|
| 10429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR921 |
0.229314725647135 |
|
| 10430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO9P |
0.229314725647135 |
|
| 10431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POGK |
0.229314725647135 |
|
| 10432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TADA1 |
0.229314725647135 |
|
| 10433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILDR2 |
0.229314725647135 |
|
| 10434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAEL |
0.229314725647135 |
|
| 10435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP65 |
0.229314725647135 |
|
| 10436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238325.1 |
0.229314725647135 |
|
| 10437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPA33 |
0.229314725647135 |
|
| 10438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP27 |
0.229314725647135 |
|
| 10439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU2F1 |
0.229314725647135 |
|
| 10440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD247 |
0.229314725647135 |
|
| 10441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREG1 |
0.229314725647135 |
|
| 10442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCSD1 |
0.229314725647135 |
|
| 10443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPZL1 |
0.229314725647135 |
|
| 10444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY10 |
0.229314725647135 |
|
| 10445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPC2 |
0.229314725647135 |
|
| 10446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF6 |
0.229314725647135 |
|
| 10447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1255B2 |
0.229314725647135 |
|
| 10448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR161 |
0.229314725647135 |
|
| 10449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIPRL |
0.229314725647135 |
|
| 10450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFT2D2 |
0.229314725647135 |
|
| 10451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD36BP1 |
0.229314725647135 |
|
| 10452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX19 |
0.229314725647135 |
|
| 10453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR557 |
0.229314725647135 |
|
| 10454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XCL2 |
0.229314725647135 |
|
| 10455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XCL1 |
0.229314725647135 |
|
| 10456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPT |
0.229314725647135 |
|
| 10457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00626 |
0.229314725647135 |
|
| 10458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00970 |
0.229314725647135 |
|
| 10459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP66 |
0.229314725647135 |
|
| 10460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1B1 |
0.229314725647135 |
|
| 10461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME7 |
0.229314725647135 |
|
| 10462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLZF1 |
0.229314725647135 |
|
| 10463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC181 |
0.229314725647135 |
|
| 10464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC19A2 |
0.229314725647135 |
|
| 10465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F5 |
0.229314725647135 |
|
| 10466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELP |
0.229314725647135 |
|
| 10467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf112 |
0.229314725647135 |
|
| 10468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELL |
0.229314725647135 |
|
| 10469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELE |
0.229314725647135 |
|
| 10470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL18 |
0.229314725647135 |
|
| 10471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCYL3 |
0.229314725647135 |
|
| 10472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL333P |
0.229314725647135 |
|
| 10473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIFAP3 |
0.229314725647135 |
|
| 10474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL269P |
0.229314725647135 |
|
| 10475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL11B |
0.229314725647135 |
|
| 10476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GORAB |
0.229314725647135 |
|
| 10477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRX1 |
0.229314725647135 |
|
| 10478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH9 |
0.229314725647135 |
|
| 10479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO3 |
0.229314725647135 |
|
| 10480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1295A |
0.229314725647135 |
|
| 10481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO6P |
0.229314725647135 |
|
| 10482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO2 |
0.229314725647135 |
|
| 10483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO1 |
0.229314725647135 |
|
| 10484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMO4 |
0.229314725647135 |
|
| 10485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238859.1 |
0.229314725647135 |
|
| 10486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRC2C |
0.229314725647135 |
|
| 10487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL425P |
0.229314725647135 |
|
| 10488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOC |
0.229314725647135 |
|
| 10489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP4 |
0.229314725647135 |
|
| 10490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000253060.1 |
0.229314725647135 |
|
| 10491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL13 |
0.229314725647135 |
|
| 10492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM3 |
0.229314725647135 |
|
| 10493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM3OS |
0.229314725647135 |
|
| 10494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR214 |
0.229314725647135 |
|
| 10495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR199A2 |
0.229314725647135 |
|
| 10496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252354.1 |
0.229314725647135 |
|
| 10497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGC |
0.229314725647135 |
|
| 10498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf105 |
0.229314725647135 |
|
| 10499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUCO |
0.229314725647135 |
|
| 10500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASLG |
0.229314725647135 |
|
| 10501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF18 |
0.229314725647135 |
|
| 10502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF4 |
0.229314725647135 |
|
| 10503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251817.1 |
0.229314725647135 |
|
| 10504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX6 |
0.229314725647135 |
|
| 10505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9C2 |
0.229314725647135 |
|
| 10506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD45 |
0.229314725647135 |
|
| 10507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238430.1 |
0.229314725647135 |
|
| 10508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL20 |
0.229314725647135 |
|
| 10509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP160 |
0.229314725647135 |
|
| 10510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPL |
0.229314725647135 |
|
| 10511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DARS2 |
0.229314725647135 |
|
| 10512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS5 |
0.229314725647135 |
|
| 10513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD78|ENSG00000208317.1 |
0.229314725647135 |
|
| 10514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB37 |
0.229314725647135 |
|
| 10515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINC1 |
0.229314725647135 |
|
| 10516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP67 |
0.229314725647135 |
|
| 10517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RC3H1 |
0.229314725647135 |
|
| 10518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP68 |
0.229314725647135 |
|
| 10519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABGAP1L |
0.229314725647135 |
|
| 10520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238872.1 |
0.229314725647135 |
|
| 10521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR52 |
0.229314725647135 |
|
| 10522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACYBP |
0.229314725647135 |
|
| 10523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS14 |
0.229314725647135 |
|
| 10524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNN |
0.229314725647135 |
|
| 10525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0040 |
0.229314725647135 |
|
| 10526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNR |
0.229314725647135 |
|
| 10527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFWD2 |
0.229314725647135 |
|
| 10528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA3 |
0.229314725647135 |
|
| 10529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPPA2 |
0.229314725647135 |
|
| 10530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASTN1 |
0.229314725647135 |
|
| 10531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR488 |
0.229314725647135 |
|
| 10532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM5B |
0.229314725647135 |
|
| 10533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC16B |
0.229314725647135 |
|
| 10534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASAL2 |
0.229314725647135 |
|
| 10535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00083 |
0.229314725647135 |
|
| 10536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX35 |
0.229314725647135 |
|
| 10537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1ORF220 |
0.229314725647135 |
|
| 10538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf220 |
0.229314725647135 |
|
| 10539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP69 |
0.229314725647135 |
|
| 10540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4424 |
0.229314725647135 |
|
| 10541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGPS2 |
0.229314725647135 |
|
| 10542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000201791.1 |
0.229314725647135 |
|
| 10543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL1 |
0.229314725647135 |
|
| 10544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM20B |
0.229314725647135 |
|
| 10545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR3A |
0.229314725647135 |
|
| 10546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABL2 |
0.229314725647135 |
|
| 10547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000201619.1 |
0.229314725647135 |
|
| 10548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000212338.1 |
0.229314725647135 |
|
| 10549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOAT1 |
0.229314725647135 |
|
| 10550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AXDND1 |
0.229314725647135 |
|
| 10551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL374P |
0.229314725647135 |
|
| 10552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPHS2 |
0.229314725647135 |
|
| 10553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD5 |
0.229314725647135 |
|
| 10554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM163A |
0.229314725647135 |
|
| 10555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR1AIP2 |
0.229314725647135 |
|
| 10556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFRG15 |
0.229314725647135 |
|
| 10557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOR1AIP1 |
0.229314725647135 |
|
| 10558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL230P |
0.229314725647135 |
|
| 10559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP350 |
0.229314725647135 |
|
| 10560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QSOX1 |
0.229314725647135 |
|
| 10561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX4 |
0.229314725647135 |
|
| 10562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACBD6 |
0.229314725647135 |
|
| 10563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3121 |
0.229314725647135 |
|
| 10564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPR1 |
0.229314725647135 |
|
| 10565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272292.1 |
0.229314725647135 |
|
| 10566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1614 |
0.229314725647135 |
|
| 10567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX6 |
0.229314725647135 |
|
| 10568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MR1 |
0.229314725647135 |
|
| 10569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IER5 |
0.229314725647135 |
|
| 10570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1E |
0.229314725647135 |
|
| 10571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP70 |
0.229314725647135 |
|
| 10572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP229 |
0.229314725647135 |
|
| 10573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF648 |
0.229314725647135 |
|
| 10574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLUL |
0.229314725647135 |
|
| 10575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEDDM1 |
0.229314725647135 |
|
| 10576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00272 |
0.229314725647135 |
|
| 10577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGSL1 |
0.229314725647135 |
|
| 10578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEL |
0.229314725647135 |
|
| 10579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS16 |
0.229314725647135 |
|
| 10580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS8 |
0.229314725647135 |
|
| 10581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPL |
0.229314725647135 |
|
| 10582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX9 |
0.229314725647135 |
|
| 10583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHCBP1L |
0.229314725647135 |
|
| 10584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP71 |
0.229314725647135 |
|
| 10585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMC1 |
0.229314725647135 |
|
| 10586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMC2 |
0.229314725647135 |
|
| 10587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMNAT2 |
0.229314725647135 |
|
| 10588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG7 |
0.229314725647135 |
|
| 10589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCF2 |
0.229314725647135 |
|
| 10590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC5 |
0.229314725647135 |
|
| 10591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGL1 |
0.229314725647135 |
|
| 10592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC4 |
0.229314725647135 |
|
| 10593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLGALT2 |
0.229314725647135 |
|
| 10594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSEN15 |
0.229314725647135 |
|
| 10595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL654P |
0.229314725647135 |
|
| 10596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf21 |
0.229314725647135 |
|
| 10597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252790.1 |
0.229314725647135 |
|
| 10598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDEM3 |
0.229314725647135 |
|
| 10599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM129A |
0.229314725647135 |
|
| 10600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP72 |
0.229314725647135 |
|
| 10601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF2 |
0.229314725647135 |
|
| 10602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT1L |
0.229314725647135 |
|
| 10603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SWT1 |
0.229314725647135 |
|
| 10604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IVNS1ABP |
0.229314725647135 |
|
| 10605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMCN1 |
0.229314725647135 |
|
| 10606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRG4 |
0.229314725647135 |
|
| 10607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPR |
0.229314725647135 |
|
| 10608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf27 |
0.229314725647135 |
|
| 10609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCLM |
0.229314725647135 |
|
| 10610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDC |
0.229314725647135 |
|
| 10611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHAT |
0.229314725647135 |
|
| 10612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF39 |
0.232053571489397 |
|
| 10613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD127 |
0.232053571489397 |
|
| 10614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP3 |
0.232053571489397 |
|
| 10615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCM |
0.232053571489397 |
|
| 10616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIS18BP1 |
0.232053571489397 |
|
| 10617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00871 |
0.232053571489397 |
|
| 10618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL10L |
0.232053571489397 |
|
| 10619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDGA2 |
0.232053571489397 |
|
| 10620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000251735.1 |
0.232053571489397 |
|
| 10621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00648 |
0.232053571489397 |
|
| 10622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548Y |
0.232053571489397 |
|
| 10623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIAM1 |
0.232481514353184 |
|
| 10624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOD1 |
0.232481514353184 |
|
| 10625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAF4 |
0.232481514353184 |
|
| 10626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA81|ENSG00000238390.1 |
0.232481514353184 |
|
| 10627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX29 |
0.234105198028437 |
|
| 10628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00354 |
0.234105198028437 |
|
| 10629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD44 |
0.234105198028437 |
|
| 10630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX1 |
0.234105198028437 |
|
| 10631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00403 |
0.234105198028437 |
|
| 10632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00404 |
0.234105198028437 |
|
| 10633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D31 |
0.239598992028609 |
|
| 10634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83A |
0.239598992028609 |
|
| 10635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221461.1 |
0.239598992028609 |
|
| 10636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4663 |
0.239598992028609 |
|
| 10637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf76 |
0.239598992028609 |
|
| 10638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZHX1 |
0.239598992028609 |
|
| 10639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238422.1 |
0.239598992028609 |
|
| 10640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD2 |
0.239598992028609 |
|
| 10641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AA1 |
0.239598992028609 |
|
| 10642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYRP1 |
0.241408248311182 |
|
| 10643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL849P |
0.241408248311182 |
|
| 10644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LURAP1L |
0.241408248311182 |
|
| 10645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPDZ |
0.241408248311182 |
|
| 10646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00583 |
0.241408248311182 |
|
| 10647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFIB |
0.241408248311182 |
|
| 10648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC21 |
0.241408248311182 |
|
| 10649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CER1 |
0.241408248311182 |
|
| 10650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FREM1 |
0.241408248311182 |
|
| 10651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL157P |
0.241408248311182 |
|
| 10652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPC3 |
0.241408248311182 |
|
| 10653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSIP1 |
0.241408248311182 |
|
| 10654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL98P |
0.241408248311182 |
|
| 10655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC171 |
0.241408248311182 |
|
| 10656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF26B |
0.245597538143624 |
|
| 10657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMYD3 |
0.245597538143624 |
|
| 10658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHCTF1 |
0.245597538143624 |
|
| 10659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNST |
0.245597538143624 |
|
| 10660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCCPDH |
0.245597538143624 |
|
| 10661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252011.1 |
0.245597538143624 |
|
| 10662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252495.1 |
0.245597538143624 |
|
| 10663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFB2M |
0.245597538143624 |
|
| 10664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF670 |
0.245597538143624 |
|
| 10665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF695 |
0.245597538143624 |
|
| 10666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF669 |
0.245597538143624 |
|
| 10667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf229 |
0.245597538143624 |
|
| 10668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF124 |
0.245597538143624 |
|
| 10669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3916 |
0.245597538143624 |
|
| 10670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP82 |
0.245597538143624 |
|
| 10671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF496 |
0.245597538143624 |
|
| 10672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP3 |
0.245597538143624 |
|
| 10673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2B11 |
0.245597538143624 |
|
| 10674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2W5 |
0.245597538143624 |
|
| 10675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCSAML |
0.245597538143624 |
|
| 10676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2C3 |
0.245597538143624 |
|
| 10677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2G2 |
0.245597538143624 |
|
| 10678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2G3 |
0.245597538143624 |
|
| 10679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD8 |
0.245597538143624 |
|
| 10680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3124 |
0.245597538143624 |
|
| 10681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11L1 |
0.245597538143624 |
|
| 10682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13G1 |
0.245597538143624 |
|
| 10683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14A16 |
0.245597538143624 |
|
| 10684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14A2 |
0.245597538143624 |
|
| 10685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14C36 |
0.245597538143624 |
|
| 10686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14I1 |
0.245597538143624 |
|
| 10687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR14K1 |
0.245597538143624 |
|
| 10688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1C1 |
0.245597538143624 |
|
| 10689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AJ1 |
0.245597538143624 |
|
| 10690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AK2 |
0.245597538143624 |
|
| 10691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2G6 |
0.245597538143624 |
|
| 10692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2L13 |
0.245597538143624 |
|
| 10693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2L2 |
0.245597538143624 |
|
| 10694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2L3 |
0.245597538143624 |
|
| 10695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2L5 |
0.245597538143624 |
|
| 10696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2L8 |
0.245597538143624 |
|
| 10697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2M2 |
0.245597538143624 |
|
| 10698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2M3 |
0.245597538143624 |
|
| 10699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2M4 |
0.245597538143624 |
|
| 10700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2M5 |
0.245597538143624 |
|
| 10701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2M7 |
0.245597538143624 |
|
| 10702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T10 |
0.245597538143624 |
|
| 10703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T11 |
0.245597538143624 |
|
| 10704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T12 |
0.245597538143624 |
|
| 10705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T1 |
0.245597538143624 |
|
| 10706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T27 |
0.245597538143624 |
|
| 10707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T29 |
0.245597538143624 |
|
| 10708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T2 |
0.245597538143624 |
|
| 10709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T33 |
0.245597538143624 |
|
| 10710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T34 |
0.245597538143624 |
|
| 10711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T35 |
0.245597538143624 |
|
| 10712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T3 |
0.245597538143624 |
|
| 10713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T4 |
0.245597538143624 |
|
| 10714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T5 |
0.245597538143624 |
|
| 10715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T6 |
0.245597538143624 |
|
| 10716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T7 |
0.245597538143624 |
|
| 10717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2T8 |
0.245597538143624 |
|
| 10718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2W3 |
0.245597538143624 |
|
| 10719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6F1 |
0.245597538143624 |
|
| 10720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGBD2 |
0.245597538143624 |
|
| 10721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BP5L |
0.245597538143624 |
|
| 10722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM58 |
0.245597538143624 |
|
| 10723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF672 |
0.245597538143624 |
|
| 10724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF692 |
0.245597538143624 |
|
| 10725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGSN |
0.249440716216841 |
|
| 10726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTP4A1 |
0.249440716216841 |
|
| 10727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF3 |
0.249440716216841 |
|
| 10728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM5B |
0.249688119240906 |
|
| 10729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCAT6 |
0.249688119240906 |
|
| 10730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF3IP3 |
0.249688119240906 |
|
| 10731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf74 |
0.249688119240906 |
|
| 10732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF6 |
0.249688119240906 |
|
| 10733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIEXF |
0.249688119240906 |
|
| 10734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT14 |
0.249688119240906 |
|
| 10735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AG1 |
0.254712779646353 |
|
| 10736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPHN3 |
0.254712779646353 |
|
| 10737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL338P |
0.256556946287566 |
|
| 10738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCP |
0.256556946287566 |
|
| 10739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCG |
0.256556946287566 |
|
| 10740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGO |
0.256556946287566 |
|
| 10741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOML2 |
0.256556946287566 |
|
| 10742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM214B |
0.256556946287566 |
|
| 10743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC13B |
0.256556946287566 |
|
| 10744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8B5P |
0.256556946287566 |
|
| 10745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUSC2 |
0.256556946287566 |
|
| 10746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM166B |
0.256556946287566 |
|
| 10747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD72 |
0.256556946287566 |
|
| 10748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4667 |
0.256556946287566 |
|
| 10749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TESK1 |
0.256556946287566 |
|
| 10750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIT1 |
0.256556946287566 |
|
| 10751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF39 |
0.256556946287566 |
|
| 10752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC107 |
0.256556946287566 |
|
| 10753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRP |
0.256556946287566 |
|
| 10754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA9 |
0.256556946287566 |
|
| 10755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL22P |
0.256556946287566 |
|
| 10756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPM2 |
0.256556946287566 |
|
| 10757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLN1 |
0.256556946287566 |
|
| 10758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB3 |
0.256556946287566 |
|
| 10759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBA2 |
0.256556946287566 |
|
| 10760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGP1 |
0.256556946287566 |
|
| 10761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSMP |
0.256556946287566 |
|
| 10762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPR2 |
0.256556946287566 |
|
| 10763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG8 |
0.256556946287566 |
|
| 10764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM221B |
0.256556946287566 |
|
| 10765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HINT2 |
0.256556946287566 |
|
| 10766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM8B |
0.256556946287566 |
|
| 10767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13J1 |
0.256556946287566 |
|
| 10768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRCT1 |
0.256556946287566 |
|
| 10769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00961 |
0.256556946287566 |
|
| 10770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2S2 |
0.256556946287566 |
|
| 10771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RECK |
0.256556946287566 |
|
| 10772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIPR2 |
0.256556946287566 |
|
| 10773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCIN |
0.256556946287566 |
|
| 10774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLTA |
0.256556946287566 |
|
| 10775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD37|ENSG00000212270.1 |
0.257806769211925 |
|
| 10776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOVA1 |
0.257806769211925 |
|
| 10777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4307 |
0.257806769211925 |
|
| 10778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00645 |
0.257806769211925 |
|
| 10779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIP3P1 |
0.257806769211925 |
|
| 10780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf23 |
0.257806769211925 |
|
| 10781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXG1 |
0.257806769211925 |
|
| 10782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKD1 |
0.257806769211925 |
|
| 10783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G2E3 |
0.257806769211925 |
|
| 10784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCFD1 |
0.257806769211925 |
|
| 10785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COCH |
0.257806769211925 |
|
| 10786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRN3 |
0.257806769211925 |
|
| 10787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR624 |
0.257806769211925 |
|
| 10788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP4S1 |
0.257806769211925 |
|
| 10789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECTD1 |
0.257806769211925 |
|
| 10790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR5A |
0.257806769211925 |
|
| 10791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTD2 |
0.257806769211925 |
|
| 10792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR33 |
0.257806769211925 |
|
| 10793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUBPL |
0.257806769211925 |
|
| 10794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP5 |
0.257806769211925 |
|
| 10795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP6 |
0.257806769211925 |
|
| 10796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL660P |
0.257806769211925 |
|
| 10797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAS3 |
0.257806769211925 |
|
| 10798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGLN3 |
0.257806769211925 |
|
| 10799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTSSA |
0.257806769211925 |
|
| 10800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EAPP |
0.257806769211925 |
|
| 10801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX6 |
0.257806769211925 |
|
| 10802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFL2 |
0.257806769211925 |
|
| 10803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAZ1A |
0.257806769211925 |
|
| 10804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP54 |
0.257806769211925 |
|
| 10805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM177A1 |
0.257806769211925 |
|
| 10806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R3C |
0.257806769211925 |
|
| 10807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0391 |
0.257806769211925 |
|
| 10808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA6 |
0.257806769211925 |
|
| 10809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBIA |
0.257806769211925 |
|
| 10810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSM2 |
0.257806769211925 |
|
| 10811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALGAPA1 |
0.257806769211925 |
|
| 10812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000253059.1 |
0.257806769211925 |
|
| 10813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238718.1 |
0.257806769211925 |
|
| 10814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRMS1L |
0.257806769211925 |
|
| 10815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00609 |
0.257806769211925 |
|
| 10816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCSC3 |
0.257806769211925 |
|
| 10817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP21 |
0.257806769211925 |
|
| 10818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBIP |
0.257806769211925 |
|
| 10819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPPA3P2 |
0.257806769211925 |
|
| 10820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTA3 |
0.257806769211925 |
|
| 10821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP257 |
0.257806769211925 |
|
| 10822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX9 |
0.257806769211925 |
|
| 10823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A21 |
0.257806769211925 |
|
| 10824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4503 |
0.257806769211925 |
|
| 10825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIPOL1 |
0.257806769211925 |
|
| 10826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXA1 |
0.257806769211925 |
|
| 10827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC6 |
0.257806769211925 |
|
| 10828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA42|ENSG00000200385.1 |
0.257806769211925 |
|
| 10829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00517 |
0.257806769211925 |
|
| 10830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSTR1 |
0.257806769211925 |
|
| 10831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC14A |
0.257806769211925 |
|
| 10832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00639 |
0.257806769211925 |
|
| 10833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC23A |
0.257806769211925 |
|
| 10834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN2 |
0.257806769211925 |
|
| 10835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC6B |
0.257806769211925 |
|
| 10836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNN |
0.257806769211925 |
|
| 10837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIA2 |
0.257806769211925 |
|
| 10838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE5 |
0.257806769211925 |
|
| 10839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO33 |
0.257806769211925 |
|
| 10840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000251858.1 |
0.257806769211925 |
|
| 10841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRFN5 |
0.257806769211925 |
|
| 10842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSCB |
0.257806769211925 |
|
| 10843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238501.1 |
0.257806769211925 |
|
| 10844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf28 |
0.257806769211925 |
|
| 10845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL28 |
0.257806769211925 |
|
| 10846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM179B |
0.257806769211925 |
|
| 10847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD58 |
0.257806769211925 |
|
| 10848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM150C |
0.259316445748128 |
|
| 10849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00575 |
0.259316445748128 |
|
| 10850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCD5 |
0.259316445748128 |
|
| 10851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV30 |
0.260645131289449 |
|
| 10852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHB6 |
0.260645131289449 |
|
| 10853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV6 |
0.260645131289449 |
|
| 10854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV5 |
0.260645131289449 |
|
| 10855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf34 |
0.260645131289449 |
|
| 10856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KEL |
0.260645131289449 |
|
| 10857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9A2 |
0.260645131289449 |
|
| 10858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6V1 |
0.260645131289449 |
|
| 10859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6W1P |
0.260645131289449 |
|
| 10860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP |
0.260645131289449 |
|
| 10861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R39 |
0.260645131289449 |
|
| 10862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R40 |
0.260645131289449 |
|
| 10863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTK1 |
0.260645131289449 |
|
| 10864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM139 |
0.260645131289449 |
|
| 10865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP2 |
0.260645131289449 |
|
| 10866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL535P |
0.260645131289449 |
|
| 10867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL481P |
0.260645131289449 |
|
| 10868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN1 |
0.260645131289449 |
|
| 10869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM131B |
0.260645131289449 |
|
| 10870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZYX |
0.260645131289449 |
|
| 10871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA1 |
0.260645131289449 |
|
| 10872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R60 |
0.260645131289449 |
|
| 10873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R41 |
0.260645131289449 |
|
| 10874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE15 |
0.260645131289449 |
|
| 10875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE6 |
0.260645131289449 |
|
| 10876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM115A |
0.260645131289449 |
|
| 10877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM115C |
0.260645131289449 |
|
| 10878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2F2 |
0.260645131289449 |
|
| 10879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2F1 |
0.260645131289449 |
|
| 10880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6B1 |
0.260645131289449 |
|
| 10881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A5 |
0.260645131289449 |
|
| 10882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A25 |
0.260645131289449 |
|
| 10883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A12 |
0.260645131289449 |
|
| 10884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A2 |
0.260645131289449 |
|
| 10885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A14 |
0.260645131289449 |
|
| 10886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF35 |
0.260645131289449 |
|
| 10887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF5 |
0.260645131289449 |
|
| 10888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE4 |
0.260645131289449 |
|
| 10889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE8 |
0.260645131289449 |
|
| 10890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOBOX |
0.260645131289449 |
|
| 10891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A1 |
0.260645131289449 |
|
| 10892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A20P |
0.260645131289449 |
|
| 10893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A42 |
0.260645131289449 |
|
| 10894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A7 |
0.260645131289449 |
|
| 10895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A9P |
0.260645131289449 |
|
| 10896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC40P |
0.260645131289449 |
|
| 10897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPK1 |
0.260645131289449 |
|
| 10898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP174 |
0.260645131289449 |
|
| 10899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL207P |
0.260645131289449 |
|
| 10900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP2 |
0.260645131289449 |
|
| 10901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548F4 |
0.260645131289449 |
|
| 10902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP249 |
0.260645131289449 |
|
| 10903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL456P |
0.260645131289449 |
|
| 10904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199370.1 |
0.260645131289449 |
|
| 10905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL72P |
0.260645131289449 |
|
| 10906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf33 |
0.260645131289449 |
|
| 10907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL1 |
0.260645131289449 |
|
| 10908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EZH2 |
0.260645131289449 |
|
| 10909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL569P |
0.260645131289449 |
|
| 10910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5 |
0.260645131289449 |
|
| 10911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1 |
0.260645131289449 |
|
| 10912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3 |
0.260645131289449 |
|
| 10913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4 |
0.260645131289449 |
|
| 10914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIA4 |
0.260645131289449 |
|
| 10915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF425 |
0.260645131289449 |
|
| 10916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF786 |
0.260645131289449 |
|
| 10917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL521P |
0.260645131289449 |
|
| 10918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF398 |
0.260645131289449 |
|
| 10919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF282 |
0.260645131289449 |
|
| 10920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF212 |
0.260645131289449 |
|
| 10921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF783 |
0.260645131289449 |
|
| 10922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252557.1 |
0.260645131289449 |
|
| 10923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF777 |
0.260645131289449 |
|
| 10924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF746 |
0.260645131289449 |
|
| 10925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF767 |
0.260645131289449 |
|
| 10926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRBA1 |
0.260645131289449 |
|
| 10927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF467 |
0.260645131289449 |
|
| 10928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSPO |
0.260645131289449 |
|
| 10929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0E2 |
0.260645131289449 |
|
| 10930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF862 |
0.260645131289449 |
|
| 10931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR3C |
0.260645131289449 |
|
| 10932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC61 |
0.260645131289449 |
|
| 10933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED6CL |
0.260645131289449 |
|
| 10934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARRES2 |
0.260645131289449 |
|
| 10935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REPIN1 |
0.260645131289449 |
|
| 10936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF775 |
0.260645131289449 |
|
| 10937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP8 |
0.260645131289449 |
|
| 10938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP7 |
0.260645131289449 |
|
| 10939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP4 |
0.260645131289449 |
|
| 10940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP6 |
0.260645131289449 |
|
| 10941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP2 |
0.260645131289449 |
|
| 10942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP1 |
0.260645131289449 |
|
| 10943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIMAP5 |
0.260645131289449 |
|
| 10944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM176B |
0.260645131289449 |
|
| 10945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM176A |
0.260645131289449 |
|
| 10946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOC1 |
0.260645131289449 |
|
| 10947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH2 |
0.260645131289449 |
|
| 10948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOS3 |
0.260645131289449 |
|
| 10949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG9B |
0.260645131289449 |
|
| 10950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB8 |
0.260645131289449 |
|
| 10951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIC3 |
0.260645131289449 |
|
| 10952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5 |
0.260645131289449 |
|
| 10953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A2 |
0.260645131289449 |
|
| 10954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIP1L1 |
0.262670023621873 |
|
| 10955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LNX1 |
0.262670023621873 |
|
| 10956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHIC2 |
0.262670023621873 |
|
| 10957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSX2 |
0.262670023621873 |
|
| 10958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238753.1 |
0.262670023621873 |
|
| 10959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFRA |
0.262670023621873 |
|
| 10960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAR1B |
0.263135979155556 |
|
| 10961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA11P |
0.263312895693809 |
|
| 10962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5I |
0.263312895693809 |
|
| 10963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPLX1 |
0.263312895693809 |
|
| 10964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKQ |
0.263312895693809 |
|
| 10965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFRL1 |
0.263312895693809 |
|
| 10966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAK |
0.263312895693809 |
|
| 10967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDUA |
0.263312895693809 |
|
| 10968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD7 |
0.263312895693809 |
|
| 10969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR571 |
0.263312895693809 |
|
| 10970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL5 |
0.263312895693809 |
|
| 10971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGF3 |
0.263312895693809 |
|
| 10972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6B |
0.263312895693809 |
|
| 10973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGG |
0.263312895693809 |
|
| 10974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL358P |
0.263312895693809 |
|
| 10975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF212 |
0.263312895693809 |
|
| 10976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A1 |
0.263312895693809 |
|
| 10977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM175 |
0.263312895693809 |
|
| 10978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF141 |
0.263312895693809 |
|
| 10979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF595 |
0.263312895693809 |
|
| 10980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF718 |
0.263312895693809 |
|
| 10981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF721 |
0.263312895693809 |
|
| 10982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF732 |
0.263312895693809 |
|
| 10983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF876P |
0.263312895693809 |
|
| 10984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED11P |
0.263312895693809 |
|
| 10985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212458.1 |
0.263312895693809 |
|
| 10986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPON2 |
0.263312895693809 |
|
| 10987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTBP1 |
0.263312895693809 |
|
| 10988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAEA |
0.263312895693809 |
|
| 10989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIPAK |
0.263312895693809 |
|
| 10990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UVSSA |
0.263312895693809 |
|
| 10991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL671P |
0.263312895693809 |
|
| 10992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WHSC1 |
0.263312895693809 |
|
| 10993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA22 |
0.263312895693809 |
|
| 10994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR943 |
0.263312895693809 |
|
| 10995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELFA |
0.263312895693809 |
|
| 10996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf48 |
0.263312895693809 |
|
| 10997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT8L |
0.263312895693809 |
|
| 10998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLN |
0.263312895693809 |
|
| 10999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS3 |
0.263312895693809 |
|
| 11000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXD4 |
0.263312895693809 |
|
| 11001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4800 |
0.263312895693809 |
|
| 11002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE28 |
0.263312895693809 |
|
| 11003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL589P |
0.263312895693809 |
|
| 11004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF4 |
0.263312895693809 |
|
| 11005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM193A |
0.263312895693809 |
|
| 11006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNIP2 |
0.263312895693809 |
|
| 11007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BP2 |
0.263312895693809 |
|
| 11008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADD1 |
0.263312895693809 |
|
| 11009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD10 |
0.263312895693809 |
|
| 11010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP14 |
0.263312895693809 |
|
| 11011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRK4 |
0.263312895693809 |
|
| 11012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTT |
0.263312895693809 |
|
| 11013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSANTD1 |
0.263312895693809 |
|
| 11014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS12 |
0.263312895693809 |
|
| 11015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HGFAC |
0.263312895693809 |
|
| 11016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK7 |
0.263312895693809 |
|
| 11017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRPAP1 |
0.263312895693809 |
|
| 11018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00955 |
0.263312895693809 |
|
| 11019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA2C |
0.263312895693809 |
|
| 11020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86EP |
0.263312895693809 |
|
| 11021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOP1 |
0.263312895693809 |
|
| 11022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM128 |
0.263312895693809 |
|
| 11023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYAR |
0.263312895693809 |
|
| 11024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB49 |
0.263312895693809 |
|
| 11025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSG1 |
0.263312895693809 |
|
| 11026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX18 |
0.263312895693809 |
|
| 11027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSX1 |
0.263312895693809 |
|
| 11028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP113 |
0.263312895693809 |
|
| 11029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTL1 |
0.263312895693809 |
|
| 11030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK32B |
0.263312895693809 |
|
| 11031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP275 |
0.263312895693809 |
|
| 11032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf6 |
0.263312895693809 |
|
| 11033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVC2 |
0.263312895693809 |
|
| 11034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVC |
0.263312895693809 |
|
| 11035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRMP1 |
0.263312895693809 |
|
| 11036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378D1 |
0.263312895693809 |
|
| 11037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf50 |
0.263312895693809 |
|
| 11038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAKMIP1 |
0.263312895693809 |
|
| 11039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFS1 |
0.263312895693809 |
|
| 11040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R2C |
0.263312895693809 |
|
| 11041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN2B2 |
0.263312895693809 |
|
| 11042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRFAP1 |
0.263312895693809 |
|
| 11043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100P |
0.263312895693809 |
|
| 11044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRFAP1L1 |
0.263312895693809 |
|
| 11045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S4 |
0.263312895693809 |
|
| 11046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0232 |
0.263312895693809 |
|
| 11047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D14 |
0.263312895693809 |
|
| 11048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP292 |
0.263312895693809 |
|
| 11049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC96 |
0.263312895693809 |
|
| 11050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TADA2B |
0.263312895693809 |
|
| 11051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRPEL1 |
0.263312895693809 |
|
| 11052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP36 |
0.263312895693809 |
|
| 11053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORCS2 |
0.263312895693809 |
|
| 11054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4798 |
0.263312895693809 |
|
| 11055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4274 |
0.263312895693809 |
|
| 11056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSAPL1 |
0.263312895693809 |
|
| 11057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR95 |
0.263312895693809 |
|
| 11058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3TC1 |
0.263312895693809 |
|
| 11059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTRA3 |
0.263312895693809 |
|
| 11060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOX3 |
0.263312895693809 |
|
| 11061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP152 |
0.263312895693809 |
|
| 11062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT44 |
0.263312895693809 |
|
| 11063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR78 |
0.263312895693809 |
|
| 11064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPZ |
0.263312895693809 |
|
| 11065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB131 |
0.263312895693809 |
|
| 11066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM90A26 |
0.263312895693809 |
|
| 11067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMX1 |
0.263312895693809 |
|
| 11068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548I2 |
0.263312895693809 |
|
| 11069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP153 |
0.263312895693809 |
|
| 11070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L10 |
0.263312895693809 |
|
| 11071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L11 |
0.263312895693809 |
|
| 11072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L12 |
0.263312895693809 |
|
| 11073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L13 |
0.263312895693809 |
|
| 11074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L15 |
0.263312895693809 |
|
| 11075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L17 |
0.263312895693809 |
|
| 11076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L18 |
0.263312895693809 |
|
| 11077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L19 |
0.263312895693809 |
|
| 11078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L20 |
0.263312895693809 |
|
| 11079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L21 |
0.263312895693809 |
|
| 11080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L22 |
0.263312895693809 |
|
| 11081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L23 |
0.263312895693809 |
|
| 11082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L24 |
0.263312895693809 |
|
| 11083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L25 |
0.263312895693809 |
|
| 11084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L26 |
0.263312895693809 |
|
| 11085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L27 |
0.263312895693809 |
|
| 11086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L28 |
0.263312895693809 |
|
| 11087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L29 |
0.263312895693809 |
|
| 11088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L30 |
0.263312895693809 |
|
| 11089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L5 |
0.263312895693809 |
|
| 11090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A9 |
0.263312895693809 |
|
| 11091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRD5 |
0.263312895693809 |
|
| 11092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP154 |
0.263312895693809 |
|
| 11093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR1 |
0.263312895693809 |
|
| 11094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3138 |
0.263312895693809 |
|
| 11095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP155 |
0.263312895693809 |
|
| 11096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF518B |
0.263312895693809 |
|
| 11097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLNK |
0.263312895693809 |
|
| 11098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR572 |
0.263312895693809 |
|
| 11099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST1 |
0.263312895693809 |
|
| 11100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP156 |
0.263312895693809 |
|
| 11101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90AB2P |
0.263312895693809 |
|
| 11102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB28 |
0.263312895693809 |
|
| 11103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOD1L1 |
0.263312895693809 |
|
| 11104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5091 |
0.263312895693809 |
|
| 11105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00504 |
0.263312895693809 |
|
| 11106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000202449.1 |
0.263312895693809 |
|
| 11107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPEB2 |
0.263312895693809 |
|
| 11108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP170 |
0.263312895693809 |
|
| 11109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF7 |
0.263312895693809 |
|
| 11110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CC2D2A |
0.263312895693809 |
|
| 11111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL5 |
0.263312895693809 |
|
| 11112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM200B |
0.263312895693809 |
|
| 11113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BST1 |
0.263312895693809 |
|
| 11114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD38 |
0.263312895693809 |
|
| 11115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFBP1 |
0.263312895693809 |
|
| 11116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFBP2 |
0.263312895693809 |
|
| 11117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROM1 |
0.263312895693809 |
|
| 11118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAPT1 |
0.263312895693809 |
|
| 11119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZEB2P1 |
0.263312895693809 |
|
| 11120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDB2 |
0.263312895693809 |
|
| 11121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000206780.1 |
0.263312895693809 |
|
| 11122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QDPR |
0.263312895693809 |
|
| 11123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLRN2 |
0.263312895693809 |
|
| 11124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238536.1 |
0.263312895693809 |
|
| 11125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAP3 |
0.263312895693809 |
|
| 11126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL315P |
0.263312895693809 |
|
| 11127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED28 |
0.263312895693809 |
|
| 11128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM184B |
0.263312895693809 |
|
| 11129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF16 |
0.263312895693809 |
|
| 11130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPG |
0.263312895693809 |
|
| 11131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCORL |
0.263312895693809 |
|
| 11132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP157 |
0.263312895693809 |
|
| 11133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLIT2 |
0.263312895693809 |
|
| 11134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACRGL |
0.263312895693809 |
|
| 11135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNIP4 |
0.263312895693809 |
|
| 11136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR125 |
0.263312895693809 |
|
| 11137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238383.1 |
0.263312895693809 |
|
| 11138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBA3 |
0.263312895693809 |
|
| 11139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPARGC1A |
0.263312895693809 |
|
| 11140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX15 |
0.263312895693809 |
|
| 11141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR573 |
0.263312895693809 |
|
| 11142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL16P |
0.263312895693809 |
|
| 11143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOD3 |
0.263312895693809 |
|
| 11144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC149 |
0.263312895693809 |
|
| 11145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGI2 |
0.263312895693809 |
|
| 11146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPSECS |
0.263312895693809 |
|
| 11147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI4K2B |
0.263312895693809 |
|
| 11148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC4 |
0.263312895693809 |
|
| 11149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC4 |
0.263312895693809 |
|
| 11150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC34A2 |
0.263312895693809 |
|
| 11151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEL1L3 |
0.263312895693809 |
|
| 11152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM20 |
0.263312895693809 |
|
| 11153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBPJ |
0.263312895693809 |
|
| 11154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCKAR |
0.263312895693809 |
|
| 11155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D19 |
0.263312895693809 |
|
| 11156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000200999.1 |
0.263312895693809 |
|
| 11157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STIM2 |
0.263312895693809 |
|
| 11158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL101P |
0.263312895693809 |
|
| 11159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH7 |
0.263312895693809 |
|
| 11160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238694.1 |
0.263312895693809 |
|
| 11161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARAP2 |
0.263312895693809 |
|
| 11162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTHD1 |
0.263312895693809 |
|
| 11163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1239 |
0.263312895693809 |
|
| 11164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4801 |
0.263312895693809 |
|
| 11165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf19 |
0.263312895693809 |
|
| 11166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELL1 |
0.263312895693809 |
|
| 11167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM2 |
0.263312895693809 |
|
| 11168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D1 |
0.263312895693809 |
|
| 11169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTTG2 |
0.263312895693809 |
|
| 11170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF3 |
0.263312895693809 |
|
| 11171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP158 |
0.263312895693809 |
|
| 11172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR10 |
0.263312895693809 |
|
| 11173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR1 |
0.263312895693809 |
|
| 11174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR6 |
0.263312895693809 |
|
| 11175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM114A1 |
0.263312895693809 |
|
| 11176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR574 |
0.263312895693809 |
|
| 11177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM156 |
0.263312895693809 |
|
| 11178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL5 |
0.263312895693809 |
|
| 11179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR19 |
0.263312895693809 |
|
| 11180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFC1 |
0.263312895693809 |
|
| 11181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLB |
0.263312895693809 |
|
| 11182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5591 |
0.263312895693809 |
|
| 11183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL9 |
0.263312895693809 |
|
| 11184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIAS |
0.263312895693809 |
|
| 11185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGDH |
0.263312895693809 |
|
| 11186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM14 |
0.263312895693809 |
|
| 11187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2K |
0.263312895693809 |
|
| 11188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL558P |
0.263312895693809 |
|
| 11189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDS5A |
0.263312895693809 |
|
| 11190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP159 |
0.263312895693809 |
|
| 11191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N4BP2 |
0.263312895693809 |
|
| 11192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000201863.1 |
0.263312895693809 |
|
| 11193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOH |
0.263312895693809 |
|
| 11194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA9 |
0.263312895693809 |
|
| 11195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM47 |
0.263312895693809 |
|
| 11196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4802 |
0.263312895693809 |
|
| 11197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN7 |
0.263312895693809 |
|
| 11198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBB2 |
0.263312895693809 |
|
| 11199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238351.1 |
0.263312895693809 |
|
| 11200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP160 |
0.263312895693809 |
|
| 11201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCHL1 |
0.263312895693809 |
|
| 11202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMCH1 |
0.263312895693809 |
|
| 11203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHOX2B |
0.263312895693809 |
|
| 11204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00682 |
0.263312895693809 |
|
| 11205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM33 |
0.263312895693809 |
|
| 11206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF4L1 |
0.263312895693809 |
|
| 11207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A9 |
0.263312895693809 |
|
| 11208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND4 |
0.263312895693809 |
|
| 11209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA3 |
0.263312895693809 |
|
| 11210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8A1 |
0.263312895693809 |
|
| 11211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRXCR1 |
0.263312895693809 |
|
| 11212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP82 |
0.263312895693809 |
|
| 11213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL691P |
0.263312895693809 |
|
| 11214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL193P |
0.263312895693809 |
|
| 11215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD8 |
0.263312895693809 |
|
| 11216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF7 |
0.263312895693809 |
|
| 11217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUF1 |
0.263312895693809 |
|
| 11218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPDA2 |
0.263312895693809 |
|
| 11219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP199 |
0.263312895693809 |
|
| 11220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRG1 |
0.263312895693809 |
|
| 11221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA2 |
0.263312895693809 |
|
| 11222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7B2 |
0.263312895693809 |
|
| 11223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA4 |
0.263312895693809 |
|
| 11224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRB1 |
0.263312895693809 |
|
| 11225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238301.1 |
0.263312895693809 |
|
| 11226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD8 |
0.263312895693809 |
|
| 11227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP10D |
0.263312895693809 |
|
| 11228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORIN |
0.263312895693809 |
|
| 11229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP215 |
0.263312895693809 |
|
| 11230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFXL1 |
0.263312895693809 |
|
| 11231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPAL1 |
0.263312895693809 |
|
| 11232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGA1 |
0.263312895693809 |
|
| 11233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXK |
0.263312895693809 |
|
| 11234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWH43 |
0.263312895693809 |
|
| 11235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRYL |
0.263312895693809 |
|
| 11236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCIAD1 |
0.263312895693809 |
|
| 11237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCIAD2 |
0.263312895693809 |
|
| 11238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAIN2 |
0.263312895693809 |
|
| 11239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A4 |
0.263312895693809 |
|
| 11240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEC |
0.263312895693809 |
|
| 11241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZAR1 |
0.263312895693809 |
|
| 11242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCUN1D4 |
0.263312895693809 |
|
| 11243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC66 |
0.263312895693809 |
|
| 11244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCB |
0.263312895693809 |
|
| 11245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA18 |
0.263312895693809 |
|
| 11246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239068.1 |
0.263312895693809 |
|
| 11247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP46 |
0.263312895693809 |
|
| 11248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DANCR |
0.263312895693809 |
|
| 11249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4449 |
0.263312895693809 |
|
| 11250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212588.1 |
0.263312895693809 |
|
| 11251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212490.1 |
0.263312895693809 |
|
| 11252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASL11B |
0.263312895693809 |
|
| 11253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFPM2 |
0.264116098786614 |
|
| 11254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXR1 |
0.264116098786614 |
|
| 11255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABRA |
0.264116098786614 |
|
| 11256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPT1 |
0.264116098786614 |
|
| 11257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP275 |
0.264116098786614 |
|
| 11258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPO2 |
0.264116098786614 |
|
| 11259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3E |
0.264116098786614 |
|
| 11260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC2 |
0.264116098786614 |
|
| 11261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM74 |
0.264116098786614 |
|
| 11262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRHR |
0.264116098786614 |
|
| 11263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDCD1 |
0.264116098786614 |
|
| 11264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENY2 |
0.264116098786614 |
|
| 11265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKHD1L1 |
0.264116098786614 |
|
| 11266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBAG9 |
0.264116098786614 |
|
| 11267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYBU |
0.264116098786614 |
|
| 11268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252559.1 |
0.264116098786614 |
|
| 11269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNV1 |
0.264116098786614 |
|
| 11270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSMD3 |
0.264116098786614 |
|
| 11271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238656.1 |
0.264116098786614 |
|
| 11272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2053 |
0.264116098786614 |
|
| 11273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPS1 |
0.264116098786614 |
|
| 11274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00536 |
0.264116098786614 |
|
| 11275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP276 |
0.264116098786614 |
|
| 11276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3H |
0.264116098786614 |
|
| 11277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP23 |
0.264116098786614 |
|
| 11278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD21 |
0.264116098786614 |
|
| 11279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3610 |
0.264116098786614 |
|
| 11280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AARD |
0.264116098786614 |
|
| 11281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A8 |
0.264116098786614 |
|
| 11282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL228P |
0.264116098786614 |
|
| 11283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL826P |
0.264116098786614 |
|
| 11284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252852.1 |
0.264116098786614 |
|
| 11285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED30 |
0.264116098786614 |
|
| 11286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXT1 |
0.264116098786614 |
|
| 11287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD12 |
0.264116098786614 |
|
| 11288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF11B |
0.264116098786614 |
|
| 11289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLEC10 |
0.264116098786614 |
|
| 11290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAL2 |
0.264116098786614 |
|
| 11291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA32|ENSG00000206776.1 |
0.264116098786614 |
|
| 11292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOV |
0.264116098786614 |
|
| 11293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP2 |
0.264116098786614 |
|
| 11294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP153 |
0.264116098786614 |
|
| 11295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF2 |
0.264116098786614 |
|
| 11296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCC1 |
0.264116098786614 |
|
| 11297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL396P |
0.264116098786614 |
|
| 11298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPTOR |
0.264116098786614 |
|
| 11299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP277 |
0.264116098786614 |
|
| 11300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL14A1 |
0.264116098786614 |
|
| 11301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL13 |
0.264116098786614 |
|
| 11302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTBP |
0.264116098786614 |
|
| 11303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTB1 |
0.264116098786614 |
|
| 11304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZHX2 |
0.264116098786614 |
|
| 11305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DERL1 |
0.264116098786614 |
|
| 11306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P5 |
0.264116098786614 |
|
| 11307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDYHV1 |
0.264116098786614 |
|
| 11308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO32 |
0.264116098786614 |
|
| 11309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP155 |
0.264116098786614 |
|
| 11310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL38 |
0.264116098786614 |
|
| 11311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA13 |
0.264116098786614 |
|
| 11312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM91A1 |
0.264116098786614 |
|
| 11313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FER1L6 |
0.264116098786614 |
|
| 11314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM65 |
0.264116098786614 |
|
| 11315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT12 |
0.264116098786614 |
|
| 11316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF139 |
0.264116098786614 |
|
| 11317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TATDN1 |
0.264116098786614 |
|
| 11318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB9 |
0.264116098786614 |
|
| 11319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTSS1 |
0.264116098786614 |
|
| 11320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4662B |
0.264116098786614 |
|
| 11321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00964 |
0.264116098786614 |
|
| 11322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF572 |
0.264116098786614 |
|
| 11323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SQLE |
0.264116098786614 |
|
| 11324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0196 |
0.264116098786614 |
|
| 11325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSMCE2 |
0.264116098786614 |
|
| 11326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL329P |
0.264116098786614 |
|
| 11327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIB1 |
0.264116098786614 |
|
| 11328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL590P |
0.264116098786614 |
|
| 11329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00861 |
0.264116098786614 |
|
| 11330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM84B |
0.264116098786614 |
|
| 11331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCAT1 |
0.264116098786614 |
|
| 11332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCAT2 |
0.264116098786614 |
|
| 11333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCAT1 |
0.264116098786614 |
|
| 11334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC8 |
0.264116098786614 |
|
| 11335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU5F1B |
0.264116098786614 |
|
| 11336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYC |
0.264116098786614 |
|
| 11337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVT1 |
0.264116098786614 |
|
| 11338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM75 |
0.264116098786614 |
|
| 11339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1205 |
0.264116098786614 |
|
| 11340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1207 |
0.264116098786614 |
|
| 11341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1208 |
0.264116098786614 |
|
| 11342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP226 |
0.264116098786614 |
|
| 11343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00977 |
0.264116098786614 |
|
| 11344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP206 |
0.264116098786614 |
|
| 11345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC26 |
0.264116098786614 |
|
| 11346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3686 |
0.264116098786614 |
|
| 11347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSDMC |
0.264116098786614 |
|
| 11348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM49B |
0.264116098786614 |
|
| 11349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000200075.1 |
0.264116098786614 |
|
| 11350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5194 |
0.264116098786614 |
|
| 11351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAP1 |
0.264116098786614 |
|
| 11352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA12|ENSG00000212342.1 |
0.264116098786614 |
|
| 11353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY8 |
0.264116098786614 |
|
| 11354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000252158.1 |
0.264116098786614 |
|
| 11355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFR3A |
0.264116098786614 |
|
| 11356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OC90 |
0.264116098786614 |
|
| 11357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHLA1 |
0.264116098786614 |
|
| 11358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ3 |
0.264116098786614 |
|
| 11359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPYR1 |
0.264116098786614 |
|
| 11360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC6 |
0.264116098786614 |
|
| 11361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM71 |
0.264116098786614 |
|
| 11362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF20L1 |
0.264116098786614 |
|
| 11363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TG |
0.264116098786614 |
|
| 11364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLA |
0.264116098786614 |
|
| 11365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WISP1 |
0.264116098786614 |
|
| 11366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDRG1 |
0.264116098786614 |
|
| 11367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL1 |
0.264116098786614 |
|
| 11368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212273.1 |
0.264116098786614 |
|
| 11369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAT |
0.264116098786614 |
|
| 11370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30B |
0.264116098786614 |
|
| 11371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30D |
0.264116098786614 |
|
| 11372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDRBS3 |
0.264116098786614 |
|
| 11373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM135B |
0.264116098786614 |
|
| 11374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL22A1 |
0.264116098786614 |
|
| 11375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000251744.1 |
0.264116098786614 |
|
| 11376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK9 |
0.264116098786614 |
|
| 11377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC9 |
0.264116098786614 |
|
| 11378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf17 |
0.264116098786614 |
|
| 11379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC7 |
0.264116098786614 |
|
| 11380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRAC1 |
0.264116098786614 |
|
| 11381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGO2 |
0.264116098786614 |
|
| 11382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND3 |
0.264116098786614 |
|
| 11383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR151A |
0.264116098786614 |
|
| 11384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTK2 |
0.264116098786614 |
|
| 11385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP278 |
0.264116098786614 |
|
| 11386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC45A4 |
0.264116098786614 |
|
| 11387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR20 |
0.264116098786614 |
|
| 11388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00051 |
0.264116098786614 |
|
| 11389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH5 |
0.264116098786614 |
|
| 11390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTP4A3 |
0.264116098786614 |
|
| 11391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD5|ENSG00000238854.1 |
0.264116098786614 |
|
| 11392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSNARE1 |
0.264116098786614 |
|
| 11393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAI1 |
0.264116098786614 |
|
| 11394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARC |
0.264116098786614 |
|
| 11395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JRK |
0.264116098786614 |
|
| 11396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSCA |
0.264116098786614 |
|
| 11397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6K |
0.264116098786614 |
|
| 11398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEM6 |
0.264116098786614 |
|
| 11399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLURP1 |
0.264116098786614 |
|
| 11400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD2 |
0.264116098786614 |
|
| 11401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6D |
0.264116098786614 |
|
| 11402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYNX1 |
0.264116098786614 |
|
| 11403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A1 |
0.270719650555864 |
|
| 11404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRH1 |
0.270719650555864 |
|
| 11405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG7 |
0.270719650555864 |
|
| 11406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272439.1 |
0.272194451745986 |
|
| 11407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNK |
0.272194451745986 |
|
| 11408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD2 |
0.272759156346144 |
|
| 11409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG24 |
0.272759156346144 |
|
| 11410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL11A2 |
0.272759156346144 |
|
| 11411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXRB |
0.272759156346144 |
|
| 11412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B8 |
0.272759156346144 |
|
| 11413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P10 |
0.272759156346144 |
|
| 11414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A7 |
0.272759156346144 |
|
| 11415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RING1 |
0.272759156346144 |
|
| 11416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG25 |
0.272759156346144 |
|
| 11417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS52 |
0.272759156346144 |
|
| 11418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS18 |
0.272759156346144 |
|
| 11419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALT4 |
0.272759156346144 |
|
| 11420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR46 |
0.272759156346144 |
|
| 11421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFDN6 |
0.272759156346144 |
|
| 11422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGL2 |
0.272759156346144 |
|
| 11423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAPBP |
0.272759156346144 |
|
| 11424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAXX |
0.272759156346144 |
|
| 11425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB22 |
0.272759156346144 |
|
| 11426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIFC1 |
0.272759156346144 |
|
| 11427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUTA |
0.272759156346144 |
|
| 11428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF1 |
0.272759156346144 |
|
| 11429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNGAP1 |
0.272759156346144 |
|
| 11430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5004 |
0.272759156346144 |
|
| 11431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB9 |
0.272759156346144 |
|
| 11432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL26P |
0.272759156346144 |
|
| 11433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAK1 |
0.272759156346144 |
|
| 11434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGNBP1 |
0.272759156346144 |
|
| 11435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00336 |
0.272759156346144 |
|
| 11436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPR3 |
0.272759156346144 |
|
| 11437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNF1 |
0.272759156346144 |
|
| 11438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBP1 |
0.272759156346144 |
|
| 11439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3934 |
0.272759156346144 |
|
| 11440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IP6K3 |
0.272759156346144 |
|
| 11441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEMD2 |
0.272759156346144 |
|
| 11442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLN |
0.272759156346144 |
|
| 11443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1275 |
0.272759156346144 |
|
| 11444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM4 |
0.272759156346144 |
|
| 11445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGA1 |
0.272759156346144 |
|
| 11446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf1 |
0.272759156346144 |
|
| 11447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT3 |
0.272759156346144 |
|
| 11448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS10 |
0.272759156346144 |
|
| 11449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACSIN1 |
0.272759156346144 |
|
| 11450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDEF |
0.272759156346144 |
|
| 11451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf106 |
0.272759156346144 |
|
| 11452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL200P |
0.272759156346144 |
|
| 11453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239059.1 |
0.272759156346144 |
|
| 11454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238484.1 |
0.272759156346144 |
|
| 11455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKS1A |
0.272759156346144 |
|
| 11456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPC |
0.272759156346144 |
|
| 11457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF11 |
0.272759156346144 |
|
| 11458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UHRF1BP1 |
0.272759156346144 |
|
| 11459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11 |
0.272759156346144 |
|
| 11460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCUBE3 |
0.272759156346144 |
|
| 11461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF76 |
0.272759156346144 |
|
| 11462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEF6 |
0.272759156346144 |
|
| 11463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPARD |
0.272759156346144 |
|
| 11464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCE |
0.272759156346144 |
|
| 11465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL10A |
0.272759156346144 |
|
| 11466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEAD3 |
0.272759156346144 |
|
| 11467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TULP1 |
0.272759156346144 |
|
| 11468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP5 |
0.272759156346144 |
|
| 11469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212579.1 |
0.272759156346144 |
|
| 11470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5690 |
0.272759156346144 |
|
| 11471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC12 |
0.272759156346144 |
|
| 11472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPSL1 |
0.272759156346144 |
|
| 11473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPSL2 |
0.272759156346144 |
|
| 11474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPS |
0.272759156346144 |
|
| 11475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFPL5 |
0.272759156346144 |
|
| 11476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPK1 |
0.272759156346144 |
|
| 11477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A8 |
0.272759156346144 |
|
| 11478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK14 |
0.272759156346144 |
|
| 11479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK13 |
0.272759156346144 |
|
| 11480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRPF3 |
0.272759156346144 |
|
| 11481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA1 |
0.272759156346144 |
|
| 11482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf222 |
0.272759156346144 |
|
| 11483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV7 |
0.272759156346144 |
|
| 11484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXT1 |
0.272759156346144 |
|
| 11485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD20 |
0.272759156346144 |
|
| 11486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL502P |
0.272759156346144 |
|
| 11487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK38 |
0.272759156346144 |
|
| 11488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL748P |
0.272759156346144 |
|
| 11489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF3 |
0.272759156346144 |
|
| 11490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3925 |
0.272759156346144 |
|
| 11491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN1A |
0.272759156346144 |
|
| 11492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB44 |
0.272759156346144 |
|
| 11493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE5 |
0.272759156346144 |
|
| 11494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIL1 |
0.272759156346144 |
|
| 11495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf89 |
0.272759156346144 |
|
| 11496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI16 |
0.272759156346144 |
|
| 11497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTCH1 |
0.272759156346144 |
|
| 11498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD2 |
0.272759156346144 |
|
| 11499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6A1P2 |
0.272759156346144 |
|
| 11500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIM1 |
0.272759156346144 |
|
| 11501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252687.1 |
0.272759156346144 |
|
| 11502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM217 |
0.272759156346144 |
|
| 11503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238375.1 |
0.272759156346144 |
|
| 11504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D22B |
0.272759156346144 |
|
| 11505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL273P |
0.272759156346144 |
|
| 11506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF8 |
0.272759156346144 |
|
| 11507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTSJD2 |
0.272759156346144 |
|
| 11508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC167 |
0.272759156346144 |
|
| 11509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4462 |
0.272759156346144 |
|
| 11510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDGA1 |
0.272759156346144 |
|
| 11511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND3 |
0.272759156346144 |
|
| 11512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL285P |
0.272759156346144 |
|
| 11513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD9 |
0.272759156346144 |
|
| 11514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45|ENSG00000200706.1 |
0.272759156346144 |
|
| 11515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLO1 |
0.272759156346144 |
|
| 11516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH8 |
0.272759156346144 |
|
| 11517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL465P |
0.272759156346144 |
|
| 11518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA8|ENSG00000212586.1 |
0.272759156346144 |
|
| 11519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLP1R |
0.272759156346144 |
|
| 11520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAYSD1 |
0.272759156346144 |
|
| 11521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK5 |
0.272759156346144 |
|
| 11522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK17 |
0.272759156346144 |
|
| 11523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK16 |
0.272759156346144 |
|
| 11524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF6 |
0.272759156346144 |
|
| 11525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAAM2 |
0.272759156346144 |
|
| 11526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOCS1 |
0.272759156346144 |
|
| 11527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRG1 |
0.272759156346144 |
|
| 11528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00951 |
0.272759156346144 |
|
| 11529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRFN2 |
0.272759156346144 |
|
| 11530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OARD1 |
0.272759156346144 |
|
| 11531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC5CL |
0.272759156346144 |
|
| 11532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPO2 |
0.272759156346144 |
|
| 11533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC2 |
0.272759156346144 |
|
| 11534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFYA |
0.272759156346144 |
|
| 11535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY10P1 |
0.272759156346144 |
|
| 11536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREML1 |
0.272759156346144 |
|
| 11537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREM2 |
0.272759156346144 |
|
| 11538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREML2 |
0.272759156346144 |
|
| 11539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREML3P |
0.272759156346144 |
|
| 11540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREML4 |
0.272759156346144 |
|
| 11541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP207 |
0.272759156346144 |
|
| 11542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREM1 |
0.272759156346144 |
|
| 11543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCR2 |
0.272759156346144 |
|
| 11544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXP4 |
0.272759156346144 |
|
| 11545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4641 |
0.272759156346144 |
|
| 11546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDFI |
0.272759156346144 |
|
| 11547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFEB |
0.272759156346144 |
|
| 11548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGC |
0.272759156346144 |
|
| 11549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRS3 |
0.272759156346144 |
|
| 11550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRICKLE4 |
0.272759156346144 |
|
| 11551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM6 |
0.272759156346144 |
|
| 11552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP49 |
0.272759156346144 |
|
| 11553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA8|ENSG00000206977.1 |
0.272759156346144 |
|
| 11554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED20 |
0.272759156346144 |
|
| 11555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BYSL |
0.272759156346144 |
|
| 11556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCND3 |
0.272759156346144 |
|
| 11557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF8 |
0.272759156346144 |
|
| 11558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf132 |
0.272759156346144 |
|
| 11559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCA1A |
0.272759156346144 |
|
| 11560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCA1B |
0.272759156346144 |
|
| 11561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS10 |
0.272759156346144 |
|
| 11562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRERF1 |
0.272759156346144 |
|
| 11563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221252.1 |
0.272759156346144 |
|
| 11564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238611.1 |
0.272759156346144 |
|
| 11565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR2 |
0.272759156346144 |
|
| 11566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPH2 |
0.272759156346144 |
|
| 11567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCC |
0.272759156346144 |
|
| 11568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTSCR1L |
0.272759156346144 |
|
| 11569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL7L1 |
0.272759156346144 |
|
| 11570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf226 |
0.272759156346144 |
|
| 11571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCRA |
0.272759156346144 |
|
| 11572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNPY3 |
0.272759156346144 |
|
| 11573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNMT |
0.272759156346144 |
|
| 11574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX6 |
0.272759156346144 |
|
| 11575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R5D |
0.272759156346144 |
|
| 11576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEA1 |
0.272759156346144 |
|
| 11577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC3 |
0.272759156346144 |
|
| 11578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP36 |
0.272759156346144 |
|
| 11579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL403P |
0.272759156346144 |
|
| 11580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL7 |
0.272759156346144 |
|
| 11581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLC4 |
0.272759156346144 |
|
| 11582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL2 |
0.272759156346144 |
|
| 11583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTK7 |
0.272759156346144 |
|
| 11584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRF |
0.272759156346144 |
|
| 11585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL9 |
0.272759156346144 |
|
| 11586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNPH1 |
0.272759156346144 |
|
| 11587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTBK1 |
0.272759156346144 |
|
| 11588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A7 |
0.272759156346144 |
|
| 11589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIP3 |
0.272759156346144 |
|
| 11590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF318 |
0.272759156346144 |
|
| 11591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC10 |
0.272759156346144 |
|
| 11592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLK2 |
0.272759156346144 |
|
| 11593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TJAP1 |
0.272759156346144 |
|
| 11594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC73 |
0.272759156346144 |
|
| 11595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR1C |
0.272759156346144 |
|
| 11596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF3 |
0.272759156346144 |
|
| 11597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPO5 |
0.272759156346144 |
|
| 11598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA15|ENSG00000252218.1 |
0.272759156346144 |
|
| 11599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLH |
0.272759156346144 |
|
| 11600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP2 |
0.272759156346144 |
|
| 11601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAD2L1BP |
0.272759156346144 |
|
| 11602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH9 |
0.272759156346144 |
|
| 11603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS18A |
0.272759156346144 |
|
| 11604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEGFA |
0.272759156346144 |
|
| 11605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf223 |
0.272759156346144 |
|
| 11606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL14 |
0.272759156346144 |
|
| 11607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM63B |
0.272759156346144 |
|
| 11608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN11 |
0.272759156346144 |
|
| 11609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC29A1 |
0.272759156346144 |
|
| 11610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90AB1 |
0.272759156346144 |
|
| 11611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4647 |
0.272759156346144 |
|
| 11612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35B2 |
0.272759156346144 |
|
| 11613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBIE |
0.272759156346144 |
|
| 11614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM151B |
0.272759156346144 |
|
| 11615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTE1 |
0.272759156346144 |
|
| 11616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AARS2 |
0.272759156346144 |
|
| 11617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATS1 |
0.272759156346144 |
|
| 11618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC5L |
0.272759156346144 |
|
| 11619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4642 |
0.272759156346144 |
|
| 11620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT3H |
0.272759156346144 |
|
| 11621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR586 |
0.272759156346144 |
|
| 11622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNX2 |
0.272759156346144 |
|
| 11623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC5 |
0.272759156346144 |
|
| 11624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP4 |
0.272759156346144 |
|
| 11625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP5 |
0.272759156346144 |
|
| 11626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCAN2 |
0.272759156346144 |
|
| 11627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP39A1 |
0.272759156346144 |
|
| 11628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A27 |
0.272759156346144 |
|
| 11629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD6 |
0.272759156346144 |
|
| 11630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G7 |
0.272759156346144 |
|
| 11631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD66 |
0.272759156346144 |
|
| 11632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEP1A |
0.272759156346144 |
|
| 11633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR116 |
0.272759156346144 |
|
| 11634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR110 |
0.272759156346144 |
|
| 11635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF21 |
0.272759156346144 |
|
| 11636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD2AP |
0.272759156346144 |
|
| 11637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR111 |
0.272759156346144 |
|
| 11638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR115 |
0.272759156346144 |
|
| 11639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP116 |
0.272759156346144 |
|
| 11640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN5 |
0.272759156346144 |
|
| 11641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCHD4 |
0.272759156346144 |
|
| 11642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUT |
0.272759156346144 |
|
| 11643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPQ |
0.272759156346144 |
|
| 11644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYATL3 |
0.272759156346144 |
|
| 11645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf141 |
0.272759156346144 |
|
| 11646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHAG |
0.272759156346144 |
|
| 11647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRISP2 |
0.272759156346144 |
|
| 11648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRISP3 |
0.272759156346144 |
|
| 11649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGK2 |
0.272759156346144 |
|
| 11650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRISP1 |
0.272759156346144 |
|
| 11651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB133 |
0.272759156346144 |
|
| 11652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB114 |
0.272759156346144 |
|
| 11653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB113 |
0.272759156346144 |
|
| 11654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB110 |
0.272759156346144 |
|
| 11655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB112 |
0.272759156346144 |
|
| 11656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL5P |
0.272999277805703 |
|
| 11657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZP3 |
0.273992592733788 |
|
| 11658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC146 |
0.273992592733788 |
|
| 11659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTX2 |
0.273992592733788 |
|
| 11660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMZP3 |
0.273992592733788 |
|
| 11661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK3B |
0.273992592733788 |
|
| 11662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGL2 |
0.273992592733788 |
|
| 11663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSAP |
0.273992592733788 |
|
| 11664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238453.1 |
0.273992592733788 |
|
| 11665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN12 |
0.273992592733788 |
|
| 11666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSBN1L |
0.273992592733788 |
|
| 11667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM60 |
0.273992592733788 |
|
| 11668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHTF2 |
0.273992592733788 |
|
| 11669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGI2 |
0.273992592733788 |
|
| 11670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL13AP17 |
0.273992592733788 |
|
| 11671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP234 |
0.273992592733788 |
|
| 11672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAI1 |
0.273992592733788 |
|
| 11673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL869P |
0.273992592733788 |
|
| 11674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL35P |
0.273992592733788 |
|
| 11675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD36 |
0.273992592733788 |
|
| 11676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAT3 |
0.273992592733788 |
|
| 11677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3C |
0.273992592733788 |
|
| 11678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HGF |
0.273992592733788 |
|
| 11679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA2D1 |
0.273992592733788 |
|
| 11680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1255B1 |
0.273992592733788 |
|
| 11681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00972 |
0.273992592733788 |
|
| 11682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM3 |
0.273992592733788 |
|
| 11683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1324L |
0.273992592733788 |
|
| 11684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMTF1 |
0.273992592733788 |
|
| 11685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM243 |
0.273992592733788 |
|
| 11686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG1 |
0.273992592733788 |
|
| 11687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CROT |
0.273992592733788 |
|
| 11688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB4 |
0.273992592733788 |
|
| 11689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB1 |
0.273992592733788 |
|
| 11690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238587.1 |
0.273992592733788 |
|
| 11691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNDC3B |
0.273992592733788 |
|
| 11692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A40 |
0.273992592733788 |
|
| 11693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBF4 |
0.273992592733788 |
|
| 11694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM22 |
0.273992592733788 |
|
| 11695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRI |
0.273992592733788 |
|
| 11696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STEAP4 |
0.273992592733788 |
|
| 11697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000207094.1 |
0.273992592733788 |
|
| 11698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf62 |
0.273992592733788 |
|
| 11699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf63 |
0.273992592733788 |
|
| 11700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L2P4 |
0.273992592733788 |
|
| 11701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STEAP1 |
0.273992592733788 |
|
| 11702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STEAP2 |
0.273992592733788 |
|
| 11703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF804B |
0.273992592733788 |
|
| 11704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP10 |
0.273992592733788 |
|
| 11705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN12 |
0.273992592733788 |
|
| 11706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK14 |
0.273992592733788 |
|
| 11707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238739.1 |
0.273992592733788 |
|
| 11708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD1 |
0.273992592733788 |
|
| 11709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTERF |
0.273992592733788 |
|
| 11710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP9 |
0.273992592733788 |
|
| 11711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP51A1 |
0.273992592733788 |
|
| 11712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRD1 |
0.273992592733788 |
|
| 11713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRIT1 |
0.273992592733788 |
|
| 11714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKIB1 |
0.273992592733788 |
|
| 11715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATAD1 |
0.273992592733788 |
|
| 11716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX1 |
0.273992592733788 |
|
| 11717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM48 |
0.273992592733788 |
|
| 11718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM133B |
0.273992592733788 |
|
| 11719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK6 |
0.273992592733788 |
|
| 11720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL7P |
0.273992592733788 |
|
| 11721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD9 |
0.273992592733788 |
|
| 11722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD9L |
0.273992592733788 |
|
| 11723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEPACAM2 |
0.273992592733788 |
|
| 11724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC132 |
0.273992592733788 |
|
| 11725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCR |
0.273992592733788 |
|
| 11726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR489 |
0.273992592733788 |
|
| 11727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR653 |
0.273992592733788 |
|
| 11728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNGT1 |
0.273992592733788 |
|
| 11729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4652 |
0.273992592733788 |
|
| 11730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFPI2 |
0.273992592733788 |
|
| 11731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG11 |
0.273992592733788 |
|
| 11732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BET1 |
0.273992592733788 |
|
| 11733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL1A2 |
0.273992592733788 |
|
| 11734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASD1 |
0.273992592733788 |
|
| 11735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCE |
0.273992592733788 |
|
| 11736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEG10 |
0.273992592733788 |
|
| 11737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP129 |
0.273992592733788 |
|
| 11738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R9A |
0.273992592733788 |
|
| 11739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238384.1 |
0.273992592733788 |
|
| 11740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PON1 |
0.273992592733788 |
|
| 11741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PON3 |
0.273992592733788 |
|
| 11742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PON2 |
0.273992592733788 |
|
| 11743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB4 |
0.273992592733788 |
|
| 11744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDK4 |
0.273992592733788 |
|
| 11745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC1I1 |
0.273992592733788 |
|
| 11746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL252P |
0.273992592733788 |
|
| 11747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX6 |
0.273992592733788 |
|
| 11748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX5 |
0.273992592733788 |
|
| 11749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00649 |
0.274138337475435 |
|
| 11750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS6 |
0.274138337475435 |
|
| 11751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A3 |
0.274138337475435 |
|
| 11752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP147 |
0.274426796400482 |
|
| 11753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00320 |
0.274426796400482 |
|
| 11754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAM2 |
0.274426796400482 |
|
| 11755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00317 |
0.274426796400482 |
|
| 11756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00308 |
0.274426796400482 |
|
| 11757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL609P |
0.274426796400482 |
|
| 11758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221345.1 |
0.275637481542909 |
|
| 11759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGFRL1 |
0.275637481542909 |
|
| 11760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00472 |
0.275637481542909 |
|
| 11761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30C2 |
0.275637481542909 |
|
| 11762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR30A |
0.275637481542909 |
|
| 11763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMS1 |
0.275637481542909 |
|
| 11764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ5 |
0.275637481542909 |
|
| 11765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4282 |
0.275637481542909 |
|
| 11766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDC1L |
0.275637481542909 |
|
| 11767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDC1 |
0.275637481542909 |
|
| 11768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPPA5 |
0.275637481542909 |
|
| 11769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHDC3L |
0.275637481542909 |
|
| 11770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OOEP |
0.275637481542909 |
|
| 11771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX43 |
0.275637481542909 |
|
| 11772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238464.1 |
0.275637481542909 |
|
| 11773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MB21D1 |
0.275637481542909 |
|
| 11774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTO1 |
0.275637481542909 |
|
| 11775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1A1 |
0.275637481542909 |
|
| 11776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A5 |
0.275637481542909 |
|
| 11777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD109 |
0.275637481542909 |
|
| 11778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL12A1 |
0.275637481542909 |
|
| 11779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7A2 |
0.275637481542909 |
|
| 11780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM30A |
0.275637481542909 |
|
| 11781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FILIP1 |
0.275637481542909 |
|
| 11782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221332.1 |
0.275637481542909 |
|
| 11783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4463 |
0.275637481542909 |
|
| 11784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP6 |
0.275637481542909 |
|
| 11785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP163 |
0.275637481542909 |
|
| 11786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO6 |
0.275637481542909 |
|
| 11787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP209 |
0.275637481542909 |
|
| 11788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239132.1 |
0.275637481542909 |
|
| 11789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPG1 |
0.275637481542909 |
|
| 11790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IBTK |
0.275637481542909 |
|
| 11791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPBG |
0.275637481542909 |
|
| 11792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE3D |
0.275637481542909 |
|
| 11793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOPEY1 |
0.275637481542909 |
|
| 11794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM3 |
0.275637481542909 |
|
| 11795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RWDD2A |
0.275637481542909 |
|
| 11796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ME1 |
0.275637481542909 |
|
| 11797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS35 |
0.275637481542909 |
|
| 11798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAP91 |
0.275637481542909 |
|
| 11799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPPLY2 |
0.275637481542909 |
|
| 11800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5R4 |
0.275637481542909 |
|
| 11801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRAP2 |
0.275637481542909 |
|
| 11802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1009 |
0.275637481542909 |
|
| 11803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX18 |
0.275637481542909 |
|
| 11804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5E |
0.275637481542909 |
|
| 11805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX14 |
0.275637481542909 |
|
| 11806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNCRIP |
0.275637481542909 |
|
| 11807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG5 |
0.275637481542909 |
|
| 11808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL643P |
0.275637481542909 |
|
| 11809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR1E |
0.275637481542909 |
|
| 11810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP209 |
0.275637481542909 |
|
| 11811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGA |
0.275637481542909 |
|
| 11812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF292 |
0.275637481542909 |
|
| 11813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB7 |
0.275637481542909 |
|
| 11814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM8 |
0.275637481542909 |
|
| 11815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf163 |
0.275637481542909 |
|
| 11816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf164 |
0.275637481542909 |
|
| 11817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6ORF165 |
0.275637481542909 |
|
| 11818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf165 |
0.275637481542909 |
|
| 11819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35A1 |
0.275637481542909 |
|
| 11820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARS2 |
0.275637481542909 |
|
| 11821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC3 |
0.275637481542909 |
|
| 11822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKIRIN2 |
0.275637481542909 |
|
| 11823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238628.1 |
0.275637481542909 |
|
| 11824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL183P |
0.275637481542909 |
|
| 11825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA1 |
0.275637481542909 |
|
| 11826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNR1 |
0.275637481542909 |
|
| 11827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNGTT |
0.275637481542909 |
|
| 11828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000222145.1 |
0.275637481542909 |
|
| 11829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNRC1 |
0.275637481542909 |
|
| 11830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL336P |
0.275637481542909 |
|
| 11831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF12 |
0.275637481542909 |
|
| 11832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PM20D2 |
0.275637481542909 |
|
| 11833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRR1 |
0.275637481542909 |
|
| 11834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRR2 |
0.275637481542909 |
|
| 11835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2J1 |
0.275637481542909 |
|
| 11836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAGD |
0.275637481542909 |
|
| 11837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD6 |
0.275637481542909 |
|
| 11838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL11P |
0.275637481542909 |
|
| 11839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM2 |
0.275637481542909 |
|
| 11840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDN1 |
0.275637481542909 |
|
| 11841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP8AP2 |
0.275637481542909 |
|
| 11842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238747.1 |
0.275637481542909 |
|
| 11843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA10 |
0.275637481542909 |
|
| 11844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BACH2 |
0.275637481542909 |
|
| 11845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP110 |
0.275637481542909 |
|
| 11846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4464 |
0.275637481542909 |
|
| 11847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K7 |
0.275637481542909 |
|
| 11848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4643 |
0.275637481542909 |
|
| 11849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL415P |
0.275637481542909 |
|
| 11850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200492.1 |
0.275637481542909 |
|
| 11851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221455.1 |
0.275637481542909 |
|
| 11852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA7 |
0.275637481542909 |
|
| 11853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000252249.1 |
0.275637481542909 |
|
| 11854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANEA |
0.275637481542909 |
|
| 11855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT9 |
0.275637481542909 |
|
| 11856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL797P |
0.275637481542909 |
|
| 11857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFL1 |
0.275637481542909 |
|
| 11858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHL5 |
0.275637481542909 |
|
| 11859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR63 |
0.275637481542909 |
|
| 11860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF4 |
0.275637481542909 |
|
| 11861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL509P |
0.275637481542909 |
|
| 11862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL32 |
0.275637481542909 |
|
| 11863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMS22L |
0.275637481542909 |
|
| 11864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2113 |
0.275637481542909 |
|
| 11865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU3F2 |
0.275637481542909 |
|
| 11866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL4 |
0.275637481542909 |
|
| 11867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AI |
0.275637481542909 |
|
| 11868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAXC |
0.275637481542909 |
|
| 11869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ3 |
0.275637481542909 |
|
| 11870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNISR |
0.275637481542909 |
|
| 11871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP45 |
0.275637481542909 |
|
| 11872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSTD3 |
0.275637481542909 |
|
| 11873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNC |
0.275637481542909 |
|
| 11874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM13 |
0.275637481542909 |
|
| 11875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCHR2 |
0.275637481542909 |
|
| 11876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXN2 |
0.279120920918732 |
|
| 11877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXRED2 |
0.279120920918732 |
|
| 11878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3D |
0.279120920918732 |
|
| 11879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG2 |
0.279120920918732 |
|
| 11880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT27 |
0.279120920918732 |
|
| 11881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVALB |
0.279120920918732 |
|
| 11882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCF4 |
0.279120920918732 |
|
| 11883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF2RB |
0.279120920918732 |
|
| 11884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239056.1 |
0.279120920918732 |
|
| 11885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX33 |
0.279120920918732 |
|
| 11886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TST |
0.279120920918732 |
|
| 11887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPST |
0.279120920918732 |
|
| 11888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD17 |
0.279120920918732 |
|
| 11889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP214 |
0.279120920918732 |
|
| 11890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS6 |
0.279120920918732 |
|
| 11891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HDM2 |
0.286146493603027 |
|
| 11892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A11 |
0.287149347428967 |
|
| 11893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00349 |
0.287680704167713 |
|
| 11894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00387 |
0.287680704167713 |
|
| 11895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00388 |
0.287680704167713 |
|
| 11896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF2P2 |
0.287680704167713 |
|
| 11897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00442 |
0.287680704167713 |
|
| 11898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP24 |
0.287680704167713 |
|
| 11899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA3C |
0.287680704167713 |
|
| 11900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00421 |
0.287680704167713 |
|
| 11901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTE2 |
0.287680704167713 |
|
| 11902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00350 |
0.287680704167713 |
|
| 11903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPHOSPH8 |
0.287680704167713 |
|
| 11904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSPC1 |
0.287680704167713 |
|
| 11905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL166P |
0.287680704167713 |
|
| 11906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM5 |
0.287680704167713 |
|
| 11907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238665.1 |
0.287680704167713 |
|
| 11908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM2 |
0.287680704167713 |
|
| 11909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA3 |
0.287680704167713 |
|
| 11910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00556 |
0.287680704167713 |
|
| 11911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB2 |
0.287680704167713 |
|
| 11912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYL1 |
0.287680704167713 |
|
| 11913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB6 |
0.287680704167713 |
|
| 11914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4499 |
0.287680704167713 |
|
| 11915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT88 |
0.287680704167713 |
|
| 11916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17D |
0.287680704167713 |
|
| 11917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N6AMT2 |
0.287680704167713 |
|
| 11918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPO4 |
0.287680704167713 |
|
| 11919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA1P30 |
0.287680704167713 |
|
| 11920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LATS2 |
0.287680704167713 |
|
| 11921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238893.1 |
0.287680704167713 |
|
| 11922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL80P |
0.287680704167713 |
|
| 11923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP18 |
0.287680704167713 |
|
| 11924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD27|ENSG00000252128.1 |
0.287680704167713 |
|
| 11925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKA3 |
0.287680704167713 |
|
| 11926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRP63 |
0.287680704167713 |
|
| 11927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRRAP2 |
0.287680704167713 |
|
| 11928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIPEPP3 |
0.287680704167713 |
|
| 11929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP25 |
0.287680704167713 |
|
| 11930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC20 |
0.287680704167713 |
|
| 11931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICU2 |
0.287680704167713 |
|
| 11932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238878.1 |
0.287680704167713 |
|
| 11933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239136.1 |
0.292782953696429 |
|
| 11934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAHM |
0.292782953696429 |
|
| 11935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCLO |
0.293871612599 |
|
| 11936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP235 |
0.293871612599 |
|
| 11937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3E |
0.293871612599 |
|
| 11938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3A |
0.293871612599 |
|
| 11939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA3D |
0.293871612599 |
|
| 11940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF5 |
0.295017945662212 |
|
| 11941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A1 |
0.295017945662212 |
|
| 11942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221060.1 |
0.295017945662212 |
|
| 11943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMOC1 |
0.295017945662212 |
|
| 11944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC8A3 |
0.295017945662212 |
|
| 11945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM21P1 |
0.295017945662212 |
|
| 11946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX16 |
0.295017945662212 |
|
| 11947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNJ2BP |
0.295017945662212 |
|
| 11948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM21 |
0.295017945662212 |
|
| 11949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM20P1 |
0.295017945662212 |
|
| 11950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM20 |
0.295017945662212 |
|
| 11951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED6 |
0.295017945662212 |
|
| 11952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL77P |
0.295017945662212 |
|
| 11953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC9 |
0.295017945662212 |
|
| 11954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K9 |
0.295017945662212 |
|
| 11955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNX |
0.295017945662212 |
|
| 11956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIPA1L1 |
0.295017945662212 |
|
| 11957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56B |
0.295017945662212 |
|
| 11958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL683P |
0.295017945662212 |
|
| 11959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS6 |
0.295017945662212 |
|
| 11960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238972.1 |
0.295017945662212 |
|
| 11961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF4 |
0.295017945662212 |
|
| 11962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE1 |
0.295017945662212 |
|
| 11963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL586P |
0.295017945662212 |
|
| 11964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM25 |
0.295017945662212 |
|
| 11965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSEN1 |
0.295017945662212 |
|
| 11966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPLN |
0.295017945662212 |
|
| 11967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUMB |
0.295017945662212 |
|
| 11968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR4 |
0.295017945662212 |
|
| 11969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf169 |
0.295017945662212 |
|
| 11970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT1 |
0.295017945662212 |
|
| 11971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT2 |
0.295017945662212 |
|
| 11972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT4 |
0.295017945662212 |
|
| 11973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT6 |
0.295017945662212 |
|
| 11974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAL1 |
0.295017945662212 |
|
| 11975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA1 |
0.295017945662212 |
|
| 11976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMSAN1 |
0.295017945662212 |
|
| 11977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4505 |
0.295017945662212 |
|
| 11978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238330.1 |
0.295017945662212 |
|
| 11979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGR2 |
0.295017945662212 |
|
| 11980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF410 |
0.295017945662212 |
|
| 11981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM161B |
0.295017945662212 |
|
| 11982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ6 |
0.295017945662212 |
|
| 11983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD5 |
0.295017945662212 |
|
| 11984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC176 |
0.295017945662212 |
|
| 11985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH6A1 |
0.295017945662212 |
|
| 11986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN52 |
0.295017945662212 |
|
| 11987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL530P |
0.295017945662212 |
|
| 11988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSX2 |
0.295017945662212 |
|
| 11989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCD4 |
0.295017945662212 |
|
| 11990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VRTN |
0.295017945662212 |
|
| 11991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNDIG1L |
0.295017945662212 |
|
| 11992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPC2 |
0.295017945662212 |
|
| 11993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4709 |
0.295017945662212 |
|
| 11994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISCA2 |
0.295017945662212 |
|
| 11995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTBP2 |
0.295017945662212 |
|
| 11996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AREL1 |
0.295017945662212 |
|
| 11997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCF1 |
0.295017945662212 |
|
| 11998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7|ENSG00000222604.1 |
0.295017945662212 |
|
| 11999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YLPM1 |
0.295017945662212 |
|
| 12000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROX2 |
0.295017945662212 |
|
| 12001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLST |
0.295017945662212 |
|
| 12002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KL1 |
0.295017945662212 |
|
| 12003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGF |
0.295017945662212 |
|
| 12004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2B2 |
0.295017945662212 |
|
| 12005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLH3 |
0.295017945662212 |
|
| 12006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACYP1 |
0.295017945662212 |
|
| 12007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC2HC1C |
0.295017945662212 |
|
| 12008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK9 |
0.295017945662212 |
|
| 12009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED10 |
0.295017945662212 |
|
| 12010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC14P |
0.295017945662212 |
|
| 12011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOS |
0.295017945662212 |
|
| 12012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JDP2 |
0.295017945662212 |
|
| 12013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BATF |
0.295017945662212 |
|
| 12014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLVCR2 |
0.295017945662212 |
|
| 12015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP387 |
0.295017945662212 |
|
| 12016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL5 |
0.295017945662212 |
|
| 12017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf1 |
0.295017945662212 |
|
| 12018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT43 |
0.295017945662212 |
|
| 12019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFB3 |
0.295017945662212 |
|
| 12020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH2L |
0.295017945662212 |
|
| 12021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRRB |
0.295017945662212 |
|
| 12022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL747P |
0.295017945662212 |
|
| 12023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VASH1 |
0.295017945662212 |
|
| 12024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGEL1 |
0.295017945662212 |
|
| 12025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf166B |
0.295017945662212 |
|
| 12026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP17 |
0.295017945662212 |
|
| 12027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL356P |
0.295017945662212 |
|
| 12028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF2BPL |
0.295017945662212 |
|
| 12029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1737 |
0.295017945662212 |
|
| 12030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM63C |
0.295017945662212 |
|
| 12031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC22 |
0.295017945662212 |
|
| 12032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA32|ENSG00000201384.1 |
0.295017945662212 |
|
| 12033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1260A |
0.295017945662212 |
|
| 12034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGB |
0.295017945662212 |
|
| 12035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMT2 |
0.295017945662212 |
|
| 12036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTZ1 |
0.295017945662212 |
|
| 12037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED8 |
0.295017945662212 |
|
| 12038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL137P |
0.295017945662212 |
|
| 12039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD15 |
0.295017945662212 |
|
| 12040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOXRED1 |
0.295017945662212 |
|
| 12041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG61 |
0.295017945662212 |
|
| 12042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIPAS39 |
0.295017945662212 |
|
| 12043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHSA1 |
0.295017945662212 |
|
| 12044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA46|ENSG00000212371.1 |
0.295017945662212 |
|
| 12045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISM2 |
0.295017945662212 |
|
| 12046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTLC2 |
0.295017945662212 |
|
| 12047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL587P |
0.295017945662212 |
|
| 12048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH1 |
0.295017945662212 |
|
| 12049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLIRP |
0.295017945662212 |
|
| 12050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNW1 |
0.295017945662212 |
|
| 12051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf178 |
0.295017945662212 |
|
| 12052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCK1 |
0.295017945662212 |
|
| 12053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP388 |
0.295017945662212 |
|
| 12054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRXN3 |
0.295017945662212 |
|
| 12055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIO2 |
0.295017945662212 |
|
| 12056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP128 |
0.295017945662212 |
|
| 12057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSHR |
0.295017945662212 |
|
| 12058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2A1 |
0.295017945662212 |
|
| 12059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA79|ENSG00000221303.1 |
0.295017945662212 |
|
| 12060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STON2 |
0.295017945662212 |
|
| 12061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEL1L |
0.295017945662212 |
|
| 12062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238978.1 |
0.295017945662212 |
|
| 12063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC28P |
0.295017945662212 |
|
| 12064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU3P3 |
0.295017945662212 |
|
| 12065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00911 |
0.295017945662212 |
|
| 12066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLRT2 |
0.295017945662212 |
|
| 12067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALC |
0.295017945662212 |
|
| 12068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR65 |
0.295017945662212 |
|
| 12069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK10 |
0.295017945662212 |
|
| 12070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA7 |
0.295017945662212 |
|
| 12071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN21 |
0.295017945662212 |
|
| 12072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H14 |
0.295017945662212 |
|
| 12073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML5 |
0.295017945662212 |
|
| 12074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC8 |
0.295017945662212 |
|
| 12075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXN3 |
0.295017945662212 |
|
| 12076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP107 |
0.295017945662212 |
|
| 12077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP255 |
0.295017945662212 |
|
| 12078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK13 |
0.295017945662212 |
|
| 12079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC1 |
0.295017945662212 |
|
| 12080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRDE2 |
0.295017945662212 |
|
| 12081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALM1 |
0.295017945662212 |
|
| 12082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00642 |
0.295017945662212 |
|
| 12083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC7B |
0.295017945662212 |
|
| 12084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA5 |
0.295017945662212 |
|
| 12085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf159 |
0.295017945662212 |
|
| 12086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11B |
0.295017945662212 |
|
| 12087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL506P |
0.295017945662212 |
|
| 12088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR68 |
0.295017945662212 |
|
| 12089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC88C |
0.295017945662212 |
|
| 12090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMEK1 |
0.295017945662212 |
|
| 12091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPERB |
0.295017945662212 |
|
| 12092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200042.1 |
0.295017945662212 |
|
| 12093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TC2N |
0.295017945662212 |
|
| 12094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLN5 |
0.295017945662212 |
|
| 12095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP11 |
0.295017945662212 |
|
| 12096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN3 |
0.295017945662212 |
|
| 12097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB1 |
0.295017945662212 |
|
| 12098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF2 |
0.295017945662212 |
|
| 12099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A4 |
0.295017945662212 |
|
| 12100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIN3 |
0.295017945662212 |
|
| 12101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGMN |
0.295017945662212 |
|
| 12102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA5 |
0.295017945662212 |
|
| 12103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHGA |
0.295017945662212 |
|
| 12104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPK1 |
0.295017945662212 |
|
| 12105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOAP1 |
0.295017945662212 |
|
| 12106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM251 |
0.295017945662212 |
|
| 12107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf142 |
0.295017945662212 |
|
| 12108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR7 |
0.295017945662212 |
|
| 12109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD7 |
0.295017945662212 |
|
| 12110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC79 |
0.295017945662212 |
|
| 12111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX8C |
0.295017945662212 |
|
| 12112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM181A |
0.295017945662212 |
|
| 12113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB2 |
0.295017945662212 |
|
| 12114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4506 |
0.295017945662212 |
|
| 12115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00521 |
0.295017945662212 |
|
| 12116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUB2 |
0.295017945662212 |
|
| 12117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX24 |
0.295017945662212 |
|
| 12118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI27L1 |
0.295017945662212 |
|
| 12119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI27 |
0.295017945662212 |
|
| 12120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI27L2 |
0.295017945662212 |
|
| 12121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP4R4 |
0.295017945662212 |
|
| 12122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA10 |
0.295017945662212 |
|
| 12123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA6 |
0.295017945662212 |
|
| 12124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA1 |
0.295017945662212 |
|
| 12125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA11 |
0.295017945662212 |
|
| 12126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA9 |
0.295017945662212 |
|
| 12127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA12 |
0.295017945662212 |
|
| 12128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA4 |
0.295017945662212 |
|
| 12129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA5 |
0.295017945662212 |
|
| 12130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA3 |
0.295017945662212 |
|
| 12131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA13P |
0.295017945662212 |
|
| 12132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSC |
0.295017945662212 |
|
| 12133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DICER1 |
0.295017945662212 |
|
| 12134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3173 |
0.295017945662212 |
|
| 12135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLMN |
0.295017945662212 |
|
| 12136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00341 |
0.295017945662212 |
|
| 12137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNE3 |
0.295017945662212 |
|
| 12138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG10 |
0.295017945662212 |
|
| 12139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA13 |
0.295017945662212 |
|
| 12140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRX5 |
0.295017945662212 |
|
| 12141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCL6 |
0.295017945662212 |
|
| 12142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCL1B |
0.295017945662212 |
|
| 12143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCL1A |
0.295017945662212 |
|
| 12144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00617 |
0.295017945662212 |
|
| 12145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf132 |
0.295017945662212 |
|
| 12146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDKRB2 |
0.295017945662212 |
|
| 12147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDKRB1 |
0.295017945662212 |
|
| 12148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP434O1614 |
0.295017945662212 |
|
| 12149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG2B |
0.295017945662212 |
|
| 12150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238776.1 |
0.295017945662212 |
|
| 12151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSKIP |
0.295017945662212 |
|
| 12152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK7 |
0.295017945662212 |
|
| 12153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPOLA |
0.295017945662212 |
|
| 12154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP108 |
0.295017945662212 |
|
| 12155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VRK1 |
0.295017945662212 |
|
| 12156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00618 |
0.295017945662212 |
|
| 12157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL710P |
0.295017945662212 |
|
| 12158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf64 |
0.295017945662212 |
|
| 12159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL714P |
0.295017945662212 |
|
| 12160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf177 |
0.295017945662212 |
|
| 12161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL11B |
0.295017945662212 |
|
| 12162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD3 |
0.295017945662212 |
|
| 12163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC85C |
0.295017945662212 |
|
| 12164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHIPL1 |
0.295017945662212 |
|
| 12165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP46A1 |
0.295017945662212 |
|
| 12166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML1 |
0.295017945662212 |
|
| 12167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVL |
0.295017945662212 |
|
| 12168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR151B |
0.295017945662212 |
|
| 12169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR342 |
0.295017945662212 |
|
| 12170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEGS2 |
0.295017945662212 |
|
| 12171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YY1 |
0.295017945662212 |
|
| 12172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A29 |
0.295017945662212 |
|
| 12173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR345 |
0.295017945662212 |
|
| 12174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL523P |
0.295017945662212 |
|
| 12175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A47 |
0.295017945662212 |
|
| 12176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WARS |
0.295017945662212 |
|
| 12177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR25 |
0.295017945662212 |
|
| 12178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP92 |
0.295017945662212 |
|
| 12179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEGAIN |
0.295017945662212 |
|
| 12180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00523 |
0.295017945662212 |
|
| 12181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLK1 |
0.295017945662212 |
|
| 12182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEG3 |
0.295017945662212 |
|
| 12183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2392 |
0.295017945662212 |
|
| 12184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR770 |
0.295017945662212 |
|
| 12185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR493 |
0.295017945662212 |
|
| 12186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR337 |
0.295017945662212 |
|
| 12187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR431 |
0.295017945662212 |
|
| 12188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR433 |
0.295017945662212 |
|
| 12189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR665 |
0.295017945662212 |
|
| 12190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTL1 |
0.295017945662212 |
|
| 12191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR127 |
0.295017945662212 |
|
| 12192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR136 |
0.295017945662212 |
|
| 12193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR432 |
0.295017945662212 |
|
| 12194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEG8 |
0.295017945662212 |
|
| 12195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR370 |
0.295017945662212 |
|
| 12196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251769.1 |
0.295017945662212 |
|
| 12197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252873.1 |
0.295017945662212 |
|
| 12198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251949.1 |
0.295017945662212 |
|
| 12199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252144.1 |
0.295017945662212 |
|
| 12200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251918.1 |
0.295017945662212 |
|
| 12201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000200150.1 |
0.295017945662212 |
|
| 12202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000201036.1 |
0.295017945662212 |
|
| 12203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000201500.1 |
0.295017945662212 |
|
| 12204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000201710.1 |
0.295017945662212 |
|
| 12205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000222095.1 |
0.295017945662212 |
|
| 12206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252009.1 |
0.295017945662212 |
|
| 12207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD113|ENSG00000222185.1 |
0.295017945662212 |
|
| 12208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR379 |
0.295017945662212 |
|
| 12209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR411 |
0.295017945662212 |
|
| 12210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR299 |
0.295017945662212 |
|
| 12211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR380 |
0.295017945662212 |
|
| 12212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1197 |
0.295017945662212 |
|
| 12213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR323A |
0.295017945662212 |
|
| 12214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR758 |
0.295017945662212 |
|
| 12215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1193 |
0.295017945662212 |
|
| 12216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR494 |
0.295017945662212 |
|
| 12217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR495 |
0.295017945662212 |
|
| 12218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR543 |
0.295017945662212 |
|
| 12219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR300 |
0.295017945662212 |
|
| 12220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR376A1 |
0.295017945662212 |
|
| 12221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR376C |
0.295017945662212 |
|
| 12222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR654 |
0.295017945662212 |
|
| 12223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR381HG |
0.295017945662212 |
|
| 12224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR381 |
0.295017945662212 |
|
| 12225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR487B |
0.295017945662212 |
|
| 12226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR539 |
0.295017945662212 |
|
| 12227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR889 |
0.295017945662212 |
|
| 12228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR544A |
0.295017945662212 |
|
| 12229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR655 |
0.295017945662212 |
|
| 12230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR487A |
0.295017945662212 |
|
| 12231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR134 |
0.295017945662212 |
|
| 12232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR382 |
0.295017945662212 |
|
| 12233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR485 |
0.295017945662212 |
|
| 12234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR323B |
0.295017945662212 |
|
| 12235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR154 |
0.295017945662212 |
|
| 12236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR377 |
0.295017945662212 |
|
| 12237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR496 |
0.295017945662212 |
|
| 12238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR369 |
0.295017945662212 |
|
| 12239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR409 |
0.295017945662212 |
|
| 12240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR410 |
0.295017945662212 |
|
| 12241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR412 |
0.295017945662212 |
|
| 12242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR541 |
0.295017945662212 |
|
| 12243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR656 |
0.295017945662212 |
|
| 12244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEG9 |
0.295017945662212 |
|
| 12245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000206761.1 |
0.295017945662212 |
|
| 12246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00524 |
0.295017945662212 |
|
| 12247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIO3OS |
0.295017945662212 |
|
| 12248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIO3 |
0.295017945662212 |
|
| 12249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R5C |
0.295017945662212 |
|
| 12250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC1H1 |
0.295017945662212 |
|
| 12251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL472P |
0.295017945662212 |
|
| 12252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90AA1 |
0.295017945662212 |
|
| 12253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR20 |
0.295017945662212 |
|
| 12254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4253 |
0.295259691429499 |
|
| 12255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACTBL1 |
0.295259691429499 |
|
| 12256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf234 |
0.295259691429499 |
|
| 12257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM1A |
0.295259691429499 |
|
| 12258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3115 |
0.295259691429499 |
|
| 12259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4419A |
0.295259691429499 |
|
| 12260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUZP1 |
0.295259691429499 |
|
| 12261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR1D |
0.295259691429499 |
|
| 12262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPR |
0.295259691429499 |
|
| 12263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF436 |
0.295259691429499 |
|
| 12264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf213 |
0.295259691429499 |
|
| 12265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEA3 |
0.295259691429499 |
|
| 12266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAP3 |
0.295259691429499 |
|
| 12267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F2 |
0.295259691429499 |
|
| 12268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ID3 |
0.295259691429499 |
|
| 12269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDS2 |
0.295259691429499 |
|
| 12270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL532P |
0.295259691429499 |
|
| 12271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB3 |
0.295259691429499 |
|
| 12272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITHD1 |
0.295259691429499 |
|
| 12273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALE |
0.295259691429499 |
|
| 12274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGCL |
0.295259691429499 |
|
| 12275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPLA2 |
0.295259691429499 |
|
| 12276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUCA1 |
0.295259691429499 |
|
| 12277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNR2 |
0.295259691429499 |
|
| 12278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL24P |
0.295259691429499 |
|
| 12279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238538.1 |
0.295259691429499 |
|
| 12280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378F |
0.295259691429499 |
|
| 12281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNRC2 |
0.295259691429499 |
|
| 12282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF10 |
0.295259691429499 |
|
| 12283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOM3 |
0.295259691429499 |
|
| 12284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL22RA1 |
0.295259691429499 |
|
| 12285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNLR1 |
0.295259691429499 |
|
| 12286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRHL3 |
0.295259691429499 |
|
| 12287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STPG1 |
0.295259691429499 |
|
| 12288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPAL3 |
0.295259691429499 |
|
| 12289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCAN3 |
0.295259691429499 |
|
| 12290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP180 |
0.298213733867728 |
|
| 12291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA24|ENSG00000252274.1 |
0.298213733867728 |
|
| 12292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB11 |
0.3019004105139 |
|
| 12293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDP1 |
0.3019004105139 |
|
| 12294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTO |
0.301991288842894 |
|
| 12295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGPP1 |
0.307110115072162 |
|
| 12296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ16 |
0.308992711870887 |
|
| 12297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ2 |
0.308992711870887 |
|
| 12298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX9 |
0.308992711870887 |
|
| 12299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSTR2 |
0.308992711870887 |
|
| 12300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG1 |
0.308992711870887 |
|
| 12301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM104A |
0.308992711870887 |
|
| 12302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf80 |
0.308992711870887 |
|
| 12303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF4L |
0.308992711870887 |
|
| 12304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42EP4 |
0.308992711870887 |
|
| 12305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDK2 |
0.308992711870887 |
|
| 12306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00469 |
0.308992711870887 |
|
| 12307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD17 |
0.308992711870887 |
|
| 12308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf77 |
0.308992711870887 |
|
| 12309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300A |
0.308992711870887 |
|
| 12310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300C |
0.308992711870887 |
|
| 12311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300E |
0.308992711870887 |
|
| 12312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300LB |
0.308992711870887 |
|
| 12313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300LD |
0.308992711870887 |
|
| 12314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD300LF |
0.308992711870887 |
|
| 12315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAI2 |
0.308992711870887 |
|
| 12316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR142 |
0.308992711870887 |
|
| 12317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRC5C |
0.308992711870887 |
|
| 12318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF19 |
0.308992711870887 |
|
| 12319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB37 |
0.308992711870887 |
|
| 12320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP448 |
0.308992711870887 |
|
| 12321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL38 |
0.308992711870887 |
|
| 12322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTYH2 |
0.308992711870887 |
|
| 12323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3615 |
0.308992711870887 |
|
| 12324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A3R1 |
0.308992711870887 |
|
| 12325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT9 |
0.308992711870887 |
|
| 12326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM104 |
0.308992711870887 |
|
| 12327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN2C |
0.308992711870887 |
|
| 12328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDXR |
0.308992711870887 |
|
| 12329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FADS6 |
0.308992711870887 |
|
| 12330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USH1G |
0.308992711870887 |
|
| 12331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOP2 |
0.308992711870887 |
|
| 12332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOP3 |
0.308992711870887 |
|
| 12333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HID1 |
0.308992711870887 |
|
| 12334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDR2L |
0.308992711870887 |
|
| 12335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICT1 |
0.308992711870887 |
|
| 12336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD2 |
0.308992711870887 |
|
| 12337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5H |
0.308992711870887 |
|
| 12338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL573P |
0.308992711870887 |
|
| 12339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A5 |
0.308992711870887 |
|
| 12340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC7 |
0.308992711870887 |
|
| 12341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HN1 |
0.308992711870887 |
|
| 12342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C |
0.308992711870887 |
|
| 12343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMO2 |
0.308992711870887 |
|
| 12344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP85 |
0.308992711870887 |
|
| 12345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGA3 |
0.308992711870887 |
|
| 12346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS7 |
0.308992711870887 |
|
| 12347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIF4GD |
0.308992711870887 |
|
| 12348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A19 |
0.308992711870887 |
|
| 12349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRB2 |
0.308992711870887 |
|
| 12350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3678 |
0.308992711870887 |
|
| 12351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0195 |
0.308992711870887 |
|
| 12352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASKIN2 |
0.308992711870887 |
|
| 12353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSEN54 |
0.308992711870887 |
|
| 12354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LLGL2 |
0.308992711870887 |
|
| 12355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO15B |
0.308992711870887 |
|
| 12356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RECQL5 |
0.308992711870887 |
|
| 12357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM5 |
0.308992711870887 |
|
| 12358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM6 |
0.308992711870887 |
|
| 12359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP30BP |
0.308992711870887 |
|
| 12360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB4 |
0.308992711870887 |
|
| 12361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALK1 |
0.308992711870887 |
|
| 12362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H3F3B |
0.308992711870887 |
|
| 12363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4738 |
0.308992711870887 |
|
| 12364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNK |
0.308992711870887 |
|
| 12365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC13D |
0.308992711870887 |
|
| 12366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP2 |
0.308992711870887 |
|
| 12367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM47 |
0.308992711870887 |
|
| 12368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM65 |
0.308992711870887 |
|
| 12369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL38 |
0.308992711870887 |
|
| 12370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBF1 |
0.308992711870887 |
|
| 12371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOX1 |
0.308992711870887 |
|
| 12372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEN1 |
0.308992711870887 |
|
| 12373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK3 |
0.308992711870887 |
|
| 12374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVPL |
0.308992711870887 |
|
| 12375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP68 |
0.308992711870887 |
|
| 12376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC7 |
0.308992711870887 |
|
| 12377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALR2 |
0.308992711870887 |
|
| 12378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZACN |
0.308992711870887 |
|
| 12379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXJ1 |
0.308992711870887 |
|
| 12380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF157 |
0.308992711870887 |
|
| 12381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QRICH2 |
0.308992711870887 |
|
| 12382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBALD2 |
0.308992711870887 |
|
| 12383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPSAP1 |
0.308992711870887 |
|
| 12384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238418.1 |
0.308992711870887 |
|
| 12385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPHK1 |
0.308992711870887 |
|
| 12386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2O |
0.308992711870887 |
|
| 12387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AANAT |
0.308992711870887 |
|
| 12388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDF2 |
0.308992711870887 |
|
| 12389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYGB |
0.308992711870887 |
|
| 12390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRCD |
0.308992711870887 |
|
| 12391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG16 |
0.308992711870887 |
|
| 12392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD1B |
0.308992711870887 |
|
| 12393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC2 |
0.308992711870887 |
|
| 12394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GALNAC1 |
0.308992711870887 |
|
| 12395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXRA7 |
0.308992711870887 |
|
| 12396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMJD6 |
0.308992711870887 |
|
| 12397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL23 |
0.308992711870887 |
|
| 12398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD11 |
0.308992711870887 |
|
| 12399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR636 |
0.308992711870887 |
|
| 12400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF2 |
0.308992711870887 |
|
| 12401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00868 |
0.308992711870887 |
|
| 12402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT5B |
0.308992711870887 |
|
| 12403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00338 |
0.308992711870887 |
|
| 12404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L1 |
0.308992711870887 |
|
| 12405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT9 |
0.308992711870887 |
|
| 12406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4316 |
0.308992711870887 |
|
| 12407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ45079 |
0.308992711870887 |
|
| 12408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNRC6C |
0.308992711870887 |
|
| 12409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC6 |
0.308992711870887 |
|
| 12410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC8 |
0.308992711870887 |
|
| 12411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf99 |
0.308992711870887 |
|
| 12412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNGR2 |
0.308992711870887 |
|
| 12413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TK1 |
0.308992711870887 |
|
| 12414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFMID |
0.308992711870887 |
|
| 12415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC5 |
0.308992711870887 |
|
| 12416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM235 |
0.308992711870887 |
|
| 12417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS3 |
0.308992711870887 |
|
| 12418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL236P |
0.308992711870887 |
|
| 12419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGS1 |
0.308992711870887 |
|
| 12420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA30|ENSG00000200063.1 |
0.308992711870887 |
|
| 12421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH17 |
0.308992711870887 |
|
| 12422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL454P |
0.308992711870887 |
|
| 12423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTH1 |
0.308992711870887 |
|
| 12424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP36 |
0.308992711870887 |
|
| 12425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMP2 |
0.308992711870887 |
|
| 12426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDC8 |
0.308992711870887 |
|
| 12427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS3BP |
0.308992711870887 |
|
| 12428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CANT1 |
0.308992711870887 |
|
| 12429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF1 |
0.308992711870887 |
|
| 12430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENGASE |
0.308992711870887 |
|
| 12431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBFOX3 |
0.308992711870887 |
|
| 12432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4739 |
0.308992711870887 |
|
| 12433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239173.1 |
0.308992711870887 |
|
| 12434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP7 |
0.308992711870887 |
|
| 12435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX2 |
0.308992711870887 |
|
| 12436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX8 |
0.308992711870887 |
|
| 12437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX4 |
0.308992711870887 |
|
| 12438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D16 |
0.308992711870887 |
|
| 12439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC40 |
0.308992711870887 |
|
| 12440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAA |
0.308992711870887 |
|
| 12441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4A3 |
0.308992711870887 |
|
| 12442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD14 |
0.308992711870887 |
|
| 12443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGSH |
0.308992711870887 |
|
| 12444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A11 |
0.308992711870887 |
|
| 12445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF213 |
0.308992711870887 |
|
| 12446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENDOV |
0.308992711870887 |
|
| 12447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4730 |
0.308992711870887 |
|
| 12448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPTX1 |
0.308992711870887 |
|
| 12449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPTOR |
0.308992711870887 |
|
| 12450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP6 |
0.308992711870887 |
|
| 12451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAIAP2 |
0.308992711870887 |
|
| 12452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AATK |
0.308992711870887 |
|
| 12453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1250 |
0.308992711870887 |
|
| 12454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR338 |
0.308992711870887 |
|
| 12455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR657 |
0.308992711870887 |
|
| 12456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZI1 |
0.308992711870887 |
|
| 12457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTHD2 |
0.308992711870887 |
|
| 12458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf89 |
0.308992711870887 |
|
| 12459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A10 |
0.308992711870887 |
|
| 12460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00482 |
0.308992711870887 |
|
| 12461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM105 |
0.308992711870887 |
|
| 12462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4740 |
0.308992711870887 |
|
| 12463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3186 |
0.308992711870887 |
|
| 12464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTG1 |
0.308992711870887 |
|
| 12465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSCN2 |
0.308992711870887 |
|
| 12466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C17orf70 |
0.308992711870887 |
|
| 12467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPLOC4 |
0.308992711870887 |
|
| 12468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN10 |
0.308992711870887 |
|
| 12469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6G |
0.308992711870887 |
|
| 12470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXLD1 |
0.308992711870887 |
|
| 12471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC137 |
0.308992711870887 |
|
| 12472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL16 |
0.308992711870887 |
|
| 12473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HGS |
0.308992711870887 |
|
| 12474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL12 |
0.308992711870887 |
|
| 12475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A10 |
0.308992711870887 |
|
| 12476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM195B |
0.308992711870887 |
|
| 12477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCGR |
0.308992711870887 |
|
| 12478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P4HB |
0.308992711870887 |
|
| 12479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R27 |
0.308992711870887 |
|
| 12480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGDIA |
0.308992711870887 |
|
| 12481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALYREF |
0.308992711870887 |
|
| 12482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC11 |
0.308992711870887 |
|
| 12483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPB |
0.308992711870887 |
|
| 12484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCYT2 |
0.308992711870887 |
|
| 12485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT7 |
0.308992711870887 |
|
| 12486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAFG |
0.308992711870887 |
|
| 12487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYADML2 |
0.308992711870887 |
|
| 12488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYCR1 |
0.308992711870887 |
|
| 12489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTUM |
0.308992711870887 |
|
| 12490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPSCR1 |
0.308992711870887 |
|
| 12491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRA13 |
0.308992711870887 |
|
| 12492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCXR |
0.308992711870887 |
|
| 12493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC45 |
0.308992711870887 |
|
| 12494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAC3 |
0.308992711870887 |
|
| 12495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFNG |
0.308992711870887 |
|
| 12496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPS1 |
0.308992711870887 |
|
| 12497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUS1L |
0.308992711870887 |
|
| 12498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASN |
0.308992711870887 |
|
| 12499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEU2 |
0.31154856938185 |
|
| 12500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP5D |
0.31154856938185 |
|
| 12501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL32P |
0.31154856938185 |
|
| 12502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA5 |
0.31154856938185 |
|
| 12503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA6|ENSG00000251791.1 |
0.31154856938185 |
|
| 12504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP40 |
0.31154856938185 |
|
| 12505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A10 |
0.31154856938185 |
|
| 12506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A8 |
0.31154856938185 |
|
| 12507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A9 |
0.31154856938185 |
|
| 12508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A7 |
0.31154856938185 |
|
| 12509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A6 |
0.31154856938185 |
|
| 12510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A5 |
0.31154856938185 |
|
| 12511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A4 |
0.31154856938185 |
|
| 12512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A3 |
0.31154856938185 |
|
| 12513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB3 |
0.31154856938185 |
|
| 12514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT1A1 |
0.31154856938185 |
|
| 12515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH2A |
0.31154856938185 |
|
| 12516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP104 |
0.312025824565574 |
|
| 12517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DFFB |
0.312025824565574 |
|
| 12518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf174 |
0.312025824565574 |
|
| 12519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AJAP1 |
0.312025824565574 |
|
| 12520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCND2 |
0.312154195708224 |
|
| 12521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN12 |
0.312154195708224 |
|
| 12522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ING3 |
0.312154195708224 |
|
| 12523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP240 |
0.312154195708224 |
|
| 12524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPED1 |
0.312154195708224 |
|
| 12525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP241 |
0.312154195708224 |
|
| 12526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT16 |
0.312154195708224 |
|
| 12527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM3C |
0.312154195708224 |
|
| 12528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP277 |
0.312154195708224 |
|
| 12529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRZ1 |
0.312154195708224 |
|
| 12530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AASS |
0.312154195708224 |
|
| 12531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEZF1 |
0.312154195708224 |
|
| 12532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADPS2 |
0.312154195708224 |
|
| 12533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF133 |
0.312154195708224 |
|
| 12534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF148 |
0.312154195708224 |
|
| 12535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R16 |
0.312154195708224 |
|
| 12536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC13A1 |
0.312154195708224 |
|
| 12537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQUB |
0.312154195708224 |
|
| 12538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA5 |
0.312154195708224 |
|
| 12539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB15 |
0.312154195708224 |
|
| 12540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMOD2 |
0.312154195708224 |
|
| 12541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASL |
0.312154195708224 |
|
| 12542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYAL4 |
0.312154195708224 |
|
| 12543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAM1 |
0.312154195708224 |
|
| 12544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM229A |
0.312154195708224 |
|
| 12545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR37 |
0.312154195708224 |
|
| 12546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POT1 |
0.312154195708224 |
|
| 12547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR592 |
0.312154195708224 |
|
| 12548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF21 |
0.313026178083562 |
|
| 12549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NALCN |
0.313841319391351 |
|
| 12550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGBL1 |
0.313841319391351 |
|
| 12551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF14 |
0.313841319391351 |
|
| 12552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2681 |
0.313841319391351 |
|
| 12553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P2 |
0.313841319391351 |
|
| 12554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4705 |
0.313841319391351 |
|
| 12555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00555 |
0.313841319391351 |
|
| 12556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPP2 |
0.313841319391351 |
|
| 12557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL21C |
0.313841319391351 |
|
| 12558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238869.1 |
0.313841319391351 |
|
| 12559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC168 |
0.313841319391351 |
|
| 12560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00283 |
0.313841319391351 |
|
| 12561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX30 |
0.313841319391351 |
|
| 12562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDELC1 |
0.313841319391351 |
|
| 12563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIVM |
0.313841319391351 |
|
| 12564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY5P8 |
0.313841319391351 |
|
| 12565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC5 |
0.313841319391351 |
|
| 12566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL21EP |
0.313841319391351 |
|
| 12567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A2 |
0.313841319391351 |
|
| 12568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP156 |
0.313893841905017 |
|
| 12569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP73 |
0.313893841905017 |
|
| 12570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM5C |
0.313893841905017 |
|
| 12571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS18 |
0.313893841905017 |
|
| 12572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS21 |
0.313893841905017 |
|
| 12573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS1 |
0.313893841905017 |
|
| 12574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS13 |
0.313893841905017 |
|
| 12575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS2 |
0.313893841905017 |
|
| 12576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP126 |
0.313893841905017 |
|
| 12577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIM1 |
0.318461557576398 |
|
| 12578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238999.1 |
0.318461557576398 |
|
| 12579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIK2 |
0.318461557576398 |
|
| 12580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA33|ENSG00000202283.1 |
0.318461557576398 |
|
| 12581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HACE1 |
0.318461557576398 |
|
| 12582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00577 |
0.318461557576398 |
|
| 12583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN28B |
0.318461557576398 |
|
| 12584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BVES |
0.318461557576398 |
|
| 12585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POPDC3 |
0.318461557576398 |
|
| 12586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PREP |
0.318461557576398 |
|
| 12587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP211 |
0.318461557576398 |
|
| 12588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM1 |
0.318461557576398 |
|
| 12589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG5 |
0.318461557576398 |
|
| 12590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL47P |
0.318461557576398 |
|
| 12591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP211 |
0.318461557576398 |
|
| 12592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIM1 |
0.318461557576398 |
|
| 12593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN4IP1 |
0.318461557576398 |
|
| 12594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QRSL1 |
0.318461557576398 |
|
| 12595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR587 |
0.318461557576398 |
|
| 12596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf203 |
0.318461557576398 |
|
| 12597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND3 |
0.318461557576398 |
|
| 12598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDSS2 |
0.318461557576398 |
|
| 12599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOBP |
0.318461557576398 |
|
| 12600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCML4 |
0.318461557576398 |
|
| 12601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC63 |
0.318461557576398 |
|
| 12602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000253090.1 |
0.318461557576398 |
|
| 12603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSTM1 |
0.318461557576398 |
|
| 12604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2E1 |
0.318461557576398 |
|
| 12605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX3 |
0.318461557576398 |
|
| 12606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238974.1 |
0.318461557576398 |
|
| 12607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP212 |
0.318461557576398 |
|
| 12608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASF1A |
0.318461557576398 |
|
| 12609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM184A |
0.318461557576398 |
|
| 12610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548B |
0.318461557576398 |
|
| 12611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN1A1 |
0.318461557576398 |
|
| 12612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3144 |
0.318461557576398 |
|
| 12613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP215 |
0.318461557576398 |
|
| 12614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D32 |
0.318461557576398 |
|
| 12615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLECP3 |
0.318461557576398 |
|
| 12616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJA1 |
0.318461557576398 |
|
| 12617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSF2 |
0.318461557576398 |
|
| 12618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERINC1 |
0.318461557576398 |
|
| 12619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKIB |
0.318461557576398 |
|
| 12620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL564P |
0.318461557576398 |
|
| 12621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP7 |
0.318461557576398 |
|
| 12622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPDL3A |
0.318461557576398 |
|
| 12623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLVS2 |
0.318461557576398 |
|
| 12624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRDN |
0.318461557576398 |
|
| 12625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF217 |
0.318461557576398 |
|
| 12626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPD52L1 |
0.318461557576398 |
|
| 12627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDDC2 |
0.318461557576398 |
|
| 12628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEY2 |
0.318461557576398 |
|
| 12629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA7 |
0.318461557576398 |
|
| 12630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP56 |
0.318461557576398 |
|
| 12631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HINT3 |
0.318461557576398 |
|
| 12632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP216 |
0.318461557576398 |
|
| 12633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT11 |
0.318461557576398 |
|
| 12634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPW |
0.318461557576398 |
|
| 12635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR588 |
0.318461557576398 |
|
| 12636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRELID1P1 |
0.318461557576398 |
|
| 12637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPO3 |
0.318461557576398 |
|
| 12638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF146 |
0.318461557576398 |
|
| 12639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECHDC1 |
0.318461557576398 |
|
| 12640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP217 |
0.318461557576398 |
|
| 12641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOGA3 |
0.318461557576398 |
|
| 12642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0408 |
0.318461557576398 |
|
| 12643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf58 |
0.318461557576398 |
|
| 12644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEMIS |
0.318461557576398 |
|
| 12645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRK |
0.318461557576398 |
|
| 12646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238938.1 |
0.318461557576398 |
|
| 12647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMA2 |
0.318461557576398 |
|
| 12648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP18 |
0.318461557576398 |
|
| 12649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM244 |
0.318461557576398 |
|
| 12650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L3MBTL3 |
0.318461557576398 |
|
| 12651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD3 |
0.318461557576398 |
|
| 12652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM200A |
0.318461557576398 |
|
| 12653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMLR1 |
0.318461557576398 |
|
| 12654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L2 |
0.318461557576398 |
|
| 12655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP7 |
0.318461557576398 |
|
| 12656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARG1 |
0.318461557576398 |
|
| 12657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED23 |
0.318461557576398 |
|
| 12658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP3 |
0.318461557576398 |
|
| 12659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2A4 |
0.318461557576398 |
|
| 12660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE9 |
0.318461557576398 |
|
| 12661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548H5 |
0.318461557576398 |
|
| 12662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP1 |
0.318461557576398 |
|
| 12663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP245 |
0.318461557576398 |
|
| 12664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTGF |
0.318461557576398 |
|
| 12665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AJ1 |
0.318461557576398 |
|
| 12666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOXD1 |
0.318461557576398 |
|
| 12667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX7 |
0.318461557576398 |
|
| 12668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR9 |
0.318461557576398 |
|
| 12669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR8 |
0.318461557576398 |
|
| 12670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR6 |
0.318461557576398 |
|
| 12671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR5 |
0.318461557576398 |
|
| 12672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR3 |
0.318461557576398 |
|
| 12673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR2 |
0.318461557576398 |
|
| 12674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAAR1 |
0.318461557576398 |
|
| 12675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VNN1 |
0.318461557576398 |
|
| 12676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VNN3 |
0.318461557576398 |
|
| 12677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VNN2 |
0.318461557576398 |
|
| 12678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC18B1 |
0.318461557576398 |
|
| 12679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS12 |
0.318461557576398 |
|
| 12680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA33|ENSG00000200534.1 |
0.318461557576398 |
|
| 12681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD100 |
0.318461557576398 |
|
| 12682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD101 |
0.318461557576398 |
|
| 12683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00326 |
0.318461557576398 |
|
| 12684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EYA4 |
0.318461557576398 |
|
| 12685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF21 |
0.318461557576398 |
|
| 12686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBPL1 |
0.318461557576398 |
|
| 12687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A12 |
0.318461557576398 |
|
| 12688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL408P |
0.318461557576398 |
|
| 12689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK1 |
0.318461557576398 |
|
| 12690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238631.1 |
0.318461557576398 |
|
| 12691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP218 |
0.318461557576398 |
|
| 12692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH8A1 |
0.318461557576398 |
|
| 12693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBS1L |
0.318461557576398 |
|
| 12694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYB |
0.318461557576398 |
|
| 12695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548A2 |
0.318461557576398 |
|
| 12696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHI1 |
0.318461557576398 |
|
| 12697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00271 |
0.318461557576398 |
|
| 12698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE7B |
0.318461557576398 |
|
| 12699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX5BP2 |
0.318461557576398 |
|
| 12700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTFR2 |
0.318461557576398 |
|
| 12701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCLAF1 |
0.318461557576398 |
|
| 12702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP7 |
0.318461557576398 |
|
| 12703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000271765.1 |
0.318461557576398 |
|
| 12704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K5 |
0.318461557576398 |
|
| 12705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP219 |
0.318461557576398 |
|
| 12706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX7 |
0.318461557576398 |
|
| 12707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA27|ENSG00000201807.1 |
0.318461557576398 |
|
| 12708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35D3 |
0.318461557576398 |
|
| 12709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL20RA |
0.318461557576398 |
|
| 12710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL22RA2 |
0.318461557576398 |
|
| 12711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNGR1 |
0.318461557576398 |
|
| 12712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLIG3 |
0.318461557576398 |
|
| 12713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252476.1 |
0.318461557576398 |
|
| 12714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP3 |
0.318461557576398 |
|
| 12715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PERP |
0.318461557576398 |
|
| 12716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1244 |
0.318461557576398 |
|
| 12717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBOV1 |
0.318461557576398 |
|
| 12718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEBP2 |
0.318461557576398 |
|
| 12719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHSL1 |
0.318461557576398 |
|
| 12720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3145 |
0.318461557576398 |
|
| 12721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC28A |
0.318461557576398 |
|
| 12722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECT2L |
0.318461557576398 |
|
| 12723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REPS1 |
0.318461557576398 |
|
| 12724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABRACL |
0.318461557576398 |
|
| 12725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECA |
0.318461557576398 |
|
| 12726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXLNB |
0.318461557576398 |
|
| 12727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CITED2 |
0.318461557576398 |
|
| 12728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP220 |
0.318461557576398 |
|
| 12729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3668 |
0.318461557576398 |
|
| 12730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4465 |
0.318461557576398 |
|
| 12731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP106 |
0.318461557576398 |
|
| 12732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMBR |
0.318461557576398 |
|
| 12733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJE1 |
0.318461557576398 |
|
| 12734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VTA1 |
0.318461557576398 |
|
| 12735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR126 |
0.318461557576398 |
|
| 12736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIVEP2 |
0.318461557576398 |
|
| 12737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIG1 |
0.318461557576398 |
|
| 12738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAT2 |
0.318461557576398 |
|
| 12739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX3 |
0.318461557576398 |
|
| 12740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP221 |
0.318461557576398 |
|
| 12741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUCA2 |
0.318461557576398 |
|
| 12742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHACTR2 |
0.318461557576398 |
|
| 12743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTV1 |
0.318461557576398 |
|
| 12744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC2HC1B |
0.318461557576398 |
|
| 12745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAGL1 |
0.318461557576398 |
|
| 12746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX11 |
0.318461557576398 |
|
| 12747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPM2A |
0.318461557576398 |
|
| 12748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO30 |
0.318461557576398 |
|
| 12749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHPRH |
0.318461557576398 |
|
| 12750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM1 |
0.318461557576398 |
|
| 12751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP222 |
0.318461557576398 |
|
| 12752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB32 |
0.318461557576398 |
|
| 12753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADGB |
0.318461557576398 |
|
| 12754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP5 |
0.318461557576398 |
|
| 12755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD5 |
0.318461557576398 |
|
| 12756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SASH1 |
0.318461557576398 |
|
| 12757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UST |
0.318461557576398 |
|
| 12758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAB2 |
0.318461557576398 |
|
| 12759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL234P |
0.318461557576398 |
|
| 12760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMO4 |
0.318461557576398 |
|
| 12761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H12D |
0.318461557576398 |
|
| 12762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIL4 |
0.318461557576398 |
|
| 12763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GINM1 |
0.318461557576398 |
|
| 12764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA2|ENSG00000202343.1 |
0.318461557576398 |
|
| 12765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KATNA1 |
0.318461557576398 |
|
| 12766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LATS1 |
0.318461557576398 |
|
| 12767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP43 |
0.318461557576398 |
|
| 12768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCMT1 |
0.318461557576398 |
|
| 12769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP11 |
0.318461557576398 |
|
| 12770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAET1E |
0.318461557576398 |
|
| 12771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAET1G |
0.318461557576398 |
|
| 12772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULBP2 |
0.318461557576398 |
|
| 12773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULBP1 |
0.318461557576398 |
|
| 12774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAET1K |
0.318461557576398 |
|
| 12775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAET1L |
0.318461557576398 |
|
| 12776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULBP3 |
0.318461557576398 |
|
| 12777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R14C |
0.318461557576398 |
|
| 12778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238594.1 |
0.318461557576398 |
|
| 12779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IYD |
0.318461557576398 |
|
| 12780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG1 |
0.318461557576398 |
|
| 12781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFD1L |
0.318461557576398 |
|
| 12782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP12 |
0.318461557576398 |
|
| 12783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P20 |
0.318461557576398 |
|
| 12784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP268 |
0.318461557576398 |
|
| 12785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238939.1 |
0.318461557576398 |
|
| 12786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB2 |
0.318461557576398 |
|
| 12787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMND1 |
0.318461557576398 |
|
| 12788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf211 |
0.318461557576398 |
|
| 12789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC170 |
0.318461557576398 |
|
| 12790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESR1 |
0.318461557576398 |
|
| 12791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNE1 |
0.318461557576398 |
|
| 12792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP223 |
0.318461557576398 |
|
| 12793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCT1 |
0.318461557576398 |
|
| 12794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIP |
0.318461557576398 |
|
| 12795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO5 |
0.318461557576398 |
|
| 12796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRF1L |
0.318461557576398 |
|
| 12797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS17 |
0.318461557576398 |
|
| 12798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP224 |
0.318461557576398 |
|
| 12799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP225 |
0.318461557576398 |
|
| 12800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPRM1 |
0.318461557576398 |
|
| 12801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPCEF1 |
0.318461557576398 |
|
| 12802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNKSR3 |
0.318461557576398 |
|
| 12803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL19 |
0.324133245380292 |
|
| 12804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL21 |
0.324133245380292 |
|
| 12805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM205A |
0.324133245380292 |
|
| 12806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM205B |
0.324133245380292 |
|
| 12807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM205CP |
0.324133245380292 |
|
| 12808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1045 |
0.324133245380292 |
|
| 12809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB5 |
0.324133245380292 |
|
| 12810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf131 |
0.324133245380292 |
|
| 12811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ00273 |
0.324133245380292 |
|
| 12812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL857P |
0.324672580497078 |
|
| 12813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCMAP |
0.324672580497078 |
|
| 12814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRM1 |
0.324672580497078 |
|
| 12815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238986.1 |
0.324672580497078 |
|
| 12816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC4 |
0.324672580497078 |
|
| 12817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNX3 |
0.324672580497078 |
|
| 12818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4425 |
0.324672580497078 |
|
| 12819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf63 |
0.324672580497078 |
|
| 12820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHCE |
0.324672580497078 |
|
| 12821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHD |
0.324672580497078 |
|
| 12822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYF2 |
0.324672580497078 |
|
| 12823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM50A |
0.324672580497078 |
|
| 12824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238889.1 |
0.324672580497078 |
|
| 12825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM57 |
0.324672580497078 |
|
| 12826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLRAP1 |
0.324672580497078 |
|
| 12827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN1C1 |
0.324672580497078 |
|
| 12828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPN1 |
0.324672580497078 |
|
| 12829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTFR1L |
0.324672580497078 |
|
| 12830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AUNIP |
0.324672580497078 |
|
| 12831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR7 |
0.324672580497078 |
|
| 12832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMN1 |
0.324672580497078 |
|
| 12833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3917 |
0.324672580497078 |
|
| 12834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAFAH2 |
0.324672580497078 |
|
| 12835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000252190.1 |
0.324672580497078 |
|
| 12836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000252691.1 |
0.324672580497078 |
|
| 12837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXTL1 |
0.324672580497078 |
|
| 12838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A2 |
0.324672580497078 |
|
| 12839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM63 |
0.324672580497078 |
|
| 12840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIK1L |
0.324672580497078 |
|
| 12841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM110D |
0.324672580497078 |
|
| 12842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF593 |
0.324672580497078 |
|
| 12843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNKSR1 |
0.324672580497078 |
|
| 12844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPER4 |
0.324672580497078 |
|
| 12845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP85 |
0.324672580497078 |
|
| 12846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BGRL3 |
0.324672580497078 |
|
| 12847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN11 |
0.324672580497078 |
|
| 12848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIM1L |
0.324672580497078 |
|
| 12849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD52 |
0.324672580497078 |
|
| 12850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL490P |
0.324672580497078 |
|
| 12851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF683 |
0.324672580497078 |
|
| 12852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN28A |
0.324672580497078 |
|
| 12853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHDDS |
0.324672580497078 |
|
| 12854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN2 |
0.324672580497078 |
|
| 12855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA1 |
0.324672580497078 |
|
| 12856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1976 |
0.324672580497078 |
|
| 12857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL679P |
0.324672580497078 |
|
| 12858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238316.1 |
0.324672580497078 |
|
| 12859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID1A |
0.324672580497078 |
|
| 12860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL501P |
0.324672580497078 |
|
| 12861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGV |
0.324672580497078 |
|
| 12862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL165P |
0.324672580497078 |
|
| 12863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC18 |
0.324672580497078 |
|
| 12864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFN |
0.324672580497078 |
|
| 12865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPN2 |
0.324672580497078 |
|
| 12866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH3 |
0.324672580497078 |
|
| 12867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDC |
0.324672580497078 |
|
| 12868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR0B2 |
0.324672580497078 |
|
| 12869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf172 |
0.324672580497078 |
|
| 12870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRNP1 |
0.324672580497078 |
|
| 12871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM46B |
0.324672580497078 |
|
| 12872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A1 |
0.324672580497078 |
|
| 12873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDTC1 |
0.324672580497078 |
|
| 12874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP68 |
0.325432353595771 |
|
| 12875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO6A1 |
0.325432353595771 |
|
| 12876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00492 |
0.325432353595771 |
|
| 12877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00491 |
0.325432353595771 |
|
| 12878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAM |
0.325432353595771 |
|
| 12879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIN1 |
0.325432353595771 |
|
| 12880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIP5K2 |
0.325432353595771 |
|
| 12881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf30 |
0.325432353595771 |
|
| 12882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT12 |
0.325432353595771 |
|
| 12883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL255P |
0.325432353595771 |
|
| 12884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA6A |
0.325432353595771 |
|
| 12885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTWD2 |
0.325432353595771 |
|
| 12886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMXL1 |
0.325432353595771 |
|
| 12887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239011.1 |
0.325432353595771 |
|
| 12888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5706 |
0.325432353595771 |
|
| 12889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP8 |
0.325432353595771 |
|
| 12890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL174P |
0.325432353595771 |
|
| 12891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP190 |
0.325432353595771 |
|
| 12892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B4 |
0.325432353595771 |
|
| 12893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239084.1 |
0.325432353595771 |
|
| 12894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239067.1 |
0.325432353595771 |
|
| 12895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM170A |
0.325432353595771 |
|
| 12896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR16 |
0.325432353595771 |
|
| 12897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTMT |
0.325432353595771 |
|
| 12898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRFBP1 |
0.325432353595771 |
|
| 12899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOX |
0.325432353595771 |
|
| 12900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF474 |
0.325432353595771 |
|
| 12901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNCAIP |
0.325432353595771 |
|
| 12902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX2 |
0.325432353595771 |
|
| 12903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252295.1 |
0.325432353595771 |
|
| 12904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX24 |
0.325432353595771 |
|
| 12905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239103.1 |
0.325432353595771 |
|
| 12906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIC |
0.325432353595771 |
|
| 12907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL689P |
0.325432353595771 |
|
| 12908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL711P |
0.325432353595771 |
|
| 12909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM6 |
0.325432353595771 |
|
| 12910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP120 |
0.325432353595771 |
|
| 12911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRIMA1 |
0.326270881048819 |
|
| 12912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP2A |
0.32639657400466 |
|
| 12913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238407.1 |
0.32639657400466 |
|
| 12914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO5 |
0.32639657400466 |
|
| 12915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF113B |
0.32639657400466 |
|
| 12916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP8 |
0.32639657400466 |
|
| 12917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3170 |
0.32639657400466 |
|
| 12918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK24 |
0.32639657400466 |
|
| 12919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL60P |
0.32639657400466 |
|
| 12920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC15A1 |
0.32639657400466 |
|
| 12921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK9 |
0.32639657400466 |
|
| 12922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAC2 |
0.32639657400466 |
|
| 12923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP9 |
0.32639657400466 |
|
| 12924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR18 |
0.32639657400466 |
|
| 12925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR183 |
0.32639657400466 |
|
| 12926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR623 |
0.32639657400466 |
|
| 12927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00449 |
0.32639657400466 |
|
| 12928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM9SF2 |
0.32639657400466 |
|
| 12929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P6 |
0.32639657400466 |
|
| 12930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLYBL |
0.32639657400466 |
|
| 12931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4306 |
0.32639657400466 |
|
| 12932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000201245.1 |
0.32639657400466 |
|
| 12933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238305.1 |
0.32639657400466 |
|
| 12934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIC5 |
0.32639657400466 |
|
| 12935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIC2 |
0.32639657400466 |
|
| 12936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00554 |
0.32639657400466 |
|
| 12937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCCA |
0.32639657400466 |
|
| 12938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGACT |
0.32639657400466 |
|
| 12939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMTC4 |
0.32639657400466 |
|
| 12940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00411 |
0.32639657400466 |
|
| 12941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF7 |
0.32639657400466 |
|
| 12942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS3 |
0.329803855544773 |
|
| 12943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC18P |
0.329803855544773 |
|
| 12944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AADACL4 |
0.329803855544773 |
|
| 12945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AADACL3 |
0.329803855544773 |
|
| 12946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238771.1 |
0.329803855544773 |
|
| 12947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf158 |
0.329803855544773 |
|
| 12948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC10 |
0.330390523739233 |
|
| 12949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWP2 |
0.330390523739233 |
|
| 12950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf33 |
0.330390523739233 |
|
| 12951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HUNK |
0.331720130924412 |
|
| 12952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00159 |
0.331720130924412 |
|
| 12953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIS18A |
0.331720130924412 |
|
| 12954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRAP |
0.331720130924412 |
|
| 12955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URB1 |
0.331720130924412 |
|
| 12956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL109P |
0.331720130924412 |
|
| 12957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA80 |
0.331720130924412 |
|
| 12958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf119 |
0.331720130924412 |
|
| 12959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVA1C |
0.331720130924412 |
|
| 12960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA33|ENSG00000252045.1 |
0.331720130924412 |
|
| 12961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP490 |
0.331720130924412 |
|
| 12962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00846 |
0.331720130924412 |
|
| 12963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP10L |
0.331720130924412 |
|
| 12964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21ORF59 |
0.331720130924412 |
|
| 12965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf59 |
0.331720130924412 |
|
| 12966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNJ1 |
0.331720130924412 |
|
| 12967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAXBP1 |
0.331720130924412 |
|
| 12968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf49 |
0.331720130924412 |
|
| 12969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf62 |
0.331720130924412 |
|
| 12970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000207098.1 |
0.331720130924412 |
|
| 12971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLIG2 |
0.331720130924412 |
|
| 12972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00945 |
0.331720130924412 |
|
| 12973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLIG1 |
0.331720130924412 |
|
| 12974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf54 |
0.331720130924412 |
|
| 12975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNAR2 |
0.331720130924412 |
|
| 12976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL10RB |
0.331720130924412 |
|
| 12977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNAR1 |
0.331720130924412 |
|
| 12978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNGR2 |
0.331720130924412 |
|
| 12979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM50B |
0.331720130924412 |
|
| 12980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC28 |
0.331720130924412 |
|
| 12981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCAM |
0.331720130924412 |
|
| 12982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT3 |
0.331720130924412 |
|
| 12983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICOSLG |
0.331720130924412 |
|
| 12984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNMT3L |
0.331720130924412 |
|
| 12985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIRE |
0.331720130924412 |
|
| 12986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKL |
0.331720130924412 |
|
| 12987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf2 |
0.331720130924412 |
|
| 12988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM2 |
0.331720130924412 |
|
| 12989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA3 |
0.333924684476643 |
|
| 12990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC16 |
0.333924684476643 |
|
| 12991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAMP1 |
0.333924684476643 |
|
| 12992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4502 |
0.333924684476643 |
|
| 12993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AR |
0.333924684476643 |
|
| 12994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPF3A |
0.333924684476643 |
|
| 12995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUFY1 |
0.334688823174327 |
|
| 12996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPH1 |
0.334688823174327 |
|
| 12997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf60 |
0.334688823174327 |
|
| 12998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CANX |
0.334688823174327 |
|
| 12999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBY3 |
0.334688823174327 |
|
| 13000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB3P22 |
0.334688823174327 |
|
| 13001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAML1 |
0.334688823174327 |
|
| 13002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTC4S |
0.334688823174327 |
|
| 13003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT4B |
0.334688823174327 |
|
| 13004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1229 |
0.334688823174327 |
|
| 13005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SQSTM1 |
0.334688823174327 |
|
| 13006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf45 |
0.334688823174327 |
|
| 13007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP150 |
0.334688823174327 |
|
| 13008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D9B |
0.334688823174327 |
|
| 13009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF130 |
0.334688823174327 |
|
| 13010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR340 |
0.334688823174327 |
|
| 13011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGEF1C |
0.334688823174327 |
|
| 13012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK9 |
0.334688823174327 |
|
| 13013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFPT2 |
0.334688823174327 |
|
| 13014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT6 |
0.334688823174327 |
|
| 13015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB3A1 |
0.334688823174327 |
|
| 13016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLT4 |
0.334688823174327 |
|
| 13017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT1 |
0.334688823174327 |
|
| 13018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2Y1 |
0.334688823174327 |
|
| 13019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00847 |
0.334688823174327 |
|
| 13020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP62 |
0.334688823174327 |
|
| 13021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTNL8 |
0.334688823174327 |
|
| 13022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTNL3 |
0.334688823174327 |
|
| 13023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTNL9 |
0.334688823174327 |
|
| 13024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB2L1 |
0.334688823174327 |
|
| 13025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4638 |
0.334688823174327 |
|
| 13026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2V1 |
0.334688823174327 |
|
| 13027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2V2 |
0.334688823174327 |
|
| 13028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F3 |
0.334688823174327 |
|
| 13029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD95|ENSG00000264549.1 |
0.334688823174327 |
|
| 13030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD96A |
0.334688823174327 |
|
| 13031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM41 |
0.334688823174327 |
|
| 13032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM52 |
0.334688823174327 |
|
| 13033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM7 |
0.334688823174327 |
|
| 13034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC5 |
0.334916945604423 |
|
| 13035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF9 |
0.334916945604423 |
|
| 13036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM3 |
0.334916945604423 |
|
| 13037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR204 |
0.334916945604423 |
|
| 13038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM2 |
0.334916945604423 |
|
| 13039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD17B |
0.334916945604423 |
|
| 13040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf85 |
0.334916945604423 |
|
| 13041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf57 |
0.334916945604423 |
|
| 13042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDA |
0.334916945604423 |
|
| 13043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP285 |
0.334916945604423 |
|
| 13044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND5 |
0.334916945604423 |
|
| 13045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC1 |
0.334916945604423 |
|
| 13046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238402.1 |
0.334916945604423 |
|
| 13047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1A1 |
0.334916945604423 |
|
| 13048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA1 |
0.334916945604423 |
|
| 13049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP286 |
0.334916945604423 |
|
| 13050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RORB |
0.334916945604423 |
|
| 13051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM6 |
0.334916945604423 |
|
| 13052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP47 |
0.334916945604423 |
|
| 13053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P1 |
0.334916945604423 |
|
| 13054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf40 |
0.334916945604423 |
|
| 13055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf41 |
0.334916945604423 |
|
| 13056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMRK1 |
0.334916945604423 |
|
| 13057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSTF1 |
0.334916945604423 |
|
| 13058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238598.1 |
0.334916945604423 |
|
| 13059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK5 |
0.334916945604423 |
|
| 13060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFK |
0.334916945604423 |
|
| 13061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT1 |
0.334916945604423 |
|
| 13062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRUNE2 |
0.334916945604423 |
|
| 13063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCA3 |
0.334916945604423 |
|
| 13064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXB2 |
0.334916945604423 |
|
| 13065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS13A |
0.334916945604423 |
|
| 13066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNA14 |
0.334916945604423 |
|
| 13067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAQ |
0.334916945604423 |
|
| 13068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM222 |
0.33537336646787 |
|
| 13069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYTL1 |
0.33537336646787 |
|
| 13070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K6 |
0.33537336646787 |
|
| 13071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCN3 |
0.33537336646787 |
|
| 13072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD164L2 |
0.33537336646787 |
|
| 13073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA6 |
0.341478012490263 |
|
| 13074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGBL4 |
0.341478012490263 |
|
| 13075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND5 |
0.341478012490263 |
|
| 13076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239144.1 |
0.341478012490263 |
|
| 13077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAVL4 |
0.341478012490263 |
|
| 13078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTA2 |
0.341478012490263 |
|
| 13079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238618.1 |
0.341478012490263 |
|
| 13080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF11 |
0.341478012490263 |
|
| 13081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC39A |
0.341478012490263 |
|
| 13082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS15 |
0.341478012490263 |
|
| 13083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL9 |
0.341478012490263 |
|
| 13084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212624.1 |
0.341478012490263 |
|
| 13085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRD1 |
0.341478012490263 |
|
| 13086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRN2 |
0.34267173176808 |
|
| 13087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR595 |
0.34267173176808 |
|
| 13088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5707 |
0.34267173176808 |
|
| 13089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESYT2 |
0.34267173176808 |
|
| 13090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00689 |
0.34267173176808 |
|
| 13091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPG2 |
0.34267173176808 |
|
| 13092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIPR2 |
0.34267173176808 |
|
| 13093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR60 |
0.34267173176808 |
|
| 13094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf66 |
0.344496801668823 |
|
| 13095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD1 |
0.344496801668823 |
|
| 13096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK8 |
0.344496801668823 |
|
| 13097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138C |
0.344496801668823 |
|
| 13098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4 |
0.344496801668823 |
|
| 13099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANK1 |
0.344496801668823 |
|
| 13100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL412P |
0.344496801668823 |
|
| 13101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKMY1 |
0.348898664440899 |
|
| 13102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP28 |
0.348898664440899 |
|
| 13103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNPEPL1 |
0.348898664440899 |
|
| 13104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN10 |
0.348898664440899 |
|
| 13105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR35 |
0.348898664440899 |
|
| 13106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP12A |
0.348898664440899 |
|
| 13107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP12B |
0.348898664440899 |
|
| 13108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF1A |
0.348898664440899 |
|
| 13109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGXT |
0.348898664440899 |
|
| 13110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf54 |
0.348898664440899 |
|
| 13111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNED1 |
0.348898664440899 |
|
| 13112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTERFD2 |
0.348898664440899 |
|
| 13113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PASK |
0.348898664440899 |
|
| 13114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R7 |
0.348898664440899 |
|
| 13115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO7 |
0.348898664440899 |
|
| 13116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDLBP |
0.348898664440899 |
|
| 13117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT2 |
0.348898664440899 |
|
| 13118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FARP2 |
0.348898664440899 |
|
| 13119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3133 |
0.348898664440899 |
|
| 13120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK25 |
0.348898664440899 |
|
| 13121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG4B |
0.348898664440899 |
|
| 13122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOK |
0.348898664440899 |
|
| 13123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXXC11 |
0.348898664440899 |
|
| 13124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
D2HGDH |
0.348898664440899 |
|
| 13125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTYMK |
0.348898664440899 |
|
| 13126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAL3ST2 |
0.348898664440899 |
|
| 13127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ING5 |
0.348898664440899 |
|
| 13128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEU4 |
0.348898664440899 |
|
| 13129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD1 |
0.348898664440899 |
|
| 13130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP122 |
0.348898664440899 |
|
| 13131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP4 |
0.348898664440899 |
|
| 13132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F7 |
0.349395841629709 |
|
| 13133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F10 |
0.349395841629709 |
|
| 13134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROZ |
0.349395841629709 |
|
| 13135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCID2 |
0.349395841629709 |
|
| 13136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMSN1 |
0.353457007989093 |
|
| 13137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRIP1 |
0.353457007989093 |
|
| 13138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP25 |
0.353457007989093 |
|
| 13139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238591.1 |
0.353457007989093 |
|
| 13140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00478 |
0.353457007989093 |
|
| 13141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf37 |
0.353457007989093 |
|
| 13142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL163P |
0.353457007989093 |
|
| 13143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXADR |
0.353457007989093 |
|
| 13144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTG3 |
0.353457007989093 |
|
| 13145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf91 |
0.353457007989093 |
|
| 13146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHODL |
0.353457007989093 |
|
| 13147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS15 |
0.353457007989093 |
|
| 13148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548X |
0.353457007989093 |
|
| 13149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKI |
0.355093934029276 |
|
| 13150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB3L2 |
0.355093934029276 |
|
| 13151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR1D1 |
0.355093934029276 |
|
| 13152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP223 |
0.355093934029276 |
|
| 13153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239145.1 |
0.355093934029276 |
|
| 13154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4468 |
0.355093934029276 |
|
| 13155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000201465.1 |
0.355093934029276 |
|
| 13156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238984.1 |
0.355093934029276 |
|
| 13157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM24 |
0.355093934029276 |
|
| 13158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239123.1 |
0.355093934029276 |
|
| 13159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVOPL |
0.355093934029276 |
|
| 13160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252188.1 |
0.355093934029276 |
|
| 13161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0A4 |
0.355093934029276 |
|
| 13162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM213 |
0.355093934029276 |
|
| 13163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1549 |
0.355093934029276 |
|
| 13164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3HAV1L |
0.355093934029276 |
|
| 13165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3HAV1 |
0.355093934029276 |
|
| 13166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC26 |
0.355093934029276 |
|
| 13167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBN2 |
0.355093934029276 |
|
| 13168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf55 |
0.355093934029276 |
|
| 13169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUC7L2 |
0.355093934029276 |
|
| 13170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRG2 |
0.355093934029276 |
|
| 13171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC2L |
0.355093934029276 |
|
| 13172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIPK2 |
0.355093934029276 |
|
| 13173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBXAS1 |
0.355093934029276 |
|
| 13174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP12 |
0.355093934029276 |
|
| 13175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JHDM1D |
0.355093934029276 |
|
| 13176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP6 |
0.357973622583703 |
|
| 13177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAXIP1 |
0.357973622583703 |
|
| 13178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR5A |
0.357973622583703 |
|
| 13179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP280 |
0.357973622583703 |
|
| 13180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSIG1 |
0.357973622583703 |
|
| 13181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLACE |
0.357973622583703 |
|
| 13182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EN2 |
0.357973622583703 |
|
| 13183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNPY1 |
0.357973622583703 |
|
| 13184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR4 |
0.360084726389901 |
|
| 13185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC1 |
0.360084726389901 |
|
| 13186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRTO4 |
0.360084726389901 |
|
| 13187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR7A3 |
0.360084726389901 |
|
| 13188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR7L |
0.360084726389901 |
|
| 13189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKR7A2 |
0.360084726389901 |
|
| 13190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PQLC2 |
0.360084726389901 |
|
| 13191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL85P |
0.360084726389901 |
|
| 13192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPZB |
0.360084726389901 |
|
| 13193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL277P |
0.360084726389901 |
|
| 13194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239027.1 |
0.360084726389901 |
|
| 13195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MINOS1 |
0.360084726389901 |
|
| 13196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBL1 |
0.360084726389901 |
|
| 13197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR6 |
0.360084726389901 |
|
| 13198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO4 |
0.360084726389901 |
|
| 13199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF186 |
0.360084726389901 |
|
| 13200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD3 |
0.360084726389901 |
|
| 13201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G2E |
0.360084726389901 |
|
| 13202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G2A |
0.360084726389901 |
|
| 13203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL304P |
0.360084726389901 |
|
| 13204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G5 |
0.360084726389901 |
|
| 13205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G2D |
0.360084726389901 |
|
| 13206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G2F |
0.360084726389901 |
|
| 13207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G2C |
0.360084726389901 |
|
| 13208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN10 |
0.360084726389901 |
|
| 13209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA5B1 |
0.360084726389901 |
|
| 13210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2N1 |
0.360084726389901 |
|
| 13211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUL1 |
0.360084726389901 |
|
| 13212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM43B |
0.360084726389901 |
|
| 13213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDA |
0.360084726389901 |
|
| 13214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PINK1 |
0.360084726389901 |
|
| 13215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDOST |
0.360084726389901 |
|
| 13216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF17 |
0.360084726389901 |
|
| 13217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D5 |
0.360084726389901 |
|
| 13218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HP1BP3 |
0.360084726389901 |
|
| 13219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4G3 |
0.360084726389901 |
|
| 13220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1256 |
0.360084726389901 |
|
| 13221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECE1 |
0.360084726389901 |
|
| 13222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF3 |
0.360084726389901 |
|
| 13223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPL |
0.360084726389901 |
|
| 13224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP1GAP |
0.360084726389901 |
|
| 13225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP48 |
0.360084726389901 |
|
| 13226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLRAD2 |
0.360084726389901 |
|
| 13227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPG2 |
0.360084726389901 |
|
| 13228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42 |
0.360084726389901 |
|
| 13229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELA3A |
0.360084726389901 |
|
| 13230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELA3B |
0.360084726389901 |
|
| 13231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00339 |
0.360084726389901 |
|
| 13232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL186P |
0.360084726389901 |
|
| 13233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL386P |
0.360084726389901 |
|
| 13234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL421P |
0.360084726389901 |
|
| 13235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL768P |
0.360084726389901 |
|
| 13236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT4 |
0.360084726389901 |
|
| 13237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4418 |
0.360084726389901 |
|
| 13238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB40 |
0.360084726389901 |
|
| 13239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA8 |
0.360084726389901 |
|
| 13240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QC |
0.360084726389901 |
|
| 13241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QB |
0.360084726389901 |
|
| 13242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHB2 |
0.360084726389901 |
|
| 13243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4684 |
0.360084726389901 |
|
| 13244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A7 |
0.365538957453401 |
|
| 13245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM209 |
0.367823768405641 |
|
| 13246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSMEM1 |
0.367823768405641 |
|
| 13247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA2 |
0.367823768405641 |
|
| 13248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA4 |
0.367823768405641 |
|
| 13249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238336.1 |
0.367823768405641 |
|
| 13250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239044.1 |
0.367823768405641 |
|
| 13251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA5 |
0.367823768405641 |
|
| 13252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA1 |
0.367823768405641 |
|
| 13253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP41 |
0.367823768405641 |
|
| 13254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEST |
0.367823768405641 |
|
| 13255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR335 |
0.367823768405641 |
|
| 13256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPG2 |
0.367823768405641 |
|
| 13257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP246 |
0.367823768405641 |
|
| 13258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSGA13 |
0.367823768405641 |
|
| 13259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF14 |
0.367823768405641 |
|
| 13260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR29A |
0.367823768405641 |
|
| 13261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR29B1 |
0.367823768405641 |
|
| 13262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKLN1 |
0.367823768405641 |
|
| 13263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PODXL |
0.367823768405641 |
|
| 13264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCA2 |
0.368350411631102 |
|
| 13265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL592P |
0.368350411631102 |
|
| 13266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VLDLR |
0.368350411631102 |
|
| 13267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNV2 |
0.368350411631102 |
|
| 13268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0020 |
0.368350411631102 |
|
| 13269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARM1P1 |
0.368350411631102 |
|
| 13270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX3 |
0.368350411631102 |
|
| 13271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIS3 |
0.368350411631102 |
|
| 13272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A1 |
0.368350411631102 |
|
| 13273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA6L |
0.368350411631102 |
|
| 13274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAPDC2 |
0.368350411631102 |
|
| 13275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC37L1 |
0.368350411631102 |
|
| 13276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AK3 |
0.368350411631102 |
|
| 13277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCL1 |
0.368350411631102 |
|
| 13278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAK2 |
0.368350411631102 |
|
| 13279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSL4 |
0.368350411631102 |
|
| 13280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSL6 |
0.368350411631102 |
|
| 13281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLN2 |
0.368350411631102 |
|
| 13282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLN1 |
0.368350411631102 |
|
| 13283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLGRKT |
0.368350411631102 |
|
| 13284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD274 |
0.368350411631102 |
|
| 13285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD1LG2 |
0.368350411631102 |
|
| 13286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1432 |
0.368350411631102 |
|
| 13287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERMP1 |
0.368350411631102 |
|
| 13288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA2026 |
0.368350411631102 |
|
| 13289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLANA |
0.368350411631102 |
|
| 13290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238654.1 |
0.368350411631102 |
|
| 13291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4665 |
0.368350411631102 |
|
| 13292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP6 |
0.368350411631102 |
|
| 13293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCL2 |
0.369164307403994 |
|
| 13294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf21 |
0.369164307403994 |
|
| 13295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN32 |
0.369164307403994 |
|
| 13296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL26P30 |
0.369164307403994 |
|
| 13297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD81 |
0.369164307403994 |
|
| 13298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM5 |
0.369164307403994 |
|
| 13299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSC4 |
0.369164307403994 |
|
| 13300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNQ1DN |
0.369164307403994 |
|
| 13301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN1C |
0.369164307403994 |
|
| 13302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A18AS |
0.369164307403994 |
|
| 13303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A18 |
0.369164307403994 |
|
| 13304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDA2 |
0.369164307403994 |
|
| 13305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L4 |
0.369164307403994 |
|
| 13306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA54 |
0.369164307403994 |
|
| 13307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARS |
0.369164307403994 |
|
| 13308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL5 |
0.369164307403994 |
|
| 13309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRE |
0.369164307403994 |
|
| 13310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRG |
0.369164307403994 |
|
| 13311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF195 |
0.369164307403994 |
|
| 13312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSC2 |
0.369164307403994 |
|
| 13313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC2 |
0.369164307403994 |
|
| 13314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ART1 |
0.369164307403994 |
|
| 13315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ART5 |
0.369164307403994 |
|
| 13316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA10 |
0.369164307403994 |
|
| 13317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP98 |
0.369164307403994 |
|
| 13318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238686.1 |
0.369164307403994 |
|
| 13319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAP2 |
0.369164307403994 |
|
| 13320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOG |
0.369164307403994 |
|
| 13321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4687 |
0.369164307403994 |
|
| 13322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STIM1 |
0.369164307403994 |
|
| 13323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7|ENSG00000206976.1 |
0.369164307403994 |
|
| 13324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRM1 |
0.369164307403994 |
|
| 13325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52B4 |
0.369164307403994 |
|
| 13326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM21 |
0.369164307403994 |
|
| 13327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52K2 |
0.369164307403994 |
|
| 13328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52K1 |
0.369164307403994 |
|
| 13329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52M1 |
0.369164307403994 |
|
| 13330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf40 |
0.369164307403994 |
|
| 13331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52I2 |
0.369164307403994 |
|
| 13332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52I1 |
0.369164307403994 |
|
| 13333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM68 |
0.369164307403994 |
|
| 13334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51D1 |
0.369164307403994 |
|
| 13335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51E1 |
0.369164307403994 |
|
| 13336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51E2 |
0.369164307403994 |
|
| 13337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51C1P |
0.369164307403994 |
|
| 13338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP26 |
0.369164307403994 |
|
| 13339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000201980.1 |
0.369164307403994 |
|
| 13340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51F1 |
0.369164307403994 |
|
| 13341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52R1 |
0.369164307403994 |
|
| 13342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51F2 |
0.369164307403994 |
|
| 13343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51S1 |
0.369164307403994 |
|
| 13344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51H1P |
0.369164307403994 |
|
| 13345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51T1 |
0.369164307403994 |
|
| 13346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51A7 |
0.369164307403994 |
|
| 13347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51G2 |
0.369164307403994 |
|
| 13348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51G1 |
0.369164307403994 |
|
| 13349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51A2 |
0.369164307403994 |
|
| 13350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51A4 |
0.369164307403994 |
|
| 13351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51L1 |
0.369164307403994 |
|
| 13352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52J3 |
0.369164307403994 |
|
| 13353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52E2 |
0.369164307403994 |
|
| 13354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52A4 |
0.369164307403994 |
|
| 13355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52A5 |
0.369164307403994 |
|
| 13356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52A1 |
0.369164307403994 |
|
| 13357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51V1 |
0.369164307403994 |
|
| 13358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBB |
0.369164307403994 |
|
| 13359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBD |
0.369164307403994 |
|
| 13360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBBP1 |
0.369164307403994 |
|
| 13361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBG1 |
0.369164307403994 |
|
| 13362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBG2 |
0.369164307403994 |
|
| 13363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBE1 |
0.369164307403994 |
|
| 13364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51B4 |
0.369164307403994 |
|
| 13365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51B2 |
0.369164307403994 |
|
| 13366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51B5 |
0.369164307403994 |
|
| 13367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51B6 |
0.369164307403994 |
|
| 13368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51M1 |
0.369164307403994 |
|
| 13369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51J1 |
0.369164307403994 |
|
| 13370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51Q1 |
0.369164307403994 |
|
| 13371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51I1 |
0.369164307403994 |
|
| 13372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR51I2 |
0.369164307403994 |
|
| 13373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52D1 |
0.369164307403994 |
|
| 13374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBQLN3 |
0.369164307403994 |
|
| 13375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBQLNL |
0.369164307403994 |
|
| 13376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52H1 |
0.369164307403994 |
|
| 13377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52B6 |
0.369164307403994 |
|
| 13378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM6 |
0.369164307403994 |
|
| 13379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM34 |
0.369164307403994 |
|
| 13380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM5 |
0.369164307403994 |
|
| 13381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM22 |
0.369164307403994 |
|
| 13382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR56B1 |
0.369164307403994 |
|
| 13383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52N4 |
0.369164307403994 |
|
| 13384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52N1 |
0.369164307403994 |
|
| 13385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52N5 |
0.369164307403994 |
|
| 13386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52N2 |
0.369164307403994 |
|
| 13387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52E6 |
0.369164307403994 |
|
| 13388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52E4 |
0.369164307403994 |
|
| 13389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52E8 |
0.369164307403994 |
|
| 13390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR56A3 |
0.369164307403994 |
|
| 13391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52L1 |
0.369164307403994 |
|
| 13392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR56A1 |
0.369164307403994 |
|
| 13393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR56A4 |
0.369164307403994 |
|
| 13394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR56B4 |
0.369164307403994 |
|
| 13395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP329 |
0.369164307403994 |
|
| 13396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52B2 |
0.369164307403994 |
|
| 13397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR52W1 |
0.369164307403994 |
|
| 13398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf42 |
0.369164307403994 |
|
| 13399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM160A2 |
0.369164307403994 |
|
| 13400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGA4 |
0.369164307403994 |
|
| 13401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCKBR |
0.369164307403994 |
|
| 13402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCDBP |
0.369164307403994 |
|
| 13403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBB1 |
0.369164307403994 |
|
| 13404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPD1 |
0.369164307403994 |
|
| 13405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPX |
0.369164307403994 |
|
| 13406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM3 |
0.369164307403994 |
|
| 13407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFIP2 |
0.369164307403994 |
|
| 13408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM10B |
0.369164307403994 |
|
| 13409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNHD1 |
0.369164307403994 |
|
| 13410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP8 |
0.369164307403994 |
|
| 13411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILK |
0.369164307403994 |
|
| 13412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF10 |
0.369164307403994 |
|
| 13413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPP1 |
0.369164307403994 |
|
| 13414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCHS1 |
0.369164307403994 |
|
| 13415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL17 |
0.369164307403994 |
|
| 13416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GVINP1 |
0.369164307403994 |
|
| 13417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AG2 |
0.369164307403994 |
|
| 13418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AG1 |
0.369164307403994 |
|
| 13419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6A2 |
0.369164307403994 |
|
| 13420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A5 |
0.369164307403994 |
|
| 13421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A2 |
0.369164307403994 |
|
| 13422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A4 |
0.369164307403994 |
|
| 13423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2D2 |
0.369164307403994 |
|
| 13424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2D3 |
0.369164307403994 |
|
| 13425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF215 |
0.369164307403994 |
|
| 13426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF214 |
0.369164307403994 |
|
| 13427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP14 |
0.369164307403994 |
|
| 13428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMXL2 |
0.369164307403994 |
|
| 13429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR302E |
0.369164307403994 |
|
| 13430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT9 |
0.369164307403994 |
|
| 13431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFML1 |
0.369164307403994 |
|
| 13432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIBP2 |
0.369164307403994 |
|
| 13433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5R2 |
0.369164307403994 |
|
| 13434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVCH2 |
0.369164307403994 |
|
| 13435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10AB1P |
0.369164307403994 |
|
| 13436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5P2 |
0.369164307403994 |
|
| 13437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5P3 |
0.369164307403994 |
|
| 13438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A6 |
0.369164307403994 |
|
| 13439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A3 |
0.369164307403994 |
|
| 13440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP10 |
0.369164307403994 |
|
| 13441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3F |
0.369164307403994 |
|
| 13442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUB |
0.369164307403994 |
|
| 13443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIC3 |
0.369164307403994 |
|
| 13444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA7 |
0.370785769722008 |
|
| 13445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBGCP3 |
0.370785769722008 |
|
| 13446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C13orf35 |
0.370785769722008 |
|
| 13447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP11A |
0.370785769722008 |
|
| 13448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCF2L |
0.370785769722008 |
|
| 13449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL283P |
0.374458190796361 |
|
| 13450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A1 |
0.375151376985357 |
|
| 13451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A2 |
0.375151376985357 |
|
| 13452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A3 |
0.375151376985357 |
|
| 13453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A4 |
0.375151376985357 |
|
| 13454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD3 |
0.375151376985357 |
|
| 13455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD5 |
0.375151376985357 |
|
| 13456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD6 |
0.375151376985357 |
|
| 13457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD7 |
0.375151376985357 |
|
| 13458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP3B |
0.375151376985357 |
|
| 13459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP3 |
0.375151376985357 |
|
| 13460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27A |
0.375151376985357 |
|
| 13461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27B |
0.375151376985357 |
|
| 13462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27C |
0.375151376985357 |
|
| 13463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27D1 |
0.375151376985357 |
|
| 13464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27E1 |
0.375151376985357 |
|
| 13465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27E2 |
0.375151376985357 |
|
| 13466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM27E3 |
0.375151376985357 |
|
| 13467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A1 |
0.375151376985357 |
|
| 13468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A2 |
0.375151376985357 |
|
| 13469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A3 |
0.375151376985357 |
|
| 13470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A4 |
0.375151376985357 |
|
| 13471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A5 |
0.375151376985357 |
|
| 13472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM74A6 |
0.375151376985357 |
|
| 13473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM95B1 |
0.375151376985357 |
|
| 13474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L2 |
0.375151376985357 |
|
| 13475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L3 |
0.375151376985357 |
|
| 13476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L4 |
0.375151376985357 |
|
| 13477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L5 |
0.375151376985357 |
|
| 13478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L6 |
0.375151376985357 |
|
| 13479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1299 |
0.375151376985357 |
|
| 13480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4477A |
0.375151376985357 |
|
| 13481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM5P2 |
0.375151376985357 |
|
| 13482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGM5 |
0.375151376985357 |
|
| 13483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL343P |
0.375151376985357 |
|
| 13484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL422P |
0.375151376985357 |
|
| 13485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL462P |
0.375151376985357 |
|
| 13486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL544P |
0.375151376985357 |
|
| 13487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL565P |
0.375151376985357 |
|
| 13488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL640P |
0.375151376985357 |
|
| 13489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL722P |
0.375151376985357 |
|
| 13490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL763P |
0.375151376985357 |
|
| 13491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL787P |
0.375151376985357 |
|
| 13492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP283 |
0.375151376985357 |
|
| 13493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP284 |
0.375151376985357 |
|
| 13494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252133.1 |
0.375151376985357 |
|
| 13495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252617.1 |
0.375151376985357 |
|
| 13496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252724.1 |
0.375151376985357 |
|
| 13497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252878.1 |
0.375151376985357 |
|
| 13498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A1 |
0.375151376985357 |
|
| 13499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A2 |
0.375151376985357 |
|
| 13500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A3 |
0.375151376985357 |
|
| 13501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A4 |
0.375151376985357 |
|
| 13502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A5 |
0.375151376985357 |
|
| 13503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A6 |
0.375151376985357 |
|
| 13504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA31A7 |
0.375151376985357 |
|
| 13505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF658 |
0.375151376985357 |
|
| 13506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM252 |
0.375151376985357 |
|
| 13507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP5K1B |
0.375151376985357 |
|
| 13508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM122A |
0.375151376985357 |
|
| 13509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKACG |
0.375151376985357 |
|
| 13510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FXN |
0.375151376985357 |
|
| 13511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TJP2 |
0.375151376985357 |
|
| 13512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM189A2 |
0.375151376985357 |
|
| 13513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBA1 |
0.375151376985357 |
|
| 13514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTAR1 |
0.375151376985357 |
|
| 13515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf135 |
0.375151376985357 |
|
| 13516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL570P |
0.375151376985357 |
|
| 13517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAMDC2 |
0.375151376985357 |
|
| 13518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0226L |
0.379491644692183 |
|
| 13519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRCH1 |
0.379491644692183 |
|
| 13520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESD |
0.379491644692183 |
|
| 13521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR2A |
0.379491644692183 |
|
| 13522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL700P |
0.379491644692183 |
|
| 13523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00444 |
0.379491644692183 |
|
| 13524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00562 |
0.379491644692183 |
|
| 13525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUCLA2 |
0.379491644692183 |
|
| 13526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT15 |
0.379491644692183 |
|
| 13527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED4 |
0.379491644692183 |
|
| 13528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITM2B |
0.379491644692183 |
|
| 13529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC3A |
0.379491644692183 |
|
| 13530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P2 |
0.379491644692183 |
|
| 13531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLNR |
0.379491644692183 |
|
| 13532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDADC1 |
0.379491644692183 |
|
| 13533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAB39L |
0.379491644692183 |
|
| 13534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETDB2 |
0.379491644692183 |
|
| 13535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF11 |
0.379491644692183 |
|
| 13536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCBTB1 |
0.379491644692183 |
|
| 13537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL11 |
0.379491644692183 |
|
| 13538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBPL |
0.379491644692183 |
|
| 13539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA3 |
0.379491644692183 |
|
| 13540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P30 |
0.379491644692183 |
|
| 13541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P9 |
0.379491644692183 |
|
| 13542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRYD7 |
0.379491644692183 |
|
| 13543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLEU1 |
0.379491644692183 |
|
| 13544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLEU2 |
0.379491644692183 |
|
| 13545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLEU7 |
0.379491644692183 |
|
| 13546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY1B2 |
0.379491644692183 |
|
| 13547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNRG |
0.379491644692183 |
|
| 13548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3613 |
0.379491644692183 |
|
| 13549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP28 |
0.379491644692183 |
|
| 13550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP29 |
0.379491644692183 |
|
| 13551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEH2B |
0.379491644692183 |
|
| 13552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM13 |
0.379491644692183 |
|
| 13553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00371 |
0.379491644692183 |
|
| 13554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM124A |
0.379491644692183 |
|
| 13555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINE3 |
0.379491644692183 |
|
| 13556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5693 |
0.379491644692183 |
|
| 13557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS6 |
0.379491644692183 |
|
| 13558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS4XP16 |
0.379491644692183 |
|
| 13559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL320P |
0.379491644692183 |
|
| 13560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4703 |
0.379491644692183 |
|
| 13561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P6 |
0.379491644692183 |
|
| 13562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDFY2 |
0.379491644692183 |
|
| 13563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL413P |
0.379491644692183 |
|
| 13564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS12 |
0.379491644692183 |
|
| 13565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC70 |
0.379491644692183 |
|
| 13566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP7B |
0.379491644692183 |
|
| 13567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG11 |
0.379491644692183 |
|
| 13568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP14C |
0.379491644692183 |
|
| 13569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK5 |
0.379491644692183 |
|
| 13570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK3 |
0.379491644692183 |
|
| 13571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THSD1 |
0.379491644692183 |
|
| 13572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P24 |
0.379491644692183 |
|
| 13573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS36 |
0.379491644692183 |
|
| 13574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKAP2 |
0.379491644692183 |
|
| 13575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00345 |
0.379491644692183 |
|
| 13576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA1L2 |
0.379491644692183 |
|
| 13577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUGT1 |
0.379491644692183 |
|
| 13578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LECT1 |
0.379491644692183 |
|
| 13579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR759 |
0.379491644692183 |
|
| 13580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH8 |
0.379491644692183 |
|
| 13581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL618P |
0.379491644692183 |
|
| 13582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00558 |
0.379491644692183 |
|
| 13583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00458 |
0.379491644692183 |
|
| 13584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5007 |
0.379491644692183 |
|
| 13585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238455.1 |
0.379491644692183 |
|
| 13586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP6 |
0.379491644692183 |
|
| 13587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR20A |
0.379491644692183 |
|
| 13588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR20B |
0.379491644692183 |
|
| 13589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR20C |
0.379491644692183 |
|
| 13590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR20D |
0.379491644692183 |
|
| 13591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR20E |
0.379491644692183 |
|
| 13592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH17 |
0.379491644692183 |
|
| 13593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP30 |
0.379491644692183 |
|
| 13594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P29 |
0.379491644692183 |
|
| 13595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIAPH3 |
0.379491644692183 |
|
| 13596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL375P |
0.379491644692183 |
|
| 13597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P28 |
0.379491644692183 |
|
| 13598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00434 |
0.379491644692183 |
|
| 13599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD3 |
0.379491644692183 |
|
| 13600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP31 |
0.379491644692183 |
|
| 13601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00378 |
0.379491644692183 |
|
| 13602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P5 |
0.379491644692183 |
|
| 13603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P31 |
0.379491644692183 |
|
| 13604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3169 |
0.379491644692183 |
|
| 13605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH20 |
0.379491644692183 |
|
| 13606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00459 |
0.379491644692183 |
|
| 13607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00448 |
0.379491644692183 |
|
| 13608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00355 |
0.379491644692183 |
|
| 13609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548X2 |
0.379491644692183 |
|
| 13610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4704 |
0.379491644692183 |
|
| 13611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH9 |
0.379491644692183 |
|
| 13612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00364 |
0.379491644692183 |
|
| 13613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL761P |
0.379491644692183 |
|
| 13614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL1 |
0.379491644692183 |
|
| 13615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P10 |
0.379491644692183 |
|
| 13616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN8OS |
0.379491644692183 |
|
| 13617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00348 |
0.379491644692183 |
|
| 13618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DACH1 |
0.379491644692183 |
|
| 13619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP32 |
0.379491644692183 |
|
| 13620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD37|ENSG00000212377.1 |
0.379491644692183 |
|
| 13621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000251715.1 |
0.379491644692183 |
|
| 13622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA9|ENSG00000199282.1 |
0.379491644692183 |
|
| 13623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MZT1 |
0.379491644692183 |
|
| 13624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BORA |
0.379491644692183 |
|
| 13625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIS3 |
0.379491644692183 |
|
| 13626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIBF1 |
0.379491644692183 |
|
| 13627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF5 |
0.379491644692183 |
|
| 13628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P8 |
0.379491644692183 |
|
| 13629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00393 |
0.379491644692183 |
|
| 13630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00392 |
0.379491644692183 |
|
| 13631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF12 |
0.379491644692183 |
|
| 13632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00402 |
0.379491644692183 |
|
| 13633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P5 |
0.379491644692183 |
|
| 13634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00381 |
0.379491644692183 |
|
| 13635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00347 |
0.379491644692183 |
|
| 13636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D4 |
0.379491644692183 |
|
| 13637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD6 |
0.379491644692183 |
|
| 13638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCHL3 |
0.379491644692183 |
|
| 13639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMO7 |
0.379491644692183 |
|
| 13640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C13orf45 |
0.379491644692183 |
|
| 13641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00561 |
0.379491644692183 |
|
| 13642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL571P |
0.379491644692183 |
|
| 13643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD12 |
0.379491644692183 |
|
| 13644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRG1 |
0.379491644692183 |
|
| 13645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLN5 |
0.379491644692183 |
|
| 13646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL3 |
0.379491644692183 |
|
| 13647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCBP2 |
0.379491644692183 |
|
| 13648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCEL |
0.379491644692183 |
|
| 13649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P7 |
0.379491644692183 |
|
| 13650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3665 |
0.379491644692183 |
|
| 13651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLAIN1 |
0.379491644692183 |
|
| 13652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDNRB |
0.379491644692183 |
|
| 13653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL810P |
0.379491644692183 |
|
| 13654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00446 |
0.379491644692183 |
|
| 13655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P3 |
0.379491644692183 |
|
| 13656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU4F1 |
0.379491644692183 |
|
| 13657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF219 |
0.379491644692183 |
|
| 13658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00331 |
0.379491644692183 |
|
| 13659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM26 |
0.379491644692183 |
|
| 13660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP33 |
0.379491644692183 |
|
| 13661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDFIP2 |
0.379491644692183 |
|
| 13662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRY2 |
0.379491644692183 |
|
| 13663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00564 |
0.379491644692183 |
|
| 13664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTMAP5 |
0.379491644692183 |
|
| 13665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK1 |
0.379491644692183 |
|
| 13666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121 |
0.380022690556597 |
|
| 13667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2IRD2P1 |
0.380022690556597 |
|
| 13668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCF1B |
0.380022690556597 |
|
| 13669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN5P2 |
0.380022690556597 |
|
| 13670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN5 |
0.380022690556597 |
|
| 13671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3L3 |
0.380022690556597 |
|
| 13672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM50 |
0.380022690556597 |
|
| 13673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM74 |
0.380022690556597 |
|
| 13674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP6 |
0.380022690556597 |
|
| 13675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD9 |
0.380022690556597 |
|
| 13676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAZ1B |
0.380022690556597 |
|
| 13677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL7B |
0.380022690556597 |
|
| 13678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBL2 |
0.380022690556597 |
|
| 13679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLXIPL |
0.380022690556597 |
|
| 13680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS37D |
0.380022690556597 |
|
| 13681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC30 |
0.380022690556597 |
|
| 13682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBSCR22 |
0.380022690556597 |
|
| 13683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX1A |
0.380022690556597 |
|
| 13684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4284 |
0.380022690556597 |
|
| 13685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD11 |
0.380022690556597 |
|
| 13686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00035 |
0.380022690556597 |
|
| 13687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL265P |
0.380022690556597 |
|
| 13688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN3 |
0.380022690556597 |
|
| 13689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN4 |
0.380022690556597 |
|
| 13690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBSCR27 |
0.380022690556597 |
|
| 13691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBSCR28 |
0.380022690556597 |
|
| 13692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELN |
0.380022690556597 |
|
| 13693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMK1 |
0.380022690556597 |
|
| 13694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4H |
0.380022690556597 |
|
| 13695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR590 |
0.380022690556597 |
|
| 13696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAT2 |
0.380022690556597 |
|
| 13697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFC2 |
0.380022690556597 |
|
| 13698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIP2 |
0.380022690556597 |
|
| 13699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HJURP |
0.381825312013829 |
|
| 13700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSL3P1 |
0.381825312013829 |
|
| 13701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM8 |
0.381825312013829 |
|
| 13702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPP2 |
0.381825312013829 |
|
| 13703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL4C |
0.381825312013829 |
|
| 13704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BP4 |
0.381825312013829 |
|
| 13705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP1 |
0.381825312013829 |
|
| 13706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT8L2 |
0.384939507502376 |
|
| 13707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSFY1P1 |
0.384939507502376 |
|
| 13708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMB3P1 |
0.384939507502376 |
|
| 13709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR11H1 |
0.384939507502376 |
|
| 13710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEH |
0.384939507502376 |
|
| 13711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTEP1 |
0.384939507502376 |
|
| 13712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR3 |
0.384939507502376 |
|
| 13713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAB4 |
0.384939507502376 |
|
| 13714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR7 |
0.384939507502376 |
|
| 13715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17RA |
0.384939507502376 |
|
| 13716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR6 |
0.384939507502376 |
|
| 13717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR5 |
0.384939507502376 |
|
| 13718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR1 |
0.384939507502376 |
|
| 13719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR3 |
0.384939507502376 |
|
| 13720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR9 |
0.384939507502376 |
|
| 13721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL843P |
0.384939507502376 |
|
| 13722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CECR2 |
0.384939507502376 |
|
| 13723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A18 |
0.384939507502376 |
|
| 13724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1E1 |
0.384939507502376 |
|
| 13725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L13 |
0.384939507502376 |
|
| 13726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251737.1 |
0.384939507502376 |
|
| 13727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BID |
0.384939507502376 |
|
| 13728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00528 |
0.384939507502376 |
|
| 13729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICAL3 |
0.384939507502376 |
|
| 13730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR648 |
0.384939507502376 |
|
| 13731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf95 |
0.384942631115593 |
|
| 13732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL596P |
0.384942631115593 |
|
| 13733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf84 |
0.384942631115593 |
|
| 13734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARK2 |
0.384942631115593 |
|
| 13735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCOR2 |
0.384942631115593 |
|
| 13736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA40 |
0.384942631115593 |
|
| 13737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX8A |
0.384942631115593 |
|
| 13738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUB1 |
0.384942631115593 |
|
| 13739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MACROD1 |
0.384942631115593 |
|
| 13740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLRT1 |
0.384942631115593 |
|
| 13741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STIP1 |
0.384942631115593 |
|
| 13742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FERMT3 |
0.384942631115593 |
|
| 13743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPT1 |
0.384942631115593 |
|
| 13744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT22 |
0.384942631115593 |
|
| 13745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC4 |
0.384942631115593 |
|
| 13746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEGFB |
0.384942631115593 |
|
| 13747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP2 |
0.384942631115593 |
|
| 13748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCB3 |
0.384942631115593 |
|
| 13749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R14B |
0.384942631115593 |
|
| 13750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAD |
0.384942631115593 |
|
| 13751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR137 |
0.384942631115593 |
|
| 13752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK4 |
0.384942631115593 |
|
| 13753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX40 |
0.384942631115593 |
|
| 13754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRRA |
0.384942631115593 |
|
| 13755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX5 |
0.384942631115593 |
|
| 13756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT112 |
0.384942631115593 |
|
| 13757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN1 |
0.385164760690509 |
|
| 13758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZRN4 |
0.385164760690509 |
|
| 13759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP360 |
0.385164760690509 |
|
| 13760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GXYLT1 |
0.385164760690509 |
|
| 13761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YAF2 |
0.385164760690509 |
|
| 13762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPHLN1 |
0.385164760690509 |
|
| 13763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL10P |
0.385164760690509 |
|
| 13764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCRB1 |
0.385164760690509 |
|
| 13765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000252917.1 |
0.385164760690509 |
|
| 13766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRICKLE1 |
0.385164760690509 |
|
| 13767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1G3 |
0.389091095806534 |
|
| 13768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF608 |
0.389091095806534 |
|
| 13769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP117 |
0.389091095806534 |
|
| 13770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD3 |
0.389091095806534 |
|
| 13771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH7A1 |
0.389091095806534 |
|
| 13772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHAX |
0.389091095806534 |
|
| 13773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf48 |
0.389091095806534 |
|
| 13774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMNB1 |
0.389091095806534 |
|
| 13775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH3 |
0.389091095806534 |
|
| 13776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf63 |
0.389091095806534 |
|
| 13777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGF10 |
0.389091095806534 |
|
| 13778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRC1 |
0.389091095806534 |
|
| 13779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTXN3 |
0.389091095806534 |
|
| 13780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A2 |
0.389091095806534 |
|
| 13781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBN2 |
0.389091095806534 |
|
| 13782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A6 |
0.389091095806534 |
|
| 13783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISOC1 |
0.389091095806534 |
|
| 13784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4633 |
0.389091095806534 |
|
| 13785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4460 |
0.389091095806534 |
|
| 13786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS19 |
0.389091095806534 |
|
| 13787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1024L |
0.389091095806534 |
|
| 13788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHSY3 |
0.389091095806534 |
|
| 13789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC10P |
0.389091095806534 |
|
| 13790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP191 |
0.389091095806534 |
|
| 13791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HINT1 |
0.389091095806534 |
|
| 13792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM7 |
0.389091095806534 |
|
| 13793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42SE2 |
0.389091095806534 |
|
| 13794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF6 |
0.389091095806534 |
|
| 13795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNIP1 |
0.389091095806534 |
|
| 13796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSL6 |
0.389091095806534 |
|
| 13797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL3 |
0.389091095806534 |
|
| 13798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF2 |
0.389091095806534 |
|
| 13799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ6|ENSG00000253067.1 |
0.389091095806534 |
|
| 13800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P4HA2 |
0.389091095806534 |
|
| 13801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM4 |
0.389091095806534 |
|
| 13802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A4 |
0.389091095806534 |
|
| 13803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3936 |
0.389091095806534 |
|
| 13804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A5 |
0.389091095806534 |
|
| 13805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf56 |
0.389091095806534 |
|
| 13806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF1 |
0.389091095806534 |
|
| 13807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL5 |
0.389091095806534 |
|
| 13808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD50 |
0.389091095806534 |
|
| 13809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL13 |
0.389091095806534 |
|
| 13810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL4 |
0.389091095806534 |
|
| 13811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF3A |
0.389091095806534 |
|
| 13812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNI2 |
0.389091095806534 |
|
| 13813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT8 |
0.389091095806534 |
|
| 13814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOWAHA |
0.389091095806534 |
|
| 13815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHROOM1 |
0.389091095806534 |
|
| 13816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP192 |
0.389091095806534 |
|
| 13817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF9 |
0.389091095806534 |
|
| 13818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRQ |
0.389091095806534 |
|
| 13819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEAP2 |
0.389091095806534 |
|
| 13820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFF4 |
0.389091095806534 |
|
| 13821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC10 |
0.389091095806534 |
|
| 13822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA4 |
0.389091095806534 |
|
| 13823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238796.1 |
0.389091095806534 |
|
| 13824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf15 |
0.389091095806534 |
|
| 13825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VDAC1 |
0.389091095806534 |
|
| 13826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF7 |
0.389091095806534 |
|
| 13827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKP1 |
0.389091095806534 |
|
| 13828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2CA |
0.389091095806534 |
|
| 13829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKL3 |
0.389091095806534 |
|
| 13830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3661 |
0.389091095806534 |
|
| 13831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2B |
0.389091095806534 |
|
| 13832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2AIPNL |
0.389091095806534 |
|
| 13833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL541P |
0.389091095806534 |
|
| 13834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF15 |
0.389091095806534 |
|
| 13835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC24A |
0.389091095806534 |
|
| 13836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMLG |
0.389091095806534 |
|
| 13837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX46 |
0.389091095806534 |
|
| 13838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf24 |
0.389091095806534 |
|
| 13839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC15 |
0.389091095806534 |
|
| 13840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBD2 |
0.389091095806534 |
|
| 13841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4461 |
0.389091095806534 |
|
| 13842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPER3 |
0.389091095806534 |
|
| 13843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITX1 |
0.389091095806534 |
|
| 13844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFY |
0.389091095806534 |
|
| 13845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf20 |
0.389091095806534 |
|
| 13846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIFAB |
0.389091095806534 |
|
| 13847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROG1 |
0.389091095806534 |
|
| 13848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCL14 |
0.389091095806534 |
|
| 13849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5692C1 |
0.389091095806534 |
|
| 13850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A48 |
0.389091095806534 |
|
| 13851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL9 |
0.389091095806534 |
|
| 13852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LECT2 |
0.389091095806534 |
|
| 13853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL21 |
0.389091095806534 |
|
| 13854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBI |
0.389091095806534 |
|
| 13855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD5 |
0.389091095806534 |
|
| 13856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC7 |
0.389091095806534 |
|
| 13857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP193 |
0.389091095806534 |
|
| 13858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOCK1 |
0.389091095806534 |
|
| 13859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL3 |
0.389091095806534 |
|
| 13860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR874 |
0.389091095806534 |
|
| 13861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA0 |
0.389091095806534 |
|
| 13862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY6R |
0.389091095806534 |
|
| 13863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOT |
0.389091095806534 |
|
| 13864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD2L2 |
0.389091095806534 |
|
| 13865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM13B |
0.389091095806534 |
|
| 13866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT8A |
0.389091095806534 |
|
| 13867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME5 |
0.389091095806534 |
|
| 13868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238605.1 |
0.389091095806534 |
|
| 13869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD8 |
0.389091095806534 |
|
| 13870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF20A |
0.389091095806534 |
|
| 13871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC23 |
0.389091095806534 |
|
| 13872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFRA3 |
0.389091095806534 |
|
| 13873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL682P |
0.389091095806534 |
|
| 13874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC25C |
0.389091095806534 |
|
| 13875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM53C |
0.389091095806534 |
|
| 13876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM3B |
0.389091095806534 |
|
| 13877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP2 |
0.389091095806534 |
|
| 13878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGR1 |
0.389091095806534 |
|
| 13879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETF1 |
0.389091095806534 |
|
| 13880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA9 |
0.389091095806534 |
|
| 13881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD63|ENSG00000222937.1 |
0.389091095806534 |
|
| 13882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD63|ENSG00000206989.1 |
0.389091095806534 |
|
| 13883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNA1 |
0.389091095806534 |
|
| 13884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238745.1 |
0.389091095806534 |
|
| 13885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL867P |
0.389091095806534 |
|
| 13886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRTM2 |
0.389091095806534 |
|
| 13887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIL1 |
0.389091095806534 |
|
| 13888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP194 |
0.389091095806534 |
|
| 13889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATR3 |
0.389091095806534 |
|
| 13890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000252213.1 |
0.389091095806534 |
|
| 13891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74A |
0.389091095806534 |
|
| 13892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP195 |
0.389091095806534 |
|
| 13893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP64 |
0.389091095806534 |
|
| 13894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAIP2 |
0.389091095806534 |
|
| 13895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC23A1 |
0.389091095806534 |
|
| 13896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MZB1 |
0.389091095806534 |
|
| 13897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROB1 |
0.389091095806534 |
|
| 13898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA24 |
0.389091095806534 |
|
| 13899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC18 |
0.389091095806534 |
|
| 13900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECSCR |
0.389091095806534 |
|
| 13901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM173 |
0.389091095806534 |
|
| 13902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2D2 |
0.389091095806534 |
|
| 13903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXXC5 |
0.389091095806534 |
|
| 13904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSD2 |
0.389091095806534 |
|
| 13905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRG2 |
0.389091095806534 |
|
| 13906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PURA |
0.389091095806534 |
|
| 13907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGIP |
0.389091095806534 |
|
| 13908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYSTM1 |
0.389091095806534 |
|
| 13909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFDN1 |
0.389091095806534 |
|
| 13910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBEGF |
0.389091095806534 |
|
| 13911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A9 |
0.389091095806534 |
|
| 13912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKHD1 |
0.389091095806534 |
|
| 13913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45|ENSG00000200051.1 |
0.389091095806534 |
|
| 13914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRA1 |
0.389091095806534 |
|
| 13915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4EBP3 |
0.389091095806534 |
|
| 13916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBB3 |
0.389091095806534 |
|
| 13917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35A4 |
0.389091095806534 |
|
| 13918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA27|ENSG00000200235.1 |
0.389091095806534 |
|
| 13919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD14 |
0.389091095806534 |
|
| 13920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA2 |
0.389091095806534 |
|
| 13921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO6 |
0.389091095806534 |
|
| 13922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IK |
0.389091095806534 |
|
| 13923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3655 |
0.389091095806534 |
|
| 13924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR55 |
0.389091095806534 |
|
| 13925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DND1 |
0.389091095806534 |
|
| 13926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HARS |
0.389091095806534 |
|
| 13927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HARS2 |
0.389091095806534 |
|
| 13928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMAT2 |
0.389091095806534 |
|
| 13929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA1 |
0.389091095806534 |
|
| 13930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA2 |
0.389091095806534 |
|
| 13931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA3 |
0.389091095806534 |
|
| 13932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA4 |
0.389091095806534 |
|
| 13933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA10 |
0.389091095806534 |
|
| 13934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA11 |
0.389091095806534 |
|
| 13935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA14 |
0.389091095806534 |
|
| 13936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA5 |
0.389091095806534 |
|
| 13937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA6 |
0.389091095806534 |
|
| 13938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA7 |
0.389091095806534 |
|
| 13939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA8 |
0.389091095806534 |
|
| 13940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA9 |
0.389091095806534 |
|
| 13941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA12 |
0.389091095806534 |
|
| 13942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHA13 |
0.389091095806534 |
|
| 13943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHAC1 |
0.389091095806534 |
|
| 13944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHAC2 |
0.389091095806534 |
|
| 13945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB1 |
0.389091095806534 |
|
| 13946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB2 |
0.389091095806534 |
|
| 13947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB3 |
0.389091095806534 |
|
| 13948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB17 |
0.389091095806534 |
|
| 13949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB4 |
0.389091095806534 |
|
| 13950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB5 |
0.389091095806534 |
|
| 13951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB6 |
0.389091095806534 |
|
| 13952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB7 |
0.389091095806534 |
|
| 13953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB16 |
0.389091095806534 |
|
| 13954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB8 |
0.389091095806534 |
|
| 13955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB10 |
0.389091095806534 |
|
| 13956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB11 |
0.389091095806534 |
|
| 13957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB12 |
0.389091095806534 |
|
| 13958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB13 |
0.389091095806534 |
|
| 13959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB14 |
0.389091095806534 |
|
| 13960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB18 |
0.389091095806534 |
|
| 13961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHB15 |
0.389091095806534 |
|
| 13962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A2 |
0.389091095806534 |
|
| 13963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF7 |
0.389091095806534 |
|
| 13964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA1 |
0.389091095806534 |
|
| 13965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA2 |
0.389091095806534 |
|
| 13966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA3 |
0.389091095806534 |
|
| 13967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB1 |
0.389091095806534 |
|
| 13968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA4 |
0.389091095806534 |
|
| 13969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB2 |
0.389091095806534 |
|
| 13970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA5 |
0.389091095806534 |
|
| 13971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB3 |
0.389091095806534 |
|
| 13972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA6 |
0.389091095806534 |
|
| 13973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA7 |
0.389091095806534 |
|
| 13974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB4 |
0.389091095806534 |
|
| 13975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA8 |
0.389091095806534 |
|
| 13976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA9 |
0.389091095806534 |
|
| 13977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA10 |
0.389091095806534 |
|
| 13978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA11 |
0.389091095806534 |
|
| 13979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB6 |
0.389091095806534 |
|
| 13980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB7 |
0.389091095806534 |
|
| 13981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGB8P |
0.389091095806534 |
|
| 13982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGA12 |
0.389091095806534 |
|
| 13983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGC3 |
0.389091095806534 |
|
| 13984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL68P |
0.389091095806534 |
|
| 13985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGC4 |
0.389091095806534 |
|
| 13986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDHGC5 |
0.389091095806534 |
|
| 13987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIAPH1 |
0.389091095806534 |
|
| 13988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC3 |
0.389091095806534 |
|
| 13989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RELL2 |
0.389091095806534 |
|
| 13990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCHSD1 |
0.389091095806534 |
|
| 13991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARAP3 |
0.389091095806534 |
|
| 13992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYRF |
0.390365497953437 |
|
| 13993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM258 |
0.390365497953437 |
|
| 13994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FADS2 |
0.390365497953437 |
|
| 13995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEN1 |
0.390365497953437 |
|
| 13996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR611 |
0.390365497953437 |
|
| 13997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FADS1 |
0.390365497953437 |
|
| 13998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1908 |
0.390365497953437 |
|
| 13999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FADS3 |
0.390365497953437 |
|
| 14000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3IL1 |
0.390365497953437 |
|
| 14001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEST1 |
0.390365497953437 |
|
| 14002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTH1 |
0.390365497953437 |
|
| 14003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INCENP |
0.390365497953437 |
|
| 14004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1D1 |
0.390365497953437 |
|
| 14005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB2A1 |
0.390365497953437 |
|
| 14006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1D2 |
0.390365497953437 |
|
| 14007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB2A2 |
0.390365497953437 |
|
| 14008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1D4 |
0.390365497953437 |
|
| 14009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASRGL1 |
0.390365497953437 |
|
| 14010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1A1 |
0.390365497953437 |
|
| 14011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHNAK |
0.390365497953437 |
|
| 14012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1G |
0.390365497953437 |
|
| 14013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3654 |
0.390365497953437 |
|
| 14014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUT1 |
0.390365497953437 |
|
| 14015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTA2 |
0.390365497953437 |
|
| 14016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML3 |
0.390365497953437 |
|
| 14017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROM1 |
0.390365497953437 |
|
| 14018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GAT3 |
0.390365497953437 |
|
| 14019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GANAB |
0.390365497953437 |
|
| 14020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS5 |
0.390365497953437 |
|
| 14021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf48 |
0.390365497953437 |
|
| 14022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf83 |
0.390365497953437 |
|
| 14023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL12 |
0.390365497953437 |
|
| 14024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA57|ENSG00000206597.1 |
0.390365497953437 |
|
| 14025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN1 |
0.390365497953437 |
|
| 14026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRN4CL |
0.390365497953437 |
|
| 14027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC3A2 |
0.390365497953437 |
|
| 14028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRM1 |
0.390365497953437 |
|
| 14029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL259P |
0.390365497953437 |
|
| 14030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A6 |
0.390365497953437 |
|
| 14031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A8 |
0.390365497953437 |
|
| 14032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A24 |
0.390365497953437 |
|
| 14033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A10 |
0.390365497953437 |
|
| 14034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A25 |
0.390365497953437 |
|
| 14035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A9 |
0.390365497953437 |
|
| 14036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRASLS5 |
0.390365497953437 |
|
| 14037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALS12 |
0.390365497953437 |
|
| 14038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARRES3 |
0.390365497953437 |
|
| 14039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRASLS2 |
0.390365497953437 |
|
| 14040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATL3 |
0.390365497953437 |
|
| 14041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN3 |
0.390365497953437 |
|
| 14042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP2D |
0.393366000672484 |
|
| 14043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP2B |
0.393366000672484 |
|
| 14044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD66|ENSG00000212532.1 |
0.393366000672484 |
|
| 14045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKHD1 |
0.393366000672484 |
|
| 14046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL580P |
0.393366000672484 |
|
| 14047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR206 |
0.393366000672484 |
|
| 14048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR133B |
0.393366000672484 |
|
| 14049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17A |
0.393366000672484 |
|
| 14050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17F |
0.393366000672484 |
|
| 14051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM3 |
0.393366000672484 |
|
| 14052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR8 |
0.393366000672484 |
|
| 14053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFHC1 |
0.393366000672484 |
|
| 14054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAM2 |
0.393366000672484 |
|
| 14055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM14A |
0.393366000672484 |
|
| 14056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTA1 |
0.393366000672484 |
|
| 14057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTA2 |
0.393366000672484 |
|
| 14058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTA5 |
0.393366000672484 |
|
| 14059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTA3 |
0.393366000672484 |
|
| 14060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSTA4 |
0.393366000672484 |
|
| 14061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SK |
0.393366000672484 |
|
| 14062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICK |
0.393366000672484 |
|
| 14063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO9 |
0.393366000672484 |
|
| 14064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL244P |
0.393366000672484 |
|
| 14065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCM1 |
0.393366000672484 |
|
| 14066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251930.1 |
0.393366000672484 |
|
| 14067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL5 |
0.393366000672484 |
|
| 14068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5685 |
0.393366000672484 |
|
| 14069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP256 |
0.393366000672484 |
|
| 14070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCLC |
0.393366000672484 |
|
| 14071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL31 |
0.393366000672484 |
|
| 14072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC1 |
0.393366000672484 |
|
| 14073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLIP |
0.393366000672484 |
|
| 14074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TINAG |
0.393366000672484 |
|
| 14075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM83B |
0.393366000672484 |
|
| 14076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCRTR2 |
0.393366000672484 |
|
| 14077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFRAL |
0.393366000672484 |
|
| 14078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGCLL1 |
0.393366000672484 |
|
| 14079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP5 |
0.393366000672484 |
|
| 14080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL21A1 |
0.393366000672484 |
|
| 14081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DST |
0.393366000672484 |
|
| 14082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND6 |
0.393366000672484 |
|
| 14083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1586 |
0.393366000672484 |
|
| 14084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF451 |
0.393366000672484 |
|
| 14085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG2 |
0.393366000672484 |
|
| 14086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB23 |
0.393366000672484 |
|
| 14087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRIM2 |
0.393366000672484 |
|
| 14088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00680 |
0.393366000672484 |
|
| 14089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548U |
0.393366000672484 |
|
| 14090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSCL2 |
0.393493433772583 |
|
| 14091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG3 |
0.393493433772583 |
|
| 14092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPUL2 |
0.393493433772583 |
|
| 14093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC9C |
0.393493433772583 |
|
| 14094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2G |
0.393493433772583 |
|
| 14095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB3 |
0.393493433772583 |
|
| 14096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF6L |
0.393493433772583 |
|
| 14097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM223 |
0.393493433772583 |
|
| 14098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM179B |
0.393493433772583 |
|
| 14099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF1 |
0.393493433772583 |
|
| 14100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX5 |
0.393493433772583 |
|
| 14101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL119P |
0.393493433772583 |
|
| 14102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR74 |
0.393493433772583 |
|
| 14103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG1 |
0.393493433772583 |
|
| 14104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATSL1 |
0.395481473205039 |
|
| 14105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBSCR16 |
0.395481473205039 |
|
| 14106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2IRD2B |
0.395481473205039 |
|
| 14107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATSL2 |
0.395481473205039 |
|
| 14108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3L1 |
0.395481473205039 |
|
| 14109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM73 |
0.395481473205039 |
|
| 14110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN5P1 |
0.395481473205039 |
|
| 14111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POM121C |
0.395481473205039 |
|
| 14112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMS2P3 |
0.395481473205039 |
|
| 14113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIP1 |
0.395481473205039 |
|
| 14114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL642P |
0.395481473205039 |
|
| 14115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL26 |
0.395481473205039 |
|
| 14116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL24 |
0.395481473205039 |
|
| 14117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDD2 |
0.395481473205039 |
|
| 14118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POR |
0.395481473205039 |
|
| 14119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4651 |
0.395481473205039 |
|
| 14120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA14A |
0.395481473205039 |
|
| 14121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM120A |
0.395481473205039 |
|
| 14122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STYXL1 |
0.395481473205039 |
|
| 14123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDH2 |
0.395481473205039 |
|
| 14124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238935.1 |
0.395481473205039 |
|
| 14125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRM3 |
0.395481473205039 |
|
| 14126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL212P |
0.395481473205039 |
|
| 14127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB1 |
0.395481473205039 |
|
| 14128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAG |
0.395481473205039 |
|
| 14129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRCRB4D |
0.395481473205039 |
|
| 14130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GL2 |
0.396471844854956 |
|
| 14131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP258 |
0.396471844854956 |
|
| 14132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM154A |
0.396471844854956 |
|
| 14133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAGA |
0.396471844854956 |
|
| 14134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA8 |
0.396471844854956 |
|
| 14135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTTN |
0.409119607503297 |
|
| 14136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS6 |
0.409119607503297 |
|
| 14137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR3C2 |
0.411371245369164 |
|
| 14138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM2 |
0.411371245369164 |
|
| 14139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTSL1 |
0.41227615410384 |
|
| 14140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3152 |
0.41227615410384 |
|
| 14141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOX3 |
0.418279493194607 |
|
| 14142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC16 |
0.418279493194607 |
|
| 14143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD9 |
0.418279493194607 |
|
| 14144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP427 |
0.418279493194607 |
|
| 14145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238645.1 |
0.418279493194607 |
|
| 14146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBL2 |
0.418279493194607 |
|
| 14147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKTIP |
0.418279493194607 |
|
| 14148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPGRIP1L |
0.418279493194607 |
|
| 14149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX3 |
0.418279493194607 |
|
| 14150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRNDE |
0.418279493194607 |
|
| 14151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX5 |
0.418279493194607 |
|
| 14152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL841P |
0.418279493194607 |
|
| 14153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX6 |
0.418279493194607 |
|
| 14154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP2 |
0.418279493194607 |
|
| 14155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPCAT2 |
0.418279493194607 |
|
| 14156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPNS2 |
0.418279493194607 |
|
| 14157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A2 |
0.418279493194607 |
|
| 14158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES1P1 |
0.418279493194607 |
|
| 14159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES1 |
0.418279493194607 |
|
| 14160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES5A |
0.418279493194607 |
|
| 14161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAO1 |
0.418279493194607 |
|
| 14162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3935 |
0.418279493194607 |
|
| 14163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMFR |
0.418279493194607 |
|
| 14164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT21 |
0.418279493194607 |
|
| 14165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGFOD1 |
0.418279493194607 |
|
| 14166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS2 |
0.418279493194607 |
|
| 14167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT4 |
0.418279493194607 |
|
| 14168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT3 |
0.418279493194607 |
|
| 14169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT2A |
0.418279493194607 |
|
| 14170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1L |
0.418279493194607 |
|
| 14171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1E |
0.418279493194607 |
|
| 14172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1M |
0.418279493194607 |
|
| 14173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1JP |
0.418279493194607 |
|
| 14174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1A |
0.418279493194607 |
|
| 14175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1DP |
0.418279493194607 |
|
| 14176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1B |
0.418279493194607 |
|
| 14177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1F |
0.418279493194607 |
|
| 14178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1G |
0.418279493194607 |
|
| 14179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1H |
0.418279493194607 |
|
| 14180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MT1X |
0.418279493194607 |
|
| 14181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP93 |
0.418279493194607 |
|
| 14182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A3 |
0.418279493194607 |
|
| 14183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERPUD1 |
0.418279493194607 |
|
| 14184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CETP |
0.418279493194607 |
|
| 14185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRC5 |
0.418279493194607 |
|
| 14186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE2 |
0.418279493194607 |
|
| 14187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM192A |
0.418279493194607 |
|
| 14188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPRY1 |
0.418279493194607 |
|
| 14189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL2BP |
0.418279493194607 |
|
| 14190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLLP |
0.418279493194607 |
|
| 14191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL22 |
0.418279493194607 |
|
| 14192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CX3CL1 |
0.418279493194607 |
|
| 14193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL17 |
0.418279493194607 |
|
| 14194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIAPIN1 |
0.418279493194607 |
|
| 14195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ9 |
0.418279493194607 |
|
| 14196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2C |
0.418279493194607 |
|
| 14197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK4 |
0.418279493194607 |
|
| 14198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC102A |
0.418279493194607 |
|
| 14199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR114 |
0.418279493194607 |
|
| 14200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR56 |
0.418279493194607 |
|
| 14201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR97 |
0.418279493194607 |
|
| 14202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC135 |
0.418279493194607 |
|
| 14203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KATNB1 |
0.418279493194607 |
|
| 14204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIFC3 |
0.418279493194607 |
|
| 14205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGB1 |
0.418279493194607 |
|
| 14206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEPP |
0.418279493194607 |
|
| 14207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USB1 |
0.418279493194607 |
|
| 14208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF319 |
0.418279493194607 |
|
| 14209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP15 |
0.418279493194607 |
|
| 14210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf80 |
0.418279493194607 |
|
| 14211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK2A2 |
0.418279493194607 |
|
| 14212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL645P |
0.418279493194607 |
|
| 14213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC113 |
0.418279493194607 |
|
| 14214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS54 |
0.418279493194607 |
|
| 14215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GINS3 |
0.418279493194607 |
|
| 14216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDRG4 |
0.418279493194607 |
|
| 14217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD6 |
0.418279493194607 |
|
| 14218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT1 |
0.418279493194607 |
|
| 14219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA46|ENSG00000207493.1 |
0.418279493194607 |
|
| 14220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA50|ENSG00000206952.2 |
0.418279493194607 |
|
| 14221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239121.1 |
0.418279493194607 |
|
| 14222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A7 |
0.418279493194607 |
|
| 14223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOT2 |
0.418279493194607 |
|
| 14224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL143P |
0.418279493194607 |
|
| 14225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH8 |
0.418279493194607 |
|
| 14226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP76 |
0.418279493194607 |
|
| 14227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238507.1 |
0.418279493194607 |
|
| 14228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH11 |
0.418279493194607 |
|
| 14229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00922 |
0.418279493194607 |
|
| 14230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP428 |
0.418279493194607 |
|
| 14231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH5 |
0.418279493194607 |
|
| 14232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00920 |
0.418279493194607 |
|
| 14233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEAN1 |
0.418279493194607 |
|
| 14234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TK2 |
0.418279493194607 |
|
| 14235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKLF |
0.418279493194607 |
|
| 14236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM1 |
0.418279493194607 |
|
| 14237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM2 |
0.418279493194607 |
|
| 14238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM3 |
0.418279493194607 |
|
| 14239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMTM4 |
0.418279493194607 |
|
| 14240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC1LI2 |
0.418279493194607 |
|
| 14241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC79 |
0.418279493194607 |
|
| 14242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAE1 |
0.418279493194607 |
|
| 14243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA7 |
0.418279493194607 |
|
| 14244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDP2 |
0.418279493194607 |
|
| 14245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH16 |
0.418279493194607 |
|
| 14246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAD |
0.418279493194607 |
|
| 14247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM96B |
0.418279493194607 |
|
| 14248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES2 |
0.418279493194607 |
|
| 14249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES3 |
0.418279493194607 |
|
| 14250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CES4A |
0.418279493194607 |
|
| 14251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL543P |
0.418279493194607 |
|
| 14252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBFB |
0.418279493194607 |
|
| 14253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf70 |
0.418279493194607 |
|
| 14254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT9 |
0.418279493194607 |
|
| 14255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL8 |
0.418279493194607 |
|
| 14256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRADD |
0.418279493194607 |
|
| 14257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSF4 |
0.418279493194607 |
|
| 14258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL3 |
0.418279493194607 |
|
| 14259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0895L |
0.418279493194607 |
|
| 14260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC3L1 |
0.418279493194607 |
|
| 14261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F4 |
0.418279493194607 |
|
| 14262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMO3 |
0.418279493194607 |
|
| 14263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR328 |
0.418279493194607 |
|
| 14264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC29 |
0.418279493194607 |
|
| 14265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM208 |
0.418279493194607 |
|
| 14266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHOD1 |
0.418279493194607 |
|
| 14267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A5 |
0.418279493194607 |
|
| 14268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG4 |
0.418279493194607 |
|
| 14269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD19 |
0.418279493194607 |
|
| 14270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP118 |
0.418279493194607 |
|
| 14271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC36 |
0.418279493194607 |
|
| 14272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPPP3 |
0.418279493194607 |
|
| 14273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC1 |
0.418279493194607 |
|
| 14274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD11B2 |
0.418279493194607 |
|
| 14275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0D1 |
0.418279493194607 |
|
| 14276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGRP |
0.418279493194607 |
|
| 14277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM65A |
0.418279493194607 |
|
| 14278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTCF |
0.418279493194607 |
|
| 14279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLTPR |
0.418279493194607 |
|
| 14280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACD |
0.418279493194607 |
|
| 14281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf86 |
0.418279493194607 |
|
| 14282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENKD1 |
0.418279493194607 |
|
| 14283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARD6A |
0.418279493194607 |
|
| 14284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFOD2 |
0.418279493194607 |
|
| 14285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP10 |
0.418279493194607 |
|
| 14286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSNAXIP1 |
0.418279493194607 |
|
| 14287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPT |
0.418279493194607 |
|
| 14288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP11 |
0.418279493194607 |
|
| 14289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTF2 |
0.418279493194607 |
|
| 14290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDC4 |
0.418279493194607 |
|
| 14291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRN1L |
0.418279493194607 |
|
| 14292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSKH1 |
0.418279493194607 |
|
| 14293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTRL |
0.418279493194607 |
|
| 14294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB10 |
0.418279493194607 |
|
| 14295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCAT |
0.418279493194607 |
|
| 14296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A4 |
0.418279493194607 |
|
| 14297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPEP3 |
0.418279493194607 |
|
| 14298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPEP2 |
0.418279493194607 |
|
| 14299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUS2L |
0.418279493194607 |
|
| 14300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX28 |
0.418279493194607 |
|
| 14301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFATC3 |
0.418279493194607 |
|
| 14302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212445.1 |
0.418279493194607 |
|
| 14303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRP2 |
0.418279493194607 |
|
| 14304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G15 |
0.418279493194607 |
|
| 14305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A6 |
0.418279493194607 |
|
| 14306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A6OS |
0.418279493194607 |
|
| 14307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT7 |
0.418279493194607 |
|
| 14308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238343.1 |
0.418279493194607 |
|
| 14309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPD3 |
0.418279493194607 |
|
| 14310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP90 |
0.418279493194607 |
|
| 14311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000252040.1 |
0.418279493194607 |
|
| 14312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000252640.1 |
0.418279493194607 |
|
| 14313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH3 |
0.418279493194607 |
|
| 14314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH1 |
0.418279493194607 |
|
| 14315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP429 |
0.418279493194607 |
|
| 14316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TANGO6 |
0.418279493194607 |
|
| 14317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS2P45 |
0.418279493194607 |
|
| 14318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAS3 |
0.418279493194607 |
|
| 14319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHTF8 |
0.418279493194607 |
|
| 14320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIRH1A |
0.418279493194607 |
|
| 14321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTB2 |
0.418279493194607 |
|
| 14322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS4A |
0.418279493194607 |
|
| 14323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG8 |
0.418279493194607 |
|
| 14324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDF |
0.418279493194607 |
|
| 14325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIP7 |
0.418279493194607 |
|
| 14326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED6 |
0.418279493194607 |
|
| 14327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TERF2 |
0.418279493194607 |
|
| 14328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5B |
0.418279493194607 |
|
| 14329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1538 |
0.418279493194607 |
|
| 14330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFAT5 |
0.418279493194607 |
|
| 14331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NQO1 |
0.418279493194607 |
|
| 14332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238683.1 |
0.418279493194607 |
|
| 14333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOB1 |
0.418279493194607 |
|
| 14334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWP2 |
0.418279493194607 |
|
| 14335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000252443.1 |
0.418279493194607 |
|
| 14336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00395 |
0.420082132765947 |
|
| 14337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAOA |
0.424479542911498 |
|
| 14338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00343 |
0.424479542911498 |
|
| 14339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00344 |
0.424479542911498 |
|
| 14340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252550.1 |
0.424479542911498 |
|
| 14341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP38 |
0.424479542911498 |
|
| 14342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00460 |
0.424479542911498 |
|
| 14343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNB2 |
0.424479542911498 |
|
| 14344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARGLU1 |
0.424479542911498 |
|
| 14345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00551 |
0.424479542911498 |
|
| 14346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00443 |
0.424479542911498 |
|
| 14347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM155A |
0.424479542911498 |
|
| 14348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD31 |
0.424479542911498 |
|
| 14349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1267 |
0.424479542911498 |
|
| 14350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIG4 |
0.424479542911498 |
|
| 14351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD13 |
0.424479542911498 |
|
| 14352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF13B |
0.424479542911498 |
|
| 14353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP39 |
0.424479542911498 |
|
| 14354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO16 |
0.424479542911498 |
|
| 14355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00676 |
0.424479542911498 |
|
| 14356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRS2 |
0.424479542911498 |
|
| 14357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP10 |
0.424479542911498 |
|
| 14358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL783P |
0.424479542911498 |
|
| 14359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A1 |
0.424479542911498 |
|
| 14360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A2 |
0.424479542911498 |
|
| 14361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238629.1 |
0.424479542911498 |
|
| 14362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB20 |
0.424479542911498 |
|
| 14363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARKD |
0.424479542911498 |
|
| 14364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARS2 |
0.424479542911498 |
|
| 14365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ING1 |
0.424479542911498 |
|
| 14366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00567 |
0.424479542911498 |
|
| 14367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00346 |
0.424479542911498 |
|
| 14368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD10 |
0.424479542911498 |
|
| 14369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACBD3 |
0.426083150725009 |
|
| 14370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP495 |
0.426513495539501 |
|
| 14371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPHD2 |
0.426513495539501 |
|
| 14372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPS4 |
0.426513495539501 |
|
| 14373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRD |
0.426513495539501 |
|
| 14374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFIP11 |
0.426513495539501 |
|
| 14375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPST2 |
0.426513495539501 |
|
| 14376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548J |
0.426513495539501 |
|
| 14377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIAT |
0.426513495539501 |
|
| 14378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MN1 |
0.426513495539501 |
|
| 14379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITPNB |
0.426513495539501 |
|
| 14380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A13 |
0.428485553941135 |
|
| 14381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR591 |
0.428485553941135 |
|
| 14382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf76 |
0.428485553941135 |
|
| 14383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHFM1 |
0.428485553941135 |
|
| 14384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACN9 |
0.428485553941135 |
|
| 14385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP104 |
0.428485553941135 |
|
| 14386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAC1 |
0.428485553941135 |
|
| 14387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASNS |
0.428485553941135 |
|
| 14388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5692A1 |
0.428485553941135 |
|
| 14389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5692C2 |
0.428485553941135 |
|
| 14390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCM2 |
0.428485553941135 |
|
| 14391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL478P |
0.428485553941135 |
|
| 14392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL13P |
0.428485553941135 |
|
| 14393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMTK2 |
0.428485553941135 |
|
| 14394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHA15 |
0.428485553941135 |
|
| 14395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECPR1 |
0.428485553941135 |
|
| 14396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRI3 |
0.428485553941135 |
|
| 14397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAIAP2L1 |
0.428485553941135 |
|
| 14398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPTX2 |
0.428485553941135 |
|
| 14399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3609 |
0.428485553941135 |
|
| 14400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMURF1 |
0.428485553941135 |
|
| 14401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM130 |
0.428485553941135 |
|
| 14402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRRAP |
0.428485553941135 |
|
| 14403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238459.1 |
0.428485553941135 |
|
| 14404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA7 |
0.428485553941135 |
|
| 14405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH16 |
0.428485553941135 |
|
| 14406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC1A |
0.428485553941135 |
|
| 14407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC1B |
0.428485553941135 |
|
| 14408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDAP1 |
0.428485553941135 |
|
| 14409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BUD31 |
0.428485553941135 |
|
| 14410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239133.1 |
0.428485553941135 |
|
| 14411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCD1 |
0.428485553941135 |
|
| 14412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF4 |
0.428485553941135 |
|
| 14413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5J2 |
0.428485553941135 |
|
| 14414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF789 |
0.428485553941135 |
|
| 14415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF394 |
0.428485553941135 |
|
| 14416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN5 |
0.428485553941135 |
|
| 14417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM200A |
0.428485553941135 |
|
| 14418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF655 |
0.428485553941135 |
|
| 14419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN25 |
0.428485553941135 |
|
| 14420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP3A5 |
0.428485553941135 |
|
| 14421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP3A7 |
0.428485553941135 |
|
| 14422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP3A4 |
0.428485553941135 |
|
| 14423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP3A43 |
0.428485553941135 |
|
| 14424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AE1 |
0.428485553941135 |
|
| 14425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM4 |
0.428485553941135 |
|
| 14426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJC3 |
0.428485553941135 |
|
| 14427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000222966.1 |
0.428485553941135 |
|
| 14428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZGP1 |
0.428485553941135 |
|
| 14429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZGP1P1 |
0.428485553941135 |
|
| 14430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN1 |
0.428485553941135 |
|
| 14431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN21 |
0.428485553941135 |
|
| 14432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF3 |
0.428485553941135 |
|
| 14433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS6 |
0.428485553941135 |
|
| 14434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM7 |
0.428485553941135 |
|
| 14435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR106B |
0.428485553941135 |
|
| 14436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR25 |
0.428485553941135 |
|
| 14437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR93 |
0.428485553941135 |
|
| 14438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP4M1 |
0.428485553941135 |
|
| 14439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF6 |
0.428485553941135 |
|
| 14440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNPY4 |
0.428485553941135 |
|
| 14441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBLAC1 |
0.428485553941135 |
|
| 14442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMTOR4 |
0.428485553941135 |
|
| 14443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf43 |
0.428485553941135 |
|
| 14444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAL3ST4 |
0.428485553941135 |
|
| 14445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4658 |
0.428485553941135 |
|
| 14446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC2 |
0.428485553941135 |
|
| 14447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3 |
0.428485553941135 |
|
| 14448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATS |
0.428485553941135 |
|
| 14449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVRIG |
0.428485553941135 |
|
| 14450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYE3 |
0.428485553941135 |
|
| 14451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PILRB |
0.428485553941135 |
|
| 14452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG3L5P |
0.428485553941135 |
|
| 14453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PILRA |
0.428485553941135 |
|
| 14454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCWPW1 |
0.428485553941135 |
|
| 14455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEPCE |
0.428485553941135 |
|
| 14456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R35 |
0.428485553941135 |
|
| 14457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf61 |
0.428485553941135 |
|
| 14458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL161P |
0.428485553941135 |
|
| 14459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC22D4 |
0.428485553941135 |
|
| 14460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NYAP1 |
0.428485553941135 |
|
| 14461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL416P |
0.428485553941135 |
|
| 14462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGFG2 |
0.428485553941135 |
|
| 14463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRCH4 |
0.428485553941135 |
|
| 14464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP25 |
0.428485553941135 |
|
| 14465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO24 |
0.428485553941135 |
|
| 14466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOSPD3 |
0.428485553941135 |
|
| 14467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCOLCE |
0.428485553941135 |
|
| 14468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFR2 |
0.428485553941135 |
|
| 14469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL6B |
0.428485553941135 |
|
| 14470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIGYF1 |
0.428485553941135 |
|
| 14471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB2 |
0.428485553941135 |
|
| 14472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POP7 |
0.428485553941135 |
|
| 14473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPO |
0.428485553941135 |
|
| 14474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZAN |
0.428485553941135 |
|
| 14475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHB4 |
0.428485553941135 |
|
| 14476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL750P |
0.428485553941135 |
|
| 14477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A9 |
0.428485553941135 |
|
| 14478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP6 |
0.428485553941135 |
|
| 14479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRT |
0.428485553941135 |
|
| 14480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACHE |
0.428485553941135 |
|
| 14481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFSP1 |
0.428485553941135 |
|
| 14482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL549P |
0.428485553941135 |
|
| 14483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC3A |
0.428485553941135 |
|
| 14484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC12 |
0.428485553941135 |
|
| 14485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC17 |
0.428485553941135 |
|
| 14486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP54 |
0.428485553941135 |
|
| 14487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM56 |
0.428485553941135 |
|
| 14488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINE1 |
0.428485553941135 |
|
| 14489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1S1 |
0.428485553941135 |
|
| 14490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4653 |
0.428485553941135 |
|
| 14491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VGF |
0.428485553941135 |
|
| 14492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT16 |
0.428485553941135 |
|
| 14493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOGAT3 |
0.428485553941135 |
|
| 14494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLOD3 |
0.428485553941135 |
|
| 14495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNHIT1 |
0.428485553941135 |
|
| 14496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN15 |
0.428485553941135 |
|
| 14497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIS1 |
0.428485553941135 |
|
| 14498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL26A1 |
0.428485553941135 |
|
| 14499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABL5 |
0.428485553941135 |
|
| 14500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL10 |
0.428485553941135 |
|
| 14501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUX1 |
0.428485553941135 |
|
| 14502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000252824.1 |
0.428485553941135 |
|
| 14503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4285 |
0.428485553941135 |
|
| 14504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2B2 |
0.428485553941135 |
|
| 14505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKRIP1 |
0.428485553941135 |
|
| 14506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548O |
0.428485553941135 |
|
| 14507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORAI2 |
0.428485553941135 |
|
| 14508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH4 |
0.428485553941135 |
|
| 14509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRWD1 |
0.428485553941135 |
|
| 14510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4467 |
0.428485553941135 |
|
| 14511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5090 |
0.428485553941135 |
|
| 14512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2J2 |
0.428485553941135 |
|
| 14513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2J3 |
0.428485553941135 |
|
| 14514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2J |
0.428485553941135 |
|
| 14515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA4B |
0.428485553941135 |
|
| 14516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA4 |
0.428485553941135 |
|
| 14517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYE2B |
0.428485553941135 |
|
| 14518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYE2 |
0.428485553941135 |
|
| 14519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK3BL |
0.428485553941135 |
|
| 14520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLD |
0.428485553941135 |
|
| 14521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMB1 |
0.428485553941135 |
|
| 14522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000238297.1 |
0.428485553941135 |
|
| 14523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMB4 |
0.428485553941135 |
|
| 14524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRCAM |
0.428485553941135 |
|
| 14525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA8 |
0.428485553941135 |
|
| 14526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP5 |
0.428485553941135 |
|
| 14527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB9 |
0.428485553941135 |
|
| 14528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf66 |
0.428485553941135 |
|
| 14529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ00325 |
0.428485553941135 |
|
| 14530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMMP2L |
0.428485553941135 |
|
| 14531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRN3 |
0.428485553941135 |
|
| 14532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238922.1 |
0.428485553941135 |
|
| 14533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK4 |
0.428485553941135 |
|
| 14534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP237 |
0.428485553941135 |
|
| 14535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF277 |
0.428485553941135 |
|
| 14536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP187 |
0.428485553941135 |
|
| 14537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFRD1 |
0.428485553941135 |
|
| 14538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSMEM1 |
0.428485553941135 |
|
| 14539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM168 |
0.428485553941135 |
|
| 14540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf60 |
0.428485553941135 |
|
| 14541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR85 |
0.428485553941135 |
|
| 14542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSRM |
0.428485553941135 |
|
| 14543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3A |
0.428485553941135 |
|
| 14544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXP2 |
0.428485553941135 |
|
| 14545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP238 |
0.428485553941135 |
|
| 14546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3666 |
0.428485553941135 |
|
| 14547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDFIC |
0.428485553941135 |
|
| 14548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000202377.1 |
0.428485553941135 |
|
| 14549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFEC |
0.428485553941135 |
|
| 14550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TES |
0.428485553941135 |
|
| 14551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAV2 |
0.428485553941135 |
|
| 14552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ185 |
0.428485553941135 |
|
| 14553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAV1 |
0.428485553941135 |
|
| 14554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MET |
0.428485553941135 |
|
| 14555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPZA2 |
0.428485553941135 |
|
| 14556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP239 |
0.428485553941135 |
|
| 14557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST7 |
0.428485553941135 |
|
| 14558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT2 |
0.428485553941135 |
|
| 14559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASZ1 |
0.428485553941135 |
|
| 14560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFTR |
0.428485553941135 |
|
| 14561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTTNBP2 |
0.428485553941135 |
|
| 14562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA38 |
0.428485553941135 |
|
| 14563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD7 |
0.428485553941135 |
|
| 14564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U1|ENSG00000271739.1 |
0.428485553941135 |
|
| 14565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM184C |
0.434147294633823 |
|
| 14566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT10 |
0.434147294633823 |
|
| 14567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP10 |
0.434147294633823 |
|
| 14568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP165 |
0.434147294633823 |
|
| 14569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4799 |
0.434147294633823 |
|
| 14570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL254P |
0.434147294633823 |
|
| 14571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP166 |
0.434147294633823 |
|
| 14572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP167 |
0.434147294633823 |
|
| 14573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLK2 |
0.434147294633823 |
|
| 14574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRBA |
0.434147294633823 |
|
| 14575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAB21L2 |
0.434147294633823 |
|
| 14576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP168 |
0.434147294633823 |
|
| 14577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS3A |
0.434147294633823 |
|
| 14578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3D19 |
0.434147294633823 |
|
| 14579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD73A |
0.434147294633823 |
|
| 14580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD73 |
0.434147294633823 |
|
| 14581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS48 |
0.434147294633823 |
|
| 14582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM160A1 |
0.434147294633823 |
|
| 14583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP35 |
0.434147294633823 |
|
| 14584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PET112 |
0.434147294633823 |
|
| 14585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP169 |
0.434147294633823 |
|
| 14586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL446P |
0.434147294633823 |
|
| 14587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW7 |
0.434147294633823 |
|
| 14588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3140 |
0.434147294633823 |
|
| 14589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4453 |
0.434147294633823 |
|
| 14590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM154 |
0.434147294633823 |
|
| 14591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD4 |
0.434147294633823 |
|
| 14592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFIP1 |
0.434147294633823 |
|
| 14593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHDC1 |
0.434147294633823 |
|
| 14594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MND1 |
0.434147294633823 |
|
| 14595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL419P |
0.434147294633823 |
|
| 14596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0922 |
0.434147294633823 |
|
| 14597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR2 |
0.434147294633823 |
|
| 14598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF175 |
0.434147294633823 |
|
| 14599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFRP2 |
0.434147294633823 |
|
| 14600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCHS2 |
0.434147294633823 |
|
| 14601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLRG1 |
0.434147294633823 |
|
| 14602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGB |
0.434147294633823 |
|
| 14603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGA |
0.434147294633823 |
|
| 14604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGG |
0.434147294633823 |
|
| 14605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRAT |
0.434147294633823 |
|
| 14606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM46 |
0.434147294633823 |
|
| 14607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY2R |
0.434147294633823 |
|
| 14608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP9 |
0.434147294633823 |
|
| 14609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY1A3 |
0.434147294633823 |
|
| 14610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY1B3 |
0.434147294633823 |
|
| 14611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIC5 |
0.434147294633823 |
|
| 14612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDO2 |
0.434147294633823 |
|
| 14613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSO |
0.434147294633823 |
|
| 14614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFC |
0.434147294633823 |
|
| 14615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRB |
0.434147294633823 |
|
| 14616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIA2 |
0.434147294633823 |
|
| 14617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM198B |
0.434147294633823 |
|
| 14618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM144 |
0.434147294633823 |
|
| 14619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXFP1 |
0.434147294633823 |
|
| 14620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf46 |
0.434147294633823 |
|
| 14621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETFDH |
0.434147294633823 |
|
| 14622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000271817.1 |
0.434147294633823 |
|
| 14623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPID |
0.434147294633823 |
|
| 14624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNIP2 |
0.434147294633823 |
|
| 14625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf45 |
0.434147294633823 |
|
| 14626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF2 |
0.434147294633823 |
|
| 14627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251979.1 |
0.434147294633823 |
|
| 14628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSTL5 |
0.434147294633823 |
|
| 14629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAF1 |
0.434147294633823 |
|
| 14630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY1R |
0.434147294633823 |
|
| 14631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPY5R |
0.434147294633823 |
|
| 14632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TKTL2 |
0.434147294633823 |
|
| 14633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMA16 |
0.434147294633823 |
|
| 14634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH1 |
0.434147294633823 |
|
| 14635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP105 |
0.434147294633823 |
|
| 14636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM218A |
0.434147294633823 |
|
| 14637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM61 |
0.434147294633823 |
|
| 14638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM60 |
0.434147294633823 |
|
| 14639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM192 |
0.434147294633823 |
|
| 14640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL2 |
0.434147294633823 |
|
| 14641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSMO1 |
0.434147294633823 |
|
| 14642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPE |
0.434147294633823 |
|
| 14643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR578 |
0.434147294633823 |
|
| 14644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLL1 |
0.434147294633823 |
|
| 14645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP170 |
0.434147294633823 |
|
| 14646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX60 |
0.434147294633823 |
|
| 14647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238744.1 |
0.434147294633823 |
|
| 14648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX60L |
0.434147294633823 |
|
| 14649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000207171.1 |
0.434147294633823 |
|
| 14650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALLD |
0.434147294633823 |
|
| 14651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBR4 |
0.434147294633823 |
|
| 14652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P17 |
0.434147294633823 |
|
| 14653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3RF1 |
0.434147294633823 |
|
| 14654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK1 |
0.434147294633823 |
|
| 14655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN3 |
0.434147294633823 |
|
| 14656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf27 |
0.434147294633823 |
|
| 14657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP3L |
0.434147294633823 |
|
| 14658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AADAT |
0.434147294633823 |
|
| 14659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90AA6P |
0.434147294633823 |
|
| 14660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC13P |
0.434147294633823 |
|
| 14661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNTL6 |
0.434147294633823 |
|
| 14662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL253P |
0.434147294633823 |
|
| 14663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT7 |
0.434147294633823 |
|
| 14664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548T |
0.434147294633823 |
|
| 14665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB2 |
0.434147294633823 |
|
| 14666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP30 |
0.434147294633823 |
|
| 14667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRG1 |
0.434147294633823 |
|
| 14668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAND2 |
0.434147294633823 |
|
| 14669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO8 |
0.434147294633823 |
|
| 14670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP44 |
0.434147294633823 |
|
| 14671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4276 |
0.434147294633823 |
|
| 14672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPGD |
0.434147294633823 |
|
| 14673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRA3 |
0.434147294633823 |
|
| 14674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM29 |
0.434147294633823 |
|
| 14675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPM6A |
0.434147294633823 |
|
| 14676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00290 |
0.434147294633823 |
|
| 14677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP13 |
0.434147294633823 |
|
| 14678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TENM3 |
0.434147294633823 |
|
| 14679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1305 |
0.434147294633823 |
|
| 14680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTD |
0.434147294633823 |
|
| 14681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM92A1P2 |
0.434147294633823 |
|
| 14682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP67 |
0.434147294633823 |
|
| 14683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252048.1 |
0.434147294633823 |
|
| 14684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWC2 |
0.434147294633823 |
|
| 14685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238319.1 |
0.434147294633823 |
|
| 14686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN22 |
0.434147294633823 |
|
| 14687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN24 |
0.434147294633823 |
|
| 14688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238596.1 |
0.434147294633823 |
|
| 14689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2AIP |
0.434147294633823 |
|
| 14690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ING2 |
0.434147294633823 |
|
| 14691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239116.1 |
0.434147294633823 |
|
| 14692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENPP6 |
0.434147294633823 |
|
| 14693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RWDD4 |
0.434147294633823 |
|
| 14694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOX2 |
0.434147294633823 |
|
| 14695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC11 |
0.434147294633823 |
|
| 14696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL28P |
0.434147294633823 |
|
| 14697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF2 |
0.434147294633823 |
|
| 14698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD79 |
0.434147294633823 |
|
| 14699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP3 |
0.434147294633823 |
|
| 14700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC111 |
0.434147294633823 |
|
| 14701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLF1IP |
0.434147294633823 |
|
| 14702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSL1 |
0.434147294633823 |
|
| 14703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELT |
0.434147294633823 |
|
| 14704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1430 |
0.434147294633823 |
|
| 14705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP2BP |
0.434147294633823 |
|
| 14706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3945 |
0.434147294633823 |
|
| 14707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4455 |
0.434147294633823 |
|
| 14708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A4 |
0.434147294633823 |
|
| 14709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX25 |
0.434147294633823 |
|
| 14710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD37 |
0.434147294633823 |
|
| 14711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFSP2 |
0.434147294633823 |
|
| 14712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4orf47 |
0.434147294633823 |
|
| 14713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC110 |
0.434147294633823 |
|
| 14714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM3 |
0.434147294633823 |
|
| 14715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORBS2 |
0.434147294633823 |
|
| 14716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239034.1 |
0.434147294633823 |
|
| 14717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR3 |
0.434147294633823 |
|
| 14718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM149A |
0.434147294633823 |
|
| 14719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000253013.1 |
0.434147294633823 |
|
| 14720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4V2 |
0.434147294633823 |
|
| 14721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLKB1 |
0.434147294633823 |
|
| 14722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F11 |
0.434147294633823 |
|
| 14723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTNR1A |
0.434147294633823 |
|
| 14724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAT1 |
0.434147294633823 |
|
| 14725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00358 |
0.442320229609537 |
|
| 14726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALM2 |
0.463835479260278 |
|
| 14727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf61 |
0.463835479260278 |
|
| 14728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA2R |
0.464839905714061 |
|
| 14729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCRL |
0.466054381693342 |
|
| 14730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APLN |
0.466054381693342 |
|
| 14731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPNPEP2 |
0.466054381693342 |
|
| 14732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SASH3 |
0.466054381693342 |
|
| 14733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC9 |
0.466054381693342 |
|
| 14734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP14A |
0.466054381693342 |
|
| 14735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCORL1 |
0.466054381693342 |
|
| 14736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELF4 |
0.466054381693342 |
|
| 14737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIFM1 |
0.466054381693342 |
|
| 14738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB33A |
0.466054381693342 |
|
| 14739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF280C |
0.466054381693342 |
|
| 14740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A14 |
0.466054381693342 |
|
| 14741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR119 |
0.466054381693342 |
|
| 14742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMX2 |
0.466054381693342 |
|
| 14743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM45B |
0.466054381693342 |
|
| 14744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENOX2 |
0.466054381693342 |
|
| 14745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP36 |
0.466054381693342 |
|
| 14746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL191P |
0.466054381693342 |
|
| 14747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF1 |
0.466054381693342 |
|
| 14748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR13H1 |
0.466054381693342 |
|
| 14749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP514 |
0.466054381693342 |
|
| 14750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MST4 |
0.466054381693342 |
|
| 14751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD7 |
0.466054381693342 |
|
| 14752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP2C |
0.466054381693342 |
|
| 14753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBNL3 |
0.466054381693342 |
|
| 14754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS6ST2 |
0.466054381693342 |
|
| 14755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP26 |
0.466054381693342 |
|
| 14756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA8|ENSG00000207100.1 |
0.466054381693342 |
|
| 14757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFDP3 |
0.466054381693342 |
|
| 14758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC4 |
0.466054381693342 |
|
| 14759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC3 |
0.466054381693342 |
|
| 14760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR106A |
0.466054381693342 |
|
| 14761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR18B |
0.466054381693342 |
|
| 14762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR19B2 |
0.466054381693342 |
|
| 14763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR20B |
0.466054381693342 |
|
| 14764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR363 |
0.466054381693342 |
|
| 14765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR92A2 |
0.466054381693342 |
|
| 14766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC160 |
0.466054381693342 |
|
| 14767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF6 |
0.466054381693342 |
|
| 14768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPRT1 |
0.466054381693342 |
|
| 14769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR450A1 |
0.466054381693342 |
|
| 14770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR450A2 |
0.466054381693342 |
|
| 14771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR450B |
0.466054381693342 |
|
| 14772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR503HG |
0.466054381693342 |
|
| 14773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR542 |
0.466054381693342 |
|
| 14774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR503 |
0.466054381693342 |
|
| 14775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00629 |
0.466054381693342 |
|
| 14776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAC1 |
0.466054381693342 |
|
| 14777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM122B |
0.466054381693342 |
|
| 14778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM122C |
0.466054381693342 |
|
| 14779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOSPD1 |
0.466054381693342 |
|
| 14780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM10 |
0.466054381693342 |
|
| 14781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM127C |
0.466054381693342 |
|
| 14782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM127A |
0.466054381693342 |
|
| 14783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM127B |
0.466054381693342 |
|
| 14784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00087 |
0.466054381693342 |
|
| 14785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00633 |
0.466054381693342 |
|
| 14786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A1 |
0.466054381693342 |
|
| 14787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A2 |
0.466054381693342 |
|
| 14788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A3 |
0.466054381693342 |
|
| 14789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A4 |
0.466054381693342 |
|
| 14790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A5 |
0.466054381693342 |
|
| 14791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT45A6 |
0.466054381693342 |
|
| 14792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf48 |
0.466054381693342 |
|
| 14793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX26B |
0.466054381693342 |
|
| 14794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00086 |
0.466054381693342 |
|
| 14795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP515 |
0.466054381693342 |
|
| 14796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAGE1 |
0.466054381693342 |
|
| 14797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF449 |
0.466054381693342 |
|
| 14798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF75D |
0.466054381693342 |
|
| 14799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMGT1 |
0.466054381693342 |
|
| 14800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A6 |
0.466054381693342 |
|
| 14801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239080.1 |
0.466054381693342 |
|
| 14802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHL1 |
0.466054381693342 |
|
| 14803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP7D3 |
0.466054381693342 |
|
| 14804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR112 |
0.466054381693342 |
|
| 14805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRS3 |
0.466054381693342 |
|
| 14806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTATSF1 |
0.466054381693342 |
|
| 14807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VGLL1 |
0.466054381693342 |
|
| 14808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR934 |
0.466054381693342 |
|
| 14809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP31 |
0.466054381693342 |
|
| 14810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF13 |
0.466054381693342 |
|
| 14811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR504 |
0.466054381693342 |
|
| 14812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F9 |
0.466054381693342 |
|
| 14813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCF2 |
0.466054381693342 |
|
| 14814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP11C |
0.466054381693342 |
|
| 14815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf66 |
0.466054381693342 |
|
| 14816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR505 |
0.466054381693342 |
|
| 14817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL727P |
0.466054381693342 |
|
| 14818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC23P |
0.466054381693342 |
|
| 14819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000252719.1 |
0.466054381693342 |
|
| 14820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238485.1 |
0.466054381693342 |
|
| 14821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX3 |
0.466054381693342 |
|
| 14822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00632 |
0.466054381693342 |
|
| 14823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDR1 |
0.466054381693342 |
|
| 14824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320D2 |
0.466054381693342 |
|
| 14825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXB1 |
0.466054381693342 |
|
| 14826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXB2 |
0.466054381693342 |
|
| 14827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDOC1 |
0.466054381693342 |
|
| 14828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEC1 |
0.466054381693342 |
|
| 14829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEC3 |
0.466054381693342 |
|
| 14830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXA1 |
0.466054381693342 |
|
| 14831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXA2 |
0.466054381693342 |
|
| 14832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXC |
0.466054381693342 |
|
| 14833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXD |
0.466054381693342 |
|
| 14834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEC2 |
0.466054381693342 |
|
| 14835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP516 |
0.466054381693342 |
|
| 14836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239188.1 |
0.466054381693342 |
|
| 14837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXN4 |
0.466054381693342 |
|
| 14838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP81 |
0.466054381693342 |
|
| 14839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP149 |
0.466054381693342 |
|
| 14840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXN3 |
0.466054381693342 |
|
| 14841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK4 |
0.466054381693342 |
|
| 14842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXN2 |
0.466054381693342 |
|
| 14843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2NL |
0.466054381693342 |
|
| 14844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP189 |
0.466054381693342 |
|
| 14845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXN1 |
0.466054381693342 |
|
| 14846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK2 |
0.466054381693342 |
|
| 14847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM257 |
0.466054381693342 |
|
| 14848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR888 |
0.466054381693342 |
|
| 14849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR890 |
0.466054381693342 |
|
| 14850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR892A |
0.466054381693342 |
|
| 14851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR892B |
0.466054381693342 |
|
| 14852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR891B |
0.466054381693342 |
|
| 14853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR891A |
0.466054381693342 |
|
| 14854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP517 |
0.466054381693342 |
|
| 14855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFF2 |
0.466054381693342 |
|
| 14856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP267 |
0.466054381693342 |
|
| 14857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR1 |
0.466054381693342 |
|
| 14858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD99L2 |
0.466054381693342 |
|
| 14859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000253009.1 |
0.466054381693342 |
|
| 14860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB3 |
0.466054381693342 |
|
| 14861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4330 |
0.466054381693342 |
|
| 14862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR50 |
0.466054381693342 |
|
| 14863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VMA21 |
0.466054381693342 |
|
| 14864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PASD1 |
0.466054381693342 |
|
| 14865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRG3 |
0.466054381693342 |
|
| 14866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FATE1 |
0.466054381693342 |
|
| 14867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGA2 |
0.466054381693342 |
|
| 14868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA4 |
0.466054381693342 |
|
| 14869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRE |
0.466054381693342 |
|
| 14870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR224 |
0.466054381693342 |
|
| 14871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR452 |
0.466054381693342 |
|
| 14872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA10 |
0.466054381693342 |
|
| 14873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA3 |
0.466054381693342 |
|
| 14874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR767 |
0.466054381693342 |
|
| 14875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRQ |
0.466054381693342 |
|
| 14876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CETN2 |
0.466054381693342 |
|
| 14877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSAG1 |
0.466054381693342 |
|
| 14878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSAG2 |
0.466054381693342 |
|
| 14879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSAG3 |
0.466054381693342 |
|
| 14880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSAG4 |
0.466054381693342 |
|
| 14881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA12 |
0.466054381693342 |
|
| 14882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA1 |
0.466054381693342 |
|
| 14883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA2B |
0.466054381693342 |
|
| 14884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA2 |
0.466054381693342 |
|
| 14885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA3 |
0.466054381693342 |
|
| 14886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA6 |
0.466054381693342 |
|
| 14887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSDHL |
0.466054381693342 |
|
| 14888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA3 |
0.466054381693342 |
|
| 14889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA5 |
0.466054381693342 |
|
| 14890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA6A |
0.466054381693342 |
|
| 14891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA6B |
0.466054381693342 |
|
| 14892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA6C |
0.466054381693342 |
|
| 14893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA6D |
0.466054381693342 |
|
| 14894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL190P |
0.466054381693342 |
|
| 14895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL667P |
0.466054381693342 |
|
| 14896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP92 |
0.466054381693342 |
|
| 14897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF185 |
0.466054381693342 |
|
| 14898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF275 |
0.466054381693342 |
|
| 14899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239037.1 |
0.466054381693342 |
|
| 14900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS7 |
0.466054381693342 |
|
| 14901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TREX2 |
0.466054381693342 |
|
| 14902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BGN |
0.466054381693342 |
|
| 14903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2B3 |
0.466054381693342 |
|
| 14904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM58A |
0.466054381693342 |
|
| 14905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP9 |
0.466054381693342 |
|
| 14906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL687P |
0.466054381693342 |
|
| 14907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNCK |
0.466054381693342 |
|
| 14908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A8 |
0.466054381693342 |
|
| 14909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAP31 |
0.466054381693342 |
|
| 14910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCD1 |
0.466054381693342 |
|
| 14911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNB3 |
0.466054381693342 |
|
| 14912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDH3G |
0.466054381693342 |
|
| 14913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPK3 |
0.466054381693342 |
|
| 14914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSR4 |
0.466054381693342 |
|
| 14915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD4 |
0.466054381693342 |
|
| 14916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36|ENSG00000251846.1 |
0.466054381693342 |
|
| 14917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L1CAM |
0.466054381693342 |
|
| 14918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCA10 |
0.466054381693342 |
|
| 14919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVPR2 |
0.466054381693342 |
|
| 14920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP4 |
0.466054381693342 |
|
| 14921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA10 |
0.466054381693342 |
|
| 14922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCFC1 |
0.466054381693342 |
|
| 14923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RENBP |
0.466054381693342 |
|
| 14924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM187 |
0.466054381693342 |
|
| 14925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRAK1 |
0.466054381693342 |
|
| 14926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MECP2 |
0.466054381693342 |
|
| 14927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR718 |
0.466054381693342 |
|
| 14928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN1LW |
0.466054381693342 |
|
| 14929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN1MW2 |
0.466054381693342 |
|
| 14930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPN1MW |
0.466054381693342 |
|
| 14931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX28P1 |
0.466054381693342 |
|
| 14932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX28P2 |
0.466054381693342 |
|
| 14933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX28 |
0.466054381693342 |
|
| 14934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TKTL1 |
0.466054381693342 |
|
| 14935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMD |
0.466054381693342 |
|
| 14936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLNA |
0.466054381693342 |
|
| 14937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL10 |
0.466054381693342 |
|
| 14938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000207165.1 |
0.466054381693342 |
|
| 14939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE1L1 |
0.466054381693342 |
|
| 14940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAZ |
0.466054381693342 |
|
| 14941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6AP1 |
0.466054381693342 |
|
| 14942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM50A |
0.466054381693342 |
|
| 14943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDI1 |
0.466054381693342 |
|
| 14944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNA3 |
0.466054381693342 |
|
| 14945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAGE3 |
0.466054381693342 |
|
| 14946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBL4A |
0.466054381693342 |
|
| 14947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A3 |
0.466054381693342 |
|
| 14948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL697P |
0.466054381693342 |
|
| 14949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL742P |
0.466054381693342 |
|
| 14950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM3A |
0.466054381693342 |
|
| 14951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G6PD |
0.466054381693342 |
|
| 14952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKBKG |
0.466054381693342 |
|
| 14953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRCC3 |
0.466054381693342 |
|
| 14954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC2 |
0.466054381693342 |
|
| 14955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMC4 |
0.466054381693342 |
|
| 14956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAG1A |
0.466054381693342 |
|
| 14957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAG1B |
0.466054381693342 |
|
| 14958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAG2 |
0.466054381693342 |
|
| 14959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKC1 |
0.466054381693342 |
|
| 14960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F8A1 |
0.466054381693342 |
|
| 14961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F8A2 |
0.466054381693342 |
|
| 14962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F8A3 |
0.466054381693342 |
|
| 14963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F8 |
0.466054381693342 |
|
| 14964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUNDC2 |
0.466054381693342 |
|
| 14965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAB3 |
0.466054381693342 |
|
| 14966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFB1 |
0.466054381693342 |
|
| 14967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFB2 |
0.466054381693342 |
|
| 14968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFB3 |
0.466054381693342 |
|
| 14969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP1 |
0.466054381693342 |
|
| 14970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTCP1 |
0.466054381693342 |
|
| 14971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB39B |
0.466054381693342 |
|
| 14972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM9 |
0.466054381693342 |
|
| 14973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA36A |
0.466054381693342 |
|
| 14974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA56 |
0.466054381693342 |
|
| 14975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMLHE |
0.466054381693342 |
|
| 14976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VBP1 |
0.466054381693342 |
|
| 14977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL9R|ENSG00000124334.12 |
0.466054381693342 |
|
| 14978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRY3|ENSG00000168939.6 |
0.466054381693342 |
|
| 14979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP7|ENSG00000124333.10 |
0.466054381693342 |
|
| 14980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASH6P|ENSG00000182484.10 |
0.466054381693342 |
|
| 14981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASIR1|ENSG00000185203.7
|
0.466054381693342
|
|
| 14982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC6BP1 |
0.468597722127392 |
|
| 14983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP65 |
0.468597722127392 |
|
| 14984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FARP1 |
0.470001850253895 |
|
| 14985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIXL1 |
0.470126955858913 |
|
| 14986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT9A |
0.470126955858913 |
|
| 14987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5008 |
0.470126955858913 |
|
| 14988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT3A |
0.470126955858913 |
|
| 14989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARF1 |
0.470126955858913 |
|
| 14990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3620 |
0.470126955858913 |
|
| 14991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf35 |
0.470126955858913 |
|
| 14992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL55 |
0.470126955858913 |
|
| 14993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJC2 |
0.470126955858913 |
|
| 14994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUK1 |
0.470126955858913 |
|
| 14995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf148 |
0.470126955858913 |
|
| 14996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IBA57 |
0.470126955858913 |
|
| 14997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf145 |
0.470126955858913 |
|
| 14998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOU |
0.470126955858913 |
|
| 14999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM78 |
0.470126955858913 |
|
| 15000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB4A |
0.470126955858913 |
|
| 15001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPHAR |
0.470126955858913 |
|
| 15002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCSAP |
0.470126955858913 |
|
| 15003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP276 |
0.470126955858913 |
|
| 15004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTA1 |
0.470126955858913 |
|
| 15005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP133 |
0.470126955858913 |
|
| 15006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB10 |
0.470126955858913 |
|
| 15007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP78 |
0.470126955858913 |
|
| 15008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF5L |
0.470126955858913 |
|
| 15009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URB2 |
0.470126955858913 |
|
| 15010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT2 |
0.470126955858913 |
|
| 15011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGBD5 |
0.470126955858913 |
|
| 15012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG2 |
0.470126955858913 |
|
| 15013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGT |
0.470126955858913 |
|
| 15014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL467P |
0.470126955858913 |
|
| 15015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN9 |
0.470126955858913 |
|
| 15016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP79 |
0.470126955858913 |
|
| 15017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf198 |
0.470126955858913 |
|
| 15018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL837P |
0.470126955858913 |
|
| 15019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238985.1 |
0.470126955858913 |
|
| 15020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC13 |
0.470126955858913 |
|
| 15021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARV1 |
0.470126955858913 |
|
| 15022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM89A |
0.470126955858913 |
|
| 15023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1182 |
0.470126955858913 |
|
| 15024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM67 |
0.470126955858913 |
|
| 15025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf131 |
0.470126955858913 |
|
| 15026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPAT |
0.470126955858913 |
|
| 15027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP80 |
0.470126955858913 |
|
| 15028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC8 |
0.470126955858913 |
|
| 15029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRTN |
0.470126955858913 |
|
| 15030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGLN1 |
0.470126955858913 |
|
| 15031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAX |
0.470126955858913 |
|
| 15032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSNAX |
0.470126955858913 |
|
| 15033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DISC1 |
0.470126955858913 |
|
| 15034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00582 |
0.470126955858913 |
|
| 15035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL299P |
0.470126955858913 |
|
| 15036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIPA1L2 |
0.470126955858913 |
|
| 15037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00158 |
0.470778416838732 |
|
| 15038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238314.1 |
0.470778416838732 |
|
| 15039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR155HG |
0.470778416838732 |
|
| 15040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00515 |
0.470778416838732 |
|
| 15041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL39 |
0.470778416838732 |
|
| 15042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAM2 |
0.470778416838732 |
|
| 15043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5J |
0.470778416838732 |
|
| 15044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABPA |
0.470778416838732 |
|
| 15045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APP |
0.470778416838732 |
|
| 15046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYYR1 |
0.470778416838732 |
|
| 15047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS1 |
0.470778416838732 |
|
| 15048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS5 |
0.470778416838732 |
|
| 15049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4759 |
0.470778416838732 |
|
| 15050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00113 |
0.470778416838732 |
|
| 15051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00314 |
0.470778416838732 |
|
| 15052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9orf92 |
0.471588755348097 |
|
| 15053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNC2 |
0.471588755348097 |
|
| 15054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL720P |
0.471588755348097 |
|
| 15055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTLN |
0.471588755348097 |
|
| 15056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC19 |
0.471976586714301 |
|
| 15057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP226 |
0.472372715492303 |
|
| 15058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDIM1 |
0.472372715492303 |
|
| 15059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00473 |
0.472372715492303 |
|
| 15060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL4A |
0.473572834654126 |
|
| 15061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMP1 |
0.473572834654126 |
|
| 15062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRTP1 |
0.473572834654126 |
|
| 15063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADPRHL1 |
0.473572834654126 |
|
| 15064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCUN1D2 |
0.473572834654126 |
|
| 15065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO3 |
0.473572834654126 |
|
| 15066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFDP1 |
0.473572834654126 |
|
| 15067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP4B |
0.473572834654126 |
|
| 15068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS6 |
0.473572834654126 |
|
| 15069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRK1 |
0.473572834654126 |
|
| 15070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00454 |
0.473572834654126 |
|
| 15071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM255B |
0.473572834654126 |
|
| 15072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00453 |
0.473572834654126 |
|
| 15073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00452 |
0.473572834654126 |
|
| 15074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00565 |
0.473572834654126 |
|
| 15075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISL1 |
0.474666550279965 |
|
| 15076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP182 |
0.474666550279965 |
|
| 15077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF1B |
0.474775890542822 |
|
| 15078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1273D |
0.474775890542822 |
|
| 15079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL731P |
0.474775890542822 |
|
| 15080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL721P |
0.474775890542822 |
|
| 15081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGD |
0.474775890542822 |
|
| 15082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APITD1 |
0.474775890542822 |
|
| 15083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORT |
0.474775890542822 |
|
| 15084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DFFA |
0.474775890542822 |
|
| 15085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX14 |
0.474775890542822 |
|
| 15086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL614P |
0.474775890542822 |
|
| 15087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASZ1 |
0.474775890542822 |
|
| 15088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf127 |
0.474775890542822 |
|
| 15089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARDBP |
0.474775890542822 |
|
| 15090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MASP2 |
0.474775890542822 |
|
| 15091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRM |
0.474775890542822 |
|
| 15092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMO1 |
0.476839403124516 |
|
| 15093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK33 |
0.476839403124516 |
|
| 15094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000252778.1 |
0.476839403124516 |
|
| 15095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM66 |
0.476839403124516 |
|
| 15096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL27A |
0.476839403124516 |
|
| 15097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000200983.1 |
0.476839403124516 |
|
| 15098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA45 |
0.476839403124516 |
|
| 15099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST5 |
0.476839403124516 |
|
| 15100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP330 |
0.476839403124516 |
|
| 15101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKIP1 |
0.476839403124516 |
|
| 15102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf16 |
0.476839403124516 |
|
| 15103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCL3 |
0.476839403124516 |
|
| 15104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM9B |
0.476839403124516 |
|
| 15105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRIP3 |
0.476839403124516 |
|
| 15106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCUBE2 |
0.476839403124516 |
|
| 15107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5691 |
0.476839403124516 |
|
| 15108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND5A |
0.476839403124516 |
|
| 15109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM41B |
0.476839403124516 |
|
| 15110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO7 |
0.476839403124516 |
|
| 15111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA23 |
0.476839403124516 |
|
| 15112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF143 |
0.476839403124516 |
|
| 15113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTR9 |
0.476839403124516 |
|
| 15114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4G2 |
0.476839403124516 |
|
| 15115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD97 |
0.476839403124516 |
|
| 15116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED5 |
0.476839403124516 |
|
| 15117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAR1 |
0.476839403124516 |
|
| 15118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP331 |
0.476839403124516 |
|
| 15119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUCB2 |
0.476839403124516 |
|
| 15120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCR3LG1 |
0.476839403124516 |
|
| 15121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ11 |
0.476839403124516 |
|
| 15122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC8 |
0.476839403124516 |
|
| 15123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USH1C |
0.476839403124516 |
|
| 15124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOG |
0.476839403124516 |
|
| 15125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOD1 |
0.476839403124516 |
|
| 15126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNC1 |
0.476839403124516 |
|
| 15127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERGEF |
0.476839403124516 |
|
| 15128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPH1 |
0.476839403124516 |
|
| 15129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAAL1 |
0.476839403124516 |
|
| 15130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAA3P |
0.476839403124516 |
|
| 15131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRX3 |
0.476839403124516 |
|
| 15132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRX4 |
0.476839403124516 |
|
| 15133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAA4 |
0.476839403124516 |
|
| 15134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAA2 |
0.476839403124516 |
|
| 15135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP333 |
0.476839403124516 |
|
| 15136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP334 |
0.476839403124516 |
|
| 15137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAA1 |
0.476839403124516 |
|
| 15138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPS5 |
0.476839403124516 |
|
| 15139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H1 |
0.476839403124516 |
|
| 15140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3159 |
0.476839403124516 |
|
| 15141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHA |
0.476839403124516 |
|
| 15142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHC |
0.476839403124516 |
|
| 15143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT3 |
0.476839403124516 |
|
| 15144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A5 |
0.476839403124516 |
|
| 15145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00678 |
0.476839403124516 |
|
| 15146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDNF |
0.476839403124516 |
|
| 15147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF18A |
0.476839403124516 |
|
| 15148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR610 |
0.476839403124516 |
|
| 15149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL15 |
0.476839403124516 |
|
| 15150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP158 |
0.476839403124516 |
|
| 15151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1549L |
0.476839403124516 |
|
| 15152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf91 |
0.476839403124516 |
|
| 15153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD59 |
0.476839403124516 |
|
| 15154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO3 |
0.476839403124516 |
|
| 15155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMO2 |
0.476839403124516 |
|
| 15156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPRIN1 |
0.476839403124516 |
|
| 15157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT10 |
0.476839403124516 |
|
| 15158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHF |
0.476839403124516 |
|
| 15159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH3 |
0.476839403124516 |
|
| 15160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf96 |
0.476839403124516 |
|
| 15161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00971 |
0.481687157747449 |
|
| 15162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CADM2 |
0.481687157747449 |
|
| 15163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5688 |
0.481687157747449 |
|
| 15164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ40 |
0.481687157747449 |
|
| 15165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP284 |
0.481687157747449 |
|
| 15166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VGLL3 |
0.481687157747449 |
|
| 15167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP2B |
0.481687157747449 |
|
| 15168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4795 |
0.481687157747449 |
|
| 15169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU1F1 |
0.481687157747449 |
|
| 15170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCD2 |
0.483483870635778 |
|
| 15171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf40 |
0.483483870635778 |
|
| 15172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A13 |
0.483483870635778 |
|
| 15173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA22|ENSG00000199571.1 |
0.483483870635778 |
|
| 15174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRK2 |
0.483483870635778 |
|
| 15175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE3C |
0.492469811859957 |
|
| 15176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL142P |
0.492469811859957 |
|
| 15177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB6 |
0.492469811859957 |
|
| 15178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSORS1C2 |
0.493950691467088 |
|
| 15179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCHCR1 |
0.493950691467088 |
|
| 15180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF19 |
0.493950691467088 |
|
| 15181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU5F1 |
0.493950691467088 |
|
| 15182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSORS1C3 |
0.493950691467088 |
|
| 15183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG27 |
0.493950691467088 |
|
| 15184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD16A |
0.493950691467088 |
|
| 15185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGER |
0.493950691467088 |
|
| 15186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT1 |
0.493950691467088 |
|
| 15187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIF1 |
0.493950691467088 |
|
| 15188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOM |
0.493950691467088 |
|
| 15189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF6B |
0.493950691467088 |
|
| 15190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1G2 |
0.493950691467088 |
|
| 15191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG6 |
0.493950691467088 |
|
| 15192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTNL2 |
0.493950691467088 |
|
| 15193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2 |
0.493950691467088 |
|
| 15194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4A |
0.493950691467088 |
|
| 15195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4B |
0.493950691467088 |
|
| 15196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf10 |
0.493950691467088 |
|
| 15197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf25 |
0.493950691467088 |
|
| 15198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf47 |
0.493950691467088 |
|
| 15199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf48 |
0.493950691467088 |
|
| 15200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFB |
0.493950691467088 |
|
| 15201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC1 |
0.493950691467088 |
|
| 15202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK2B |
0.493950691467088 |
|
| 15203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP21A1P |
0.493950691467088 |
|
| 15204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP21A2 |
0.493950691467088 |
|
| 15205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDAH2 |
0.493950691467088 |
|
| 15206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX39B |
0.493950691467088 |
|
| 15207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOM3Z |
0.493950691467088 |
|
| 15208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFL8 |
0.493950691467088 |
|
| 15209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHMT2 |
0.493950691467088 |
|
| 15210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBPL |
0.493950691467088 |
|
| 15211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPANK1 |
0.493950691467088 |
|
| 15212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPSM3 |
0.493950691467088 |
|
| 15213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG23 |
0.493950691467088 |
|
| 15214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCP5 |
0.493950691467088 |
|
| 15215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA1A |
0.493950691467088 |
|
| 15216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA1B |
0.493950691467088 |
|
| 15217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA1L |
0.493950691467088 |
|
| 15218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM2 |
0.493950691467088 |
|
| 15219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LST1 |
0.493950691467088 |
|
| 15220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTA |
0.493950691467088 |
|
| 15221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTB |
0.493950691467088 |
|
| 15222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G5B |
0.493950691467088 |
|
| 15223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G5C |
0.493950691467088 |
|
| 15224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G6C |
0.493950691467088 |
|
| 15225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G6D |
0.493950691467088 |
|
| 15226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G6E |
0.493950691467088 |
|
| 15227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY6G6F |
0.493950691467088 |
|
| 15228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCCD1 |
0.493950691467088 |
|
| 15229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGT1 |
0.493950691467088 |
|
| 15230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICA |
0.493950691467088 |
|
| 15231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICB |
0.493950691467088 |
|
| 15232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1236 |
0.493950691467088 |
|
| 15233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3135B |
0.493950691467088 |
|
| 15234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4646 |
0.493950691467088 |
|
| 15235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSH5 |
0.493950691467088 |
|
| 15236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCR3 |
0.493950691467088 |
|
| 15237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELFE |
0.493950691467088 |
|
| 15238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEU1 |
0.493950691467088 |
|
| 15239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBIL1 |
0.493950691467088 |
|
| 15240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTCH4 |
0.493950691467088 |
|
| 15241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBX2 |
0.493950691467088 |
|
| 15242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R2P1 |
0.493950691467088 |
|
| 15243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPT2 |
0.493950691467088 |
|
| 15244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRC2A |
0.493950691467088 |
|
| 15245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRT1 |
0.493950691467088 |
|
| 15246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB8 |
0.493950691467088 |
|
| 15247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB9 |
0.493950691467088 |
|
| 15248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP206 |
0.493950691467088 |
|
| 15249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF5 |
0.493950691467088 |
|
| 15250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAPCD1 |
0.493950691467088 |
|
| 15251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKIV2L |
0.493950691467088 |
|
| 15252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC44A4 |
0.493950691467088 |
|
| 15253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA38|ENSG00000200816.1 |
0.493950691467088 |
|
| 15254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD117 |
0.493950691467088 |
|
| 15255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD48 |
0.493950691467088 |
|
| 15256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD52 |
0.493950691467088 |
|
| 15257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD84 |
0.493950691467088 |
|
| 15258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK19 |
0.493950691467088 |
|
| 15259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAP1 |
0.493950691467088 |
|
| 15260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAP2 |
0.493950691467088 |
|
| 15261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNF |
0.493950691467088 |
|
| 15262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNXB |
0.493950691467088 |
|
| 15263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VARS |
0.493950691467088 |
|
| 15264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA7 |
0.493950691467088 |
|
| 15265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB12 |
0.493950691467088 |
|
| 15266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS22 |
0.503834818419737 |
|
| 15267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO43 |
0.503834818419737 |
|
| 15268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2K |
0.503834818419737 |
|
| 15269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG1 |
0.503834818419737 |
|
| 15270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF19A |
0.503834818419737 |
|
| 15271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4471 |
0.503834818419737 |
|
| 15272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD46 |
0.503834818419737 |
|
| 15273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX31 |
0.503834818419737 |
|
| 15274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC1 |
0.503834818419737 |
|
| 15275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC41P |
0.503834818419737 |
|
| 15276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAZ |
0.503834818419737 |
|
| 15277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL685P |
0.503834818419737 |
|
| 15278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP249 |
0.503834818419737 |
|
| 15279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF706 |
0.503834818419737 |
|
| 15280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACAP1 |
0.503834818419737 |
|
| 15281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL563P |
0.503834818419737 |
|
| 15282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRHL2 |
0.503834818419737 |
|
| 15283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCALD |
0.503834818419737 |
|
| 15284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238372.1 |
0.503834818419737 |
|
| 15285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5680 |
0.503834818419737 |
|
| 15286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRM2B |
0.503834818419737 |
|
| 15287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR5 |
0.503834818419737 |
|
| 15288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238533.1 |
0.503834818419737 |
|
| 15289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC8P |
0.503834818419737 |
|
| 15290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF1 |
0.503834818419737 |
|
| 15291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF10 |
0.503834818419737 |
|
| 15292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZIN1 |
0.503834818419737 |
|
| 15293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1C1 |
0.503834818419737 |
|
| 15294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf56 |
0.503834818419737 |
|
| 15295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAALC |
0.503834818419737 |
|
| 15296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3151 |
0.503834818419737 |
|
| 15297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD6 |
0.503834818419737 |
|
| 15298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTHRC1 |
0.503834818419737 |
|
| 15299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A32 |
0.503834818419737 |
|
| 15300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF13 |
0.503834818419737 |
|
| 15301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMS2 |
0.503834818419737 |
|
| 15302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238687.1 |
0.503834818419737 |
|
| 15303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYS |
0.503834818419737 |
|
| 15304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCSTAMP |
0.503834818419737 |
|
| 15305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548A3 |
0.503834818419737 |
|
| 15306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP12 |
0.503834818419737 |
|
| 15307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO9 |
0.503966049414477 |
|
| 15308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATHL1 |
0.503966049414477 |
|
| 15309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALNT4 |
0.503966049414477 |
|
| 15310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BET1L |
0.503966049414477 |
|
| 15311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFITM1 |
0.503966049414477 |
|
| 15312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFITM2 |
0.503966049414477 |
|
| 15313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFITM3 |
0.503966049414477 |
|
| 15314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFITM5 |
0.503966049414477 |
|
| 15315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRP6 |
0.503966049414477 |
|
| 15316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF3 |
0.503966049414477 |
|
| 15317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKP3 |
0.503966049414477 |
|
| 15318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD13 |
0.503966049414477 |
|
| 15319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTDSS2 |
0.503966049414477 |
|
| 15320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIC8A |
0.503966049414477 |
|
| 15321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL838P |
0.503966049414477 |
|
| 15322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB1C1 |
0.503966049414477 |
|
| 15323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGIRR |
0.503966049414477 |
|
| 15324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT3 |
0.503966049414477 |
|
| 15325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNH1 |
0.503966049414477 |
|
| 15326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRAS |
0.503966049414477 |
|
| 15327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC56 |
0.503966049414477 |
|
| 15328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf35 |
0.503966049414477 |
|
| 15329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF7 |
0.503966049414477 |
|
| 15330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR210HG |
0.503966049414477 |
|
| 15331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR210 |
0.503966049414477 |
|
| 15332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHRF1 |
0.503966049414477 |
|
| 15333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDHR5 |
0.503966049414477 |
|
| 15334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF7 |
0.503966049414477 |
|
| 15335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCT |
0.503966049414477 |
|
| 15336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRD4 |
0.503966049414477 |
|
| 15337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEAF1 |
0.503966049414477 |
|
| 15338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS8L2 |
0.503966049414477 |
|
| 15339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM80 |
0.503966049414477 |
|
| 15340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TALDO1 |
0.503966049414477 |
|
| 15341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDDC1 |
0.503966049414477 |
|
| 15342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEND1 |
0.503966049414477 |
|
| 15343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A22 |
0.503966049414477 |
|
| 15344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIDD |
0.503966049414477 |
|
| 15345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPLP2 |
0.503966049414477 |
|
| 15346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA52 |
0.503966049414477 |
|
| 15347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA2 |
0.503966049414477 |
|
| 15348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD151 |
0.503966049414477 |
|
| 15349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB4A |
0.503966049414477 |
|
| 15350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2L |
0.503966049414477 |
|
| 15351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN4 |
0.503966049414477 |
|
| 15352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHID1 |
0.503966049414477 |
|
| 15353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP2A2 |
0.503966049414477 |
|
| 15354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC6 |
0.503966049414477 |
|
| 15355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC2 |
0.503966049414477 |
|
| 15356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC5AC |
0.503966049414477 |
|
| 15357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC5B |
0.503966049414477 |
|
| 15358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOLLIP |
0.503966049414477 |
|
| 15359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB2 |
0.503966049414477 |
|
| 15360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP8 |
0.503966049414477 |
|
| 15361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSD |
0.503966049414477 |
|
| 15362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM99A |
0.503966049414477 |
|
| 15363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM99B |
0.503966049414477 |
|
| 15364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFITM10 |
0.503966049414477 |
|
| 15365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSP1|ENSG00000130592.9 |
0.503966049414477 |
|
| 15366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4298 |
0.503966049414477 |
|
| 15367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT8 |
0.503966049414477 |
|
| 15368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNI2 |
0.503966049414477 |
|
| 15369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf89 |
0.503966049414477 |
|
| 15370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNT3 |
0.503966049414477 |
|
| 15371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL23 |
0.503966049414477 |
|
| 15372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H19 |
0.503966049414477 |
|
| 15373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF2 |
0.503966049414477 |
|
| 15374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR483 |
0.503966049414477 |
|
| 15375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INS |
0.503966049414477 |
|
| 15376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4686 |
0.503966049414477 |
|
| 15377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TH |
0.503966049414477 |
|
| 15378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN9 |
0.507053757239922 |
|
| 15379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238545.1 |
0.507053757239922 |
|
| 15380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239094.1 |
0.507053757239922 |
|
| 15381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP1 |
0.507053757239922 |
|
| 15382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP165 |
0.507053757239922 |
|
| 15383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf95 |
0.507053757239922 |
|
| 15384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPKB |
0.507053757239922 |
|
| 15385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSEN2 |
0.507053757239922 |
|
| 15386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCK3 |
0.507053757239922 |
|
| 15387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42BPA |
0.507053757239922 |
|
| 15388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP77 |
0.507053757239922 |
|
| 15389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF678 |
0.507053757239922 |
|
| 15390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMJD4 |
0.507053757239922 |
|
| 15391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAP47 |
0.507053757239922 |
|
| 15392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS38 |
0.507053757239922 |
|
| 15393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA8P1 |
0.507878346540013 |
|
| 15394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFHAS1 |
0.508975302691799 |
|
| 15395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWOX |
0.509552752484337 |
|
| 15396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00161 |
0.509979119747606 |
|
| 15397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N6AMT1 |
0.509979119747606 |
|
| 15398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTN1 |
0.509979119747606 |
|
| 15399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RWDD2B |
0.509979119747606 |
|
| 15400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K7CL |
0.509979119747606 |
|
| 15401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212479.1 |
0.509979119747606 |
|
| 15402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BACH1 |
0.509979119747606 |
|
| 15403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00189 |
0.509979119747606 |
|
| 15404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239171.1 |
0.509979119747606 |
|
| 15405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIK1 |
0.509979119747606 |
|
| 15406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN17 |
0.509979119747606 |
|
| 15407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00307 |
0.509979119747606 |
|
| 15408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN8 |
0.509979119747606 |
|
| 15409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4327 |
0.509979119747606 |
|
| 15410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR72 |
0.510033517779458 |
|
| 15411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC13C |
0.510033517779458 |
|
| 15412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSL24D1 |
0.510033517779458 |
|
| 15413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB27A |
0.510033517779458 |
|
| 15414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGB |
0.510033517779458 |
|
| 15415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCPG1 |
0.510033517779458 |
|
| 15416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR628 |
0.510033517779458 |
|
| 15417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf65 |
0.510033517779458 |
|
| 15418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYX1C1 |
0.510033517779458 |
|
| 15419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYGO1 |
0.510033517779458 |
|
| 15420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF7IP2 |
0.514069378935141 |
|
| 15421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO4 |
0.516789076623062 |
|
| 15422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A8 |
0.516789076623062 |
|
| 15423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP20 |
0.516789076623062 |
|
| 15424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238800.1 |
0.516789076623062 |
|
| 15425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL56P |
0.517360832594974 |
|
| 15426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WEE1 |
0.517360832594974 |
|
| 15427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238387.1 |
0.517360832594974 |
|
| 15428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SWAP70 |
0.517360832594974 |
|
| 15429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP50 |
0.517360832594974 |
|
| 15430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBF2 |
0.517360832594974 |
|
| 15431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADM |
0.517360832594974 |
|
| 15432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMPD3 |
0.517360832594974 |
|
| 15433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC33P |
0.517360832594974 |
|
| 15434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L8 |
0.517360832594974 |
|
| 15435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF141 |
0.517360832594974 |
|
| 15436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYVE1 |
0.517360832594974 |
|
| 15437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRVI1 |
0.517360832594974 |
|
| 15438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT18 |
0.517360832594974 |
|
| 15439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK2A3 |
0.517360832594974 |
|
| 15440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4299 |
0.517360832594974 |
|
| 15441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP47 |
0.517360832594974 |
|
| 15442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKK3 |
0.517360832594974 |
|
| 15443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICAL2 |
0.517360832594974 |
|
| 15444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICALCL |
0.517360832594974 |
|
| 15445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARVA |
0.517360832594974 |
|
| 15446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEAD1 |
0.517360832594974 |
|
| 15447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA16|ENSG00000252329.1 |
0.517360832594974 |
|
| 15448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00958 |
0.517360832594974 |
|
| 15449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARNTL |
0.517360832594974 |
|
| 15450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP151 |
0.517360832594974 |
|
| 15451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD10 |
0.517360832594974 |
|
| 15452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPON1 |
0.517360832594974 |
|
| 15453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP332 |
0.517360832594974 |
|
| 15454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAS2 |
0.517360832594974 |
|
| 15455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPB1 |
0.517360832594974 |
|
| 15456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA1 |
0.517360832594974 |
|
| 15457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE3B |
0.517360832594974 |
|
| 15458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP2R1 |
0.517360832594974 |
|
| 15459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCB |
0.517360832594974 |
|
| 15460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCA |
0.517360832594974 |
|
| 15461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSC |
0.517360832594974 |
|
| 15462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL188P |
0.517360832594974 |
|
| 15463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA7 |
0.517360832594974 |
|
| 15464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP90 |
0.517360832594974 |
|
| 15465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7E14P |
0.517360832594974 |
|
| 15466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS13 |
0.517360832594974 |
|
| 15467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14A |
0.517360832594974 |
|
| 15468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14B |
0.517360832594974 |
|
| 15469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3C2A |
0.517360832594974 |
|
| 15470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHAL6A |
0.517360832594974 |
|
| 15471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSG101 |
0.517360832594974 |
|
| 15472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UEVLD |
0.517360832594974 |
|
| 15473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTY2D1 |
0.517360832594974 |
|
| 15474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM86A |
0.517360832594974 |
|
| 15475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF22 |
0.517360832594974 |
|
| 15476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN5 |
0.517360832594974 |
|
| 15477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRX1 |
0.517360832594974 |
|
| 15478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRGPRX2 |
0.517360832594974 |
|
| 15479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC13 |
0.517360832594974 |
|
| 15480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRP3 |
0.517360832594974 |
|
| 15481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F8 |
0.517360832594974 |
|
| 15482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAV2 |
0.517360832594974 |
|
| 15483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP335 |
0.517360832594974 |
|
| 15484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4486 |
0.517360832594974 |
|
| 15485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA1|ENSG00000207407.1 |
0.517360832594974 |
|
| 15486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4694 |
0.517360832594974 |
|
| 15487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBX1 |
0.517360832594974 |
|
| 15488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTATIP2 |
0.517360832594974 |
|
| 15489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELL1 |
0.517360832594974 |
|
| 15490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP336 |
0.517360832594974 |
|
| 15491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP337 |
0.517360832594974 |
|
| 15492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO5 |
0.517360832594974 |
|
| 15493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A6 |
0.517360832594974 |
|
| 15494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCF |
0.517360832594974 |
|
| 15495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS2 |
0.517360832594974 |
|
| 15496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP338 |
0.517360832594974 |
|
| 15497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVIP |
0.517360832594974 |
|
| 15498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC179 |
0.517360832594974 |
|
| 15499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUZP2 |
0.517360832594974 |
|
| 15500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO3 |
0.517360832594974 |
|
| 15501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC15 |
0.517360832594974 |
|
| 15502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A12 |
0.517360832594974 |
|
| 15503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIBIN |
0.517360832594974 |
|
| 15504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBOX1 |
0.517360832594974 |
|
| 15505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC34 |
0.517360832594974 |
|
| 15506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGR4 |
0.517360832594974 |
|
| 15507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN7C |
0.517360832594974 |
|
| 15508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP339 |
0.517360832594974 |
|
| 15509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL240P |
0.517360832594974 |
|
| 15510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA4 |
0.517360832594974 |
|
| 15511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSHB |
0.517360832594974 |
|
| 15512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL14EP |
0.517360832594974 |
|
| 15513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPPED2 |
0.517360832594974 |
|
| 15514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCDC1 |
0.517360832594974 |
|
| 15515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC24 |
0.517360832594974 |
|
| 15516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMMP1L |
0.517360832594974 |
|
| 15517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELP4 |
0.517360832594974 |
|
| 15518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX6 |
0.517360832594974 |
|
| 15519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCN1 |
0.517360832594974 |
|
| 15520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212551.1 |
0.517360832594974 |
|
| 15521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WT1 |
0.517360832594974 |
|
| 15522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3M |
0.517360832594974 |
|
| 15523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC73 |
0.517360832594974 |
|
| 15524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRG4 |
0.517360832594974 |
|
| 15525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QSER1 |
0.517360832594974 |
|
| 15526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPDC7 |
0.517360832594974 |
|
| 15527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11L1 |
0.517360832594974 |
|
| 15528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTF3 |
0.517360832594974 |
|
| 15529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIPK3 |
0.517360832594974 |
|
| 15530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABTB2 |
0.517360832594974 |
|
| 15531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAT |
0.517360832594974 |
|
| 15532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELF5 |
0.517360832594974 |
|
| 15533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APIP |
0.517360832594974 |
|
| 15534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDHX |
0.517360832594974 |
|
| 15535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1343 |
0.517360832594974 |
|
| 15536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD44 |
0.517360832594974 |
|
| 15537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A2 |
0.517360832594974 |
|
| 15538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAMR1 |
0.517360832594974 |
|
| 15539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FJX1 |
0.517360832594974 |
|
| 15540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM44 |
0.517360832594974 |
|
| 15541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLRAD3 |
0.517360832594974 |
|
| 15542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3973 |
0.517360832594974 |
|
| 15543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD9 |
0.517360832594974 |
|
| 15544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00610 |
0.517360832594974 |
|
| 15545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR5L |
0.517360832594974 |
|
| 15546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF6 |
0.517360832594974 |
|
| 15547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAG1 |
0.517360832594974 |
|
| 15548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAG2 |
0.517360832594974 |
|
| 15549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf74 |
0.517360832594974 |
|
| 15550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000251838.1 |
0.517360832594974 |
|
| 15551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC4C |
0.517360832594974 |
|
| 15552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPKP3 |
0.517360832594974 |
|
| 15553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
API5 |
0.517360832594974 |
|
| 15554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC17 |
0.517360832594974 |
|
| 15555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP287 |
0.517360832594974 |
|
| 15556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B12 |
0.517360832594974 |
|
| 15557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR670 |
0.517360832594974 |
|
| 15558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK8IP1 |
0.517360832594974 |
|
| 15559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf94 |
0.517360832594974 |
|
| 15560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX16 |
0.517360832594974 |
|
| 15561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYLTL1B |
0.517360832594974 |
|
| 15562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF21A |
0.517360832594974 |
|
| 15563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB3L1 |
0.517360832594974 |
|
| 15564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKZ |
0.517360832594974 |
|
| 15565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRM4 |
0.517360832594974 |
|
| 15566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDK |
0.517360832594974 |
|
| 15567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4688 |
0.517360832594974 |
|
| 15568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMBRA1 |
0.517360832594974 |
|
| 15569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HARBI1 |
0.517360832594974 |
|
| 15570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG13 |
0.517360832594974 |
|
| 15571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP1 |
0.517360832594974 |
|
| 15572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF408 |
0.517360832594974 |
|
| 15573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F2 |
0.517360832594974 |
|
| 15574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKAP5 |
0.517360832594974 |
|
| 15575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5582 |
0.517360832594974 |
|
| 15576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD67|ENSG00000252427.1 |
0.517360832594974 |
|
| 15577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD67|ENSG00000212135.1 |
0.517360832594974 |
|
| 15578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP4 |
0.517360832594974 |
|
| 15579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFGAP2 |
0.517360832594974 |
|
| 15580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACSIN3 |
0.517360832594974 |
|
| 15581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL772P |
0.517360832594974 |
|
| 15582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDB2 |
0.517360832594974 |
|
| 15583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACP2 |
0.517360832594974 |
|
| 15584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1H3 |
0.517360832594974 |
|
| 15585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MADD |
0.517360832594974 |
|
| 15586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBPC3 |
0.517360832594974 |
|
| 15587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPI1 |
0.517360832594974 |
|
| 15588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4487 |
0.517360832594974 |
|
| 15589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A13 |
0.517360832594974 |
|
| 15590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMC3 |
0.517360832594974 |
|
| 15591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPSN |
0.517360832594974 |
|
| 15592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF1 |
0.517360832594974 |
|
| 15593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL652P |
0.517360832594974 |
|
| 15594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS3 |
0.517360832594974 |
|
| 15595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPMT1 |
0.517360832594974 |
|
| 15596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD4 |
0.517360832594974 |
|
| 15597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF4 |
0.517360832594974 |
|
| 15598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM180B |
0.517360832594974 |
|
| 15599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTCH2 |
0.517360832594974 |
|
| 15600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGBL2 |
0.517360832594974 |
|
| 15601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP75 |
0.527287649560314 |
|
| 15602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000251861.1 |
0.527287649560314 |
|
| 15603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA2 |
0.533360635184073 |
|
| 15604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL11 |
0.534810283048949 |
|
| 15605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFTUD1P1 |
0.53663188902951 |
|
| 15606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPG4P5 |
0.53663188902951 |
|
| 15607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L4 |
0.53663188902951 |
|
| 15608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L5 |
0.53663188902951 |
|
| 15609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL331P |
0.53663188902951 |
|
| 15610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL417P |
0.53663188902951 |
|
| 15611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Q2P1 |
0.53663188902951 |
|
| 15612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE10A |
0.537168163572596 |
|
| 15613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4417 |
0.537945858554291 |
|
| 15614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4689 |
0.537945858554291 |
|
| 15615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNE |
0.544098775588058 |
|
| 15616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF38 |
0.544098775588058 |
|
| 15617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MELK |
0.544098775588058 |
|
| 15618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4475 |
0.544098775588058 |
|
| 15619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX5 |
0.544098775588058 |
|
| 15620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4540 |
0.544098775588058 |
|
| 15621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4476 |
0.544098775588058 |
|
| 15622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC7 |
0.544098775588058 |
|
| 15623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRHPR |
0.544098775588058 |
|
| 15624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB5 |
0.544098775588058 |
|
| 15625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL463P |
0.544098775588058 |
|
| 15626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR1E |
0.544098775588058 |
|
| 15627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO10 |
0.544098775588058 |
|
| 15628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM5 |
0.544098775588058 |
|
| 15629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMPD1 |
0.544098775588058 |
|
| 15630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP171 |
0.544098775588058 |
|
| 15631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT10B |
0.544098775588058 |
|
| 15632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC3 |
0.544098775588058 |
|
| 15633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF10 |
0.544098775588058 |
|
| 15634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A51 |
0.544098775588058 |
|
| 15635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHB |
0.544098775588058 |
|
| 15636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000200026.1 |
0.544098775588058 |
|
| 15637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238313.1 |
0.544098775588058 |
|
| 15638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1B1 |
0.544098775588058 |
|
| 15639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBPL1 |
0.544098775588058 |
|
| 15640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD18A |
0.544098775588058 |
|
| 15641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX18P3 |
0.544098775588058 |
|
| 15642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM201A |
0.544098775588058 |
|
| 15643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD34B |
0.544424038550688 |
|
| 15644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF17 |
0.546275773197377 |
|
| 15645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPJ |
0.546275773197377 |
|
| 15646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTE2P1 |
0.546275773197377 |
|
| 15647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSP1|ENSG00000269099.1 |
0.546275773197377 |
|
| 15648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC3 |
0.546275773197377 |
|
| 15649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMER2 |
0.546275773197377 |
|
| 15650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUPL1 |
0.546275773197377 |
|
| 15651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8A2 |
0.546275773197377 |
|
| 15652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL289P |
0.546275773197377 |
|
| 15653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL741P |
0.546275773197377 |
|
| 15654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P3 |
0.546275773197377 |
|
| 15655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA2 |
0.546275773197377 |
|
| 15656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00415 |
0.546275773197377 |
|
| 15657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF6 |
0.546275773197377 |
|
| 15658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK8 |
0.546275773197377 |
|
| 15659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASF3 |
0.546275773197377 |
|
| 15660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR12 |
0.546275773197377 |
|
| 15661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3KBP1 |
0.547315263576348 |
|
| 15662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISX |
0.54870892103437 |
|
| 15663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGXB4 |
0.54870892103437 |
|
| 15664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOM1 |
0.54870892103437 |
|
| 15665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3909 |
0.54870892103437 |
|
| 15666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMOX1 |
0.54870892103437 |
|
| 15667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM5 |
0.54870892103437 |
|
| 15668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf52 |
0.549283653766478 |
|
| 15669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDR2 |
0.549283653766478 |
|
| 15670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF2K |
0.549283653766478 |
|
| 15671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF6 |
0.549283653766478 |
|
| 15672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL9 |
0.549283653766478 |
|
| 15673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB3 |
0.549283653766478 |
|
| 15674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB4 |
0.549283653766478 |
|
| 15675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB5 |
0.549283653766478 |
|
| 15676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOA |
0.549283653766478 |
|
| 15677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD9 |
0.549283653766478 |
|
| 15678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3E |
0.549283653766478 |
|
| 15679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL245P |
0.549283653766478 |
|
| 15680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRN3P1 |
0.549283653766478 |
|
| 15681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRN3P3 |
0.549283653766478 |
|
| 15682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA6|ENSG00000252798.1 |
0.549283653766478 |
|
| 15683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR42E2 |
0.549283653766478 |
|
| 15684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG1P1 |
0.549283653766478 |
|
| 15685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRC2 |
0.549283653766478 |
|
| 15686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA3A |
0.549283653766478 |
|
| 15687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238712.1 |
0.549283653766478 |
|
| 15688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238954.1 |
0.549283653766478 |
|
| 15689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239172.1 |
0.549283653766478 |
|
| 15690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST2 |
0.549283653766478 |
|
| 15691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP31 |
0.549283653766478 |
|
| 15692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCNN1G |
0.549283653766478 |
|
| 15693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCNN1B |
0.549283653766478 |
|
| 15694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG7 |
0.549283653766478 |
|
| 15695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP23 |
0.549283653766478 |
|
| 15696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212593.1 |
0.549283653766478 |
|
| 15697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGA2 |
0.549283653766478 |
|
| 15698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EARS2 |
0.549283653766478 |
|
| 15699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBFD1 |
0.549283653766478 |
|
| 15700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAB1 |
0.549283653766478 |
|
| 15701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALB2 |
0.549283653766478 |
|
| 15702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN5 |
0.549283653766478 |
|
| 15703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK1 |
0.549283653766478 |
|
| 15704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERN2 |
0.549283653766478 |
|
| 15705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHP2 |
0.549283653766478 |
|
| 15706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCB |
0.549283653766478 |
|
| 15707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNG3 |
0.549283653766478 |
|
| 15708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA1|ENSG00000201541.1 |
0.549283653766478 |
|
| 15709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP6 |
0.549283653766478 |
|
| 15710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNRC6A |
0.549283653766478 |
|
| 15711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A11 |
0.549283653766478 |
|
| 15712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP17 |
0.549283653766478 |
|
| 15713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCMT1 |
0.549283653766478 |
|
| 15714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL557P |
0.549283653766478 |
|
| 15715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP8 |
0.549283653766478 |
|
| 15716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZKSCAN2 |
0.549283653766478 |
|
| 15717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST4 |
0.549283653766478 |
|
| 15718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548W |
0.549283653766478 |
|
| 15719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP405 |
0.549283653766478 |
|
| 15720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf82 |
0.549283653766478 |
|
| 15721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNK1 |
0.551415627934456 |
|
| 15722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD52 |
0.551415627934456 |
|
| 15723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA20|ENSG00000201660.1 |
0.552012903167621 |
|
| 15724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLGN4X |
0.552012903167621 |
|
| 15725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAF1 |
0.555159231283418 |
|
| 15726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2C |
0.555159231283418 |
|
| 15727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4421 |
0.555159231283418 |
|
| 15728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf185 |
0.555159231283418 |
|
| 15729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF21A |
0.55603327620479 |
|
| 15730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGS2 |
0.563027151408395 |
|
| 15731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4A |
0.563027151408395 |
|
| 15732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCHL5 |
0.563027151408395 |
|
| 15733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000238754.1 |
0.563027151408395 |
|
| 15734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TROVE2 |
0.563027151408395 |
|
| 15735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRX2 |
0.563027151408395 |
|
| 15736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1278 |
0.563027151408395 |
|
| 15737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALT2 |
0.563027151408395 |
|
| 15738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252241.1 |
0.563027151408395 |
|
| 15739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNT2 |
0.563027151408395 |
|
| 15740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4735 |
0.563027151408395 |
|
| 15741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFH |
0.563027151408395 |
|
| 15742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFHR1 |
0.563027151408395 |
|
| 15743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFHR2 |
0.563027151408395 |
|
| 15744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFHR3 |
0.563027151408395 |
|
| 15745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFHR4 |
0.563027151408395 |
|
| 15746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFHR5 |
0.563027151408395 |
|
| 15747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F13B |
0.563027151408395 |
|
| 15748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPM |
0.563027151408395 |
|
| 15749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB41 |
0.563027151408395 |
|
| 15750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRB1 |
0.563027151408395 |
|
| 15751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND1B |
0.563027151408395 |
|
| 15752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf53 |
0.563027151408395 |
|
| 15753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX9 |
0.563027151408395 |
|
| 15754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK7 |
0.563027151408395 |
|
| 15755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1G3 |
0.563027151408395 |
|
| 15756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRC |
0.563027151408395 |
|
| 15757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181A1HG |
0.563027151408395 |
|
| 15758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181A1 |
0.563027151408395 |
|
| 15759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181B1 |
0.563027151408395 |
|
| 15760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR5A2 |
0.563027151408395 |
|
| 15761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00862 |
0.563027151408395 |
|
| 15762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF281 |
0.563027151408395 |
|
| 15763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF14 |
0.563027151408395 |
|
| 15764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX59 |
0.563027151408395 |
|
| 15765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMSAP2 |
0.563027151408395 |
|
| 15766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR25 |
0.563027151408395 |
|
| 15767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf106 |
0.563027151408395 |
|
| 15768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF21B |
0.563027151408395 |
|
| 15769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1S |
0.563027151408395 |
|
| 15770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCL5 |
0.563027151408395 |
|
| 15771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM9 |
0.563027151408395 |
|
| 15772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFN1 |
0.563027151408395 |
|
| 15773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKP1 |
0.563027151408395 |
|
| 15774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNT2 |
0.563027151408395 |
|
| 15775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAD1 |
0.563027151408395 |
|
| 15776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNNI1 |
0.563027151408395 |
|
| 15777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDA3 |
0.563027151408395 |
|
| 15778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRP1 |
0.563027151408395 |
|
| 15779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS10P7 |
0.563027151408395 |
|
| 15780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAV1 |
0.563027151408395 |
|
| 15781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5191 |
0.563027151408395 |
|
| 15782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1231 |
0.563027151408395 |
|
| 15783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO9 |
0.563027151408395 |
|
| 15784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA4 |
0.563027151408395 |
|
| 15785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMOD1 |
0.563027151408395 |
|
| 15786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM17A |
0.563027151408395 |
|
| 15787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000206637.1 |
0.563027151408395 |
|
| 15788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNPEP |
0.563027151408395 |
|
| 15789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELF3 |
0.563027151408395 |
|
| 15790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR37L1 |
0.563027151408395 |
|
| 15791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL8A |
0.563027151408395 |
|
| 15792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN7 |
0.563027151408395 |
|
| 15793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRVP |
0.563027151408395 |
|
| 15794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGR6 |
0.563027151408395 |
|
| 15795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238571.1 |
0.563027151408395 |
|
| 15796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239046.1 |
0.563027151408395 |
|
| 15797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2T |
0.563027151408395 |
|
| 15798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R12B |
0.563027151408395 |
|
| 15799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272262.1 |
0.563027151408395 |
|
| 15800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000253042.1 |
0.563027151408395 |
|
| 15801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT2 |
0.563027151408395 |
|
| 15802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABIF |
0.563027151408395 |
|
| 15803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL12 |
0.563027151408395 |
|
| 15804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADIPOR1 |
0.563027151408395 |
|
| 15805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB5R1 |
0.563027151408395 |
|
| 15806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM183A |
0.563027151408395 |
|
| 15807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIA4 |
0.563027151408395 |
|
| 15808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOG |
0.563027151408395 |
|
| 15809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADORA1 |
0.563027151408395 |
|
| 15810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBPH |
0.563027151408395 |
|
| 15811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHI3L1 |
0.563027151408395 |
|
| 15812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHIT1 |
0.563027151408395 |
|
| 15813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTG2 |
0.563027151408395 |
|
| 15814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMOD |
0.563027151408395 |
|
| 15815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRELP |
0.563027151408395 |
|
| 15816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPTC |
0.563027151408395 |
|
| 15817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM81 |
0.563027151408395 |
|
| 15818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP5 |
0.563027151408395 |
|
| 15819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSTYK |
0.563027151408395 |
|
| 15820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCC2 |
0.563027151408395 |
|
| 15821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUAK2 |
0.563027151408395 |
|
| 15822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC8A |
0.563027151408395 |
|
| 15823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEMD1 |
0.563027151408395 |
|
| 15824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR135B |
0.563027151408395 |
|
| 15825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK18 |
0.563027151408395 |
|
| 15826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD4 |
0.563027151408395 |
|
| 15827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELK4 |
0.563027151408395 |
|
| 15828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC45A3 |
0.563027151408395 |
|
| 15829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUCKS1 |
0.563027151408395 |
|
| 15830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000201944.1 |
0.563027151408395 |
|
| 15831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB7L1 |
0.563027151408395 |
|
| 15832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC41A1 |
0.563027151408395 |
|
| 15833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PM20D1 |
0.563027151408395 |
|
| 15834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A9 |
0.563027151408395 |
|
| 15835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM72A |
0.563027151408395 |
|
| 15836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVPR1B |
0.563027151408395 |
|
| 15837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf186 |
0.563027151408395 |
|
| 15838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD60|ENSG00000252692.1 |
0.563027151408395 |
|
| 15839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSE |
0.563027151408395 |
|
| 15840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRGAP2 |
0.563027151408395 |
|
| 15841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKBKE |
0.563027151408395 |
|
| 15842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf147 |
0.563027151408395 |
|
| 15843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF5 |
0.563027151408395 |
|
| 15844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2D |
0.563027151408395 |
|
| 15845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYRK3 |
0.563027151408395 |
|
| 15846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252853.1 |
0.563027151408395 |
|
| 15847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPKAPK2 |
0.563027151408395 |
|
| 15848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL10 |
0.563027151408395 |
|
| 15849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL19 |
0.563027151408395 |
|
| 15850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL20 |
0.563027151408395 |
|
| 15851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL24 |
0.563027151408395 |
|
| 15852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAIM3 |
0.563027151408395 |
|
| 15853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGR |
0.563027151408395 |
|
| 15854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCAMR |
0.563027151408395 |
|
| 15855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf116 |
0.563027151408395 |
|
| 15856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238401.1 |
0.563027151408395 |
|
| 15857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YOD1 |
0.563027151408395 |
|
| 15858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKFB2 |
0.563027151408395 |
|
| 15859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4BPB |
0.563027151408395 |
|
| 15860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C4BPA |
0.563027151408395 |
|
| 15861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD55 |
0.563027151408395 |
|
| 15862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CR2 |
0.563027151408395 |
|
| 15863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CR1 |
0.563027151408395 |
|
| 15864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CR1L |
0.563027151408395 |
|
| 15865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD46 |
0.563027151408395 |
|
| 15866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR29B2 |
0.563027151408395 |
|
| 15867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR29C |
0.563027151408395 |
|
| 15868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf132 |
0.563027151408395 |
|
| 15869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD34 |
0.563027151408395 |
|
| 15870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNA2 |
0.563027151408395 |
|
| 15871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR205HG |
0.563027151408395 |
|
| 15872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK1G |
0.563027151408395 |
|
| 15873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMB3 |
0.563027151408395 |
|
| 15874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4260 |
0.563027151408395 |
|
| 15875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G0S2 |
0.563027151408395 |
|
| 15876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD11B1 |
0.563027151408395 |
|
| 15877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERTAD4 |
0.563027151408395 |
|
| 15878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH1 |
0.563027151408395 |
|
| 15879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCOR3 |
0.563027151408395 |
|
| 15880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF5 |
0.563027151408395 |
|
| 15881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00467 |
0.563027151408395 |
|
| 15882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RD3 |
0.563027151408395 |
|
| 15883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A1 |
0.563027151408395 |
|
| 15884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK2 |
0.563027151408395 |
|
| 15885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPGAT1 |
0.563027151408395 |
|
| 15886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL344P |
0.563027151408395 |
|
| 15887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS7 |
0.563027151408395 |
|
| 15888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212187.1 |
0.563027151408395 |
|
| 15889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTL |
0.563027151408395 |
|
| 15890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3122 |
0.563027151408395 |
|
| 15891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP98 |
0.563027151408395 |
|
| 15892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R5A |
0.563027151408395 |
|
| 15893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA16B |
0.563027151408395 |
|
| 15894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM206 |
0.563027151408395 |
|
| 15895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NENF |
0.563027151408395 |
|
| 15896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF3 |
0.563027151408395 |
|
| 15897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL512P |
0.563027151408395 |
|
| 15898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71A |
0.563027151408395 |
|
| 15899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BATF3 |
0.563027151408395 |
|
| 15900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSL1 |
0.563027151408395 |
|
| 15901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TATDN3 |
0.563027151408395 |
|
| 15902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf227 |
0.563027151408395 |
|
| 15903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLVCR1 |
0.563027151408395 |
|
| 15904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VASH2 |
0.563027151408395 |
|
| 15905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGEL2 |
0.563027151408395 |
|
| 15906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KC1 |
0.563027151408395 |
|
| 15907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROX1 |
0.563027151408395 |
|
| 15908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMYD2 |
0.563027151408395 |
|
| 15909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN14 |
0.563027151408395 |
|
| 15910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPF |
0.563027151408395 |
|
| 15911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK2 |
0.563027151408395 |
|
| 15912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD3 |
0.563027151408395 |
|
| 15913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USH2A |
0.563027151408395 |
|
| 15914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD116|ENSG00000202498.1 |
0.563027151408395 |
|
| 15915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRRG |
0.563027151408395 |
|
| 15916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH2 |
0.563027151408395 |
|
| 15917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA17 |
0.563027151408395 |
|
| 15918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00210 |
0.563027151408395 |
|
| 15919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP15 |
0.563027151408395 |
|
| 15920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFB2 |
0.563027151408395 |
|
| 15921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf143 |
0.563027151408395 |
|
| 15922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212610.1 |
0.563027151408395 |
|
| 15923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPLAL1 |
0.563027151408395 |
|
| 15924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A10 |
0.563027151408395 |
|
| 15925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP76 |
0.563027151408395 |
|
| 15926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221673.1 |
0.563027151408395 |
|
| 15927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPRS |
0.563027151408395 |
|
| 15928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238798.1 |
0.563027151408395 |
|
| 15929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPNT1 |
0.563027151408395 |
|
| 15930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IARS2 |
0.563027151408395 |
|
| 15931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR215 |
0.563027151408395 |
|
| 15932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238576.1 |
0.563027151408395 |
|
| 15933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3GAP2 |
0.563027151408395 |
|
| 15934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA36B |
0.563027151408395 |
|
| 15935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARK1 |
0.563027151408395 |
|
| 15936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL464P |
0.563027151408395 |
|
| 15937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC1P2 |
0.563027151408395 |
|
| 15938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf115 |
0.563027151408395 |
|
| 15939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARC2 |
0.563027151408395 |
|
| 15940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARC1 |
0.563027151408395 |
|
| 15941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC35P |
0.563027151408395 |
|
| 15942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HLX |
0.563027151408395 |
|
| 15943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF9 |
0.568234053378637 |
|
| 15944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL766P |
0.568234053378637 |
|
| 15945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00424 |
0.568234053378637 |
|
| 15946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00621 |
0.568234053378637 |
|
| 15947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD36|ENSG00000253094.1 |
0.568234053378637 |
|
| 15948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P4 |
0.568234053378637 |
|
| 15949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00362 |
0.568234053378637 |
|
| 15950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCG |
0.568234053378637 |
|
| 15951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SACS |
0.568234053378637 |
|
| 15952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00327 |
0.568234053378637 |
|
| 15953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00352 |
0.568234053378637 |
|
| 15954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A19P |
0.568234053378637 |
|
| 15955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF9B |
0.568234053378637 |
|
| 15956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIPEP |
0.568234053378637 |
|
| 15957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA13 |
0.568234053378637 |
|
| 15958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF19 |
0.568234053378637 |
|
| 15959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2276 |
0.568234053378637 |
|
| 15960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF9 |
0.568234053378637 |
|
| 15961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00566 |
0.568234053378637 |
|
| 15962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP4 |
0.568234053378637 |
|
| 15963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTE2P6 |
0.568234053378637 |
|
| 15964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP12A |
0.568234053378637 |
|
| 15965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P7 |
0.568234053378637 |
|
| 15966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPS2 |
0.570056915095566 |
|
| 15967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIPR1L1 |
0.570056915095566 |
|
| 15968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIPR1L2 |
0.570056915095566 |
|
| 15969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIPR1 |
0.570056915095566 |
|
| 15970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRR1 |
0.570056915095566 |
|
| 15971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000251893.2 |
0.570056915095566 |
|
| 15972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL734P |
0.570056915095566 |
|
| 15973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDA1 |
0.570056915095566 |
|
| 15974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L1 |
0.570056915095566 |
|
| 15975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP172 |
0.570056915095566 |
|
| 15976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS10 |
0.570056915095566 |
|
| 15977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL8 |
0.570056915095566 |
|
| 15978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC17 |
0.570056915095566 |
|
| 15979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRP2 |
0.570056915095566 |
|
| 15980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F7 |
0.570056915095566 |
|
| 15981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238769.1 |
0.570056915095566 |
|
| 15982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAV3 |
0.570056915095566 |
|
| 15983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT1 |
0.570056915095566 |
|
| 15984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1252 |
0.570056915095566 |
|
| 15985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL696P |
0.570056915095566 |
|
| 15986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAWR |
0.570056915095566 |
|
| 15987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R12A |
0.570056915095566 |
|
| 15988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP363 |
0.570056915095566 |
|
| 15989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOGL |
0.570056915095566 |
|
| 15990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP261 |
0.570056915095566 |
|
| 15991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRQ |
0.570056915095566 |
|
| 15992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYF6 |
0.570056915095566 |
|
| 15993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYF5 |
0.570056915095566 |
|
| 15994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIN7A |
0.570056915095566 |
|
| 15995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR617 |
0.570056915095566 |
|
| 15996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSS3 |
0.570056915095566 |
|
| 15997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR618 |
0.570056915095566 |
|
| 15998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4699 |
0.570056915095566 |
|
| 15999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIA2 |
0.570056915095566 |
|
| 16000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC59 |
0.570056915095566 |
|
| 16001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL25 |
0.570056915095566 |
|
| 16002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMTC2 |
0.570056915095566 |
|
| 16003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000221148.1 |
0.570056915095566 |
|
| 16004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U7|ENSG00000272215.1 |
0.570056915095566 |
|
| 16005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRAP |
0.570056915095566 |
|
| 16006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAD10 |
0.570056915095566 |
|
| 16007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH2 |
0.570056915095566 |
|
| 16008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPKAPK5 |
0.570056915095566 |
|
| 16009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM1A |
0.570056915095566 |
|
| 16010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM116 |
0.570056915095566 |
|
| 16011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERP29 |
0.570056915095566 |
|
| 16012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA25 |
0.570056915095566 |
|
| 16013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3657 |
0.570056915095566 |
|
| 16014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAFD1 |
0.570056915095566 |
|
| 16015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECTD4 |
0.570056915095566 |
|
| 16016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP71 |
0.570056915095566 |
|
| 16017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN11 |
0.570056915095566 |
|
| 16018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL6 |
0.570056915095566 |
|
| 16019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPH3A |
0.570056915095566 |
|
| 16020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAS1 |
0.570056915095566 |
|
| 16021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAS3 |
0.570056915095566 |
|
| 16022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAS2 |
0.570056915095566 |
|
| 16023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTX1 |
0.570056915095566 |
|
| 16024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASAL1 |
0.570056915095566 |
|
| 16025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC42B |
0.570056915095566 |
|
| 16026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX54 |
0.570056915095566 |
|
| 16027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf52 |
0.570056915095566 |
|
| 16028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCD |
0.570056915095566 |
|
| 16029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPCN1 |
0.570056915095566 |
|
| 16030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A6 |
0.570056915095566 |
|
| 16031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARGE |
0.572452358205106 |
|
| 16032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA76|ENSG00000253007.2 |
0.572452358205106 |
|
| 16033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASD2 |
0.572452358205106 |
|
| 16034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL6 |
0.572452358205106 |
|
| 16035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MB |
0.572452358205106 |
|
| 16036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL5 |
0.572452358205106 |
|
| 16037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBFOX2 |
0.572452358205106 |
|
| 16038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL3 |
0.572452358205106 |
|
| 16039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL4 |
0.572452358205106 |
|
| 16040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL1 |
0.572452358205106 |
|
| 16041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOL2 |
0.572452358205106 |
|
| 16042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH9 |
0.572452358205106 |
|
| 16043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL349P |
0.572452358205106 |
|
| 16044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIGYF2 |
0.573078848979853 |
|
| 16045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ13 |
0.573078848979853 |
|
| 16046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf82 |
0.573078848979853 |
|
| 16047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL204P |
0.573078848979853 |
|
| 16048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBX2 |
0.573078848979853 |
|
| 16049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB18 |
0.573078848979853 |
|
| 16050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCA1 |
0.573078848979853 |
|
| 16051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACKR3 |
0.573078848979853 |
|
| 16052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS8 |
0.573078848979853 |
|
| 16053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A3 |
0.573078848979853 |
|
| 16054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLPH |
0.573078848979853 |
|
| 16055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRLH |
0.573078848979853 |
|
| 16056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB17 |
0.573078848979853 |
|
| 16057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRFIP1 |
0.573078848979853 |
|
| 16058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM44 |
0.573078848979853 |
|
| 16059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAMP1 |
0.573078848979853 |
|
| 16060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD39|ENSG00000263723.1 |
0.573078848979853 |
|
| 16061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2F |
0.573078848979853 |
|
| 16062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCLY |
0.573078848979853 |
|
| 16063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESPNL |
0.573078848979853 |
|
| 16064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL30 |
0.573078848979853 |
|
| 16065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM132B |
0.573078848979853 |
|
| 16066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILKAP |
0.573078848979853 |
|
| 16067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES6 |
0.573078848979853 |
|
| 16068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PER2 |
0.573078848979853 |
|
| 16069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF3IP1 |
0.573078848979853 |
|
| 16070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB1 |
0.573078848979853 |
|
| 16071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC4 |
0.573078848979853 |
|
| 16072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4440 |
0.573078848979853 |
|
| 16073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4441 |
0.573078848979853 |
|
| 16074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWIST2 |
0.573078848979853 |
|
| 16075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4269 |
0.573078848979853 |
|
| 16076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2467 |
0.573078848979853 |
|
| 16077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA10 |
0.573078848979853 |
|
| 16078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4786 |
0.573078848979853 |
|
| 16079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6B2 |
0.573078848979853 |
|
| 16080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR21 |
0.573078848979853 |
|
| 16081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6B3 |
0.573078848979853 |
|
| 16082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYEOV2 |
0.573078848979853 |
|
| 16083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOS |
0.573078848979853 |
|
| 16084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC1 |
0.573078848979853 |
|
| 16085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR149 |
0.573078848979853 |
|
| 16086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QKI |
0.574118045833436 |
|
| 16087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACRG |
0.574997230382978 |
|
| 16088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOK |
0.577937326984674 |
|
| 16089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF839 |
0.577937326984674 |
|
| 16090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CINP |
0.577937326984674 |
|
| 16091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239061.1 |
0.577937326984674 |
|
| 16092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECPR2 |
0.577937326984674 |
|
| 16093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD9 |
0.577937326984674 |
|
| 16094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4309 |
0.577937326984674 |
|
| 16095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL546P |
0.577937326984674 |
|
| 16096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCOR1 |
0.577937326984674 |
|
| 16097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF3 |
0.577937326984674 |
|
| 16098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238853.1 |
0.577937326984674 |
|
| 16099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMN |
0.577937326984674 |
|
| 16100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42BPB |
0.577937326984674 |
|
| 16101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC3L4 |
0.577937326984674 |
|
| 16102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00677 |
0.577937326984674 |
|
| 16103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP2 |
0.577937326984674 |
|
| 16104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00605 |
0.577937326984674 |
|
| 16105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF5 |
0.577937326984674 |
|
| 16106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA28 |
0.577937326984674 |
|
| 16107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARK3 |
0.577937326984674 |
|
| 16108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKB |
0.577937326984674 |
|
| 16109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT61A |
0.577937326984674 |
|
| 16110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG5 |
0.577937326984674 |
|
| 16111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLC1 |
0.577937326984674 |
|
| 16112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOPT1 |
0.577937326984674 |
|
| 16113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC3 |
0.577937326984674 |
|
| 16114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE21 |
0.577937326984674 |
|
| 16115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R13B |
0.577937326984674 |
|
| 16116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD51|ENSG00000202275.1 |
0.577937326984674 |
|
| 16117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00637 |
0.577937326984674 |
|
| 16118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf2 |
0.577937326984674 |
|
| 16119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD9 |
0.577937326984674 |
|
| 16120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RD3L |
0.577937326984674 |
|
| 16121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL634P |
0.577937326984674 |
|
| 16122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPG |
0.577937326984674 |
|
| 16123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR203 |
0.577937326984674 |
|
| 16124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF26A |
0.577937326984674 |
|
| 16125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf144 |
0.577937326984674 |
|
| 16126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM179 |
0.577937326984674 |
|
| 16127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf180 |
0.577937326984674 |
|
| 16128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4710 |
0.577937326984674 |
|
| 16129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INF2 |
0.577937326984674 |
|
| 16130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADSSL1 |
0.577937326984674 |
|
| 16131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIVA1 |
0.577937326984674 |
|
| 16132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKT1 |
0.577937326984674 |
|
| 16133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB42 |
0.577937326984674 |
|
| 16134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00638 |
0.577937326984674 |
|
| 16135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP170B |
0.577937326984674 |
|
| 16136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLD4 |
0.577937326984674 |
|
| 16137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHNAK2 |
0.577937326984674 |
|
| 16138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf79 |
0.577937326984674 |
|
| 16139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA4 |
0.577937326984674 |
|
| 16140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR132 |
0.577937326984674 |
|
| 16141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAG2 |
0.577937326984674 |
|
| 16142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT14 |
0.577937326984674 |
|
| 16143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRF1 |
0.577937326984674 |
|
| 16144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD6 |
0.577937326984674 |
|
| 16145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PACS2 |
0.577937326984674 |
|
| 16146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX22 |
0.577937326984674 |
|
| 16147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTA1 |
0.577937326984674 |
|
| 16148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIP2 |
0.577937326984674 |
|
| 16149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C14orf80 |
0.577937326984674 |
|
| 16150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIP1 |
0.577937326984674 |
|
| 16151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM6 |
0.577937326984674 |
|
| 16152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHA1 |
0.577937326984674 |
|
| 16153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHA2 |
0.577937326984674 |
|
| 16154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHD |
0.577937326984674 |
|
| 16155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHE |
0.577937326984674 |
|
| 16156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHG1 |
0.577937326984674 |
|
| 16157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHG2 |
0.577937326984674 |
|
| 16158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHG3 |
0.577937326984674 |
|
| 16159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHG4 |
0.577937326984674 |
|
| 16160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ1 |
0.577937326984674 |
|
| 16161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ2 |
0.577937326984674 |
|
| 16162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ3 |
0.577937326984674 |
|
| 16163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ4 |
0.577937326984674 |
|
| 16164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ5 |
0.577937326984674 |
|
| 16165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHJ6 |
0.577937326984674 |
|
| 16166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGHM |
0.577937326984674 |
|
| 16167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0125 |
0.577937326984674 |
|
| 16168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00221 |
0.577937326984674 |
|
| 16169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00226 |
0.577937326984674 |
|
| 16170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP389 |
0.577937326984674 |
|
| 16171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM121 |
0.577937326984674 |
|
| 16172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF1 |
0.57995390247947 |
|
| 16173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL519P |
0.57995390247947 |
|
| 16174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS12 |
0.57995390247947 |
|
| 16175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN8A |
0.57995390247947 |
|
| 16176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVRL1 |
0.57995390247947 |
|
| 16177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD33 |
0.57995390247947 |
|
| 16178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVR1B |
0.57995390247947 |
|
| 16179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRASP |
0.57995390247947 |
|
| 16180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR4A1 |
0.57995390247947 |
|
| 16181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf44 |
0.57995390247947 |
|
| 16182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7E47P |
0.57995390247947 |
|
| 16183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT80 |
0.57995390247947 |
|
| 16184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf80 |
0.57995390247947 |
|
| 16185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00592 |
0.57995390247947 |
|
| 16186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT7 |
0.57995390247947 |
|
| 16187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT121P |
0.57995390247947 |
|
| 16188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT86 |
0.57995390247947 |
|
| 16189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT81 |
0.57995390247947 |
|
| 16190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT83 |
0.57995390247947 |
|
| 16191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT84 |
0.57995390247947 |
|
| 16192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT85 |
0.57995390247947 |
|
| 16193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT82 |
0.57995390247947 |
|
| 16194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT6B |
0.57995390247947 |
|
| 16195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT6C |
0.57995390247947 |
|
| 16196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT75 |
0.57995390247947 |
|
| 16197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT6A |
0.57995390247947 |
|
| 16198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP7 |
0.57995390247947 |
|
| 16199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP1 |
0.57995390247947 |
|
| 16200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMHR2 |
0.57995390247947 |
|
| 16201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBP2 |
0.57995390247947 |
|
| 16202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR13 |
0.57995390247947 |
|
| 16203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K12 |
0.57995390247947 |
|
| 16204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARBP2 |
0.57995390247947 |
|
| 16205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPFF |
0.57995390247947 |
|
| 16206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF7 |
0.57995390247947 |
|
| 16207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5G2 |
0.57995390247947 |
|
| 16208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCOCO1 |
0.57995390247947 |
|
| 16209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD81|ENSG00000223213.1 |
0.57995390247947 |
|
| 16210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP289 |
0.57995390247947 |
|
| 16211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC13 |
0.57995390247947 |
|
| 16212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC12 |
0.57995390247947 |
|
| 16213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOTAIR |
0.57995390247947 |
|
| 16214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC11 |
0.57995390247947 |
|
| 16215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC10 |
0.57995390247947 |
|
| 16216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC5 |
0.57995390247947 |
|
| 16217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC6 |
0.57995390247947 |
|
| 16218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR196A2 |
0.57995390247947 |
|
| 16219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC9 |
0.57995390247947 |
|
| 16220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC8 |
0.57995390247947 |
|
| 16221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXC4 |
0.57995390247947 |
|
| 16222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR615 |
0.57995390247947 |
|
| 16223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMUG1 |
0.57995390247947 |
|
| 16224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM14 |
0.582174422164008 |
|
| 16225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA2 |
0.582174422164008 |
|
| 16226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAM1 |
0.582174422164008 |
|
| 16227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238450.1 |
0.582174422164008 |
|
| 16228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACTB2 |
0.582174422164008 |
|
| 16229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL19P |
0.582174422164008 |
|
| 16230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR9 |
0.582174422164008 |
|
| 16231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EYA1 |
0.582174422164008 |
|
| 16232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000200191.1 |
0.582174422164008 |
|
| 16233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSC |
0.582174422164008 |
|
| 16234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPA1 |
0.582174422164008 |
|
| 16235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP271 |
0.582174422164008 |
|
| 16236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNB2 |
0.582174422164008 |
|
| 16237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TERF1 |
0.582174422164008 |
|
| 16238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBSPON |
0.582174422164008 |
|
| 16239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL7 |
0.582174422164008 |
|
| 16240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH10 |
0.582174422164008 |
|
| 16241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAU2 |
0.582174422164008 |
|
| 16242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2W |
0.582174422164008 |
|
| 16243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB1 |
0.582174422164008 |
|
| 16244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM70 |
0.582174422164008 |
|
| 16245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY96 |
0.582174422164008 |
|
| 16246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UMPS |
0.586571344474728 |
|
| 16247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR544B |
0.586571344474728 |
|
| 16248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB5 |
0.586571344474728 |
|
| 16249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC13 |
0.586571344474728 |
|
| 16250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEG1 |
0.586571344474728 |
|
| 16251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP137 |
0.586571344474728 |
|
| 16252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A8 |
0.586571344474728 |
|
| 16253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5092 |
0.586571344474728 |
|
| 16254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF148 |
0.586571344474728 |
|
| 16255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX4 |
0.586571344474728 |
|
| 16256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238992.1 |
0.586571344474728 |
|
| 16257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL11 |
0.586571344474728 |
|
| 16258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548I1 |
0.586571344474728 |
|
| 16259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG1L |
0.586571344474728 |
|
| 16260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86JP |
0.586571344474728 |
|
| 16261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROPN1B |
0.586571344474728 |
|
| 16262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC41A3 |
0.586571344474728 |
|
| 16263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1L1 |
0.586571344474728 |
|
| 16264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U1|ENSG00000272020.1 |
0.586571344474728 |
|
| 16265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF15 |
0.586571344474728 |
|
| 16266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC37 |
0.586571344474728 |
|
| 16267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZXDC |
0.586571344474728 |
|
| 16268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UROC1 |
0.586571344474728 |
|
| 16269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf22 |
0.586571344474728 |
|
| 16270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST13 |
0.586571344474728 |
|
| 16271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP138 |
0.586571344474728 |
|
| 16272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAIN2 |
0.586895108417315 |
|
| 16273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMG1 |
0.588562888919847 |
|
| 16274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238329.1 |
0.588562888919847 |
|
| 16275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC7 |
0.588562888919847 |
|
| 16276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ7 |
0.588562888919847 |
|
| 16277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPRIPL2 |
0.588562888919847 |
|
| 16278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT17 |
0.588562888919847 |
|
| 16279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC19A |
0.588562888919847 |
|
| 16280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC5 |
0.588562888919847 |
|
| 16281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDE1 |
0.588562888919847 |
|
| 16282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCP110 |
0.588562888919847 |
|
| 16283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf62 |
0.588562888919847 |
|
| 16284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNOP1 |
0.588562888919847 |
|
| 16285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCK |
0.588562888919847 |
|
| 16286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRC5B |
0.588562888919847 |
|
| 16287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR139 |
0.588562888919847 |
|
| 16288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP2 |
0.588562888919847 |
|
| 16289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UMOD |
0.588562888919847 |
|
| 16290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDILT |
0.588562888919847 |
|
| 16291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM5 |
0.588562888919847 |
|
| 16292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM2A |
0.588562888919847 |
|
| 16293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM2B |
0.588562888919847 |
|
| 16294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM1 |
0.588562888919847 |
|
| 16295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM3 |
0.588562888919847 |
|
| 16296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THUMPD1 |
0.588562888919847 |
|
| 16297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERI2 |
0.588562888919847 |
|
| 16298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCUN1D3 |
0.588562888919847 |
|
| 16299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM1 |
0.588562888919847 |
|
| 16300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH3 |
0.588562888919847 |
|
| 16301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM159 |
0.588562888919847 |
|
| 16302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZP2 |
0.588562888919847 |
|
| 16303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKS4B |
0.588562888919847 |
|
| 16304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYM |
0.588562888919847 |
|
| 16305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM8 |
0.588562888919847 |
|
| 16306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSMCE1 |
0.588562888919847 |
|
| 16307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL4R |
0.588562888919847 |
|
| 16308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL21R |
0.588562888919847 |
|
| 16309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C1 |
0.588562888919847 |
|
| 16310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0556 |
0.588562888919847 |
|
| 16311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSG1L |
0.588562888919847 |
|
| 16312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPO6 |
0.588562888919847 |
|
| 16313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000200652.1 |
0.588562888919847 |
|
| 16314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBK1 |
0.588562888919847 |
|
| 16315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB6 |
0.588562888919847 |
|
| 16316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLN3 |
0.588562888919847 |
|
| 16317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3CL |
0.588562888919847 |
|
| 16318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB7 |
0.588562888919847 |
|
| 16319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238703.1 |
0.588562888919847 |
|
| 16320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBR |
0.588562888919847 |
|
| 16321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL27 |
0.588562888919847 |
|
| 16322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUPR1 |
0.588562888919847 |
|
| 16323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC101 |
0.588562888919847 |
|
| 16324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1A2 |
0.588562888919847 |
|
| 16325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1A1 |
0.588562888919847 |
|
| 16326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2A1 |
0.588562888919847 |
|
| 16327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN2L |
0.588562888919847 |
|
| 16328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD19 |
0.588562888919847 |
|
| 16329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3C |
0.588562888919847 |
|
| 16330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAT |
0.588562888919847 |
|
| 16331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4517 |
0.588562888919847 |
|
| 16332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4721 |
0.588562888919847 |
|
| 16333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFATC2IP |
0.588562888919847 |
|
| 16334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB8 |
0.588562888919847 |
|
| 16335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB9 |
0.588562888919847 |
|
| 16336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABEP2 |
0.588562888919847 |
|
| 16337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRN3P2 |
0.588562888919847 |
|
| 16338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2B1 |
0.588562888919847 |
|
| 16339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA43|ENSG00000252461.1 |
0.588562888919847 |
|
| 16340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPNS1 |
0.588562888919847 |
|
| 16341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUFM |
0.588562888919847 |
|
| 16342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238352.1 |
0.588562888919847 |
|
| 16343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238684.1 |
0.588562888919847 |
|
| 16344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238699.1 |
0.588562888919847 |
|
| 16345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX29P2 |
0.588562888919847 |
|
| 16346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB11 |
0.588562888919847 |
|
| 16347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDOA |
0.588562888919847 |
|
| 16348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPHD1 |
0.588562888919847 |
|
| 16349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOLA2B |
0.588562888919847 |
|
| 16350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOLA2 |
0.588562888919847 |
|
| 16351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf54 |
0.588562888919847 |
|
| 16352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf92 |
0.588562888919847 |
|
| 16353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDIPT |
0.588562888919847 |
|
| 16354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO1A |
0.588562888919847 |
|
| 16355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOC2A |
0.588562888919847 |
|
| 16356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM57B |
0.588562888919847 |
|
| 16357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPD3 |
0.588562888919847 |
|
| 16358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIRIP3 |
0.588562888919847 |
|
| 16359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INO80E |
0.588562888919847 |
|
| 16360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD13 |
0.588562888919847 |
|
| 16361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF22 |
0.588562888919847 |
|
| 16362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK3 |
0.588562888919847 |
|
| 16363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAZ |
0.588562888919847 |
|
| 16364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MVP |
0.588562888919847 |
|
| 16365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGR1 |
0.588562888919847 |
|
| 16366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP4C |
0.588562888919847 |
|
| 16367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRT2 |
0.588562888919847 |
|
| 16368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QPRT |
0.588562888919847 |
|
| 16369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP127 |
0.588562888919847 |
|
| 16370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEZ6L2 |
0.588562888919847 |
|
| 16371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLX1A |
0.588562888919847 |
|
| 16372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLX1B |
0.588562888919847 |
|
| 16373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPN |
0.588562888919847 |
|
| 16374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1A3 |
0.588562888919847 |
|
| 16375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1A4 |
0.588562888919847 |
|
| 16376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAOK2 |
0.588562888919847 |
|
| 16377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX6 |
0.588562888919847 |
|
| 16378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM219 |
0.588562888919847 |
|
| 16379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YPEL3 |
0.588562888919847 |
|
| 16380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZG16 |
0.588562888919847 |
|
| 16381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238639.1 |
0.588562888919847 |
|
| 16382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239114.1 |
0.588562888919847 |
|
| 16383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239193.1 |
0.588562888919847 |
|
| 16384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD2BP2 |
0.588562888919847 |
|
| 16385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D10B |
0.588562888919847 |
|
| 16386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLPF |
0.588562888919847 |
|
| 16387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT1 |
0.588562888919847 |
|
| 16388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF48 |
0.588562888919847 |
|
| 16389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF771 |
0.588562888919847 |
|
| 16390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTPP1 |
0.588562888919847 |
|
| 16391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA42|ENSG00000199787.1 |
0.588562888919847 |
|
| 16392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPHS2 |
0.588562888919847 |
|
| 16393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAL |
0.588562888919847 |
|
| 16394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4518 |
0.588562888919847 |
|
| 16395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF747 |
0.588562888919847 |
|
| 16396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF768 |
0.588562888919847 |
|
| 16397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF764 |
0.588562888919847 |
|
| 16398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF688 |
0.588562888919847 |
|
| 16399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF785 |
0.588562888919847 |
|
| 16400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF689 |
0.588562888919847 |
|
| 16401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBRS |
0.588562888919847 |
|
| 16402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR14 |
0.588562888919847 |
|
| 16403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRCAP |
0.588562888919847 |
|
| 16404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA30|ENSG00000206755.1 |
0.588562888919847 |
|
| 16405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHKG2 |
0.588562888919847 |
|
| 16406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf93 |
0.588562888919847 |
|
| 16407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF40 |
0.588562888919847 |
|
| 16408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF629 |
0.588562888919847 |
|
| 16409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL7C |
0.588562888919847 |
|
| 16410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4519 |
0.588562888919847 |
|
| 16411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR762 |
0.588562888919847 |
|
| 16412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTF1 |
0.588562888919847 |
|
| 16413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL19 |
0.588562888919847 |
|
| 16414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORAI3 |
0.588562888919847 |
|
| 16415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD1A |
0.588562888919847 |
|
| 16416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD3B7 |
0.588562888919847 |
|
| 16417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX1B |
0.588562888919847 |
|
| 16418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX4 |
0.588562888919847 |
|
| 16419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF668 |
0.588562888919847 |
|
| 16420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS53 |
0.588562888919847 |
|
| 16421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF646 |
0.588562888919847 |
|
| 16422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VKORC1 |
0.588562888919847 |
|
| 16423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCKDK |
0.588562888919847 |
|
| 16424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JPH1 |
0.590285651166499 |
|
| 16425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDAP1 |
0.590285651166499 |
|
| 16426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5681A |
0.590285651166499 |
|
| 16427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PI15 |
0.590285651166499 |
|
| 16428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRISPLD1 |
0.590285651166499 |
|
| 16429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC9 |
0.590285651166499 |
|
| 16430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNF4G |
0.590285651166499 |
|
| 16431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238595.1 |
0.590285651166499 |
|
| 16432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFHX4 |
0.590285651166499 |
|
| 16433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX2 |
0.590285651166499 |
|
| 16434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKIA |
0.590285651166499 |
|
| 16435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC2HC1A |
0.590285651166499 |
|
| 16436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL7 |
0.590285651166499 |
|
| 16437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMN2 |
0.590285651166499 |
|
| 16438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEY1 |
0.590285651166499 |
|
| 16439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS28 |
0.590285651166499 |
|
| 16440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPD52 |
0.590285651166499 |
|
| 16441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL41P |
0.590285651166499 |
|
| 16442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5708 |
0.590285651166499 |
|
| 16443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA20|ENSG00000206649.1 |
0.590285651166499 |
|
| 16444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB10 |
0.590285651166499 |
|
| 16445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL107P |
0.590285651166499 |
|
| 16446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF704 |
0.590285651166499 |
|
| 16447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL308P |
0.590285651166499 |
|
| 16448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAG1 |
0.590285651166499 |
|
| 16449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP5 |
0.590285651166499 |
|
| 16450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMP2 |
0.590285651166499 |
|
| 16451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP9 |
0.590285651166499 |
|
| 16452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP4 |
0.590285651166499 |
|
| 16453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP12 |
0.590285651166499 |
|
| 16454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPA1P |
0.590285651166499 |
|
| 16455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPA1 |
0.590285651166499 |
|
| 16456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC10A5 |
0.590285651166499 |
|
| 16457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND1 |
0.590285651166499 |
|
| 16458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP4C |
0.590285651166499 |
|
| 16459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX16 |
0.590285651166499 |
|
| 16460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALYL |
0.590285651166499 |
|
| 16461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238566.1 |
0.590285651166499 |
|
| 16462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRCC1 |
0.590285651166499 |
|
| 16463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F5 |
0.590285651166499 |
|
| 16464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf59 |
0.590285651166499 |
|
| 16465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA13 |
0.590285651166499 |
|
| 16466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA1 |
0.590285651166499 |
|
| 16467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA3 |
0.590285651166499 |
|
| 16468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA2 |
0.590285651166499 |
|
| 16469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO1L10P|ENSG00000255940.1 |
0.590285651166499 |
|
| 16470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO1L10P|ENSG00000270416.1 |
0.590285651166499 |
|
| 16471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO1L11P |
0.590285651166499 |
|
| 16472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO1L1 |
0.590285651166499 |
|
| 16473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0D2 |
0.590285651166499 |
|
| 16474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSKH2 |
0.590285651166499 |
|
| 16475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A13 |
0.590285651166499 |
|
| 16476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWP1 |
0.590285651166499 |
|
| 16477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMDN1 |
0.590285651166499 |
|
| 16478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE3 |
0.590285651166499 |
|
| 16479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGB3 |
0.590285651166499 |
|
| 16480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNBD1 |
0.590285651166499 |
|
| 16481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RAPL1 |
0.592359932770068 |
|
| 16482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4666B |
0.592359932770068 |
|
| 16483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBIAD1 |
0.593070630053759 |
|
| 16484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO2 |
0.593070630053759 |
|
| 16485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO44 |
0.593070630053759 |
|
| 16486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO6 |
0.593070630053759 |
|
| 16487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAD2L2 |
0.593070630053759 |
|
| 16488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRAXIN |
0.593070630053759 |
|
| 16489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGTRAP |
0.593070630053759 |
|
| 16490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf167 |
0.593070630053759 |
|
| 16491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFR |
0.593070630053759 |
|
| 16492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN6 |
0.593070630053759 |
|
| 16493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPPA |
0.593070630053759 |
|
| 16494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPPB |
0.593070630053759 |
|
| 16495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA2013 |
0.593070630053759 |
|
| 16496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLOD1 |
0.593070630053759 |
|
| 16497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFN2 |
0.593070630053759 |
|
| 16498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIIP |
0.593070630053759 |
|
| 16499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL649P |
0.593070630053759 |
|
| 16500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF8 |
0.593070630053759 |
|
| 16501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF1B |
0.593070630053759 |
|
| 16502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4632 |
0.593070630053759 |
|
| 16503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252969.1 |
0.593070630053759 |
|
| 16504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS13D |
0.593070630053759 |
|
| 16505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA59A |
0.593070630053759 |
|
| 16506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH1 |
0.59608013032511 |
|
| 16507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0141 |
0.59608013032511 |
|
| 16508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH12 |
0.59608013032511 |
|
| 16509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF14 |
0.59608013032511 |
|
| 16510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPDA1 |
0.59608013032511 |
|
| 16511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDFIP1 |
0.59608013032511 |
|
| 16512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRY4 |
0.59608013032511 |
|
| 16513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF1 |
0.59608013032511 |
|
| 16514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP26 |
0.59608013032511 |
|
| 16515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR3C1 |
0.59608013032511 |
|
| 16516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5197 |
0.59608013032511 |
|
| 16517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMHB1 |
0.59608013032511 |
|
| 16518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL87P |
0.59608013032511 |
|
| 16519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF5 |
0.59608013032511 |
|
| 16520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD16 |
0.59608013032511 |
|
| 16521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP246 |
0.59608013032511 |
|
| 16522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRELID2 |
0.59608013032511 |
|
| 16523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRXCR2 |
0.59608013032511 |
|
| 16524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3RF2 |
0.59608013032511 |
|
| 16525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAC8L1 |
0.59608013032511 |
|
| 16526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARS |
0.59608013032511 |
|
| 16527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM27 |
0.59608013032511 |
|
| 16528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU4F3 |
0.59608013032511 |
|
| 16529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCERG1 |
0.59608013032511 |
|
| 16530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR151 |
0.59608013032511 |
|
| 16531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP196 |
0.59608013032511 |
|
| 16532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R2B |
0.59608013032511 |
|
| 16533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL791P |
0.59608013032511 |
|
| 16534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK32A |
0.59608013032511 |
|
| 16535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYSL3 |
0.59608013032511 |
|
| 16536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAKMIP2 |
0.59608013032511 |
|
| 16537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK1 |
0.59608013032511 |
|
| 16538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCGB3A2 |
0.59608013032511 |
|
| 16539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf46 |
0.59608013032511 |
|
| 16540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK5 |
0.59608013032511 |
|
| 16541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK14 |
0.59608013032511 |
|
| 16542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK6 |
0.59608013032511 |
|
| 16543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK13 |
0.59608013032511 |
|
| 16544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK7 |
0.59608013032511 |
|
| 16545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINK9 |
0.59608013032511 |
|
| 16546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO38 |
0.59608013032511 |
|
| 16547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR4 |
0.59608013032511 |
|
| 16548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRB2 |
0.59608013032511 |
|
| 16549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3TC2 |
0.59608013032511 |
|
| 16550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR584 |
0.59608013032511 |
|
| 16551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP145 |
0.59608013032511 |
|
| 16552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABLIM3 |
0.59608013032511 |
|
| 16553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFAP1L1 |
0.59608013032511 |
|
| 16554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRPEL2 |
0.59608013032511 |
|
| 16555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCYOX1L |
0.59608013032511 |
|
| 16556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17B |
0.59608013032511 |
|
| 16557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR143HG |
0.59608013032511 |
|
| 16558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR143 |
0.59608013032511 |
|
| 16559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR145 |
0.59608013032511 |
|
| 16560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1A1 |
0.59608013032511 |
|
| 16561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF37 |
0.59608013032511 |
|
| 16562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221043.1 |
0.59608013032511 |
|
| 16563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL868P |
0.59608013032511 |
|
| 16564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378A |
0.59608013032511 |
|
| 16565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPARGC1B |
0.59608013032511 |
|
| 16566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6A |
0.59608013032511 |
|
| 16567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A2 |
0.59608013032511 |
|
| 16568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD6 |
0.59608013032511 |
|
| 16569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGXB3 |
0.59608013032511 |
|
| 16570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238369.1 |
0.59608013032511 |
|
| 16571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF1R |
0.59608013032511 |
|
| 16572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFRB |
0.59608013032511 |
|
| 16573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDX1 |
0.59608013032511 |
|
| 16574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A7 |
0.59608013032511 |
|
| 16575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK2A |
0.59608013032511 |
|
| 16576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSI |
0.59608013032511 |
|
| 16577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCOF1 |
0.59608013032511 |
|
| 16578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD74 |
0.59608013032511 |
|
| 16579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS14 |
0.59608013032511 |
|
| 16580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDST1 |
0.59608013032511 |
|
| 16581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239191.1 |
0.59608013032511 |
|
| 16582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNPO |
0.59608013032511 |
|
| 16583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOZ3 |
0.59608013032511 |
|
| 16584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM22 |
0.59608013032511 |
|
| 16585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN4 |
0.59608013032511 |
|
| 16586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM3 |
0.59608013032511 |
|
| 16587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRGM |
0.59608013032511 |
|
| 16588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF300 |
0.59608013032511 |
|
| 16589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF300P1 |
0.59608013032511 |
|
| 16590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX3 |
0.59608013032511 |
|
| 16591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNIP1 |
0.59608013032511 |
|
| 16592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA6 |
0.59608013032511 |
|
| 16593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC69 |
0.59608013032511 |
|
| 16594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GM2A |
0.59608013032511 |
|
| 16595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC36A3 |
0.59608013032511 |
|
| 16596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC36A2 |
0.59608013032511 |
|
| 16597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC36A1 |
0.59608013032511 |
|
| 16598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP197 |
0.59608013032511 |
|
| 16599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAT2 |
0.59608013032511 |
|
| 16600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPARC |
0.59608013032511 |
|
| 16601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP232 |
0.59608013032511 |
|
| 16602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATOX1 |
0.59608013032511 |
|
| 16603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G3BP1 |
0.59608013032511 |
|
| 16604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRA1 |
0.59608013032511 |
|
| 16605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP198 |
0.59608013032511 |
|
| 16606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMUR2 |
0.59608013032511 |
|
| 16607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIA1 |
0.59608013032511 |
|
| 16608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL177P |
0.59608013032511 |
|
| 16609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM114A2 |
0.59608013032511 |
|
| 16610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP3 |
0.59608013032511 |
|
| 16611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT10 |
0.59608013032511 |
|
| 16612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1294 |
0.59608013032511 |
|
| 16613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL655P |
0.59608013032511 |
|
| 16614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP30L |
0.59608013032511 |
|
| 16615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAND1 |
0.59608013032511 |
|
| 16616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3141 |
0.59608013032511 |
|
| 16617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1303 |
0.59608013032511 |
|
| 16618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL439P |
0.59608013032511 |
|
| 16619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMD4 |
0.59608013032511 |
|
| 16620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAVCR1 |
0.59608013032511 |
|
| 16621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAVCR2 |
0.59608013032511 |
|
| 16622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED7 |
0.59608013032511 |
|
| 16623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITK |
0.59608013032511 |
|
| 16624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71B |
0.59608013032511 |
|
| 16625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYFIP2 |
0.59608013032511 |
|
| 16626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC9 |
0.59608013032511 |
|
| 16627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM19 |
0.59608013032511 |
|
| 16628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPAL4 |
0.59608013032511 |
|
| 16629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX30 |
0.59608013032511 |
|
| 16630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf52 |
0.59608013032511 |
|
| 16631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THG1L |
0.59608013032511 |
|
| 16632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM11 |
0.59608013032511 |
|
| 16633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLINT1 |
0.59608013032511 |
|
| 16634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBF1 |
0.59608013032511 |
|
| 16635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF145 |
0.59608013032511 |
|
| 16636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000252458.1 |
0.59608013032511 |
|
| 16637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBLCP1 |
0.59608013032511 |
|
| 16638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL12B |
0.59608013032511 |
|
| 16639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC2P |
0.59608013032511 |
|
| 16640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA1B |
0.59608013032511 |
|
| 16641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC1 |
0.59608013032511 |
|
| 16642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWWP2A |
0.59608013032511 |
|
| 16643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP6 |
0.59608013032511 |
|
| 16644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNJL |
0.59608013032511 |
|
| 16645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL295P |
0.59608013032511 |
|
| 16646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF2 |
0.59608013032511 |
|
| 16647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf54 |
0.59608013032511 |
|
| 16648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLU7 |
0.59608013032511 |
|
| 16649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTTG1 |
0.59608013032511 |
|
| 16650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR146A |
0.59608013032511 |
|
| 16651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3142 |
0.59608013032511 |
|
| 16652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP10B |
0.59608013032511 |
|
| 16653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWC1 |
0.59608013032511 |
|
| 16654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RARS |
0.59608013032511 |
|
| 16655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLL1 |
0.59608013032511 |
|
| 16656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PANK3 |
0.59608013032511 |
|
| 16657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR103A1 |
0.59608013032511 |
|
| 16658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLIT3 |
0.59608013032511 |
|
| 16659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR585 |
0.59608013032511 |
|
| 16660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDL1 |
0.59608013032511 |
|
| 16661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK2 |
0.59608013032511 |
|
| 16662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM196B |
0.59608013032511 |
|
| 16663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378E |
0.59608013032511 |
|
| 16664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXI1 |
0.59608013032511 |
|
| 16665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf58 |
0.59608013032511 |
|
| 16666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCP2 |
0.59608013032511 |
|
| 16667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNIP1 |
0.59608013032511 |
|
| 16668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMB1 |
0.59608013032511 |
|
| 16669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4454 |
0.59608013032511 |
|
| 16670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRP |
0.59608013032511 |
|
| 16671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP17 |
0.59608013032511 |
|
| 16672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL623P |
0.59608013032511 |
|
| 16673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252387.1 |
0.59608013032511 |
|
| 16674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLX3 |
0.59608013032511 |
|
| 16675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL339P |
0.59608013032511 |
|
| 16676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000206909.1 |
0.59608013032511 |
|
| 16677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3912 |
0.59608013032511 |
|
| 16678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPM1 |
0.59608013032511 |
|
| 16679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF18 |
0.59608013032511 |
|
| 16680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf50 |
0.59608013032511 |
|
| 16681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW11 |
0.59608013032511 |
|
| 16682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB9 |
0.59608013032511 |
|
| 16683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK10 |
0.59608013032511 |
|
| 16684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBTD2 |
0.59608013032511 |
|
| 16685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA57|ENSG00000212529.1 |
0.59608013032511 |
|
| 16686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3PXD2B |
0.59608013032511 |
|
| 16687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEURL1B |
0.59608013032511 |
|
| 16688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5003 |
0.59608013032511 |
|
| 16689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP1 |
0.59608013032511 |
|
| 16690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERGIC1 |
0.59608013032511 |
|
| 16691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL26L1 |
0.59608013032511 |
|
| 16692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0E1 |
0.59608013032511 |
|
| 16693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74B |
0.59608013032511 |
|
| 16694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREBRF |
0.59608013032511 |
|
| 16695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIP1 |
0.59608013032511 |
|
| 16696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP200 |
0.59608013032511 |
|
| 16697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STC2 |
0.59608013032511 |
|
| 16698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOD1 |
0.59608013032511 |
|
| 16699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPEB4 |
0.59608013032511 |
|
| 16700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf47 |
0.59608013032511 |
|
| 16701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSG2 |
0.59608013032511 |
|
| 16702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4634 |
0.59608013032511 |
|
| 16703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSX2 |
0.59608013032511 |
|
| 16704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRD1 |
0.59608013032511 |
|
| 16705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239026.1 |
0.59608013032511 |
|
| 16706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFXN1 |
0.59608013032511 |
|
| 16707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP148 |
0.59608013032511 |
|
| 16708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRH2 |
0.59608013032511 |
|
| 16709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPLX2 |
0.59608013032511 |
|
| 16710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC3 |
0.59608013032511 |
|
| 16711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM153B |
0.59608013032511 |
|
| 16712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIMC1 |
0.59608013032511 |
|
| 16713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1191 |
0.59608013032511 |
|
| 16714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL10 |
0.59608013032511 |
|
| 16715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1271 |
0.59608013032511 |
|
| 16716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP16 |
0.59608013032511 |
|
| 16717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIGD2A |
0.59608013032511 |
|
| 16718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLTB |
0.59608013032511 |
|
| 16719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAF2 |
0.59608013032511 |
|
| 16720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF44 |
0.59608013032511 |
|
| 16721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDHR2 |
0.59608013032511 |
|
| 16722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL684P |
0.59608013032511 |
|
| 16723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRIN1 |
0.59608013032511 |
|
| 16724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNCB |
0.59608013032511 |
|
| 16725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4E1B |
0.59608013032511 |
|
| 16726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HK3 |
0.59608013032511 |
|
| 16727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4281 |
0.59608013032511 |
|
| 16728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN17 |
0.59608013032511 |
|
| 16729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC5A |
0.59608013032511 |
|
| 16730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UIMC1 |
0.59608013032511 |
|
| 16731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF346 |
0.59608013032511 |
|
| 16732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR4 |
0.59608013032511 |
|
| 16733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSD1 |
0.59608013032511 |
|
| 16734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXD3 |
0.59608013032511 |
|
| 16735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB24 |
0.59608013032511 |
|
| 16736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRELID1 |
0.59608013032511 |
|
| 16737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMAN2 |
0.59608013032511 |
|
| 16738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL562P |
0.59608013032511 |
|
| 16739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS14 |
0.59608013032511 |
|
| 16740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC34A1 |
0.59608013032511 |
|
| 16741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F12 |
0.59608013032511 |
|
| 16742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRK6 |
0.59608013032511 |
|
| 16743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFN3 |
0.59608013032511 |
|
| 16744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR7 |
0.59608013032511 |
|
| 16745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBN1 |
0.59608013032511 |
|
| 16746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM7 |
0.59608013032511 |
|
| 16747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK3 |
0.59608013032511 |
|
| 16748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX41 |
0.59608013032511 |
|
| 16749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM193B |
0.59608013032511 |
|
| 16750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED9 |
0.59608013032511 |
|
| 16751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT7 |
0.59608013032511 |
|
| 16752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM153A |
0.59608013032511 |
|
| 16753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROP1 |
0.59608013032511 |
|
| 16754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM153C |
0.59608013032511 |
|
| 16755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N4BP3 |
0.59608013032511 |
|
| 16756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMND5B |
0.59608013032511 |
|
| 16757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHP2 |
0.59608013032511 |
|
| 16758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPAB |
0.59608013032511 |
|
| 16759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHYKPL |
0.59608013032511 |
|
| 16760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL23A1 |
0.59608013032511 |
|
| 16761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL646P |
0.59608013032511 |
|
| 16762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLK4 |
0.59608013032511 |
|
| 16763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP70 |
0.59608013032511 |
|
| 16764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF354A |
0.59608013032511 |
|
| 16765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AACSP1 |
0.59608013032511 |
|
| 16766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF354B |
0.59608013032511 |
|
| 16767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP2 |
0.59608013032511 |
|
| 16768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF454 |
0.59608013032511 |
|
| 16769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRM6 |
0.59608013032511 |
|
| 16770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF879 |
0.59608013032511 |
|
| 16771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF354C |
0.59608013032511 |
|
| 16772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS2 |
0.59608013032511 |
|
| 16773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL71P |
0.59608013032511 |
|
| 16774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC37A3 |
0.601959556211142 |
|
| 16775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB19 |
0.601959556211142 |
|
| 16776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP247 |
0.601959556211142 |
|
| 16777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP248 |
0.601959556211142 |
|
| 16778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238868.1 |
0.601959556211142 |
|
| 16779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKRN1 |
0.601959556211142 |
|
| 16780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND2A |
0.601959556211142 |
|
| 16781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL771P |
0.601959556211142 |
|
| 16782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCK2 |
0.601959556211142 |
|
| 16783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB2 |
0.601959556211142 |
|
| 16784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRAF |
0.601959556211142 |
|
| 16785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000271932.1 |
0.601959556211142 |
|
| 16786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS33 |
0.601959556211142 |
|
| 16787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM178B |
0.601959556211142 |
|
| 16788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGK |
0.601959556211142 |
|
| 16789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1147 |
0.601959556211142 |
|
| 16790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WEE2 |
0.601959556211142 |
|
| 16791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSBP1 |
0.601959556211142 |
|
| 16792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R3 |
0.601959556211142 |
|
| 16793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R4 |
0.601959556211142 |
|
| 16794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R5 |
0.601959556211142 |
|
| 16795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS37 |
0.601959556211142 |
|
| 16796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9A3P |
0.601959556211142 |
|
| 16797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9A1P |
0.601959556211142 |
|
| 16798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAM |
0.601959556211142 |
|
| 16799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9A4 |
0.601959556211142 |
|
| 16800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC5A |
0.601959556211142 |
|
| 16801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R38 |
0.601959556211142 |
|
| 16802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOXD2P |
0.601959556211142 |
|
| 16803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS58 |
0.601959556211142 |
|
| 16804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L6 |
0.601959556211142 |
|
| 16805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS1 |
0.601959556211142 |
|
| 16806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS3P2 |
0.601959556211142 |
|
| 16807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS3P3 |
0.601959556211142 |
|
| 16808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBC2 |
0.601959556211142 |
|
| 16809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV19 |
0.601959556211142 |
|
| 16810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV27 |
0.601959556211142 |
|
| 16811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV28 |
0.601959556211142 |
|
| 16812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV2 |
0.601959556211142 |
|
| 16813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRBV9 |
0.601959556211142 |
|
| 16814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASTK |
0.601959556211142 |
|
| 16815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMUB1 |
0.601959556211142 |
|
| 16816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGAP3 |
0.601959556211142 |
|
| 16817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00477 |
0.603469877434583 |
|
| 16818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL38P |
0.603469877434583 |
|
| 16819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAT1 |
0.603469877434583 |
|
| 16820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf77 |
0.603469877434583 |
|
| 16821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRMP |
0.603469877434583 |
|
| 16822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC1 |
0.603469877434583 |
|
| 16823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM5 |
0.603469877434583 |
|
| 16824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRAS |
0.603469877434583 |
|
| 16825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFLTD1 |
0.603469877434583 |
|
| 16826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP262 |
0.603469877434583 |
|
| 16827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF8 |
0.603469877434583 |
|
| 16828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHE41 |
0.603469877434583 |
|
| 16829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSPN |
0.603469877434583 |
|
| 16830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPR2 |
0.603469877434583 |
|
| 16831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP354 |
0.603469877434583 |
|
| 16832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASUN |
0.603469877434583 |
|
| 16833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR1OP2 |
0.603469877434583 |
|
| 16834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM7SF3 |
0.603469877434583 |
|
| 16835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED21 |
0.603469877434583 |
|
| 16836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf71 |
0.603469877434583 |
|
| 16837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK38L |
0.603469877434583 |
|
| 16838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARNTL2 |
0.603469877434583 |
|
| 16839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCO2 |
0.603469877434583 |
|
| 16840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPFIBP1 |
0.603469877434583 |
|
| 16841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REP15 |
0.603469877434583 |
|
| 16842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS35 |
0.603469877434583 |
|
| 16843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANSC4 |
0.603469877434583 |
|
| 16844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL42 |
0.603469877434583 |
|
| 16845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP15 |
0.603469877434583 |
|
| 16846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTHLH |
0.603469877434583 |
|
| 16847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC91 |
0.603469877434583 |
|
| 16848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP355 |
0.603469877434583 |
|
| 16849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAR2 |
0.603469877434583 |
|
| 16850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERGIC2 |
0.603469877434583 |
|
| 16851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OVCH1 |
0.603469877434583 |
|
| 16852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMTC1 |
0.603469877434583 |
|
| 16853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000253052.1 |
0.603469877434583 |
|
| 16854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP356 |
0.603469877434583 |
|
| 16855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO8 |
0.603469877434583 |
|
| 16856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPRIN2 |
0.603469877434583 |
|
| 16857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00941 |
0.603469877434583 |
|
| 16858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN11 |
0.603469877434583 |
|
| 16859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX11 |
0.603469877434583 |
|
| 16860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212533.1 |
0.603469877434583 |
|
| 16861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM60A |
0.603469877434583 |
|
| 16862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238661.1 |
0.603469877434583 |
|
| 16863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND5B |
0.603469877434583 |
|
| 16864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239033.1 |
0.603469877434583 |
|
| 16865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL20 |
0.603469877434583 |
|
| 16866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMN1 |
0.603469877434583 |
|
| 16867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMN1P1 |
0.603469877434583 |
|
| 16868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H3F3C |
0.603469877434583 |
|
| 16869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252204.1 |
0.603469877434583 |
|
| 16870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1551 |
0.603469877434583 |
|
| 16871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BICD1 |
0.603469877434583 |
|
| 16872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD4 |
0.603469877434583 |
|
| 16873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1L |
0.603469877434583 |
|
| 16874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YARS2 |
0.603469877434583 |
|
| 16875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKP2 |
0.603469877434583 |
|
| 16876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251863.1 |
0.603469877434583 |
|
| 16877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAG2 |
0.606019540570096 |
|
| 16878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNTL5 |
0.606019540570096 |
|
| 16879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT11 |
0.606019540570096 |
|
| 16880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239045.1 |
0.606019540570096 |
|
| 16881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KMT2C |
0.606019540570096 |
|
| 16882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP5P3 |
0.606019540570096 |
|
| 16883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP250 |
0.606019540570096 |
|
| 16884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238557.1 |
0.606019540570096 |
|
| 16885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212590.1 |
0.606019540570096 |
|
| 16886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC2 |
0.606019540570096 |
|
| 16887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL811P |
0.606019540570096 |
|
| 16888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL845P |
0.606019540570096 |
|
| 16889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR3B |
0.606019540570096 |
|
| 16890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF4L2 |
0.607482370982783 |
|
| 16891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP16 |
0.607482370982783 |
|
| 16892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP272 |
0.607482370982783 |
|
| 16893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPK2 |
0.607482370982783 |
|
| 16894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSGIN2 |
0.607482370982783 |
|
| 16895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBN |
0.607482370982783 |
|
| 16896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DECR1 |
0.607482370982783 |
|
| 16897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALB1 |
0.607482370982783 |
|
| 16898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00534 |
0.607482370982783 |
|
| 16899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP273 |
0.607482370982783 |
|
| 16900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM64 |
0.607482370982783 |
|
| 16901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NECAB1 |
0.607482370982783 |
|
| 16902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM55A |
0.607482370982783 |
|
| 16903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD6B |
0.607482370982783 |
|
| 16904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC69 |
0.607482370982783 |
|
| 16905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL777P |
0.607482370982783 |
|
| 16906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4661 |
0.607482370982783 |
|
| 16907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC26A7 |
0.607482370982783 |
|
| 16908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GBX1 |
0.609093707839701 |
|
| 16909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB10 |
0.609093707839701 |
|
| 16910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCA1P1 |
0.609093707839701 |
|
| 16911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCF2 |
0.609093707839701 |
|
| 16912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHPF2 |
0.609093707839701 |
|
| 16913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR671 |
0.609093707839701 |
|
| 16914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCD3 |
0.609093707839701 |
|
| 16915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUB1 |
0.609093707839701 |
|
| 16916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR86 |
0.609093707839701 |
|
| 16917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGN |
0.609093707839701 |
|
| 16918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3907 |
0.609093707839701 |
|
| 16919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHEB |
0.609093707839701 |
|
| 16920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL76P |
0.609093707839701 |
|
| 16921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFASC |
0.615343350138829 |
|
| 16922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252946.1 |
0.615343350138829 |
|
| 16923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTN2 |
0.615343350138829 |
|
| 16924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THBS2 |
0.623437216852966 |
|
| 16925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR27 |
0.623437216852966 |
|
| 16926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf120 |
0.623437216852966 |
|
| 16927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF10 |
0.623437216852966 |
|
| 16928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTE3 |
0.623437216852966 |
|
| 16929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf70 |
0.623437216852966 |
|
| 16930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00242 |
0.623437216852966 |
|
| 16931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00574 |
0.623437216852966 |
|
| 16932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLL1 |
0.623437216852966 |
|
| 16933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM120B |
0.623437216852966 |
|
| 16934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4644 |
0.623437216852966 |
|
| 16935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMB1 |
0.623437216852966 |
|
| 16936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBP |
0.623437216852966 |
|
| 16937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD2 |
0.623437216852966 |
|
| 16938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL13B |
0.624886194996345 |
|
| 16939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROS1 |
0.624886194996345 |
|
| 16940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX19 |
0.624886194996345 |
|
| 16941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHFRL1 |
0.624886194996345 |
|
| 16942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN3 |
0.624886194996345 |
|
| 16943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00879 |
0.624886194996345 |
|
| 16944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFD2P1 |
0.624886194996345 |
|
| 16945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L12 |
0.624886194996345 |
|
| 16946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA6 |
0.624886194996345 |
|
| 16947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL6 |
0.624886194996345 |
|
| 16948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBG3|ENSG00000233280.2 |
0.624886194996345 |
|
| 16949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBG3|ENSG00000080200.5 |
0.624886194996345 |
|
| 16950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MINA |
0.624886194996345 |
|
| 16951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRR3 |
0.624886194996345 |
|
| 16952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AC1 |
0.624886194996345 |
|
| 16953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AC2 |
0.624886194996345 |
|
| 16954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H1 |
0.624886194996345 |
|
| 16955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H14 |
0.624886194996345 |
|
| 16956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H15 |
0.624886194996345 |
|
| 16957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H6 |
0.624886194996345 |
|
| 16958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H2 |
0.624886194996345 |
|
| 16959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5H8P |
0.624886194996345 |
|
| 16960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5K4 |
0.624886194996345 |
|
| 16961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5K3 |
0.624886194996345 |
|
| 16962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5K1 |
0.624886194996345 |
|
| 16963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDND1 |
0.624886194996345 |
|
| 16964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5K2 |
0.624886194996345 |
|
| 16965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPOX |
0.624886194996345 |
|
| 16966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR15 |
0.624886194996345 |
|
| 16967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL6 |
0.624886194996345 |
|
| 16968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCBLD2 |
0.624886194996345 |
|
| 16969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00973 |
0.624886194996345 |
|
| 16970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL8A1 |
0.624886194996345 |
|
| 16971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMSS1 |
0.624886194996345 |
|
| 16972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FILIP1L |
0.624886194996345 |
|
| 16973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3921 |
0.624886194996345 |
|
| 16974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM30C |
0.624886194996345 |
|
| 16975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD61|ENSG00000238377.1 |
0.624886194996345 |
|
| 16976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D23 |
0.624886194996345 |
|
| 16977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIT2 |
0.624886194996345 |
|
| 16978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOMM70A |
0.624886194996345 |
|
| 16979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LNP1 |
0.624886194996345 |
|
| 16980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM45A |
0.624886194996345 |
|
| 16981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR128 |
0.624886194996345 |
|
| 16982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252989.1 |
0.624886194996345 |
|
| 16983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFG |
0.624886194996345 |
|
| 16984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA2018 |
0.624886194996345 |
|
| 16985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA50 |
0.624886194996345 |
|
| 16986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1A |
0.624886194996345 |
|
| 16987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD1C |
0.624886194996345 |
|
| 16988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC23 |
0.624886194996345 |
|
| 16989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1407 |
0.624886194996345 |
|
| 16990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QTRTD1 |
0.624886194996345 |
|
| 16991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRD3 |
0.624886194996345 |
|
| 16992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF80 |
0.624886194996345 |
|
| 16993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGIT |
0.624886194996345 |
|
| 16994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR568 |
0.624886194996345 |
|
| 16995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB20 |
0.624886194996345 |
|
| 16996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4796 |
0.624886194996345 |
|
| 16997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAP43 |
0.624886194996345 |
|
| 16998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL815P |
0.624886194996345 |
|
| 16999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00903 |
0.624886194996345 |
|
| 17000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL582P |
0.624886194996345 |
|
| 17001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUSC7 |
0.624886194996345 |
|
| 17002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4447 |
0.624886194996345 |
|
| 17003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00901 |
0.624886194996345 |
|
| 17004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF11 |
0.624886194996345 |
|
| 17005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf30 |
0.624886194996345 |
|
| 17006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPK1B |
0.624886194996345 |
|
| 17007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALT4 |
0.624886194996345 |
|
| 17008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP31 |
0.624886194996345 |
|
| 17009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM39A |
0.624886194996345 |
|
| 17010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POGLUT1 |
0.624886194996345 |
|
| 17011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMMDC1 |
0.624886194996345 |
|
| 17012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD80 |
0.624886194996345 |
|
| 17013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADPRH |
0.624886194996345 |
|
| 17014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA1A |
0.624886194996345 |
|
| 17015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POPDC2 |
0.624886194996345 |
|
| 17016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX17 |
0.624886194996345 |
|
| 17017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAATS1 |
0.624886194996345 |
|
| 17018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1I2 |
0.624886194996345 |
|
| 17019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSK3B |
0.624886194996345 |
|
| 17020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL762P |
0.624886194996345 |
|
| 17021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL397P |
0.624886194996345 |
|
| 17022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR156 |
0.624886194996345 |
|
| 17023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC58 |
0.624886194996345 |
|
| 17024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSTL1 |
0.624886194996345 |
|
| 17025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB4 |
0.624886194996345 |
|
| 17026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HGD |
0.624886194996345 |
|
| 17027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABL3 |
0.624886194996345 |
|
| 17028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2E1 |
0.624886194996345 |
|
| 17029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP5L |
0.624886194996345 |
|
| 17030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5682 |
0.624886194996345 |
|
| 17031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLQ |
0.624886194996345 |
|
| 17032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARGFX |
0.624886194996345 |
|
| 17033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO40 |
0.624886194996345 |
|
| 17034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGB1 |
0.624886194996345 |
|
| 17035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCLS1 |
0.624886194996345 |
|
| 17036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL172P |
0.624886194996345 |
|
| 17037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238670.1 |
0.624886194996345 |
|
| 17038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCB1 |
0.624886194996345 |
|
| 17039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EAF2 |
0.624886194996345 |
|
| 17040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC15A2 |
0.624886194996345 |
|
| 17041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILDR1 |
0.624886194996345 |
|
| 17042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD86 |
0.624886194996345 |
|
| 17043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASR |
0.624886194996345 |
|
| 17044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252170.1 |
0.624886194996345 |
|
| 17045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTA |
0.624886194996345 |
|
| 17046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC58 |
0.624886194996345 |
|
| 17047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM162A |
0.624886194996345 |
|
| 17048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR5B |
0.624886194996345 |
|
| 17049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KPNA1 |
0.624886194996345 |
|
| 17050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP9 |
0.624886194996345 |
|
| 17051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTX3L |
0.624886194996345 |
|
| 17052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP15 |
0.624886194996345 |
|
| 17053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP14 |
0.624886194996345 |
|
| 17054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPBAP1 |
0.624886194996345 |
|
| 17055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238480.1 |
0.624886194996345 |
|
| 17056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRC2 |
0.624886194996345 |
|
| 17057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA5B |
0.624886194996345 |
|
| 17058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIA5 |
0.624886194996345 |
|
| 17059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC22A |
0.624886194996345 |
|
| 17060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY5 |
0.624886194996345 |
|
| 17061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPLB |
0.624886194996345 |
|
| 17062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLK |
0.624886194996345 |
|
| 17063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA5 |
0.624886194996345 |
|
| 17064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC14 |
0.624886194996345 |
|
| 17065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROPN1 |
0.624886194996345 |
|
| 17066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KALRN |
0.624886194996345 |
|
| 17067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5002 |
0.624886194996345 |
|
| 17068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNRD3NB |
0.624886194996345 |
|
| 17069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNRD3 |
0.624886194996345 |
|
| 17070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP210P1 |
0.624886194996345 |
|
| 17071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD6 |
0.624886194996345 |
|
| 17072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNA1 |
0.624886194996345 |
|
| 17073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf56 |
0.624886194996345 |
|
| 17074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRA1 |
0.624886194996345 |
|
| 17075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM2 |
0.624886194996345 |
|
| 17076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PODXL2 |
0.624886194996345 |
|
| 17077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABTB1 |
0.624886194996345 |
|
| 17078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGLL |
0.624886194996345 |
|
| 17079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD12 |
0.624886194996345 |
|
| 17080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP139 |
0.624886194996345 |
|
| 17081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC61A1 |
0.624886194996345 |
|
| 17082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUVBL1 |
0.624886194996345 |
|
| 17083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEFSEC |
0.624886194996345 |
|
| 17084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1280 |
0.624886194996345 |
|
| 17085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB8 |
0.624886194996345 |
|
| 17086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA2 |
0.624886194996345 |
|
| 17087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf27 |
0.624886194996345 |
|
| 17088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPN1 |
0.624886194996345 |
|
| 17089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA24|ENSG00000207130.1 |
0.624886194996345 |
|
| 17090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB7A |
0.624886194996345 |
|
| 17091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL698P |
0.624886194996345 |
|
| 17092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAD9 |
0.624886194996345 |
|
| 17093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1257 |
0.624886194996345 |
|
| 17094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCC1 |
0.624886194996345 |
|
| 17095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GP9 |
0.624886194996345 |
|
| 17096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252435.1 |
0.624886194996345 |
|
| 17097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238874.1 |
0.624886194996345 |
|
| 17098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB43 |
0.624886194996345 |
|
| 17099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISY1 |
0.624886194996345 |
|
| 17100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNBP |
0.624886194996345 |
|
| 17101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPG1 |
0.624886194996345 |
|
| 17102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf37 |
0.624886194996345 |
|
| 17103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H1FX |
0.624886194996345 |
|
| 17104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL32P3 |
0.624886194996345 |
|
| 17105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7B |
0.624886194996345 |
|
| 17106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB12 |
0.624886194996345 |
|
| 17107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD4 |
0.624886194996345 |
|
| 17108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT122 |
0.624886194996345 |
|
| 17109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHO |
0.624886194996345 |
|
| 17110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H1FOO |
0.624886194996345 |
|
| 17111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXND1 |
0.624886194996345 |
|
| 17112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL752P |
0.624886194996345 |
|
| 17113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCC1 |
0.624886194996345 |
|
| 17114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRH |
0.624886194996345 |
|
| 17115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG1L2 |
0.624886194996345 |
|
| 17116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86HP |
0.624886194996345 |
|
| 17117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A4P2 |
0.624886194996345 |
|
| 17118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A5 |
0.624886194996345 |
|
| 17119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A6 |
0.624886194996345 |
|
| 17120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R4 |
0.624886194996345 |
|
| 17121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP212 |
0.624886194996345 |
|
| 17122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2C1 |
0.624886194996345 |
|
| 17123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASTE1 |
0.624886194996345 |
|
| 17124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEK11 |
0.624886194996345 |
|
| 17125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT16P |
0.624886194996345 |
|
| 17126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT16 |
0.624886194996345 |
|
| 17127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL3 |
0.624886194996345 |
|
| 17128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA58|ENSG00000249020.1 |
0.624886194996345 |
|
| 17129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE4 |
0.624886194996345 |
|
| 17130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5704 |
0.624886194996345 |
|
| 17131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238701.1 |
0.624886194996345 |
|
| 17132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACPP |
0.624886194996345 |
|
| 17133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC13 |
0.624886194996345 |
|
| 17134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAD11 |
0.624886194996345 |
|
| 17135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPHP3 |
0.624886194996345 |
|
| 17136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACKR4 |
0.624886194996345 |
|
| 17137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA5 |
0.624886194996345 |
|
| 17138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM108 |
0.624886194996345 |
|
| 17139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BFSP2 |
0.624886194996345 |
|
| 17140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA33|ENSG00000201827.1 |
0.624886194996345 |
|
| 17141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDV3 |
0.624886194996345 |
|
| 17142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOPBP1 |
0.624886194996345 |
|
| 17143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFP1 |
0.624886194996345 |
|
| 17144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP140 |
0.624886194996345 |
|
| 17145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TF |
0.624886194996345 |
|
| 17146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPRB |
0.624886194996345 |
|
| 17147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB6B |
0.624886194996345 |
|
| 17148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf36 |
0.624886194996345 |
|
| 17149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO2A1 |
0.624886194996345 |
|
| 17150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RYK |
0.624886194996345 |
|
| 17151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL39P5 |
0.624886194996345 |
|
| 17152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMOTL2 |
0.624886194996345 |
|
| 17153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4788 |
0.624886194996345 |
|
| 17154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC13 |
0.624886194996345 |
|
| 17155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP63 |
0.624886194996345 |
|
| 17156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHB1 |
0.624886194996345 |
|
| 17157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KY |
0.624886194996345 |
|
| 17158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP141 |
0.624886194996345 |
|
| 17159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251800.1 |
0.624886194996345 |
|
| 17160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIC4 |
0.624886194996345 |
|
| 17161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIC1 |
0.624886194996345 |
|
| 17162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGTR1 |
0.624886194996345 |
|
| 17163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPB1 |
0.624886194996345 |
|
| 17164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA3 |
0.624886194996345 |
|
| 17165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYG1 |
0.624886194996345 |
|
| 17166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HLTF |
0.624886194996345 |
|
| 17167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPS3 |
0.624886194996345 |
|
| 17168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CP |
0.624886194996345 |
|
| 17169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPHL1P |
0.624886194996345 |
|
| 17170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF18 |
0.624886194996345 |
|
| 17171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF1 |
0.624886194996345 |
|
| 17172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF4 |
0.624886194996345 |
|
| 17173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWTR1 |
0.624886194996345 |
|
| 17174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD2 |
0.624886194996345 |
|
| 17175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKUB1 |
0.624886194996345 |
|
| 17176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF13 |
0.624886194996345 |
|
| 17177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFN2 |
0.624886194996345 |
|
| 17178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000243321.2 |
0.624886194996345 |
|
| 17179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC22D2 |
0.624886194996345 |
|
| 17180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERP1 |
0.624886194996345 |
|
| 17181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2A |
0.624886194996345 |
|
| 17182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELT |
0.624886194996345 |
|
| 17183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM194A |
0.624886194996345 |
|
| 17184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIAH2 |
0.624886194996345 |
|
| 17185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM188B2 |
0.624886194996345 |
|
| 17186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLRN1 |
0.624886194996345 |
|
| 17187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED12L |
0.624886194996345 |
|
| 17188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP145 |
0.624886194996345 |
|
| 17189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR171 |
0.624886194996345 |
|
| 17190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY14 |
0.624886194996345 |
|
| 17191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR87 |
0.624886194996345 |
|
| 17192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY13 |
0.624886194996345 |
|
| 17193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY12 |
0.624886194996345 |
|
| 17194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF10 |
0.624886194996345 |
|
| 17195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5186 |
0.624886194996345 |
|
| 17196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AADACL2 |
0.624886194996345 |
|
| 17197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AADAC |
0.624886194996345 |
|
| 17198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUCNR1 |
0.624886194996345 |
|
| 17199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBNL1 |
0.624886194996345 |
|
| 17200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM14E |
0.624886194996345 |
|
| 17201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR70 |
0.626515703617611 |
|
| 17202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG18 |
0.627562389891066 |
|
| 17203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP21 |
0.627562389891066 |
|
| 17204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM39 |
0.627562389891066 |
|
| 17205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNL1 |
0.627562389891066 |
|
| 17206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR3 |
0.627562389891066 |
|
| 17207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCF1 |
0.627562389891066 |
|
| 17208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR877 |
0.627562389891066 |
|
| 17209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R10 |
0.627562389891066 |
|
| 17210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS18B |
0.627562389891066 |
|
| 17211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAT1 |
0.627562389891066 |
|
| 17212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf136 |
0.627562389891066 |
|
| 17213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX16 |
0.627562389891066 |
|
| 17214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRM |
0.627562389891066 |
|
| 17215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R18 |
0.627562389891066 |
|
| 17216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDC1 |
0.627562389891066 |
|
| 17217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB |
0.627562389891066 |
|
| 17218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLOT1 |
0.627562389891066 |
|
| 17219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IER3 |
0.627562389891066 |
|
| 17220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL353P |
0.627562389891066 |
|
| 17221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG20 |
0.627562389891066 |
|
| 17222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00243 |
0.627562389891066 |
|
| 17223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDR1 |
0.627562389891066 |
|
| 17224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP186 |
0.627562389891066 |
|
| 17225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4640 |
0.627562389891066 |
|
| 17226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H4 |
0.627562389891066 |
|
| 17227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL175P |
0.627562389891066 |
|
| 17228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VARS2 |
0.627562389891066 |
|
| 17229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTA2 |
0.627562389891066 |
|
| 17230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPCR1 |
0.627562389891066 |
|
| 17231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG21 |
0.627562389891066 |
|
| 17232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC21 |
0.627562389891066 |
|
| 17233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC22 |
0.627562389891066 |
|
| 17234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCG22 |
0.627562389891066 |
|
| 17235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf15 |
0.627562389891066 |
|
| 17236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDSN |
0.627562389891066 |
|
| 17237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSORS1C1 |
0.627562389891066 |
|
| 17238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX1 |
0.629494194721827 |
|
| 17239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP73 |
0.629494194721827 |
|
| 17240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS16 |
0.629494194721827 |
|
| 17241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0947 |
0.629494194721827 |
|
| 17242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED10 |
0.629494194721827 |
|
| 17243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2QL1 |
0.629494194721827 |
|
| 17244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSUN2 |
0.629494194721827 |
|
| 17245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRD5A1 |
0.629494194721827 |
|
| 17246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPD7 |
0.629494194721827 |
|
| 17247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP79 |
0.629494194721827 |
|
| 17248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP176 |
0.629494194721827 |
|
| 17249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY2 |
0.629494194721827 |
|
| 17250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf49 |
0.629494194721827 |
|
| 17251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRR |
0.629494194721827 |
|
| 17252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASTKD3 |
0.629494194721827 |
|
| 17253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4458 |
0.629494194721827 |
|
| 17254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA5A |
0.629494194721827 |
|
| 17255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4636 |
0.629494194721827 |
|
| 17256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD123 |
0.629494194721827 |
|
| 17257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R1 |
0.629494194721827 |
|
| 17258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP177 |
0.629494194721827 |
|
| 17259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf34 |
0.640572272263343 |
|
| 17260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP269 |
0.640572272263343 |
|
| 17261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULF1 |
0.640572272263343 |
|
| 17262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO5A1 |
0.640572272263343 |
|
| 17263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP29 |
0.640572272263343 |
|
| 17264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL675P |
0.640572272263343 |
|
| 17265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP270 |
0.640572272263343 |
|
| 17266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32AP1 |
0.643466785135491 |
|
| 17267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPH6 |
0.643466785135491 |
|
| 17268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3942 |
0.643466785135491 |
|
| 17269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4510 |
0.643466785135491 |
|
| 17270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf41 |
0.643466785135491 |
|
| 17271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1A1P1 |
0.643466785135491 |
|
| 17272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212511.1 |
0.643466785135491 |
|
| 17273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEIS2 |
0.643466785135491 |
|
| 17274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO5A |
0.643466785135491 |
|
| 17275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRED1 |
0.643466785135491 |
|
| 17276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM98B |
0.643466785135491 |
|
| 17277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRP1 |
0.643466785135491 |
|
| 17278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf53 |
0.643466785135491 |
|
| 17279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf54 |
0.643466785135491 |
|
| 17280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THBS1 |
0.643466785135491 |
|
| 17281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSIP1 |
0.643466785135491 |
|
| 17282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFL6 |
0.647052901559322 |
|
| 17283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP20 |
0.647052901559322 |
|
| 17284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEANC |
0.647052901559322 |
|
| 17285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB9A |
0.647052901559322 |
|
| 17286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC2 |
0.647052901559322 |
|
| 17287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OFD1 |
0.647052901559322 |
|
| 17288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPM6B |
0.647052901559322 |
|
| 17289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN8 |
0.647052901559322 |
|
| 17290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRA2 |
0.647052901559322 |
|
| 17291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTSL3 |
0.647947395305013 |
|
| 17292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00933 |
0.647947395305013 |
|
| 17293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN2 |
0.647947395305013 |
|
| 17294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAND2P |
0.647947395305013 |
|
| 17295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR73 |
0.647947395305013 |
|
| 17296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMB |
0.647947395305013 |
|
| 17297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC11A |
0.647947395305013 |
|
| 17298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF592 |
0.647947395305013 |
|
| 17299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPK3 |
0.647947395305013 |
|
| 17300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000200991.1 |
0.647947395305013 |
|
| 17301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC28A1 |
0.647947395305013 |
|
| 17302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE8A |
0.647947395305013 |
|
| 17303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPG4P12 |
0.647947395305013 |
|
| 17304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL428P |
0.647947395305013 |
|
| 17305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP13 |
0.647947395305013 |
|
| 17306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL25 |
0.647947395305013 |
|
| 17307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1276 |
0.647947395305013 |
|
| 17308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AP |
0.647947395305013 |
|
| 17309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGBL1 |
0.647947395305013 |
|
| 17310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP400 |
0.647947395305013 |
|
| 17311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000200206.1 |
0.647947395305013 |
|
| 17312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00052 |
0.647947395305013 |
|
| 17313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTRK3 |
0.647947395305013 |
|
| 17314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL46 |
0.647947395305013 |
|
| 17315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS11 |
0.647947395305013 |
|
| 17316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DET1 |
0.647947395305013 |
|
| 17317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1179 |
0.647947395305013 |
|
| 17318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AEN |
0.647947395305013 |
|
| 17319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISG20 |
0.647947395305013 |
|
| 17320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAN |
0.647947395305013 |
|
| 17321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAPLN3 |
0.647947395305013 |
|
| 17322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFGE8 |
0.647947395305013 |
|
| 17323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHCG |
0.647947395305013 |
|
| 17324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00928 |
0.647947395305013 |
|
| 17325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TICRR |
0.647947395305013 |
|
| 17326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF7 |
0.647947395305013 |
|
| 17327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLIN1 |
0.647947395305013 |
|
| 17328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX11A |
0.647947395305013 |
|
| 17329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR93 |
0.647947395305013 |
|
| 17330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MESP1 |
0.647947395305013 |
|
| 17331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MESP2 |
0.647947395305013 |
|
| 17332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANPEP |
0.647947395305013 |
|
| 17333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3S2 |
0.647947395305013 |
|
| 17334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5094 |
0.647947395305013 |
|
| 17335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5009 |
0.647947395305013 |
|
| 17336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf38 |
0.647947395305013 |
|
| 17337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF710 |
0.647947395305013 |
|
| 17338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3174 |
0.647947395305013 |
|
| 17339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDH2 |
0.647947395305013 |
|
| 17340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL755P |
0.647947395305013 |
|
| 17341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4B |
0.647947395305013 |
|
| 17342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL346P |
0.647947395305013 |
|
| 17343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIB1 |
0.647947395305013 |
|
| 17344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPGP1 |
0.647947395305013 |
|
| 17345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL13 |
0.647947395305013 |
|
| 17346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGRN |
0.647947395305013 |
|
| 17347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL736P |
0.647947395305013 |
|
| 17348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABARAPL3 |
0.647947395305013 |
|
| 17349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQGAP1 |
0.647947395305013 |
|
| 17350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF774 |
0.647947395305013 |
|
| 17351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTC3 |
0.647947395305013 |
|
| 17352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLM |
0.647947395305013 |
|
| 17353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD18|ENSG00000200677.1 |
0.647947395305013 |
|
| 17354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL363P |
0.647947395305013 |
|
| 17355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FURIN |
0.647947395305013 |
|
| 17356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FES |
0.647947395305013 |
|
| 17357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN2A2 |
0.647947395305013 |
|
| 17358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDDC3 |
0.647947395305013 |
|
| 17359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC45A |
0.647947395305013 |
|
| 17360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCCD1 |
0.647947395305013 |
|
| 17361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRC1 |
0.647947395305013 |
|
| 17362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS33B |
0.647947395305013 |
|
| 17363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SV2B |
0.647947395305013 |
|
| 17364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238981.1 |
0.647947395305013 |
|
| 17365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO3A1 |
0.647947395305013 |
|
| 17366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA2 |
0.647947395305013 |
|
| 17367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000239197.1 |
0.647947395305013 |
|
| 17368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf32 |
0.647947395305013 |
|
| 17369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00930 |
0.647947395305013 |
|
| 17370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM174B |
0.647947395305013 |
|
| 17371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL599P |
0.647947395305013 |
|
| 17372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD2 |
0.647947395305013 |
|
| 17373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3175 |
0.647947395305013 |
|
| 17374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGMA |
0.647947395305013 |
|
| 17375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCTP2 |
0.647947395305013 |
|
| 17376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00924 |
0.647947395305013 |
|
| 17377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2F2 |
0.647947395305013 |
|
| 17378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1469 |
0.647947395305013 |
|
| 17379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP254 |
0.647947395305013 |
|
| 17380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA8 |
0.647947395305013 |
|
| 17381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP181 |
0.647947395305013 |
|
| 17382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL677P |
0.647947395305013 |
|
| 17383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP401 |
0.647947395305013 |
|
| 17384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00923 |
0.647947395305013 |
|
| 17385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRDC4 |
0.647947395305013 |
|
| 17386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM169B |
0.647947395305013 |
|
| 17387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF1R |
0.647947395305013 |
|
| 17388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4714 |
0.647947395305013 |
|
| 17389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGPEP1L |
0.647947395305013 |
|
| 17390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNM |
0.647947395305013 |
|
| 17391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC23 |
0.647947395305013 |
|
| 17392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC28 |
0.647947395305013 |
|
| 17393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEF2A |
0.647947395305013 |
|
| 17394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP779J2370 |
0.647947395305013 |
|
| 17395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYSMD4 |
0.647947395305013 |
|
| 17396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1P46 |
0.647947395305013 |
|
| 17397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL484P |
0.647947395305013 |
|
| 17398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS17 |
0.647947395305013 |
|
| 17399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP402 |
0.647947395305013 |
|
| 17400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS3 |
0.647947395305013 |
|
| 17401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA41 |
0.647947395305013 |
|
| 17402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINS |
0.647947395305013 |
|
| 17403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB7 |
0.647947395305013 |
|
| 17404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1A3 |
0.647947395305013 |
|
| 17405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRK1 |
0.647947395305013 |
|
| 17406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHSY1 |
0.647947395305013 |
|
| 17407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIMP |
0.647947395305013 |
|
| 17408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPA1 |
0.647947395305013 |
|
| 17409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK6 |
0.647947395305013 |
|
| 17410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX11L9 |
0.647947395305013 |
|
| 17411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1P47 |
0.647947395305013 |
|
| 17412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138E |
0.647947395305013 |
|
| 17413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F13P |
0.647947395305013 |
|
| 17414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F15 |
0.647947395305013 |
|
| 17415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F4 |
0.647947395305013 |
|
| 17416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F6 |
0.647947395305013 |
|
| 17417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL209P |
0.647947395305013 |
|
| 17418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARSL2 |
0.647947395305013 |
|
| 17419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM2D3 |
0.647947395305013 |
|
| 17420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASH3P |
0.647947395305013 |
|
| 17421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238502.1 |
0.647947395305013 |
|
| 17422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIO |
0.651521966815056 |
|
| 17423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM105A |
0.651521966815056 |
|
| 17424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM105B |
0.651521966815056 |
|
| 17425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKH |
0.651521966815056 |
|
| 17426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4637 |
0.651521966815056 |
|
| 17427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000202269.1 |
0.651521966815056 |
|
| 17428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL7 |
0.651521966815056 |
|
| 17429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR887 |
0.651521966815056 |
|
| 17430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP178 |
0.651521966815056 |
|
| 17431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH11 |
0.651521966815056 |
|
| 17432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF622 |
0.651521966815056 |
|
| 17433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM134B |
0.651521966815056 |
|
| 17434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO10 |
0.651521966815056 |
|
| 17435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP179 |
0.651521966815056 |
|
| 17436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BASP1 |
0.651521966815056 |
|
| 17437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP180 |
0.651521966815056 |
|
| 17438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTH1P10 |
0.651521966815056 |
|
| 17439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP133 |
0.651521966815056 |
|
| 17440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238702.1 |
0.651521966815056 |
|
| 17441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIER2 |
0.653304148956797 |
|
| 17442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THEG |
0.653304148956797 |
|
| 17443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD4C |
0.653304148956797 |
|
| 17444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHC2 |
0.653304148956797 |
|
| 17445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP462 |
0.653304148956797 |
|
| 17446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF3L2 |
0.653304148956797 |
|
| 17447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MADCAM1 |
0.653304148956797 |
|
| 17448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPGS1 |
0.653304148956797 |
|
| 17449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC34 |
0.653304148956797 |
|
| 17450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZMM |
0.653304148956797 |
|
| 17451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BSG |
0.653304148956797 |
|
| 17452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCN2 |
0.653304148956797 |
|
| 17453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLRMT |
0.653304148956797 |
|
| 17454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF22 |
0.653304148956797 |
|
| 17455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF126 |
0.653304148956797 |
|
| 17456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSTL3 |
0.653304148956797 |
|
| 17457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS57 |
0.653304148956797 |
|
| 17458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALM |
0.653304148956797 |
|
| 17459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MISP |
0.653304148956797 |
|
| 17460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTBP1 |
0.653304148956797 |
|
| 17461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4745 |
0.653304148956797 |
|
| 17462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AZU1 |
0.653304148956797 |
|
| 17463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPPR3 |
0.653304148956797 |
|
| 17464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3187 |
0.653304148956797 |
|
| 17465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID3A |
0.653304148956797 |
|
| 17466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFD |
0.653304148956797 |
|
| 17467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELANE |
0.653304148956797 |
|
| 17468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KISS1R |
0.653304148956797 |
|
| 17469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED16 |
0.653304148956797 |
|
| 17470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRTN3 |
0.653304148956797 |
|
| 17471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HDM4 |
0.653304148956797 |
|
| 17472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR18 |
0.653304148956797 |
|
| 17473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN3B |
0.653304148956797 |
|
| 17474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM259 |
0.653304148956797 |
|
| 17475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKX |
0.654109748501471 |
|
| 17476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000232512.2 |
0.654232261995789 |
|
| 17477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP489 |
0.654232261995789 |
|
| 17478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR143 |
0.657253946307189 |
|
| 17479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHROOM2 |
0.657253946307189 |
|
| 17480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOCK3 |
0.65840366569579 |
|
| 17481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP171 |
0.65840366569579 |
|
| 17482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL776P |
0.65840366569579 |
|
| 17483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP188 |
0.65840366569579 |
|
| 17484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA10 |
0.65840366569579 |
|
| 17485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC5 |
0.659054570520475 |
|
| 17486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFB1I1 |
0.659054570520475 |
|
| 17487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A2 |
0.659054570520475 |
|
| 17488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf58 |
0.659054570520475 |
|
| 17489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHSP |
0.659054570520475 |
|
| 17490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138F |
0.661204114195095 |
|
| 17491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F17 |
0.661204114195095 |
|
| 17492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAP2C |
0.661204114195095 |
|
| 17493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASH5P |
0.661204114195095 |
|
| 17494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNN2 |
0.661204114195095 |
|
| 17495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA7 |
0.661204114195095 |
|
| 17496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMHA1 |
0.661204114195095 |
|
| 17497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2E |
0.661204114195095 |
|
| 17498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX4 |
0.661204114195095 |
|
| 17499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBNO2 |
0.661204114195095 |
|
| 17500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK11 |
0.661204114195095 |
|
| 17501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5D |
0.661204114195095 |
|
| 17502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf26 |
0.661204114195095 |
|
| 17503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIRBP |
0.661204114195095 |
|
| 17504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIDN |
0.661204114195095 |
|
| 17505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf24 |
0.661204114195095 |
|
| 17506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNA2 |
0.661204114195095 |
|
| 17507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUM1 |
0.661204114195095 |
|
| 17508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS7 |
0.661204114195095 |
|
| 17509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAMT |
0.661204114195095 |
|
| 17510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAZAP1 |
0.661204114195095 |
|
| 17511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS15 |
0.661204114195095 |
|
| 17512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APC2 |
0.661204114195095 |
|
| 17513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf25 |
0.661204114195095 |
|
| 17514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK4 |
0.661204114195095 |
|
| 17515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP6 |
0.661204114195095 |
|
| 17516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTSL5 |
0.661204114195095 |
|
| 17517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK5 |
0.661204114195095 |
|
| 17518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEX3D |
0.661204114195095 |
|
| 17519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3 |
0.661204114195095 |
|
| 17520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL477P |
0.661204114195095 |
|
| 17521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCR11 |
0.661204114195095 |
|
| 17522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF3 |
0.661204114195095 |
|
| 17523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8B3 |
0.661204114195095 |
|
| 17524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF16 |
0.661204114195095 |
|
| 17525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1909 |
0.661204114195095 |
|
| 17526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ONECUT3 |
0.661204114195095 |
|
| 17527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REXO1 |
0.661204114195095 |
|
| 17528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD17A |
0.661204114195095 |
|
| 17529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAT3 |
0.661204114195095 |
|
| 17530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAMP4 |
0.661204114195095 |
|
| 17531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1G2 |
0.661204114195095 |
|
| 17532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD2 |
0.661204114195095 |
|
| 17533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL226P |
0.661204114195095 |
|
| 17534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKNK2 |
0.661204114195095 |
|
| 17535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB3A |
0.661204114195095 |
|
| 17536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3D1 |
0.661204114195095 |
|
| 17537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IZUMO4 |
0.661204114195095 |
|
| 17538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOT1L |
0.661204114195095 |
|
| 17539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1227 |
0.661204114195095 |
|
| 17540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHJ1 |
0.661204114195095 |
|
| 17541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3A2 |
0.661204114195095 |
|
| 17542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMH |
0.661204114195095 |
|
| 17543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JSRP1 |
0.661204114195095 |
|
| 17544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4321 |
0.661204114195095 |
|
| 17545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf35 |
0.661204114195095 |
|
| 17546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAZ1 |
0.661204114195095 |
|
| 17547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINGO3 |
0.661204114195095 |
|
| 17548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM7 |
0.661204114195095 |
|
| 17549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPPL2B |
0.661204114195095 |
|
| 17550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS9 |
0.661204114195095 |
|
| 17551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMNB2 |
0.661204114195095 |
|
| 17552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM13 |
0.661204114195095 |
|
| 17553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GADD45B |
0.661204114195095 |
|
| 17554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG7 |
0.661204114195095 |
|
| 17555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRAS1 |
0.661204114195095 |
|
| 17556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A3 |
0.661204114195095 |
|
| 17557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGTA |
0.661204114195095 |
|
| 17558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOP1 |
0.661204114195095 |
|
| 17559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF554 |
0.661204114195095 |
|
| 17560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF555 |
0.661204114195095 |
|
| 17561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF556 |
0.661204114195095 |
|
| 17562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF57 |
0.661204114195095 |
|
| 17563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF77 |
0.661204114195095 |
|
| 17564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLE6 |
0.661204114195095 |
|
| 17565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLE2 |
0.661204114195095 |
|
| 17566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AES |
0.661204114195095 |
|
| 17567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNA11 |
0.661204114195095 |
|
| 17568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNA15 |
0.661204114195095 |
|
| 17569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S1PR4 |
0.661204114195095 |
|
| 17570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCLN |
0.661204114195095 |
|
| 17571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF5 |
0.661204114195095 |
|
| 17572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFIC |
0.661204114195095 |
|
| 17573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf77 |
0.661204114195095 |
|
| 17574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOHH |
0.661204114195095 |
|
| 17575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL866P |
0.661204114195095 |
|
| 17576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZR1 |
0.661204114195095 |
|
| 17577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38|ENSG00000252408.1 |
0.661204114195095 |
|
| 17578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf71 |
0.661204114195095 |
|
| 17579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD12 |
0.661204114195095 |
|
| 17580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIPC3 |
0.661204114195095 |
|
| 17581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMG20B |
0.661204114195095 |
|
| 17582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBXA2R |
0.661204114195095 |
|
| 17583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACTIN |
0.661204114195095 |
|
| 17584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIP5K1C |
0.661204114195095 |
|
| 17585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TJP3 |
0.661204114195095 |
|
| 17586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBA3 |
0.661204114195095 |
|
| 17587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL54 |
0.661204114195095 |
|
| 17588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAX2 |
0.661204114195095 |
|
| 17589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATK |
0.661204114195095 |
|
| 17590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFR2 |
0.661204114195095 |
|
| 17591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATCAY |
0.661204114195095 |
|
| 17592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL202P |
0.661204114195095 |
|
| 17593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMRK2 |
0.661204114195095 |
|
| 17594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAPK3 |
0.661204114195095 |
|
| 17595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR637 |
0.661204114195095 |
|
| 17596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF2 |
0.661204114195095 |
|
| 17597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD37|ENSG00000206775.1 |
0.661204114195095 |
|
| 17598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIAS4 |
0.661204114195095 |
|
| 17599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB7A |
0.661204114195095 |
|
| 17600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K2 |
0.661204114195095 |
|
| 17601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB3L3 |
0.661204114195095 |
|
| 17602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT6 |
0.661204114195095 |
|
| 17603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD24 |
0.661204114195095 |
|
| 17604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL84P |
0.661204114195095 |
|
| 17605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBI3 |
0.661204114195095 |
|
| 17606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC94 |
0.661204114195095 |
|
| 17607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHD |
0.661204114195095 |
|
| 17608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMIGD2 |
0.661204114195095 |
|
| 17609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSD1 |
0.661204114195095 |
|
| 17610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAP2 |
0.661204114195095 |
|
| 17611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPND |
0.661204114195095 |
|
| 17612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GL1 |
0.661204114195095 |
|
| 17613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAF1A |
0.661204114195095 |
|
| 17614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf10 |
0.661204114195095 |
|
| 17615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDGFRP2 |
0.661204114195095 |
|
| 17616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRG1 |
0.661204114195095 |
|
| 17617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4746 |
0.661204114195095 |
|
| 17618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLIN4 |
0.661204114195095 |
|
| 17619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLIN5 |
0.661204114195095 |
|
| 17620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL121P |
0.661204114195095 |
|
| 17621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL528P |
0.661204114195095 |
|
| 17622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA6B |
0.661204114195095 |
|
| 17623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP8L1 |
0.661204114195095 |
|
| 17624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN6 |
0.661204114195095 |
|
| 17625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP9 |
0.661204114195095 |
|
| 17626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEM1A |
0.661204114195095 |
|
| 17627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TICAM1 |
0.661204114195095 |
|
| 17628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLIN3 |
0.661204114195095 |
|
| 17629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRDC5 |
0.661204114195095 |
|
| 17630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UHRF1 |
0.661204114195095 |
|
| 17631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4747 |
0.661204114195095 |
|
| 17632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM4B |
0.661204114195095 |
|
| 17633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRS |
0.661204114195095 |
|
| 17634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL626P |
0.661204114195095 |
|
| 17635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNRF4 |
0.661204114195095 |
|
| 17636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TINCR |
0.661204114195095 |
|
| 17637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAFB2 |
0.661204114195095 |
|
| 17638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAFB |
0.661204114195095 |
|
| 17639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL36 |
0.661204114195095 |
|
| 17640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf70 |
0.661204114195095 |
|
| 17641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD11B1L |
0.661204114195095 |
|
| 17642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LONP1 |
0.661204114195095 |
|
| 17643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPERD |
0.661204114195095 |
|
| 17644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUS3L |
0.661204114195095 |
|
| 17645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR22 |
0.661204114195095 |
|
| 17646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRTN |
0.661204114195095 |
|
| 17647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT3 |
0.661204114195095 |
|
| 17648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT5 |
0.661204114195095 |
|
| 17649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT6 |
0.661204114195095 |
|
| 17650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA11 |
0.661204114195095 |
|
| 17651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPS |
0.661204114195095 |
|
| 17652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VMAC |
0.661204114195095 |
|
| 17653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP3 |
0.661204114195095 |
|
| 17654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX2 |
0.661204114195095 |
|
| 17655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSBG2 |
0.661204114195095 |
|
| 17656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT1 |
0.661204114195095 |
|
| 17657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACER1 |
0.661204114195095 |
|
| 17658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPP |
0.661204114195095 |
|
| 17659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH7 |
0.661204114195095 |
|
| 17660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2F1 |
0.661204114195095 |
|
| 17661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSPN |
0.661204114195095 |
|
| 17662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHSRP |
0.661204114195095 |
|
| 17663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3940 |
0.661204114195095 |
|
| 17664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A41 |
0.661204114195095 |
|
| 17665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A23 |
0.661204114195095 |
|
| 17666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRB3 |
0.661204114195095 |
|
| 17667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND1C |
0.661204114195095 |
|
| 17668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB4A |
0.661204114195095 |
|
| 17669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF9 |
0.661204114195095 |
|
| 17670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD70 |
0.661204114195095 |
|
| 17671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF14 |
0.661204114195095 |
|
| 17672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3 |
0.661204114195095 |
|
| 17673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR108 |
0.661204114195095 |
|
| 17674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP10 |
0.661204114195095 |
|
| 17675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D3A |
0.661204114195095 |
|
| 17676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAV1 |
0.661204114195095 |
|
| 17677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMR1 |
0.661204114195095 |
|
| 17678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMR4P |
0.661204114195095 |
|
| 17679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3L2 |
0.661204114195095 |
|
| 17680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3L3 |
0.661204114195095 |
|
| 17681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3L4 |
0.661204114195095 |
|
| 17682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3L5 |
0.661204114195095 |
|
| 17683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF557 |
0.661204114195095 |
|
| 17684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSR |
0.661204114195095 |
|
| 17685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF18 |
0.661204114195095 |
|
| 17686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX11G |
0.661204114195095 |
|
| 17687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf45 |
0.661204114195095 |
|
| 17688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF358 |
0.661204114195095 |
|
| 17689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCOLN1 |
0.661204114195095 |
|
| 17690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA6 |
0.661204114195095 |
|
| 17691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMSAP3 |
0.661204114195095 |
|
| 17692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAB2 |
0.661204114195095 |
|
| 17693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCP2 |
0.661204114195095 |
|
| 17694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PET100 |
0.661204114195095 |
|
| 17695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STXBP2 |
0.661204114195095 |
|
| 17696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RETN |
0.661204114195095 |
|
| 17697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf59 |
0.661204114195095 |
|
| 17698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC5 |
0.661204114195095 |
|
| 17699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCER2 |
0.661204114195095 |
|
| 17700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4G |
0.661204114195095 |
|
| 17701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD209 |
0.661204114195095 |
|
| 17702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4M |
0.661204114195095 |
|
| 17703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVI5L |
0.661204114195095 |
|
| 17704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC8E |
0.661204114195095 |
|
| 17705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP463 |
0.661204114195095 |
|
| 17706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K7 |
0.661204114195095 |
|
| 17707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL115P |
0.661204114195095 |
|
| 17708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBR3L |
0.661204114195095 |
|
| 17709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPC2 |
0.661204114195095 |
|
| 17710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTXN1 |
0.661204114195095 |
|
| 17711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM44 |
0.661204114195095 |
|
| 17712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAVL1 |
0.661204114195095 |
|
| 17713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL25 |
0.661204114195095 |
|
| 17714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBN3 |
0.661204114195095 |
|
| 17715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS4 |
0.661204114195095 |
|
| 17716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD320 |
0.661204114195095 |
|
| 17717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA7 |
0.661204114195095 |
|
| 17718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS28 |
0.661204114195095 |
|
| 17719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANK3 |
0.661204114195095 |
|
| 17720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL4 |
0.661204114195095 |
|
| 17721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4999 |
0.661204114195095 |
|
| 17722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11B |
0.661204114195095 |
|
| 17723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH2 |
0.661204114195095 |
|
| 17724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPM |
0.661204114195095 |
|
| 17725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAM1 |
0.661204114195095 |
|
| 17726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF414 |
0.661204114195095 |
|
| 17727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1F |
0.661204114195095 |
|
| 17728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS10 |
0.661204114195095 |
|
| 17729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTL9 |
0.661204114195095 |
|
| 17730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2Z1 |
0.661204114195095 |
|
| 17731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF558 |
0.661204114195095 |
|
| 17732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD3L1 |
0.661204114195095 |
|
| 17733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC16 |
0.661204114195095 |
|
| 17734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1M1 |
0.661204114195095 |
|
| 17735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7G2 |
0.661204114195095 |
|
| 17736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7G1 |
0.661204114195095 |
|
| 17737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7G3 |
0.661204114195095 |
|
| 17738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF317 |
0.661204114195095 |
|
| 17739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7D2 |
0.661204114195095 |
|
| 17740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7D4 |
0.661204114195095 |
|
| 17741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7E24 |
0.661204114195095 |
|
| 17742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7E19P |
0.661204114195095 |
|
| 17743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF699 |
0.661204114195095 |
|
| 17744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF177 |
0.661204114195095 |
|
| 17745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF559 |
0.661204114195095 |
|
| 17746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF266 |
0.661204114195095 |
|
| 17747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF560 |
0.661204114195095 |
|
| 17748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF426 |
0.661204114195095 |
|
| 17749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF121 |
0.661204114195095 |
|
| 17750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF561 |
0.661204114195095 |
|
| 17751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf82 |
0.661204114195095 |
|
| 17752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF562 |
0.661204114195095 |
|
| 17753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF812 |
0.661204114195095 |
|
| 17754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF846 |
0.661204114195095 |
|
| 17755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL12 |
0.661204114195095 |
|
| 17756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000200237.1 |
0.661204114195095 |
|
| 17757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL94P |
0.661204114195095 |
|
| 17758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBL5 |
0.661204114195095 |
|
| 17759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIN1 |
0.661204114195095 |
|
| 17760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFM2 |
0.661204114195095 |
|
| 17761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL5A3 |
0.661204114195095 |
|
| 17762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH8 |
0.661204114195095 |
|
| 17763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3P1 |
0.661204114195095 |
|
| 17764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5589 |
0.661204114195095 |
|
| 17765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf66 |
0.661204114195095 |
|
| 17766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL6 |
0.661204114195095 |
|
| 17767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAN |
0.661204114195095 |
|
| 17768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD105 |
0.661204114195095 |
|
| 17769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY11 |
0.661204114195095 |
|
| 17770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD105B |
0.661204114195095 |
|
| 17771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3G |
0.661204114195095 |
|
| 17772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNMT1 |
0.661204114195095 |
|
| 17773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S1PR2 |
0.661204114195095 |
|
| 17774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4322 |
0.661204114195095 |
|
| 17775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL4 |
0.661204114195095 |
|
| 17776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICAM1 |
0.661204114195095 |
|
| 17777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICAM4 |
0.661204114195095 |
|
| 17778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICAM5 |
0.661204114195095 |
|
| 17779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZGLP1 |
0.661204114195095 |
|
| 17780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDX1L |
0.661204114195095 |
|
| 17781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAVER1 |
0.661204114195095 |
|
| 17782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICAM3 |
0.661204114195095 |
|
| 17783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYK2 |
0.661204114195095 |
|
| 17784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC37 |
0.661204114195095 |
|
| 17785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1181 |
0.661204114195095 |
|
| 17786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE4A |
0.661204114195095 |
|
| 17787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KEAP1 |
0.661204114195095 |
|
| 17788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S1PR5 |
0.661204114195095 |
|
| 17789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG4D |
0.661204114195095 |
|
| 17790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1238 |
0.661204114195095 |
|
| 17791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRI1 |
0.661204114195095 |
|
| 17792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1M2 |
0.661204114195095 |
|
| 17793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN2D |
0.661204114195095 |
|
| 17794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC44A2 |
0.661204114195095 |
|
| 17795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILF3 |
0.661204114195095 |
|
| 17796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QTRT1 |
0.661204114195095 |
|
| 17797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM2 |
0.661204114195095 |
|
| 17798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR638 |
0.661204114195095 |
|
| 17799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4748 |
0.661204114195095 |
|
| 17800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR199A1 |
0.661204114195095 |
|
| 17801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf38 |
0.661204114195095 |
|
| 17802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED1 |
0.661204114195095 |
|
| 17803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARM1 |
0.661204114195095 |
|
| 17804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF2 |
0.661204114195095 |
|
| 17805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf52 |
0.661204114195095 |
|
| 17806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCA4 |
0.661204114195095 |
|
| 17807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL192P |
0.661204114195095 |
|
| 17808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLR |
0.661204114195095 |
|
| 17809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPC24 |
0.661204114195095 |
|
| 17810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANK2 |
0.661204114195095 |
|
| 17811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK6 |
0.661204114195095 |
|
| 17812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL298P |
0.661204114195095 |
|
| 17813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf80 |
0.661204114195095 |
|
| 17814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN16 |
0.661204114195095 |
|
| 17815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3D |
0.661204114195095 |
|
| 17816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC159 |
0.661204114195095 |
|
| 17817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM205 |
0.661204114195095 |
|
| 17818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP761J1410 |
0.661204114195095 |
|
| 17819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPOR |
0.661204114195095 |
|
| 17820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SWSAP1 |
0.661204114195095 |
|
| 17821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGL3 |
0.661204114195095 |
|
| 17822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC151 |
0.661204114195095 |
|
| 17823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCSH |
0.661204114195095 |
|
| 17824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238349.1 |
0.661204114195095 |
|
| 17825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAVL3 |
0.661204114195095 |
|
| 17826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL669P |
0.661204114195095 |
|
| 17827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF653 |
0.661204114195095 |
|
| 17828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECSIT |
0.661204114195095 |
|
| 17829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL833P |
0.661204114195095 |
|
| 17830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNN1 |
0.661204114195095 |
|
| 17831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOF1 |
0.661204114195095 |
|
| 17832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF627 |
0.661204114195095 |
|
| 17833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACP5 |
0.661204114195095 |
|
| 17834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF833P |
0.661204114195095 |
|
| 17835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF823 |
0.661204114195095 |
|
| 17836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF441 |
0.661204114195095 |
|
| 17837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF491 |
0.661204114195095 |
|
| 17838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF439 |
0.661204114195095 |
|
| 17839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF440 |
0.661204114195095 |
|
| 17840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF69 |
0.661204114195095 |
|
| 17841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF700 |
0.661204114195095 |
|
| 17842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF763 |
0.661204114195095 |
|
| 17843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP464 |
0.661204114195095 |
|
| 17844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF433 |
0.661204114195095 |
|
| 17845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP465 |
0.661204114195095 |
|
| 17846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF878 |
0.661204114195095 |
|
| 17847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP466 |
0.661204114195095 |
|
| 17848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF844 |
0.661204114195095 |
|
| 17849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF788 |
0.661204114195095 |
|
| 17850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF20 |
0.661204114195095 |
|
| 17851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP467 |
0.661204114195095 |
|
| 17852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF625 |
0.661204114195095 |
|
| 17853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF136 |
0.661204114195095 |
|
| 17854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF44 |
0.661204114195095 |
|
| 17855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF563 |
0.661204114195095 |
|
| 17856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF442 |
0.661204114195095 |
|
| 17857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF443 |
0.661204114195095 |
|
| 17858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF799 |
0.661204114195095 |
|
| 17859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF709 |
0.661204114195095 |
|
| 17860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF564 |
0.661204114195095 |
|
| 17861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF490 |
0.661204114195095 |
|
| 17862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF791 |
0.661204114195095 |
|
| 17863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN2B1 |
0.661204114195095 |
|
| 17864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR83OS |
0.661204114195095 |
|
| 17865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR83 |
0.661204114195095 |
|
| 17866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHPS |
0.661204114195095 |
|
| 17867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW9 |
0.661204114195095 |
|
| 17868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNPO2 |
0.661204114195095 |
|
| 17869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD41|ENSG00000209702.1 |
0.661204114195095 |
|
| 17870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf43 |
0.661204114195095 |
|
| 17871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASNA1 |
0.661204114195095 |
|
| 17872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEST2 |
0.661204114195095 |
|
| 17873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOOK2 |
0.661204114195095 |
|
| 17874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5684 |
0.661204114195095 |
|
| 17875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JUNB |
0.661204114195095 |
|
| 17876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX2 |
0.661204114195095 |
|
| 17877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEH2A |
0.661204114195095 |
|
| 17878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTBDN |
0.661204114195095 |
|
| 17879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAST1 |
0.661204114195095 |
|
| 17880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE2 |
0.661204114195095 |
|
| 17881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF1 |
0.661204114195095 |
|
| 17882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCDH |
0.661204114195095 |
|
| 17883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCE2 |
0.661204114195095 |
|
| 17884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FARSA |
0.661204114195095 |
|
| 17885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5695 |
0.661204114195095 |
|
| 17886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALR |
0.661204114195095 |
|
| 17887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD23A |
0.661204114195095 |
|
| 17888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GADD45GIP1 |
0.661204114195095 |
|
| 17889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAND5 |
0.661204114195095 |
|
| 17890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFIX |
0.661204114195095 |
|
| 17891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYL1 |
0.661204114195095 |
|
| 17892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT1 |
0.661204114195095 |
|
| 17893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACC1 |
0.661204114195095 |
|
| 17894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX10 |
0.661204114195095 |
|
| 17895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IER2 |
0.661204114195095 |
|
| 17896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1A |
0.661204114195095 |
|
| 17897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC130 |
0.661204114195095 |
|
| 17898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRI1 |
0.661204114195095 |
|
| 17899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf53 |
0.661204114195095 |
|
| 17900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM4 |
0.661204114195095 |
|
| 17901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL619P |
0.661204114195095 |
|
| 17902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR27A |
0.661204114195095 |
|
| 17903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR23A |
0.661204114195095 |
|
| 17904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOS3 |
0.661204114195095 |
|
| 17905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181C |
0.661204114195095 |
|
| 17906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR181D |
0.661204114195095 |
|
| 17907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf57 |
0.661204114195095 |
|
| 17908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CC2D1A |
0.661204114195095 |
|
| 17909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PODNL1 |
0.661204114195095 |
|
| 17910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF15 |
0.661204114195095 |
|
| 17911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX1 |
0.661204114195095 |
|
| 17912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL27RA |
0.661204114195095 |
|
| 17913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLN3 |
0.661204114195095 |
|
| 17914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PALM3 |
0.661204114195095 |
|
| 17915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf67 |
0.661204114195095 |
|
| 17916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKACA |
0.661204114195095 |
|
| 17917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAMD1 |
0.661204114195095 |
|
| 17918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASF1B |
0.661204114195095 |
|
| 17919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPHN1 |
0.661204114195095 |
|
| 17920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL231P |
0.661204114195095 |
|
| 17921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD97 |
0.661204114195095 |
|
| 17922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX39A |
0.661204114195095 |
|
| 17923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKN1 |
0.661204114195095 |
|
| 17924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIPC1 |
0.661204114195095 |
|
| 17925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGER1 |
0.661204114195095 |
|
| 17926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB1 |
0.661204114195095 |
|
| 17927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR639 |
0.661204114195095 |
|
| 17928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TECR |
0.661204114195095 |
|
| 17929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB7 |
0.661204114195095 |
|
| 17930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC17A |
0.661204114195095 |
|
| 17931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL337P |
0.661204114195095 |
|
| 17932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL842P |
0.661204114195095 |
|
| 17933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMR3 |
0.661204114195095 |
|
| 17934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF333 |
0.661204114195095 |
|
| 17935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMR2 |
0.661204114195095 |
|
| 17936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7A5 |
0.661204114195095 |
|
| 17937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7C1 |
0.661204114195095 |
|
| 17938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7A10 |
0.661204114195095 |
|
| 17939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7A17 |
0.661204114195095 |
|
| 17940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR7C2 |
0.661204114195095 |
|
| 17941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A6 |
0.661204114195095 |
|
| 17942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC105 |
0.661204114195095 |
|
| 17943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP14 |
0.661204114195095 |
|
| 17944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1I1 |
0.661204114195095 |
|
| 17945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYDE1 |
0.661204114195095 |
|
| 17946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ILVBL |
0.661204114195095 |
|
| 17947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTCH3 |
0.661204114195095 |
|
| 17948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHX3 |
0.661204114195095 |
|
| 17949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD4 |
0.661204114195095 |
|
| 17950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP8 |
0.661204114195095 |
|
| 17951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP8L |
0.661204114195095 |
|
| 17952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIZ |
0.661204114195095 |
|
| 17953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1470 |
0.661204114195095 |
|
| 17954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASAL3 |
0.661204114195095 |
|
| 17955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGLYRP2 |
0.661204114195095 |
|
| 17956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F22 |
0.661204114195095 |
|
| 17957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F23P |
0.661204114195095 |
|
| 17958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F8 |
0.661204114195095 |
|
| 17959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F3 |
0.661204114195095 |
|
| 17960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F12 |
0.661204114195095 |
|
| 17961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10H2 |
0.661204114195095 |
|
| 17962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10H3 |
0.661204114195095 |
|
| 17963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F24P |
0.661204114195095 |
|
| 17964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10H5 |
0.661204114195095 |
|
| 17965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10H1 |
0.661204114195095 |
|
| 17966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCA1 |
0.661204114195095 |
|
| 17967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F2 |
0.661204114195095 |
|
| 17968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F11 |
0.661204114195095 |
|
| 17969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10H4 |
0.661204114195095 |
|
| 17970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00661 |
0.661204114195095 |
|
| 17971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00905 |
0.661204114195095 |
|
| 17972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPM4 |
0.661204114195095 |
|
| 17973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB8A |
0.661204114195095 |
|
| 17974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSH2D |
0.661204114195095 |
|
| 17975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIB3 |
0.661204114195095 |
|
| 17976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM32A |
0.661204114195095 |
|
| 17977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1M1 |
0.661204114195095 |
|
| 17978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF2 |
0.661204114195095 |
|
| 17979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS15L1 |
0.661204114195095 |
|
| 17980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL844P |
0.661204114195095 |
|
| 17981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALR3 |
0.661204114195095 |
|
| 17982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf44 |
0.661204114195095 |
|
| 17983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHERP |
0.661204114195095 |
|
| 17984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL146P |
0.661204114195095 |
|
| 17985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35E1 |
0.661204114195095 |
|
| 17986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED26 |
0.661204114195095 |
|
| 17987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM7 |
0.661204114195095 |
|
| 17988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM38A |
0.661204114195095 |
|
| 17989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NWD1 |
0.661204114195095 |
|
| 17990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIN3B |
0.661204114195095 |
|
| 17991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F2RL3 |
0.661204114195095 |
|
| 17992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPAMD8 |
0.661204114195095 |
|
| 17993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL835P |
0.661204114195095 |
|
| 17994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL823P |
0.661204114195095 |
|
| 17995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS8 |
0.661204114195095 |
|
| 17996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO9B |
0.661204114195095 |
|
| 17997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCEL1 |
0.661204114195095 |
|
| 17998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USE1 |
0.661204114195095 |
|
| 17999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2F6 |
0.661204114195095 |
|
| 18000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USHBP1 |
0.661204114195095 |
|
| 18001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BABAM1 |
0.661204114195095 |
|
| 18002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKLE1 |
0.661204114195095 |
|
| 18003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD8 |
0.661204114195095 |
|
| 18004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL34 |
0.661204114195095 |
|
| 18005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDA1 |
0.661204114195095 |
|
| 18006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO8 |
0.661204114195095 |
|
| 18007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP3 |
0.661204114195095 |
|
| 18008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLVAP |
0.661204114195095 |
|
| 18009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BST2 |
0.661204114195095 |
|
| 18010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MVB12A |
0.661204114195095 |
|
| 18011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM221 |
0.661204114195095 |
|
| 18012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXNL1 |
0.661204114195095 |
|
| 18013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A1 |
0.661204114195095 |
|
| 18014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGLS |
0.661204114195095 |
|
| 18015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM129C |
0.661204114195095 |
|
| 18016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLGALT1 |
0.661204114195095 |
|
| 18017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC13A |
0.661204114195095 |
|
| 18018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1S |
0.661204114195095 |
|
| 18019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCHO1 |
0.661204114195095 |
|
| 18020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT3 |
0.661204114195095 |
|
| 18021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSL3 |
0.661204114195095 |
|
| 18022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JAK3 |
0.661204114195095 |
|
| 18023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL18A |
0.661204114195095 |
|
| 18024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000207166.1 |
0.661204114195095 |
|
| 18025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A5 |
0.661204114195095 |
|
| 18026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC124 |
0.661204114195095 |
|
| 18027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP468 |
0.661204114195095 |
|
| 18028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRDC2 |
0.661204114195095 |
|
| 18029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL12RB1 |
0.661204114195095 |
|
| 18030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAST3 |
0.661204114195095 |
|
| 18031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R2 |
0.661204114195095 |
|
| 18032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFI30 |
0.661204114195095 |
|
| 18033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPV17L2 |
0.661204114195095 |
|
| 18034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3A |
0.661204114195095 |
|
| 18035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE4C |
0.661204114195095 |
|
| 18036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1683 |
0.661204114195095 |
|
| 18037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JUND |
0.661204114195095 |
|
| 18038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3188 |
0.661204114195095 |
|
| 18039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM4 |
0.661204114195095 |
|
| 18040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL513P |
0.661204114195095 |
|
| 18041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGPEP1 |
0.661204114195095 |
|
| 18042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF15 |
0.661204114195095 |
|
| 18043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3189 |
0.661204114195095 |
|
| 18044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC25 |
0.661204114195095 |
|
| 18045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSBP4 |
0.661204114195095 |
|
| 18046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELL |
0.661204114195095 |
|
| 18047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISYNA1 |
0.661204114195095 |
|
| 18048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP8 |
0.661204114195095 |
|
| 18049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KXD1 |
0.661204114195095 |
|
| 18050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRLF1 |
0.661204114195095 |
|
| 18051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBA52 |
0.661204114195095 |
|
| 18052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C19orf60 |
0.661204114195095 |
|
| 18053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM59L |
0.661204114195095 |
|
| 18054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL155P |
0.661204114195095 |
|
| 18055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL26 |
0.661204114195095 |
|
| 18056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRTC1 |
0.661204114195095 |
|
| 18057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMP |
0.661204114195095 |
|
| 18058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPF1 |
0.661204114195095 |
|
| 18059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS1 |
0.661204114195095 |
|
| 18060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF1 |
0.661204114195095 |
|
| 18061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPE |
0.661204114195095 |
|
| 18062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX49 |
0.661204114195095 |
|
| 18063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOMER3 |
0.661204114195095 |
|
| 18064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL70P |
0.661204114195095 |
|
| 18065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUGP2 |
0.661204114195095 |
|
| 18066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC6 |
0.661204114195095 |
|
| 18067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A42 |
0.661204114195095 |
|
| 18068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM161A |
0.661204114195095 |
|
| 18069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEF2B |
0.661204114195095 |
|
| 18070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEF2BNB |
0.661204114195095 |
|
| 18071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFXANK |
0.661204114195095 |
|
| 18072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2C2AP |
0.661204114195095 |
|
| 18073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAN |
0.661204114195095 |
|
| 18074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAPLN4 |
0.661204114195095 |
|
| 18075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM6SF2 |
0.661204114195095 |
|
| 18076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUGP1 |
0.661204114195095 |
|
| 18077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAU2 |
0.661204114195095 |
|
| 18078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATAD2A |
0.661204114195095 |
|
| 18079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR640 |
0.661204114195095 |
|
| 18080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA13 |
0.661204114195095 |
|
| 18081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSK6 |
0.661204114195095 |
|
| 18082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YJEFN3 |
0.661204114195095 |
|
| 18083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CILP2 |
0.661204114195095 |
|
| 18084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBX4 |
0.661204114195095 |
|
| 18085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR2 |
0.661204114195095 |
|
| 18086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMIP |
0.661204114195095 |
|
| 18087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP13A1 |
0.661204114195095 |
|
| 18088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF101 |
0.661204114195095 |
|
| 18089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00663 |
0.661204114195095 |
|
| 18090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF14 |
0.661204114195095 |
|
| 18091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF506 |
0.661204114195095 |
|
| 18092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF253 |
0.661204114195095 |
|
| 18093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF430 |
0.661204114195095 |
|
| 18094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF486 |
0.661204114195095 |
|
| 18095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF626 |
0.661204114195095 |
|
| 18096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF66 |
0.661204114195095 |
|
| 18097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF682 |
0.661204114195095 |
|
| 18098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF737 |
0.661204114195095 |
|
| 18099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF826P |
0.661204114195095 |
|
| 18100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF85 |
0.661204114195095 |
|
| 18101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF90 |
0.661204114195095 |
|
| 18102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF93 |
0.661204114195095 |
|
| 18103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF714 |
0.661204114195095 |
|
| 18104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP469 |
0.661204114195095 |
|
| 18105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF431 |
0.661204114195095 |
|
| 18106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF708 |
0.661204114195095 |
|
| 18107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF738 |
0.661204114195095 |
|
| 18108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP6 |
0.6615261532993 |
|
| 18109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MANSC1 |
0.6615261532993 |
|
| 18110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOH12CR2 |
0.6615261532993 |
|
| 18111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOH12CR1 |
0.6615261532993 |
|
| 18112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP16 |
0.6615261532993 |
|
| 18113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREBL2 |
0.6615261532993 |
|
| 18114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR19 |
0.6615261532993 |
|
| 18115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKN1B |
0.6615261532993 |
|
| 18116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOLD1 |
0.6615261532993 |
|
| 18117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR613 |
0.6615261532993 |
|
| 18118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX47 |
0.6615261532993 |
|
| 18119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRC5A |
0.6615261532993 |
|
| 18120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRC5D |
0.6615261532993 |
|
| 18121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSG1 |
0.6615261532993 |
|
| 18122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEBP1 |
0.6615261532993 |
|
| 18123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR7P1 |
0.6615261532993 |
|
| 18124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1467 |
0.6615261532993 |
|
| 18125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR614 |
0.6615261532993 |
|
| 18126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD88 |
0.6615261532993 |
|
| 18127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMP1 |
0.6615261532993 |
|
| 18128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf36 |
0.6615261532993 |
|
| 18129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP353 |
0.6615261532993 |
|
| 18130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP162 |
0.6615261532993 |
|
| 18131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL676P |
0.6615261532993 |
|
| 18132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL30P11 |
0.6615261532993 |
|
| 18133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF7IP |
0.6615261532993 |
|
| 18134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY9 |
0.661948287781817 |
|
| 18135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOM1 |
0.662779839104573 |
|
| 18136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL12A |
0.662779839104573 |
|
| 18137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL12B |
0.662779839104573 |
|
| 18138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGIF1 |
0.662779839104573 |
|
| 18139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238863.1 |
0.662779839104573 |
|
| 18140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLGAP1 |
0.662779839104573 |
|
| 18141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL39P |
0.662779839104573 |
|
| 18142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238445.1 |
0.662779839104573 |
|
| 18143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238790.1 |
0.662779839104573 |
|
| 18144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf42 |
0.662779839104573 |
|
| 18145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00667 |
0.662779839104573 |
|
| 18146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00526 |
0.662779839104573 |
|
| 18147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB14 |
0.662779839104573 |
|
| 18148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L3 |
0.662779839104573 |
|
| 18149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snR65|ENSG00000252576.1 |
0.662779839104573 |
|
| 18150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252572.1 |
0.662779839104573 |
|
| 18151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3976 |
0.662779839104573 |
|
| 18152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM200C |
0.662779839104573 |
|
| 18153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
L3MBTL4 |
0.662779839104573 |
|
| 18154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL282P |
0.662779839104573 |
|
| 18155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL723P |
0.662779839104573 |
|
| 18156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL6P27 |
0.662779839104573 |
|
| 18157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC2 |
0.662779839104573 |
|
| 18158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAPA |
0.662779839104573 |
|
| 18159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP450 |
0.662779839104573 |
|
| 18160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239031.1 |
0.662779839104573 |
|
| 18161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APCDD1 |
0.662779839104573 |
|
| 18162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAPG |
0.662779839104573 |
|
| 18163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIEZO2 |
0.662779839104573 |
|
| 18164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPB1P |
0.662779839104573 |
|
| 18165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNAL |
0.662779839104573 |
|
| 18166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP1B |
0.662779839104573 |
|
| 18167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPPE1 |
0.662779839104573 |
|
| 18168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPA2 |
0.662779839104573 |
|
| 18169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD62 |
0.662779839104573 |
|
| 18170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIDEA |
0.662779839104573 |
|
| 18171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB6 |
0.662779839104573 |
|
| 18172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFG3L2 |
0.662779839104573 |
|
| 18173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLMO1 |
0.662779839104573 |
|
| 18174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIRE1 |
0.662779839104573 |
|
| 18175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238309.1 |
0.662779839104573 |
|
| 18176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP76 |
0.662779839104573 |
|
| 18177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMG2 |
0.662779839104573 |
|
| 18178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN2 |
0.662779839104573 |
|
| 18179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEH1L |
0.662779839104573 |
|
| 18180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP192 |
0.662779839104573 |
|
| 18181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDLRAD4 |
0.662779839104573 |
|
| 18182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5190 |
0.662779839104573 |
|
| 18183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4526 |
0.662779839104573 |
|
| 18184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM210A |
0.662779839104573 |
|
| 18185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL362P |
0.662779839104573 |
|
| 18186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNMT |
0.662779839104573 |
|
| 18187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MC5R |
0.662779839104573 |
|
| 18188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MC2R |
0.662779839104573 |
|
| 18189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF519 |
0.662779839104573 |
|
| 18190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A5P |
0.662779839104573 |
|
| 18191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F35P |
0.662779839104573 |
|
| 18192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXADRP3 |
0.662779839104573 |
|
| 18193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEC |
0.662779839104573 |
|
| 18194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD30B |
0.662779839104573 |
|
| 18195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL662P |
0.662779839104573 |
|
| 18196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROCK1 |
0.662779839104573 |
|
| 18197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GREB1L |
0.662779839104573 |
|
| 18198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD23|ENSG00000221139.1 |
0.662779839104573 |
|
| 18199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESCO1 |
0.662779839104573 |
|
| 18200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPD1 |
0.662779839104573 |
|
| 18201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD3 |
0.662779839104573 |
|
| 18202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320C1 |
0.662779839104573 |
|
| 18203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC20P |
0.662779839104573 |
|
| 18204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA6 |
0.662779839104573 |
|
| 18205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238907.1 |
0.662779839104573 |
|
| 18206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTAGE1 |
0.662779839104573 |
|
| 18207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP8 |
0.662779839104573 |
|
| 18208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238537.1 |
0.662779839104573 |
|
| 18209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4741 |
0.662779839104573 |
|
| 18210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL745P |
0.662779839104573 |
|
| 18211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABLES1 |
0.662779839104573 |
|
| 18212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM241 |
0.662779839104573 |
|
| 18213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIOK3 |
0.662779839104573 |
|
| 18214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf8 |
0.662779839104573 |
|
| 18215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPC1 |
0.662779839104573 |
|
| 18216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD29 |
0.662779839104573 |
|
| 18217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMA3 |
0.662779839104573 |
|
| 18218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC39C |
0.662779839104573 |
|
| 18219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABYR |
0.662779839104573 |
|
| 18220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL1A |
0.662779839104573 |
|
| 18221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP452 |
0.662779839104573 |
|
| 18222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL247P |
0.662779839104573 |
|
| 18223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320C2 |
0.662779839104573 |
|
| 18224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPACT |
0.662779839104573 |
|
| 18225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRH4 |
0.662779839104573 |
|
| 18226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF521 |
0.662779839104573 |
|
| 18227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP455 |
0.662779839104573 |
|
| 18228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4319 |
0.662779839104573 |
|
| 18229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC14A1 |
0.662779839104573 |
|
| 18230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIGLEC15 |
0.662779839104573 |
|
| 18231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSTPIP2 |
0.662779839104573 |
|
| 18232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP26 |
0.662779839104573 |
|
| 18233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5A1 |
0.662779839104573 |
|
| 18234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS1 |
0.662779839104573 |
|
| 18235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOXHD1 |
0.662779839104573 |
|
| 18236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA5 |
0.662779839104573 |
|
| 18237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIAS2 |
0.662779839104573 |
|
| 18238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB3B |
0.662779839104573 |
|
| 18239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB3CL2 |
0.662779839104573 |
|
| 18240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB3CL |
0.662779839104573 |
|
| 18241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB3C |
0.662779839104573 |
|
| 18242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDHD2 |
0.662779839104573 |
|
| 18243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IER3IP1 |
0.662779839104573 |
|
| 18244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKOR2 |
0.662779839104573 |
|
| 18245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4527 |
0.662779839104573 |
|
| 18246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD2 |
0.662779839104573 |
|
| 18247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB7C |
0.662779839104573 |
|
| 18248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP456 |
0.662779839104573 |
|
| 18249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTIF |
0.662779839104573 |
|
| 18250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4743 |
0.662779839104573 |
|
| 18251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD7 |
0.662779839104573 |
|
| 18252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYM |
0.662779839104573 |
|
| 18253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4744 |
0.662779839104573 |
|
| 18254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf32 |
0.662779839104573 |
|
| 18255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1539 |
0.662779839104573 |
|
| 18256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL17 |
0.662779839104573 |
|
| 18257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD58C |
0.662779839104573 |
|
| 18258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD58A |
0.662779839104573 |
|
| 18259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD58B |
0.662779839104573 |
|
| 18260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPG |
0.662779839104573 |
|
| 18261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAA2 |
0.662779839104573 |
|
| 18262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000251992.1 |
0.662779839104573 |
|
| 18263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA17|ENSG00000267322.1 |
0.662779839104573 |
|
| 18264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA18|ENSG00000252139.1 |
0.662779839104573 |
|
| 18265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO5B |
0.662779839104573 |
|
| 18266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP457 |
0.662779839104573 |
|
| 18267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL310P |
0.662779839104573 |
|
| 18268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC11 |
0.662779839104573 |
|
| 18269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD1 |
0.662779839104573 |
|
| 18270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXXC1 |
0.662779839104573 |
|
| 18271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP458 |
0.662779839104573 |
|
| 18272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKA1 |
0.662779839104573 |
|
| 18273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK4 |
0.662779839104573 |
|
| 18274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRO |
0.662779839104573 |
|
| 18275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ME2 |
0.662779839104573 |
|
| 18276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELAC1 |
0.662779839104573 |
|
| 18277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL695P |
0.662779839104573 |
|
| 18278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEX3C |
0.662779839104573 |
|
| 18279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238885.1 |
0.662779839104573 |
|
| 18280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD2 |
0.662779839104573 |
|
| 18281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA37 |
0.662779839104573 |
|
| 18282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLI |
0.662779839104573 |
|
| 18283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD6 |
0.662779839104573 |
|
| 18284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf54 |
0.662779839104573 |
|
| 18285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNAP |
0.662779839104573 |
|
| 18286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB27B |
0.662779839104573 |
|
| 18287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC68 |
0.662779839104573 |
|
| 18288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP459 |
0.662779839104573 |
|
| 18289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF4 |
0.662779839104573 |
|
| 18290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4529 |
0.662779839104573 |
|
| 18291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000201816.1 |
0.662779839104573 |
|
| 18292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNL1 |
0.662779839104573 |
|
| 18293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR7 |
0.662779839104573 |
|
| 18294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212539.1 |
0.662779839104573 |
|
| 18295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOD1L2 |
0.662779839104573 |
|
| 18296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA3 |
0.662779839104573 |
|
| 18297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ONECUT2 |
0.662779839104573 |
|
| 18298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FECH |
0.662779839104573 |
|
| 18299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NARS |
0.662779839104573 |
|
| 18300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8B1 |
0.662779839104573 |
|
| 18301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEDD4L |
0.662779839104573 |
|
| 18302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR122 |
0.662779839104573 |
|
| 18303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPK2 |
0.662779839104573 |
|
| 18304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD28|ENSG00000252284.1 |
0.662779839104573 |
|
| 18305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MALT1 |
0.662779839104573 |
|
| 18306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL112P |
0.662779839104573 |
|
| 18307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000199713.1 |
0.662779839104573 |
|
| 18308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF532 |
0.662779839104573 |
|
| 18309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OACYLP |
0.662779839104573 |
|
| 18310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC11C |
0.662779839104573 |
|
| 18311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRP |
0.662779839104573 |
|
| 18312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAX |
0.662779839104573 |
|
| 18313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPLX4 |
0.662779839104573 |
|
| 18314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMAN1 |
0.662779839104573 |
|
| 18315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCBE1 |
0.662779839104573 |
|
| 18316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMAIP1 |
0.662779839104573 |
|
| 18317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL342P |
0.662779839104573 |
|
| 18318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MC4R |
0.662779839104573 |
|
| 18319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH20 |
0.662779839104573 |
|
| 18320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF152 |
0.662779839104573 |
|
| 18321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGN |
0.662779839104573 |
|
| 18322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1468 |
0.662779839104573 |
|
| 18323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF11A |
0.662779839104573 |
|
| 18324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC2 |
0.662779839104573 |
|
| 18325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL705P |
0.662779839104573 |
|
| 18326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLPP1 |
0.662779839104573 |
|
| 18327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2 |
0.662779839104573 |
|
| 18328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238988.1 |
0.662779839104573 |
|
| 18329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDSR |
0.662779839104573 |
|
| 18330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS4B |
0.662779839104573 |
|
| 18331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB5 |
0.662779839104573 |
|
| 18332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB12 |
0.662779839104573 |
|
| 18333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB13 |
0.662779839104573 |
|
| 18334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB4 |
0.662779839104573 |
|
| 18335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB11 |
0.662779839104573 |
|
| 18336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB3 |
0.662779839104573 |
|
| 18337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB7 |
0.662779839104573 |
|
| 18338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB2 |
0.662779839104573 |
|
| 18339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB10 |
0.662779839104573 |
|
| 18340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMSD |
0.662779839104573 |
|
| 18341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB8 |
0.662779839104573 |
|
| 18342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00305 |
0.662779839104573 |
|
| 18343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH7 |
0.662779839104573 |
|
| 18344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH19 |
0.662779839104573 |
|
| 18345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5011 |
0.662779839104573 |
|
| 18346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSEL |
0.662779839104573 |
|
| 18347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMX3 |
0.662779839104573 |
|
| 18348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC102B |
0.662779839104573 |
|
| 18349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK6 |
0.662779839104573 |
|
| 18350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD226 |
0.662779839104573 |
|
| 18351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKNOX1 |
0.663703881542696 |
|
| 18352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBS |
0.663703881542696 |
|
| 18353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U2AF1 |
0.663703881542696 |
|
| 18354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L2 |
0.666720304184637 |
|
| 18355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L3 |
0.666720304184637 |
|
| 18356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L4 |
0.666720304184637 |
|
| 18357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L5 |
0.666720304184637 |
|
| 18358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L6 |
0.666720304184637 |
|
| 18359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4L7 |
0.666720304184637 |
|
| 18360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUX4 |
0.666720304184637 |
|
| 18361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRG1 |
0.666720304184637 |
|
| 18362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRG2 |
0.666720304184637 |
|
| 18363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90AA4P |
0.666720304184637 |
|
| 18364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP174 |
0.666720304184637 |
|
| 18365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP175 |
0.666720304184637 |
|
| 18366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIML1 |
0.666720304184637 |
|
| 18367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIML2 |
0.666720304184637 |
|
| 18368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP42 |
0.666720304184637 |
|
| 18369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL474P |
0.669103026900834 |
|
| 18370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF20 |
0.669103026900834 |
|
| 18371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MICU3 |
0.669103026900834 |
|
| 18372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC2 |
0.669103026900834 |
|
| 18373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT7 |
0.669103026900834 |
|
| 18374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS37A |
0.669103026900834 |
|
| 18375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR7 |
0.669103026900834 |
|
| 18376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A2 |
0.669103026900834 |
|
| 18377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDGFRL |
0.669103026900834 |
|
| 18378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTUS1 |
0.669103026900834 |
|
| 18379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548V |
0.669103026900834 |
|
| 18380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP256 |
0.669103026900834 |
|
| 18381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGL1 |
0.669103026900834 |
|
| 18382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCM1 |
0.669103026900834 |
|
| 18383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAH1 |
0.669103026900834 |
|
| 18384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT1 |
0.669103026900834 |
|
| 18385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT2 |
0.669103026900834 |
|
| 18386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSD3 |
0.669103026900834 |
|
| 18387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000201157.1 |
0.669103026900834 |
|
| 18388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D4A |
0.669103026900834 |
|
| 18389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSGALNACT1 |
0.669103026900834 |
|
| 18390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS10 |
0.669103026900834 |
|
| 18391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPL |
0.669103026900834 |
|
| 18392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC18A1 |
0.669103026900834 |
|
| 18393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1B2 |
0.669103026900834 |
|
| 18394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZTS1 |
0.669103026900834 |
|
| 18395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251944.1 |
0.669103026900834 |
|
| 18396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFRA2 |
0.669103026900834 |
|
| 18397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK2 |
0.669103026900834 |
|
| 18398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPO7 |
0.669103026900834 |
|
| 18399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPM2 |
0.669103026900834 |
|
| 18400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238466.1 |
0.669103026900834 |
|
| 18401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF17 |
0.669103026900834 |
|
| 18402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMTN |
0.669103026900834 |
|
| 18403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM160B2 |
0.669103026900834 |
|
| 18404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT18 |
0.669103026900834 |
|
| 18405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HR |
0.669103026900834 |
|
| 18406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP4 |
0.669103026900834 |
|
| 18407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGI3 |
0.669103026900834 |
|
| 18408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTPC |
0.669103026900834 |
|
| 18409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP1 |
0.669103026900834 |
|
| 18410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHYHIP |
0.669103026900834 |
|
| 18411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320A |
0.669103026900834 |
|
| 18412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3D |
0.669103026900834 |
|
| 18413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIWIL2 |
0.669103026900834 |
|
| 18414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP3CC |
0.669103026900834 |
|
| 18415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A14 |
0.669103026900834 |
|
| 18416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORBS3 |
0.669103026900834 |
|
| 18417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDLIM2 |
0.669103026900834 |
|
| 18418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf58 |
0.669103026900834 |
|
| 18419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1967 |
0.669103026900834 |
|
| 18420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIN3 |
0.669103026900834 |
|
| 18421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGR3 |
0.669103026900834 |
|
| 18422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEBP4 |
0.669103026900834 |
|
| 18423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL303P |
0.669103026900834 |
|
| 18424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOBTB2 |
0.669103026900834 |
|
| 18425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF10B |
0.669103026900834 |
|
| 18426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF10C |
0.669103026900834 |
|
| 18427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF10D |
0.669103026900834 |
|
| 18428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF10A |
0.669103026900834 |
|
| 18429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP7 |
0.669103026900834 |
|
| 18430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HCC1 |
0.669103026900834 |
|
| 18431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOXL2 |
0.669103026900834 |
|
| 18432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENTPD4 |
0.669103026900834 |
|
| 18433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A37 |
0.669103026900834 |
|
| 18434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FP15737 |
0.669103026900834 |
|
| 18435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000207027.1 |
0.669103026900834 |
|
| 18436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STC1 |
0.669103026900834 |
|
| 18437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM28 |
0.669103026900834 |
|
| 18438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMDEC1 |
0.669103026900834 |
|
| 18439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM7 |
0.669103026900834 |
|
| 18440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEFM |
0.669103026900834 |
|
| 18441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEFL |
0.669103026900834 |
|
| 18442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL651P |
0.669103026900834 |
|
| 18443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK5 |
0.669103026900834 |
|
| 18444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNRH1 |
0.669103026900834 |
|
| 18445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD9 |
0.669103026900834 |
|
| 18446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA2 |
0.669103026900834 |
|
| 18447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBF2 |
0.669103026900834 |
|
| 18448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP258 |
0.669103026900834 |
|
| 18449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R2A |
0.669103026900834 |
|
| 18450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIP3L |
0.669103026900834 |
|
| 18451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDAD1P1 |
0.669103026900834 |
|
| 18452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNMA2 |
0.669103026900834 |
|
| 18453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYSL2 |
0.669103026900834 |
|
| 18454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA1A |
0.669103026900834 |
|
| 18455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548H4 |
0.669103026900834 |
|
| 18456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMN4 |
0.669103026900834 |
|
| 18457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM35 |
0.669103026900834 |
|
| 18458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTK2B |
0.669103026900834 |
|
| 18459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA2 |
0.669103026900834 |
|
| 18460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHX2 |
0.669103026900834 |
|
| 18461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLU |
0.669103026900834 |
|
| 18462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARA3 |
0.669103026900834 |
|
| 18463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3622B |
0.669103026900834 |
|
| 18464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC25 |
0.669103026900834 |
|
| 18465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238624.1 |
0.669103026900834 |
|
| 18466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESCO2 |
0.669103026900834 |
|
| 18467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBK |
0.669103026900834 |
|
| 18468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARA5 |
0.669103026900834 |
|
| 18469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4287 |
0.669103026900834 |
|
| 18470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUGGC |
0.669103026900834 |
|
| 18471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELP3 |
0.669103026900834 |
|
| 18472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNOC |
0.669103026900834 |
|
| 18473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF395 |
0.669103026900834 |
|
| 18474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO16 |
0.669103026900834 |
|
| 18475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD3 |
0.669103026900834 |
|
| 18476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4288 |
0.669103026900834 |
|
| 18477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP259 |
0.669103026900834 |
|
| 18478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXTL3 |
0.669103026900834 |
|
| 18479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS9 |
0.669103026900834 |
|
| 18480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMBOX1 |
0.669103026900834 |
|
| 18481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP260 |
0.669103026900834 |
|
| 18482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF13B |
0.669103026900834 |
|
| 18483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL781P |
0.669103026900834 |
|
| 18484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP4 |
0.669103026900834 |
|
| 18485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00589 |
0.669103026900834 |
|
| 18486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM183CP |
0.669103026900834 |
|
| 18487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3148 |
0.669103026900834 |
|
| 18488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM66 |
0.669103026900834 |
|
| 18489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPROTL1 |
0.669103026900834 |
|
| 18490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBOAT4 |
0.669103026900834 |
|
| 18491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN6 |
0.669103026900834 |
|
| 18492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBBP1 |
0.669103026900834 |
|
| 18493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBPMS |
0.669103026900834 |
|
| 18494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2E2 |
0.669103026900834 |
|
| 18495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM18 |
0.669103026900834 |
|
| 18496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSR |
0.669103026900834 |
|
| 18497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN8 |
0.669103026900834 |
|
| 18498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2CB |
0.669103026900834 |
|
| 18499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX15 |
0.669103026900834 |
|
| 18500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PURG |
0.669103026900834 |
|
| 18501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WRN |
0.669103026900834 |
|
| 18502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP261 |
0.669103026900834 |
|
| 18503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRG1 |
0.669103026900834 |
|
| 18504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP262 |
0.669103026900834 |
|
| 18505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP263 |
0.669103026900834 |
|
| 18506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUT10 |
0.669103026900834 |
|
| 18507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTI2 |
0.669103026900834 |
|
| 18508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAK16 |
0.669103026900834 |
|
| 18509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD13 |
0.669103026900834 |
|
| 18510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252505.1 |
0.669103026900834 |
|
| 18511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF122 |
0.669103026900834 |
|
| 18512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL621P |
0.669103026900834 |
|
| 18513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP26 |
0.669103026900834 |
|
| 18514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL457P |
0.669103026900834 |
|
| 18515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC5D |
0.669103026900834 |
|
| 18516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP201 |
0.669103026900834 |
|
| 18517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP264 |
0.669103026900834 |
|
| 18518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNU1 |
0.669103026900834 |
|
| 18519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF703 |
0.669103026900834 |
|
| 18520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERLIN2 |
0.669103026900834 |
|
| 18521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR124 |
0.669103026900834 |
|
| 18522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROSC |
0.669103026900834 |
|
| 18523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRF2 |
0.669103026900834 |
|
| 18524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11FIP1 |
0.669103026900834 |
|
| 18525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL709P |
0.669103026900834 |
|
| 18526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOT1L1 |
0.669103026900834 |
|
| 18527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRB3 |
0.669103026900834 |
|
| 18528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4EBP1 |
0.669103026900834 |
|
| 18529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASH2L |
0.669103026900834 |
|
| 18530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAR |
0.669103026900834 |
|
| 18531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSM1 |
0.669103026900834 |
|
| 18532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAG4 |
0.669103026900834 |
|
| 18533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDHD2 |
0.669103026900834 |
|
| 18534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAPDC1B |
0.669103026900834 |
|
| 18535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WHSC1L1 |
0.669103026900834 |
|
| 18536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LETM2 |
0.669103026900834 |
|
| 18537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR1 |
0.669103026900834 |
|
| 18538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS20P22 |
0.669103026900834 |
|
| 18539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf86 |
0.669103026900834 |
|
| 18540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACC1 |
0.669103026900834 |
|
| 18541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA2 |
0.669103026900834 |
|
| 18542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTRA4 |
0.669103026900834 |
|
| 18543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM2D2 |
0.669103026900834 |
|
| 18544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM9 |
0.669103026900834 |
|
| 18545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38|ENSG00000207199.1 |
0.669103026900834 |
|
| 18546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM32 |
0.669103026900834 |
|
| 18547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM5 |
0.669103026900834 |
|
| 18548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM3A |
0.669103026900834 |
|
| 18549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM18 |
0.669103026900834 |
|
| 18550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM2 |
0.669103026900834 |
|
| 18551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDO1 |
0.669103026900834 |
|
| 18552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDO2 |
0.669103026900834 |
|
| 18553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf4 |
0.669103026900834 |
|
| 18554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMAT4 |
0.669103026900834 |
|
| 18555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFRP1 |
0.669103026900834 |
|
| 18556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AO |
0.669103026900834 |
|
| 18557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD65|ENSG00000238936.1 |
0.669103026900834 |
|
| 18558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA7 |
0.669103026900834 |
|
| 18559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GINS4 |
0.669103026900834 |
|
| 18560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT6 |
0.669103026900834 |
|
| 18561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANK1 |
0.669103026900834 |
|
| 18562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR486 |
0.669103026900834 |
|
| 18563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL149P |
0.669103026900834 |
|
| 18564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT6A |
0.669103026900834 |
|
| 18565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000238966.1 |
0.669103026900834 |
|
| 18566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3M2 |
0.669103026900834 |
|
| 18567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAT |
0.669103026900834 |
|
| 18568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238714.1 |
0.669103026900834 |
|
| 18569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKBKB |
0.669103026900834 |
|
| 18570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLB |
0.669103026900834 |
|
| 18571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKK4 |
0.669103026900834 |
|
| 18572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VDAC3 |
0.669103026900834 |
|
| 18573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC20A2 |
0.669103026900834 |
|
| 18574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM19 |
0.669103026900834 |
|
| 18575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNB3 |
0.669103026900834 |
|
| 18576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA6 |
0.669103026900834 |
|
| 18577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP1 |
0.669103026900834 |
|
| 18578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF170 |
0.669103026900834 |
|
| 18579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL806P |
0.669103026900834 |
|
| 18580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOOK3 |
0.669103026900834 |
|
| 18581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4469 |
0.669103026900834 |
|
| 18582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNTA |
0.669103026900834 |
|
| 18583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HGSNAT |
0.669103026900834 |
|
| 18584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEA |
0.669103026900834 |
|
| 18585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP41 |
0.669103026900834 |
|
| 18586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK196 |
0.669103026900834 |
|
| 18587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000201329.1 |
0.669103026900834 |
|
| 18588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00293 |
0.669103026900834 |
|
| 18589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP32 |
0.669103026900834 |
|
| 18590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPD |
0.669103026900834 |
|
| 18591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKDC |
0.669103026900834 |
|
| 18592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM4 |
0.669103026900834 |
|
| 18593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2V2 |
0.669103026900834 |
|
| 18594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB1 |
0.669103026900834 |
|
| 18595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAI2 |
0.669103026900834 |
|
| 18596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf22 |
0.669103026900834 |
|
| 18597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP294 |
0.669103026900834 |
|
| 18598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTG1 |
0.669103026900834 |
|
| 18599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7|ENSG00000201316.1 |
0.669103026900834 |
|
| 18600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXDNL |
0.669103026900834 |
|
| 18601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCMTD1 |
0.669103026900834 |
|
| 18602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST18 |
0.669103026900834 |
|
| 18603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM150A |
0.669103026900834 |
|
| 18604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RB1CC1 |
0.669103026900834 |
|
| 18605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPBWR1 |
0.669103026900834 |
|
| 18606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPRK1 |
0.669103026900834 |
|
| 18607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1H |
0.669103026900834 |
|
| 18608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS20 |
0.669103026900834 |
|
| 18609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEA1 |
0.669103026900834 |
|
| 18610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPLA1 |
0.669103026900834 |
|
| 18611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL15 |
0.669103026900834 |
|
| 18612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC32P |
0.669103026900834 |
|
| 18613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU105C |
0.669103026900834 |
|
| 18614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL250P |
0.669103026900834 |
|
| 18615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX17 |
0.669103026900834 |
|
| 18616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RP1 |
0.669103026900834 |
|
| 18617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR4 |
0.669103026900834 |
|
| 18618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM68 |
0.669103026900834 |
|
| 18619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP265 |
0.669103026900834 |
|
| 18620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGS1 |
0.669103026900834 |
|
| 18621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYN |
0.669103026900834 |
|
| 18622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA1|ENSG00000199405.1 |
0.669103026900834 |
|
| 18623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL798P |
0.669103026900834 |
|
| 18624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL323P |
0.669103026900834 |
|
| 18625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS20 |
0.669103026900834 |
|
| 18626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD54 |
0.669103026900834 |
|
| 18627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOS |
0.669103026900834 |
|
| 18628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000221093.1 |
0.669103026900834 |
|
| 18629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAG1 |
0.669103026900834 |
|
| 18630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD7 |
0.669103026900834 |
|
| 18631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR16C5 |
0.669103026900834 |
|
| 18632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR16C6P |
0.669103026900834 |
|
| 18633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PENK |
0.669103026900834 |
|
| 18634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00968 |
0.669103026900834 |
|
| 18635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPAD1 |
0.669103026900834 |
|
| 18636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP266 |
0.669103026900834 |
|
| 18637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00588 |
0.669103026900834 |
|
| 18638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM110B |
0.669103026900834 |
|
| 18639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN2B |
0.669103026900834 |
|
| 18640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP7A1 |
0.669103026900834 |
|
| 18641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDCBP |
0.669103026900834 |
|
| 18642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSMAF |
0.669103026900834 |
|
| 18643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238433.1 |
0.669103026900834 |
|
| 18644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TOX |
0.669103026900834 |
|
| 18645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000206853.1 |
0.669103026900834 |
|
| 18646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP267 |
0.669103026900834 |
|
| 18647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA8 |
0.669103026900834 |
|
| 18648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB2A |
0.669103026900834 |
|
| 18649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD7 |
0.669103026900834 |
|
| 18650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLVS1 |
0.669103026900834 |
|
| 18651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPH |
0.669103026900834 |
|
| 18652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP97 |
0.669103026900834 |
|
| 18653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4470 |
0.669103026900834 |
|
| 18654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAIN3 |
0.669103026900834 |
|
| 18655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGH |
0.669103026900834 |
|
| 18656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTPA |
0.669103026900834 |
|
| 18657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YTHDF3 |
0.669103026900834 |
|
| 18658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL135P |
0.669103026900834 |
|
| 18659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP135 |
0.669103026900834 |
|
| 18660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00966 |
0.669103026900834 |
|
| 18661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHE22 |
0.669103026900834 |
|
| 18662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP7B1 |
0.669103026900834 |
|
| 18663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC1 |
0.669103026900834 |
|
| 18664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTFR1 |
0.669103026900834 |
|
| 18665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE7A |
0.669103026900834 |
|
| 18666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC5B |
0.669103026900834 |
|
| 18667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM55 |
0.669103026900834 |
|
| 18668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRH |
0.669103026900834 |
|
| 18669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00967 |
0.669103026900834 |
|
| 18670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADHFE1 |
0.669103026900834 |
|
| 18671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRS1 |
0.669103026900834 |
|
| 18672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf46 |
0.669103026900834 |
|
| 18673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBL1 |
0.669103026900834 |
|
| 18674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCPIP1 |
0.669103026900834 |
|
| 18675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf44 |
0.669103026900834 |
|
| 18676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK3 |
0.669103026900834 |
|
| 18677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCMDC2 |
0.669103026900834 |
|
| 18678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG6 |
0.669103026900834 |
|
| 18679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD87 |
0.669103026900834 |
|
| 18680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF24 |
0.669103026900834 |
|
| 18681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R42 |
0.669103026900834 |
|
| 18682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS5 |
0.669103026900834 |
|
| 18683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPP1 |
0.669103026900834 |
|
| 18684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP268 |
0.669103026900834 |
|
| 18685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARFGEF1 |
0.669103026900834 |
|
| 18686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPA6 |
0.669103026900834 |
|
| 18687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PREX2 |
0.669103026900834 |
|
| 18688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETFA |
0.669576149235144 |
|
| 18689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GART |
0.671612955314523 |
|
| 18690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SON |
0.671612955314523 |
|
| 18691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DONSON |
0.671612955314523 |
|
| 18692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYZL1 |
0.671612955314523 |
|
| 18693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITSN1 |
0.671612955314523 |
|
| 18694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5O |
0.671612955314523 |
|
| 18695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL740P |
0.671612955314523 |
|
| 18696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00310 |
0.671612955314523 |
|
| 18697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNE1 |
0.671612955314523 |
|
| 18698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNE2 |
0.671612955314523 |
|
| 18699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCAN1 |
0.671612955314523 |
|
| 18700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM11 |
0.671612955314523 |
|
| 18701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221398.1 |
0.671612955314523 |
|
| 18702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIC6 |
0.671612955314523 |
|
| 18703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00160 |
0.671612955314523 |
|
| 18704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNX1 |
0.671612955314523 |
|
| 18705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR802 |
0.671612955314523 |
|
| 18706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG68 |
0.671612955314523 |
|
| 18707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD4 |
0.671612955314523 |
|
| 18708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBR1 |
0.671612955314523 |
|
| 18709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBR3 |
0.671612955314523 |
|
| 18710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOPEY2 |
0.671612955314523 |
|
| 18711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL73P |
0.671612955314523 |
|
| 18712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238851.1 |
0.671612955314523 |
|
| 18713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORC3 |
0.671612955314523 |
|
| 18714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAF1B |
0.671612955314523 |
|
| 18715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN14 |
0.671612955314523 |
|
| 18716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIM2 |
0.671612955314523 |
|
| 18717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HLCS |
0.671612955314523 |
|
| 18718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP491 |
0.671612955314523 |
|
| 18719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPPLY3 |
0.671612955314523 |
|
| 18720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGP |
0.671612955314523 |
|
| 18721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC3 |
0.671612955314523 |
|
| 18722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCR9 |
0.671612955314523 |
|
| 18723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL678P |
0.671612955314523 |
|
| 18724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCR3 |
0.671612955314523 |
|
| 18725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYRK1A |
0.671612955314523 |
|
| 18726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ6 |
0.671612955314523 |
|
| 18727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCR4 |
0.671612955314523 |
|
| 18728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCR8 |
0.671612955314523 |
|
| 18729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ15 |
0.671612955314523 |
|
| 18730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238581.1 |
0.671612955314523 |
|
| 18731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSCR10 |
0.671612955314523 |
|
| 18732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERG |
0.671612955314523 |
|
| 18733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00114 |
0.671612955314523 |
|
| 18734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETS2 |
0.671612955314523 |
|
| 18735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA62|ENSG00000272015.1 |
0.671612955314523 |
|
| 18736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMG1 |
0.671612955314523 |
|
| 18737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRWD1 |
0.671612955314523 |
|
| 18738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN1 |
0.671612955314523 |
|
| 18739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238556.1 |
0.671612955314523 |
|
| 18740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WRB |
0.671612955314523 |
|
| 18741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCA5L |
0.671612955314523 |
|
| 18742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BGR |
0.671612955314523 |
|
| 18743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALT5 |
0.671612955314523 |
|
| 18744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf88 |
0.671612955314523 |
|
| 18745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGSF5 |
0.671612955314523 |
|
| 18746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCP4 |
0.671612955314523 |
|
| 18747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4760 |
0.671612955314523 |
|
| 18748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000207147.1 |
0.671612955314523 |
|
| 18749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00323 |
0.671612955314523 |
|
| 18750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BACE2 |
0.671612955314523 |
|
| 18751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3197 |
0.671612955314523 |
|
| 18752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM3B |
0.671612955314523 |
|
| 18753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MX2 |
0.671612955314523 |
|
| 18754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MX1 |
0.671612955314523 |
|
| 18755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS2 |
0.671612955314523 |
|
| 18756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA32|ENSG00000207503.1 |
0.671612955314523 |
|
| 18757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252771.1 |
0.671612955314523 |
|
| 18758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00111 |
0.671612955314523 |
|
| 18759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00479 |
0.671612955314523 |
|
| 18760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00112 |
0.671612955314523 |
|
| 18761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPK4 |
0.671612955314523 |
|
| 18762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM15 |
0.671612955314523 |
|
| 18763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000251778.1 |
0.671612955314523 |
|
| 18764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD2 |
0.671612955314523 |
|
| 18765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB21 |
0.671612955314523 |
|
| 18766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UMODL1 |
0.671612955314523 |
|
| 18767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf128 |
0.671612955314523 |
|
| 18768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCG1 |
0.671612955314523 |
|
| 18769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP492 |
0.671612955314523 |
|
| 18770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFF3 |
0.671612955314523 |
|
| 18771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFF2 |
0.671612955314523 |
|
| 18772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFF1 |
0.671612955314523 |
|
| 18773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS3 |
0.671612955314523 |
|
| 18774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBASH3A |
0.671612955314523 |
|
| 18775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH1 |
0.671612955314523 |
|
| 18776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC37A1 |
0.671612955314523 |
|
| 18777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE9A |
0.671612955314523 |
|
| 18778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR4 |
0.671612955314523 |
|
| 18779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFV3 |
0.671612955314523 |
|
| 18780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5692B |
0.671612955314523 |
|
| 18781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYAA |
0.671612955314523 |
|
| 18782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00313 |
0.671612955314523 |
|
| 18783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00319 |
0.671612955314523 |
|
| 18784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00322 |
0.671612955314523 |
|
| 18785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIK1 |
0.671612955314523 |
|
| 18786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSF2BP |
0.671612955314523 |
|
| 18787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP1B |
0.671612955314523 |
|
| 18788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDXK |
0.671612955314523 |
|
| 18789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTB |
0.671612955314523 |
|
| 18790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRP1 |
0.671612955314523 |
|
| 18791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ6|ENSG00000264452.1 |
0.671612955314523 |
|
| 18792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ6|ENSG00000266692.1 |
0.671612955314523 |
|
| 18793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC3 |
0.671612955314523 |
|
| 18794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC3DN |
0.671612955314523 |
|
| 18795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPEAR |
0.671612955314523 |
|
| 18796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf90 |
0.671612955314523 |
|
| 18797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2G2 |
0.671612955314523 |
|
| 18798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMO3 |
0.671612955314523 |
|
| 18799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTTG1IP |
0.671612955314523 |
|
| 18800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB2 |
0.671612955314523 |
|
| 18801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf67 |
0.671612955314523 |
|
| 18802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM207A |
0.671612955314523 |
|
| 18803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00163 |
0.671612955314523 |
|
| 18804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00162 |
0.671612955314523 |
|
| 18805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSR4P1 |
0.671612955314523 |
|
| 18806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADARB1 |
0.671612955314523 |
|
| 18807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRED57 |
0.671612955314523 |
|
| 18808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRED58 |
0.671612955314523 |
|
| 18809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL18A1 |
0.671612955314523 |
|
| 18810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00205 |
0.671612955314523 |
|
| 18811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00315 |
0.671612955314523 |
|
| 18812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00316 |
0.671612955314523 |
|
| 18813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00334 |
0.671612955314523 |
|
| 18814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBP3 |
0.671612955314523 |
|
| 18815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POFUT2 |
0.671612955314523 |
|
| 18816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC19A1 |
0.671612955314523 |
|
| 18817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRED60 |
0.671612955314523 |
|
| 18818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRED62 |
0.671612955314523 |
|
| 18819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A1 |
0.671612955314523 |
|
| 18820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL6A2 |
0.671612955314523 |
|
| 18821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTCD |
0.671612955314523 |
|
| 18822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATC1L |
0.671612955314523 |
|
| 18823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LSS |
0.671612955314523 |
|
| 18824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM3AP |
0.671612955314523 |
|
| 18825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C21orf58 |
0.671612955314523 |
|
| 18826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIP2A |
0.671612955314523 |
|
| 18827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNT |
0.671612955314523 |
|
| 18828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT2 |
0.671612955314523 |
|
| 18829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100B |
0.671612955314523 |
|
| 18830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YBEY |
0.671612955314523 |
|
| 18831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252291.1 |
0.67227464788205 |
|
| 18832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4770 |
0.67227464788205 |
|
| 18833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBL1X |
0.67227464788205 |
|
| 18834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NELL2 |
0.67691089233711 |
|
| 18835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBX2 |
0.67691089233711 |
|
| 18836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP361 |
0.67691089233711 |
|
| 18837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO6 |
0.67691089233711 |
|
| 18838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID2 |
0.67691089233711 |
|
| 18839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL246P |
0.67691089233711 |
|
| 18840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAF11 |
0.67691089233711 |
|
| 18841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A1 |
0.67691089233711 |
|
| 18842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP28 |
0.678714535152573 |
|
| 18843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00668 |
0.678714535152573 |
|
| 18844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMA1 |
0.678714535152573 |
|
| 18845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL537P |
0.678714535152573 |
|
| 18846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC30 |
0.678714535152573 |
|
| 18847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212626.1 |
0.678714535152573 |
|
| 18848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRM |
0.678714535152573 |
|
| 18849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199856.1 |
0.678714535152573 |
|
| 18850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL50P |
0.678714535152573 |
|
| 18851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB12 |
0.678714535152573 |
|
| 18852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOGA2 |
0.678714535152573 |
|
| 18853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFV2 |
0.678714535152573 |
|
| 18854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD12 |
0.678714535152573 |
|
| 18855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239087.1 |
0.678714535152573 |
|
| 18856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWSG1 |
0.678714535152573 |
|
| 18857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALBP1 |
0.678714535152573 |
|
| 18858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP4R1 |
0.678714535152573 |
|
| 18859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB31 |
0.678714535152573 |
|
| 18860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL862P |
0.678714535152573 |
|
| 18861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP449 |
0.678714535152573 |
|
| 18862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD81|ENSG00000212278.1 |
0.679073920773287 |
|
| 18863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL58P |
0.679073920773287 |
|
| 18864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238674.1 |
0.679073920773287 |
|
| 18865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSBP1 |
0.679073920773287 |
|
| 18866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252083.1 |
0.679073920773287 |
|
| 18867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP12 |
0.679652240733806 |
|
| 18868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL21 |
0.679652240733806 |
|
| 18869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD102 |
0.679652240733806 |
|
| 18870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA27|ENSG00000207051.1 |
0.679652240733806 |
|
| 18871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASL11A |
0.679652240733806 |
|
| 18872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P1 |
0.679652240733806 |
|
| 18873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3A |
0.679652240733806 |
|
| 18874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTIF3 |
0.679652240733806 |
|
| 18875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LNX2 |
0.679652240733806 |
|
| 18876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR1D |
0.679652240733806 |
|
| 18877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSX1 |
0.679652240733806 |
|
| 18878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5EP2 |
0.679652240733806 |
|
| 18879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDX2 |
0.679652240733806 |
|
| 18880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00543 |
0.679652240733806 |
|
| 18881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDX1 |
0.679652240733806 |
|
| 18882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URAD |
0.679652240733806 |
|
| 18883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL272P |
0.679652240733806 |
|
| 18884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLT3 |
0.679652240733806 |
|
| 18885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAN3 |
0.679652240733806 |
|
| 18886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLT1 |
0.679652240733806 |
|
| 18887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMP |
0.679652240733806 |
|
| 18888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC46A3 |
0.679652240733806 |
|
| 18889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTUS2 |
0.679652240733806 |
|
| 18890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A1 |
0.679652240733806 |
|
| 18891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBL3 |
0.679652240733806 |
|
| 18892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00297 |
0.679652240733806 |
|
| 18893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00572 |
0.679652240733806 |
|
| 18894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00544 |
0.679652240733806 |
|
| 18895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00365 |
0.679652240733806 |
|
| 18896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KATNAL1 |
0.679652240733806 |
|
| 18897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00427 |
0.679652240733806 |
|
| 18898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00426 |
0.679652240733806 |
|
| 18899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGB1 |
0.679652240733806 |
|
| 18900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USPL1 |
0.679652240733806 |
|
| 18901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALOX5AP |
0.679652240733806 |
|
| 18902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00398 |
0.679652240733806 |
|
| 18903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00545 |
0.679652240733806 |
|
| 18904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEDAG |
0.679652240733806 |
|
| 18905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX26 |
0.679652240733806 |
|
| 18906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPH1 |
0.679652240733806 |
|
| 18907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALTL |
0.679652240733806 |
|
| 18908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXFP2 |
0.679652240733806 |
|
| 18909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1DP3 |
0.679652240733806 |
|
| 18910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRY |
0.679652240733806 |
|
| 18911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZAR1L |
0.679652240733806 |
|
| 18912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRCA2 |
0.679652240733806 |
|
| 18913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N4BP2L1 |
0.679652240733806 |
|
| 18914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA16|ENSG00000212293.1 |
0.679652240733806 |
|
| 18915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N4BP2L2 |
0.679652240733806 |
|
| 18916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDS5B |
0.679652240733806 |
|
| 18917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY1P4 |
0.679652240733806 |
|
| 18918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00423 |
0.679652240733806 |
|
| 18919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KL |
0.679652240733806 |
|
| 18920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD13 |
0.679652240733806 |
|
| 18921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFC3 |
0.679652240733806 |
|
| 18922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000199196.1 |
0.679652240733806 |
|
| 18923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00457 |
0.679652240733806 |
|
| 18924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBEA |
0.679652240733806 |
|
| 18925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAB21L1 |
0.679652240733806 |
|
| 18926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00445 |
0.679652240733806 |
|
| 18927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCLK1 |
0.679652240733806 |
|
| 18928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOHLH2 |
0.679652240733806 |
|
| 18929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC169 |
0.679652240733806 |
|
| 18930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPG20 |
0.679652240733806 |
|
| 18931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPG20OS |
0.679652240733806 |
|
| 18932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNA1 |
0.679652240733806 |
|
| 18933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERTM1 |
0.679652240733806 |
|
| 18934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL2BPP3 |
0.679652240733806 |
|
| 18935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFXAP |
0.679652240733806 |
|
| 18936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD9 |
0.679652240733806 |
|
| 18937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG5 |
0.679652240733806 |
|
| 18938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC8 |
0.679652240733806 |
|
| 18939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT20H |
0.679652240733806 |
|
| 18940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1A1L |
0.679652240733806 |
|
| 18941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP1 |
0.679652240733806 |
|
| 18942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POSTN |
0.679652240733806 |
|
| 18943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC4 |
0.679652240733806 |
|
| 18944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP26 |
0.679652240733806 |
|
| 18945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00571 |
0.679652240733806 |
|
| 18946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UFM1 |
0.679652240733806 |
|
| 18947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00366 |
0.679652240733806 |
|
| 18948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FREM2 |
0.679652240733806 |
|
| 18949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOML3 |
0.679652240733806 |
|
| 18950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROSER1 |
0.679652240733806 |
|
| 18951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLRC3 |
0.679652240733806 |
|
| 18952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFP |
0.679652240733806 |
|
| 18953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238408.1 |
0.679652240733806 |
|
| 18954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG6 |
0.679652240733806 |
|
| 18955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4305 |
0.679652240733806 |
|
| 18956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P14 |
0.679652240733806 |
|
| 18957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD116|ENSG00000212553.1 |
0.679652240733806 |
|
| 18958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00332 |
0.679652240733806 |
|
| 18959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P9 |
0.679652240733806 |
|
| 18960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP2 |
0.679652240733806 |
|
| 18961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00598 |
0.679652240733806 |
|
| 18962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXO1 |
0.679652240733806 |
|
| 18963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320D1 |
0.679652240733806 |
|
| 18964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS31 |
0.679652240733806 |
|
| 18965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A15 |
0.679652240733806 |
|
| 18966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR621 |
0.679652240733806 |
|
| 18967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTE2P5 |
0.679652240733806 |
|
| 18968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUGT1P3 |
0.679652240733806 |
|
| 18969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELF1 |
0.679652240733806 |
|
| 18970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP4 |
0.679652240733806 |
|
| 18971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3168 |
0.679652240733806 |
|
| 18972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL597P |
0.679652240733806 |
|
| 18973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD6 |
0.679652240733806 |
|
| 18974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238651.1 |
0.679652240733806 |
|
| 18975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD7 |
0.679652240733806 |
|
| 18976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRF1 |
0.679652240733806 |
|
| 18977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA16 |
0.679652240733806 |
|
| 18978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGCC |
0.679652240733806 |
|
| 18979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA8 |
0.679652240733806 |
|
| 18980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5006 |
0.679652240733806 |
|
| 18981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL515P |
0.679652240733806 |
|
| 18982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKH |
0.679652240733806 |
|
| 18983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP11 |
0.679652240733806 |
|
| 18984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFSF11 |
0.679652240733806 |
|
| 18985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM216B |
0.679652240733806 |
|
| 18986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC15 |
0.679652240733806 |
|
| 18987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENOX1 |
0.679652240733806 |
|
| 18988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPSTI1 |
0.679652240733806 |
|
| 18989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00400 |
0.679652240733806 |
|
| 18990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC122 |
0.679652240733806 |
|
| 18991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACC1 |
0.679652240733806 |
|
| 18992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00284 |
0.679652240733806 |
|
| 18993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM2 |
0.679652240733806 |
|
| 18994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERP2 |
0.679652240733806 |
|
| 18995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC22D1 |
0.679652240733806 |
|
| 18996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238932.1 |
0.679652240733806 |
|
| 18997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00330 |
0.679652240733806 |
|
| 18998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUFIP1 |
0.679652240733806 |
|
| 18999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1704 |
0.679652240733806 |
|
| 19000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL49P |
0.679652240733806 |
|
| 19001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP3 |
0.679652240733806 |
|
| 19002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2F2 |
0.679652240733806 |
|
| 19003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000271818.1 |
0.679652240733806 |
|
| 19004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD4 |
0.679652240733806 |
|
| 19005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000253051.1 |
0.679652240733806 |
|
| 19006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPT1 |
0.679652240733806 |
|
| 19007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000199477.1 |
0.679652240733806 |
|
| 19008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A30 |
0.679652240733806 |
|
| 19009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG3 |
0.679652240733806 |
|
| 19010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM194B |
0.679652240733806 |
|
| 19011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP27 |
0.679652240733806 |
|
| 19012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPERT |
0.679652240733806 |
|
| 19013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIAH3 |
0.679652240733806 |
|
| 19014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H13 |
0.679652240733806 |
|
| 19015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPB2 |
0.679652240733806 |
|
| 19016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCP1 |
0.679652240733806 |
|
| 19017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL288P |
0.679652240733806 |
|
| 19018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC63 |
0.679652240733806 |
|
| 19019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238483.1 |
0.679652240733806 |
|
| 19020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP5 |
0.679652240733806 |
|
| 19021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00563 |
0.679652240733806 |
|
| 19022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00441 |
0.679652240733806 |
|
| 19023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RB1 |
0.679652240733806 |
|
| 19024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR6 |
0.679652240733806 |
|
| 19025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCBTB2 |
0.679652240733806 |
|
| 19026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00462 |
0.679652240733806 |
|
| 19027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYSLTR2 |
0.679652240733806 |
|
| 19028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLFM4 |
0.679652240733806 |
|
| 19029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00333 |
0.679652240733806 |
|
| 19030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00351 |
0.679652240733806 |
|
| 19031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK6 |
0.679652240733806 |
|
| 19032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4500HG |
0.679652240733806 |
|
| 19033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4500 |
0.679652240733806 |
|
| 19034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLITRK5 |
0.679652240733806 |
|
| 19035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00433 |
0.679652240733806 |
|
| 19036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00560 |
0.679652240733806 |
|
| 19037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00440 |
0.679652240733806 |
|
| 19038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00353 |
0.679652240733806 |
|
| 19039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD38|ENSG00000200733.1 |
0.679652240733806 |
|
| 19040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00559 |
0.679652240733806 |
|
| 19041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP34 |
0.679652240733806 |
|
| 19042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR622 |
0.679652240733806 |
|
| 19043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00410 |
0.679652240733806 |
|
| 19044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00379 |
0.679652240733806 |
|
| 19045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR17HG |
0.679652240733806 |
|
| 19046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC5 |
0.679652240733806 |
|
| 19047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC3P |
0.679652240733806 |
|
| 19048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AS |
0.679652240733806 |
|
| 19049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPC6 |
0.679652240733806 |
|
| 19050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD22 |
0.679652240733806 |
|
| 19051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP35 |
0.679652240733806 |
|
| 19052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCT |
0.679652240733806 |
|
| 19053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGDS |
0.679652240733806 |
|
| 19054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR180 |
0.679652240733806 |
|
| 19055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP36 |
0.679652240733806 |
|
| 19056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL585P |
0.679652240733806 |
|
| 19057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00391 |
0.679652240733806 |
|
| 19058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX21 |
0.679652240733806 |
|
| 19059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00557 |
0.679652240733806 |
|
| 19060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC4 |
0.679652240733806 |
|
| 19061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238463.1 |
0.679652240733806 |
|
| 19062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY3P8 |
0.679652240733806 |
|
| 19063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P27 |
0.679652240733806 |
|
| 19064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN10 |
0.679652240733806 |
|
| 19065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DZIP1 |
0.679652240733806 |
|
| 19066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC3 |
0.679652240733806 |
|
| 19067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snR65|ENSG00000251901.1 |
0.679652240733806 |
|
| 19068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGGT2 |
0.679652240733806 |
|
| 19069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS6ST3 |
0.679652240733806 |
|
| 19070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL164P |
0.679652240733806 |
|
| 19071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00359 |
0.679652240733806 |
|
| 19072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP7 |
0.679652240733806 |
|
| 19073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252154.1 |
0.679652240733806 |
|
| 19074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM173B |
0.679959380543113 |
|
| 19075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT5 |
0.679959380543113 |
|
| 19076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMBL |
0.679959380543113 |
|
| 19077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH6 |
0.679959380543113 |
|
| 19078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROPN1L |
0.679959380543113 |
|
| 19079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD33B |
0.679959380543113 |
|
| 19080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAP |
0.679959380543113 |
|
| 19081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNND2 |
0.679959380543113 |
|
| 19082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT49 |
0.679959380543113 |
|
| 19083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH5 |
0.679959380543113 |
|
| 19084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH18 |
0.679959380543113 |
|
| 19085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH12 |
0.679959380543113 |
|
| 19086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMCHL1 |
0.679959380543113 |
|
| 19087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL572P |
0.679959380543113 |
|
| 19088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM9 |
0.679959380543113 |
|
| 19089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf17 |
0.679959380543113 |
|
| 19090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH10 |
0.679959380543113 |
|
| 19091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD29 |
0.679959380543113 |
|
| 19092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RXFP3 |
0.679959380543113 |
|
| 19093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMACR |
0.679959380543113 |
|
| 19094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF3 |
0.679959380543113 |
|
| 19095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAI14 |
0.679959380543113 |
|
| 19096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC45A2 |
0.679959380543113 |
|
| 19097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC23L |
0.679959380543113 |
|
| 19098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD1 |
0.679959380543113 |
|
| 19099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRIX1 |
0.679959380543113 |
|
| 19100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC21 |
0.679959380543113 |
|
| 19101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGXT2 |
0.679959380543113 |
|
| 19102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRLR |
0.679959380543113 |
|
| 19103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000201368.1 |
0.679959380543113 |
|
| 19104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPEF2 |
0.679959380543113 |
|
| 19105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL7R |
0.679959380543113 |
|
| 19106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPSL |
0.679959380543113 |
|
| 19107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT3A1 |
0.679959380543113 |
|
| 19108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGT3A2 |
0.679959380543113 |
|
| 19109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMBRD2 |
0.679959380543113 |
|
| 19110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR580 |
0.679959380543113 |
|
| 19111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKP2 |
0.679959380543113 |
|
| 19112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NADK2 |
0.679959380543113 |
|
| 19113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP3L |
0.679959380543113 |
|
| 19114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP181 |
0.679959380543113 |
|
| 19115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A3 |
0.679959380543113 |
|
| 19116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPBL |
0.679959380543113 |
|
| 19117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf42 |
0.679959380543113 |
|
| 19118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL37P |
0.679959380543113 |
|
| 19119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP155 |
0.679959380543113 |
|
| 19120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDNF |
0.679959380543113 |
|
| 19121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGFLAM |
0.679959380543113 |
|
| 19122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIFR |
0.679959380543113 |
|
| 19123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3650 |
0.679959380543113 |
|
| 19124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSMR |
0.679959380543113 |
|
| 19125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RICTOR |
0.679959380543113 |
|
| 19126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FYB |
0.679959380543113 |
|
| 19127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C9 |
0.679959380543113 |
|
| 19128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAB2 |
0.679959380543113 |
|
| 19129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00603 |
0.679959380543113 |
|
| 19130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00604 |
0.679959380543113 |
|
| 19131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000199552.1 |
0.679959380543113 |
|
| 19132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGER4 |
0.679959380543113 |
|
| 19133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC33 |
0.679959380543113 |
|
| 19134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAA1 |
0.679959380543113 |
|
| 19135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA57|ENSG00000212567.1 |
0.679959380543113 |
|
| 19136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL37 |
0.679959380543113 |
|
| 19137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD72 |
0.679959380543113 |
|
| 19138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARD6 |
0.679959380543113 |
|
| 19139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7 |
0.679959380543113 |
|
| 19140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MROH2B |
0.679959380543113 |
|
| 19141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6 |
0.679959380543113 |
|
| 19142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCXD3 |
0.679959380543113 |
|
| 19143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXCT1 |
0.679959380543113 |
|
| 19144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf51 |
0.679959380543113 |
|
| 19145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO4 |
0.679959380543113 |
|
| 19146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GHR |
0.679959380543113 |
|
| 19147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC152 |
0.679959380543113 |
|
| 19148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPP1 |
0.679959380543113 |
|
| 19149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF131 |
0.679959380543113 |
|
| 19150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIM1 |
0.679959380543113 |
|
| 19151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGCS1 |
0.679959380543113 |
|
| 19152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL28 |
0.679959380543113 |
|
| 19153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf28 |
0.679959380543113 |
|
| 19154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf34 |
0.679959380543113 |
|
| 19155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAIP1 |
0.679959380543113 |
|
| 19156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NNT |
0.679959380543113 |
|
| 19157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF10 |
0.679959380543113 |
|
| 19158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL383P |
0.679959380543113 |
|
| 19159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS30 |
0.679959380543113 |
|
| 19160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCN1 |
0.679959380543113 |
|
| 19161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMB |
0.679959380543113 |
|
| 19162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP8 |
0.679959380543113 |
|
| 19163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00892 |
0.69268706518787 |
|
| 19164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD40LG |
0.69268706518787 |
|
| 19165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF6 |
0.69268706518787 |
|
| 19166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMX |
0.69268706518787 |
|
| 19167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD61|ENSG00000206979.1 |
0.69268706518787 |
|
| 19168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR101 |
0.69268706518787 |
|
| 19169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZIC3 |
0.69268706518787 |
|
| 19170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL325P |
0.69268706518787 |
|
| 19171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf51A |
0.69268706518787 |
|
| 19172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf51B |
0.69268706518787 |
|
| 19173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR513C |
0.69268706518787 |
|
| 19174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR513B |
0.69268706518787 |
|
| 19175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR513A1 |
0.69268706518787 |
|
| 19176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR513A2 |
0.69268706518787 |
|
| 19177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR506 |
0.69268706518787 |
|
| 19178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR507 |
0.69268706518787 |
|
| 19179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR508 |
0.69268706518787 |
|
| 19180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR514B |
0.69268706518787 |
|
| 19181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR510 |
0.69268706518787 |
|
| 19182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR514A1 |
0.69268706518787 |
|
| 19183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR514A2 |
0.69268706518787 |
|
| 19184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR514A3 |
0.69268706518787 |
|
| 19185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMR1 |
0.69268706518787 |
|
| 19186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMR1NB |
0.69268706518787 |
|
| 19187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDS |
0.69268706518787 |
|
| 19188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00893 |
0.69268706518787 |
|
| 19189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf40A |
0.69268706518787 |
|
| 19190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf40B |
0.69268706518787 |
|
| 19191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSFX1 |
0.69268706518787 |
|
| 19192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSFX2 |
0.69268706518787 |
|
| 19193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00894 |
0.69268706518787 |
|
| 19194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA11 |
0.69268706518787 |
|
| 19195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA8 |
0.69268706518787 |
|
| 19196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA9B |
0.69268706518787 |
|
| 19197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEA9 |
0.69268706518787 |
|
| 19198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM185A |
0.69268706518787 |
|
| 19199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2114 |
0.69268706518787 |
|
| 19200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAMLD1 |
0.69268706518787 |
|
| 19201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTM1 |
0.69268706518787 |
|
| 19202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B4GALNT3 |
0.695832944934578 |
|
| 19203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC77 |
0.695832944934578 |
|
| 19204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138D |
0.695832944934578 |
|
| 19205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQSEC3 |
0.695832944934578 |
|
| 19206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM5A |
0.695832944934578 |
|
| 19207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NINJ2 |
0.695832944934578 |
|
| 19208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC16P |
0.695832944934578 |
|
| 19209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A12 |
0.695832944934578 |
|
| 19210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A13 |
0.695832944934578 |
|
| 19211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL852P |
0.695832944934578 |
|
| 19212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL14 |
0.695832944934578 |
|
| 19213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00942 |
0.695832944934578 |
|
| 19214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3649 |
0.695832944934578 |
|
| 19215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT5B |
0.695832944934578 |
|
| 19216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN9 |
0.698489624381422 |
|
| 19217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA5 |
0.701155509146606 |
|
| 19218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTSF1 |
0.701155509146606 |
|
| 19219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCKAP1L |
0.701155509146606 |
|
| 19220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE1B |
0.701155509146606 |
|
| 19221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R1A |
0.701155509146606 |
|
| 19222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYCAM1 |
0.701155509146606 |
|
| 19223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACRT |
0.701155509146606 |
|
| 19224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCD |
0.701155509146606 |
|
| 19225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUCL1 |
0.701155509146606 |
|
| 19226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TESPA1 |
0.701155509146606 |
|
| 19227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROD4 |
0.701155509146606 |
|
| 19228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9K2 |
0.701155509146606 |
|
| 19229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10A7 |
0.701155509146606 |
|
| 19230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C74 |
0.701155509146606 |
|
| 19231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C6 |
0.701155509146606 |
|
| 19232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C1 |
0.701155509146606 |
|
| 19233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C3 |
0.701155509146606 |
|
| 19234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C75 |
0.701155509146606 |
|
| 19235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C65 |
0.701155509146606 |
|
| 19236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C76 |
0.701155509146606 |
|
| 19237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C2 |
0.701155509146606 |
|
| 19238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C70 |
0.701155509146606 |
|
| 19239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C68 |
0.701155509146606 |
|
| 19240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6C4 |
0.701155509146606 |
|
| 19241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2AP1 |
0.701155509146606 |
|
| 19242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10P1 |
0.701155509146606 |
|
| 19243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL7B |
0.701155509146606 |
|
| 19244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA7 |
0.701155509146606 |
|
| 19245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S1 |
0.701155509146606 |
|
| 19246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH5 |
0.701155509146606 |
|
| 19247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD63 |
0.701155509146606 |
|
| 19248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF11 |
0.701155509146606 |
|
| 19249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SARNP |
0.701155509146606 |
|
| 19250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC14 |
0.701155509146606 |
|
| 19251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORMDL2 |
0.701155509146606 |
|
| 19252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM198B |
0.701155509146606 |
|
| 19253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP19 |
0.701155509146606 |
|
| 19254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIBG |
0.701155509146606 |
|
| 19255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKA |
0.701155509146606 |
|
| 19256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMEL |
0.701155509146606 |
|
| 19257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK2 |
0.701155509146606 |
|
| 19258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB5B |
0.701155509146606 |
|
| 19259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUOX |
0.701155509146606 |
|
| 19260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHMT2 |
0.701155509146606 |
|
| 19261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA4L2 |
0.701155509146606 |
|
| 19262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAC3 |
0.701155509146606 |
|
| 19263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRIG3 |
0.701155509146606 |
|
| 19264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A7 |
0.701155509146606 |
|
| 19265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPD1 |
0.701247995545868 |
|
| 19266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB4 |
0.701247995545868 |
|
| 19267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFTN2 |
0.701247995545868 |
|
| 19268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARS2 |
0.701247995545868 |
|
| 19269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOLL |
0.701247995545868 |
|
| 19270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCL1 |
0.701247995545868 |
|
| 19271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXGR1 |
0.701609102388683 |
|
| 19272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238522.1 |
0.701609102388683 |
|
| 19273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBNL2 |
0.701609102388683 |
|
| 19274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP37 |
0.701609102388683 |
|
| 19275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIDR |
0.710109146413949 |
|
| 19276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5C1B |
0.715467723928792 |
|
| 19277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH14 |
0.715467723928792 |
|
| 19278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4757 |
0.715467723928792 |
|
| 19279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSR1 |
0.715467723928792 |
|
| 19280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00954 |
0.715467723928792 |
|
| 19281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC32 |
0.715467723928792 |
|
| 19282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR35 |
0.715467723928792 |
|
| 19283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATN3 |
0.715467723928792 |
|
| 19284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAPTM4A |
0.715467723928792 |
|
| 19285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL140P |
0.715467723928792 |
|
| 19286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDC1 |
0.715467723928792 |
|
| 19287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUM2 |
0.715467723928792 |
|
| 19288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP86 |
0.715467723928792 |
|
| 19289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOB |
0.715467723928792 |
|
| 19290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS1BP3 |
0.715467723928792 |
|
| 19291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF7 |
0.715467723928792 |
|
| 19292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf43 |
0.715467723928792 |
|
| 19293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOB |
0.715467723928792 |
|
| 19294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRD15 |
0.715467723928792 |
|
| 19295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL117P |
0.715467723928792 |
|
| 19296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP87 |
0.715467723928792 |
|
| 19297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP27 |
0.715467723928792 |
|
| 19298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL29 |
0.715467723928792 |
|
| 19299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA21|ENSG00000251805.1 |
0.715467723928792 |
|
| 19300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOA1 |
0.715467723928792 |
|
| 19301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP88 |
0.715467723928792 |
|
| 19302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTRHD1 |
0.715467723928792 |
|
| 19303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPO |
0.715467723928792 |
|
| 19304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCY3 |
0.715467723928792 |
|
| 19305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC27 |
0.715467723928792 |
|
| 19306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD14 |
0.715467723928792 |
|
| 19307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFR3B |
0.715467723928792 |
|
| 19308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL856P |
0.715467723928792 |
|
| 19309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POMC |
0.715467723928792 |
|
| 19310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNMT3A |
0.715467723928792 |
|
| 19311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1301 |
0.715467723928792 |
|
| 19312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTNB |
0.715467723928792 |
|
| 19313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASXL2 |
0.715467723928792 |
|
| 19314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF3C |
0.715467723928792 |
|
| 19315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB10 |
0.715467723928792 |
|
| 19316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAREML |
0.715467723928792 |
|
| 19317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HADHA |
0.715467723928792 |
|
| 19318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HADHB |
0.715467723928792 |
|
| 19319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPT1 |
0.715467723928792 |
|
| 19320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR113 |
0.715467723928792 |
|
| 19321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRC1 |
0.715467723928792 |
|
| 19322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTOF |
0.715467723928792 |
|
| 19323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf70 |
0.715467723928792 |
|
| 19324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIB4 |
0.715467723928792 |
|
| 19325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK3 |
0.715467723928792 |
|
| 19326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPA |
0.715467723928792 |
|
| 19327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F6 |
0.715467723928792 |
|
| 19328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPYSL5 |
0.715467723928792 |
|
| 19329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPRE3 |
0.715467723928792 |
|
| 19330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM214 |
0.715467723928792 |
|
| 19331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGBL5 |
0.715467723928792 |
|
| 19332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OST4 |
0.715467723928792 |
|
| 19333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMILIN1 |
0.715467723928792 |
|
| 19334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KHK |
0.715467723928792 |
|
| 19335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGREF1 |
0.715467723928792 |
|
| 19336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD1 |
0.715467723928792 |
|
| 19337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PREB |
0.715467723928792 |
|
| 19338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf53 |
0.715467723928792 |
|
| 19339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF23 |
0.715467723928792 |
|
| 19340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A6 |
0.715467723928792 |
|
| 19341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATRAID |
0.715467723928792 |
|
| 19342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAD |
0.715467723928792 |
|
| 19343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A3 |
0.715467723928792 |
|
| 19344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC5G |
0.715467723928792 |
|
| 19345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM54 |
0.715467723928792 |
|
| 19346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPV17 |
0.715467723928792 |
|
| 19347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UCN |
0.715467723928792 |
|
| 19348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C2 |
0.715467723928792 |
|
| 19349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2B4 |
0.715467723928792 |
|
| 19350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX17 |
0.715467723928792 |
|
| 19351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF513 |
0.715467723928792 |
|
| 19352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1G |
0.715467723928792 |
|
| 19353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRBP1 |
0.715467723928792 |
|
| 19354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT172 |
0.715467723928792 |
|
| 19355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRTCAP3 |
0.715467723928792 |
|
| 19356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC4 |
0.715467723928792 |
|
| 19357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCKR |
0.715467723928792 |
|
| 19358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf16 |
0.715467723928792 |
|
| 19359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF512 |
0.715467723928792 |
|
| 19360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC121 |
0.715467723928792 |
|
| 19361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPN1 |
0.715467723928792 |
|
| 19362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA36|ENSG00000206731.1 |
0.715467723928792 |
|
| 19363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUPT7L |
0.715467723928792 |
|
| 19364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A1AP |
0.715467723928792 |
|
| 19365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL33 |
0.715467723928792 |
|
| 19366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBKS |
0.715467723928792 |
|
| 19367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRE |
0.715467723928792 |
|
| 19368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4263 |
0.715467723928792 |
|
| 19369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOSL2 |
0.715467723928792 |
|
| 19370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLB1 |
0.715467723928792 |
|
| 19371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP89 |
0.715467723928792 |
|
| 19372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1CB |
0.715467723928792 |
|
| 19373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM179A |
0.715467723928792 |
|
| 19374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD53 |
0.715467723928792 |
|
| 19375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD92 |
0.715467723928792 |
|
| 19376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPDYA |
0.715467723928792 |
|
| 19377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT61B |
0.715467723928792 |
|
| 19378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR43 |
0.715467723928792 |
|
| 19379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf71 |
0.715467723928792 |
|
| 19380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIP4 |
0.715467723928792 |
|
| 19381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALK |
0.715467723928792 |
|
| 19382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL516P |
0.715467723928792 |
|
| 19383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YPEL5 |
0.715467723928792 |
|
| 19384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000207187.1 |
0.715467723928792 |
|
| 19385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LBH |
0.715467723928792 |
|
| 19386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCLAT1 |
0.715467723928792 |
|
| 19387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN13 |
0.715467723928792 |
|
| 19388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT14 |
0.715467723928792 |
|
| 19389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN14 |
0.715467723928792 |
|
| 19390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP90 |
0.715467723928792 |
|
| 19391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHD3 |
0.715467723928792 |
|
| 19392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XDH |
0.715467723928792 |
|
| 19393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRD5A2 |
0.715467723928792 |
|
| 19394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY30 |
0.715467723928792 |
|
| 19395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEMO1 |
0.715467723928792 |
|
| 19396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAST |
0.715467723928792 |
|
| 19397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A6 |
0.715467723928792 |
|
| 19398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRC4 |
0.715467723928792 |
|
| 19399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF4 |
0.715467723928792 |
|
| 19400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIRC6 |
0.715467723928792 |
|
| 19401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00486 |
0.715467723928792 |
|
| 19402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTBP1 |
0.715467723928792 |
|
| 19403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4765 |
0.715467723928792 |
|
| 19404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR558 |
0.715467723928792 |
|
| 19405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252502.1 |
0.715467723928792 |
|
| 19406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC27 |
0.715467723928792 |
|
| 19407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP91 |
0.715467723928792 |
|
| 19408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP92 |
0.715467723928792 |
|
| 19409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRP3 |
0.715467723928792 |
|
| 19410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM98A |
0.715467723928792 |
|
| 19411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYADML |
0.715467723928792 |
|
| 19412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL602P |
0.715467723928792 |
|
| 19413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AD |
0.715467723928792 |
|
| 19414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIM1 |
0.715467723928792 |
|
| 19415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEZ2 |
0.715467723928792 |
|
| 19416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIT |
0.715467723928792 |
|
| 19417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRN |
0.715467723928792 |
|
| 19418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEATR5B |
0.715467723928792 |
|
| 19419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPATCH11 |
0.715467723928792 |
|
| 19420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2AK2 |
0.715467723928792 |
|
| 19421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT6B1 |
0.715467723928792 |
|
| 19422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEBPZ |
0.715467723928792 |
|
| 19423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF7 |
0.715467723928792 |
|
| 19424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKD3 |
0.715467723928792 |
|
| 19425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
QPCT |
0.715467723928792 |
|
| 19426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC42EP3 |
0.715467723928792 |
|
| 19427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00211 |
0.715467723928792 |
|
| 19428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMDN2 |
0.715467723928792 |
|
| 19429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP1B1 |
0.715467723928792 |
|
| 19430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATL2 |
0.715467723928792 |
|
| 19431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPLL |
0.715467723928792 |
|
| 19432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALM |
0.715467723928792 |
|
| 19433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN6 |
0.715467723928792 |
|
| 19434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF7 |
0.715467723928792 |
|
| 19435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX57 |
0.715467723928792 |
|
| 19436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORN2 |
0.715467723928792 |
|
| 19437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF33 |
0.715467723928792 |
|
| 19438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL96P |
0.715467723928792 |
|
| 19439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOS1 |
0.715467723928792 |
|
| 19440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKL4 |
0.715467723928792 |
|
| 19441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4K3 |
0.715467723928792 |
|
| 19442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000252473.1 |
0.715467723928792 |
|
| 19443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM178A |
0.715467723928792 |
|
| 19444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THUMPD2 |
0.715467723928792 |
|
| 19445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC8A1 |
0.715467723928792 |
|
| 19446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA1P57 |
0.715467723928792 |
|
| 19447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ247 |
0.715467723928792 |
|
| 19448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf91 |
0.715467723928792 |
|
| 19449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKDCC |
0.715467723928792 |
|
| 19450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML4 |
0.715467723928792 |
|
| 19451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7A2L |
0.715467723928792 |
|
| 19452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNG3 |
0.715467723928792 |
|
| 19453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD75|ENSG00000221300.1 |
0.715467723928792 |
|
| 19454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTA3 |
0.715467723928792 |
|
| 19455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OXER1 |
0.715467723928792 |
|
| 19456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAAO |
0.715467723928792 |
|
| 19457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THADA |
0.715467723928792 |
|
| 19458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP36L2 |
0.715467723928792 |
|
| 19459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHH2 |
0.715467723928792 |
|
| 19460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP66 |
0.715467723928792 |
|
| 19461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC2LI1 |
0.715467723928792 |
|
| 19462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCG5 |
0.715467723928792 |
|
| 19463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCG8 |
0.715467723928792 |
|
| 19464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRPPRC |
0.715467723928792 |
|
| 19465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1B |
0.715467723928792 |
|
| 19466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239052.1 |
0.715467723928792 |
|
| 19467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC3A1 |
0.715467723928792 |
|
| 19468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PREPL |
0.715467723928792 |
|
| 19469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMKMT |
0.715467723928792 |
|
| 19470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX3 |
0.715467723928792 |
|
| 19471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIX2 |
0.715467723928792 |
|
| 19472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRBD1 |
0.715467723928792 |
|
| 19473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL414P |
0.715467723928792 |
|
| 19474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKCE |
0.715467723928792 |
|
| 19475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPAS1 |
0.715467723928792 |
|
| 19476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM247 |
0.715467723928792 |
|
| 19477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL817P |
0.715467723928792 |
|
| 19478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1E2 |
0.715467723928792 |
|
| 19479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOQ |
0.715467723928792 |
|
| 19480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGF |
0.715467723928792 |
|
| 19481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRIPT |
0.715467723928792 |
|
| 19482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS5 |
0.715467723928792 |
|
| 19483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCFD2 |
0.715467723928792 |
|
| 19484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC7A |
0.715467723928792 |
|
| 19485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCYRN1 |
0.715467723928792 |
|
| 19486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPCAM |
0.715467723928792 |
|
| 19487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP119 |
0.715467723928792 |
|
| 19488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR559 |
0.715467723928792 |
|
| 19489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSH2 |
0.715467723928792 |
|
| 19490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK12 |
0.715467723928792 |
|
| 19491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSH6 |
0.715467723928792 |
|
| 19492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO11 |
0.715467723928792 |
|
| 19493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP224 |
0.715467723928792 |
|
| 19494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXN2 |
0.715467723928792 |
|
| 19495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R21 |
0.715467723928792 |
|
| 19496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STON1 |
0.715467723928792 |
|
| 19497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2A1L |
0.715467723928792 |
|
| 19498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHCGR |
0.715467723928792 |
|
| 19499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSHR |
0.715467723928792 |
|
| 19500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212580.1 |
0.715467723928792 |
|
| 19501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRXN1 |
0.715467723928792 |
|
| 19502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4431 |
0.715467723928792 |
|
| 19503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA16|ENSG00000251942.1 |
0.715467723928792 |
|
| 19504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB3 |
0.715467723928792 |
|
| 19505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAC2 |
0.715467723928792 |
|
| 19506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERLEC1 |
0.715467723928792 |
|
| 19507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238756.1 |
0.715467723928792 |
|
| 19508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3682 |
0.715467723928792 |
|
| 19509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR75 |
0.715467723928792 |
|
| 19510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSME4 |
0.715467723928792 |
|
| 19511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACYP2 |
0.715467723928792 |
|
| 19512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf73 |
0.715467723928792 |
|
| 19513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTBN1 |
0.715467723928792 |
|
| 19514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPYL6 |
0.715467723928792 |
|
| 19515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EML6 |
0.715467723928792 |
|
| 19516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN4 |
0.715467723928792 |
|
| 19517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLHC1 |
0.715467723928792 |
|
| 19518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS27A |
0.715467723928792 |
|
| 19519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTIF2 |
0.715467723928792 |
|
| 19520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRORSD1P |
0.715467723928792 |
|
| 19521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC88A |
0.715467723928792 |
|
| 19522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC104 |
0.715467723928792 |
|
| 19523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMEK2 |
0.715467723928792 |
|
| 19524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA12|ENSG00000212175.1 |
0.715467723928792 |
|
| 19525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPT1 |
0.715467723928792 |
|
| 19526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFEMP1 |
0.715467723928792 |
|
| 19527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP208 |
0.715467723928792 |
|
| 19528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR216A |
0.715467723928792 |
|
| 19529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR217 |
0.715467723928792 |
|
| 19530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR216B |
0.715467723928792 |
|
| 19531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC85A |
0.715467723928792 |
|
| 19532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP93 |
0.715467723928792 |
|
| 19533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238690.1 |
0.715467723928792 |
|
| 19534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD78|ENSG00000212168.1 |
0.715467723928792 |
|
| 19535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VRK2 |
0.715467723928792 |
|
| 19536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCL |
0.715467723928792 |
|
| 19537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP94 |
0.715467723928792 |
|
| 19538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4432 |
0.715467723928792 |
|
| 19539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL11A |
0.715467723928792 |
|
| 19540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL361P |
0.715467723928792 |
|
| 19541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAPOLG |
0.715467723928792 |
|
| 19542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL632P |
0.715467723928792 |
|
| 19543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REL |
0.715467723928792 |
|
| 19544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUS10 |
0.715467723928792 |
|
| 19545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP95 |
0.715467723928792 |
|
| 19546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX13 |
0.715467723928792 |
|
| 19547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1841 |
0.715467723928792 |
|
| 19548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf74 |
0.715467723928792 |
|
| 19549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHSA2 |
0.715467723928792 |
|
| 19550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP34 |
0.715467723928792 |
|
| 19551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70B |
0.715467723928792 |
|
| 19552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPO1 |
0.715467723928792 |
|
| 19553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM161A |
0.715467723928792 |
|
| 19554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT4 |
0.715467723928792 |
|
| 19555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD1 |
0.715467723928792 |
|
| 19556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT2 |
0.715467723928792 |
|
| 19557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5192 |
0.715467723928792 |
|
| 19558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL51P |
0.715467723928792 |
|
| 19559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238809.1 |
0.715467723928792 |
|
| 19560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL18P |
0.715467723928792 |
|
| 19561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM17 |
0.715467723928792 |
|
| 19562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHBP1 |
0.715467723928792 |
|
| 19563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTX1 |
0.715467723928792 |
|
| 19564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBIL5P2 |
0.715467723928792 |
|
| 19565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDPCP |
0.715467723928792 |
|
| 19566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDH1 |
0.715467723928792 |
|
| 19567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS4XP5 |
0.715467723928792 |
|
| 19568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGP2 |
0.715467723928792 |
|
| 19569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA59|ENSG00000251775.1 |
0.715467723928792 |
|
| 19570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS54 |
0.715467723928792 |
|
| 19571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PELI1 |
0.715467723928792 |
|
| 19572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00309 |
0.715467723928792 |
|
| 19573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4433 |
0.715467723928792 |
|
| 19574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGALSL |
0.715467723928792 |
|
| 19575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFTPH |
0.715467723928792 |
|
| 19576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERTAD2 |
0.715467723928792 |
|
| 19577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL341P |
0.715467723928792 |
|
| 19578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL211P |
0.715467723928792 |
|
| 19579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238696.1 |
0.715467723928792 |
|
| 19580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC1A4 |
0.715467723928792 |
|
| 19581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP68 |
0.715467723928792 |
|
| 19582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB1A |
0.715467723928792 |
|
| 19583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA74|ENSG00000272025.1 |
0.715467723928792 |
|
| 19584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR2 |
0.715467723928792 |
|
| 19585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRED2 |
0.715467723928792 |
|
| 19586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL635P |
0.715467723928792 |
|
| 19587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
Vault|ENSG00000251900.1 |
0.715467723928792 |
|
| 19588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4778 |
0.715467723928792 |
|
| 19589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEIS1 |
0.715467723928792 |
|
| 19590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETAA1 |
0.715467723928792 |
|
| 19591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1D |
0.715467723928792 |
|
| 19592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR92 |
0.715467723928792 |
|
| 19593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP3R1 |
0.715467723928792 |
|
| 19594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNO1 |
0.715467723928792 |
|
| 19595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNRIP1 |
0.715467723928792 |
|
| 19596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEK |
0.715467723928792 |
|
| 19597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APLF |
0.715467723928792 |
|
| 19598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP25 |
0.715467723928792 |
|
| 19599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO48 |
0.715467723928792 |
|
| 19600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROKR1 |
0.715467723928792 |
|
| 19601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP10 |
0.715467723928792 |
|
| 19602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GKN2 |
0.715467723928792 |
|
| 19603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GKN1 |
0.715467723928792 |
|
| 19604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANTXR1 |
0.715467723928792 |
|
| 19605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3126 |
0.715467723928792 |
|
| 19606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP96 |
0.715467723928792 |
|
| 19607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFPT1 |
0.715467723928792 |
|
| 19608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFU1 |
0.715467723928792 |
|
| 19609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAK1 |
0.715467723928792 |
|
| 19610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL604P |
0.715467723928792 |
|
| 19611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA36C |
0.715467723928792 |
|
| 19612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA4 |
0.715467723928792 |
|
| 19613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238708.1 |
0.715467723928792 |
|
| 19614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMCL1 |
0.715467723928792 |
|
| 19615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP27 |
0.715467723928792 |
|
| 19616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXD1 |
0.715467723928792 |
|
| 19617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238465.1 |
0.715467723928792 |
|
| 19618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239072.1 |
0.715467723928792 |
|
| 19619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASPRV1 |
0.715467723928792 |
|
| 19620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL470P |
0.715467723928792 |
|
| 19621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCBP1 |
0.715467723928792 |
|
| 19622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf42 |
0.715467723928792 |
|
| 19623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIA1 |
0.715467723928792 |
|
| 19624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCYOX1 |
0.715467723928792 |
|
| 19625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPG |
0.715467723928792 |
|
| 19626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM136A |
0.715467723928792 |
|
| 19627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFA |
0.715467723928792 |
|
| 19628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADD2 |
0.715467723928792 |
|
| 19629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIGLA |
0.715467723928792 |
|
| 19630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4F |
0.715467723928792 |
|
| 19631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD207 |
0.715467723928792 |
|
| 19632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAX2 |
0.715467723928792 |
|
| 19633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1B1 |
0.715467723928792 |
|
| 19634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239064.1 |
0.715467723928792 |
|
| 19635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL160P |
0.715467723928792 |
|
| 19636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD53 |
0.715467723928792 |
|
| 19637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX261 |
0.715467723928792 |
|
| 19638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAGK |
0.715467723928792 |
|
| 19639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCEE |
0.715467723928792 |
|
| 19640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPHOSPH10 |
0.715467723928792 |
|
| 19641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAIP2B |
0.715467723928792 |
|
| 19642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF638 |
0.715467723928792 |
|
| 19643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYSF |
0.715467723928792 |
|
| 19644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP26B1 |
0.715467723928792 |
|
| 19645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC6B |
0.715467723928792 |
|
| 19646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD78|ENSG00000212378.1 |
0.715467723928792 |
|
| 19647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPR |
0.715467723928792 |
|
| 19648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMX1 |
0.715467723928792 |
|
| 19649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFXN5 |
0.715467723928792 |
|
| 19650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11FIP5 |
0.715467723928792 |
|
| 19651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOTO |
0.715467723928792 |
|
| 19652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMYD5 |
0.715467723928792 |
|
| 19653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT7 |
0.715467723928792 |
|
| 19654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRADC1 |
0.715467723928792 |
|
| 19655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO41 |
0.715467723928792 |
|
| 19656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EGR4 |
0.715467723928792 |
|
| 19657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALMS1 |
0.715467723928792 |
|
| 19658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALMS1P |
0.715467723928792 |
|
| 19659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAT8 |
0.715467723928792 |
|
| 19660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPRKB |
0.715467723928792 |
|
| 19661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP11 |
0.715467723928792 |
|
| 19662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf78 |
0.715467723928792 |
|
| 19663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAMBP |
0.715467723928792 |
|
| 19664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTG2 |
0.715467723928792 |
|
| 19665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGUOK |
0.715467723928792 |
|
| 19666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP97 |
0.715467723928792 |
|
| 19667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TET3 |
0.715467723928792 |
|
| 19668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOLA3 |
0.715467723928792 |
|
| 19669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGC10955 |
0.715467723928792 |
|
| 19670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOB1A |
0.715467723928792 |
|
| 19671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFD2 |
0.715467723928792 |
|
| 19672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A5 |
0.715467723928792 |
|
| 19673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCTN1 |
0.715467723928792 |
|
| 19674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf81 |
0.715467723928792 |
|
| 19675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR54 |
0.715467723928792 |
|
| 19676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTKN |
0.715467723928792 |
|
| 19677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INO80B |
0.715467723928792 |
|
| 19678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP1 |
0.715467723928792 |
|
| 19679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOGS |
0.715467723928792 |
|
| 19680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC142 |
0.715467723928792 |
|
| 19681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL53 |
0.715467723928792 |
|
| 19682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC31 |
0.715467723928792 |
|
| 19683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LBX2 |
0.715467723928792 |
|
| 19684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGF1 |
0.715467723928792 |
|
| 19685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLX2 |
0.715467723928792 |
|
| 19686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DQX1 |
0.715467723928792 |
|
| 19687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AUP1 |
0.715467723928792 |
|
| 19688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTRA2 |
0.715467723928792 |
|
| 19689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOXL3 |
0.715467723928792 |
|
| 19690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOK1 |
0.715467723928792 |
|
| 19691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
M1AP |
0.715467723928792 |
|
| 19692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4F |
0.715467723928792 |
|
| 19693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HK2 |
0.715467723928792 |
|
| 19694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLE4 |
0.715467723928792 |
|
| 19695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TACR1 |
0.715467723928792 |
|
| 19696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5000 |
0.715467723928792 |
|
| 19697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238521.1 |
0.715467723928792 |
|
| 19698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVA1A |
0.715467723928792 |
|
| 19699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000238410.1 |
0.715467723928792 |
|
| 19700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCFC2 |
0.715467723928792 |
|
| 19701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL19 |
0.715467723928792 |
|
| 19702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221638.1 |
0.715467723928792 |
|
| 19703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239018.1 |
0.715467723928792 |
|
| 19704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP203 |
0.715467723928792 |
|
| 19705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP164 |
0.715467723928792 |
|
| 19706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRTM4 |
0.715467723928792 |
|
| 19707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP98 |
0.715467723928792 |
|
| 19708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNA2 |
0.715467723928792 |
|
| 19709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG1A |
0.715467723928792 |
|
| 19710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG1B |
0.715467723928792 |
|
| 19711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG1P |
0.715467723928792 |
|
| 19712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG3A |
0.715467723928792 |
|
| 19713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REG3G |
0.715467723928792 |
|
| 19714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4264 |
0.715467723928792 |
|
| 19715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRTM1 |
0.715467723928792 |
|
| 19716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP99 |
0.715467723928792 |
|
| 19717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL201P |
0.715467723928792 |
|
| 19718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252298.1 |
0.715467723928792 |
|
| 19719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUNDC2P2 |
0.715467723928792 |
|
| 19720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUCLG1 |
0.715467723928792 |
|
| 19721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH6 |
0.715467723928792 |
|
| 19722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRABD2A |
0.715467723928792 |
|
| 19723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMSB10 |
0.715467723928792 |
|
| 19724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCMF1 |
0.715467723928792 |
|
| 19725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF7L1 |
0.715467723928792 |
|
| 19726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGOLN2 |
0.715467723928792 |
|
| 19727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RETSAT |
0.715467723928792 |
|
| 19728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELMOD3 |
0.715467723928792 |
|
| 19729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL113P |
0.715467723928792 |
|
| 19730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPG |
0.715467723928792 |
|
| 19731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D6 |
0.715467723928792 |
|
| 19732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL251P |
0.715467723928792 |
|
| 19733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL830P |
0.715467723928792 |
|
| 19734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAT2A |
0.715467723928792 |
|
| 19735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GGCX |
0.715467723928792 |
|
| 19736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP8 |
0.715467723928792 |
|
| 19737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL126P |
0.715467723928792 |
|
| 19738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP5 |
0.715467723928792 |
|
| 19739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF181 |
0.715467723928792 |
|
| 19740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf68 |
0.715467723928792 |
|
| 19741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM150A |
0.715467723928792 |
|
| 19742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP39 |
0.715467723928792 |
|
| 19743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFTPB |
0.715467723928792 |
|
| 19744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNLY |
0.715467723928792 |
|
| 19745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATOH8 |
0.715467723928792 |
|
| 19746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP83 |
0.715467723928792 |
|
| 19747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL5 |
0.715467723928792 |
|
| 19748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR1A |
0.715467723928792 |
|
| 19749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMMT |
0.715467723928792 |
|
| 19750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4779 |
0.715467723928792 |
|
| 19751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL35 |
0.715467723928792 |
|
| 19752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCD3 |
0.715467723928792 |
|
| 19753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP1 |
0.715467723928792 |
|
| 19754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD94 |
0.715467723928792 |
|
| 19755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000202537.1 |
0.715467723928792 |
|
| 19756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA19|ENSG00000251974.1 |
0.715467723928792 |
|
| 19757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM3A |
0.715467723928792 |
|
| 19758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP3 |
0.715467723928792 |
|
| 19759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF103 |
0.715467723928792 |
|
| 19760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMND5A |
0.715467723928792 |
|
| 19761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD8A |
0.715467723928792 |
|
| 19762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD8B |
0.715467723928792 |
|
| 19763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00152 |
0.715467723928792 |
|
| 19764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLGLB1 |
0.715467723928792 |
|
| 19765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLGLB2 |
0.715467723928792 |
|
| 19766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD1 |
0.715467723928792 |
|
| 19767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD2 |
0.715467723928792 |
|
| 19768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238979.1 |
0.715467723928792 |
|
| 19769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRCC1 |
0.715467723928792 |
|
| 19770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMYD1 |
0.715467723928792 |
|
| 19771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4780 |
0.715467723928792 |
|
| 19772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FABP1 |
0.715467723928792 |
|
| 19773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THNSL2 |
0.715467723928792 |
|
| 19774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P15 |
0.715467723928792 |
|
| 19775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239049.1 |
0.715467723928792 |
|
| 19776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXI3 |
0.715467723928792 |
|
| 19777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX37 |
0.715467723928792 |
|
| 19778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2AK3 |
0.715467723928792 |
|
| 19779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPIA |
0.715467723928792 |
|
| 19780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD36BP2 |
0.715467723928792 |
|
| 19781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4436A |
0.715467723928792 |
|
| 19782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKC |
0.715467723928792 |
|
| 19783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKJ1 |
0.715467723928792 |
|
| 19784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKJ2 |
0.715467723928792 |
|
| 19785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKJ3 |
0.715467723928792 |
|
| 19786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKJ4 |
0.715467723928792 |
|
| 19787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGKJ5 |
0.715467723928792 |
|
| 19788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP100 |
0.715467723928792 |
|
| 19789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9B1P2 |
0.715467723928792 |
|
| 19790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A8P |
0.715467723928792 |
|
| 19791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT4 |
0.715467723928792 |
|
| 19792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL575P |
0.715467723928792 |
|
| 19793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAL |
0.715467723928792 |
|
| 19794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS5 |
0.715467723928792 |
|
| 19795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF514 |
0.715467723928792 |
|
| 19796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF2 |
0.715467723928792 |
|
| 19797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROM2 |
0.715467723928792 |
|
| 19798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNIP3 |
0.715467723928792 |
|
| 19799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAHD2A |
0.715467723928792 |
|
| 19800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ14082 |
0.715467723928792 |
|
| 19801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00342 |
0.715467723928792 |
|
| 19802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM43 |
0.715467723928792 |
|
| 19803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD36C |
0.715467723928792 |
|
| 19804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAHD2CP |
0.715467723928792 |
|
| 19805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL210P |
0.715467723928792 |
|
| 19806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPAT2 |
0.715467723928792 |
|
| 19807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADRA2B |
0.715467723928792 |
|
| 19808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASTL |
0.715467723928792 |
|
| 19809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP2 |
0.715467723928792 |
|
| 19810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD7 |
0.715467723928792 |
|
| 19811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM127 |
0.715467723928792 |
|
| 19812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIAO1 |
0.715467723928792 |
|
| 19813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP200 |
0.715467723928792 |
|
| 19814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPRIPL1 |
0.715467723928792 |
|
| 19815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPH |
0.715467723928792 |
|
| 19816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR1B |
0.715467723928792 |
|
| 19817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD36B |
0.715467723928792 |
|
| 19818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD36 |
0.715467723928792 |
|
| 19819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX5B |
0.715467723928792 |
|
| 19820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAHD2B |
0.715467723928792 |
|
| 19821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL313P |
0.715467723928792 |
|
| 19822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZAP70 |
0.715467723928792 |
|
| 19823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM131 |
0.715467723928792 |
|
| 19824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA3B |
0.715467723928792 |
|
| 19825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNGA3 |
0.715467723928792 |
|
| 19826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP4A |
0.715467723928792 |
|
| 19827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COA5 |
0.715467723928792 |
|
| 19828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC50 |
0.715467723928792 |
|
| 19829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT4A |
0.715467723928792 |
|
| 19830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1211L |
0.715467723928792 |
|
| 19831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSGA10 |
0.715467723928792 |
|
| 19832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf15 |
0.715467723928792 |
|
| 19833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPT1 |
0.715467723928792 |
|
| 19834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL30 |
0.715467723928792 |
|
| 19835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MITD1 |
0.715467723928792 |
|
| 19836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYG1 |
0.715467723928792 |
|
| 19837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYG2 |
0.715467723928792 |
|
| 19838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC9 |
0.715467723928792 |
|
| 19839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF5B |
0.715467723928792 |
|
| 19840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REV1 |
0.715467723928792 |
|
| 19841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFF3 |
0.715467723928792 |
|
| 19842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LONRF2 |
0.715467723928792 |
|
| 19843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST10 |
0.715467723928792 |
|
| 19844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMS |
0.715467723928792 |
|
| 19845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL611P |
0.715467723928792 |
|
| 19846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCL3 |
0.715467723928792 |
|
| 19847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238328.1 |
0.715467723928792 |
|
| 19848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL360P |
0.715467723928792 |
|
| 19849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAS2 |
0.715467723928792 |
|
| 19850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL31 |
0.715467723928792 |
|
| 19851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D8 |
0.715467723928792 |
|
| 19852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL548P |
0.715467723928792 |
|
| 19853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT11 |
0.715467723928792 |
|
| 19854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF149 |
0.715467723928792 |
|
| 19855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD89 |
0.715467723928792 |
|
| 19856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5696 |
0.715467723928792 |
|
| 19857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREG2 |
0.715467723928792 |
|
| 19858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX8 |
0.715467723928792 |
|
| 19859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP4K4 |
0.715467723928792 |
|
| 19860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ20373 |
0.715467723928792 |
|
| 19861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1R2 |
0.715467723928792 |
|
| 19862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR17 |
0.71711246428002 |
|
| 19863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000201516.1 |
0.71711246428002 |
|
| 19864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA4 |
0.71711246428002 |
|
| 19865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB5 |
0.71711246428002 |
|
| 19866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPCS3 |
0.71711246428002 |
|
| 19867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEGFC |
0.71711246428002 |
|
| 19868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP136 |
0.71711246428002 |
|
| 19869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEIL3 |
0.71711246428002 |
|
| 19870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGA |
0.71711246428002 |
|
| 19871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP172 |
0.71711246428002 |
|
| 19872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252388.1 |
0.71711246428002 |
|
| 19873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP173 |
0.71711246428002 |
|
| 19874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD65|ENSG00000212191.1 |
0.71711246428002 |
|
| 19875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE8 |
0.721852277287223 |
|
| 19876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239134.1 |
0.721976616640983 |
|
| 19877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP231 |
0.721976616640983 |
|
| 19878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUNX1T1 |
0.721976616640983 |
|
| 19879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIQK |
0.721976616640983 |
|
| 19880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf87 |
0.721976616640983 |
|
| 19881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00535 |
0.721976616640983 |
|
| 19882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP274 |
0.721976616640983 |
|
| 19883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM92A1 |
0.721976616640983 |
|
| 19884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM12B |
0.721976616640983 |
|
| 19885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM67 |
0.721976616640983 |
|
| 19886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDP1 |
0.721976616640983 |
|
| 19887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378D2 |
0.721976616640983 |
|
| 19888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH17 |
0.721976616640983 |
|
| 19889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEM |
0.721976616640983 |
|
| 19890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSBP |
0.721976616640983 |
|
| 19891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD54B |
0.721976616640983 |
|
| 19892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1429 |
0.721976616640983 |
|
| 19893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESRP1 |
0.721976616640983 |
|
| 19894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L4 |
0.721976616640983 |
|
| 19895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INTS8 |
0.721976616640983 |
|
| 19896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNE2 |
0.721976616640983 |
|
| 19897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF6 |
0.721976616640983 |
|
| 19898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238791.1 |
0.721976616640983 |
|
| 19899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53INP1 |
0.721976616640983 |
|
| 19900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3150B |
0.721976616640983 |
|
| 19901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHF2 |
0.721976616640983 |
|
| 19902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf37 |
0.721976616640983 |
|
| 19903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF6 |
0.721976616640983 |
|
| 19904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTERFD1 |
0.721976616640983 |
|
| 19905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTDSS1 |
0.721976616640983 |
|
| 19906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UQCRB |
0.721976616640983 |
|
| 19907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RERGL |
0.723975447935174 |
|
| 19908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3C2G |
0.723975447935174 |
|
| 19909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCZ1 |
0.723975447935174 |
|
| 19910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPZA3 |
0.723975447935174 |
|
| 19911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA5 |
0.723975447935174 |
|
| 19912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL459P |
0.723975447935174 |
|
| 19913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL67P |
0.723975447935174 |
|
| 19914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AEBP2 |
0.723975447935174 |
|
| 19915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE3A |
0.723975447935174 |
|
| 19916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO1C1 |
0.723975447935174 |
|
| 19917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO1B1 |
0.723975447935174 |
|
| 19918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO1A2 |
0.723975447935174 |
|
| 19919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IAPP |
0.723975447935174 |
|
| 19920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYROXD1 |
0.723975447935174 |
|
| 19921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RECQL |
0.723975447935174 |
|
| 19922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLT1B |
0.723975447935174 |
|
| 19923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf39 |
0.723975447935174 |
|
| 19924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYS2 |
0.723975447935174 |
|
| 19925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHB |
0.723975447935174 |
|
| 19926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ8 |
0.723975447935174 |
|
| 19927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC9 |
0.723975447935174 |
|
| 19928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMAS |
0.723975447935174 |
|
| 19929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA1 |
0.723975447935174 |
|
| 19930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD5 |
0.723975447935174 |
|
| 19931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETNK1 |
0.723975447935174 |
|
| 19932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX5 |
0.723975447935174 |
|
| 19933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR920 |
0.723975447935174 |
|
| 19934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERICH1 |
0.726275839612535 |
|
| 19935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO25 |
0.726275839612535 |
|
| 19936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4F21 |
0.726275839612535 |
|
| 19937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL23AP53 |
0.726275839612535 |
|
| 19938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDRP |
0.726275839612535 |
|
| 19939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF596 |
0.726275839612535 |
|
| 19940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLGAP2 |
0.726275839612535 |
|
| 19941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLN8 |
0.726275839612535 |
|
| 19942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR596 |
0.726275839612535 |
|
| 19943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF10 |
0.726275839612535 |
|
| 19944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD11 |
0.726275839612535 |
|
| 19945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYOM2 |
0.726275839612535 |
|
| 19946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP251 |
0.726275839612535 |
|
| 19947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL872P |
0.726275839612535 |
|
| 19948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000206661.1 |
0.726275839612535 |
|
| 19949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL318P |
0.726275839612535 |
|
| 19950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP159 |
0.726275839612535 |
|
| 19951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCPH1 |
0.726275839612535 |
|
| 19952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPT2 |
0.726275839612535 |
|
| 19953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT5 |
0.726275839612535 |
|
| 19954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4659A |
0.726275839612535 |
|
| 19955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR5 |
0.726275839612535 |
|
| 19956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB1 |
0.726275839612535 |
|
| 19957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA6 |
0.726275839612535 |
|
| 19958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA4 |
0.726275839612535 |
|
| 19959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG1L13P |
0.726275839612535 |
|
| 19960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA1B |
0.726275839612535 |
|
| 19961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA1 |
0.726275839612535 |
|
| 19962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA3 |
0.726275839612535 |
|
| 19963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFA5 |
0.726275839612535 |
|
| 19964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB103A |
0.726275839612535 |
|
| 19965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB103B |
0.726275839612535 |
|
| 19966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB104A |
0.726275839612535 |
|
| 19967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB104B |
0.726275839612535 |
|
| 19968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB105A |
0.726275839612535 |
|
| 19969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB105B |
0.726275839612535 |
|
| 19970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB106A |
0.726275839612535 |
|
| 19971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB106B |
0.726275839612535 |
|
| 19972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB107A |
0.726275839612535 |
|
| 19973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB107B |
0.726275839612535 |
|
| 19974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB4A |
0.726275839612535 |
|
| 19975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB4B |
0.726275839612535 |
|
| 19976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM66B |
0.726275839612535 |
|
| 19977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM66E |
0.726275839612535 |
|
| 19978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM85B |
0.726275839612535 |
|
| 19979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86B3P |
0.726275839612535 |
|
| 19980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM90A24P |
0.726275839612535 |
|
| 19981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRLE1 |
0.726275839612535 |
|
| 19982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548I3 |
0.726275839612535 |
|
| 19983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGK223 |
0.726275839612535 |
|
| 19984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG11A |
0.726275839612535 |
|
| 19985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG11B |
0.726275839612535 |
|
| 19986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF705B |
0.726275839612535 |
|
| 19987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF705G |
0.726275839612535 |
|
| 19988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL178P |
0.726275839612535 |
|
| 19989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN23 |
0.726275839612535 |
|
| 19990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000207244.1 |
0.726275839612535 |
|
| 19991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERI1 |
0.726275839612535 |
|
| 19992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4660 |
0.726275839612535 |
|
| 19993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3B |
0.726275839612535 |
|
| 19994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252543.1 |
0.726275839612535 |
|
| 19995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNKS |
0.726275839612535 |
|
| 19996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR597 |
0.726275839612535 |
|
| 19997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239065.1 |
0.726275839612535 |
|
| 19998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00599 |
0.726275839612535 |
|
| 19999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238496.1 |
0.726275839612535 |
|
| 20000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSRA |
0.726275839612535 |
|
| 20001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS51 |
0.726275839612535 |
|
| 20002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS55 |
0.726275839612535 |
|
| 20003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RP1L1 |
0.726275839612535 |
|
| 20004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4286 |
0.726275839612535 |
|
| 20005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf74 |
0.726275839612535 |
|
| 20006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP252 |
0.726275839612535 |
|
| 20007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX7 |
0.726275839612535 |
|
| 20008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PINX1 |
0.726275839612535 |
|
| 20009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252565.1 |
0.726275839612535 |
|
| 20010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKR6 |
0.726275839612535 |
|
| 20011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR598 |
0.726275839612535 |
|
| 20012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00529 |
0.726275839612535 |
|
| 20013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR9 |
0.726275839612535 |
|
| 20014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35G5 |
0.726275839612535 |
|
| 20015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDH |
0.726275839612535 |
|
| 20016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf12 |
0.726275839612535 |
|
| 20017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL293P |
0.726275839612535 |
|
| 20018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM167A |
0.726275839612535 |
|
| 20019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLK |
0.726275839612535 |
|
| 20020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00208 |
0.726275839612535 |
|
| 20021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA4 |
0.726275839612535 |
|
| 20022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf49 |
0.726275839612535 |
|
| 20023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEIL2 |
0.726275839612535 |
|
| 20024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSB |
0.726275839612535 |
|
| 20025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB130|ENSG00000232948.1 |
0.726275839612535 |
|
| 20026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB130|ENSG00000233050.1 |
0.726275839612535 |
|
| 20027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB134 |
0.726275839612535 |
|
| 20028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB135 |
0.726275839612535 |
|
| 20029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEFB136 |
0.726275839612535 |
|
| 20030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM66A |
0.726275839612535 |
|
| 20031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM66D |
0.726275839612535 |
|
| 20032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86B1 |
0.726275839612535 |
|
| 20033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86B2 |
0.726275839612535 |
|
| 20034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FDFT1 |
0.726275839612535 |
|
| 20035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP253 |
0.726275839612535 |
|
| 20036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP254 |
0.726275839612535 |
|
| 20037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP17L2 |
0.726275839612535 |
|
| 20038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF705D |
0.726275839612535 |
|
| 20039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5692A2 |
0.726275839612535 |
|
| 20040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LONRF1 |
0.726275839612535 |
|
| 20041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00681 |
0.726275839612535 |
|
| 20042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1456 |
0.726275839612535 |
|
| 20043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLC1 |
0.726275839612535 |
|
| 20044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP255 |
0.726275839612535 |
|
| 20045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf48 |
0.726275839612535 |
|
| 20046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCZ |
0.726275839612535 |
|
| 20047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR383 |
0.726275839612535 |
|
| 20048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUSC3 |
0.726275839612535 |
|
| 20049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSR1 |
0.726275839612535 |
|
| 20050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIB1 |
0.729149591418157 |
|
| 20051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA81|ENSG00000252677.1 |
0.729149591418157 |
|
| 20052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL233P |
0.729149591418157 |
|
| 20053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000199977.1 |
0.729149591418157 |
|
| 20054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP451 |
0.729149591418157 |
|
| 20055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNXL2 |
0.735859511124121 |
|
| 20056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000206901.1 |
0.737591740503987 |
|
| 20057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KYNU |
0.737591740503987 |
|
| 20058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP15 |
0.737591740503987 |
|
| 20059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQR |
0.738983976049476 |
|
| 20060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF770 |
0.738983976049476 |
|
| 20061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR176 |
0.738983976049476 |
|
| 20062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2AK4 |
0.738983976049476 |
|
| 20063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238564.1 |
0.738983976049476 |
|
| 20064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP14 |
0.738983976049476 |
|
| 20065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMF |
0.738983976049476 |
|
| 20066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSMD1 |
0.739587571993416 |
|
| 20067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP10 |
0.743082834147403 |
|
| 20068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTPCR |
0.743082834147403 |
|
| 20069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLK4 |
0.743082834147403 |
|
| 20070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNK1 |
0.743082834147403 |
|
| 20071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4427 |
0.743082834147403 |
|
| 20072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00635 |
0.744434755880492 |
|
| 20073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00636 |
0.744434755880492 |
|
| 20074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD47 |
0.744434755880492 |
|
| 20075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT57 |
0.744434755880492 |
|
| 20076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHLA2 |
0.744434755880492 |
|
| 20077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH15 |
0.744434755880492 |
|
| 20078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1524 |
0.744434755880492 |
|
| 20079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000202379.1 |
0.744434755880492 |
|
| 20080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DZIP3 |
0.744434755880492 |
|
| 20081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED2 |
0.744434755880492 |
|
| 20082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSL3 |
0.744816832348176 |
|
| 20083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMPD4 |
0.744816832348176 |
|
| 20084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000271814.1 |
0.744816832348176 |
|
| 20085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPS2 |
0.744816832348176 |
|
| 20086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR7 |
0.744816832348176 |
|
| 20087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR8 |
0.744816832348176 |
|
| 20088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMSB4X |
0.744816832348176 |
|
| 20089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM9C |
0.744816832348176 |
|
| 20090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN3L |
0.744816832348176 |
|
| 20091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTH |
0.746256803484528 |
|
| 20092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMTA1 |
0.749292236615001 |
|
| 20093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP3 |
0.749292236615001 |
|
| 20094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PER3 |
0.749292236615001 |
|
| 20095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTS2 |
0.749292236615001 |
|
| 20096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF9 |
0.749292236615001 |
|
| 20097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARK7 |
0.749292236615001 |
|
| 20098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERRFI1 |
0.749292236615001 |
|
| 20099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL729P |
0.749292236615001 |
|
| 20100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC45A1 |
0.749292236615001 |
|
| 20101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RERE |
0.749292236615001 |
|
| 20102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA77|ENSG00000221083.1 |
0.749292236615001 |
|
| 20103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENO1 |
0.749292236615001 |
|
| 20104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA6 |
0.749292236615001 |
|
| 20105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL451P |
0.749292236615001 |
|
| 20106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A7 |
0.749292236615001 |
|
| 20107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A5 |
0.749292236615001 |
|
| 20108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA16|ENSG00000252404.1 |
0.749292236615001 |
|
| 20109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR157 |
0.749292236615001 |
|
| 20110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR34A |
0.749292236615001 |
|
| 20111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H6PD |
0.749292236615001 |
|
| 20112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPSB1 |
0.749292236615001 |
|
| 20113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP40 |
0.749292236615001 |
|
| 20114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A33 |
0.749292236615001 |
|
| 20115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM201 |
0.749292236615001 |
|
| 20116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf200 |
0.749292236615001 |
|
| 20117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3CD |
0.749292236615001 |
|
| 20118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLSTN1 |
0.749292236615001 |
|
| 20119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNNBIP1 |
0.749292236615001 |
|
| 20120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LZIC |
0.749292236615001 |
|
| 20121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMNAT1 |
0.749292236615001 |
|
| 20122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP269 |
0.749292236615001 |
|
| 20123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5697 |
0.749292236615001 |
|
| 20124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP7 |
0.749292236615001 |
|
| 20125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE4B |
0.749292236615001 |
|
| 20126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C7orf13 |
0.750422167824739 |
|
| 20127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF32 |
0.750422167824739 |
|
| 20128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMBR1 |
0.750422167824739 |
|
| 20129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOM1 |
0.750422167824739 |
|
| 20130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNX1 |
0.750422167824739 |
|
| 20131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD17C |
0.751683334743338 |
|
| 20132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1199 |
0.751683334743338 |
|
| 20133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR549 |
0.751683334743338 |
|
| 20134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MESDC2 |
0.751683334743338 |
|
| 20135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4514 |
0.751683334743338 |
|
| 20136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MESDC1 |
0.751683334743338 |
|
| 20137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf26 |
0.751683334743338 |
|
| 20138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL16 |
0.751683334743338 |
|
| 20139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD5 |
0.751683334743338 |
|
| 20140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMC3 |
0.751683334743338 |
|
| 20141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEX3B |
0.751683334743338 |
|
| 20142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFTUD1 |
0.751683334743338 |
|
| 20143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM154B |
0.751683334743338 |
|
| 20144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPG4P8 |
0.751683334743338 |
|
| 20145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L10|ENSG00000205281.6 |
0.751683334743338 |
|
| 20146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L10|ENSG00000254374.2 |
0.751683334743338 |
|
| 20147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L9|ENSG00000196648.6 |
0.751683334743338 |
|
| 20148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L9|ENSG00000197978.8 |
0.751683334743338 |
|
| 20149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL256P |
0.751683334743338 |
|
| 20150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL410P |
0.751683334743338 |
|
| 20151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL61P |
0.751683334743338 |
|
| 20152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS17 |
0.751683334743338 |
|
| 20153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Q2P2 |
0.751683334743338 |
|
| 20154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Q2P3 |
0.751683334743338 |
|
| 20155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPEB1 |
0.751683334743338 |
|
| 20156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS17L |
0.751683334743338 |
|
| 20157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3B2 |
0.751683334743338 |
|
| 20158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA15|ENSG00000252690.2 |
0.751683334743338 |
|
| 20159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSD2 |
0.751683334743338 |
|
| 20160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WHAMM |
0.751683334743338 |
|
| 20161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOMER2 |
0.751683334743338 |
|
| 20162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf40 |
0.751683334743338 |
|
| 20163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM103A1 |
0.751683334743338 |
|
| 20164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD1 |
0.751683334743338 |
|
| 20165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4515 |
0.751683334743338 |
|
| 20166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM6SF1 |
0.751683334743338 |
|
| 20167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDGFRP3 |
0.751683334743338 |
|
| 20168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNC1 |
0.751683334743338 |
|
| 20169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3GL3 |
0.751683334743338 |
|
| 20170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM33 |
0.754663961606666 |
|
| 20171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHH |
0.754663961606666 |
|
| 20172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BUB1B |
0.755452078321079 |
|
| 20173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK6 |
0.755452078321079 |
|
| 20174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf56 |
0.755452078321079 |
|
| 20175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCB2 |
0.755452078321079 |
|
| 20176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD63 |
0.755452078321079 |
|
| 20177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00984 |
0.755452078321079 |
|
| 20178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf52 |
0.755452078321079 |
|
| 20179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP392 |
0.755452078321079 |
|
| 20180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHGR1 |
0.755452078321079 |
|
| 20181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DISP2 |
0.755452078321079 |
|
| 20182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00594 |
0.755452078321079 |
|
| 20183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNSTRN |
0.755452078321079 |
|
| 20184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IVD |
0.755452078321079 |
|
| 20185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAHD1 |
0.755452078321079 |
|
| 20186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST14 |
0.755452078321079 |
|
| 20187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf57 |
0.755452078321079 |
|
| 20188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPUSD2 |
0.755452078321079 |
|
| 20189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC5 |
0.755452078321079 |
|
| 20190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238559.1 |
0.755452078321079 |
|
| 20191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL376P |
0.755452078321079 |
|
| 20192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51 |
0.755452078321079 |
|
| 20193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMDN3 |
0.755452078321079 |
|
| 20194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCHFR |
0.755452078321079 |
|
| 20195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf62 |
0.755452078321079 |
|
| 20196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC17 |
0.755452078321079 |
|
| 20197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFYVE19 |
0.755452078321079 |
|
| 20198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R14D |
0.755452078321079 |
|
| 20199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPINT1 |
0.755452078321079 |
|
| 20200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOV |
0.755452078321079 |
|
| 20201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS18 |
0.755452078321079 |
|
| 20202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLL4 |
0.755452078321079 |
|
| 20203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHAC1 |
0.755452078321079 |
|
| 20204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INO80 |
0.755452078321079 |
|
| 20205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXD1 |
0.755452078321079 |
|
| 20206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL497P |
0.755452078321079 |
|
| 20207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHP1 |
0.755452078321079 |
|
| 20208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OIP5 |
0.755452078321079 |
|
| 20209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUSAP1 |
0.755452078321079 |
|
| 20210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF1 |
0.755452078321079 |
|
| 20211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTF1 |
0.755452078321079 |
|
| 20212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITPKA |
0.755452078321079 |
|
| 20213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTK |
0.755452078321079 |
|
| 20214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPAP1 |
0.755452078321079 |
|
| 20215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYRO3 |
0.755452078321079 |
|
| 20216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGA |
0.755452078321079 |
|
| 20217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR626 |
0.755452078321079 |
|
| 20218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPKBP1 |
0.755452078321079 |
|
| 20219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMJD7 |
0.755452078321079 |
|
| 20220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4B |
0.755452078321079 |
|
| 20221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP393 |
0.755452078321079 |
|
| 20222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPTBN5 |
0.755452078321079 |
|
| 20223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4310 |
0.755452078321079 |
|
| 20224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EHD4 |
0.755452078321079 |
|
| 20225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4E |
0.755452078321079 |
|
| 20226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4D |
0.755452078321079 |
|
| 20227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G4F |
0.755452078321079 |
|
| 20228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS39 |
0.755452078321079 |
|
| 20229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR627 |
0.755452078321079 |
|
| 20230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM87A |
0.755452078321079 |
|
| 20231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GANC |
0.755452078321079 |
|
| 20232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN3 |
0.755452078321079 |
|
| 20233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF106 |
0.755452078321079 |
|
| 20234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAP23 |
0.755452078321079 |
|
| 20235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC57 |
0.755452078321079 |
|
| 20236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAUS2 |
0.755452078321079 |
|
| 20237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD9 |
0.755452078321079 |
|
| 20238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239025.1 |
0.755452078321079 |
|
| 20239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDAN1 |
0.755452078321079 |
|
| 20240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTBK2 |
0.755452078321079 |
|
| 20241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR1 |
0.755452078321079 |
|
| 20242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB42 |
0.755452078321079 |
|
| 20243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM62 |
0.755452078321079 |
|
| 20244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNDBP1 |
0.755452078321079 |
|
| 20245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM5 |
0.755452078321079 |
|
| 20246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGM7 |
0.755452078321079 |
|
| 20247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCMT2 |
0.755452078321079 |
|
| 20248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAL |
0.755452078321079 |
|
| 20249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN29 |
0.755452078321079 |
|
| 20250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBGCP4 |
0.755452078321079 |
|
| 20251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL487P |
0.755452078321079 |
|
| 20252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53BP1 |
0.755452078321079 |
|
| 20253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1A |
0.755452078321079 |
|
| 20254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIP5K1 |
0.755452078321079 |
|
| 20255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPER2P1 |
0.755452078321079 |
|
| 20256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CATSPER2 |
0.755452078321079 |
|
| 20257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKMT1A |
0.755452078321079 |
|
| 20258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKMT1B |
0.755452078321079 |
|
| 20259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRC |
0.755452078321079 |
|
| 20260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238494.1 |
0.755452078321079 |
|
| 20261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238535.1 |
0.755452078321079 |
|
| 20262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIA3 |
0.755452078321079 |
|
| 20263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELL3 |
0.755452078321079 |
|
| 20264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERF2 |
0.755452078321079 |
|
| 20265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYPK |
0.755452078321079 |
|
| 20266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1282 |
0.755452078321079 |
|
| 20267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERINC4 |
0.755452078321079 |
|
| 20268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP1 |
0.755452078321079 |
|
| 20269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR76 |
0.755452078321079 |
|
| 20270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD5 |
0.755452078321079 |
|
| 20271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASC4 |
0.755452078321079 |
|
| 20272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDSPL2 |
0.755452078321079 |
|
| 20273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL347P |
0.755452078321079 |
|
| 20274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF3J |
0.755452078321079 |
|
| 20275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPG11 |
0.755452078321079 |
|
| 20276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATL2 |
0.755452078321079 |
|
| 20277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B2M |
0.755452078321079 |
|
| 20278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM69 |
0.755452078321079 |
|
| 20279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf43 |
0.755452078321079 |
|
| 20280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SORD |
0.755452078321079 |
|
| 20281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUOX2 |
0.755452078321079 |
|
| 20282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUOXA2 |
0.755452078321079 |
|
| 20283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUOXA1 |
0.755452078321079 |
|
| 20284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUOX1 |
0.755452078321079 |
|
| 20285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHF |
0.755452078321079 |
|
| 20286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000261709.2 |
0.755452078321079 |
|
| 20287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC28A2 |
0.755452078321079 |
|
| 20288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATM |
0.755452078321079 |
|
| 20289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA5L1 |
0.755452078321079 |
|
| 20290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf48 |
0.755452078321079 |
|
| 20291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR147B |
0.755452078321079 |
|
| 20292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A4 |
0.755452078321079 |
|
| 20293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238583.1 |
0.755452078321079 |
|
| 20294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN2P46 |
0.755452078321079 |
|
| 20295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA41|ENSG00000207516.1 |
0.755452078321079 |
|
| 20296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S6 |
0.755452078321079 |
|
| 20297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SQRDL |
0.755452078321079 |
|
| 20298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD11|ENSG00000238819.1 |
0.755452078321079 |
|
| 20299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP101 |
0.755452078321079 |
|
| 20300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG62 |
0.755452078321079 |
|
| 20301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA6D |
0.755452078321079 |
|
| 20302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP139 |
0.755452078321079 |
|
| 20303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A5 |
0.755452078321079 |
|
| 20304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYEF2 |
0.755452078321079 |
|
| 20305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTXN2 |
0.755452078321079 |
|
| 20306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A1 |
0.755452078321079 |
|
| 20307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUT |
0.755452078321079 |
|
| 20308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBN1 |
0.755452078321079 |
|
| 20309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP152 |
0.755452078321079 |
|
| 20310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHC4 |
0.755452078321079 |
|
| 20311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EID1 |
0.755452078321079 |
|
| 20312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SECISBP2L |
0.755452078321079 |
|
| 20313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL577P |
0.755452078321079 |
|
| 20314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS2 |
0.755452078321079 |
|
| 20315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALK2 |
0.755452078321079 |
|
| 20316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4716 |
0.755452078321079 |
|
| 20317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL307P |
0.755452078321079 |
|
| 20318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM227B |
0.755452078321079 |
|
| 20319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF7 |
0.755452078321079 |
|
| 20320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTWD1 |
0.755452078321079 |
|
| 20321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP8B4 |
0.755452078321079 |
|
| 20322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP394 |
0.755452078321079 |
|
| 20323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC27A2 |
0.755452078321079 |
|
| 20324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDC |
0.755452078321079 |
|
| 20325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL494P |
0.755452078321079 |
|
| 20326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABPB1 |
0.755452078321079 |
|
| 20327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000271819.1 |
0.755452078321079 |
|
| 20328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4712 |
0.755452078321079 |
|
| 20329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP8 |
0.755452078321079 |
|
| 20330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP395 |
0.755452078321079 |
|
| 20331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP50 |
0.755452078321079 |
|
| 20332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM7 |
0.755452078321079 |
|
| 20333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL354P |
0.755452078321079 |
|
| 20334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPPL2A |
0.755452078321079 |
|
| 20335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP4E1 |
0.755452078321079 |
|
| 20336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP8L3 |
0.755452078321079 |
|
| 20337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP19A1 |
0.755452078321079 |
|
| 20338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4713 |
0.755452078321079 |
|
| 20339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLDN |
0.755452078321079 |
|
| 20340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMXL2 |
0.755452078321079 |
|
| 20341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCG3 |
0.755452078321079 |
|
| 20342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYSMD2 |
0.755452078321079 |
|
| 20343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMOD2 |
0.755452078321079 |
|
| 20344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMOD3 |
0.755452078321079 |
|
| 20345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U6|ENSG00000272337.1 |
0.755452078321079 |
|
| 20346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEO1 |
0.755452078321079 |
|
| 20347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK6 |
0.755452078321079 |
|
| 20348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L10 |
0.755452078321079 |
|
| 20349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB5 |
0.755452078321079 |
|
| 20350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO5C |
0.755452078321079 |
|
| 20351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1266 |
0.755452078321079 |
|
| 20352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO5A |
0.755452078321079 |
|
| 20353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPP19 |
0.755452078321079 |
|
| 20354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM214A |
0.755452078321079 |
|
| 20355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ONECUT1 |
0.755452078321079 |
|
| 20356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRTG |
0.755452078321079 |
|
| 20357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEDD4 |
0.755452078321079 |
|
| 20358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238513.1 |
0.755452078321079 |
|
| 20359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL568P |
0.755452078321079 |
|
| 20360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX7 |
0.755452078321079 |
|
| 20361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX9 |
0.755452078321079 |
|
| 20362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MNS1 |
0.755452078321079 |
|
| 20363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF280D |
0.755452078321079 |
|
| 20364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF12 |
0.755452078321079 |
|
| 20365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239035.1 |
0.755452078321079 |
|
| 20366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00926 |
0.755452078321079 |
|
| 20367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGNL1 |
0.755452078321079 |
|
| 20368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCOM1 |
0.755452078321079 |
|
| 20369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYZAP |
0.755452078321079 |
|
| 20370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2M |
0.755452078321079 |
|
| 20371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1A2 |
0.755452078321079 |
|
| 20372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQP9 |
0.755452078321079 |
|
| 20373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPC |
0.755452078321079 |
|
| 20374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM10 |
0.755452078321079 |
|
| 20375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239100.1 |
0.755452078321079 |
|
| 20376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP95 |
0.755452078321079 |
|
| 20377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000200318.1 |
0.755452078321079 |
|
| 20378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM63B |
0.755452078321079 |
|
| 20379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF111 |
0.755452078321079 |
|
| 20380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLTM |
0.755452078321079 |
|
| 20381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNB2 |
0.755452078321079 |
|
| 20382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1E |
0.755452078321079 |
|
| 20383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15ORF31 |
0.755452078321079 |
|
| 20384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2116 |
0.755452078321079 |
|
| 20385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHAL6B |
0.755452078321079 |
|
| 20386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM81A |
0.755452078321079 |
|
| 20387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238767.1 |
0.755452078321079 |
|
| 20388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP396 |
0.755452078321079 |
|
| 20389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT3 |
0.755452078321079 |
|
| 20390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2A2 |
0.755452078321079 |
|
| 20391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BNIP2 |
0.755452078321079 |
|
| 20392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXB1 |
0.755452078321079 |
|
| 20393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANXA2 |
0.755452078321079 |
|
| 20394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NARG2 |
0.755452078321079 |
|
| 20395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RORA |
0.755452078321079 |
|
| 20396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP397 |
0.755452078321079 |
|
| 20397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS13C |
0.755452078321079 |
|
| 20398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL613P |
0.755452078321079 |
|
| 20399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD4A |
0.755452078321079 |
|
| 20400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2CD4B |
0.755452078321079 |
|
| 20401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLN2 |
0.755452078321079 |
|
| 20402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR190A |
0.755452078321079 |
|
| 20403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPM1 |
0.755452078321079 |
|
| 20404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LACTB |
0.755452078321079 |
|
| 20405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS27L |
0.755452078321079 |
|
| 20406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB8B |
0.755452078321079 |
|
| 20407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APH1B |
0.755452078321079 |
|
| 20408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA12 |
0.755452078321079 |
|
| 20409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP3 |
0.755452078321079 |
|
| 20410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL22 |
0.755452078321079 |
|
| 20411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC1 |
0.755452078321079 |
|
| 20412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR422A |
0.755452078321079 |
|
| 20413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAPK2 |
0.755452078321079 |
|
| 20414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM96A |
0.755452078321079 |
|
| 20415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX1 |
0.755452078321079 |
|
| 20416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX22 |
0.755452078321079 |
|
| 20417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIB |
0.755452078321079 |
|
| 20418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSNK1G1 |
0.755452078321079 |
|
| 20419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000252774.1 |
0.755452078321079 |
|
| 20420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0101 |
0.755452078321079 |
|
| 20421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP4 |
0.755452078321079 |
|
| 20422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL595P |
0.755452078321079 |
|
| 20423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL707P |
0.755452078321079 |
|
| 20424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF609 |
0.755452078321079 |
|
| 20425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OAZ2 |
0.755452078321079 |
|
| 20426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBPMS2 |
0.755452078321079 |
|
| 20427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1272 |
0.755452078321079 |
|
| 20428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIF1 |
0.755452078321079 |
|
| 20429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHO2 |
0.755452078321079 |
|
| 20430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL348P |
0.755452078321079 |
|
| 20431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKDD1A |
0.755452078321079 |
|
| 20432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPG21 |
0.755452078321079 |
|
| 20433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTFMT |
0.755452078321079 |
|
| 20434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC51B |
0.755452078321079 |
|
| 20435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASL12 |
0.755452078321079 |
|
| 20436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KBTBD13 |
0.755452078321079 |
|
| 20437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBAP1L |
0.755452078321079 |
|
| 20438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD7 |
0.755452078321079 |
|
| 20439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPX |
0.755452078321079 |
|
| 20440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CILP |
0.755452078321079 |
|
| 20441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP16 |
0.755452078321079 |
|
| 20442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA24|ENSG00000206903.1 |
0.755452078321079 |
|
| 20443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGDCC3 |
0.755452078321079 |
|
| 20444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGDCC4 |
0.755452078321079 |
|
| 20445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP8 |
0.755452078321079 |
|
| 20446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPLAD1 |
0.755452078321079 |
|
| 20447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238715.1 |
0.755452078321079 |
|
| 20448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWA9 |
0.755452078321079 |
|
| 20449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC24A1 |
0.755452078321079 |
|
| 20450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENND4A |
0.755452078321079 |
|
| 20451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238311.1 |
0.755452078321079 |
|
| 20452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4511 |
0.755452078321079 |
|
| 20453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11A |
0.755452078321079 |
|
| 20454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEGF11 |
0.755452078321079 |
|
| 20455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4311 |
0.755452078321079 |
|
| 20456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIS3L |
0.755452078321079 |
|
| 20457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIPIN |
0.755452078321079 |
|
| 20458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA14 |
0.755452078321079 |
|
| 20459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K1 |
0.755452078321079 |
|
| 20460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAPC5 |
0.755452078321079 |
|
| 20461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4512 |
0.755452078321079 |
|
| 20462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL4 |
0.755452078321079 |
|
| 20463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD18C |
0.755452078321079 |
|
| 20464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD16 |
0.755452078321079 |
|
| 20465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD18A |
0.755452078321079 |
|
| 20466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD18B |
0.755452078321079 |
|
| 20467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZWILCH |
0.755452078321079 |
|
| 20468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCTL |
0.755452078321079 |
|
| 20469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD6 |
0.755452078321079 |
|
| 20470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMAD3 |
0.755452078321079 |
|
| 20471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAGAB |
0.755452078321079 |
|
| 20472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQCH |
0.755452078321079 |
|
| 20473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf61 |
0.755452078321079 |
|
| 20474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K5 |
0.755452078321079 |
|
| 20475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKOR1 |
0.755452078321079 |
|
| 20476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIAS1 |
0.755452078321079 |
|
| 20477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALML4 |
0.755452078321079 |
|
| 20478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLN6 |
0.755452078321079 |
|
| 20479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEM1B |
0.755452078321079 |
|
| 20480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA11 |
0.755452078321079 |
|
| 20481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO2B |
0.755452078321079 |
|
| 20482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32A |
0.755452078321079 |
|
| 20483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4312 |
0.755452078321079 |
|
| 20484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPESP1 |
0.755452078321079 |
|
| 20485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOX5 |
0.755452078321079 |
|
| 20486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00277 |
0.755452078321079 |
|
| 20487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLCE |
0.755452078321079 |
|
| 20488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL438P |
0.755452078321079 |
|
| 20489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR5 |
0.755452078321079 |
|
| 20490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA77|ENSG00000221376.1 |
0.755452078321079 |
|
| 20491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP398 |
0.755452078321079 |
|
| 20492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF23 |
0.755452078321079 |
|
| 20493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPLP1 |
0.755452078321079 |
|
| 20494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000207119.1 |
0.755452078321079 |
|
| 20495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00593 |
0.755452078321079 |
|
| 20496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLE3 |
0.755452078321079 |
|
| 20497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR629 |
0.755452078321079 |
|
| 20498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UACA |
0.755452078321079 |
|
| 20499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL29P30 |
0.755452078321079 |
|
| 20500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP6 |
0.755452078321079 |
|
| 20501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC49 |
0.755452078321079 |
|
| 20502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP10 |
0.755452078321079 |
|
| 20503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THSD4 |
0.755452078321079 |
|
| 20504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT62 |
0.755452078321079 |
|
| 20505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2E3 |
0.755452078321079 |
|
| 20506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO9A |
0.755452078321079 |
|
| 20507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP399 |
0.755452078321079 |
|
| 20508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP8 |
0.755452078321079 |
|
| 20509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRAMD2 |
0.755452078321079 |
|
| 20510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKM |
0.755452078321079 |
|
| 20511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP6 |
0.755452078321079 |
|
| 20512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CELF6 |
0.755452078321079 |
|
| 20513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEXA |
0.755452078321079 |
|
| 20514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM202 |
0.755452078321079 |
|
| 20515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARIH1 |
0.755452078321079 |
|
| 20516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR630 |
0.755452078321079 |
|
| 20517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6B |
0.755452078321079 |
|
| 20518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL485P |
0.755452078321079 |
|
| 20519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL853P |
0.755452078321079 |
|
| 20520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIGD2B |
0.755452078321079 |
|
| 20521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS4 |
0.755452078321079 |
|
| 20522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADPGK |
0.755452078321079 |
|
| 20523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEO1 |
0.755452078321079 |
|
| 20524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCN4 |
0.755452078321079 |
|
| 20525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf60 |
0.755452078321079 |
|
| 20526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPTN |
0.755452078321079 |
|
| 20527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD276 |
0.755452078321079 |
|
| 20528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf59 |
0.755452078321079 |
|
| 20529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD27 |
0.755752128723876 |
|
| 20530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAPBPL |
0.755752128723876 |
|
| 20531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAMP1 |
0.755752128723876 |
|
| 20532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL51 |
0.755752128723876 |
|
| 20533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCAPD2 |
0.755752128723876 |
|
| 20534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA10 |
0.755752128723876 |
|
| 20535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAPDH |
0.755752128723876 |
|
| 20536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFFO1 |
0.755752128723876 |
|
| 20537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP2 |
0.755752128723876 |
|
| 20538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD4 |
0.755752128723876 |
|
| 20539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA11|ENSG00000251898.1 |
0.755752128723876 |
|
| 20540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR5 |
0.755752128723876 |
|
| 20541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACRBP |
0.755752128723876 |
|
| 20542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ING4 |
0.755752128723876 |
|
| 20543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF384 |
0.755752128723876 |
|
| 20544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIANP |
0.755752128723876 |
|
| 20545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS7A |
0.755752128723876 |
|
| 20546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLF2 |
0.755752128723876 |
|
| 20547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTMS |
0.755752128723876 |
|
| 20548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAG3 |
0.755752128723876 |
|
| 20549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL380P |
0.755752128723876 |
|
| 20550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD4 |
0.755752128723876 |
|
| 20551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR162 |
0.755752128723876 |
|
| 20552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEPREL2 |
0.755752128723876 |
|
| 20553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNB3 |
0.755752128723876 |
|
| 20554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA3 |
0.755752128723876 |
|
| 20555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP5 |
0.755752128723876 |
|
| 20556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPSB2 |
0.755752128723876 |
|
| 20557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPI1 |
0.755752128723876 |
|
| 20558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC23 |
0.755752128723876 |
|
| 20559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL13P5 |
0.755752128723876 |
|
| 20560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM49A |
0.755825399101231 |
|
| 20561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP168 |
0.755825399101231 |
|
| 20562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51AP2 |
0.755825399101231 |
|
| 20563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSNL1 |
0.755825399101231 |
|
| 20564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC6 |
0.755825399101231 |
|
| 20565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEN1 |
0.755825399101231 |
|
| 20566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSGN1 |
0.755825399101231 |
|
| 20567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNS3 |
0.755825399101231 |
|
| 20568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212455.1 |
0.755825399101231 |
|
| 20569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERC1 |
0.759300714820473 |
|
| 20570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADIPOR2 |
0.759300714820473 |
|
| 20571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA2D4 |
0.759300714820473 |
|
| 20572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRTM2 |
0.759300714820473 |
|
| 20573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00940 |
0.759300714820473 |
|
| 20574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCP1B |
0.759300714820473 |
|
| 20575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1C |
0.759300714820473 |
|
| 20576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX3P4 |
0.759300714820473 |
|
| 20577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP4 |
0.759300714820473 |
|
| 20578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITFG2 |
0.759300714820473 |
|
| 20579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRIP2 |
0.759300714820473 |
|
| 20580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXM1 |
0.759300714820473 |
|
| 20581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHNO1 |
0.759300714820473 |
|
| 20582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TULP3 |
0.759300714820473 |
|
| 20583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEAD4 |
0.759300714820473 |
|
| 20584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRMT8 |
0.759300714820473 |
|
| 20585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFCAB4B |
0.759300714820473 |
|
| 20586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARP11 |
0.759300714820473 |
|
| 20587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCND2 |
0.759300714820473 |
|
| 20588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf5 |
0.759300714820473 |
|
| 20589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF23 |
0.759300714820473 |
|
| 20590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF6 |
0.759300714820473 |
|
| 20591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf4 |
0.759300714820473 |
|
| 20592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD51AP1 |
0.759300714820473 |
|
| 20593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYRK4 |
0.759300714820473 |
|
| 20594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA9 |
0.759300714820473 |
|
| 20595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP3 |
0.759300714820473 |
|
| 20596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT8 |
0.759300714820473 |
|
| 20597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA6 |
0.759300714820473 |
|
| 20598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA1 |
0.759300714820473 |
|
| 20599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNA5 |
0.759300714820473 |
|
| 20600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTF3 |
0.759300714820473 |
|
| 20601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANO2 |
0.759300714820473 |
|
| 20602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWF |
0.759300714820473 |
|
| 20603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL69P |
0.759300714820473 |
|
| 20604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD9 |
0.759300714820473 |
|
| 20605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG6 |
0.759300714820473 |
|
| 20606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF1A |
0.759300714820473 |
|
| 20607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL391P |
0.759300714820473 |
|
| 20608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCNN1A |
0.759300714820473 |
|
| 20609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTBR |
0.759300714820473 |
|
| 20610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSTNP2 |
0.759300714820473 |
|
| 20611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENO2 |
0.759300714820473 |
|
| 20612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATN1 |
0.759300714820473 |
|
| 20613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf57 |
0.759300714820473 |
|
| 20614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN6 |
0.759300714820473 |
|
| 20615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR141 |
0.759300714820473 |
|
| 20616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR200C |
0.759300714820473 |
|
| 20617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHB2 |
0.759300714820473 |
|
| 20618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA12 |
0.759300714820473 |
|
| 20619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMG1 |
0.759300714820473 |
|
| 20620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPCAT3 |
0.759300714820473 |
|
| 20621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1S |
0.759300714820473 |
|
| 20622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1R |
0.759300714820473 |
|
| 20623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1RL |
0.759300714820473 |
|
| 20624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP5 |
0.759300714820473 |
|
| 20625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLSTN3 |
0.759300714820473 |
|
| 20626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEX5 |
0.759300714820473 |
|
| 20627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSM4 |
0.759300714820473 |
|
| 20628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD163L1 |
0.759300714820473 |
|
| 20629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD163 |
0.759300714820473 |
|
| 20630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOBEC1 |
0.759300714820473 |
|
| 20631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDF3 |
0.759300714820473 |
|
| 20632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPPA3 |
0.759300714820473 |
|
| 20633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4C |
0.759300714820473 |
|
| 20634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOGNB |
0.759300714820473 |
|
| 20635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOG |
0.759300714820473 |
|
| 20636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NANOGP1 |
0.759300714820473 |
|
| 20637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A14 |
0.759300714820473 |
|
| 20638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC2A3 |
0.759300714820473 |
|
| 20639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXJ2 |
0.759300714820473 |
|
| 20640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3AR1 |
0.759300714820473 |
|
| 20641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NECAP1 |
0.759300714820473 |
|
| 20642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4A |
0.759300714820473 |
|
| 20643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF705A |
0.759300714820473 |
|
| 20644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM66C |
0.759300714820473 |
|
| 20645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86FP |
0.759300714820473 |
|
| 20646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM90A1 |
0.759300714820473 |
|
| 20647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00937 |
0.759300714820473 |
|
| 20648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC6A |
0.759300714820473 |
|
| 20649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4D |
0.759300714820473 |
|
| 20650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC4E |
0.759300714820473 |
|
| 20651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLBD1 |
0.762903326323955 |
|
| 20652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP134 |
0.762903326323955 |
|
| 20653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY2C |
0.762903326323955 |
|
| 20654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2AFJ |
0.762903326323955 |
|
| 20655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST4H4 |
0.762903326323955 |
|
| 20656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP11 |
0.762903326323955 |
|
| 20657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf60 |
0.762903326323955 |
|
| 20658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCO3 |
0.762903326323955 |
|
| 20659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ART4 |
0.762903326323955 |
|
| 20660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGP |
0.762903326323955 |
|
| 20661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERP27 |
0.762903326323955 |
|
| 20662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGDIB |
0.762903326323955 |
|
| 20663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6H |
0.762903326323955 |
|
| 20664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RERG |
0.762903326323955 |
|
| 20665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRO |
0.762903326323955 |
|
| 20666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC15A5 |
0.762903326323955 |
|
| 20667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGST1 |
0.762903326323955 |
|
| 20668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMO3 |
0.762903326323955 |
|
| 20669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP16 |
0.764379270881824 |
|
| 20670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT8 |
0.764379270881824 |
|
| 20671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPHP4 |
0.768566538461914 |
|
| 20672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNAB2 |
0.768566538461914 |
|
| 20673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD5 |
0.768566538461914 |
|
| 20674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL22 |
0.768566538461914 |
|
| 20675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF207 |
0.768566538461914 |
|
| 20676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICMT |
0.768566538461914 |
|
| 20677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00337 |
0.768566538461914 |
|
| 20678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR153 |
0.768566538461914 |
|
| 20679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES3 |
0.768566538461914 |
|
| 20680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT7 |
0.768566538461914 |
|
| 20681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HES2 |
0.768566538461914 |
|
| 20682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESPN |
0.768566538461914 |
|
| 20683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4252 |
0.768566538461914 |
|
| 20684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG5 |
0.768566538461914 |
|
| 20685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF25 |
0.768566538461914 |
|
| 20686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL9 |
0.768566538461914 |
|
| 20687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS1R1 |
0.768566538461914 |
|
| 20688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB48 |
0.768566538461914 |
|
| 20689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL21 |
0.768566538461914 |
|
| 20690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF13 |
0.768566538461914 |
|
| 20691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP3 |
0.768566538461914 |
|
| 20692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC11 |
0.768566538461914 |
|
| 20693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239166.1 |
0.768566538461914 |
|
| 20694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HUWE1 |
0.769564072942742 |
|
| 20695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHF8 |
0.769564072942742 |
|
| 20696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP505 |
0.769564072942742 |
|
| 20697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252175.1 |
0.769564072942742 |
|
| 20698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM120C |
0.769564072942742 |
|
| 20699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNK3 |
0.769564072942742 |
|
| 20700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD1 |
0.769564072942742 |
|
| 20701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSR2 |
0.769564072942742 |
|
| 20702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNL3L |
0.769564072942742 |
|
| 20703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL366P |
0.769811954958352 |
|
| 20704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf118 |
0.772432913452893 |
|
| 20705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN4 |
0.772539095427511 |
|
| 20706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MID1 |
0.772539095427511 |
|
| 20707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WWC3 |
0.772539095427511 |
|
| 20708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC10 |
0.774591493807829 |
|
| 20709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTOR |
0.774591493807829 |
|
| 20710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS20 |
0.778391821631824 |
|
| 20711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUS7L |
0.778391821631824 |
|
| 20712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRAK4 |
0.778391821631824 |
|
| 20713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TWF1 |
0.778391821631824 |
|
| 20714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM117 |
0.778391821631824 |
|
| 20715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A2 |
0.778391821631824 |
|
| 20716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A4 |
0.778391821631824 |
|
| 20717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMIGO2 |
0.778391821631824 |
|
| 20718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCED1B |
0.778391821631824 |
|
| 20719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4698 |
0.778391821631824 |
|
| 20720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000199566.1 |
0.778391821631824 |
|
| 20721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4494 |
0.778391821631824 |
|
| 20722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPAP3 |
0.778391821631824 |
|
| 20723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENDOU |
0.778391821631824 |
|
| 20724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF3 |
0.778391821631824 |
|
| 20725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC48A1 |
0.778391821631824 |
|
| 20726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC7 |
0.778391821631824 |
|
| 20727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VDR |
0.778391821631824 |
|
| 20728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM106C |
0.778391821631824 |
|
| 20729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL2A1 |
0.778391821631824 |
|
| 20730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP1 |
0.778391821631824 |
|
| 20731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKM |
0.778391821631824 |
|
| 20732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB8 |
0.778391821631824 |
|
| 20733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf68 |
0.778391821631824 |
|
| 20734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP779L1853 |
0.778391821631824 |
|
| 20735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10AD1 |
0.778391821631824 |
|
| 20736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H1FNT |
0.778391821631824 |
|
| 20737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF641 |
0.778391821631824 |
|
| 20738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32D |
0.778391821631824 |
|
| 20739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf54 |
0.778391821631824 |
|
| 20740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8S1 |
0.778391821631824 |
|
| 20741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LALBA |
0.778391821631824 |
|
| 20742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP10 |
0.77901266418713 |
|
| 20743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HHIPL2 |
0.77901266418713 |
|
| 20744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1A |
0.77901266418713 |
|
| 20745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIA3 |
0.77901266418713 |
|
| 20746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIDA |
0.77901266418713 |
|
| 20747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BROX |
0.77901266418713 |
|
| 20748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL276P |
0.77901266418713 |
|
| 20749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM177B |
0.77901266418713 |
|
| 20750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DISP1 |
0.77901266418713 |
|
| 20751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239054.1 |
0.77901266418713 |
|
| 20752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLR5 |
0.77901266418713 |
|
| 20753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUSD4 |
0.77901266418713 |
|
| 20754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1orf65 |
0.77901266418713 |
|
| 20755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN8 |
0.77901266418713 |
|
| 20756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN2 |
0.77901266418713 |
|
| 20757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53BP2 |
0.77901266418713 |
|
| 20758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP49 |
0.77901266418713 |
|
| 20759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO28 |
0.77901266418713 |
|
| 20760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEGS1 |
0.77901266418713 |
|
| 20761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000201898.1 |
0.77901266418713 |
|
| 20762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NVL |
0.77901266418713 |
|
| 20763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR320B2 |
0.77901266418713 |
|
| 20764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238856.1 |
0.77901266418713 |
|
| 20765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNIH4 |
0.77901266418713 |
|
| 20766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR26 |
0.77901266418713 |
|
| 20767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4742 |
0.77901266418713 |
|
| 20768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNIH3 |
0.77901266418713 |
|
| 20769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH14 |
0.77901266418713 |
|
| 20770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LBR |
0.77901266418713 |
|
| 20771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENAH |
0.77901266418713 |
|
| 20772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP9 |
0.77901266418713 |
|
| 20773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHX1 |
0.77901266418713 |
|
| 20774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM63A |
0.77901266418713 |
|
| 20775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEFTY1 |
0.77901266418713 |
|
| 20776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYCR2 |
0.77901266418713 |
|
| 20777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEFTY2 |
0.77901266418713 |
|
| 20778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDE2 |
0.77901266418713 |
|
| 20779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H3F3A |
0.77901266418713 |
|
| 20780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OBSCN |
0.77901266418713 |
|
| 20781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTNL10 |
0.77901266418713 |
|
| 20782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST3H2A |
0.77901266418713 |
|
| 20783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST3H2BB |
0.77901266418713 |
|
| 20784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIST3H3 |
0.77901266418713 |
|
| 20785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4666A |
0.77901266418713 |
|
| 20786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S10 |
0.77901266418713 |
|
| 20787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S11 |
0.77901266418713 |
|
| 20788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S12 |
0.77901266418713 |
|
| 20789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S13 |
0.77901266418713 |
|
| 20790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S14 |
0.77901266418713 |
|
| 20791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S15 |
0.77901266418713 |
|
| 20792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S16 |
0.77901266418713 |
|
| 20793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S17 |
0.77901266418713 |
|
| 20794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S1 |
0.77901266418713 |
|
| 20795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S2 |
0.77901266418713 |
|
| 20796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S3 |
0.77901266418713 |
|
| 20797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S4 |
0.77901266418713 |
|
| 20798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S5 |
0.77901266418713 |
|
| 20799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S6 |
0.77901266418713 |
|
| 20800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S7 |
0.77901266418713 |
|
| 20801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S8 |
0.77901266418713 |
|
| 20802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5S9 |
0.77901266418713 |
|
| 20803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP18 |
0.77901266418713 |
|
| 20804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP19 |
0.77901266418713 |
|
| 20805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF187 |
0.77901266418713 |
|
| 20806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000206878.1 |
0.77901266418713 |
|
| 20807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM11 |
0.77901266418713 |
|
| 20808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM17 |
0.77901266418713 |
|
| 20809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC6P |
0.781264577367354 |
|
| 20810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR1F |
0.781264577367354 |
|
| 20811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CGGBP1 |
0.781264577367354 |
|
| 20812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF654 |
0.781264577367354 |
|
| 20813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf38 |
0.781264577367354 |
|
| 20814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA3 |
0.781264577367354 |
|
| 20815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212598.1 |
0.781264577367354 |
|
| 20816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABI3BP |
0.781264577367354 |
|
| 20817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238312.1 |
0.781264577367354 |
|
| 20818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMPG2 |
0.781264577367354 |
|
| 20819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SENP7 |
0.781264577367354 |
|
| 20820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238525.1 |
0.781264577367354 |
|
| 20821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT10C |
0.781264577367354 |
|
| 20822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCNP |
0.781264577367354 |
|
| 20823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB11 |
0.781264577367354 |
|
| 20824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL24 |
0.781264577367354 |
|
| 20825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP97 |
0.781264577367354 |
|
| 20826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPE3 |
0.781264577367354 |
|
| 20827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFKBIZ |
0.781264577367354 |
|
| 20828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZPLD1 |
0.781264577367354 |
|
| 20829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AB |
0.781264577367354 |
|
| 20830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALCAM |
0.781264577367354 |
|
| 20831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLB |
0.781264577367354 |
|
| 20832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00882 |
0.781264577367354 |
|
| 20833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00883 |
0.781264577367354 |
|
| 20834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC54 |
0.781264577367354 |
|
| 20835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBX |
0.781264577367354 |
|
| 20836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RETNLB |
0.781264577367354 |
|
| 20837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAT1 |
0.781264577367354 |
|
| 20838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPPA2 |
0.781264577367354 |
|
| 20839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCA1C |
0.781264577367354 |
|
| 20840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00488 |
0.781264577367354 |
|
| 20841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORC1 |
0.781264577367354 |
|
| 20842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000221633.1 |
0.781264577367354 |
|
| 20843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPPA4 |
0.781264577367354 |
|
| 20844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4445 |
0.781264577367354 |
|
| 20845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC15P |
0.781264577367354 |
|
| 20846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD96 |
0.781264577367354 |
|
| 20847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCXD2 |
0.781264577367354 |
|
| 20848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLDB2 |
0.781264577367354 |
|
| 20849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABHD10 |
0.781264577367354 |
|
| 20850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAGLN3 |
0.781264577367354 |
|
| 20851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPRSS7 |
0.781264577367354 |
|
| 20852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf52 |
0.781264577367354 |
|
| 20853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR567 |
0.781264577367354 |
|
| 20854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCSAM |
0.781264577367354 |
|
| 20855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9C1 |
0.781264577367354 |
|
| 20856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD200 |
0.781264577367354 |
|
| 20857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTLA |
0.781264577367354 |
|
| 20858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG3 |
0.781264577367354 |
|
| 20859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35A5 |
0.781264577367354 |
|
| 20860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC80 |
0.781264577367354 |
|
| 20861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD200R1L |
0.781264577367354 |
|
| 20862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD200R1 |
0.781264577367354 |
|
| 20863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP8 |
0.781264577367354 |
|
| 20864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf17 |
0.781264577367354 |
|
| 20865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000253076.1 |
0.781264577367354 |
|
| 20866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BOC |
0.781264577367354 |
|
| 20867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR52 |
0.781264577367354 |
|
| 20868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPICE1 |
0.781264577367354 |
|
| 20869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIDT1 |
0.781264577367354 |
|
| 20870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4446 |
0.781264577367354 |
|
| 20871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL767P |
0.781264577367354 |
|
| 20872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000253004.1 |
0.781264577367354 |
|
| 20873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R3A |
0.781264577367354 |
|
| 20874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSL2 |
0.781264577367354 |
|
| 20875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCCB |
0.781264577367354 |
|
| 20876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG1 |
0.781264577367354 |
|
| 20877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P4 |
0.781264577367354 |
|
| 20878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35G2 |
0.781264577367354 |
|
| 20879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCK1 |
0.781264577367354 |
|
| 20880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL20RB |
0.781264577367354 |
|
| 20881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP142 |
0.781264577367354 |
|
| 20882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX14 |
0.781264577367354 |
|
| 20883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN18 |
0.781264577367354 |
|
| 20884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A4GNT |
0.781264577367354 |
|
| 20885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DZIP1L |
0.781264577367354 |
|
| 20886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBR1 |
0.781264577367354 |
|
| 20887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC8 |
0.781264577367354 |
|
| 20888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME9 |
0.781264577367354 |
|
| 20889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRAS |
0.781264577367354 |
|
| 20890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESYT3 |
0.781264577367354 |
|
| 20891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP70 |
0.781264577367354 |
|
| 20892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAIM |
0.781264577367354 |
|
| 20893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3CB |
0.781264577367354 |
|
| 20894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf72 |
0.781264577367354 |
|
| 20895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXL2 |
0.781264577367354 |
|
| 20896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS22 |
0.781264577367354 |
|
| 20897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR23A |
0.781264577367354 |
|
| 20898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR23B |
0.781264577367354 |
|
| 20899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR23C |
0.781264577367354 |
|
| 20900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPESC1 |
0.781264577367354 |
|
| 20901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPB2 |
0.781264577367354 |
|
| 20902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP2 |
0.781264577367354 |
|
| 20903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBP1 |
0.781264577367354 |
|
| 20904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMNAT3 |
0.781264577367354 |
|
| 20905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP124 |
0.781264577367354 |
|
| 20906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL724P |
0.781264577367354 |
|
| 20907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLSTN2 |
0.781264577367354 |
|
| 20908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM42 |
0.781264577367354 |
|
| 20909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A36 |
0.781264577367354 |
|
| 20910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPSB4 |
0.781264577367354 |
|
| 20911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACPL2 |
0.781264577367354 |
|
| 20912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB38 |
0.781264577367354 |
|
| 20913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA2 |
0.781264577367354 |
|
| 20914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF7 |
0.781264577367354 |
|
| 20915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRK7 |
0.781264577367354 |
|
| 20916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1B3 |
0.781264577367354 |
|
| 20917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFDP2 |
0.781264577367354 |
|
| 20918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GK5 |
0.781264577367354 |
|
| 20919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRN1 |
0.781264577367354 |
|
| 20920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATR |
0.781264577367354 |
|
| 20921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP143 |
0.781264577367354 |
|
| 20922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLS1 |
0.781264577367354 |
|
| 20923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP25 |
0.781264577367354 |
|
| 20924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC1 |
0.781264577367354 |
|
| 20925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCOLCE2 |
0.781264577367354 |
|
| 20926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR9 |
0.781264577367354 |
|
| 20927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U2SURP |
0.781264577367354 |
|
| 20928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST2 |
0.781264577367354 |
|
| 20929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBX2P1 |
0.781264577367354 |
|
| 20930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A9 |
0.781264577367354 |
|
| 20931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf58 |
0.781264577367354 |
|
| 20932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP144 |
0.781264577367354 |
|
| 20933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLOD2 |
0.781264577367354 |
|
| 20934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLSCR4 |
0.781264577367354 |
|
| 20935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLSCR2 |
0.781264577367354 |
|
| 20936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLSCR1 |
0.781264577367354 |
|
| 20937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLSCR5 |
0.781264577367354 |
|
| 20938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY1 |
0.781264577367354 |
|
| 20939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP2B |
0.781264577367354 |
|
| 20940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL300P |
0.781264577367354 |
|
| 20941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf79 |
0.781264577367354 |
|
| 20942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000201398.1 |
0.781264577367354 |
|
| 20943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF26 |
0.781264577367354 |
|
| 20944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX36 |
0.781264577367354 |
|
| 20945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000271922.1 |
0.781264577367354 |
|
| 20946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR149 |
0.781264577367354 |
|
| 20947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MME |
0.781264577367354 |
|
| 20948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCH1 |
0.781264577367354 |
|
| 20949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C3orf33 |
0.781264577367354 |
|
| 20950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC33A1 |
0.781264577367354 |
|
| 20951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMPS |
0.781264577367354 |
|
| 20952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNAB1 |
0.781264577367354 |
|
| 20953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSR3 |
0.781264577367354 |
|
| 20954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIPARP |
0.781264577367354 |
|
| 20955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00886 |
0.781264577367354 |
|
| 20956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE1A |
0.782944314097327 |
|
| 20957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL267P |
0.782944314097327 |
|
| 20958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN2B |
0.785601793137142 |
|
| 20959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL46P |
0.785601793137142 |
|
| 20960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000271794.1 |
0.788000771900993 |
|
| 20961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANGPTL7 |
0.788000771900993 |
|
| 20962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCHD2 |
0.788000771900993 |
|
| 20963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDHD1 |
0.789190202224425 |
|
| 20964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4767 |
0.789190202224425 |
|
| 20965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR651 |
0.789190202224425 |
|
| 20966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNPLA4 |
0.789190202224425 |
|
| 20967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STS |
0.789190202224425 |
|
| 20968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCX2 |
0.789190202224425 |
|
| 20969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCX3A |
0.789190202224425 |
|
| 20970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCX |
0.789190202224425 |
|
| 20971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAL1 |
0.789190202224425 |
|
| 20972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VCX3B |
0.789190202224425 |
|
| 20973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G16 |
0.790960149305901 |
|
| 20974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR2D |
0.794858378670207 |
|
| 20975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMMECR1L |
0.794858378670207 |
|
| 20976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAP130 |
0.794858378670207 |
|
| 20977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UGGT1 |
0.794858378670207 |
|
| 20978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL206P |
0.794858378670207 |
|
| 20979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS6ST1 |
0.794858378670207 |
|
| 20980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP103 |
0.794858378670207 |
|
| 20981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238546.1 |
0.794858378670207 |
|
| 20982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB6C |
0.794858378670207 |
|
| 20983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC115 |
0.794858378670207 |
|
| 20984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC74B |
0.794858378670207 |
|
| 20985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F43P |
0.794858378670207 |
|
| 20986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMP4 |
0.794858378670207 |
|
| 20987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MZT2B |
0.794858378670207 |
|
| 20988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEF |
0.794858378670207 |
|
| 20989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN18 |
0.794858378670207 |
|
| 20990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPD4 |
0.794858378670207 |
|
| 20991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA3E |
0.794858378670207 |
|
| 20992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFC1B |
0.794858378670207 |
|
| 20993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFC1 |
0.794858378670207 |
|
| 20994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F30P |
0.794858378670207 |
|
| 20995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEI |
0.794858378670207 |
|
| 20996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEJ |
0.794858378670207 |
|
| 20997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR148 |
0.794858378670207 |
|
| 20998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMER3 |
0.794858378670207 |
|
| 20999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF4 |
0.794858378670207 |
|
| 21000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA4|ENSG00000252829.2 |
0.794858378670207 |
|
| 21001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD30BL |
0.794858378670207 |
|
| 21002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR39 |
0.794858378670207 |
|
| 21003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR663B |
0.794858378670207 |
|
| 21004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP103 |
0.794858378670207 |
|
| 21005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD1 |
0.794858378670207 |
|
| 21006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCKAP5 |
0.794858378670207 |
|
| 21007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT5 |
0.794858378670207 |
|
| 21008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3679 |
0.794858378670207 |
|
| 21009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP104 |
0.794858378670207 |
|
| 21010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM163 |
0.794858378670207 |
|
| 21011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACMSD |
0.794858378670207 |
|
| 21012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5590 |
0.794858378670207 |
|
| 21013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNT2 |
0.794858378670207 |
|
| 21014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K19 |
0.794858378670207 |
|
| 21015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3GAP1 |
0.794858378670207 |
|
| 21016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238337.1 |
0.794858378670207 |
|
| 21017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000208308.1 |
0.794858378670207 |
|
| 21018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZRANB3 |
0.794858378670207 |
|
| 21019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
R3HDM1 |
0.794858378670207 |
|
| 21020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN4 |
0.794858378670207 |
|
| 21021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LCT |
0.794858378670207 |
|
| 21022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCM6 |
0.794858378670207 |
|
| 21023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DARS |
0.794858378670207 |
|
| 21024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR4 |
0.794858378670207 |
|
| 21025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THSD7B |
0.794858378670207 |
|
| 21026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPOPL |
0.794858378670207 |
|
| 21027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPH2 |
0.794858378670207 |
|
| 21028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP286 |
0.794858378670207 |
|
| 21029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTDC1 |
0.794858378670207 |
|
| 21030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZEB2 |
0.794858378670207 |
|
| 21031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX41 |
0.794858378670207 |
|
| 21032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snR65|ENSG00000253036.1 |
0.794858378670207 |
|
| 21033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238860.1 |
0.794858378670207 |
|
| 21034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVR2A |
0.794858378670207 |
|
| 21035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC4 |
0.794858378670207 |
|
| 21036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBD5 |
0.794858378670207 |
|
| 21037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPC2 |
0.794858378670207 |
|
| 21038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF5C |
0.794858378670207 |
|
| 21039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD6B |
0.794858378670207 |
|
| 21040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYPD6 |
0.794858378670207 |
|
| 21041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RND3 |
0.794858378670207 |
|
| 21042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM43 |
0.794858378670207 |
|
| 21043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMI |
0.794858378670207 |
|
| 21044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFAIP6 |
0.794858378670207 |
|
| 21045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL124P |
0.794858378670207 |
|
| 21046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIF1 |
0.794858378670207 |
|
| 21047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEB |
0.794858378670207 |
|
| 21048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL5A |
0.794858378670207 |
|
| 21049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNB4 |
0.794858378670207 |
|
| 21050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT13 |
0.794858378670207 |
|
| 21051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP107 |
0.794858378670207 |
|
| 21052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR4A2 |
0.794858378670207 |
|
| 21053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238543.1 |
0.794858378670207 |
|
| 21054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238481.1 |
0.794858378670207 |
|
| 21055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPD2 |
0.794858378670207 |
|
| 21056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT5 |
0.794858378670207 |
|
| 21057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP281 |
0.794858378670207 |
|
| 21058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERMN |
0.794858378670207 |
|
| 21059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYTIP |
0.794858378670207 |
|
| 21060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVR1C |
0.794858378670207 |
|
| 21061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACVR1 |
0.794858378670207 |
|
| 21062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPP2 |
0.794858378670207 |
|
| 21063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC148 |
0.794858378670207 |
|
| 21064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL393P |
0.794858378670207 |
|
| 21065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKP4 |
0.794858378670207 |
|
| 21066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ5 |
0.794858378670207 |
|
| 21067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TANC1 |
0.794858378670207 |
|
| 21068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB6 |
0.794858378670207 |
|
| 21069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMS1 |
0.794858378670207 |
|
| 21070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRPP3 |
0.794858378670207 |
|
| 21071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4785 |
0.794858378670207 |
|
| 21072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL423P |
0.794858378670207 |
|
| 21073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TANK |
0.794858378670207 |
|
| 21074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A10 |
0.794858378670207 |
|
| 21075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP4 |
0.794858378670207 |
|
| 21076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCG |
0.794858378670207 |
|
| 21077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAP |
0.794858378670207 |
|
| 21078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFIH1 |
0.794858378670207 |
|
| 21079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCA |
0.794858378670207 |
|
| 21080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNH7 |
0.794858378670207 |
|
| 21081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP109 |
0.794858378670207 |
|
| 21082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEND2 |
0.795789009737103 |
|
| 21083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCML2 |
0.795789009737103 |
|
| 21084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKL5 |
0.795789009737103 |
|
| 21085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RS1 |
0.795789009737103 |
|
| 21086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPEF1 |
0.795789009737103 |
|
| 21087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR64 |
0.795789009737103 |
|
| 21088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHKA2 |
0.795789009737103 |
|
| 21089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL48P |
0.795789009737103 |
|
| 21090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDHA1 |
0.795789009737103 |
|
| 21091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K15 |
0.795789009737103 |
|
| 21092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf23 |
0.795789009737103 |
|
| 21093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP7D2 |
0.795789009737103 |
|
| 21094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR23C |
0.795789009737103 |
|
| 21095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF1AX |
0.795789009737103 |
|
| 21096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA3 |
0.795789009737103 |
|
| 21097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP183 |
0.795789009737103 |
|
| 21098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNKSR2 |
0.795789009737103 |
|
| 21099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL34 |
0.795789009737103 |
|
| 21100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMPX |
0.795789009737103 |
|
| 21101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBTPS2 |
0.795789009737103 |
|
| 21102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YY2 |
0.795789009737103 |
|
| 21103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMS |
0.795789009737103 |
|
| 21104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHEX |
0.795789009737103 |
|
| 21105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL436P |
0.795789009737103 |
|
| 21106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF645 |
0.795789009737103 |
|
| 21107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX53 |
0.795789009737103 |
|
| 21108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCHD1 |
0.795789009737103 |
|
| 21109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA68|ENSG00000201407.1 |
0.795789009737103 |
|
| 21110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFX |
0.795789009737103 |
|
| 21111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDK3 |
0.795789009737103 |
|
| 21112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCYT1B |
0.795789009737103 |
|
| 21113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLA1 |
0.795789009737103 |
|
| 21114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA23 |
0.795789009737103 |
|
| 21115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARX |
0.795789009737103 |
|
| 21116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL91P |
0.795789009737103 |
|
| 21117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB18 |
0.795789009737103 |
|
| 21118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB6 |
0.795789009737103 |
|
| 21119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB5 |
0.795789009737103 |
|
| 21120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VENTXP1 |
0.795789009737103 |
|
| 21121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF8L2 |
0.795789009737103 |
|
| 21122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB10 |
0.795789009737103 |
|
| 21123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF8L1 |
0.795789009737103 |
|
| 21124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000201666.1 |
0.795789009737103 |
|
| 21125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP500 |
0.795789009737103 |
|
| 21126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB2 |
0.795789009737103 |
|
| 21127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB3 |
0.795789009737103 |
|
| 21128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB4 |
0.795789009737103 |
|
| 21129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB1 |
0.795789009737103 |
|
| 21130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR0B1 |
0.795789009737103 |
|
| 21131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf21 |
0.795789009737103 |
|
| 21132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GK |
0.795789009737103 |
|
| 21133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAB3 |
0.795789009737103 |
|
| 21134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTHL17 |
0.795789009737103 |
|
| 21135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP501 |
0.795789009737103 |
|
| 21136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM47A |
0.795789009737103 |
|
| 21137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM47 |
0.795789009737103 |
|
| 21138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM47B |
0.795789009737103 |
|
| 21139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB16 |
0.795789009737103 |
|
| 21140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf22 |
0.795789009737103 |
|
| 21141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHDC2 |
0.795789009737103 |
|
| 21142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf30 |
0.795789009737103 |
|
| 21143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM47C |
0.795789009737103 |
|
| 21144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRRG1 |
0.795789009737103 |
|
| 21145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF2 |
0.795789009737103 |
|
| 21146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LANCL3 |
0.795789009737103 |
|
| 21147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XK |
0.795789009737103 |
|
| 21148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYBB |
0.795789009737103 |
|
| 21149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLT3 |
0.795789009737103 |
|
| 21150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf27 |
0.795789009737103 |
|
| 21151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AJ2 |
0.795789009737103 |
|
| 21152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPX |
0.795789009737103 |
|
| 21153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYTL5 |
0.795789009737103 |
|
| 21154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPGR |
0.795789009737103 |
|
| 21155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252050.1 |
0.795789009737103 |
|
| 21156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTC |
0.795789009737103 |
|
| 21157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN7 |
0.795789009737103 |
|
| 21158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MID1IP1 |
0.795789009737103 |
|
| 21159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3937 |
0.795789009737103 |
|
| 21160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL732P |
0.795789009737103 |
|
| 21161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1587 |
0.795789009737103 |
|
| 21162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCOR |
0.795789009737103 |
|
| 21163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COPS7B |
0.800250314060929 |
|
| 21164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1471 |
0.800250314060929 |
|
| 21165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPPC |
0.800250314060929 |
|
| 21166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIS3L2 |
0.800250314060929 |
|
| 21167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR562 |
0.800250314060929 |
|
| 21168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPPL2 |
0.800250314060929 |
|
| 21169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPP |
0.800250314060929 |
|
| 21170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECEL1P2 |
0.800250314060929 |
|
| 21171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALPI |
0.800250314060929 |
|
| 21172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECEL1 |
0.800250314060929 |
|
| 21173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS56 |
0.800250314060929 |
|
| 21174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRND |
0.800250314060929 |
|
| 21175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNG |
0.800250314060929 |
|
| 21176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD1 |
0.800250314060929 |
|
| 21177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF4E2 |
0.800250314060929 |
|
| 21178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5001 |
0.800250314060929 |
|
| 21179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFHD1 |
0.800250314060929 |
|
| 21180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL359P |
0.800250314060929 |
|
| 21181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239170.1 |
0.800250314060929 |
|
| 21182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDA2R |
0.804399475074785 |
|
| 21183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AR |
0.804399475074785 |
|
| 21184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OPHN1 |
0.804399475074785 |
|
| 21185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YIPF6 |
0.804399475074785 |
|
| 21186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD8 |
0.804399475074785 |
|
| 21187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNB1 |
0.804399475074785 |
|
| 21188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PJA1 |
0.804399475074785 |
|
| 21189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00269 |
0.804399475074785 |
|
| 21190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM155B |
0.804399475074785 |
|
| 21191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDA |
0.804399475074785 |
|
| 21192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212434.1 |
0.804399475074785 |
|
| 21193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AWAT2 |
0.804399475074785 |
|
| 21194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGAT2L6 |
0.804399475074785 |
|
| 21195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGBP1 |
0.804399475074785 |
|
| 21196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR676 |
0.804399475074785 |
|
| 21197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD6A |
0.804399475074785 |
|
| 21198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL581P |
0.804399475074785 |
|
| 21199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AWAT1 |
0.804399475074785 |
|
| 21200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP507 |
0.804399475074785 |
|
| 21201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY4 |
0.804399475074785 |
|
| 21202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARR3 |
0.804399475074785 |
|
| 21203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD11 |
0.804399475074785 |
|
| 21204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB41 |
0.804399475074785 |
|
| 21205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF4A |
0.804399475074785 |
|
| 21206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P23 |
0.804399475074785 |
|
| 21207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GDPD2 |
0.804399475074785 |
|
| 21208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLG3 |
0.804399475074785 |
|
| 21209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX11 |
0.804399475074785 |
|
| 21210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199769.1 |
0.804399475074785 |
|
| 21211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A3 |
0.804399475074785 |
|
| 21212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX12 |
0.804399475074785 |
|
| 21213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL746P |
0.804399475074785 |
|
| 21214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf65 |
0.804399475074785 |
|
| 21215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXO4 |
0.804399475074785 |
|
| 21216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL2RG |
0.804399475074785 |
|
| 21217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED12 |
0.804399475074785 |
|
| 21218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLGN3 |
0.804399475074785 |
|
| 21219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJB1 |
0.804399475074785 |
|
| 21220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMYM3 |
0.804399475074785 |
|
| 21221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NONO |
0.804399475074785 |
|
| 21222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB1BP2 |
0.804399475074785 |
|
| 21223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1 |
0.804399475074785 |
|
| 21224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252525.1 |
0.804399475074785 |
|
| 21225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INGX |
0.804399475074785 |
|
| 21226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGT |
0.804399475074785 |
|
| 21227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACRC |
0.804399475074785 |
|
| 21228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR3 |
0.804399475074785 |
|
| 21229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf49 |
0.804399475074785 |
|
| 21230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf49B |
0.804399475074785 |
|
| 21231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHSL2 |
0.804399475074785 |
|
| 21232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGAG4 |
0.804399475074785 |
|
| 21233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIN4 |
0.804399475074785 |
|
| 21234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL388P |
0.804399475074785 |
|
| 21235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC6L |
0.804399475074785 |
|
| 21236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL264P |
0.804399475074785 |
|
| 21237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS4X |
0.804399475074785 |
|
| 21238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CITED1 |
0.804399475074785 |
|
| 21239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC8 |
0.804399475074785 |
|
| 21240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHKA1 |
0.804399475074785 |
|
| 21241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000202482.1 |
0.804399475074785 |
|
| 21242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTC1B |
0.804399475074785 |
|
| 21243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM226A |
0.804399475074785 |
|
| 21244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMRTC1 |
0.804399475074785 |
|
| 21245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00684 |
0.804399475074785 |
|
| 21246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC1L2B |
0.804399475074785 |
|
| 21247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC1L2A |
0.804399475074785 |
|
| 21248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L6 |
0.804399475074785 |
|
| 21249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L2 |
0.804399475074785 |
|
| 21250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDX4 |
0.804399475074785 |
|
| 21251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2K4P1 |
0.804399475074785 |
|
| 21252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHIC1 |
0.804399475074785 |
|
| 21253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSIX |
0.804399475074785 |
|
| 21254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XIST |
0.804399475074785 |
|
| 21255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JPX |
0.804399475074785 |
|
| 21256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTX |
0.804399475074785 |
|
| 21257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKS1B |
0.808880959177662 |
|
| 21258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR374B |
0.810162474655136 |
|
| 21259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR421 |
0.810162474655136 |
|
| 21260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL648P |
0.810162474655136 |
|
| 21261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR374A |
0.810162474655136 |
|
| 21262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR545 |
0.810162474655136 |
|
| 21263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC13 |
0.810162474655136 |
|
| 21264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL790P |
0.810162474655136 |
|
| 21265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A2 |
0.810162474655136 |
|
| 21266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL641P |
0.810162474655136 |
|
| 21267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RLIM |
0.810162474655136 |
|
| 21268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA2022 |
0.810162474655136 |
|
| 21269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB7 |
0.810162474655136 |
|
| 21270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEE2 |
0.810162474655136 |
|
| 21271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPRT |
0.810162474655136 |
|
| 21272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC15 |
0.810162474655136 |
|
| 21273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PBDC1 |
0.810162474655136 |
|
| 21274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEE1 |
0.810162474655136 |
|
| 21275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP508 |
0.810162474655136 |
|
| 21276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP7A |
0.810162474655136 |
|
| 21277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGK1 |
0.810162474655136 |
|
| 21278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF9B |
0.810162474655136 |
|
| 21279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYSLTR1 |
0.810162474655136 |
|
| 21280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC5 |
0.810162474655136 |
|
| 21281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAR4 |
0.810162474655136 |
|
| 21282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY10 |
0.810162474655136 |
|
| 21283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR174 |
0.810162474655136 |
|
| 21284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITM2A |
0.810162474655136 |
|
| 21285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX22 |
0.810162474655136 |
|
| 21286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM46D |
0.810162474655136 |
|
| 21287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRWD3 |
0.810162474655136 |
|
| 21288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000239008.1 |
0.810162474655136 |
|
| 21289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGN5 |
0.810162474655136 |
|
| 21290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3BGRL |
0.810162474655136 |
|
| 21291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA4|ENSG00000202183.1 |
0.810162474655136 |
|
| 21292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU3F4 |
0.810162474655136 |
|
| 21293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYLC1 |
0.810162474655136 |
|
| 21294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS6KA6 |
0.810162474655136 |
|
| 21295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548I4 |
0.810162474655136 |
|
| 21296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDX |
0.810162474655136 |
|
| 21297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOOL |
0.810162474655136 |
|
| 21298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POF1B |
0.810162474655136 |
|
| 21299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SATL1 |
0.810162474655136 |
|
| 21300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2DNL |
0.810162474655136 |
|
| 21301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF711 |
0.810162474655136 |
|
| 21302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHM |
0.810162474655136 |
|
| 21303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR361 |
0.810162474655136 |
|
| 21304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DACH2 |
0.810162474655136 |
|
| 21305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45|ENSG00000200422.1 |
0.810162474655136 |
|
| 21306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL4 |
0.810162474655136 |
|
| 21307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000252016.1 |
0.810162474655136 |
|
| 21308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPXCR1 |
0.810162474655136 |
|
| 21309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGIF2LX |
0.810162474655136 |
|
| 21310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPC5 |
0.810162474655136 |
|
| 21311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH11X |
0.810162474655136 |
|
| 21312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM133A |
0.810162474655136 |
|
| 21313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAP1L3 |
0.810162474655136 |
|
| 21314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548M |
0.810162474655136 |
|
| 21315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL379P |
0.810162474655136 |
|
| 21316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP510 |
0.810162474655136 |
|
| 21317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP194 |
0.810162474655136 |
|
| 21318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIAPH2 |
0.810162474655136 |
|
| 21319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPA4 |
0.810162474655136 |
|
| 21320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL74P |
0.810162474655136 |
|
| 21321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000252296.1 |
0.810162474655136 |
|
| 21322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDH19 |
0.810162474655136 |
|
| 21323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNMD |
0.810162474655136 |
|
| 21324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN6 |
0.810162474655136 |
|
| 21325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRPX2 |
0.810162474655136 |
|
| 21326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYTL4 |
0.810162474655136 |
|
| 21327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSTF2 |
0.810162474655136 |
|
| 21328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA9|ENSG00000202231.1 |
0.810162474655136 |
|
| 21329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOX1 |
0.810162474655136 |
|
| 21330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL13A |
0.810162474655136 |
|
| 21331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM35 |
0.810162474655136 |
|
| 21332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRMT2B |
0.810162474655136 |
|
| 21333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XKRX |
0.810162474655136 |
|
| 21334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPI |
0.810162474655136 |
|
| 21335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRP2 |
0.810162474655136 |
|
| 21336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF7L |
0.810162474655136 |
|
| 21337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTK |
0.810162474655136 |
|
| 21338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM8A |
0.810162474655136 |
|
| 21339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL36A |
0.810162474655136 |
|
| 21340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLA |
0.810162474655136 |
|
| 21341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPH2 |
0.810162474655136 |
|
| 21342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX4 |
0.810162474655136 |
|
| 21343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX1 |
0.810162474655136 |
|
| 21344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX6 |
0.810162474655136 |
|
| 21345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX3 |
0.810162474655136 |
|
| 21346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX2 |
0.810162474655136 |
|
| 21347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF5 |
0.810162474655136 |
|
| 21348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZMAT1 |
0.810162474655136 |
|
| 21349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL2 |
0.810162474655136 |
|
| 21350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL6 |
0.810162474655136 |
|
| 21351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEX5 |
0.810162474655136 |
|
| 21352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11X3P |
0.810162474655136 |
|
| 21353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF2 |
0.810162474655136 |
|
| 21354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11X1 |
0.810162474655136 |
|
| 21355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF2B |
0.810162474655136 |
|
| 21356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11X2 |
0.810162474655136 |
|
| 21357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMSB15A |
0.810162474655136 |
|
| 21358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF4 |
0.810162474655136 |
|
| 21359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMCX5 |
0.810162474655136 |
|
| 21360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRASP1 |
0.810162474655136 |
|
| 21361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPRASP2 |
0.810162474655136 |
|
| 21362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BHLHB9 |
0.810162474655136 |
|
| 21363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00630 |
0.810162474655136 |
|
| 21364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB40AL |
0.810162474655136 |
|
| 21365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEX1 |
0.810162474655136 |
|
| 21366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXF3 |
0.810162474655136 |
|
| 21367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEX4 |
0.810162474655136 |
|
| 21368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL8 |
0.810162474655136 |
|
| 21369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL5 |
0.810162474655136 |
|
| 21370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEX2 |
0.810162474655136 |
|
| 21371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL7 |
0.810162474655136 |
|
| 21372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WBP5 |
0.810162474655136 |
|
| 21373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NGFRAP1 |
0.810162474655136 |
|
| 21374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB40A |
0.810162474655136 |
|
| 21375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL4 |
0.810162474655136 |
|
| 21376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL3 |
0.810162474655136 |
|
| 21377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEAL1 |
0.810162474655136 |
|
| 21378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORF4L2 |
0.810162474655136 |
|
| 21379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRA4 |
0.810162474655136 |
|
| 21380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM31 |
0.810162474655136 |
|
| 21381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLP1 |
0.810162474655136 |
|
| 21382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB9B |
0.810162474655136 |
|
| 21383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP511 |
0.810162474655136 |
|
| 21384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMSB15B |
0.810162474655136 |
|
| 21385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2BFM |
0.810162474655136 |
|
| 21386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
H2BFWT |
0.810162474655136 |
|
| 21387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A53 |
0.810162474655136 |
|
| 21388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC18 |
0.810162474655136 |
|
| 21389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM199X |
0.810162474655136 |
|
| 21390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESX1 |
0.810162474655136 |
|
| 21391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RAPL2 |
0.810162474655136 |
|
| 21392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX13A |
0.810162474655136 |
|
| 21393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRK |
0.810162474655136 |
|
| 21394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINA7 |
0.810162474655136 |
|
| 21395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUM1L1 |
0.810162474655136 |
|
| 21396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf57 |
0.810162474655136 |
|
| 21397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AN |
0.810162474655136 |
|
| 21398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF128 |
0.810162474655136 |
|
| 21399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D8B |
0.810162474655136 |
|
| 21400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORC4 |
0.810162474655136 |
|
| 21401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN2 |
0.810162474655136 |
|
| 21402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPPLY1 |
0.810162474655136 |
|
| 21403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP62CL |
0.810162474655136 |
|
| 21404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIH1D3 |
0.810162474655136 |
|
| 21405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM41 |
0.810162474655136 |
|
| 21406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMPD3 |
0.810162474655136 |
|
| 21407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPS1 |
0.810162474655136 |
|
| 21408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC22D3 |
0.810162474655136 |
|
| 21409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCBP2L |
0.810162474655136 |
|
| 21410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MID2 |
0.810162474655136 |
|
| 21411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEX13B |
0.810162474655136 |
|
| 21412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG1 |
0.810162474655136 |
|
| 21413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD10 |
0.810162474655136 |
|
| 21414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG4A |
0.810162474655136 |
|
| 21415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A6 |
0.810162474655136 |
|
| 21416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A5 |
0.810162474655136 |
|
| 21417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRS4 |
0.810162474655136 |
|
| 21418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUCY2F |
0.810162474655136 |
|
| 21419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXT2 |
0.810162474655136 |
|
| 21420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNE1L |
0.810162474655136 |
|
| 21421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSL4 |
0.810162474655136 |
|
| 21422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM164 |
0.810162474655136 |
|
| 21423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR652 |
0.810162474655136 |
|
| 21424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3978 |
0.810162474655136 |
|
| 21425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMMECR1 |
0.810162474655136 |
|
| 21426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD96B |
0.810162474655136 |
|
| 21427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG5P2 |
0.810162474655136 |
|
| 21428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGAG1 |
0.810162474655136 |
|
| 21429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDGF1P3 |
0.810162474655136 |
|
| 21430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRDL1 |
0.810162474655136 |
|
| 21431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK3 |
0.810162474655136 |
|
| 21432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN6 |
0.810162474655136 |
|
| 21433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCX |
0.810162474655136 |
|
| 21434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00890 |
0.810162474655136 |
|
| 21435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL661P |
0.810162474655136 |
|
| 21436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG13 |
0.810162474655136 |
|
| 21437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP512 |
0.810162474655136 |
|
| 21438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC5 |
0.810162474655136 |
|
| 21439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPC5OS |
0.810162474655136 |
|
| 21440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC16 |
0.810162474655136 |
|
| 21441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFPL1 |
0.810162474655136 |
|
| 21442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMOT |
0.810162474655136 |
|
| 21443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4329 |
0.810162474655136 |
|
| 21444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL266P |
0.810162474655136 |
|
| 21445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238811.1 |
0.810162474655136 |
|
| 21446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000201674.1 |
0.810162474655136 |
|
| 21447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL93P |
0.810162474655136 |
|
| 21448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD30 |
0.810162474655136 |
|
| 21449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR2C |
0.810162474655136 |
|
| 21450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA35|ENSG00000208839.1 |
0.810162474655136 |
|
| 21451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR764 |
0.810162474655136 |
|
| 21452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1912 |
0.810162474655136 |
|
| 21453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1298 |
0.810162474655136 |
|
| 21454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1911 |
0.810162474655136 |
|
| 21455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR448 |
0.810162474655136 |
|
| 21456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL13RA2 |
0.810162474655136 |
|
| 21457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRCH2 |
0.810162474655136 |
|
| 21458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUZP4 |
0.810162474655136 |
|
| 21459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMXL3 |
0.810162474655136 |
|
| 21460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA35|ENSG00000271907.1 |
0.810162474655136 |
|
| 21461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000252441.1 |
0.810162474655136 |
|
| 21462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLS3 |
0.810162474655136 |
|
| 21463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL712P |
0.810162474655136 |
|
| 21464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGTR2 |
0.810162474655136 |
|
| 21465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A14 |
0.810162474655136 |
|
| 21466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf61 |
0.810162474655136 |
|
| 21467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL13 |
0.810162474655136 |
|
| 21468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR44 |
0.810162474655136 |
|
| 21469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1277 |
0.810162474655136 |
|
| 21470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK11 |
0.810162474655136 |
|
| 21471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL13RA1 |
0.810162474655136 |
|
| 21472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA35|ENSG00000239182.1 |
0.810162474655136 |
|
| 21473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC12 |
0.810162474655136 |
|
| 21474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LONRF3 |
0.810162474655136 |
|
| 21475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1210 |
0.810162474655136 |
|
| 21476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGRMC1 |
0.810162474655136 |
|
| 21477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL118P |
0.810162474655136 |
|
| 21478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A43 |
0.810162474655136 |
|
| 21479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A5 |
0.810162474655136 |
|
| 21480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf56 |
0.810162474655136 |
|
| 21481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2A |
0.810162474655136 |
|
| 21482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKRF |
0.810162474655136 |
|
| 21483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT6 |
0.810162474655136 |
|
| 21484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR766 |
0.810162474655136 |
|
| 21485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOWAHD |
0.810162474655136 |
|
| 21486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL39 |
0.810162474655136 |
|
| 21487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA69|ENSG00000206622.1 |
0.810162474655136 |
|
| 21488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UPF3B |
0.810162474655136 |
|
| 21489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA1 |
0.810162474655136 |
|
| 21490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF113A |
0.810162474655136 |
|
| 21491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP14 |
0.810162474655136 |
|
| 21492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAP |
0.810162474655136 |
|
| 21493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOXF2B |
0.810162474655136 |
|
| 21494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOXF1 |
0.810162474655136 |
|
| 21495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKAPP1 |
0.810162474655136 |
|
| 21496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOXF2 |
0.810162474655136 |
|
| 21497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB33 |
0.810162474655136 |
|
| 21498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM255A |
0.810162474655136 |
|
| 21499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP1B4 |
0.810162474655136 |
|
| 21500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAMP2 |
0.810162474655136 |
|
| 21501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL4B |
0.810162474655136 |
|
| 21502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000272179.1 |
0.810162474655136 |
|
| 21503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCTS1 |
0.810162474655136 |
|
| 21504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1GALT1C1 |
0.810162474655136 |
|
| 21505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A10 |
0.810162474655136 |
|
| 21506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A11 |
0.810162474655136 |
|
| 21507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A12 |
0.810162474655136 |
|
| 21508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A1 |
0.810162474655136 |
|
| 21509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A2 |
0.810162474655136 |
|
| 21510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A3 |
0.810162474655136 |
|
| 21511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A4 |
0.810162474655136 |
|
| 21512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A5 |
0.810162474655136 |
|
| 21513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A6 |
0.810162474655136 |
|
| 21514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A7 |
0.810162474655136 |
|
| 21515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A8 |
0.810162474655136 |
|
| 21516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47A9 |
0.810162474655136 |
|
| 21517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT47B1 |
0.810162474655136 |
|
| 21518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLUD2 |
0.810162474655136 |
|
| 21519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3672 |
0.810162474655136 |
|
| 21520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212321.1 |
0.810162474655136 |
|
| 21521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIA3 |
0.810162474655136 |
|
| 21522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC2 |
0.810162474655136 |
|
| 21523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL29P |
0.810162474655136 |
|
| 21524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XIAP |
0.810162474655136 |
|
| 21525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAG2 |
0.810162474655136 |
|
| 21526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239058.1 |
0.810162474655136 |
|
| 21527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252693.1 |
0.810162474655136 |
|
| 21528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D1A |
0.810162474655136 |
|
| 21529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TENM1 |
0.810162474655136 |
|
| 21530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238626.1 |
0.810162474655136 |
|
| 21531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF12L2 |
0.810162474655136 |
|
| 21532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF12L1 |
0.810162474655136 |
|
| 21533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf64 |
0.810162474655136 |
|
| 21534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP513 |
0.810162474655136 |
|
| 21535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCA1 |
0.810162474655136 |
|
| 21536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1R1 |
0.810576447593369 |
|
| 21537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RL2 |
0.810576447593369 |
|
| 21538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL18R1 |
0.810576447593369 |
|
| 21539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RL1 |
0.810576447593369 |
|
| 21540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL18RAP |
0.810576447593369 |
|
| 21541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4772 |
0.810576447593369 |
|
| 21542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A4 |
0.810576447593369 |
|
| 21543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A2 |
0.810576447593369 |
|
| 21544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD9 |
0.810576447593369 |
|
| 21545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM182 |
0.810576447593369 |
|
| 21546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000199727.1 |
0.810576447593369 |
|
| 21547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000207249.1 |
0.810576447593369 |
|
| 21548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU3F3 |
0.810576447593369 |
|
| 21549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS9 |
0.810576447593369 |
|
| 21550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR45 |
0.810576447593369 |
|
| 21551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TGFBRAP1 |
0.810576447593369 |
|
| 21552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf49 |
0.810576447593369 |
|
| 21553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FHL2 |
0.810576447593369 |
|
| 21554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCK2 |
0.810576447593369 |
|
| 21555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf40 |
0.810576447593369 |
|
| 21556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UXS1 |
0.810576447593369 |
|
| 21557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLGLA |
0.810576447593369 |
|
| 21558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD3 |
0.810576447593369 |
|
| 21559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD8BP |
0.810576447593369 |
|
| 21560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST6GAL2 |
0.810576447593369 |
|
| 21561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GACAT1 |
0.810576447593369 |
|
| 21562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD4 |
0.810576447593369 |
|
| 21563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC5A7 |
0.810576447593369 |
|
| 21564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1C3 |
0.810576447593369 |
|
| 21565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1C2 |
0.810576447593369 |
|
| 21566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1C2P1 |
0.810576447593369 |
|
| 21567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SULT1C4 |
0.810576447593369 |
|
| 21568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCC2 |
0.810576447593369 |
|
| 21569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMS1 |
0.810576447593369 |
|
| 21570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP2 |
0.810576447593369 |
|
| 21571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC138 |
0.810576447593369 |
|
| 21572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDAR |
0.810576447593369 |
|
| 21573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3RF3 |
0.810576447593369 |
|
| 21574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4265 |
0.810576447593369 |
|
| 21575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4266 |
0.810576447593369 |
|
| 21576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT10 |
0.810576447593369 |
|
| 21577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOWAHC |
0.810576447593369 |
|
| 21578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BUB1 |
0.810576447593369 |
|
| 21579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMS3L |
0.810576447593369 |
|
| 21580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMS3|ENSG00000256977.6 |
0.810576447593369 |
|
| 21581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMS3|ENSG00000257207.4 |
0.810576447593369 |
|
| 21582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00116 |
0.810576447593369 |
|
| 21583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MALL |
0.810576447593369 |
|
| 21584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4267 |
0.810576447593369 |
|
| 21585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4436B1 |
0.810576447593369 |
|
| 21586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4436B2 |
0.810576447593369 |
|
| 21587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPHP1 |
0.810576447593369 |
|
| 21588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD5 |
0.810576447593369 |
|
| 21589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD6 |
0.810576447593369 |
|
| 21590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOXL |
0.810576447593369 |
|
| 21591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L11 |
0.810576447593369 |
|
| 21592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC1 |
0.810576447593369 |
|
| 21593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MERTK |
0.810576447593369 |
|
| 21594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL297P |
0.810576447593369 |
|
| 21595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM87B |
0.810576447593369 |
|
| 21596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBLN7 |
0.810576447593369 |
|
| 21597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H8 |
0.810576447593369 |
|
| 21598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238951.1 |
0.810576447593369 |
|
| 21599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H6 |
0.810576447593369 |
|
| 21600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGPD8 |
0.810576447593369 |
|
| 21601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTL |
0.810576447593369 |
|
| 21602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR1B |
0.810576447593369 |
|
| 21603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHCHD5 |
0.810576447593369 |
|
| 21604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC20A1 |
0.810576447593369 |
|
| 21605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5DC4 |
0.810576447593369 |
|
| 21606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKAP2L |
0.810576447593369 |
|
| 21607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1A |
0.810576447593369 |
|
| 21608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1B |
0.810576447593369 |
|
| 21609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL37 |
0.810576447593369 |
|
| 21610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL36G |
0.810576447593369 |
|
| 21611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL36A |
0.810576447593369 |
|
| 21612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL36B |
0.810576447593369 |
|
| 21613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL36RN |
0.810576447593369 |
|
| 21614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1F10 |
0.810576447593369 |
|
| 21615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL1RN |
0.810576447593369 |
|
| 21616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSD4 |
0.810576447593369 |
|
| 21617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX8 |
0.810576447593369 |
|
| 21618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBWD2 |
0.810576447593369 |
|
| 21619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD4L1 |
0.810576447593369 |
|
| 21620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM138B |
0.810576447593369 |
|
| 21621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RABL2A |
0.810576447593369 |
|
| 21622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL23AP7 |
0.810576447593369 |
|
| 21623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASH2P |
0.810576447593369 |
|
| 21624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35F5 |
0.810576447593369 |
|
| 21625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4782 |
0.810576447593369 |
|
| 21626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239077.1 |
0.810576447593369 |
|
| 21627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR3 |
0.810576447593369 |
|
| 21628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000212182.1 |
0.810576447593369 |
|
| 21629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238520.1 |
0.810576447593369 |
|
| 21630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPP10 |
0.810576447593369 |
|
| 21631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX18 |
0.810576447593369 |
|
| 21632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR5BP |
0.810576447593369 |
|
| 21633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC93 |
0.810576447593369 |
|
| 21634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL111P |
0.810576447593369 |
|
| 21635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INSIG2 |
0.810576447593369 |
|
| 21636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EN1 |
0.810576447593369 |
|
| 21637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCO |
0.810576447593369 |
|
| 21638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QL2 |
0.810576447593369 |
|
| 21639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL468P |
0.810576447593369 |
|
| 21640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STEAP3 |
0.810576447593369 |
|
| 21641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf76 |
0.810576447593369 |
|
| 21642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBI |
0.810576447593369 |
|
| 21643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM37 |
0.810576447593369 |
|
| 21644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCTR |
0.810576447593369 |
|
| 21645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCDP1 |
0.810576447593369 |
|
| 21646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM177 |
0.810576447593369 |
|
| 21647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN4 |
0.810576447593369 |
|
| 21648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238368.1 |
0.810576447593369 |
|
| 21649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L5 |
0.810576447593369 |
|
| 21650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM185B |
0.810576447593369 |
|
| 21651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RALB |
0.810576447593369 |
|
| 21652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INHBB |
0.810576447593369 |
|
| 21653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ14816 |
0.810576447593369 |
|
| 21654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLI2 |
0.810576447593369 |
|
| 21655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFCP2L1 |
0.810576447593369 |
|
| 21656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLASP1 |
0.810576447593369 |
|
| 21657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC |
0.810576447593369 |
|
| 21658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238341.1 |
0.810576447593369 |
|
| 21659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKI67IP |
0.810576447593369 |
|
| 21660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSN |
0.810576447593369 |
|
| 21661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP102 |
0.810576447593369 |
|
| 21662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP5 |
0.810576447593369 |
|
| 21663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP102 |
0.810576447593369 |
|
| 21664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYPC |
0.810576447593369 |
|
| 21665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BIN1 |
0.810576447593369 |
|
| 21666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP27C1 |
0.810576447593369 |
|
| 21667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC3 |
0.810576447593369 |
|
| 21668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K2 |
0.810576447593369 |
|
| 21669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4783 |
0.810576447593369 |
|
| 21670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PROC |
0.810576447593369 |
|
| 21671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IWS1 |
0.810576447593369 |
|
| 21672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO7B |
0.810576447593369 |
|
| 21673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIMS2 |
0.810576447593369 |
|
| 21674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR17 |
0.810576447593369 |
|
| 21675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFT2D3 |
0.810576447593369 |
|
| 21676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR33 |
0.810576447593369 |
|
| 21677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P7 |
0.810576447593369 |
|
| 21678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM168B |
0.810576447593369 |
|
| 21679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHB2 |
0.810576447593369 |
|
| 21680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F31P |
0.810576447593369 |
|
| 21681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4784 |
0.810576447593369 |
|
| 21682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MZT2A |
0.810576447593369 |
|
| 21683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEE |
0.810576447593369 |
|
| 21684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA3D |
0.810576447593369 |
|
| 21685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC74A |
0.810576447593369 |
|
| 21686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf27A |
0.810576447593369 |
|
| 21687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf27B |
0.810576447593369 |
|
| 21688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL701P |
0.810576447593369 |
|
| 21689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP154 |
0.810576447593369 |
|
| 21690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP93 |
0.810576447593369 |
|
| 21691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP141 |
0.810576447593369 |
|
| 21692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP105 |
0.810576447593369 |
|
| 21693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNMT |
0.810576447593369 |
|
| 21694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212181.1 |
0.810576447593369 |
|
| 21695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMADHC |
0.810576447593369 |
|
| 21696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAM2 |
0.810576447593369 |
|
| 21697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMNL2 |
0.810576447593369 |
|
| 21698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF40A |
0.810576447593369 |
|
| 21699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL6IP6 |
0.810576447593369 |
|
| 21700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000200377.1 |
0.810576447593369 |
|
| 21701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPRM |
0.810576447593369 |
|
| 21702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNJ3 |
0.810576447593369 |
|
| 21703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAPL1 |
0.810576447593369 |
|
| 21704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDSUB1 |
0.810576447593369 |
|
| 21705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAZ2B |
0.810576447593369 |
|
| 21706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH7 |
0.810576447593369 |
|
| 21707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD302 |
0.810576447593369 |
|
| 21708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY75 |
0.810576447593369 |
|
| 21709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2R1 |
0.810576447593369 |
|
| 21710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD14 |
0.810576447593369 |
|
| 21711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBR1 |
0.810576447593369 |
|
| 21712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238570.1 |
0.810576447593369 |
|
| 21713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIGN |
0.810576447593369 |
|
| 21714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRB14 |
0.810576447593369 |
|
| 21715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COBLL1 |
0.810576447593369 |
|
| 21716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70F |
0.810576447593369 |
|
| 21717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP110 |
0.810576447593369 |
|
| 21718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP111 |
0.810576447593369 |
|
| 21719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A11 |
0.810576447593369 |
|
| 21720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN3A |
0.810576447593369 |
|
| 21721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL455P |
0.810576447593369 |
|
| 21722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN2A |
0.810576447593369 |
|
| 21723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSRNP3 |
0.810576447593369 |
|
| 21724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT3 |
0.810576447593369 |
|
| 21725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC21B |
0.810576447593369 |
|
| 21726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN1A |
0.810576447593369 |
|
| 21727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP152 |
0.810576447593369 |
|
| 21728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN9A |
0.810576447593369 |
|
| 21729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238662.1 |
0.810576447593369 |
|
| 21730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCN7A |
0.810576447593369 |
|
| 21731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XIRP2 |
0.810576447593369 |
|
| 21732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GALT1 |
0.810576447593369 |
|
| 21733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK39 |
0.810576447593369 |
|
| 21734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL95P |
0.810576447593369 |
|
| 21735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL813P |
0.810576447593369 |
|
| 21736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERS6 |
0.810576447593369 |
|
| 21737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4774 |
0.810576447593369 |
|
| 21738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOSTRIN |
0.810576447593369 |
|
| 21739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPC25 |
0.810576447593369 |
|
| 21740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
G6PC2 |
0.810576447593369 |
|
| 21741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB11 |
0.810576447593369 |
|
| 21742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRS9 |
0.810576447593369 |
|
| 21743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP2 |
0.810576447593369 |
|
| 21744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BBS5 |
0.810576447593369 |
|
| 21745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL41 |
0.810576447593369 |
|
| 21746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASTKD1 |
0.810576447593369 |
|
| 21747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIG |
0.810576447593369 |
|
| 21748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC173 |
0.810576447593369 |
|
| 21749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL23 |
0.810576447593369 |
|
| 21750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHOSPHO2 |
0.810576447593369 |
|
| 21751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000206961.1 |
0.810576447593369 |
|
| 21752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSB |
0.810576447593369 |
|
| 21753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL5 |
0.810576447593369 |
|
| 21754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252981.1 |
0.810576447593369 |
|
| 21755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBR3 |
0.810576447593369 |
|
| 21756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO3B |
0.810576447593369 |
|
| 21757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP5 |
0.810576447593369 |
|
| 21758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERICH2 |
0.810576447593369 |
|
| 21759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAD1 |
0.810576447593369 |
|
| 21760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GORASP2 |
0.810576447593369 |
|
| 21761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238567.1 |
0.810576447593369 |
|
| 21762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCAF17 |
0.810576447593369 |
|
| 21763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYBRD1 |
0.810576447593369 |
|
| 21764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNC1I2 |
0.810576447593369 |
|
| 21765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A12 |
0.810576447593369 |
|
| 21766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAT1 |
0.810576447593369 |
|
| 21767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METAP1D |
0.810576447593369 |
|
| 21768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX1 |
0.810576447593369 |
|
| 21769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DLX2 |
0.810576447593369 |
|
| 21770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238572.1 |
0.810576447593369 |
|
| 21771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA6 |
0.810576447593369 |
|
| 21772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDK1 |
0.810576447593369 |
|
| 21773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239041.1 |
0.810576447593369 |
|
| 21774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPGEF4 |
0.810576447593369 |
|
| 21775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLTK |
0.810576447593369 |
|
| 21776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDCA7 |
0.810576447593369 |
|
| 21777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP3 |
0.810576447593369 |
|
| 21778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLA1 |
0.810576447593369 |
|
| 21779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL65P |
0.810576447593369 |
|
| 21780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP9 |
0.810576447593369 |
|
| 21781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIR1 |
0.810576447593369 |
|
| 21782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCRN3 |
0.810576447593369 |
|
| 21783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR155 |
0.810576447593369 |
|
| 21784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIPF1 |
0.810576447593369 |
|
| 21785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA1 |
0.810576447593369 |
|
| 21786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHN1 |
0.810576447593369 |
|
| 21787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATF2 |
0.810576447593369 |
|
| 21788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR933 |
0.810576447593369 |
|
| 21789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5G3 |
0.810576447593369 |
|
| 21790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1715 |
0.810576447593369 |
|
| 21791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EVX2 |
0.810576447593369 |
|
| 21792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD13 |
0.810576447593369 |
|
| 21793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD12 |
0.810576447593369 |
|
| 21794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD10 |
0.810576447593369 |
|
| 21795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD11 |
0.810576447593369 |
|
| 21796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD9 |
0.810576447593369 |
|
| 21797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD8 |
0.810576447593369 |
|
| 21798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD3 |
0.810576447593369 |
|
| 21799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD4 |
0.810576447593369 |
|
| 21800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR10B |
0.810576447593369 |
|
| 21801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HOXD1 |
0.810576447593369 |
|
| 21802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTX2 |
0.810576447593369 |
|
| 21803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC14P |
0.810576447593369 |
|
| 21804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP112 |
0.810576447593369 |
|
| 21805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNRNPA3 |
0.810576447593369 |
|
| 21806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFE2L2 |
0.810576447593369 |
|
| 21807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3128 |
0.810576447593369 |
|
| 21808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238295.1 |
0.810576447593369 |
|
| 21809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPS |
0.810576447593369 |
|
| 21810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC30B |
0.810576447593369 |
|
| 21811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC30A |
0.810576447593369 |
|
| 21812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE11A |
0.810576447593369 |
|
| 21813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM45 |
0.810576447593369 |
|
| 21814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBPL6 |
0.810576447593369 |
|
| 21815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKRA |
0.810576447593369 |
|
| 21816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DFNB59 |
0.810576447593369 |
|
| 21817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP7 |
0.810576447593369 |
|
| 21818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHA3 |
0.810576447593369 |
|
| 21819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTN |
0.810576447593369 |
|
| 21820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC141 |
0.810576447593369 |
|
| 21821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA59|ENSG00000252000.1 |
0.810576447593369 |
|
| 21822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SESTD1 |
0.810576447593369 |
|
| 21823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238339.1 |
0.810576447593369 |
|
| 21824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF385B |
0.810576447593369 |
|
| 21825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1258 |
0.810576447593369 |
|
| 21826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA43|ENSG00000202216.1 |
0.810576447593369 |
|
| 21827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWC22 |
0.810576447593369 |
|
| 21828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2E3 |
0.810576447593369 |
|
| 21829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4437 |
0.810576447593369 |
|
| 21830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA4 |
0.810576447593369 |
|
| 21831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CERKL |
0.810576447593369 |
|
| 21832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEUROD1 |
0.810576447593369 |
|
| 21833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC19P |
0.810576447593369 |
|
| 21834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSFA2 |
0.810576447593369 |
|
| 21835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R1C |
0.810576447593369 |
|
| 21836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP113 |
0.810576447593369 |
|
| 21837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJC10 |
0.810576447593369 |
|
| 21838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRZB |
0.810576447593369 |
|
| 21839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCKAP1 |
0.810576447593369 |
|
| 21840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA77|ENSG00000221498.1 |
0.810576447593369 |
|
| 21841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP19 |
0.810576447593369 |
|
| 21842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP35 |
0.810576447593369 |
|
| 21843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238306.1 |
0.810576447593369 |
|
| 21844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AE1 |
0.810576447593369 |
|
| 21845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF804A |
0.810576447593369 |
|
| 21846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FSIP2 |
0.810576447593369 |
|
| 21847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000212581.1 |
0.810576447593369 |
|
| 21848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H15 |
0.810576447593369 |
|
| 21849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAV |
0.810576447593369 |
|
| 21850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM171B |
0.810576447593369 |
|
| 21851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM2 |
0.810576447593369 |
|
| 21852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP42 |
0.810576447593369 |
|
| 21853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALCRL |
0.810576447593369 |
|
| 21854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFPI |
0.810576447593369 |
|
| 21855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP114 |
0.810576447593369 |
|
| 21856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GULP1 |
0.810576447593369 |
|
| 21857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR561 |
0.810576447593369 |
|
| 21858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRC1 |
0.810576447593369 |
|
| 21859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL3A1 |
0.810576447593369 |
|
| 21860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1245A |
0.810576447593369 |
|
| 21861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL5A2 |
0.810576447593369 |
|
| 21862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3129 |
0.810576447593369 |
|
| 21863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR75 |
0.810576447593369 |
|
| 21864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC40A1 |
0.810576447593369 |
|
| 21865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASNSD1 |
0.810576447593369 |
|
| 21866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKAR |
0.810576447593369 |
|
| 21867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSGEPL1 |
0.810576447593369 |
|
| 21868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORMDL1 |
0.810576447593369 |
|
| 21869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMS1 |
0.810576447593369 |
|
| 21870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf88 |
0.810576447593369 |
|
| 21871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSTN |
0.810576447593369 |
|
| 21872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIBCH |
0.810576447593369 |
|
| 21873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INPP1 |
0.810576447593369 |
|
| 21874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD6 |
0.810576447593369 |
|
| 21875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM194B |
0.810576447593369 |
|
| 21876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP179 |
0.810576447593369 |
|
| 21877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAB1 |
0.810576447593369 |
|
| 21878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLS |
0.810576447593369 |
|
| 21879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT1 |
0.810576447593369 |
|
| 21880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT4 |
0.810576447593369 |
|
| 21881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1B |
0.810576447593369 |
|
| 21882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NABP1 |
0.810576447593369 |
|
| 21883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDPR |
0.810576447593369 |
|
| 21884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEFF2 |
0.810576447593369 |
|
| 21885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCGEM1 |
0.810576447593369 |
|
| 21886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD59|ENSG00000252517.1 |
0.810576447593369 |
|
| 21887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A10 |
0.810576447593369 |
|
| 21888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH7 |
0.810576447593369 |
|
| 21889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK17B |
0.810576447593369 |
|
| 21890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HECW2 |
0.810576447593369 |
|
| 21891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239161.1 |
0.810576447593369 |
|
| 21892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL820P |
0.810576447593369 |
|
| 21893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC150 |
0.810576447593369 |
|
| 21894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA16|ENSG00000252923.1 |
0.810576447593369 |
|
| 21895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF3C3 |
0.810576447593369 |
|
| 21896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf66 |
0.810576447593369 |
|
| 21897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAP1 |
0.810576447593369 |
|
| 21898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD44 |
0.810576447593369 |
|
| 21899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B1 |
0.810576447593369 |
|
| 21900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA4|ENSG00000202434.1 |
0.810576447593369 |
|
| 21901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ10B |
0.810576447593369 |
|
| 21902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPE1 |
0.810576447593369 |
|
| 21903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SATB2 |
0.810576447593369 |
|
| 21904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTCDNL1 |
0.810576447593369 |
|
| 21905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL717P |
0.810576447593369 |
|
| 21906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf69 |
0.810576447593369 |
|
| 21907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYW5 |
0.810576447593369 |
|
| 21908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf47 |
0.810576447593369 |
|
| 21909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATS2L |
0.810576447593369 |
|
| 21910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD18 |
0.810576447593369 |
|
| 21911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGOL2 |
0.810576447593369 |
|
| 21912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOX1 |
0.810576447593369 |
|
| 21913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AOX2P |
0.810576447593369 |
|
| 21914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BZW1 |
0.810576447593369 |
|
| 21915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP115 |
0.810576447593369 |
|
| 21916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLK1 |
0.810576447593369 |
|
| 21917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPIL3 |
0.810576447593369 |
|
| 21918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIF3L1 |
0.810576447593369 |
|
| 21919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC2 |
0.810576447593369 |
|
| 21920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL694P |
0.810576447593369 |
|
| 21921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM126B |
0.810576447593369 |
|
| 21922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB3 |
0.810576447593369 |
|
| 21923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFLAR |
0.810576447593369 |
|
| 21924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP10 |
0.810576447593369 |
|
| 21925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP8 |
0.810576447593369 |
|
| 21926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALS2CR12 |
0.810576447593369 |
|
| 21927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAK2 |
0.810576447593369 |
|
| 21928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRADB |
0.810576447593369 |
|
| 21929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALS2CR11 |
0.810576447593369 |
|
| 21930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM237 |
0.810576447593369 |
|
| 21931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPP4 |
0.810576447593369 |
|
| 21932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALS2 |
0.810576447593369 |
|
| 21933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK15 |
0.810576447593369 |
|
| 21934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD7 |
0.810576447593369 |
|
| 21935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238770.1 |
0.810576447593369 |
|
| 21936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUMO1 |
0.810576447593369 |
|
| 21937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP58 |
0.810576447593369 |
|
| 21938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD70|ENSG00000212534.1 |
0.810576447593369 |
|
| 21939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD70|ENSG00000212309.1 |
0.810576447593369 |
|
| 21940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD11B |
0.810576447593369 |
|
| 21941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD11|ENSG00000238317.1 |
0.810576447593369 |
|
| 21942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL753P |
0.810576447593369 |
|
| 21943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL40P |
0.810576447593369 |
|
| 21944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMPR2 |
0.810576447593369 |
|
| 21945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM117B |
0.810576447593369 |
|
| 21946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICA1L |
0.810576447593369 |
|
| 21947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR12 |
0.810576447593369 |
|
| 21948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARF |
0.810576447593369 |
|
| 21949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBEAL1 |
0.810576447593369 |
|
| 21950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA1|ENSG00000202059.1 |
0.810576447593369 |
|
| 21951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP20A1 |
0.810576447593369 |
|
| 21952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL670P |
0.810576447593369 |
|
| 21953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABI2 |
0.810576447593369 |
|
| 21954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAPH1 |
0.810576447593369 |
|
| 21955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD28 |
0.810576447593369 |
|
| 21956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTLA4 |
0.810576447593369 |
|
| 21957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ICOS |
0.810576447593369 |
|
| 21958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARD3B |
0.810576447593369 |
|
| 21959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRP2 |
0.810576447593369 |
|
| 21960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP178 |
0.810576447593369 |
|
| 21961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INO80D |
0.810576447593369 |
|
| 21962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
Vault|ENSG00000252485.1 |
0.810576447593369 |
|
| 21963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS1 |
0.810576447593369 |
|
| 21964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1B2 |
0.810576447593369 |
|
| 21965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA41|ENSG00000207406.1 |
0.810576447593369 |
|
| 21966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD51|ENSG00000207047.2 |
0.810576447593369 |
|
| 21967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR1 |
0.810576447593369 |
|
| 21968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP200 |
0.810576447593369 |
|
| 21969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP260 |
0.810576447593369 |
|
| 21970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDBF2 |
0.810576447593369 |
|
| 21971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM23 |
0.810576447593369 |
|
| 21972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYTN |
0.810576447593369 |
|
| 21973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDH1B |
0.810576447593369 |
|
| 21974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FASTKD2 |
0.810576447593369 |
|
| 21975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPO |
0.810576447593369 |
|
| 21976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF7 |
0.810576447593369 |
|
| 21977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2355 |
0.810576447593369 |
|
| 21978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREB1 |
0.810576447593369 |
|
| 21979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL21A |
0.810576447593369 |
|
| 21980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNYL1 |
0.810576447593369 |
|
| 21981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4775 |
0.810576447593369 |
|
| 21982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD5 |
0.810576447593369 |
|
| 21983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHM3 |
0.810576447593369 |
|
| 21984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP116 |
0.810576447593369 |
|
| 21985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238582.1 |
0.810576447593369 |
|
| 21986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGEP |
0.810576447593369 |
|
| 21987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGD |
0.810576447593369 |
|
| 21988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGC |
0.810576447593369 |
|
| 21989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGB |
0.810576447593369 |
|
| 21990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYGA |
0.810576447593369 |
|
| 21991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf80 |
0.810576447593369 |
|
| 21992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDH1 |
0.810576447593369 |
|
| 21993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIKFYVE |
0.810576447593369 |
|
| 21994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTH2R |
0.810576447593369 |
|
| 21995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP117 |
0.810576447593369 |
|
| 21996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP2 |
0.810576447593369 |
|
| 21997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP118 |
0.810576447593369 |
|
| 21998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC80 |
0.810576447593369 |
|
| 21999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPE |
0.810576447593369 |
|
| 22000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANSL1L |
0.810576447593369 |
|
| 22001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACADL |
0.810576447593369 |
|
| 22002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL1 |
0.810576447593369 |
|
| 22003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LANCL1 |
0.810576447593369 |
|
| 22004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPS1 |
0.810576447593369 |
|
| 22005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERBB4 |
0.810576447593369 |
|
| 22006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP119 |
0.810576447593369 |
|
| 22007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548F2 |
0.810576447593369 |
|
| 22008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKZF2 |
0.810576447593369 |
|
| 22009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPAG16 |
0.810576447593369 |
|
| 22010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4438 |
0.810576447593369 |
|
| 22011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWC2L |
0.810576447593369 |
|
| 22012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BARD1 |
0.810576447593369 |
|
| 22013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000207274.1 |
0.810576447593369 |
|
| 22014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA12 |
0.810576447593369 |
|
| 22015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238663.1 |
0.810576447593369 |
|
| 22016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATIC |
0.810576447593369 |
|
| 22017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FN1 |
0.810576447593369 |
|
| 22018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00607 |
0.810576447593369 |
|
| 22019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MREG |
0.810576447593369 |
|
| 22020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PECR |
0.810576447593369 |
|
| 22021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM169 |
0.810576447593369 |
|
| 22022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XRCC5 |
0.810576447593369 |
|
| 22023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARCH4 |
0.810576447593369 |
|
| 22024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCAL1 |
0.810576447593369 |
|
| 22025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL37A |
0.810576447593369 |
|
| 22026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP2 |
0.810576447593369 |
|
| 22027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFBP5 |
0.810576447593369 |
|
| 22028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP120 |
0.810576447593369 |
|
| 22029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNP1 |
0.810576447593369 |
|
| 22030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP43 |
0.810576447593369 |
|
| 22031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIRC3 |
0.810576447593369 |
|
| 22032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNS1 |
0.810576447593369 |
|
| 22033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RUFY4 |
0.810576447593369 |
|
| 22034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR2P1 |
0.810576447593369 |
|
| 22035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR2 |
0.810576447593369 |
|
| 22036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXCR1 |
0.810576447593369 |
|
| 22037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238428.1 |
0.810576447593369 |
|
| 22038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC2 |
0.810576447593369 |
|
| 22039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AAMP |
0.810576447593369 |
|
| 22040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPBAR1 |
0.810576447593369 |
|
| 22041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNKD |
0.810576447593369 |
|
| 22042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMBIM1 |
0.810576447593369 |
|
| 22043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238736.1 |
0.810576447593369 |
|
| 22044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf62 |
0.810576447593369 |
|
| 22045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC11A1 |
0.810576447593369 |
|
| 22046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTDSP1 |
0.810576447593369 |
|
| 22047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR26B |
0.810576447593369 |
|
| 22048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VIL1 |
0.810576447593369 |
|
| 22049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP37 |
0.810576447593369 |
|
| 22050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP38 |
0.810576447593369 |
|
| 22051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RQCD1 |
0.810576447593369 |
|
| 22052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCD4 |
0.810576447593369 |
|
| 22053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000252805.1 |
0.810576447593369 |
|
| 22054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF142 |
0.810576447593369 |
|
| 22055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCS1L |
0.810576447593369 |
|
| 22056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF25 |
0.810576447593369 |
|
| 22057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK36 |
0.810576447593369 |
|
| 22058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL4 |
0.810576447593369 |
|
| 22059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP27A1 |
0.810576447593369 |
|
| 22060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAG3 |
0.810576447593369 |
|
| 22061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT6 |
0.810576447593369 |
|
| 22062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WNT10A |
0.810576447593369 |
|
| 22063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK5R2 |
0.810576447593369 |
|
| 22064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00608 |
0.810576447593369 |
|
| 22065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBA2 |
0.810576447593369 |
|
| 22066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEV |
0.810576447593369 |
|
| 22067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC108 |
0.810576447593369 |
|
| 22068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR375 |
0.810576447593369 |
|
| 22069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IHH |
0.810576447593369 |
|
| 22070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3131 |
0.810576447593369 |
|
| 22071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHEJ1 |
0.810576447593369 |
|
| 22072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC23A3 |
0.810576447593369 |
|
| 22073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL764P |
0.810576447593369 |
|
| 22074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNPPD1 |
0.810576447593369 |
|
| 22075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM134A |
0.810576447593369 |
|
| 22076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND2B |
0.810576447593369 |
|
| 22077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB6 |
0.810576447593369 |
|
| 22078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG9A |
0.810576447593369 |
|
| 22079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKZF1 |
0.810576447593369 |
|
| 22080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLB1L |
0.810576447593369 |
|
| 22081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK16 |
0.810576447593369 |
|
| 22082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA4A |
0.810576447593369 |
|
| 22083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBA4B |
0.810576447593369 |
|
| 22084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJB2 |
0.810576447593369 |
|
| 22085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRN |
0.810576447593369 |
|
| 22086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RESP18 |
0.810576447593369 |
|
| 22087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNPEP |
0.810576447593369 |
|
| 22088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DES |
0.810576447593369 |
|
| 22089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPEG |
0.810576447593369 |
|
| 22090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMPPA |
0.810576447593369 |
|
| 22091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASIC4 |
0.810576447593369 |
|
| 22092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHPF |
0.810576447593369 |
|
| 22093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM198 |
0.810576447593369 |
|
| 22094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3132 |
0.810576447593369 |
|
| 22095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OBSL1 |
0.810576447593369 |
|
| 22096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
INHA |
0.810576447593369 |
|
| 22097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP213 |
0.810576447593369 |
|
| 22098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK11IP |
0.810576447593369 |
|
| 22099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC4A3 |
0.810576447593369 |
|
| 22100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4268 |
0.810576447593369 |
|
| 22101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPHA4 |
0.810576447593369 |
|
| 22102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAX3 |
0.810576447593369 |
|
| 22103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC140 |
0.810576447593369 |
|
| 22104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGPP2 |
0.810576447593369 |
|
| 22105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FARSB |
0.810576447593369 |
|
| 22106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOGAT1 |
0.810576447593369 |
|
| 22107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238852.1 |
0.810576447593369 |
|
| 22108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSL3 |
0.810576447593369 |
|
| 22109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNE4 |
0.810576447593369 |
|
| 22110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL807P |
0.810576447593369 |
|
| 22111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCG2 |
0.810576447593369 |
|
| 22112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1S3 |
0.810576447593369 |
|
| 22113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDFY1 |
0.810576447593369 |
|
| 22114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL44 |
0.810576447593369 |
|
| 22115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINE2 |
0.810576447593369 |
|
| 22116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM124B |
0.810576447593369 |
|
| 22117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUL3 |
0.810576447593369 |
|
| 22118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DOCK10 |
0.810576447593369 |
|
| 22119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4439 |
0.810576447593369 |
|
| 22120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NYAP2 |
0.810576447593369 |
|
| 22121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5702 |
0.810576447593369 |
|
| 22122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRS1 |
0.810576447593369 |
|
| 22123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDD1 |
0.810576447593369 |
|
| 22124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212391.1 |
0.810576447593369 |
|
| 22125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A4 |
0.810576447593369 |
|
| 22126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A3 |
0.810576447593369 |
|
| 22127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFF |
0.810576447593369 |
|
| 22128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TM4SF20 |
0.810576447593369 |
|
| 22129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGFG1 |
0.810576447593369 |
|
| 22130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5703 |
0.810576447593369 |
|
| 22131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf83 |
0.810576447593369 |
|
| 22132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC19A3 |
0.810576447593369 |
|
| 22133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP121 |
0.810576447593369 |
|
| 22134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCL20 |
0.810576447593369 |
|
| 22135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAW1 |
0.810576447593369 |
|
| 22136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA25|ENSG00000272237.1 |
0.810576447593369 |
|
| 22137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPHKAP |
0.810576447593369 |
|
| 22138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251801.1 |
0.810576447593369 |
|
| 22139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PID1 |
0.810576447593369 |
|
| 22140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP283 |
0.810576447593369 |
|
| 22141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNER |
0.810576447593369 |
|
| 22142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO36 |
0.810576447593369 |
|
| 22143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP12 |
0.810576447593369 |
|
| 22144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC16A14 |
0.810576447593369 |
|
| 22145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNY4P19 |
0.810576447593369 |
|
| 22146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP110 |
0.810576447593369 |
|
| 22147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP140 |
0.810576447593369 |
|
| 22148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP140L |
0.810576447593369 |
|
| 22149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SP100 |
0.810576447593369 |
|
| 22150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL834P |
0.810576447593369 |
|
| 22151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAB39 |
0.810576447593369 |
|
| 22152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITM2C |
0.810576447593369 |
|
| 22153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR55 |
0.810576447593369 |
|
| 22154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA3 |
0.810576447593369 |
|
| 22155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf72 |
0.810576447593369 |
|
| 22156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD1 |
0.810576447593369 |
|
| 22157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR2B |
0.810576447593369 |
|
| 22158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARMC9 |
0.810576447593369 |
|
| 22159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4777 |
0.810576447593369 |
|
| 22160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT7 |
0.810576447593369 |
|
| 22161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATAD2B |
0.81080603715401 |
|
| 22162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBXN2A |
0.81080603715401 |
|
| 22163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL610P |
0.81080603715401 |
|
| 22164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFSD2B |
0.81080603715401 |
|
| 22165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf44 |
0.81080603715401 |
|
| 22166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKBP1B |
0.81080603715401 |
|
| 22167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B14 |
0.81080603715401 |
|
| 22168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM228B |
0.81080603715401 |
|
| 22169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53I3 |
0.81080603715401 |
|
| 22170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFN4 |
0.81080603715401 |
|
| 22171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM228A |
0.81080603715401 |
|
| 22172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITSN2 |
0.81080603715401 |
|
| 22173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEURL3 |
0.81080603715401 |
|
| 22174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID5A |
0.81080603715401 |
|
| 22175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KANSL3 |
0.81080603715401 |
|
| 22176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FER1L5 |
0.81080603715401 |
|
| 22177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMAN2L |
0.81080603715401 |
|
| 22178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNNM4 |
0.81080603715401 |
|
| 22179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3127 |
0.81080603715401 |
|
| 22180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNNM3 |
0.81080603715401 |
|
| 22181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD23 |
0.81080603715401 |
|
| 22182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD39 |
0.81080603715401 |
|
| 22183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA4C |
0.81080603715401 |
|
| 22184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM178B |
0.81080603715401 |
|
| 22185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP101 |
0.81080603715401 |
|
| 22186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238760.1 |
0.81080603715401 |
|
| 22187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KAT8 |
0.820045456064907 |
|
| 22188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS8 |
0.820045456064907 |
|
| 22189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS36 |
0.820045456064907 |
|
| 22190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUS |
0.820045456064907 |
|
| 22191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf98 |
0.820045456064907 |
|
| 22192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYCARD |
0.820045456064907 |
|
| 22193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PYDC1 |
0.820045456064907 |
|
| 22194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM72 |
0.820045456064907 |
|
| 22195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAM |
0.820045456064907 |
|
| 22196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAX |
0.820045456064907 |
|
| 22197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGAD |
0.820045456064907 |
|
| 22198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6A2 |
0.820045456064907 |
|
| 22199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLUHP3 |
0.820045456064907 |
|
| 22200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF720 |
0.820045456064907 |
|
| 22201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCL |
0.822778697063981 |
|
| 22202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000206885.1 |
0.822778697063981 |
|
| 22203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD20 |
0.822778697063981 |
|
| 22204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD82 |
0.822778697063981 |
|
| 22205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf57 |
0.822778697063981 |
|
| 22206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00471 |
0.822778697063981 |
|
| 22207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMUR1 |
0.822778697063981 |
|
| 22208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL499P |
0.822778697063981 |
|
| 22209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGC4771 |
0.822778697063981 |
|
| 22210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTMA |
0.822778697063981 |
|
| 22211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE6D |
0.822778697063981 |
|
| 22212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLEC12 |
0.823785797752587 |
|
| 22213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROCK1P1 |
0.823785797752587 |
|
| 22214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC1 |
0.823785797752587 |
|
| 22215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP14 |
0.823785797752587 |
|
| 22216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C18orf56 |
0.823785797752587 |
|
| 22217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CETN1 |
0.823785797752587 |
|
| 22218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLUL1 |
0.823785797752587 |
|
| 22219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENOSF1 |
0.823785797752587 |
|
| 22220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP146 |
0.823785797752587 |
|
| 22221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TYMS |
0.823785797752587 |
|
| 22222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YES1 |
0.823785797752587 |
|
| 22223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADCYAP1 |
0.823785797752587 |
|
| 22224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00470 |
0.823785797752587 |
|
| 22225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP72 |
0.823785797752587 |
|
| 22226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL4 |
0.823785797752587 |
|
| 22227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBX3P2 |
0.823785797752587 |
|
| 22228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDC80 |
0.823785797752587 |
|
| 22229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMCHD1 |
0.823785797752587 |
|
| 22230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU109|ENSG00000238575.1 |
0.823785797752587 |
|
| 22231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238425.1 |
0.823785797752587 |
|
| 22232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMILIN2 |
0.823785797752587 |
|
| 22233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPIN2 |
0.823785797752587 |
|
| 22234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252258.1 |
0.823785797752587 |
|
| 22235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B5 |
0.824006749847894 |
|
| 22236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDC2 |
0.829134535195262 |
|
| 22237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPQ |
0.829134535195262 |
|
| 22238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPYL5 |
0.829134535195262 |
|
| 22239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000207215.1 |
0.829134535195262 |
|
| 22240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTDH |
0.829134535195262 |
|
| 22241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAPTM4B |
0.829134535195262 |
|
| 22242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MATN2 |
0.829134535195262 |
|
| 22243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL30 |
0.829134535195262 |
|
| 22244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA72|ENSG00000207067.1 |
0.829134535195262 |
|
| 22245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C8orf47 |
0.829134535195262 |
|
| 22246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRSP12 |
0.829134535195262 |
|
| 22247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POP1 |
0.829134535195262 |
|
| 22248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPAL2 |
0.829134535195262 |
|
| 22249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STK3 |
0.829134535195262 |
|
| 22250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNS2 |
0.829134535195262 |
|
| 22251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP85 |
0.829134535195262 |
|
| 22252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSR2 |
0.829134535195262 |
|
| 22253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS13B |
0.829134535195262 |
|
| 22254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR599 |
0.829134535195262 |
|
| 22255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR875 |
0.829134535195262 |
|
| 22256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL350P |
0.829134535195262 |
|
| 22257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6C |
0.829134535195262 |
|
| 22258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD77|ENSG00000212414.1 |
0.829134535195262 |
|
| 22259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1273A |
0.829134535195262 |
|
| 22260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC73 |
0.831512660758991 |
|
| 22261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LARP1 |
0.833504423789858 |
|
| 22262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAXDC2 |
0.833504423789858 |
|
| 22263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR378H |
0.833504423789858 |
|
| 22264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT8 |
0.833504423789858 |
|
| 22265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GEMIN5 |
0.833504423789858 |
|
| 22266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL22 |
0.833504423789858 |
|
| 22267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF4B |
0.833504423789858 |
|
| 22268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP199 |
0.833504423789858 |
|
| 22269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGCD |
0.833504423789858 |
|
| 22270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITIH6 |
0.83804453634337 |
|
| 22271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGED2 |
0.83804453634337 |
|
| 22272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221716.1 |
0.83804453634337 |
|
| 22273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRO |
0.83804453634337 |
|
| 22274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11|ENSG00000221750.1 |
0.83804453634337 |
|
| 22275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PFKFB1 |
0.83804453634337 |
|
| 22276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALAS2 |
0.83804453634337 |
|
| 22277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APEX2 |
0.83804453634337 |
|
| 22278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE2B |
0.83804453634337 |
|
| 22279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE2 |
0.83804453634337 |
|
| 22280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM104B |
0.83804453634337 |
|
| 22281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L10 |
0.83804453634337 |
|
| 22282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE5 |
0.83804453634337 |
|
| 22283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE3 |
0.83804453634337 |
|
| 22284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEH1 |
0.83804453634337 |
|
| 22285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP51 |
0.83804453634337 |
|
| 22286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXR2 |
0.83804453634337 |
|
| 22287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRAGB |
0.83804453634337 |
|
| 22288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252961.1 |
0.83804453634337 |
|
| 22289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF8 |
0.83804453634337 |
|
| 22290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBQLN2 |
0.83804453634337 |
|
| 22291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIN3 |
0.83804453634337 |
|
| 22292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIN2A |
0.83804453634337 |
|
| 22293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIN2B |
0.83804453634337 |
|
| 22294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAAH2 |
0.83804453634337 |
|
| 22295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZXDB |
0.83804453634337 |
|
| 22296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZXDA |
0.83804453634337 |
|
| 22297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKZF4 |
0.843437878145172 |
|
| 22298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS26 |
0.843437878145172 |
|
| 22299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERBB3 |
0.843437878145172 |
|
| 22300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PA2G4 |
0.843437878145172 |
|
| 22301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL41 |
0.843437878145172 |
|
| 22302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESYT1 |
0.843437878145172 |
|
| 22303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H10 |
0.843437878145172 |
|
| 22304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL6B |
0.843437878145172 |
|
| 22305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL6 |
0.843437878145172 |
|
| 22306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMARCC2 |
0.843437878145172 |
|
| 22307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL770P |
0.843437878145172 |
|
| 22308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF41 |
0.843437878145172 |
|
| 22309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NABP2 |
0.843437878145172 |
|
| 22310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC39A5 |
0.843437878145172 |
|
| 22311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD52 |
0.843437878145172 |
|
| 22312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ10A |
0.843437878145172 |
|
| 22313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CS |
0.843437878145172 |
|
| 22314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNPY2 |
0.843437878145172 |
|
| 22315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAN2 |
0.843437878145172 |
|
| 22316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL23A |
0.843437878145172 |
|
| 22317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT2 |
0.843437878145172 |
|
| 22318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOF |
0.843437878145172 |
|
| 22319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMELESS |
0.843437878145172 |
|
| 22320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIP |
0.843437878145172 |
|
| 22321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPRYD4 |
0.843437878145172 |
|
| 22322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLS2 |
0.843437878145172 |
|
| 22323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBMS2 |
0.843437878145172 |
|
| 22324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAZ2A |
0.843437878145172 |
|
| 22325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP5B |
0.843437878145172 |
|
| 22326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD59A |
0.843437878145172 |
|
| 22327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGES3 |
0.843437878145172 |
|
| 22328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL809P |
0.843437878145172 |
|
| 22329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NACA |
0.843437878145172 |
|
| 22330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRIM1 |
0.843437878145172 |
|
| 22331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B6 |
0.843437878145172 |
|
| 22332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212383.1 |
0.843437878145172 |
|
| 22333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR9C7 |
0.843437878145172 |
|
| 22334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RDH16 |
0.843437878145172 |
|
| 22335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR182 |
0.843437878145172 |
|
| 22336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBCBP |
0.843437878145172 |
|
| 22337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBTB39 |
0.843437878145172 |
|
| 22338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAC3 |
0.843437878145172 |
|
| 22339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1A |
0.843437878145172 |
|
| 22340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM194A |
0.843437878145172 |
|
| 22341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAB2 |
0.843437878145172 |
|
| 22342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAT6 |
0.843437878145172 |
|
| 22343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRP1 |
0.843437878145172 |
|
| 22344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1228 |
0.843437878145172 |
|
| 22345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NXPH4 |
0.843437878145172 |
|
| 22346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA19|ENSG00000251822.1 |
0.843437878145172 |
|
| 22347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D15 |
0.843437878145172 |
|
| 22348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPH2 |
0.843437878145172 |
|
| 22349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRHDE |
0.843437878145172 |
|
| 22350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000201809.1 |
0.843437878145172 |
|
| 22351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN7L3B |
0.843437878145172 |
|
| 22352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLBD2 |
0.843437878145172 |
|
| 22353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDS |
0.843437878145172 |
|
| 22354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDSL |
0.843437878145172 |
|
| 22355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHX5 |
0.843437878145172 |
|
| 22356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM19 |
0.843437878145172 |
|
| 22357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM9B |
0.847395587090254 |
|
| 22358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP499 |
0.847395587090254 |
|
| 22359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBAS |
0.849902663314802 |
|
| 22360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX1 |
0.849902663314802 |
|
| 22361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238371.1 |
0.849902663314802 |
|
| 22362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCNOS |
0.849902663314802 |
|
| 22363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYCN |
0.849902663314802 |
|
| 22364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL104P |
0.849902663314802 |
|
| 22365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000251704.1 |
0.849902663314802 |
|
| 22366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNC2 |
0.851042132762291 |
|
| 22367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGDIG |
0.853208455471206 |
|
| 22368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AXIN1 |
0.853208455471206 |
|
| 22369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf11 |
0.853208455471206 |
|
| 22370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAPN15 |
0.853208455471206 |
|
| 22371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX11L10 |
0.853208455471206 |
|
| 22372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DECR2 |
0.853208455471206 |
|
| 22373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBA1 |
0.853208455471206 |
|
| 22374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBA2 |
0.853208455471206 |
|
| 22375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBM |
0.853208455471206 |
|
| 22376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBQ1 |
0.853208455471206 |
|
| 22377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HBZ |
0.853208455471206 |
|
| 22378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITFG3 |
0.853208455471206 |
|
| 22379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUC7L |
0.853208455471206 |
|
| 22380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3176 |
0.853208455471206 |
|
| 22381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5587 |
0.853208455471206 |
|
| 22382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPG |
0.853208455471206 |
|
| 22383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL28 |
0.853208455471206 |
|
| 22384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLRC4 |
0.853208455471206 |
|
| 22385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME4 |
0.853208455471206 |
|
| 22386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPRL3 |
0.853208455471206 |
|
| 22387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIA2 |
0.853208455471206 |
|
| 22388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGQ |
0.853208455471206 |
|
| 22389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3K |
0.853208455471206 |
|
| 22390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB11FIP3 |
0.853208455471206 |
|
| 22391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS11 |
0.853208455471206 |
|
| 22392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDF1 |
0.853208455471206 |
|
| 22393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP25 |
0.853208455471206 |
|
| 22394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM8A |
0.853208455471206 |
|
| 22395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASH4P |
0.853208455471206 |
|
| 22396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WASIR2 |
0.853208455471206 |
|
| 22397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPS8 |
0.855943849774787 |
|
| 22398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRAP |
0.855943849774787 |
|
| 22399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DERA |
0.855943849774787 |
|
| 22400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC37P |
0.856292334092232 |
|
| 22401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00299 |
0.856292334092232 |
|
| 22402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ID2 |
0.856292334092232 |
|
| 22403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIDINS220 |
0.856292334092232 |
|
| 22404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBOAT2 |
0.856292334092232 |
|
| 22405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238888.1 |
0.856292334092232 |
|
| 22406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASAP2 |
0.856292334092232 |
|
| 22407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGB1BP1 |
0.856292334092232 |
|
| 22408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF3 |
0.856292334092232 |
|
| 22409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IAH1 |
0.856292334092232 |
|
| 22410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAM17 |
0.856292334092232 |
|
| 22411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238462.1 |
0.856292334092232 |
|
| 22412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YWHAQ |
0.856292334092232 |
|
| 22413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1B |
0.856292334092232 |
|
| 22414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRHL1 |
0.856292334092232 |
|
| 22415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF11 |
0.856292334092232 |
|
| 22416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYS1 |
0.856292334092232 |
|
| 22417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA26|ENSG00000212558.1 |
0.856292334092232 |
|
| 22418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRM2 |
0.856292334092232 |
|
| 22419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf48 |
0.856292334092232 |
|
| 22420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA2|ENSG00000206647.1 |
0.856292334092232 |
|
| 22421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4261 |
0.856292334092232 |
|
| 22422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL66P |
0.856292334092232 |
|
| 22423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000206898.1 |
0.856292334092232 |
|
| 22424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPCAL1 |
0.856292334092232 |
|
| 22425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODC1 |
0.856292334092232 |
|
| 22426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA80B |
0.856292334092232 |
|
| 22427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL10 |
0.856292334092232 |
|
| 22428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL832P |
0.856292334092232 |
|
| 22429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V1C2 |
0.856292334092232 |
|
| 22430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDIA6 |
0.856292334092232 |
|
| 22431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNF1 |
0.856292334092232 |
|
| 22432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C2orf50 |
0.856292334092232 |
|
| 22433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PQLC3 |
0.856292334092232 |
|
| 22434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROCK2 |
0.856292334092232 |
|
| 22435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00570 |
0.856292334092232 |
|
| 22436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F6 |
0.856292334092232 |
|
| 22437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP84 |
0.856292334092232 |
|
| 22438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GREB1 |
0.856292334092232 |
|
| 22439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4429 |
0.856292334092232 |
|
| 22440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP85 |
0.856292334092232 |
|
| 22441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL674P |
0.856292334092232 |
|
| 22442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTSR2 |
0.856292334092232 |
|
| 22443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPIN1 |
0.856292334092232 |
|
| 22444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548S |
0.856292334092232 |
|
| 22445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4262 |
0.856292334092232 |
|
| 22446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD18|ENSG00000238503.1 |
0.856292334092232 |
|
| 22447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3681 |
0.856292334092232 |
|
| 22448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIB2 |
0.856292334092232 |
|
| 22449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3125 |
0.856292334092232 |
|
| 22450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM84A |
0.856292334092232 |
|
| 22451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD20A11P |
0.857589067005251 |
|
| 22452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD30BP2 |
0.857589067005251 |
|
| 22453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAGE2 |
0.857589067005251 |
|
| 22454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP4F29P |
0.857589067005251 |
|
| 22455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3648 |
0.857589067005251 |
|
| 22456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3687 |
0.857589067005251 |
|
| 22457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTED |
0.857589067005251 |
|
| 22458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL52P |
0.857589067005251 |
|
| 22459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000252199.1 |
0.857589067005251 |
|
| 22460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT4P2 |
0.857589067005251 |
|
| 22461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPTE |
0.857589067005251 |
|
| 22462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP488 |
0.857589067005251 |
|
| 22463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIPI |
0.857589067005251 |
|
| 22464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM11 |
0.857589067005251 |
|
| 22465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC13 |
0.857589067005251 |
|
| 22466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPA13 |
0.857589067005251 |
|
| 22467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000201025.1 |
0.857589067005251 |
|
| 22468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR99A |
0.857589067005251 |
|
| 22469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7C |
0.857589067005251 |
|
| 22470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR125B2 |
0.857589067005251 |
|
| 22471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BFAR |
0.860466300935801 |
|
| 22472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC1 |
0.860466300935801 |
|
| 22473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC6P1 |
0.860466300935801 |
|
| 22474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC6 |
0.860466300935801 |
|
| 22475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL6IP1 |
0.860466300935801 |
|
| 22476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf45 |
0.860466300935801 |
|
| 22477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOPNL |
0.860466300935801 |
|
| 22478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0430 |
0.860466300935801 |
|
| 22479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR484 |
0.860466300935801 |
|
| 22480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPV17L |
0.860466300935801 |
|
| 22481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYH11 |
0.860466300935801 |
|
| 22482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDE1 |
0.860466300935801 |
|
| 22483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOMO1 |
0.860466300935801 |
|
| 22484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOMO2 |
0.860466300935801 |
|
| 22485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOMO3 |
0.860466300935801 |
|
| 22486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA1 |
0.860466300935801 |
|
| 22487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA2 |
0.860466300935801 |
|
| 22488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA3 |
0.860466300935801 |
|
| 22489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA5 |
0.860466300935801 |
|
| 22490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA7 |
0.860466300935801 |
|
| 22491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPA8 |
0.860466300935801 |
|
| 22492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPIPP1 |
0.860466300935801 |
|
| 22493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTAN1 |
0.860466300935801 |
|
| 22494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDXDC1 |
0.860466300935801 |
|
| 22495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1P5 |
0.860466300935801 |
|
| 22496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1P6 |
0.860466300935801 |
|
| 22497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G10 |
0.860466300935801 |
|
| 22498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL90P |
0.860466300935801 |
|
| 22499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS15A |
0.860466300935801 |
|
| 22500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RRN3 |
0.860466300935801 |
|
| 22501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XYLT1 |
0.860466300935801 |
|
| 22502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF843 |
0.863897941862753 |
|
| 22503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD26P1 |
0.863901004779933 |
|
| 22504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP23P1 |
0.863901004779933 |
|
| 22505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P4 |
0.863901004779933 |
|
| 22506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P5 |
0.863901004779933 |
|
| 22507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P8 |
0.863901004779933 |
|
| 22508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00273 |
0.863901004779933 |
|
| 22509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP406 |
0.863901004779933 |
|
| 22510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP407 |
0.863901004779933 |
|
| 22511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP408 |
0.863901004779933 |
|
| 22512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP409 |
0.863901004779933 |
|
| 22513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP410 |
0.863901004779933 |
|
| 22514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP413 |
0.863901004779933 |
|
| 22515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP415 |
0.863901004779933 |
|
| 22516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP416 |
0.863901004779933 |
|
| 22517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP417 |
0.863901004779933 |
|
| 22518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP418 |
0.863901004779933 |
|
| 22519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP419 |
0.863901004779933 |
|
| 22520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP420 |
0.863901004779933 |
|
| 22521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP421 |
0.863901004779933 |
|
| 22522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP422 |
0.863901004779933 |
|
| 22523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP423 |
0.863901004779933 |
|
| 22524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A10P |
0.863901004779933 |
|
| 22525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG3B |
0.863901004779933 |
|
| 22526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG3C |
0.863901004779933 |
|
| 22527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG3D |
0.863901004779933 |
|
| 22528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TP53TG3 |
0.863901004779933 |
|
| 22529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF267 |
0.863901004779933 |
|
| 22530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR140 |
0.863901004779933 |
|
| 22531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC18A |
0.863901004779933 |
|
| 22532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC18C |
0.863901004779933 |
|
| 22533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDPR |
0.863901004779933 |
|
| 22534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDXDC2P |
0.863901004779933 |
|
| 22535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG63 |
0.863901004779933 |
|
| 22536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238734.1 |
0.863901004779933 |
|
| 22537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AARS |
0.863901004779933 |
|
| 22538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOSC6 |
0.863901004779933 |
|
| 22539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL407P |
0.863901004779933 |
|
| 22540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL279P |
0.863901004779933 |
|
| 22541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX19B |
0.863901004779933 |
|
| 22542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX19A |
0.863901004779933 |
|
| 22543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST3GAL2 |
0.863901004779933 |
|
| 22544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUK |
0.863901004779933 |
|
| 22545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COG4 |
0.863901004779933 |
|
| 22546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SF3B3 |
0.863901004779933 |
|
| 22547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD111B |
0.863901004779933 |
|
| 22548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD111|ENSG00000221066.1 |
0.863901004779933 |
|
| 22549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL34 |
0.863901004779933 |
|
| 22550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ00418 |
0.863901004779933 |
|
| 22551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTSS1L |
0.863901004779933 |
|
| 22552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAC14 |
0.863901004779933 |
|
| 22553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYDIN |
0.863901004779933 |
|
| 22554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC25P |
0.863901004779933 |
|
| 22555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251700.1 |
0.863901004779933 |
|
| 22556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTSJD1 |
0.863901004779933 |
|
| 22557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CALB2 |
0.863901004779933 |
|
| 22558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF23 |
0.863901004779933 |
|
| 22559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF19 |
0.863901004779933 |
|
| 22560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST4 |
0.863901004779933 |
|
| 22561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAT |
0.863901004779933 |
|
| 22562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARVELD3 |
0.863901004779933 |
|
| 22563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHLPP2 |
0.863901004779933 |
|
| 22564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70D |
0.863901004779933 |
|
| 22565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1G1 |
0.863901004779933 |
|
| 22566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD71 |
0.863901004779933 |
|
| 22567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN1L |
0.863901004779933 |
|
| 22568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF821 |
0.863901004779933 |
|
| 22569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IST1 |
0.863901004779933 |
|
| 22570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1L3 |
0.863901004779933 |
|
| 22571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHODH |
0.863901004779933 |
|
| 22572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNL4B |
0.863901004779933 |
|
| 22573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPR |
0.863901004779933 |
|
| 22574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HP |
0.863901004779933 |
|
| 22575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX38 |
0.863901004779933 |
|
| 22576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMFBP1 |
0.863901004779933 |
|
| 22577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFHX3 |
0.863901004779933 |
|
| 22578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCCAT5 |
0.863901004779933 |
|
| 22579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf47 |
0.863901004779933 |
|
| 22580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLG1 |
0.863901004779933 |
|
| 22581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFWD3 |
0.863901004779933 |
|
| 22582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLKL |
0.863901004779933 |
|
| 22583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FA2H |
0.863901004779933 |
|
| 22584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR59 |
0.863901004779933 |
|
| 22585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNRF1 |
0.863901004779933 |
|
| 22586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHD |
0.863901004779933 |
|
| 22587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP1 |
0.863901004779933 |
|
| 22588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTRB1 |
0.863901004779933 |
|
| 22589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTRB2 |
0.863901004779933 |
|
| 22590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAR1 |
0.863901004779933 |
|
| 22591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFDP1 |
0.863901004779933 |
|
| 22592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA76|ENSG00000252122.1 |
0.863901004779933 |
|
| 22593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM170A |
0.863901004779933 |
|
| 22594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST6 |
0.863901004779933 |
|
| 22595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST5 |
0.863901004779933 |
|
| 22596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM231 |
0.863901004779933 |
|
| 22597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABARAPL2 |
0.863901004779933 |
|
| 22598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAT1 |
0.863901004779933 |
|
| 22599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KARS |
0.863901004779933 |
|
| 22600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TERF2IP |
0.863901004779933 |
|
| 22601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL520P |
0.863901004779933 |
|
| 22602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP430 |
0.863901004779933 |
|
| 22603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTNAP4 |
0.863901004779933 |
|
| 22604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP233 |
0.863901004779933 |
|
| 22605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD33|ENSG00000252022.1 |
0.863901004779933 |
|
| 22606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4719 |
0.863901004779933 |
|
| 22607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MON1B |
0.863901004779933 |
|
| 22608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCE1L |
0.863901004779933 |
|
| 22609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS18 |
0.863901004779933 |
|
| 22610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT7 |
0.863901004779933 |
|
| 22611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VAT1L |
0.863901004779933 |
|
| 22612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC3A |
0.863901004779933 |
|
| 22613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIH1 |
0.863901004779933 |
|
| 22614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP431 |
0.863901004779933 |
|
| 22615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAF |
0.863901004779933 |
|
| 22616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLRB2 |
0.863901004779933 |
|
| 22617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDYL2 |
0.863901004779933 |
|
| 22618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMC2 |
0.863901004779933 |
|
| 22619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPN |
0.863901004779933 |
|
| 22620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATMIN |
0.863901004779933 |
|
| 22621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf46 |
0.863901004779933 |
|
| 22622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCSH |
0.863901004779933 |
|
| 22623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1L2 |
0.863901004779933 |
|
| 22624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCMO1 |
0.863901004779933 |
|
| 22625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAN |
0.863901004779933 |
|
| 22626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4720 |
0.863901004779933 |
|
| 22627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMIP |
0.863901004779933 |
|
| 22628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCG2 |
0.863901004779933 |
|
| 22629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000260682.2 |
0.863901004779933 |
|
| 22630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDR42E1 |
0.863901004779933 |
|
| 22631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B2 |
0.863901004779933 |
|
| 22632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPHOSPH6 |
0.863901004779933 |
|
| 22633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP190 |
0.863901004779933 |
|
| 22634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238321.1 |
0.863901004779933 |
|
| 22635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH13 |
0.863901004779933 |
|
| 22636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL134P |
0.863901004779933 |
|
| 22637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3182 |
0.863901004779933 |
|
| 22638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSBP1 |
0.863901004779933 |
|
| 22639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLYCD |
0.863901004779933 |
|
| 22640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSGIN1 |
0.863901004779933 |
|
| 22641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NECAB2 |
0.863901004779933 |
|
| 22642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBTPS1 |
0.863901004779933 |
|
| 22643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP432 |
0.863901004779933 |
|
| 22644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A8 |
0.863901004779933 |
|
| 22645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSDL1 |
0.863901004779933 |
|
| 22646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAAF1 |
0.863901004779933 |
|
| 22647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAD2 |
0.863901004779933 |
|
| 22648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2C2 |
0.863901004779933 |
|
| 22649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COTL1 |
0.863901004779933 |
|
| 22650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRISPLD2 |
0.863901004779933 |
|
| 22651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNG4 |
0.863901004779933 |
|
| 22652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL36 |
0.863901004779933 |
|
| 22653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP433 |
0.863901004779933 |
|
| 22654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF1C |
0.863901004779933 |
|
| 22655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TLDC1 |
0.863901004779933 |
|
| 22656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP10 |
0.863901004779933 |
|
| 22657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFDC1 |
0.863901004779933 |
|
| 22658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC7 |
0.863901004779933 |
|
| 22659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0513 |
0.863901004779933 |
|
| 22660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM92B |
0.863901004779933 |
|
| 22661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00311 |
0.863901004779933 |
|
| 22662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5093 |
0.863901004779933 |
|
| 22663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSE1 |
0.863901004779933 |
|
| 22664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL381P |
0.863901004779933 |
|
| 22665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GINS2 |
0.863901004779933 |
|
| 22666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf74 |
0.863901004779933 |
|
| 22667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1910 |
0.863901004779933 |
|
| 22668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC8 |
0.863901004779933 |
|
| 22669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX4I1 |
0.863901004779933 |
|
| 22670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF8 |
0.863901004779933 |
|
| 22671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00917 |
0.863901004779933 |
|
| 22672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FENDRR |
0.863901004779933 |
|
| 22673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXF1 |
0.863901004779933 |
|
| 22674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFSD |
0.863901004779933 |
|
| 22675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXC2 |
0.863901004779933 |
|
| 22676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXL1 |
0.863901004779933 |
|
| 22677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf95 |
0.863901004779933 |
|
| 22678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239186.1 |
0.863901004779933 |
|
| 22679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO31 |
0.863901004779933 |
|
| 22680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1LC3B |
0.863901004779933 |
|
| 22681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC14 |
0.863901004779933 |
|
| 22682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JPH3 |
0.863901004779933 |
|
| 22683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ00104 |
0.863901004779933 |
|
| 22684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHDC4 |
0.863901004779933 |
|
| 22685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC7A5 |
0.863901004779933 |
|
| 22686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA5A |
0.863901004779933 |
|
| 22687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BANP |
0.863901004779933 |
|
| 22688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF469 |
0.863901004779933 |
|
| 22689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFPM1 |
0.863901004779933 |
|
| 22690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSF3 |
0.863901004779933 |
|
| 22691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APRT |
0.863901004779933 |
|
| 22692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBFA2T3 |
0.863901004779933 |
|
| 22693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH15 |
0.863901004779933 |
|
| 22694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDT1 |
0.863901004779933 |
|
| 22695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTU2 |
0.863901004779933 |
|
| 22696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYBA |
0.863901004779933 |
|
| 22697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNS |
0.863901004779933 |
|
| 22698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL17C |
0.863901004779933 |
|
| 22699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00304 |
0.863901004779933 |
|
| 22700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4722 |
0.863901004779933 |
|
| 22701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5189 |
0.863901004779933 |
|
| 22702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MVD |
0.863901004779933 |
|
| 22703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PABPN1L |
0.863901004779933 |
|
| 22704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIEZO1 |
0.863901004779933 |
|
| 22705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF166 |
0.863901004779933 |
|
| 22706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A31 |
0.863901004779933 |
|
| 22707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNAI3 |
0.863901004779933 |
|
| 22708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC2L |
0.863901004779933 |
|
| 22709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H18 |
0.863901004779933 |
|
| 22710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF778 |
0.863901004779933 |
|
| 22711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD11 |
0.863901004779933 |
|
| 22712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AFG3L1P |
0.863901004779933 |
|
| 22713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf3 |
0.863901004779933 |
|
| 22714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK10 |
0.863901004779933 |
|
| 22715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPBD1 |
0.863901004779933 |
|
| 22716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHMP1A |
0.863901004779933 |
|
| 22717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPNE7 |
0.863901004779933 |
|
| 22718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DBNDD1 |
0.863901004779933 |
|
| 22719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEF8 |
0.863901004779933 |
|
| 22720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPEP1 |
0.863901004779933 |
|
| 22721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM157C |
0.863901004779933 |
|
| 22722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCA |
0.863901004779933 |
|
| 22723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS8 |
0.863901004779933 |
|
| 22724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MC1R |
0.863901004779933 |
|
| 22725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM7 |
0.863901004779933 |
|
| 22726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL13 |
0.863901004779933 |
|
| 22727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD68 |
0.863901004779933 |
|
| 22728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA2L |
0.863901004779933 |
|
| 22729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA33 |
0.863901004779933 |
|
| 22730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPG7 |
0.863901004779933 |
|
| 22731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIRE2 |
0.863901004779933 |
|
| 22732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCF25 |
0.863901004779933 |
|
| 22733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB3 |
0.863901004779933 |
|
| 22734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB8P7 |
0.863901004779933 |
|
| 22735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
URAHP |
0.863901004779933 |
|
| 22736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS9D1 |
0.863901004779933 |
|
| 22737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF276 |
0.863901004779933 |
|
| 22738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARK2 |
0.864795775625334 |
|
| 22739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD45|ENSG00000231297.2 |
0.865107274330825 |
|
| 22740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
T |
0.865107274330825 |
|
| 22741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR18 |
0.865107274330825 |
|
| 22742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFT2D1 |
0.865107274330825 |
|
| 22743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPC1 |
0.865107274330825 |
|
| 22744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1913 |
0.865107274330825 |
|
| 22745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASET2 |
0.865107274330825 |
|
| 22746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGFR1OP |
0.865107274330825 |
|
| 22747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3939 |
0.865107274330825 |
|
| 22748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCR6 |
0.865107274330825 |
|
| 22749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP10L2 |
0.865107274330825 |
|
| 22750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf123 |
0.865107274330825 |
|
| 22751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR31 |
0.865107274330825 |
|
| 22752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLLT4 |
0.865107274330825 |
|
| 22753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP10 |
0.865107274330825 |
|
| 22754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTLL2 |
0.865107274330825 |
|
| 22755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC93A |
0.865107274330825 |
|
| 22756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DACT2 |
0.865107274330825 |
|
| 22757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRMD1 |
0.865107274330825 |
|
| 22758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF25 |
0.865107274330825 |
|
| 22759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMOC2 |
0.865107274330825 |
|
| 22760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFAND6 |
0.866556565935283 |
|
| 22761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBB1 |
0.868381128498661 |
|
| 22762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRYBA4 |
0.868381128498661 |
|
| 22763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACP1 |
0.871328705351595 |
|
| 22764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM110C |
0.871328705351595 |
|
| 22765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM150B |
0.871328705351595 |
|
| 22766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH3YL1 |
0.871328705351595 |
|
| 22767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM18 |
0.871328705351595 |
|
| 22768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYT1L |
0.871328705351595 |
|
| 22769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXDN |
0.871328705351595 |
|
| 22770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNTG2 |
0.871328705351595 |
|
| 22771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPO |
0.871328705351595 |
|
| 22772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238722.1 |
0.871328705351595 |
|
| 22773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSC1 |
0.871328705351595 |
|
| 22774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC12 |
0.871328705351595 |
|
| 22775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADI1 |
0.871328705351595 |
|
| 22776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNASEH1 |
0.871328705351595 |
|
| 22777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS7 |
0.871328705351595 |
|
| 22778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA73|ENSG00000252531.1 |
0.871328705351595 |
|
| 22779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COLEC11 |
0.871328705351595 |
|
| 22780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALLC |
0.871328705351595 |
|
| 22781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCDC2C |
0.871328705351595 |
|
| 22782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL531P |
0.871328705351595 |
|
| 22783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252238.1 |
0.871328705351595 |
|
| 22784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX11 |
0.871328705351595 |
|
| 22785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ30594 |
0.871328705351595 |
|
| 22786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00487 |
0.871328705351595 |
|
| 22787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMPK2 |
0.871328705351595 |
|
| 22788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSAD2 |
0.871328705351595 |
|
| 22789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF144A |
0.871328705351595 |
|
| 22790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP112 |
0.871328705351595 |
|
| 22791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA1 |
0.875075112264419 |
|
| 22792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PELO |
0.875075112264419 |
|
| 22793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITGA2 |
0.875075112264419 |
|
| 22794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOCS2 |
0.875075112264419 |
|
| 22795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FST |
0.875075112264419 |
|
| 22796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS4 |
0.875075112264419 |
|
| 22797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL15 |
0.875075112264419 |
|
| 22798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR581 |
0.875075112264419 |
|
| 22799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL801P |
0.875075112264419 |
|
| 22800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4459 |
0.875075112264419 |
|
| 22801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB3 |
0.875075112264419 |
|
| 22802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX18 |
0.875075112264419 |
|
| 22803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ESM1 |
0.875075112264419 |
|
| 22804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZMK |
0.875075112264419 |
|
| 22805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GZMA |
0.875075112264419 |
|
| 22806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDC20B |
0.875075112264419 |
|
| 22807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPX8 |
0.875075112264419 |
|
| 22808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR449A |
0.875075112264419 |
|
| 22809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR449B |
0.875075112264419 |
|
| 22810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR449C |
0.875075112264419 |
|
| 22811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCIDAS |
0.875075112264419 |
|
| 22812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNO |
0.875075112264419 |
|
| 22813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX29 |
0.875075112264419 |
|
| 22814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SKIV2L2 |
0.875075112264419 |
|
| 22815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPAP2A |
0.875075112264419 |
|
| 22816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5687 |
0.875075112264419 |
|
| 22817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A9 |
0.875075112264419 |
|
| 22818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX4 |
0.875075112264419 |
|
| 22819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP183 |
0.875075112264419 |
|
| 22820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL31RA |
0.875075112264419 |
|
| 22821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL6ST |
0.875075112264419 |
|
| 22822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238326.1 |
0.875075112264419 |
|
| 22823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD55 |
0.875075112264419 |
|
| 22824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP184 |
0.875075112264419 |
|
| 22825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP185 |
0.875075112264419 |
|
| 22826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC2P |
0.875075112264419 |
|
| 22827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K1 |
0.875075112264419 |
|
| 22828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238717.1 |
0.875075112264419 |
|
| 22829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD9 |
0.875075112264419 |
|
| 22830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIER3 |
0.875075112264419 |
|
| 22831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPBP1 |
0.875075112264419 |
|
| 22832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTBL2 |
0.875075112264419 |
|
| 22833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238899.1 |
0.875075112264419 |
|
| 22834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLK2 |
0.875075112264419 |
|
| 22835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAPT |
0.875075112264419 |
|
| 22836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AE2 |
0.875075112264419 |
|
| 22837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3C |
0.875075112264419 |
|
| 22838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE4D |
0.875075112264419 |
|
| 22839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR582 |
0.875075112264419 |
|
| 22840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FKSG52 |
0.875075112264419 |
|
| 22841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PART1 |
0.875075112264419 |
|
| 22842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPDC1B |
0.875075112264419 |
|
| 22843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL7 |
0.875075112264419 |
|
| 22844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC8 |
0.875075112264419 |
|
| 22845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFAF2 |
0.875075112264419 |
|
| 22846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM15 |
0.875075112264419 |
|
| 22847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSWIM6 |
0.875075112264419 |
|
| 22848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf64 |
0.875075112264419 |
|
| 22849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP157 |
0.875075112264419 |
|
| 22850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF2A |
0.875075112264419 |
|
| 22851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIMT1 |
0.875075112264419 |
|
| 22852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IPO11 |
0.875075112264419 |
|
| 22853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKS1B|ENSG00000268942.1 |
0.875075112264419 |
|
| 22854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC70 |
0.875075112264419 |
|
| 22855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HTR1A |
0.875075112264419 |
|
| 22856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF180 |
0.875075112264419 |
|
| 22857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGS7BP |
0.875075112264419 |
|
| 22858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL169P |
0.875075112264419 |
|
| 22859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM159B |
0.875075112264419 |
|
| 22860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SREK1IP1 |
0.875075112264419 |
|
| 22861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CWC27 |
0.875075112264419 |
|
| 22862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS6 |
0.875075112264419 |
|
| 22863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPK |
0.875075112264419 |
|
| 22864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPWD1 |
0.875075112264419 |
|
| 22865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM23 |
0.875075112264419 |
|
| 22866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAPPC13 |
0.875075112264419 |
|
| 22867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SGTB |
0.875075112264419 |
|
| 22868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLN |
0.875075112264419 |
|
| 22869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERBB2IP |
0.875075112264419 |
|
| 22870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA76|ENSG00000252904.1 |
0.875075112264419 |
|
| 22871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SREK1 |
0.875075112264419 |
|
| 22872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238400.1 |
0.875075112264419 |
|
| 22873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAST4 |
0.875075112264419 |
|
| 22874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD180 |
0.875075112264419 |
|
| 22875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIK3R1 |
0.875075112264419 |
|
| 22876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000212249.2 |
0.875075112264419 |
|
| 22877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
7SK|ENSG00000249352.3 |
0.875075112264419 |
|
| 22878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC30A5 |
0.875075112264419 |
|
| 22879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL103P |
0.875075112264419 |
|
| 22880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA50|ENSG00000220986.1 |
0.875075112264419 |
|
| 22881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNB1 |
0.875075112264419 |
|
| 22882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238334.1 |
0.875075112264419 |
|
| 22883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPH |
0.875075112264419 |
|
| 22884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS36 |
0.875075112264419 |
|
| 22885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK7 |
0.875075112264419 |
|
| 22886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC125 |
0.875075112264419 |
|
| 22887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAF9 |
0.875075112264419 |
|
| 22888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD17 |
0.875075112264419 |
|
| 22889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MARVELD2 |
0.875075112264419 |
|
| 22890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H2B |
0.875075112264419 |
|
| 22891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H2C |
0.875075112264419 |
|
| 22892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H2 |
0.875075112264419 |
|
| 22893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GUSBP3 |
0.875075112264419 |
|
| 22894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAIP |
0.875075112264419 |
|
| 22895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCLN |
0.875075112264419 |
|
| 22896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL476P |
0.875075112264419 |
|
| 22897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL616P |
0.875075112264419 |
|
| 22898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL9P |
0.875075112264419 |
|
| 22899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERF1A |
0.875075112264419 |
|
| 22900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERF1B |
0.875075112264419 |
|
| 22901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMN1 |
0.875075112264419 |
|
| 22902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMN2 |
0.875075112264419 |
|
| 22903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238451.1 |
0.875075112264419 |
|
| 22904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238740.1 |
0.875075112264419 |
|
| 22905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMCHL2 |
0.875075112264419 |
|
| 22906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BDP1 |
0.875075112264419 |
|
| 22907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCCC2 |
0.875075112264419 |
|
| 22908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARTPT |
0.875075112264419 |
|
| 22909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1B |
0.875075112264419 |
|
| 22910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4803 |
0.875075112264419 |
|
| 22911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS27 |
0.875075112264419 |
|
| 22912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL153P |
0.875075112264419 |
|
| 22913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTCD2 |
0.875075112264419 |
|
| 22914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF366 |
0.875075112264419 |
|
| 22915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNPO1 |
0.875075112264419 |
|
| 22916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4804 |
0.875075112264419 |
|
| 22917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FCHO2 |
0.875075112264419 |
|
| 22918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM171 |
0.875075112264419 |
|
| 22919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM174 |
0.875075112264419 |
|
| 22920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXD1 |
0.875075112264419 |
|
| 22921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTF3 |
0.875075112264419 |
|
| 22922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRA2 |
0.875075112264419 |
|
| 22923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UTP15 |
0.875075112264419 |
|
| 22924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF28 |
0.875075112264419 |
|
| 22925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL814P |
0.875075112264419 |
|
| 22926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ENC1 |
0.875075112264419 |
|
| 22927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEXB |
0.875075112264419 |
|
| 22928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFM2 |
0.875075112264419 |
|
| 22929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NSA2 |
0.875075112264419 |
|
| 22930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM169A |
0.875075112264419 |
|
| 22931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000212363.1 |
0.875075112264419 |
|
| 22932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT4 |
0.875075112264419 |
|
| 22933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD31 |
0.875075112264419 |
|
| 22934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COL4A3BP |
0.875075112264419 |
|
| 22935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGCR |
0.875075112264419 |
|
| 22936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLK |
0.875075112264419 |
|
| 22937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKDD1B |
0.875075112264419 |
|
| 22938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POC5 |
0.875075112264419 |
|
| 22939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SV2C |
0.875075112264419 |
|
| 22940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP186 |
0.875075112264419 |
|
| 22941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQGAP2 |
0.875075112264419 |
|
| 22942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F2RL2 |
0.875075112264419 |
|
| 22943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F2R |
0.875075112264419 |
|
| 22944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F2RL1 |
0.875075112264419 |
|
| 22945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL208P |
0.875075112264419 |
|
| 22946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238688.1 |
0.875075112264419 |
|
| 22947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100Z |
0.875075112264419 |
|
| 22948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC36P |
0.875075112264419 |
|
| 22949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRHBP |
0.875075112264419 |
|
| 22950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGGF1 |
0.875075112264419 |
|
| 22951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED3 |
0.875075112264419 |
|
| 22952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA47 |
0.875075112264419 |
|
| 22953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDE8B |
0.875075112264419 |
|
| 22954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR41 |
0.875075112264419 |
|
| 22955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTP |
0.875075112264419 |
|
| 22956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBCA |
0.875075112264419 |
|
| 22957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3B1 |
0.875075112264419 |
|
| 22958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAMP1 |
0.875075112264419 |
|
| 22959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LHFPL2 |
0.875075112264419 |
|
| 22960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSB |
0.875075112264419 |
|
| 22961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDIL3 |
0.875075112264419 |
|
| 22962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBPF22P |
0.875075112264419 |
|
| 22963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7C |
0.875075112264419 |
|
| 22964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3607 |
0.875075112264419 |
|
| 22965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP34 |
0.875075112264419 |
|
| 22966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4280 |
0.875075112264419 |
|
| 22967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASA1 |
0.875075112264419 |
|
| 22968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL629P |
0.875075112264419 |
|
| 22969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNH |
0.875075112264419 |
|
| 22970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM161B |
0.875075112264419 |
|
| 22971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP187 |
0.875075112264419 |
|
| 22972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000206958.1 |
0.875075112264419 |
|
| 22973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00461 |
0.875075112264419 |
|
| 22974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEF2C |
0.875075112264419 |
|
| 22975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3660 |
0.875075112264419 |
|
| 22976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CETN3 |
0.875075112264419 |
|
| 22977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBLAC2 |
0.875075112264419 |
|
| 22978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3G |
0.875075112264419 |
|
| 22979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYSMD3 |
0.875075112264419 |
|
| 22980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR98 |
0.875075112264419 |
|
| 22981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUCAT1 |
0.875075112264419 |
|
| 22982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARRDC3 |
0.875075112264419 |
|
| 22983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2F1 |
0.875075112264419 |
|
| 22984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM172A |
0.875075112264419 |
|
| 22985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR2277 |
0.875075112264419 |
|
| 22986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POU5F2 |
0.875075112264419 |
|
| 22987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA0825 |
0.875075112264419 |
|
| 22988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD32 |
0.875075112264419 |
|
| 22989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCTP1 |
0.875075112264419 |
|
| 22990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM81B |
0.875075112264419 |
|
| 22991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TTC37 |
0.875075112264419 |
|
| 22992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSK |
0.875075112264419 |
|
| 22993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR150 |
0.875075112264419 |
|
| 22994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFESD |
0.875075112264419 |
|
| 22995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPATA9 |
0.875075112264419 |
|
| 22996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOBTB3 |
0.875075112264419 |
|
| 22997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLRX |
0.875075112264419 |
|
| 22998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf27 |
0.875075112264419 |
|
| 22999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELL2 |
0.875075112264419 |
|
| 23000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR583 |
0.875075112264419 |
|
| 23001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK1 |
0.875075112264419 |
|
| 23002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAST |
0.875075112264419 |
|
| 23003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERAP1 |
0.875075112264419 |
|
| 23004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERAP2 |
0.875075112264419 |
|
| 23005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LNPEP |
0.875075112264419 |
|
| 23006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LIX1 |
0.875075112264419 |
|
| 23007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIOK2 |
0.875075112264419 |
|
| 23008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RGMB |
0.875075112264419 |
|
| 23009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHD1 |
0.875075112264419 |
|
| 23010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM174A |
0.875075112264419 |
|
| 23011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP62 |
0.875075112264419 |
|
| 23012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST8SIA4 |
0.875075112264419 |
|
| 23013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548P |
0.875075112264419 |
|
| 23014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP106 |
0.875930950486731 |
|
| 23015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIN4 |
0.88470270522988 |
|
| 23016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGEF9 |
0.88470270522988 |
|
| 23017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1468 |
0.88470270522988 |
|
| 23018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMER1 |
0.88470270522988 |
|
| 23019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL799P |
0.88470270522988 |
|
| 23020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB12 |
0.88470270522988 |
|
| 23021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR8 |
0.88470270522988 |
|
| 23022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC4H2 |
0.88470270522988 |
|
| 23023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H12B |
0.88470270522988 |
|
| 23024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LAS1L |
0.88470270522988 |
|
| 23025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSN |
0.88470270522988 |
|
| 23026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR223 |
0.88470270522988 |
|
| 23027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG4 |
0.88470270522988 |
|
| 23028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HEPH |
0.88470270522988 |
|
| 23029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX8 |
0.887316441872286 |
|
| 23030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSTR5 |
0.887316441872286 |
|
| 23031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX5 |
0.888543198432086 |
|
| 23032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP216 |
0.888543198432086 |
|
| 23033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBX3 |
0.888543198432086 |
|
| 23034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA27|ENSG00000252459.1 |
0.888543198432086 |
|
| 23035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL865P |
0.888543198432086 |
|
| 23036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD56|ENSG00000200112.1 |
0.888543198432086 |
|
| 23037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED13L |
0.888543198432086 |
|
| 23038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR620 |
0.888543198432086 |
|
| 23039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00173 |
0.888543198432086 |
|
| 23040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP1LC3B2 |
0.888543198432086 |
|
| 23041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf49 |
0.888543198432086 |
|
| 23042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNFT2 |
0.888543198432086 |
|
| 23043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HRK |
0.888543198432086 |
|
| 23044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXW8 |
0.888543198432086 |
|
| 23045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TESC |
0.888543198432086 |
|
| 23046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO21 |
0.888543198432086 |
|
| 23047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOS1 |
0.888543198432086 |
|
| 23048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KSR2 |
0.888543198432086 |
|
| 23049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFC5 |
0.888543198432086 |
|
| 23050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WSB2 |
0.888543198432086 |
|
| 23051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VSIG10 |
0.888543198432086 |
|
| 23052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEBP1 |
0.888543198432086 |
|
| 23053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAOK3 |
0.888543198432086 |
|
| 23054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUDS3 |
0.888543198432086 |
|
| 23055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP374 |
0.888543198432086 |
|
| 23056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA38|ENSG00000201042.1 |
0.888543198432086 |
|
| 23057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRM4 |
0.888543198432086 |
|
| 23058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL508P |
0.888543198432086 |
|
| 23059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSPB8 |
0.888543198432086 |
|
| 23060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC60 |
0.888543198432086 |
|
| 23061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM233 |
0.888543198432086 |
|
| 23062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP197 |
0.888543198432086 |
|
| 23063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRKAB1 |
0.888543198432086 |
|
| 23064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIT |
0.888543198432086 |
|
| 23065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1178 |
0.888543198432086 |
|
| 23066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC64 |
0.888543198432086 |
|
| 23067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000272464.1 |
0.888543198432086 |
|
| 23068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB35 |
0.888543198432086 |
|
| 23069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCN1L1 |
0.888543198432086 |
|
| 23070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4498 |
0.888543198432086 |
|
| 23071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPLP0 |
0.888543198432086 |
|
| 23072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXN |
0.888543198432086 |
|
| 23073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT4 |
0.888543198432086 |
|
| 23074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLA2G1B |
0.888543198432086 |
|
| 23075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSI1 |
0.888543198432086 |
|
| 23076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS27P25 |
0.888543198432086 |
|
| 23077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX6A1 |
0.888543198432086 |
|
| 23078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATC |
0.888543198432086 |
|
| 23079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIAP1 |
0.888543198432086 |
|
| 23080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRSF9 |
0.888543198432086 |
|
| 23081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLL1 |
0.888543198432086 |
|
| 23082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COQ5 |
0.888543198432086 |
|
| 23083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF10 |
0.888543198432086 |
|
| 23084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POP5 |
0.888543198432086 |
|
| 23085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CABP1 |
0.888543198432086 |
|
| 23086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLEC |
0.888543198432086 |
|
| 23087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNC119B |
0.888543198432086 |
|
| 23088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4700 |
0.888543198432086 |
|
| 23089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACADS |
0.888543198432086 |
|
| 23090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPPL3 |
0.888543198432086 |
|
| 23091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HNF1A |
0.888543198432086 |
|
| 23092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf43 |
0.888543198432086 |
|
| 23093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OASL |
0.888543198432086 |
|
| 23094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70|ENSG00000201945.1 |
0.888543198432086 |
|
| 23095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX7 |
0.888543198432086 |
|
| 23096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX4 |
0.888543198432086 |
|
| 23097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMKK2 |
0.888543198432086 |
|
| 23098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC5 |
0.888543198432086 |
|
| 23099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF34 |
0.888543198432086 |
|
| 23100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM2B |
0.888543198432086 |
|
| 23101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORAI1 |
0.888543198432086 |
|
| 23102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORN3 |
0.888543198432086 |
|
| 23103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM120B |
0.888543198432086 |
|
| 23104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOF |
0.888543198432086 |
|
| 23105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD1B |
0.888543198432086 |
|
| 23106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HPD |
0.888543198432086 |
|
| 23107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMD9 |
0.888543198432086 |
|
| 23108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR66 |
0.888543198432086 |
|
| 23109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL7A |
0.888543198432086 |
|
| 23110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLXIP |
0.888543198432086 |
|
| 23111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC43 |
0.888543198432086 |
|
| 23112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL31 |
0.888543198432086 |
|
| 23113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
B3GNT4 |
0.888543198432086 |
|
| 23114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DIABLO |
0.888543198432086 |
|
| 23115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS33A |
0.888543198432086 |
|
| 23116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLIP1 |
0.888543198432086 |
|
| 23117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZCCHC8 |
0.888543198432086 |
|
| 23118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA9|ENSG00000252192.1 |
0.888543198432086 |
|
| 23119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSRC2 |
0.888543198432086 |
|
| 23120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KNTC1 |
0.888543198432086 |
|
| 23121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCAR1 |
0.888543198432086 |
|
| 23122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCAR2 |
0.888543198432086 |
|
| 23123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCAR3 |
0.888543198432086 |
|
| 23124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DENR |
0.888543198432086 |
|
| 23125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC62 |
0.888543198432086 |
|
| 23126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIP1R |
0.888543198432086 |
|
| 23127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS37B |
0.888543198432086 |
|
| 23128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCB9 |
0.888543198432086 |
|
| 23129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL6IP4 |
0.888543198432086 |
|
| 23130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OGFOD2 |
0.888543198432086 |
|
| 23131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PITPNM2 |
0.888543198432086 |
|
| 23132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4304 |
0.888543198432086 |
|
| 23133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL133P |
0.888543198432086 |
|
| 23134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPHOSPH9 |
0.888543198432086 |
|
| 23135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf65 |
0.888543198432086 |
|
| 23136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK2AP1 |
0.888543198432086 |
|
| 23137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP375 |
0.888543198432086 |
|
| 23138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SBNO1 |
0.888543198432086 |
|
| 23139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SETD8 |
0.888543198432086 |
|
| 23140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RILPL2 |
0.888543198432086 |
|
| 23141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP35 |
0.888543198432086 |
|
| 23142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RILPL1 |
0.888543198432086 |
|
| 23143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3908 |
0.888543198432086 |
|
| 23144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED2 |
0.888543198432086 |
|
| 23145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX55 |
0.888543198432086 |
|
| 23146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA9|ENSG00000206897.1 |
0.888543198432086 |
|
| 23147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2B1 |
0.888543198432086 |
|
| 23148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0A2 |
0.888543198432086 |
|
| 23149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H3 |
0.888543198432086 |
|
| 23150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTN2 |
0.888543198432086 |
|
| 23151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH10 |
0.888543198432086 |
|
| 23152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC92 |
0.888543198432086 |
|
| 23153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAH10OS |
0.888543198432086 |
|
| 23154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF664 |
0.888543198432086 |
|
| 23155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM101A |
0.888543198432086 |
|
| 23156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NCOR2 |
0.888543198432086 |
|
| 23157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARB1 |
0.888543198432086 |
|
| 23158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBC |
0.888543198432086 |
|
| 23159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5188 |
0.888543198432086 |
|
| 23160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL22P19 |
0.888543198432086 |
|
| 23161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHX37 |
0.888543198432086 |
|
| 23162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRI3BP |
0.888543198432086 |
|
| 23163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AACS |
0.888543198432086 |
|
| 23164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM132B |
0.888543198432086 |
|
| 23165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00939 |
0.888543198432086 |
|
| 23166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00943 |
0.888543198432086 |
|
| 23167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00944 |
0.888543198432086 |
|
| 23168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00507 |
0.888543198432086 |
|
| 23169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00508 |
0.888543198432086 |
|
| 23170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4419B |
0.888543198432086 |
|
| 23171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3612 |
0.888543198432086 |
|
| 23172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM132C |
0.888543198432086 |
|
| 23173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238895.1 |
0.888543198432086 |
|
| 23174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC15A4 |
0.888543198432086 |
|
| 23175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLT1D1 |
0.888543198432086 |
|
| 23176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM132D |
0.888543198432086 |
|
| 23177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FZD10 |
0.888543198432086 |
|
| 23178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIWIL1 |
0.888543198432086 |
|
| 23179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMBP2 |
0.888543198432086 |
|
| 23180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL534P |
0.888543198432086 |
|
| 23181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX2 |
0.888543198432086 |
|
| 23182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238822.1 |
0.888543198432086 |
|
| 23183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAN |
0.888543198432086 |
|
| 23184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR133 |
0.888543198432086 |
|
| 23185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP376 |
0.888543198432086 |
|
| 23186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP377 |
0.888543198432086 |
|
| 23187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SFSWAP |
0.888543198432086 |
|
| 23188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP378 |
0.888543198432086 |
|
| 23189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP17 |
0.888543198432086 |
|
| 23190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK1 |
0.888543198432086 |
|
| 23191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PUS1 |
0.888543198432086 |
|
| 23192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EP400 |
0.888543198432086 |
|
| 23193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA49 |
0.888543198432086 |
|
| 23194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EP400NL |
0.888543198432086 |
|
| 23195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX51 |
0.888543198432086 |
|
| 23196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT9 |
0.888543198432086 |
|
| 23197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOC4L |
0.888543198432086 |
|
| 23198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MUC8 |
0.888543198432086 |
|
| 23199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBRSL1 |
0.888543198432086 |
|
| 23200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANHX |
0.888543198432086 |
|
| 23201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKLE2 |
0.888543198432086 |
|
| 23202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHFR |
0.888543198432086 |
|
| 23203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA3 |
0.888543198432086 |
|
| 23204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRCOL1 |
0.888543198432086 |
|
| 23205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX2 |
0.888543198432086 |
|
| 23206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAM5 |
0.888543198432086 |
|
| 23207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLE |
0.888543198432086 |
|
| 23208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXMP2 |
0.888543198432086 |
|
| 23209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP379 |
0.888543198432086 |
|
| 23210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC12P |
0.888543198432086 |
|
| 23211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF10 |
0.888543198432086 |
|
| 23212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF140 |
0.888543198432086 |
|
| 23213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF268 |
0.888543198432086 |
|
| 23214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF26 |
0.888543198432086 |
|
| 23215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF605 |
0.888543198432086 |
|
| 23216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF84 |
0.888543198432086 |
|
| 23217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF891 |
0.888543198432086 |
|
| 23218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RYR3 |
0.891126565454363 |
|
| 23219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVEN |
0.891126565454363 |
|
| 23220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRM5 |
0.891126565454363 |
|
| 23221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC7 |
0.891126565454363 |
|
| 23222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGBD4 |
0.891126565454363 |
|
| 23223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KATNBL1 |
0.891126565454363 |
|
| 23224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMC4 |
0.891126565454363 |
|
| 23225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A6 |
0.891126565454363 |
|
| 23226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOP10 |
0.891126565454363 |
|
| 23227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUTM1 |
0.891126565454363 |
|
| 23228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPCAT4 |
0.891126565454363 |
|
| 23229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8A |
0.891126565454363 |
|
| 23230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8B |
0.891126565454363 |
|
| 23231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000252425.1 |
0.891126565454363 |
|
| 23232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GJD2 |
0.891126565454363 |
|
| 23233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTC1 |
0.891126565454363 |
|
| 23234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP22 |
0.89174293696279 |
|
| 23235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC2 |
0.89174293696279 |
|
| 23236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HUS1B |
0.89174293696279 |
|
| 23237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRF4 |
0.89174293696279 |
|
| 23238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238438.1 |
0.89174293696279 |
|
| 23239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXQ1 |
0.89174293696279 |
|
| 23240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXF2 |
0.89174293696279 |
|
| 23241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL352P |
0.89174293696279 |
|
| 23242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXC1 |
0.89174293696279 |
|
| 23243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMDS |
0.89174293696279 |
|
| 23244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf195 |
0.89174293696279 |
|
| 23245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLK4 |
0.89174293696279 |
|
| 23246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WRNIP1 |
0.89174293696279 |
|
| 23247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB1 |
0.89174293696279 |
|
| 23248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4645 |
0.89174293696279 |
|
| 23249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB9 |
0.89174293696279 |
|
| 23250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPINB6 |
0.89174293696279 |
|
| 23251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NQO2 |
0.89174293696279 |
|
| 23252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIPK1 |
0.89174293696279 |
|
| 23253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP201 |
0.89174293696279 |
|
| 23254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BPHL |
0.89174293696279 |
|
| 23255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB2A |
0.89174293696279 |
|
| 23256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBB2B |
0.89174293696279 |
|
| 23257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMG4 |
0.89174293696279 |
|
| 23258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A23 |
0.89174293696279 |
|
| 23259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PXDC1 |
0.89174293696279 |
|
| 23260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM50B |
0.89174293696279 |
|
| 23261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6ORF50 |
0.89174293696279 |
|
| 23262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF4B |
0.89174293696279 |
|
| 23263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM217A |
0.89174293696279 |
|
| 23264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252668.1 |
0.89174293696279 |
|
| 23265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf201 |
0.89174293696279 |
|
| 23266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECI2 |
0.89174293696279 |
|
| 23267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP202 |
0.89174293696279 |
|
| 23268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238801.1 |
0.89174293696279 |
|
| 23269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDYL |
0.89174293696279 |
|
| 23270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP40 |
0.89174293696279 |
|
| 23271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMRPP2 |
0.89174293696279 |
|
| 23272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3G |
0.89174293696279 |
|
| 23273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYRM4 |
0.89174293696279 |
|
| 23274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3691 |
0.89174293696279 |
|
| 23275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FARS2 |
0.89174293696279 |
|
| 23276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL221P |
0.89174293696279 |
|
| 23277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRN1 |
0.89174293696279 |
|
| 23278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
F13A1 |
0.89174293696279 |
|
| 23279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5683 |
0.89174293696279 |
|
| 23280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LY86 |
0.89174293696279 |
|
| 23281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL554P |
0.89174293696279 |
|
| 23282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251762.1 |
0.89174293696279 |
|
| 23283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RREB1 |
0.89174293696279 |
|
| 23284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSR1 |
0.89174293696279 |
|
| 23285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAGE1 |
0.89174293696279 |
|
| 23286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIOK1 |
0.89174293696279 |
|
| 23287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DSP |
0.89174293696279 |
|
| 23288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRNP48 |
0.89174293696279 |
|
| 23289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP6 |
0.89174293696279 |
|
| 23290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC5 |
0.89174293696279 |
|
| 23291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BLOC1S5 |
0.89174293696279 |
|
| 23292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEF1E1 |
0.89174293696279 |
|
| 23293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35B3 |
0.89174293696279 |
|
| 23294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HULC |
0.89174293696279 |
|
| 23295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OFCC1 |
0.89174293696279 |
|
| 23296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC21P |
0.89174293696279 |
|
| 23297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP2A |
0.89174293696279 |
|
| 23298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00518 |
0.89174293696279 |
|
| 23299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5689 |
0.89174293696279 |
|
| 23300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT2 |
0.89174293696279 |
|
| 23301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf52 |
0.89174293696279 |
|
| 23302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCNT6 |
0.89174293696279 |
|
| 23303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAK1IP1 |
0.89174293696279 |
|
| 23304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM14C |
0.89174293696279 |
|
| 23305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCP2L |
0.89174293696279 |
|
| 23306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM14B |
0.89174293696279 |
|
| 23307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP203 |
0.89174293696279 |
|
| 23308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAK |
0.89174293696279 |
|
| 23309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GCM2 |
0.89174293696279 |
|
| 23310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELOVL2 |
0.89174293696279 |
|
| 23311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238896.1 |
0.89174293696279 |
|
| 23312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM13 |
0.89174293696279 |
|
| 23313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEDD9 |
0.89174293696279 |
|
| 23314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM170B |
0.89174293696279 |
|
| 23315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA67|ENSG00000207419.1 |
0.89174293696279 |
|
| 23316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADTRP |
0.89174293696279 |
|
| 23317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HIVEP1 |
0.89174293696279 |
|
| 23318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDN1 |
0.89174293696279 |
|
| 23319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP293 |
0.89174293696279 |
|
| 23320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHACTR1 |
0.89174293696279 |
|
| 23321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D7 |
0.89174293696279 |
|
| 23322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFOD1 |
0.89174293696279 |
|
| 23323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP204 |
0.89174293696279 |
|
| 23324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIRT5 |
0.89174293696279 |
|
| 23325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOL7 |
0.89174293696279 |
|
| 23326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RANBP9 |
0.89174293696279 |
|
| 23327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCUR1 |
0.89174293696279 |
|
| 23328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF182 |
0.89174293696279 |
|
| 23329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD83 |
0.89174293696279 |
|
| 23330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL332P |
0.89174293696279 |
|
| 23331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JARID2 |
0.89174293696279 |
|
| 23332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTNBP1 |
0.89174293696279 |
|
| 23333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLIP |
0.89174293696279 |
|
| 23334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4639 |
0.89174293696279 |
|
| 23335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U3|ENSG00000251793.1 |
0.89174293696279 |
|
| 23336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GMPR |
0.89174293696279 |
|
| 23337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN1 |
0.89174293696279 |
|
| 23338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STMND1 |
0.89174293696279 |
|
| 23339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM24 |
0.89174293696279 |
|
| 23340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAP2 |
0.89174293696279 |
|
| 23341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM8A1 |
0.89174293696279 |
|
| 23342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP153 |
0.89174293696279 |
|
| 23343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP204 |
0.89174293696279 |
|
| 23344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIF13A |
0.89174293696279 |
|
| 23345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHLRC1 |
0.89174293696279 |
|
| 23346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPMT |
0.89174293696279 |
|
| 23347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM1B |
0.89174293696279 |
|
| 23348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEK |
0.89174293696279 |
|
| 23349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF144B |
0.89174293696279 |
|
| 23350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238458.1 |
0.89174293696279 |
|
| 23351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548A1 |
0.89174293696279 |
|
| 23352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP205 |
0.89174293696279 |
|
| 23353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ID4 |
0.89174293696279 |
|
| 23354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MBOAT1 |
0.89174293696279 |
|
| 23355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E2F3 |
0.89174293696279 |
|
| 23356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL128P |
0.89174293696279 |
|
| 23357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDKAL1 |
0.89174293696279 |
|
| 23358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DMD |
0.892840494485933 |
|
| 23359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3915 |
0.892840494485933 |
|
| 23360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548F5 |
0.892840494485933 |
|
| 23361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238969.1 |
0.892840494485933 |
|
| 23362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00276 |
0.895525857213583 |
|
| 23363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP17A|ENSG00000197976.6 |
0.900294826926443 |
|
| 23364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSD |
0.900294826926443 |
|
| 23365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSE |
0.900294826926443 |
|
| 23366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSF |
0.900294826926443 |
|
| 23367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARSH |
0.900294826926443 |
|
| 23368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASMTL|ENSG00000169093.10 |
0.900294826926443 |
|
| 23369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASMT|ENSG00000196433.6 |
0.900294826926443 |
|
| 23370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD99P1|ENSG00000223773.2 |
0.900294826926443 |
|
| 23371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD99|ENSG00000002586.13 |
0.900294826926443 |
|
| 23372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRLF2|ENSG00000205755.6 |
0.900294826926443 |
|
| 23373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSF2RA|ENSG00000198223.9 |
0.900294826926443 |
|
| 23374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DHRSX|ENSG00000169084.8 |
0.900294826926443 |
|
| 23375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTPBP6|ENSG00000178605.8 |
0.900294826926443 |
|
| 23376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GYG2 |
0.900294826926443 |
|
| 23377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL3RA|ENSG00000185291.6 |
0.900294826926443 |
|
| 23378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00102|ENSG00000230542.1 |
0.900294826926443 |
|
| 23379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00106|ENSG00000236871.2 |
0.900294826926443 |
|
| 23380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00685|ENSG00000226179.1 |
0.900294826926443 |
|
| 23381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3690|ENSG00000265658.1 |
0.900294826926443 |
|
| 23382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RY8|ENSG00000182162.5 |
0.900294826926443 |
|
| 23383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLCXD1|ENSG00000182378.8 |
0.900294826926443 |
|
| 23384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP2R3B|ENSG00000167393.12 |
0.900294826926443 |
|
| 23385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL355P|ENSG00000265350.1 |
0.900294826926443 |
|
| 23386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL578P |
0.900294826926443 |
|
| 23387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP498|ENSG00000223274.1 |
0.900294826926443 |
|
| 23388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHOX|ENSG00000185960.8 |
0.900294826926443 |
|
| 23389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A6|ENSG00000169100.8 |
0.900294826926443 |
|
| 23390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XG |
0.900294826926443 |
|
| 23391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZBED1|ENSG00000214717.4 |
0.900294826926443 |
|
| 23392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000251848.1 |
0.900294826926443 |
|
| 23393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf28 |
0.900294826926443 |
|
| 23394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MXRA5 |
0.900294826926443 |
|
| 23395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212214.1 |
0.900294826926443 |
|
| 23396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C1QTNF8 |
0.903386287622754 |
|
| 23397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1H |
0.903386287622754 |
|
| 23398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS29P |
0.903386287622754 |
|
| 23399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPSAB1 |
0.903386287622754 |
|
| 23400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPSB2 |
0.903386287622754 |
|
| 23401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPSD1 |
0.903386287622754 |
|
| 23402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPSG1 |
0.903386287622754 |
|
| 23403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2I |
0.903386287622754 |
|
| 23404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BAIAP3 |
0.903386287622754 |
|
| 23405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPTG |
0.903386287622754 |
|
| 23406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSR3 |
0.903386287622754 |
|
| 23407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNKL |
0.903386287622754 |
|
| 23408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf91 |
0.903386287622754 |
|
| 23409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC154 |
0.903386287622754 |
|
| 23410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN7 |
0.903386287622754 |
|
| 23411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTX4 |
0.903386287622754 |
|
| 23412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TELO2 |
0.903386287622754 |
|
| 23413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT140 |
0.903386287622754 |
|
| 23414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM204 |
0.903386287622754 |
|
| 23415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRAMP1L |
0.903386287622754 |
|
| 23416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HN1L |
0.903386287622754 |
|
| 23417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAPK8IP3 |
0.903386287622754 |
|
| 23418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3177 |
0.903386287622754 |
|
| 23419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EME2 |
0.903386287622754 |
|
| 23420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPS34 |
0.903386287622754 |
|
| 23421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NME3 |
0.903386287622754 |
|
| 23422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUBP2 |
0.903386287622754 |
|
| 23423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPSB3 |
0.903386287622754 |
|
| 23424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAGH |
0.903386287622754 |
|
| 23425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGFALS |
0.903386287622754 |
|
| 23426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAHD1 |
0.903386287622754 |
|
| 23427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEIOB |
0.903386287622754 |
|
| 23428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL367P |
0.903386287622754 |
|
| 23429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HS3ST6 |
0.903386287622754 |
|
| 23430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSRB1 |
0.903386287622754 |
|
| 23431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPL3L |
0.903386287622754 |
|
| 23432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFB10 |
0.903386287622754 |
|
| 23433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNF151 |
0.903386287622754 |
|
| 23434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS2 |
0.903386287622754 |
|
| 23435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG9 |
0.903386287622754 |
|
| 23436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA10 |
0.903386287622754 |
|
| 23437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA64|ENSG00000207405.1 |
0.903386287622754 |
|
| 23438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBL3 |
0.903386287622754 |
|
| 23439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOXO1 |
0.903386287622754 |
|
| 23440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GFER |
0.903386287622754 |
|
| 23441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNGR3 |
0.903386287622754 |
|
| 23442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPW |
0.903386287622754 |
|
| 23443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF598 |
0.903386287622754 |
|
| 23444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL219P |
0.903386287622754 |
|
| 23445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A3R2 |
0.903386287622754 |
|
| 23446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTHL1 |
0.903386287622754 |
|
| 23447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSC2 |
0.903386287622754 |
|
| 23448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1225 |
0.903386287622754 |
|
| 23449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKD1 |
0.903386287622754 |
|
| 23450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASKIN1 |
0.903386287622754 |
|
| 23451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4516 |
0.903386287622754 |
|
| 23452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB26 |
0.903386287622754 |
|
| 23453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD60|ENSG00000206630.1 |
0.903386287622754 |
|
| 23454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAF7 |
0.903386287622754 |
|
| 23455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MLST8 |
0.903386287622754 |
|
| 23456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRICD5 |
0.903386287622754 |
|
| 23457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGP |
0.903386287622754 |
|
| 23458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE1L2 |
0.903386287622754 |
|
| 23459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
E4F1 |
0.903386287622754 |
|
| 23460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ECI1 |
0.903386287622754 |
|
| 23461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNPS1 |
0.903386287622754 |
|
| 23462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR940 |
0.903386287622754 |
|
| 23463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3677 |
0.903386287622754 |
|
| 23464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA3 |
0.903386287622754 |
|
| 23465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4717 |
0.903386287622754 |
|
| 23466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCA17P |
0.903386287622754 |
|
| 23467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNF |
0.903386287622754 |
|
| 23468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf59 |
0.903386287622754 |
|
| 23469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTN3 |
0.903386287622754 |
|
| 23470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D24 |
0.903386287622754 |
|
| 23471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6C |
0.903386287622754 |
|
| 23472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6V0C |
0.903386287622754 |
|
| 23473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMDHD2 |
0.903386287622754 |
|
| 23474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEMP1 |
0.903386287622754 |
|
| 23475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3178 |
0.903386287622754 |
|
| 23476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDPK1 |
0.903386287622754 |
|
| 23477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD5 |
0.903386287622754 |
|
| 23478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDPK2 |
0.903386287622754 |
|
| 23479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS27 |
0.903386287622754 |
|
| 23480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRRM2 |
0.903386287622754 |
|
| 23481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCEB2 |
0.903386287622754 |
|
| 23482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS33 |
0.903386287622754 |
|
| 23483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS41 |
0.903386287622754 |
|
| 23484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA3|ENSG00000221719.1 |
0.903386287622754 |
|
| 23485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS21 |
0.903386287622754 |
|
| 23486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZG16B |
0.903386287622754 |
|
| 23487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS30P |
0.903386287622754 |
|
| 23488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRSS22 |
0.903386287622754 |
|
| 23489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLYWCH2 |
0.903386287622754 |
|
| 23490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLYWCH1 |
0.903386287622754 |
|
| 23491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KREMEN2 |
0.903386287622754 |
|
| 23492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAQR4 |
0.903386287622754 |
|
| 23493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PKMYT1 |
0.903386287622754 |
|
| 23494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00514 |
0.903386287622754 |
|
| 23495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN6 |
0.903386287622754 |
|
| 23496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN9 |
0.903386287622754 |
|
| 23497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC64B |
0.903386287622754 |
|
| 23498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCFC1R1 |
0.903386287622754 |
|
| 23499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THOC6 |
0.903386287622754 |
|
| 23500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF12A |
0.903386287622754 |
|
| 23501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMP25 |
0.903386287622754 |
|
| 23502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL32 |
0.903386287622754 |
|
| 23503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN10 |
0.903386287622754 |
|
| 23504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF205 |
0.903386287622754 |
|
| 23505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF213 |
0.903386287622754 |
|
| 23506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASP16 |
0.903386287622754 |
|
| 23507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1F1 |
0.903386287622754 |
|
| 23508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF200 |
0.903386287622754 |
|
| 23509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MEFV |
0.903386287622754 |
|
| 23510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF263 |
0.903386287622754 |
|
| 23511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIGD7 |
0.903386287622754 |
|
| 23512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF75A |
0.903386287622754 |
|
| 23513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR2C1 |
0.903386287622754 |
|
| 23514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTRNR2L4 |
0.903386287622754 |
|
| 23515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZSCAN32 |
0.903386287622754 |
|
| 23516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF174 |
0.903386287622754 |
|
| 23517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF597 |
0.903386287622754 |
|
| 23518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAA60 |
0.903386287622754 |
|
| 23519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf90 |
0.903386287622754 |
|
| 23520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLUAP1 |
0.903386287622754 |
|
| 23521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NLRC3 |
0.903386287622754 |
|
| 23522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLX4 |
0.903386287622754 |
|
| 23523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNASE1 |
0.903386287622754 |
|
| 23524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRAP1 |
0.903386287622754 |
|
| 23525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CREBBP |
0.903386287622754 |
|
| 23526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRL |
0.903386287622754 |
|
| 23527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFAP4 |
0.903386287622754 |
|
| 23528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLIS2 |
0.903386287622754 |
|
| 23529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAM16 |
0.903386287622754 |
|
| 23530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO7 |
0.903386287622754 |
|
| 23531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VASN |
0.903386287622754 |
|
| 23532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJA3 |
0.903386287622754 |
|
| 23533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NMRAL1 |
0.903386287622754 |
|
| 23534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMOX2 |
0.903386287622754 |
|
| 23535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDIP1 |
0.903386287622754 |
|
| 23536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf96 |
0.903386287622754 |
|
| 23537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBALD1 |
0.903386287622754 |
|
| 23538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGRN1 |
0.903386287622754 |
|
| 23539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL850P |
0.903386287622754 |
|
| 23540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT16L1 |
0.903386287622754 |
|
| 23541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKS3 |
0.903386287622754 |
|
| 23542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf71 |
0.903386287622754 |
|
| 23543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF500 |
0.903386287622754 |
|
| 23544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEPT12 |
0.903386287622754 |
|
| 23545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMIM22 |
0.903386287622754 |
|
| 23546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYR1 |
0.903386287622754 |
|
| 23547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ROGDI |
0.903386287622754 |
|
| 23548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBN1 |
0.903386287622754 |
|
| 23549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPL |
0.903386287622754 |
|
| 23550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEC14L5 |
0.903386287622754 |
|
| 23551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NAGPA |
0.903386287622754 |
|
| 23552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALG1 |
0.903386287622754 |
|
| 23553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf89 |
0.903386287622754 |
|
| 23554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM86A |
0.903386287622754 |
|
| 23555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBFOX1 |
0.903386287622754 |
|
| 23556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000252138.1 |
0.903386287622754 |
|
| 23557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM114 |
0.903386287622754 |
|
| 23558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METTL22 |
0.903386287622754 |
|
| 23559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABAT |
0.903386287622754 |
|
| 23560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL743P |
0.903386287622754 |
|
| 23561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM186 |
0.903386287622754 |
|
| 23562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMM2 |
0.903386287622754 |
|
| 23563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf72 |
0.903386287622754 |
|
| 23564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CARHSP1 |
0.903386287622754 |
|
| 23565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP7 |
0.903386287622754 |
|
| 23566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP403 |
0.903386287622754 |
|
| 23567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP404 |
0.903386287622754 |
|
| 23568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIN2A |
0.903386287622754 |
|
| 23569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL493P |
0.903386287622754 |
|
| 23570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL99P |
0.903386287622754 |
|
| 23571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EMP2 |
0.903386287622754 |
|
| 23572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TEKT5 |
0.903386287622754 |
|
| 23573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUBP1 |
0.903386287622754 |
|
| 23574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TVP23A |
0.903386287622754 |
|
| 23575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIITA |
0.903386287622754 |
|
| 23576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEXI |
0.903386287622754 |
|
| 23577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC16A |
0.903386287622754 |
|
| 23578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMI2 |
0.903386287622754 |
|
| 23579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS1 |
0.903386287622754 |
|
| 23580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNP2 |
0.903386287622754 |
|
| 23581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRM3 |
0.903386287622754 |
|
| 23582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212228.1 |
0.903386287622754 |
|
| 23583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRM2 |
0.903386287622754 |
|
| 23584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRM1 |
0.903386287622754 |
|
| 23585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238409.1 |
0.903386287622754 |
|
| 23586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548H2 |
0.903386287622754 |
|
| 23587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000272310.1 |
0.903386287622754 |
|
| 23588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL522P |
0.903386287622754 |
|
| 23589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LITAF |
0.903386287622754 |
|
| 23590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNN |
0.903386287622754 |
|
| 23591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNDC11 |
0.903386287622754 |
|
| 23592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZC3H7A |
0.903386287622754 |
|
| 23593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCAR4 |
0.903386287622754 |
|
| 23594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSL1D1 |
0.903386287622754 |
|
| 23595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSPT1 |
0.903386287622754 |
|
| 23596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNFRSF17 |
0.903386287622754 |
|
| 23597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX29 |
0.903386287622754 |
|
| 23598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACA64|ENSG00000238685.1 |
0.903386287622754 |
|
| 23599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPPED1 |
0.903386287622754 |
|
| 23600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4718 |
0.903386287622754 |
|
| 23601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA27|ENSG00000199474.1 |
0.903386287622754 |
|
| 23602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHISA9 |
0.903386287622754 |
|
| 23603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERCC4 |
0.903386287622754 |
|
| 23604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKL2 |
0.903386287622754 |
|
| 23605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR193B |
0.903386287622754 |
|
| 23606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR365A |
0.903386287622754 |
|
| 23607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARN |
0.903386287622754 |
|
| 23608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL274P |
0.903386287622754 |
|
| 23609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHCBP1 |
0.907250179293045 |
|
| 23610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS35 |
0.907250179293045 |
|
| 23611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ORC6 |
0.907250179293045 |
|
| 23612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYLK3 |
0.907250179293045 |
|
| 23613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf87 |
0.907250179293045 |
|
| 23614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPT2 |
0.907250179293045 |
|
| 23615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJA2 |
0.907250179293045 |
|
| 23616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NETO2 |
0.907250179293045 |
|
| 23617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238834.1 |
0.907250179293045 |
|
| 23618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ITFG1 |
0.907250179293045 |
|
| 23619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP424 |
0.907250179293045 |
|
| 23620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHKB |
0.907250179293045 |
|
| 23621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP425 |
0.907250179293045 |
|
| 23622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC12 |
0.907250179293045 |
|
| 23623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ABCC11 |
0.907250179293045 |
|
| 23624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LONP2 |
0.907250179293045 |
|
| 23625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIAH1 |
0.907250179293045 |
|
| 23626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL54P |
0.907250179293045 |
|
| 23627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239013.1 |
0.907250179293045 |
|
| 23628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
N4BP1 |
0.907250179293045 |
|
| 23629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239038.1 |
0.907250179293045 |
|
| 23630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CBLN1 |
0.907250179293045 |
|
| 23631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf78 |
0.907250179293045 |
|
| 23632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D21 |
0.907791654046941 |
|
| 23633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LOXL1 |
0.907791654046941 |
|
| 23634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STOML1 |
0.907791654046941 |
|
| 23635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PML |
0.907791654046941 |
|
| 23636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6A |
0.907791654046941 |
|
| 23637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISLR2 |
0.907791654046941 |
|
| 23638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL429P |
0.907791654046941 |
|
| 23639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISLR |
0.907791654046941 |
|
| 23640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STRA6 |
0.907791654046941 |
|
| 23641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC33 |
0.907791654046941 |
|
| 23642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP11A1 |
0.907791654046941 |
|
| 23643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SEMA7A |
0.907791654046941 |
|
| 23644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBL7 |
0.907791654046941 |
|
| 23645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD77|ENSG00000212279.2 |
0.907791654046941 |
|
| 23646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID3B |
0.907791654046941 |
|
| 23647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLK3 |
0.907791654046941 |
|
| 23648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EDC3 |
0.907791654046941 |
|
| 23649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP1A1 |
0.907791654046941 |
|
| 23650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYP1A2 |
0.907791654046941 |
|
| 23651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSK |
0.907791654046941 |
|
| 23652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4513 |
0.907791654046941 |
|
| 23653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMAN1L |
0.907791654046941 |
|
| 23654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPLX3 |
0.907791654046941 |
|
| 23655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK3 |
0.907791654046941 |
|
| 23656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAMP2 |
0.907791654046941 |
|
| 23657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPI |
0.907791654046941 |
|
| 23658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM219B |
0.907791654046941 |
|
| 23659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX5A |
0.907791654046941 |
|
| 23660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPP25 |
0.907791654046941 |
|
| 23661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAMP5 |
0.907791654046941 |
|
| 23662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPCDC |
0.907791654046941 |
|
| 23663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA20|ENSG00000252722.1 |
0.907791654046941 |
|
| 23664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf39 |
0.907791654046941 |
|
| 23665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1P34 |
0.907791654046941 |
|
| 23666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6C |
0.907791654046941 |
|
| 23667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6D |
0.907791654046941 |
|
| 23668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL327P |
0.907791654046941 |
|
| 23669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL489P |
0.907791654046941 |
|
| 23670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANP32BP1 |
0.907791654046941 |
|
| 23671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD4 |
0.907791654046941 |
|
| 23672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEIL1 |
0.907791654046941 |
|
| 23673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN2C1 |
0.907791654046941 |
|
| 23674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR631 |
0.907791654046941 |
|
| 23675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SIN3A |
0.907791654046941 |
|
| 23676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPN9 |
0.907791654046941 |
|
| 23677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNUPN |
0.907791654046941 |
|
| 23678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IMP3 |
0.907791654046941 |
|
| 23679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX33 |
0.907791654046941 |
|
| 23680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CSPG4 |
0.907791654046941 |
|
| 23681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ODF3L1 |
0.907791654046941 |
|
| 23682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNM1P35 |
0.907791654046941 |
|
| 23683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4313 |
0.907791654046941 |
|
| 23684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL319P |
0.907791654046941 |
|
| 23685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252372.1 |
0.907791654046941 |
|
| 23686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2Q2 |
0.907791654046941 |
|
| 23687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL510P |
0.907791654046941 |
|
| 23688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXO22 |
0.907791654046941 |
|
| 23689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NRG4 |
0.907791654046941 |
|
| 23690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf27 |
0.907791654046941 |
|
| 23691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISL2 |
0.907791654046941 |
|
| 23692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAPER |
0.907791654046941 |
|
| 23693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3713 |
0.907791654046941 |
|
| 23694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP217 |
0.907791654046941 |
|
| 23695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RCN2 |
0.907791654046941 |
|
| 23696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL278P |
0.907791654046941 |
|
| 23697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSTPIP1 |
0.907791654046941 |
|
| 23698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN3 |
0.907791654046941 |
|
| 23699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PEAK1 |
0.907791654046941 |
|
| 23700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMG20A |
0.907791654046941 |
|
| 23701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINGO1 |
0.907791654046941 |
|
| 23702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL214P |
0.907791654046941 |
|
| 23703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D2B |
0.907791654046941 |
|
| 23704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1827 |
0.907791654046941 |
|
| 23705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2D7 |
0.907791654046941 |
|
| 23706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA63|ENSG00000199633.1 |
0.907791654046941 |
|
| 23707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CIB2 |
0.907791654046941 |
|
| 23708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IDH3A |
0.907791654046941 |
|
| 23709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACSBG1 |
0.907791654046941 |
|
| 23710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DNAJA4 |
0.907791654046941 |
|
| 23711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR61 |
0.907791654046941 |
|
| 23712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRABP1 |
0.907791654046941 |
|
| 23713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IREB2 |
0.907791654046941 |
|
| 23714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HYKK |
0.907791654046941 |
|
| 23715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PSMA4 |
0.907791654046941 |
|
| 23716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA5 |
0.907791654046941 |
|
| 23717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA3 |
0.907791654046941 |
|
| 23718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNB4 |
0.907791654046941 |
|
| 23719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS7 |
0.907791654046941 |
|
| 23720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MORF4L1 |
0.907791654046941 |
|
| 23721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTSH |
0.907791654046941 |
|
| 23722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASGRF1 |
0.907791654046941 |
|
| 23723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR184 |
0.907791654046941 |
|
| 23724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD34C |
0.907791654046941 |
|
| 23725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED3 |
0.907791654046941 |
|
| 23726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1024 |
0.907791654046941 |
|
| 23727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTHFS |
0.907791654046941 |
|
| 23728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ST20 |
0.907791654046941 |
|
| 23729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15ORF37 |
0.907791654046941 |
|
| 23730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C15orf37 |
0.907791654046941 |
|
| 23731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2A1 |
0.907791654046941 |
|
| 23732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000251881.1 |
0.907791654046941 |
|
| 23733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAH |
0.907791654046941 |
|
| 23734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00927 |
0.907791654046941 |
|
| 23735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARNT2 |
0.907791654046941 |
|
| 23736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A15 |
0.907908963008553 |
|
| 23737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN19 |
0.907908963008553 |
|
| 23738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRIQ1 |
0.907908963008553 |
|
| 23739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALX1 |
0.907908963008553 |
|
| 23740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF9 |
0.907908963008553 |
|
| 23741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTS |
0.907908963008553 |
|
| 23742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MGAT4C |
0.907908963008553 |
|
| 23743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf50 |
0.907908963008553 |
|
| 23744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf29 |
0.907908963008553 |
|
| 23745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP290 |
0.907908963008553 |
|
| 23746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP364 |
0.907908963008553 |
|
| 23747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMTC3 |
0.907908963008553 |
|
| 23748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KITLG |
0.907908963008553 |
|
| 23749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP6 |
0.907908963008553 |
|
| 23750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POC1B |
0.907908963008553 |
|
| 23751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GALNT4 |
0.907908963008553 |
|
| 23752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2B1 |
0.907908963008553 |
|
| 23753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00936 |
0.907908963008553 |
|
| 23754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP365 |
0.907908963008553 |
|
| 23755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCER1 |
0.907908963008553 |
|
| 23756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00615 |
0.907908963008553 |
|
| 23757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPYC |
0.907908963008553 |
|
| 23758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KERA |
0.907908963008553 |
|
| 23759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LUM |
0.907908963008553 |
|
| 23760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCN |
0.907908963008553 |
|
| 23761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf79 |
0.907908963008553 |
|
| 23762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTG1 |
0.907908963008553 |
|
| 23763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLLU1OS |
0.907908963008553 |
|
| 23764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLLU1 |
0.907908963008553 |
|
| 23765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238865.1 |
0.907908963008553 |
|
| 23766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf74 |
0.907908963008553 |
|
| 23767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG7 |
0.907908963008553 |
|
| 23768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EEA1 |
0.907908963008553 |
|
| 23769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000201502.1 |
0.907908963008553 |
|
| 23770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238361.1 |
0.907908963008553 |
|
| 23771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239073.1 |
0.907908963008553 |
|
| 23772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT4 |
0.907908963008553 |
|
| 23773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2N |
0.907908963008553 |
|
| 23774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL42 |
0.907908963008553 |
|
| 23775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL737P |
0.907908963008553 |
|
| 23776 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOCS2 |
0.907908963008553 |
|
| 23777 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRADD |
0.907908963008553 |
|
| 23778 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL630P |
0.907908963008553 |
|
| 23779 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP263 |
0.907908963008553 |
|
| 23780 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLXNC1 |
0.907908963008553 |
|
| 23781 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC41 |
0.907908963008553 |
|
| 23782 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL330P |
0.907908963008553 |
|
| 23783 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL483P |
0.907908963008553 |
|
| 23784 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR5700 |
0.907908963008553 |
|
| 23785 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCC3 |
0.907908963008553 |
|
| 23786 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRT19P2 |
0.907908963008553 |
|
| 23787 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR492 |
0.907908963008553 |
|
| 23788 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFA12 |
0.907908963008553 |
|
| 23789 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR2C1 |
0.907908963008553 |
|
| 23790 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGD6 |
0.907908963008553 |
|
| 23791 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VEZT |
0.907908963008553 |
|
| 23792 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR331 |
0.907908963008553 |
|
| 23793 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3685 |
0.907908963008553 |
|
| 23794 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METAP2 |
0.907908963008553 |
|
| 23795 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP44 |
0.907908963008553 |
|
| 23796 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAM1P5 |
0.907908963008553 |
|
| 23797 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NTN4 |
0.907908963008553 |
|
| 23798 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPF |
0.907908963008553 |
|
| 23799 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC38 |
0.907908963008553 |
|
| 23800 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMDHD1 |
0.907908963008553 |
|
| 23801 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAL |
0.907908963008553 |
|
| 23802 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LTA4H |
0.907908963008553 |
|
| 23803 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL88P |
0.907908963008553 |
|
| 23804 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELK3 |
0.907908963008553 |
|
| 23805 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDK17 |
0.907908963008553 |
|
| 23806 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP11 |
0.907908963008553 |
|
| 23807 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf55 |
0.907908963008553 |
|
| 23808 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf63 |
0.907908963008553 |
|
| 23809 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NEDD1 |
0.907908963008553 |
|
| 23810 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RMST |
0.907908963008553 |
|
| 23811 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1251 |
0.907908963008553 |
|
| 23812 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR135A2 |
0.907908963008553 |
|
| 23813 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4495 |
0.907908963008553 |
|
| 23814 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4303 |
0.907908963008553 |
|
| 23815 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A7P1 |
0.907908963008553 |
|
| 23816 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMPO |
0.907908963008553 |
|
| 23817 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL179P |
0.907908963008553 |
|
| 23818 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A3 |
0.907908963008553 |
|
| 23819 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA53 |
0.907908963008553 |
|
| 23820 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IKBIP |
0.907908963008553 |
|
| 23821 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APAF1 |
0.907908963008553 |
|
| 23822 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP366 |
0.907908963008553 |
|
| 23823 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM71C |
0.907908963008553 |
|
| 23824 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UHRF1BP1L |
0.907908963008553 |
|
| 23825 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA2B |
0.907908963008553 |
|
| 23826 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL176P |
0.907908963008553 |
|
| 23827 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTR6 |
0.907908963008553 |
|
| 23828 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DEPDC4 |
0.907908963008553 |
|
| 23829 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCYL2 |
0.907908963008553 |
|
| 23830 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC17A8 |
0.907908963008553 |
|
| 23831 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238748.1 |
0.907908963008553 |
|
| 23832 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NR1H4 |
0.907908963008553 |
|
| 23833 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAS2L3 |
0.907908963008553 |
|
| 23834 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL1 |
0.907908963008553 |
|
| 23835 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP367 |
0.907908963008553 |
|
| 23836 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPIC |
0.907908963008553 |
|
| 23837 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYBPC1 |
0.907908963008553 |
|
| 23838 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHPT1 |
0.907908963008553 |
|
| 23839 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYCP3 |
0.907908963008553 |
|
| 23840 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNPTAB |
0.907908963008553 |
|
| 23841 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP368 |
0.907908963008553 |
|
| 23842 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238940.1 |
0.907908963008553 |
|
| 23843 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP369 |
0.907908963008553 |
|
| 23844 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DRAM1 |
0.907908963008553 |
|
| 23845 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC53 |
0.907908963008553 |
|
| 23846 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP37 |
0.907908963008553 |
|
| 23847 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PARPBP |
0.907908963008553 |
|
| 23848 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PMCH |
0.907908963008553 |
|
| 23849 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL793P |
0.907908963008553 |
|
| 23850 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF1 |
0.907908963008553 |
|
| 23851 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00485 |
0.907908963008553 |
|
| 23852 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAH |
0.907908963008553 |
|
| 23853 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCL1 |
0.907908963008553 |
|
| 23854 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf42 |
0.907908963008553 |
|
| 23855 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STAB2 |
0.907908963008553 |
|
| 23856 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000212594.1 |
0.907908963008553 |
|
| 23857 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238914.1 |
0.907908963008553 |
|
| 23858 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NT5DC3 |
0.907908963008553 |
|
| 23859 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSP90B1 |
0.907908963008553 |
|
| 23860 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3652 |
0.907908963008553 |
|
| 23861 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf73 |
0.907908963008553 |
|
| 23862 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TDG |
0.907908963008553 |
|
| 23863 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLT8D2 |
0.907908963008553 |
|
| 23864 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCFC2 |
0.907908963008553 |
|
| 23865 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NFYB |
0.907908963008553 |
|
| 23866 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP370 |
0.907908963008553 |
|
| 23867 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXNRD1 |
0.907908963008553 |
|
| 23868 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EID3 |
0.907908963008553 |
|
| 23869 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST11 |
0.907908963008553 |
|
| 23870 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3922 |
0.907908963008553 |
|
| 23871 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC41A2 |
0.907908963008553 |
|
| 23872 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf45 |
0.907908963008553 |
|
| 23873 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALDH1L2 |
0.907908963008553 |
|
| 23874 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KIAA1033 |
0.907908963008553 |
|
| 23875 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APPL2 |
0.907908963008553 |
|
| 23876 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf75 |
0.907908963008553 |
|
| 23877 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUAK1 |
0.907908963008553 |
|
| 23878 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CKAP4 |
0.907908963008553 |
|
| 23879 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP11L2 |
0.907908963008553 |
|
| 23880 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POLR3B |
0.907908963008553 |
|
| 23881 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RFX4 |
0.907908963008553 |
|
| 23882 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIC8B |
0.907908963008553 |
|
| 23883 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf23 |
0.907908963008553 |
|
| 23884 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTERFD3 |
0.907908963008553 |
|
| 23885 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CRY1 |
0.907908963008553 |
|
| 23886 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD11 |
0.907908963008553 |
|
| 23887 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD74|ENSG00000200897.1 |
0.907908963008553 |
|
| 23888 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP371 |
0.907908963008553 |
|
| 23889 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWP1 |
0.907908963008553 |
|
| 23890 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDM4 |
0.907908963008553 |
|
| 23891 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASCL4 |
0.907908963008553 |
|
| 23892 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WSCD2 |
0.907908963008553 |
|
| 23893 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CMKLR1 |
0.907908963008553 |
|
| 23894 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FICD |
0.907908963008553 |
|
| 23895 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SART3 |
0.907908963008553 |
|
| 23896 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ISCU |
0.907908963008553 |
|
| 23897 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM119 |
0.907908963008553 |
|
| 23898 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SELPLG |
0.907908963008553 |
|
| 23899 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CORO1C |
0.907908963008553 |
|
| 23900 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA40|ENSG00000264043.2 |
0.907908963008553 |
|
| 23901 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSH1 |
0.907908963008553 |
|
| 23902 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR619 |
0.907908963008553 |
|
| 23903 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAO |
0.907908963008553 |
|
| 23904 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SVOP |
0.907908963008553 |
|
| 23905 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP30 |
0.907908963008553 |
|
| 23906 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP372 |
0.907908963008553 |
|
| 23907 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ALKBH2 |
0.907908963008553 |
|
| 23908 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UNG |
0.907908963008553 |
|
| 23909 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACACB |
0.907908963008553 |
|
| 23910 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXN4 |
0.907908963008553 |
|
| 23911 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYO1H |
0.907908963008553 |
|
| 23912 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCTD10 |
0.907908963008553 |
|
| 23913 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE3B |
0.907908963008553 |
|
| 23914 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MMAB |
0.907908963008553 |
|
| 23915 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MVK |
0.907908963008553 |
|
| 23916 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP250 |
0.907908963008553 |
|
| 23917 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM222A |
0.907908963008553 |
|
| 23918 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPV4 |
0.907908963008553 |
|
| 23919 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4497 |
0.907908963008553 |
|
| 23920 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLTP |
0.907908963008553 |
|
| 23921 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL441P |
0.907908963008553 |
|
| 23922 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCHP |
0.907908963008553 |
|
| 23923 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIT2 |
0.907908963008553 |
|
| 23924 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANKRD13A |
0.907908963008553 |
|
| 23925 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf76 |
0.907908963008553 |
|
| 23926 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFT81 |
0.907908963008553 |
|
| 23927 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP2A2 |
0.907908963008553 |
|
| 23928 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL769P |
0.907908963008553 |
|
| 23929 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ANAPC7 |
0.907908963008553 |
|
| 23930 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARPC3 |
0.907908963008553 |
|
| 23931 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPN3 |
0.907908963008553 |
|
| 23932 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM216A |
0.907908963008553 |
|
| 23933 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS29 |
0.907908963008553 |
|
| 23934 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD50|ENSG00000202335.1 |
0.907908963008553 |
|
| 23935 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAD9B |
0.907908963008553 |
|
| 23936 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPTC7 |
0.907908963008553 |
|
| 23937 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCTN1 |
0.907908963008553 |
|
| 23938 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HVCN1 |
0.907908963008553 |
|
| 23939 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL387P |
0.907908963008553 |
|
| 23940 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1CC |
0.907908963008553 |
|
| 23941 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC63 |
0.907908963008553 |
|
| 23942 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYL2 |
0.907908963008553 |
|
| 23943 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CUX2 |
0.907908963008553 |
|
| 23944 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP373 |
0.907908963008553 |
|
| 23945 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM109A |
0.907908963008553 |
|
| 23946 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SH2B3 |
0.907908963008553 |
|
| 23947 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATXN2 |
0.907908963008553 |
|
| 23948 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHEK2P2 |
0.912142853058329 |
|
| 23949 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CT60 |
0.912142853058329 |
|
| 23950 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYFIP1 |
0.912142853058329 |
|
| 23951 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DKFZP547L112 |
0.912142853058329 |
|
| 23952 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L1 |
0.912142853058329 |
|
| 23953 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L2 |
0.912142853058329 |
|
| 23954 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L6 |
0.912142853058329 |
|
| 23955 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8DP |
0.912142853058329 |
|
| 23956 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8EP |
0.912142853058329 |
|
| 23957 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8I |
0.912142853058329 |
|
| 23958 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8S |
0.912142853058329 |
|
| 23959 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P2 |
0.912142853058329 |
|
| 23960 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P3 |
0.912142853058329 |
|
| 23961 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1268A |
0.912142853058329 |
|
| 23962 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NBEAP1 |
0.912142853058329 |
|
| 23963 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPA1 |
0.912142853058329 |
|
| 23964 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NIPA2 |
0.912142853058329 |
|
| 23965 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4M2 |
0.912142853058329 |
|
| 23966 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4N4 |
0.912142853058329 |
|
| 23967 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEB2 |
0.912142853058329 |
|
| 23968 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
POTEB |
0.912142853058329 |
|
| 23969 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL106P |
0.912142853058329 |
|
| 23970 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL400P |
0.912142853058329 |
|
| 23971 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL495P |
0.912142853058329 |
|
| 23972 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL536P |
0.912142853058329 |
|
| 23973 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL545P |
0.912142853058329 |
|
| 23974 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL584P |
0.912142853058329 |
|
| 23975 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL759P |
0.912142853058329 |
|
| 23976 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TUBGCP5 |
0.912142853058329 |
|
| 23977 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WHAMMP3 |
0.912142853058329 |
|
| 23978 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238960.1 |
0.912142853058329 |
|
| 23979 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239083.1 |
0.912142853058329 |
|
| 23980 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4508 |
0.912142853058329 |
|
| 23981 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKRN3 |
0.912142853058329 |
|
| 23982 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEL2 |
0.912142853058329 |
|
| 23983 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDN |
0.912142853058329 |
|
| 23984 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWRN1 |
0.912142853058329 |
|
| 23985 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PWRN2 |
0.912142853058329 |
|
| 23986 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPAP1 |
0.912142853058329 |
|
| 23987 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNRPN |
0.912142853058329 |
|
| 23988 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238615.1 |
0.912142853058329 |
|
| 23989 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNURF |
0.912142853058329 |
|
| 23990 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNHG14 |
0.912142853058329 |
|
| 23991 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD64|ENSG00000270704.2 |
0.912142853058329 |
|
| 23992 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD108 |
0.912142853058329 |
|
| 23993 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD109A |
0.912142853058329 |
|
| 23994 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD115|ENSG00000212428.1 |
0.912142853058329 |
|
| 23995 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD109B |
0.912142853058329 |
|
| 23996 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE3A |
0.912142853058329 |
|
| 23997 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP10A |
0.912142853058329 |
|
| 23998 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP390 |
0.912142853058329 |
|
| 23999 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4715 |
0.912142853058329 |
|
| 24000 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA48|ENSG00000212604.1 |
0.912142853058329 |
|
| 24001 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00929 |
0.912142853058329 |
|
| 24002 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRB3 |
0.912142853058329 |
|
| 24003 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRA5 |
0.912142853058329 |
|
| 24004 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABRG3 |
0.912142853058329 |
|
| 24005 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP391 |
0.912142853058329 |
|
| 24006 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OCA2 |
0.912142853058329 |
|
| 24007 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2 |
0.912142853058329 |
|
| 24008 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APBA2 |
0.912142853058329 |
|
| 24009 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP11B |
0.912142853058329 |
|
| 24010 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRFAM7A |
0.912142853058329 |
|
| 24011 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM189A1 |
0.912142853058329 |
|
| 24012 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA6L7P |
0.912142853058329 |
|
| 24013 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8F |
0.912142853058329 |
|
| 24014 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8G |
0.912142853058329 |
|
| 24015 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8H |
0.912142853058329 |
|
| 24016 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8J |
0.912142853058329 |
|
| 24017 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8M |
0.912142853058329 |
|
| 24018 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8Q |
0.912142853058329 |
|
| 24019 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8R |
0.912142853058329 |
|
| 24020 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8T |
0.912142853058329 |
|
| 24021 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HERC2P9 |
0.912142853058329 |
|
| 24022 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDNL2 |
0.912142853058329 |
|
| 24023 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL196P |
0.912142853058329 |
|
| 24024 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL238P |
0.912142853058329 |
|
| 24025 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL469P |
0.912142853058329 |
|
| 24026 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL628P |
0.912142853058329 |
|
| 24027 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL673P |
0.912142853058329 |
|
| 24028 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL719P |
0.912142853058329 |
|
| 24029 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL796P |
0.912142853058329 |
|
| 24030 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL829P |
0.912142853058329 |
|
| 24031 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL82P |
0.912142853058329 |
|
| 24032 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TJP1 |
0.912142853058329 |
|
| 24033 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000207430.1 |
0.912142853058329 |
|
| 24034 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000207432.1 |
0.912142853058329 |
|
| 24035 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000238519.1 |
0.912142853058329 |
|
| 24036 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000252602.1 |
0.912142853058329 |
|
| 24037 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK4P2 |
0.912142853058329 |
|
| 24038 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK4P3 |
0.912142853058329 |
|
| 24039 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WHAMMP2 |
0.912142853058329 |
|
| 24040 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoZ278 |
0.912142853058329 |
|
| 24041 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAN1 |
0.912142853058329 |
|
| 24042 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR10 |
0.912142853058329 |
|
| 24043 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRPM1 |
0.912142853058329 |
|
| 24044 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR211 |
0.912142853058329 |
|
| 24045 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLF13 |
0.912142853058329 |
|
| 24046 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD7A |
0.912142853058329 |
|
| 24047 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP11A |
0.912142853058329 |
|
| 24048 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHRNA7 |
0.912142853058329 |
|
| 24049 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8K |
0.912142853058329 |
|
| 24050 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8N |
0.912142853058329 |
|
| 24051 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLGA8O |
0.912142853058329 |
|
| 24052 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL185P |
0.912142853058329 |
|
| 24053 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL286P |
0.912142853058329 |
|
| 24054 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL539P |
0.912142853058329 |
|
| 24055 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000206849.1 |
0.912142853058329 |
|
| 24056 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000206987.1 |
0.912142853058329 |
|
| 24057 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ULK4P1 |
0.912142853058329 |
|
| 24058 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCG5 |
0.912142853058329 |
|
| 24059 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GREM1 |
0.912142853058329 |
|
| 24060 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FMN1 |
0.912142853058329 |
|
| 24061 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238342.1 |
0.912142853058329 |
|
| 24062 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD77|ENSG00000212415.1 |
0.912142853058329 |
|
| 24063 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMCO5B |
0.912142853058329 |
|
| 24064 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL802P |
0.917159876782164 |
|
| 24065 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP188 |
0.917159876782164 |
|
| 24066 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLCO4C1 |
0.917159876782164 |
|
| 24067 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP189 |
0.917159876782164 |
|
| 24068 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM232 |
0.917159876782164 |
|
| 24069 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548F3 |
0.917159876782164 |
|
| 24070 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC25A46 |
0.917159876782164 |
|
| 24071 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSLP |
0.917159876782164 |
|
| 24072 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR36 |
0.917159876782164 |
|
| 24073 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAMK4 |
0.917159876782164 |
|
| 24074 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STARD4 |
0.917159876782164 |
|
| 24075 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NREP |
0.917159876782164 |
|
| 24076 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP57 |
0.917159876782164 |
|
| 24077 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EPB41L4A |
0.917159876782164 |
|
| 24078 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA13 |
0.917159876782164 |
|
| 24079 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FLJ11235 |
0.917159876782164 |
|
| 24080 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APC |
0.917159876782164 |
|
| 24081 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRP19 |
0.917159876782164 |
|
| 24082 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REEP5 |
0.917159876782164 |
|
| 24083 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZRSR1 |
0.917159876782164 |
|
| 24084 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DCP2 |
0.917159876782164 |
|
| 24085 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MCC |
0.917159876782164 |
|
| 24086 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSSK1B |
0.917159876782164 |
|
| 24087 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC13P |
0.917159876782164 |
|
| 24088 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YTHDC2 |
0.917159876782164 |
|
| 24089 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP89 |
0.917159876782164 |
|
| 24090 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNN2 |
0.917159876782164 |
|
| 24091 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM36 |
0.917159876782164 |
|
| 24092 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGGT1B |
0.917159876782164 |
|
| 24093 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC112 |
0.917159876782164 |
|
| 24094 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FEM1C |
0.917159876782164 |
|
| 24095 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TICAM2 |
0.917159876782164 |
|
| 24096 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMED7 |
0.917159876782164 |
|
| 24097 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDO1 |
0.917159876782164 |
|
| 24098 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATG12 |
0.917159876782164 |
|
| 24099 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP3S1 |
0.917159876782164 |
|
| 24100 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AQPEP |
0.917159876782164 |
|
| 24101 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARL14EPL |
0.917159876782164 |
|
| 24102 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COMMD10 |
0.917159876782164 |
|
| 24103 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238920.1 |
0.919630928636466 |
|
| 24104 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATP6AP2 |
0.919630928636466 |
|
| 24105 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf38 |
0.919630928636466 |
|
| 24106 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED14 |
0.919630928636466 |
|
| 24107 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP9X |
0.919630928636466 |
|
| 24108 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP502 |
0.919630928636466 |
|
| 24109 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDX3X |
0.919630928636466 |
|
| 24110 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL15P |
0.919630928636466 |
|
| 24111 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NYX |
0.919630928636466 |
|
| 24112 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CASK |
0.919630928636466 |
|
| 24113 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL406P |
0.919630928636466 |
|
| 24114 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL144P |
0.919630928636466 |
|
| 24115 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR34 |
0.919630928636466 |
|
| 24116 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR82 |
0.919630928636466 |
|
| 24117 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAOA |
0.919630928636466 |
|
| 24118 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAOB |
0.919630928636466 |
|
| 24119 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDP |
0.919630928636466 |
|
| 24120 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFHC2 |
0.919630928636466 |
|
| 24121 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FUNDC1 |
0.919630928636466 |
|
| 24122 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL291P |
0.919630928636466 |
|
| 24123 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DUSP21 |
0.919630928636466 |
|
| 24124 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM6A |
0.919630928636466 |
|
| 24125 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf36 |
0.919630928636466 |
|
| 24126 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR221 |
0.919630928636466 |
|
| 24127 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR222 |
0.919630928636466 |
|
| 24128 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD77|ENSG00000212347.2 |
0.919630928636466 |
|
| 24129 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KRBOX4 |
0.919630928636466 |
|
| 24130 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF674 |
0.919630928636466 |
|
| 24131 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHST7 |
0.919630928636466 |
|
| 24132 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A7 |
0.919630928636466 |
|
| 24133 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARAF |
0.919630928636466 |
|
| 24134 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYN1 |
0.919630928636466 |
|
| 24135 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMP1 |
0.919630928636466 |
|
| 24136 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4769 |
0.919630928636466 |
|
| 24137 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CFP |
0.919630928636466 |
|
| 24138 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ELK1 |
0.919630928636466 |
|
| 24139 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UXT |
0.919630928636466 |
|
| 24140 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXXC1P1 |
0.919630928636466 |
|
| 24141 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF81 |
0.919630928636466 |
|
| 24142 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA5B |
0.919630928636466 |
|
| 24143 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPACA5 |
0.919630928636466 |
|
| 24144 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX6 |
0.919630928636466 |
|
| 24145 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF182 |
0.919630928636466 |
|
| 24146 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZNF630 |
0.919630928636466 |
|
| 24147 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238473.1 |
0.919630928636466 |
|
| 24148 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX5 |
0.919630928636466 |
|
| 24149 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP503 |
0.919630928636466 |
|
| 24150 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX1 |
0.919630928636466 |
|
| 24151 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX3 |
0.919630928636466 |
|
| 24152 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX4B |
0.919630928636466 |
|
| 24153 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX4 |
0.919630928636466 |
|
| 24154 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX9 |
0.919630928636466 |
|
| 24155 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC38A5 |
0.919630928636466 |
|
| 24156 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FTSJ1 |
0.919630928636466 |
|
| 24157 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PORCN |
0.919630928636466 |
|
| 24158 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EBP |
0.919630928636466 |
|
| 24159 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D25 |
0.919630928636466 |
|
| 24160 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000239017.1 |
0.919630928636466 |
|
| 24161 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBM3 |
0.919630928636466 |
|
| 24162 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR13 |
0.919630928636466 |
|
| 24163 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WAS |
0.919630928636466 |
|
| 24164 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUV39H1 |
0.919630928636466 |
|
| 24165 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLOD5 |
0.919630928636466 |
|
| 24166 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GATA1 |
0.919630928636466 |
|
| 24167 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HDAC6 |
0.919630928636466 |
|
| 24168 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ERAS |
0.919630928636466 |
|
| 24169 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PCSK1N |
0.919630928636466 |
|
| 24170 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM17B |
0.919630928636466 |
|
| 24171 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PQBP1 |
0.919630928636466 |
|
| 24172 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIM2 |
0.919630928636466 |
|
| 24173 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35A2 |
0.919630928636466 |
|
| 24174 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OTUD5 |
0.919630928636466 |
|
| 24175 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCND1 |
0.919630928636466 |
|
| 24176 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIPAP1 |
0.919630928636466 |
|
| 24177 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL139P |
0.919630928636466 |
|
| 24178 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFE3 |
0.919630928636466 |
|
| 24179 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC120 |
0.919630928636466 |
|
| 24180 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRAF2 |
0.919630928636466 |
|
| 24181 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR45 |
0.919630928636466 |
|
| 24182 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPKOW |
0.919630928636466 |
|
| 24183 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL262P |
0.919630928636466 |
|
| 24184 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGIX |
0.919630928636466 |
|
| 24185 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLP2 |
0.919630928636466 |
|
| 24186 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRICKLE3 |
0.919630928636466 |
|
| 24187 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYP |
0.919630928636466 |
|
| 24188 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CACNA1F |
0.919630928636466 |
|
| 24189 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC22 |
0.919630928636466 |
|
| 24190 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOXP3 |
0.919630928636466 |
|
| 24191 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R3F |
0.919630928636466 |
|
| 24192 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE10 |
0.919630928636466 |
|
| 24193 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12B |
0.919630928636466 |
|
| 24194 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12C |
0.919630928636466 |
|
| 24195 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12D |
0.919630928636466 |
|
| 24196 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12E |
0.919630928636466 |
|
| 24197 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12F |
0.919630928636466 |
|
| 24198 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12G |
0.919630928636466 |
|
| 24199 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12H |
0.919630928636466 |
|
| 24200 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12I |
0.919630928636466 |
|
| 24201 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE12J |
0.919630928636466 |
|
| 24202 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE13 |
0.919630928636466 |
|
| 24203 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE2A |
0.919630928636466 |
|
| 24204 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE2B |
0.919630928636466 |
|
| 24205 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE2C |
0.919630928636466 |
|
| 24206 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE2D |
0.919630928636466 |
|
| 24207 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE2E |
0.919630928636466 |
|
| 24208 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GAGE1 |
0.919630928636466 |
|
| 24209 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE1 |
0.919630928636466 |
|
| 24210 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PAGE4 |
0.919630928636466 |
|
| 24211 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP27X |
0.919630928636466 |
|
| 24212 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLCN5 |
0.919630928636466 |
|
| 24213 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR532 |
0.919630928636466 |
|
| 24214 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR188 |
0.919630928636466 |
|
| 24215 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR362 |
0.919630928636466 |
|
| 24216 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR500A |
0.919630928636466 |
|
| 24217 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR500B |
0.919630928636466 |
|
| 24218 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR501 |
0.919630928636466 |
|
| 24219 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR660 |
0.919630928636466 |
|
| 24220 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR502 |
0.919630928636466 |
|
| 24221 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AKAP4 |
0.919630928636466 |
|
| 24222 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCNB3 |
0.919630928636466 |
|
| 24223 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DGKK |
0.919630928636466 |
|
| 24224 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SHROOM4 |
0.919630928636466 |
|
| 24225 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMP15 |
0.919630928636466 |
|
| 24226 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT10 |
0.919630928636466 |
|
| 24227 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf67 |
0.919630928636466 |
|
| 24228 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUDT11 |
0.919630928636466 |
|
| 24229 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CENPVP1 |
0.919630928636466 |
|
| 24230 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GSPT2 |
0.919630928636466 |
|
| 24231 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGED1 |
0.919630928636466 |
|
| 24232 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGED4B |
0.919630928636466 |
|
| 24233 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGED4 |
0.919630928636466 |
|
| 24234 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11D |
0.919630928636466 |
|
| 24235 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA11E |
0.919630928636466 |
|
| 24236 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE2B |
0.919630928636466 |
|
| 24237 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE1A |
0.919630928636466 |
|
| 24238 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE1B |
0.919630928636466 |
|
| 24239 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE2 |
0.919630928636466 |
|
| 24240 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE1C |
0.919630928636466 |
|
| 24241 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE1D |
0.919630928636466 |
|
| 24242 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE1E |
0.919630928636466 |
|
| 24243 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX7 |
0.919630928636466 |
|
| 24244 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP504 |
0.919630928636466 |
|
| 24245 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX2 |
0.919630928636466 |
|
| 24246 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSX2B |
0.919630928636466 |
|
| 24247 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SPANXN5 |
0.919630928636466 |
|
| 24248 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE5 |
0.919630928636466 |
|
| 24249 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM156A |
0.919630928636466 |
|
| 24250 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM156B |
0.919630928636466 |
|
| 24251 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XAGE3 |
0.919630928636466 |
|
| 24252 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GPR173 |
0.919630928636466 |
|
| 24253 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPYL2 |
0.919630928636466 |
|
| 24254 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KDM5C |
0.919630928636466 |
|
| 24255 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IQSEC2 |
0.919630928636466 |
|
| 24256 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMC1A |
0.919630928636466 |
|
| 24257 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIBC1 |
0.919630928636466 |
|
| 24258 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HSD17B10 |
0.919630928636466 |
|
| 24259 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR98 |
0.919630928636466 |
|
| 24260 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7F2 |
0.919630928636466 |
|
| 24261 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FANCB |
0.921541027663098 |
|
| 24262 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MOSPD2 |
0.921541027663098 |
|
| 24263 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACE2 |
0.921541027663098 |
|
| 24264 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB11 |
0.921541027663098 |
|
| 24265 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ASB9 |
0.921541027663098 |
|
| 24266 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BMX |
0.921541027663098 |
|
| 24267 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FIGF |
0.921541027663098 |
|
| 24268 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIGA |
0.921541027663098 |
|
| 24269 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PIR |
0.921541027663098 |
|
| 24270 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM27 |
0.921541027663098 |
|
| 24271 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA5BP1 |
0.921541027663098 |
|
| 24272 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CA5B |
0.921541027663098 |
|
| 24273 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA7|ENSG00000200620.1 |
0.921541027663098 |
|
| 24274 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZRSR2 |
0.921541027663098 |
|
| 24275 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AP1S2 |
0.921541027663098 |
|
| 24276 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRPR |
0.921541027663098 |
|
| 24277 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGEB17 |
0.921541027663098 |
|
| 24278 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL658P |
0.921541027663098 |
|
| 24279 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTPS2 |
0.921541027663098 |
|
| 24280 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AM |
0.921541027663098 |
|
| 24281 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
S100G |
0.921541027663098 |
|
| 24282 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYAP1 |
0.921541027663098 |
|
| 24283 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TXLNG |
0.921541027663098 |
|
| 24284 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RBBP7 |
0.921541027663098 |
|
| 24285 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
REPS2 |
0.921541027663098 |
|
| 24286 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA16|ENSG00000201467.1 |
0.921541027663098 |
|
| 24287 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4768 |
0.921541027663098 |
|
| 24288 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NHS |
0.921541027663098 |
|
| 24289 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238764.1 |
0.921541027663098 |
|
| 24290 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCML1 |
0.921541027663098 |
|
| 24291 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAI2 |
0.921541027663098 |
|
| 24292 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238327.1 |
0.921541027663098 |
|
| 24293 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRDX4 |
0.921541027663098 |
|
| 24294 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACOT9 |
0.921541027663098 |
|
| 24295 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SAT1 |
0.921541027663098 |
|
| 24296 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APOO |
0.921541027663098 |
|
| 24297 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CXorf58 |
0.921541027663098 |
|
| 24298 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLHL15 |
0.921541027663098 |
|
| 24299 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2S3 |
0.921541027663098 |
|
| 24300 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNBP4 |
0.922751702660171 |
|
| 24301 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252447.1 |
0.922751702660171 |
|
| 24302 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP160 |
0.922751702660171 |
|
| 24303 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP340 |
0.922751702660171 |
|
| 24304 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRJ |
0.922751702660171 |
|
| 24305 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3161 |
0.922751702660171 |
|
| 24306 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4B1 |
0.922751702660171 |
|
| 24307 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4X2 |
0.922751702660171 |
|
| 24308 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4X1 |
0.922751702660171 |
|
| 24309 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4S1 |
0.922751702660171 |
|
| 24310 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C3 |
0.922751702660171 |
|
| 24311 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC86 |
0.92739405702184 |
|
| 24312 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTGDR2 |
0.92739405702184 |
|
| 24313 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZP1 |
0.92739405702184 |
|
| 24314 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRPF19 |
0.92739405702184 |
|
| 24315 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM109 |
0.92739405702184 |
|
| 24316 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCAF8 |
0.946208050760563 |
|
| 24317 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIAM2 |
0.946208050760563 |
|
| 24318 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1273C |
0.946208050760563 |
|
| 24319 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
U8|ENSG00000238963.1 |
0.946208050760563 |
|
| 24320 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TFB1M |
0.946208050760563 |
|
| 24321 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLDN20 |
0.946208050760563 |
|
| 24322 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NOX3 |
0.946208050760563 |
|
| 24323 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR1202 |
0.946208050760563 |
|
| 24324 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD28|ENSG00000212295.1 |
0.946208050760563 |
|
| 24325 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARID1B |
0.946208050760563 |
|
| 24326 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4466 |
0.946208050760563 |
|
| 24327 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM242 |
0.946208050760563 |
|
| 24328 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000252609.1 |
0.946208050760563 |
|
| 24329 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC14 |
0.946208050760563 |
|
| 24330 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3692 |
0.946208050760563 |
|
| 24331 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNX9 |
0.946208050760563 |
|
| 24332 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYNJ2 |
0.946208050760563 |
|
| 24333 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERAC1 |
0.946208050760563 |
|
| 24334 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GTF2H5 |
0.946208050760563 |
|
| 24335 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TULP4 |
0.946208050760563 |
|
| 24336 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL173P |
0.946208050760563 |
|
| 24337 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM181 |
0.946208050760563 |
|
| 24338 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYNLT1 |
0.946208050760563 |
|
| 24339 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYTL3 |
0.946208050760563 |
|
| 24340 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EZR |
0.946208050760563 |
|
| 24341 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3918 |
0.946208050760563 |
|
| 24342 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSTCP1 |
0.946208050760563 |
|
| 24343 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C6orf99 |
0.946208050760563 |
|
| 24344 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RSPH3 |
0.946208050760563 |
|
| 24345 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAGAP |
0.946208050760563 |
|
| 24346 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FNDC1 |
0.946208050760563 |
|
| 24347 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOD2 |
0.946208050760563 |
|
| 24348 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU4ATAC18P |
0.946208050760563 |
|
| 24349 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WTAP |
0.946208050760563 |
|
| 24350 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACAT2 |
0.946208050760563 |
|
| 24351 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCP1 |
0.946208050760563 |
|
| 24352 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA20|ENSG00000207392.1 |
0.946208050760563 |
|
| 24353 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA29 |
0.946208050760563 |
|
| 24354 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL18 |
0.946208050760563 |
|
| 24355 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PNLDC1 |
0.946208050760563 |
|
| 24356 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAS1 |
0.946208050760563 |
|
| 24357 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IGF2R |
0.946208050760563 |
|
| 24358 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AIRN |
0.946208050760563 |
|
| 24359 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A1 |
0.946208050760563 |
|
| 24360 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A2 |
0.946208050760563 |
|
| 24361 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC22A3 |
0.946208050760563 |
|
| 24362 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPAL2 |
0.946208050760563 |
|
| 24363 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPA |
0.946208050760563 |
|
| 24364 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLG |
0.946208050760563 |
|
| 24365 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAP3K4 |
0.946208050760563 |
|
| 24366 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AGPAT4 |
0.946208050760563 |
|
| 24367 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ARHGAP6 |
0.948917015056726 |
|
| 24368 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HCCS |
0.948917015056726 |
|
| 24369 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AMELX |
0.948917015056726 |
|
| 24370 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548AX |
0.948917015056726 |
|
| 24371 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA31|ENSG00000252337.1 |
0.950011937580516 |
|
| 24372 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EFNA5 |
0.950011937580516 |
|
| 24373 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL782P |
0.950011937580516 |
|
| 24374 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP122 |
0.950011937580516 |
|
| 24375 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL17 |
0.950011937580516 |
|
| 24376 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FER |
0.950011937580516 |
|
| 24377 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PJA2 |
0.950011937580516 |
|
| 24378 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAN2A1 |
0.950011937580516 |
|
| 24379 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP230 |
0.950011937580516 |
|
| 24380 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A2ML1 |
0.957993104389604 |
|
| 24381 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PHC1 |
0.957993104389604 |
|
| 24382 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
M6PR |
0.957993104389604 |
|
| 24383 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRG1 |
0.957993104389604 |
|
| 24384 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00612 |
0.957993104389604 |
|
| 24385 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A2M |
0.957993104389604 |
|
| 24386 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PZP |
0.957993104389604 |
|
| 24387 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
A2MP1 |
0.957993104389604 |
|
| 24388 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00987 |
0.957993104389604 |
|
| 24389 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212432.1 |
0.957993104389604 |
|
| 24390 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA75|ENSG00000212440.1 |
0.957993104389604 |
|
| 24391 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRB1 |
0.957993104389604 |
|
| 24392 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC2D |
0.957993104389604 |
|
| 24393 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLECL1 |
0.957993104389604 |
|
| 24394 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD69 |
0.957993104389604 |
|
| 24395 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRF1 |
0.957993104389604 |
|
| 24396 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC2B |
0.957993104389604 |
|
| 24397 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRF2 |
0.957993104389604 |
|
| 24398 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC2A |
0.957993104389604 |
|
| 24399 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC9A |
0.957993104389604 |
|
| 24400 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC1A |
0.957993104389604 |
|
| 24401 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP161 |
0.957993104389604 |
|
| 24402 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC7A |
0.957993104389604 |
|
| 24403 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OLR1 |
0.957993104389604 |
|
| 24404 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM52B |
0.957993104389604 |
|
| 24405 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GABARAPL1 |
0.957993104389604 |
|
| 24406 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRD1 |
0.957993104389604 |
|
| 24407 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRK1 |
0.957993104389604 |
|
| 24408 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRC4 |
0.957993104389604 |
|
| 24409 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRC1 |
0.957993104389604 |
|
| 24410 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRC2 |
0.957993104389604 |
|
| 24411 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRC3 |
0.957993104389604 |
|
| 24412 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EIF2S3L |
0.957993104389604 |
|
| 24413 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KLRAP1 |
0.957993104389604 |
|
| 24414 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGOHB |
0.957993104389604 |
|
| 24415 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STYK1 |
0.957993104389604 |
|
| 24416 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YBX3 |
0.957993104389604 |
|
| 24417 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R7 |
0.957993104389604 |
|
| 24418 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R8 |
0.957993104389604 |
|
| 24419 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R9 |
0.957993104389604 |
|
| 24420 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR4 |
0.957993104389604 |
|
| 24421 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R10 |
0.957993104389604 |
|
| 24422 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRH1 |
0.957993104389604 |
|
| 24423 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R13 |
0.957993104389604 |
|
| 24424 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRH2 |
0.957993104389604 |
|
| 24425 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R14 |
0.957993104389604 |
|
| 24426 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R50 |
0.957993104389604 |
|
| 24427 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R20 |
0.957993104389604 |
|
| 24428 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R19 |
0.957993104389604 |
|
| 24429 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R30 |
0.957993104389604 |
|
| 24430 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R31 |
0.957993104389604 |
|
| 24431 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R42 |
0.957993104389604 |
|
| 24432 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R43 |
0.957993104389604 |
|
| 24433 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R46 |
0.957993104389604 |
|
| 24434 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TAS2R64P |
0.957993104389604 |
|
| 24435 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRB3 |
0.957993104389604 |
|
| 24436 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRB4 |
0.957993104389604 |
|
| 24437 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRB1 |
0.957993104389604 |
|
| 24438 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRB2 |
0.957993104389604 |
|
| 24439 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ETV6 |
0.957993104389604 |
|
| 24440 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BCL2L14 |
0.957993104389604 |
|
| 24441 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ACTRT1 |
0.95803891731607 |
|
| 24442 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR325 |
0.959740840663529 |
|
| 24443 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP509 |
0.959740840663529 |
|
| 24444 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FGF16 |
0.959740840663529 |
|
| 24445 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ATRX |
0.959740840663529 |
|
| 24446 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MAGT1 |
0.959740840663529 |
|
| 24447 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL460P |
0.959740840663529 |
|
| 24448 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
COX7B |
0.959740840663529 |
|
| 24449 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGAM4 |
0.959740840663529 |
|
| 24450 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM9A |
0.960906219996914 |
|
| 24451 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CHTF18 |
0.962317819471595 |
|
| 24452 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNG13 |
0.962317819471595 |
|
| 24453 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR662 |
0.962317819471595 |
|
| 24454 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSLNL |
0.962317819471595 |
|
| 24455 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSLN |
0.962317819471595 |
|
| 24456 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRR25 |
0.962317819471595 |
|
| 24457 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPUSD1 |
0.962317819471595 |
|
| 24458 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LMF1 |
0.962317819471595 |
|
| 24459 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SOX6 |
0.974886402681466 |
|
| 24460 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf58 |
0.974886402681466 |
|
| 24461 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9G1 |
0.976252039082835 |
|
| 24462 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9G4 |
0.976252039082835 |
|
| 24463 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5G5P |
0.976252039082835 |
|
| 24464 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AK2 |
0.976252039082835 |
|
| 24465 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC55 |
0.976252039082835 |
|
| 24466 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
APLNR |
0.976252039082835 |
|
| 24467 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TNKS1BP1 |
0.976252039082835 |
|
| 24468 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SSRP1 |
0.976252039082835 |
|
| 24469 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238692.1 |
0.976252039082835 |
|
| 24470 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
P2RX3 |
0.976252039082835 |
|
| 24471 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRG3 |
0.976252039082835 |
|
| 24472 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PRG2 |
0.976252039082835 |
|
| 24473 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC43A3 |
0.976252039082835 |
|
| 24474 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP341 |
0.976252039082835 |
|
| 24475 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP259 |
0.976252039082835 |
|
| 24476 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RTN4RL2 |
0.976252039082835 |
|
| 24477 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC43A1 |
0.976252039082835 |
|
| 24478 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TIMM10 |
0.976252039082835 |
|
| 24479 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SMTNL1 |
0.976252039082835 |
|
| 24480 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
UBE2L6 |
0.976252039082835 |
|
| 24481 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SERPING1 |
0.976252039082835 |
|
| 24482 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR130A |
0.976252039082835 |
|
| 24483 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YPEL4 |
0.976252039082835 |
|
| 24484 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLP1 |
0.976252039082835 |
|
| 24485 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC5 |
0.976252039082835 |
|
| 24486 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MED19 |
0.976252039082835 |
|
| 24487 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMX2 |
0.976252039082835 |
|
| 24488 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BTBD18 |
0.976252039082835 |
|
| 24489 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C11orf31 |
0.976252039082835 |
|
| 24490 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CTNND1 |
0.976252039082835 |
|
| 24491 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9Q1 |
0.976252039082835 |
|
| 24492 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR6Q1 |
0.976252039082835 |
|
| 24493 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9I1 |
0.976252039082835 |
|
| 24494 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR9Q2 |
0.976252039082835 |
|
| 24495 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1S2 |
0.976252039082835 |
|
| 24496 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR1S1 |
0.976252039082835 |
|
| 24497 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10Q1 |
0.976252039082835 |
|
| 24498 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10W1 |
0.976252039082835 |
|
| 24499 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5B17 |
0.976252039082835 |
|
| 24500 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5B3 |
0.976252039082835 |
|
| 24501 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5B2 |
0.976252039082835 |
|
| 24502 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5B12 |
0.976252039082835 |
|
| 24503 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5B21 |
0.976252039082835 |
|
| 24504 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPXN |
0.976252039082835 |
|
| 24505 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFP91 |
0.976252039082835 |
|
| 24506 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNTF |
0.976252039082835 |
|
| 24507 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYATL2 |
0.976252039082835 |
|
| 24508 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYATL1P2 |
0.976252039082835 |
|
| 24509 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYATL1 |
0.976252039082835 |
|
| 24510 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM111B |
0.976252039082835 |
|
| 24511 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM111A |
0.976252039082835 |
|
| 24512 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AN1 |
0.976252039082835 |
|
| 24513 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5A2 |
0.976252039082835 |
|
| 24514 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5A1 |
0.976252039082835 |
|
| 24515 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D6 |
0.976252039082835 |
|
| 24516 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D10 |
0.976252039082835 |
|
| 24517 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D11 |
0.976252039082835 |
|
| 24518 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4D9 |
0.976252039082835 |
|
| 24519 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OSBP |
0.976252039082835 |
|
| 24520 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR3162 |
0.976252039082835 |
|
| 24521 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PATL1 |
0.976252039082835 |
|
| 24522 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP192 |
0.976252039082835 |
|
| 24523 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10V1 |
0.976252039082835 |
|
| 24524 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STX3 |
0.976252039082835 |
|
| 24525 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL16 |
0.976252039082835 |
|
| 24526 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GIF |
0.976252039082835 |
|
| 24527 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TCN1 |
0.976252039082835 |
|
| 24528 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OOSP1 |
0.976252039082835 |
|
| 24529 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLAC1L |
0.976252039082835 |
|
| 24530 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A3 |
0.976252039082835 |
|
| 24531 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A2 |
0.976252039082835 |
|
| 24532 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A6A |
0.976252039082835 |
|
| 24533 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A4E |
0.976252039082835 |
|
| 24534 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A4A |
0.976252039082835 |
|
| 24535 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A6E |
0.976252039082835 |
|
| 24536 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A14 |
0.976252039082835 |
|
| 24537 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A7 |
0.976252039082835 |
|
| 24538 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A5 |
0.976252039082835 |
|
| 24539 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A1 |
0.976252039082835 |
|
| 24540 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A12 |
0.976252039082835 |
|
| 24541 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A13 |
0.976252039082835 |
|
| 24542 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LINC00301 |
0.976252039082835 |
|
| 24543 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A8 |
0.976252039082835 |
|
| 24544 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A18 |
0.976252039082835 |
|
| 24545 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A15 |
0.976252039082835 |
|
| 24546 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MS4A10 |
0.976252039082835 |
|
| 24547 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM132A |
0.976252039082835 |
|
| 24548 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC15A3 |
0.976252039082835 |
|
| 24549 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD6 |
0.976252039082835 |
|
| 24550 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CD5 |
0.976252039082835 |
|
| 24551 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VPS37C |
0.976252039082835 |
|
| 24552 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGA3 |
0.976252039082835 |
|
| 24553 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGA4 |
0.976252039082835 |
|
| 24554 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PGA5 |
0.976252039082835 |
|
| 24555 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
VWCE |
0.976252039082835 |
|
| 24556 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DDB1 |
0.976252039082835 |
|
| 24557 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAK |
0.976252039082835 |
|
| 24558 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CYB561A3 |
0.976252039082835 |
|
| 24559 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM138 |
0.976252039082835 |
|
| 24560 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM216 |
0.976252039082835 |
|
| 24561 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF7 |
0.976252039082835 |
|
| 24562 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHAF2 |
0.976252039082835 |
|
| 24563 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL23P |
0.976252039082835 |
|
| 24564 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPP1R32 |
0.976252039082835 |
|
| 24565 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC10B |
0.976252039082835 |
|
| 24566 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4488 |
0.976252039082835 |
|
| 24567 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SYT7 |
0.976252039082835 |
|
| 24568 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPLP0P2 |
0.976252039082835 |
|
| 24569 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DAGLA |
0.976252039082835 |
|
| 24570 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PVRL3 |
0.976851180904576 |
|
| 24571 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH9 |
0.977598298541 |
|
| 24572 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA51|ENSG00000207177.1 |
0.977598298541 |
|
| 24573 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB40C |
0.979198515537145 |
|
| 24574 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C16orf13 |
0.979198515537145 |
|
| 24575 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM195A |
0.979198515537145 |
|
| 24576 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR90 |
0.979198515537145 |
|
| 24577 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WFIKKN1 |
0.979198515537145 |
|
| 24578 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHOT2 |
0.979198515537145 |
|
| 24579 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
JMJD8 |
0.979198515537145 |
|
| 24580 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RHBDL1 |
0.979198515537145 |
|
| 24581 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
STUB1 |
0.979198515537145 |
|
| 24582 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FBXL16 |
0.979198515537145 |
|
| 24583 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WDR24 |
0.979198515537145 |
|
| 24584 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
METRN |
0.979198515537145 |
|
| 24585 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC78 |
0.979198515537145 |
|
| 24586 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM173A |
0.979198515537145 |
|
| 24587 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HAGHL |
0.979198515537145 |
|
| 24588 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NARFL |
0.979198515537145 |
|
| 24589 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA18|ENSG00000252601.1 |
0.981599002649653 |
|
| 24590 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP207 |
0.981599002649653 |
|
| 24591 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CDH6 |
0.981599002649653 |
|
| 24592 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DROSHA |
0.981599002649653 |
|
| 24593 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf22 |
0.981599002649653 |
|
| 24594 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDZD2 |
0.981599002649653 |
|
| 24595 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238864.1 |
0.981599002649653 |
|
| 24596 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4279 |
0.981599002649653 |
|
| 24597 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GOLPH3 |
0.981599002649653 |
|
| 24598 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MTMR12 |
0.981599002649653 |
|
| 24599 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFR |
0.981599002649653 |
|
| 24600 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR579 |
0.981599002649653 |
|
| 24601 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SUB1 |
0.981599002649653 |
|
| 24602 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NPR3 |
0.981599002649653 |
|
| 24603 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TARS |
0.981599002649653 |
|
| 24604 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ADAMTS12 |
0.981599002649653 |
|
| 24605 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SCARNA11|ENSG00000252727.1 |
0.98255178698789 |
|
| 24606 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AICDA |
0.98255178698789 |
|
| 24607 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MFAP5 |
0.98255178698789 |
|
| 24608 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RIMKLB |
0.98255178698789 |
|
| 24609 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC12A |
0.98255178698789 |
|
| 24610 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC1B |
0.98255178698789 |
|
| 24611 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLEC12B |
0.98255178698789 |
|
| 24612 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR10AG1 |
0.987255543294179 |
|
| 24613 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4A15 |
0.987255543294179 |
|
| 24614 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4A16 |
0.987255543294179 |
|
| 24615 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4A5 |
0.987255543294179 |
|
| 24616 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C11 |
0.987255543294179 |
|
| 24617 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C15 |
0.987255543294179 |
|
| 24618 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C16 |
0.987255543294179 |
|
| 24619 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C46 |
0.987255543294179 |
|
| 24620 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C6 |
0.987255543294179 |
|
| 24621 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4P4 |
0.987255543294179 |
|
| 24622 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4S2 |
0.987255543294179 |
|
| 24623 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AS1 |
0.987255543294179 |
|
| 24624 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5D13 |
0.987255543294179 |
|
| 24625 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5D14 |
0.987255543294179 |
|
| 24626 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5D16 |
0.987255543294179 |
|
| 24627 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5D18 |
0.987255543294179 |
|
| 24628 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5F1 |
0.987255543294179 |
|
| 24629 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5I1 |
0.987255543294179 |
|
| 24630 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5J2 |
0.987255543294179 |
|
| 24631 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5L1 |
0.987255543294179 |
|
| 24632 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5L2 |
0.987255543294179 |
|
| 24633 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5T2 |
0.987255543294179 |
|
| 24634 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5W2 |
0.987255543294179 |
|
| 24635 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8H2 |
0.987255543294179 |
|
| 24636 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8H3 |
0.987255543294179 |
|
| 24637 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8I2 |
0.987255543294179 |
|
| 24638 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8J3 |
0.987255543294179 |
|
| 24639 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8K5 |
0.987255543294179 |
|
| 24640 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM48 |
0.987255543294179 |
|
| 24641 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM51HP |
0.987255543294179 |
|
| 24642 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM51 |
0.987255543294179 |
|
| 24643 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5T3 |
0.987255543294179 |
|
| 24644 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5T1 |
0.987255543294179 |
|
| 24645 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8H1 |
0.987255543294179 |
|
| 24646 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8K3 |
0.987255543294179 |
|
| 24647 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8K1 |
0.987255543294179 |
|
| 24648 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8J1 |
0.987255543294179 |
|
| 24649 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR8U1 |
0.987255543294179 |
|
| 24650 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5R1 |
0.987255543294179 |
|
| 24651 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M9 |
0.987255543294179 |
|
| 24652 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M3 |
0.987255543294179 |
|
| 24653 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M8 |
0.987255543294179 |
|
| 24654 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M11 |
0.987255543294179 |
|
| 24655 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M10 |
0.987255543294179 |
|
| 24656 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5M1 |
0.987255543294179 |
|
| 24657 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AP2 |
0.987255543294179 |
|
| 24658 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR5AR1 |
0.987255543294179 |
|
| 24659 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GLYAT |
0.987255543294179 |
|
| 24660 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DTX4 |
0.987255543294179 |
|
| 24661 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MPEG1 |
0.987255543294179 |
|
| 24662 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL42P |
0.987255543294179 |
|
| 24663 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL435P |
0.987255543294179 |
|
| 24664 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FAM19A2 |
0.989466014326502 |
|
| 24665 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD112|ENSG00000252883.1 |
0.989466014326502 |
|
| 24666 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
USP15 |
0.989466014326502 |
|
| 24667 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MON2 |
0.989466014326502 |
|
| 24668 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf61 |
0.989466014326502 |
|
| 24669 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIRLET7I |
0.989466014326502 |
|
| 24670 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PPM1H |
0.989466014326502 |
|
| 24671 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238475.1 |
0.989466014326502 |
|
| 24672 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LDHAL6CP |
0.989466014326502 |
|
| 24673 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AVPR1A |
0.989466014326502 |
|
| 24674 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DPY19L2 |
0.989466014326502 |
|
| 24675 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM5 |
0.989466014326502 |
|
| 24676 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SRGAP1 |
0.989466014326502 |
|
| 24677 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf66 |
0.989466014326502 |
|
| 24678 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPS11P6 |
0.989466014326502 |
|
| 24679 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C12orf56 |
0.989466014326502 |
|
| 24680 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238440.1 |
0.989466014326502 |
|
| 24681 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
XPOT |
0.989466014326502 |
|
| 24682 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBK1 |
0.989466014326502 |
|
| 24683 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORD83 |
0.989466014326502 |
|
| 24684 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RASSF3 |
0.989466014326502 |
|
| 24685 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR548C |
0.989466014326502 |
|
| 24686 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GNS |
0.989466014326502 |
|
| 24687 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238592.1 |
0.989466014326502 |
|
| 24688 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TBC1D30 |
0.989466014326502 |
|
| 24689 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNU6ATAC42P |
0.989466014326502 |
|
| 24690 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
WIF1 |
0.989466014326502 |
|
| 24691 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LEMD3 |
0.989466014326502 |
|
| 24692 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MSRB3 |
0.989466014326502 |
|
| 24693 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RPSAP52 |
0.989466014326502 |
|
| 24694 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HMGA2 |
0.989466014326502 |
|
| 24695 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RNA5SP362 |
0.989466014326502 |
|
| 24696 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LLPH |
0.989466014326502 |
|
| 24697 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMBIM4 |
0.989466014326502 |
|
| 24698 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRAK3 |
0.989466014326502 |
|
| 24699 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SKP166 |
0.989466014326502 |
|
| 24700 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
HELB |
0.989466014326502 |
|
| 24701 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
snoU13|ENSG00000238528.1 |
0.989466014326502 |
|
| 24702 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
GRIP1 |
0.989466014326502 |
|
| 24703 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CAND1 |
0.989466014326502 |
|
| 24704 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
DYRK2 |
0.989466014326502 |
|
| 24705 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IFNG |
0.989466014326502 |
|
| 24706 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL26 |
0.989466014326502 |
|
| 24707 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IL22 |
0.989466014326502 |
|
| 24708 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDM1 |
0.989466014326502 |
|
| 24709 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAP1B |
0.989466014326502 |
|
| 24710 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA70G |
0.989466014326502 |
|
| 24711 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NUP107 |
0.989466014326502 |
|
| 24712 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC35E3 |
0.989466014326502 |
|
| 24713 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MDM2 |
0.989466014326502 |
|
| 24714 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPM |
0.989466014326502 |
|
| 24715 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CPSF6 |
0.989466014326502 |
|
| 24716 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LYZ |
0.989466014326502 |
|
| 24717 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
YEATS4 |
0.989466014326502 |
|
| 24718 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RN7SL804P |
0.989466014326502 |
|
| 24719 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FRS2 |
0.989466014326502 |
|
| 24720 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCT2 |
0.989466014326502 |
|
| 24721 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC10 |
0.989466014326502 |
|
| 24722 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BEST3 |
0.989466014326502 |
|
| 24723 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB3IP |
0.989466014326502 |
|
| 24724 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MYRFL |
0.989466014326502 |
|
| 24725 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CNOT2 |
0.989466014326502 |
|
| 24726 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
KCNMB4 |
0.989466014326502 |
|
| 24727 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRB |
0.989466014326502 |
|
| 24728 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PTPRR |
0.989466014326502 |
|
| 24729 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TSPAN8 |
0.989466014326502 |
|
| 24730 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LGR5 |
0.989466014326502 |
|
| 24731 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZFC3H1 |
0.989466014326502 |
|
| 24732 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SNORA17|ENSG00000212461.1 |
0.989466014326502 |
|
| 24733 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
THAP2 |
0.989466014326502 |
|
| 24734 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TMEM19 |
0.989466014326502 |
|
| 24735 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
RAB21 |
0.989466014326502 |
|
| 24736 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MKRN9P |
0.989466014326502 |
|
| 24737 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
AHRR |
0.991413080948181 |
|
| 24738 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
BRD9 |
0.991413080948181 |
|
| 24739 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf55 |
0.991413080948181 |
|
| 24740 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CCDC127 |
0.991413080948181 |
|
| 24741 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CEP72 |
0.991413080948181 |
|
| 24742 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
EXOC3 |
0.991413080948181 |
|
| 24743 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LRRC14B |
0.991413080948181 |
|
| 24744 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4456 |
0.991413080948181 |
|
| 24745 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PDCD6 |
0.991413080948181 |
|
| 24746 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
PLEKHG4B |
0.991413080948181 |
|
| 24747 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHA |
0.991413080948181 |
|
| 24748 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC9A3 |
0.991413080948181 |
|
| 24749 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TPPP |
0.991413080948181 |
|
| 24750 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIP13 |
0.991413080948181 |
|
| 24751 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC11B |
0.991413080948181 |
|
| 24752 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
ZDHHC11 |
0.991413080948181 |
|
| 24753 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NKD2 |
0.991413080948181 |
|
| 24754 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4635 |
0.991413080948181 |
|
| 24755 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC12A7 |
0.991413080948181 |
|
| 24756 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A18 |
0.991413080948181 |
|
| 24757 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A19 |
0.991413080948181 |
|
| 24758 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TERT |
0.991413080948181 |
|
| 24759 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4457 |
0.991413080948181 |
|
| 24760 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
CLPTM1L |
0.991413080948181 |
|
| 24761 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SLC6A3 |
0.991413080948181 |
|
| 24762 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX4 |
0.991413080948181 |
|
| 24763 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
LPCAT1 |
0.991413080948181 |
|
| 24764 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MIR4277 |
0.991413080948181 |
|
| 24765 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
MRPL36 |
0.991413080948181 |
|
| 24766 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
NDUFS6 |
0.991413080948181 |
|
| 24767 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
SDHAP3 |
0.991413080948181 |
|
| 24768 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
C5orf38 |
0.991413080948181 |
|
| 24769 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
IRX2 |
0.991413080948181 |
|
| 24770 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4A47 |
0.995309625077801 |
|
| 24771 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C5 |
0.995309625077801 |
|
| 24772 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM49B |
0.995309625077801 |
|
| 24773 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
TRIM64C |
0.995309625077801 |
|
| 24774 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
FOLH1 |
0.995309625077801 |
|
| 24775 |
Brain Lower Grade Glioma (LGG) |
Bevacizumab |
OR4C13 |
0.995309625077801 |
|
